PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Iso, H; Imano, H; Yamagishi, K; Ohira, T; Cui, R; Noda, H; Sato, S; Kiyama, M; Okada, T; Hitsumoto, S; Tanigawa, T; Kitamura, A				Iso, Hiroyasu; Imano, Hironori; Yamagishi, Kazumasa; Ohira, Tetsuya; Cui, Renzhe; Noda, Hiroyuki; Sato, Shinichi; Kiyama, Masahiko; Okada, Takeo; Hitsumoto, Shinichi; Tanigawa, Takeshi; Kitamura, Akihiko		CIRCS Investigators	Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: The Circulatory Risk in Communities Study (CIRCS)	ATHEROSCLEROSIS			English	Article						Triglycerides; Fasting; Non-fasting; Ischemic heart disease; Ischemic stroke; Follow-up studies	CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; SERUM TRIGLYCERIDES; GENERAL-POPULATION; INSULIN-RESISTANCE; STROKE; APOLIPOPROTEINS; LIPIDS; EVENTS; DENSE	Background: Non-fasting triglycerides were reported to have a greater impact on risk of ischemic cardiovascular events than fasting triglycerides. However, evidence from Asia, where the prevalence of dyslipidemia is generally lower, has been limited. Methods: We used 1975-1986 baseline surveys to investigate cohort data of 10,659 (4264 men and 6395 women) residents aged 40-69 years, initially free from ischemic heart disease and stroke, in four Japanese communities. Serum triglyceride concentrations at baseline were obtained for 2424 fasting (>8 h after meal) and 8235 non-fasting (<8 h after meal) participants. Results: During the 22-year follow-up, 284 (165 men and 119 women) developed ischemic heart disease and 666 (349 men and 317 women) ischemic stroke. After adjustment for age, sex and known cardiovascular risk factors, multivariable hazard ratios (95%CI) of ischemic cardiovascular disease (ischemic heart disease and ischemic stroke) for the highest versus lowest quartiles of triglycerides were 1.71 (1.14-2.59), P for trend = 0.013, for fasting participants and 1.60 (1.25-2.05), P for trend <0.001, for non-fasting participants. The positive associations did not differ between fasting and non-fasting men, while they were strong for non-fasting women. They were stronger for ischemic heart disease than for ischemic stroke. After further adjustment for HDL-cholesterol, these associations were slightly attenuated, but remained statistically significant. Conclusion: Non-fasting as well as fasting triglycerides are predictive of risk of ischemic cardiovascular disease for Japanese men, as are non-fasting triglycerides for women. (C) 2014 Published by Elsevier Ireland Ltd.	[Iso, Hiroyasu; Imano, Hironori; Ohira, Tetsuya; Cui, Renzhe; Noda, Hiroyuki] Osaka Univ, Grad Sch Med, Dept Social Med, Suita, Osaka 5650871, Japan; [Imano, Hironori; Ohira, Tetsuya; Kiyama, Masahiko; Okada, Takeo; Kitamura, Akihiko] Osaka Ctr Canc & Cardiovasc Dis Prevent, Higashinari Ku, Osaka 5370025, Japan; [Yamagishi, Kazumasa] Univ Tsukuba, Fac Med, Dept Publ Hlth Med, Tsukuba, Ibaraki 3058575, Japan; [Sato, Shinichi] Chiba Prefectural Inst Publ Hlth, Nitona Govt Off Bldg, Chuo Ku, Chiba 2608715, Japan; [Hitsumoto, Shinichi] Ehime Univ Hosp, Total Med Support Ctr, Toon 7910295, Japan; [Tanigawa, Takeshi] Ehime Univ, Grad Sch Med, Dept Environm Hlth & Social Med, Toon 7910295, Japan	Iso, H (reprint author), Osaka Univ, Grad Sch Med, Dept Social Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	iso@pbhel.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [04304036, 02454209, 50223053, 06454234, 08457125, 10470103, 12470092, 19590629, 19590663, 15659146]	This study was supported in part by a Grant-in-Aid for Scientific Research A [grant number 04304036], Scientific Research B [grant numbers 02454209, 50223053, 06454234, 08457125, 10470103 and 12470092], Scientific Research C [grant numbers 19590629 and 19590663], and Exploratory Research [grant number 15659146] from the Japan Society for the Promotion of Science.	Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Satoh H, 2006, CIRC J, V70, P227, DOI 10.1253/circj.70.227; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; REAVEN GM, 1993, J CLIN INVEST, V92, P141, DOI 10.1172/JCI116541; Eberly LE, 2003, ARCH INTERN MED, V163, P1077, DOI 10.1001/archinte.163.9.1077; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Iso H, 2001, AM J EPIDEMIOL, V153, P490, DOI 10.1093/aje/153.5.490; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473; Mora S, 2008, CIRCULATION, V118, P993, DOI 10.1161/CIRCULATIONAHA.108.777334; Imano H, 2009, STROKE, V40, P1571, DOI 10.1161/STROKEAHA.108.538629; Jeppesen J, 1998, CIRCULATION, V97, P1029; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Labreuche J, 2009, ATHEROSCLEROSIS, V203, P331, DOI 10.1016/j.atherosclerosis.2008.08.040; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298; AUSTIN M A, 1988, Journal of the American Medical Association, V260, P1917, DOI 10.1001/jama.260.13.1917; Branchi A, 2006, INTERN EMERG MED, V1, P287, DOI 10.1007/BF02934762; Couillard Charles, 1999, Arteriosclerosis Thrombosis and Vascular Biology, V19, P2448; Freedman DS, 1996, ANN EPIDEMIOL, V6, P74, DOI 10.1016/1047-2797(95)00091-7; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Imano H, 2012, PREV MED, V55, P603, DOI 10.1016/j.ypmed.2012.09.013; Iso H, 2007, STROKE, V38, P1744, DOI 10.1161/STROKEAHA.106.469072; Jackson KG, 2010, ATHEROSCLEROSIS, V208, P246, DOI 10.1016/j.atherosclerosis.2009.06.030; Kirkendall WM, 1980, CIRCULATION, V62, p1146A; Klop B, 2011, CLIN CHIM ACTA, V412, P2183, DOI 10.1016/j.cca.2011.08.010; LINDENSTROM E, 1994, BMJ-BRIT MED J, V309, P11; Maruyama K, 2009, J ATHEROSCLER THROMB, V16, P714; Nakajima K, 2009, CLIN CHIM ACTA, V404, P124, DOI 10.1016/j.cca.2009.03.051; Nakamura Masakazu, 2003, J Atheroscler Thromb, V10, P145; Nakamura M, 1982, Rinsho Byori, V30, P325; STENSVOLD I, 1993, BRIT MED J, V307, P1318; WHO Expert Committee on Prevention of Coronary Heart Disease, 1982, WHO TECHNICAL REPORT, V678; TAN K, 1993, LANCET, V342, P781, DOI 10.1016/0140-6736(93)91544-V	36	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	NOV	2014	237	1					361	368		10.1016/j.atherosclerosis.2014.08.028		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT5WT	WOS:000345011300053		
J	Ogita, M; Miyauchi, K; Jiang, M; Kasai, T; Tsuboi, S; Naito, R; Konishi, H; Dohi, T; Yokoyama, T; Okazaki, S; Shimada, K; Bujo, H; Daida, H				Ogita, Manabu; Miyauchi, Katsumi; Jiang, Meizi; Kasai, Takatoshi; Tsuboi, Shuta; Naito, Ryo; Konishi, Hirokazu; Dohi, Tomotaka; Yokoyama, Takayuki; Okazaki, Shinya; Shimada, Kazunori; Bujo, Hideaki; Daida, Hiroyuki			Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury	ATHEROSCLEROSIS			English	Article						Percutaneous coronary intervention; Smooth muscle cell; Vascular injury; Restenosis; Biomarker	RECEPTOR FAMILY-MEMBER; ELUTING STENT; TIME-COURSE; RESTENOSIS; MIGRATION; ANGIOPLASTY; ATHEROSCLEROSIS; EXPRESSION; MODEL	Objective: Restenosis after vascular intervention remains a major clinical problem. Circulating LR11 has been shown a novel marker of intimal smooth muscle cell (SMC) proliferation in human and animal studies. The present study was performed to clarify the clinical significance of circulating LR11 in patients with stable angina pectoris after coronary stenting. Methods and results: We firstly investigated the circulating sLR11 levels for 28 days after arterial injury in mice, and then assessed time-dependent change in circulating sLR11 level after coronary stenting in a clinical study. Mouse sLR11 levels rapidly increased to 4.0-fold of the control value without cuff placement at postoperative day (POD) 14, and the levels gradually declined to 3.1-fold of the control value until POD 28 in mice. The circulating soluble LR11 levels were measured (before and at 14, 60 and 240 days after coronary stenting in a clinical study of 102 consecutive patients with stable angina pectoris who were treated with percutaneous coronary intervention. Circulating sLR11 levels were significantly increased on days 14 and 60 after the procedure and positively associated with the angiographic late loss index. Conclusions: Our study suggested that circulating sLR11 levels may be a potential marker for angiographic late loss in patients after coronary stenting. Further mechanistic studies are expected to know the clinical significance of sLR11 as a novel marker for intimal SMC. (C) 2014 Published by Elsevier Ireland Ltd.	[Ogita, Manabu; Miyauchi, Katsumi; Kasai, Takatoshi; Tsuboi, Shuta; Naito, Ryo; Konishi, Hirokazu; Dohi, Tomotaka; Yokoyama, Takayuki; Okazaki, Shinya; Shimada, Kazunori; Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1130033, Japan; [Jiang, Meizi; Bujo, Hideaki] Univ Sakura, Med Ctr, Dept Clin Lab & Expt Res Med, Kagoshima, Japan	Miyauchi, K (reprint author), Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1130033, Japan.	ktmmy@med.juntendo.ac.jp			Health and Labor Science Research Grants for Translational Research, Japan	Health and Labor Science Research Grants for Translational Research, Japan.	Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Aikawa M, 1997, CIRCULATION, V96, P82; Fukuda D, 2010, CIRCULATION, V122, P2005, DOI 10.1161/CIRCULATIONAHA.110.986968; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Dangas G, 1996, AM HEART J, V132, P428, DOI 10.1016/S0002-8703(96)90442-1; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; NOBUYOSHI M, 1988, J AM COLL CARDIOL, V12, P616; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Jiang M, 2008, J CLIN INVEST, V118, P2733, DOI 10.1172/JCI32381; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; HANKE H, 1990, CIRC RES, V67, P651; Matsuo M, 2009, CLIN CHEM, V55, P1801, DOI 10.1373/clinchem.2009.127027; Nakagawa Y, 2010, AM J CARDIOL, V106, P329, DOI 10.1016/j.amjcard.2010.03.031; Bujo H, 2006, ARTERIOSCL THROM VAS, V26, P1246, DOI 10.1161/01.ATV.0000219692.78477.17; Takahashi M, 2010, ATHEROSCLEROSIS, V210, P581, DOI 10.1016/j.atherosclerosis.2009.12.010; Zhu YJ, 2004, CIRC RES, V94, P752, DOI 10.1161/01.RES.0000120862.79154.0F; Jiang MZ, 2006, BIOCHEM BIOPH RES CO, V348, P1367, DOI 10.1016/j.bbrc.2006.07.204; Kanaki T, 1999, ARTERIOSCL THROM VAS, V19, P2687; Farooq V, 2011, CIRC-CARDIOVASC INTE, V4, P195, DOI 10.1161/CIRCINTERVENTIONS.110.959882; CARTER AJ, 1994, J AM COLL CARDIOL, V24, P1398; Zhu YJ, 2002, CIRCULATION, V105, P1830, DOI 10.1161/01.CIR.0000014413.91312.EF; Daniel JM, 2010, ARTERIOSCL THROM VAS, V30, P1890, DOI 10.1161/ATVBAHA.110.209692; Farb A, 2002, CIRCULATION, V105, P2973; Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007; Indolfi C, 2000, BASIC RES CARDIOL, V95, P179, DOI 10.1007/s003950050180; KUNTZ RE, 1993, J AM COLL CARDIOL, V21, P15; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Takeshi K, 1993, J AM COLL CARDIOL, V21, p1557e63; Wadeh AJ, 2001, EUR HEART J, V22, p669e75	30	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	NOV	2014	237	1					374	378		10.1016/j.atherosclerosis.2014.08.044		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT5WT	WOS:000345011300055		
J	Hida, T; Yamashita, T				Hida, Tokimasa; Yamashita, Toshiharu			Pigmented mammary Paget's disease presenting with dermoscopic features of multiple dots	AUSTRALASIAN JOURNAL OF DERMATOLOGY			English	Editorial Material							ELIMINATION		[Hida, Tokimasa; Yamashita, Toshiharu] Sapporo Med Univ, Dept Dermatol, Sapporo, Hokkaido 0608543, Japan	Hida, T (reprint author), Sapporo Med Univ, Dept Dermatol, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	hidat@sapmed.ac.jp					Hida T, 2012, EUR J DERMATOL, V22, P121, DOI 10.1684/ejd.2011.1580; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Arai Kazumori, 1997, Journal of Dermatology (Tokyo), V24, P539; GOETTE DK, 1987, J DERMATOL SURG ONC, V13, P68; Kinoshita Satoki, 2007, Breast Cancer, V14, P105, DOI 10.2325/jbcs.14.105; Lee EA, 2011, ANN DERMATOL, V23, P73, DOI 10.5021/ad.2011.23.1.73; Ohnishi A, 2008, ACTA DERM-VENEREOL, V88, P164, DOI 10.2340/00015555-0345	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-8380	1440-0960		AUSTRALAS J DERMATOL	Australas. J. Dermatol.	NOV	2014	55	4					260	262		10.1111/ajd.12086		3	Dermatology	Dermatology	AU0UJ	WOS:000345340000036		
J	Yasuda, M; Igarashi, N; Nagai, Y; Tamura, A; Ishikawa, O				Yasuda, Masahito; Igarashi, Naoya; Nagai, Yayoi; Tamura, Atsushi; Ishikawa, Osamu			Primary cutaneous CD4+small/medium T-cell lymphoma with aggressive clinical course	AUSTRALASIAN JOURNAL OF DERMATOLOGY			English	Letter							CLASSIFICATION		[Yasuda, Masahito; Nagai, Yayoi; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gumma 371, Japan; [Igarashi, Naoya] Igarashi Skin Clin, Maebashi, Gumma, Japan; [Tamura, Atsushi] Isesaki City Hosp, Isesaki, Gunma, Japan	Yasuda, M (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gumma 371, Japan.						Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Garcia-Herrera A, 2008, J CLIN ONCOL, V26, P3364, DOI 10.1200/JCO.2008.16.1307; Burg G, 2005, J CUTAN PATHOL, V32, P647, DOI 10.1111/j.0303-6987.2005.00495.x; Swerdlow S, 2008, WHO CLASSIFICATION T	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-8380	1440-0960		AUSTRALAS J DERMATOL	Australas. J. Dermatol.	NOV	2014	55	4					304	306		10.1111/ajd.12208		4	Dermatology	Dermatology	AU0UJ	WOS:000345340000049		
J	Deguchi, Y; Kohno, Y; Ohno, H				Deguchi, Yuki; Kohno, Yuki; Ohno, Hiroyuki			Design of Ionic Liquid-Derived Polyelectrolyte Gels Toward Reversible Water Absorption/Desorption System Driven by Small Temperature Change	AUSTRALIAN JOURNAL OF CHEMISTRY			English	Article							LIVING CATIONIC-POLYMERIZATION; RESPONSIVE DIBLOCK COPOLYMERS; POLY(IONIC LIQUID); POLYMERS; POLY(N-ISOPROPYLACRYLAMIDE); SOLVENTS; GELATION; LCST	Suitably designed polyelectrolytes derived from tributyl-n-alkylphosphonium 3-sulfopropylmethacrylate-type ionic liquid (IL) monomers undergo a lower critical solution temperature (LCST)-type phase transition, and their transition temperature is a function of the alkyl chain length on the phosphonium cations. Based on this finding, we have successfully prepared chemically cross-linked polyelectrolyte gels, poly(IL) gels, to show the LCST-type phase change. The hydrated state of the prepared poly(IL) gels varied widely with temperature. They desorbed water by elevating the temperature only by a few degrees. Their transition temperature was finely controlled by mixing the composition of IL monomers with different alkyl chain lengths.	[Deguchi, Yuki; Kohno, Yuki; Ohno, Hiroyuki] Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan; [Deguchi, Yuki; Kohno, Yuki; Ohno, Hiroyuki] Tokyo Univ Agr & Technol, Funct Ion Liquid Labs, Grad Sch Engn, Koganei, Tokyo 1848588, Japan	Ohno, H (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	ohnoh@cc.tuat.ac.jp	Ohno, Hiroyuki/F-6459-2012	Ohno, Hiroyuki/0000-0001-9716-3495	Japan Society for the Promotion of Science [21225007]	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 21225007).	Huynh CT, 2011, MACROMOLECULES, V44, P6629, DOI 10.1021/ma201261m; Plechkova NV, 2008, CHEM SOC REV, V37, P123, DOI 10.1039/b006677j; Ribot JC, 2012, SOFT MATTER, V8, P1025, DOI 10.1039/c1sm06468a; Ayres L, 2003, MACROMOLECULES, V36, P5967, DOI 10.1021/ma025727h; TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P341, DOI 10.1021/bc00023a006; Blanazs A, 2012, J AM CHEM SOC, V134, P9741, DOI 10.1021/ja3024059; Tang ZL, 2012, POLYMERS-BASEL, V4, P1478, DOI 10.3390/polym4031478; Chu ZL, 2011, CHEM COMMUN, V47, P7191, DOI 10.1039/c1cc11428j; Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n; Ribot JC, 2010, J MATER CHEM, V20, P8279, DOI 10.1039/c0jm02061c; Kohno Y, 2012, CHEM COMMUN, V48, P7119, DOI 10.1039/c2cc31638b; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Men YJ, 2013, ACS MACRO LETT, V2, P456, DOI 10.1021/mz400155r; Kanazawa H, 2004, ANAL BIOANAL CHEM, V378, P46, DOI 10.1007/s00216-003-2336-9; Men YJ, 2012, POLYM CHEM-UK, V3, P871, DOI 10.1039/c2py20011b; Kohno Y, 2012, AUST J CHEM, V65, P91, DOI 10.1071/CH11378; Yuan JY, 2013, PROG POLYM SCI, V38, P1009, DOI 10.1016/j.progpolymsci.2013.04.002; Aoshima S, 2004, MACROMOL SYMP, V215, P151, DOI 10.1002/masy.200451113; DONG L C, 1986, Journal of Controlled Release, V4, P223, DOI 10.1016/0168-3659(86)90006-4; Eeckman F, 2004, INT J PHARM, V273, P109, DOI 10.1016/j.ijpharm.2003.12.013; Freemantle M, 1998, CHEM ENG NEWS, V76, P32, DOI 10.1021/cen-v076n013.p032; Harmon M. E., 2003, POLYMER, V44, P454710, DOI [10.16/S0032-3861(03)00463-4, DOI 10.1016/S0032-3861(03)00463-4]; Heskins M.a.G.J.E., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI DOI 10.1080/10601326808051910; Hoogenboom R, 2008, CHEM COMMUN, P5758, DOI 10.1039/b813140f; Kohno Y, 2011, AUST J CHEM, V64, P1560, DOI 10.1071/CH11278; Kohno Y, 2013, AUST J CHEM, V66, P1393, DOI 10.1071/CH13301; Kohno Y, 2012, PHYS CHEM CHEM PHYS, V14, P5063, DOI 10.1039/c2cp24026b; Kohno Y., 2012, CHEM COMMUN, V48, P11882; Nishio T, 2009, J CHROMATOGR A, V1216, P7427, DOI 10.1016/j.chroma.2009.04.047; Ohno H, 1998, CHEM LETT, P751, DOI 10.1246/cl.1998.751; Sugihara S, 2004, MACROMOLECULES, V37, P336, DOI 10.1021/ma035037t; WILKES JS, 1992, J CHEM SOC CHEM COMM, P965, DOI 10.1039/c39920000965	32	4	4	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	0004-9425	1445-0038		AUST J CHEM	Aust. J. Chem.	NOV	2014	67	11					1666	1670		10.1071/CH14038		5	Chemistry, Multidisciplinary	Chemistry	AT4QC	WOS:000344924300018		
J	Nagakubo, T; Demizu, Y; Kanda, Y; Misawa, T; Shoda, T; Okuhira, K; Sekino, Y; Naito, M; Kurihara, M				Nagakubo, Takaya; Demizu, Yosuke; Kanda, Yasunari; Misawa, Takashi; Shoda, Takuji; Okuhira, Keiichiro; Sekino, Yuko; Naito, Mikihiko; Kurihara, Masaaki			Development of Cell-Penetrating R7 Fragment-Conjugated Helical Peptides as Inhibitors of Estrogen Receptor-Mediated Transcription	BIOCONJUGATE CHEMISTRY			English	Article							BREAST-CANCER CELLS; COACTIVATOR INTERACTIONS; CYCLE PROGRESSION; TAMOXIFEN; THERAPY; ALPHA; MODULATORS; REGULATORS; INDUCER; BINDING	The heptaarginine (R7)-conjugated peptide 5 was designed and synthesized as an inhibitor of ER-coactivator interactions and ER-mediated transcription at the cellular level. The R7-conjugated peptide 5 was able to enter ER-positive T47D cells efficiently, and treatment with 3 mu M of 5 downregulated the mRNA expression of pS2 (an ER-mediated gene) by 87%.	[Nagakubo, Takaya; Demizu, Yosuke; Kanda, Yasunari; Misawa, Takashi; Shoda, Takuji; Okuhira, Keiichiro; Sekino, Yuko; Naito, Mikihiko; Kurihara, Masaaki] Natl Inst Hlth Sci, Tokyo 1588501, Japan; [Nagakubo, Takaya; Kurihara, Masaaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	Demizu, Y (reprint author), Natl Inst Hlth Sci, Tokyo 1588501, Japan.	demizu@nihs.go.jp; masaaki@nihs.go.jp			JSPS KAKENHI [26460169, 26670041, 25893038]; Tokyo Biochemical Research Foundation	This study was supported, in part, by JSPS KAKENHI Grant Numbers 26460169 (Y.D.), 26670041 (Y.K.), and 25893038 (T.M.) and by a Grant-in-Aid from the Tokyo Biochemical Research Foundation (Y.D.).	Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Bernstein L, 1999, J NATL CANCER I, V91, P1654, DOI 10.1093/jnci/91.19.1654; Phan T, 2010, CHEM COMMUN, V46, P8207, DOI 10.1039/c0cc02727h; Heery DM, 1997, NATURE, V387, P733; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Tints K, 2014, INT J MOL SCI, V15, P5680, DOI 10.3390/ijms15045680; Shoda T, 2014, BIOORG MED CHEM LETT, V24, P87, DOI 10.1016/j.bmcl.2013.11.078; Leduc AM, 2003, P NATL ACAD SCI USA, V100, P11273, DOI 10.1073/pnas.1934759100; Yamashita H, 2014, BIOORGAN MED CHEM, V22, P2403, DOI 10.1016/j.bmc.2014.03.005; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Demizu Y, 2012, BIOORG MED CHEM LETT, V22, P1793, DOI 10.1016/j.bmcl.2011.11.086; Baumann CK, 2007, DRUGS, V67, P2335; Carraz M, 2009, CHEM BIOL, V16, P702, DOI 10.1016/j.chembiol.2009.06.009; Demizu Y, 2013, BIOORG MED CHEM LETT, V23, P4292, DOI 10.1016/j.bmcl.2013.06.002; ABE O, 1992, LANCET, V339, P71; Foster JS, 2001, MOL CELL BIOL, V21, P794, DOI 10.1128/MCB.21.3.794-810.2001; Galande AK, 2005, CHEMBIOCHEM, V6, P1991, DOI 10.1002/cbic.200500083; Hall JM, 2000, MOL ENDOCRINOL, V14, P2010, DOI 10.1210/me.14.12.2010; Howell SJ, 2004, BEST PRACT RES CL EN, V18, P47, DOI 10.1016/j.beem.2003.08.002; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Phillips C., 2011, J AM CHEM SOC, V46, P8207	26	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	NOV	2014	25	11					1921	1924		10.1021/bc500480e		4	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	AU0JK	WOS:000345309000003		
J	Uehara, T; Rokugawa, T; Kinoshita, M; Nemoto, S; Lazaro, GGF; Hanaoka, H; Arano, Y				Uehara, Tomoya; Rokugawa, Takemi; Kinoshita, Mai; Nemoto, Souki; Lazaro, Guerra Gomez Fransisco; Hanaoka, Hirofumi; Arano, Yasushi			Ga-67/68-Labeling Agent That Liberates Ga-67/68-NOTA-Methionine by Lysosomal Proteolysis of Parental Low Molecular Weight Polypeptides to Reduce Renal Radioactivity Levels	BIOCONJUGATE CHEMISTRY			English	Article							ANTIBODIES; METABOLISM; FRAGMENTS; PEPTIDES; CANCER; FV; RADIOPHARMACEUTICALS; BIODISTRIBUTION; LOCALIZATION; XENOGRAFTS	The renal localization of gallium-67 or gallium-68 (Ga-67/68)-labeled low molecular weight (LMW) probes such as peptides and antibody fragments constitutes a problem in targeted imaging. Wu et al. previously showed that Ga-67-labeled S-2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (SCN-Bz-NOTA)-conjugated methionine (Ga-67-NOTA-Met) was rapidly excreted from the kidney in urine following lysosomal proteolysis of the parental Ga-67-NOTA-Bz-SCN-disulfide-stabilized Fv fragment (Bioconjugate Chem., (1997) 8, 365-369). In the present study, a new Ga-67/88-labeling reagent for LMW probes that liberates Ga-67/68-NOTA-Met was designed, synthesized, and evaluated using longer-lived Ga-67 in order to reduce renal radioactivity levels. We employed a methionine-isoleucine (MI) dipeptide bond as the cleavable linkage. The amine residue of MI was coupled with SCN-Bz-NOTA for Ga-67-labeling, while the carboxylic acid residue of MI was derivatized to maleimide for antibody conjugation in order to synthesize NOTA-MI-Mal. A Fab fragment of the anti-Her2 antibody was thiolated with iminothiolane, and NOTA-MI-Mal was conjugated with the antibody fragment by maleimide-thiol chemistry. The Fab fragment was also conjugated with SCN-Bz-NOTA (NOTA-Fab) for comparison. Ga-67-NOTA-MI-Fab was obtained at radiochemical yields of over 95% and was stable in murine serum for 24 h. In the biodistribution study using normal mice, Ga-67-NOTA-MI-Fab registered significantly lower renal radioactivity levels from 1 to 6 h postinjection than those of Ga-67-NOTA-Fab. An analysis of urine samples obtained 6 h after the injection of Ga-67-NOTA-MI-Fab showed that the majority of radioactivity was excreted as Ga-67-NOTA-Met. In the biodistribution study using tumor-bearing mice, the tumor to kidney ratios of Ga-67-NOTA-MI-Fab were 4 times higher (6 h postinjection) than those of Ga-67-NOTA-Fab. Although further studies including the structure of radiometabolites and/or cleavable linkages are required, the results of the present study indicate that the current chemical design is applicable to the development of Ga-67-labeled Fabs for low renal radioactivity levels.	[Uehara, Tomoya; Rokugawa, Takemi; Kinoshita, Mai; Nemoto, Souki; Lazaro, Guerra Gomez Fransisco; Hanaoka, Hirofumi; Arano, Yasushi] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2638675, Japan	Uehara, T (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2638675, Japan.	tuehara@chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported in part by a Grant-in-Aid for Young Scientists (A) and Special Funds for Education and Research (Development of SPECT Probes for Pharmaceutical Innovation) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We would also like to thank FUJIFILM RI Pharma Co. Ltd. for providing <SUP>67</SUP>GaCl<INF>3</INF>.	Akizawa H, 2008, ADV DRUG DELIVER REV, V60, P1319, DOI 10.1016/j.addr.2008.04.005; YOKOTA T, 1992, CANCER RES, V52, P3402; Wu CC, 1997, BIOCONJUGATE CHEM, V8, P365, DOI 10.1021/bc970032k; Krausz Y, 2011, MOL IMAGING BIOL, V13, P583, DOI 10.1007/s11307-010-0374-1; Akizawa H, 2001, NUCL MED BIOL, V28, P459, DOI 10.1016/S0969-8051(01)00207-4; KELLER O, 1975, HELV CHIM ACTA, V58, P531, DOI 10.1002/hlca.19750580224; Akizawa H, 1998, BIOCONJUGATE CHEM, V9, P662, DOI 10.1021/bc9702258; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Belimezi MM, 2006, CANCER IMMUNOL IMMUN, V55, P1091, DOI 10.1007/s00262-005-0100-z; Gomez FLG, 2012, BIOCONJUGATE CHEM, V23, P2229, DOI 10.1021/bc300340g; WEBBER KO, 1995, MOL IMMUNOL, V32, P249, DOI 10.1016/0161-5890(94)00150-Y; Tang Y, 2005, NUCL MED BIOL, V32, P51, DOI 10.1016/j.nucmedbio.204.08.003; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Arano Y, 1996, BIOCONJUGATE CHEM, V7, P628, DOI 10.1021/bc960058w; ARANO Y, 1994, J NUCL MED, V35, P326; ARANO Y, 1991, BIOCONJUGATE CHEM, V2, P71, DOI 10.1021/bc00008a001; BEHR TM, 1995, J NUCL MED, V36, P430; CHOI CW, 1995, CANCER RES, V55, P5323; Fani Melpomeni, 2008, Contrast Media Mol Imaging, V3, P67, DOI 10.1002/cmmi.232; GRASSETT.DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Green M A, 1989, Int J Rad Appl Instrum B, V16, P435, DOI 10.1016/0883-2897(89)90053-6; IMAI S, 1986, EXP ANIM TOKYO, V35, P263; Jae M. J., 2008, J NUCL MED, V49, P830; Tsai SW, 2001, BIOCONJUGATE CHEM, V12, P264, DOI 10.1021/bc0000987; Weiner RE, 1996, NUCL MED BIOL, V23, P745, DOI 10.1016/0969-8051(96)00119-9	25	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	NOV	2014	25	11					2038	2045		10.1021/bc5004058		8	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	AU0JK	WOS:000345309000015		
J	Nishio, S; Kohno, Y; Iwata, Y; Arai, M; Okumura, H; Oshima, K; Nadano, D; Matsuda, T				Nishio, Shunsuke; Kohno, Yoshinori; Iwata, Yuki; Arai, Mayumi; Okumura, Hiroki; Oshima, Kenzi; Nadano, Daita; Matsuda, Tsukasa			Glycosylated Chicken ZP2 Accumulates in the Egg Coat of Immature Oocytes and Remains Localized to the Germinal Disc Region of Mature Eggs	BIOLOGY OF REPRODUCTION			English	Article						amphibians; fertilization; fish; fowl; non-mammals; oocyte maturation; reptiles; vitelline membrane; vertebrates; zona pellucida	ZONA-PELLUCIDA PROTEIN; QUAIL COTURNIX-JAPONICA; HENS OVUM; PERIVITELLINE LAYER; IN-VITRO; SPERM; SPERMATOZOA; ENVELOPE; IDENTIFICATION; GLYCOPROTEIN	Vertebrate eggs are surrounded by an egg coat, which is a specific extracellular egg matrix consisting of several glycoproteins with a conserved zona pellucida (ZP) domain. Two mammalian egg coat subunits, ZP2 and ZP3, have been suggested to act as sperm receptors. In bird eggs, however, ZP2 has never been identified in the egg coat of mature oocytes and ovulated eggs. Here we report that chicken ZP2 is expressed in immature small follicles and remains as an egg-coat component locally in the germinal disc region of mature eggs. RT-PCR analysis indicated marked expression of the ZP2 and ZP4 genes in the granulosa cells of immature white follicles, whereas the ZP3 and ZPD genes showed marked expression in the cells of maturing yellow follicles. ZP2 was identified in the egg coat isolated from immature follicles as a heavily N-glycosylated glycoprotein of similar to 200 kDa, which was enzymatically converted to a 70-kDa deglycosylated form. Immunoblotting and immunohistological analyses showed that ZP2 was localized around the germinal disc region of mature follicles. ZP2 was accumulated in the egg coat of immature white follicles at the earlier stages of oocyte development and became a minor component in the egg coat of maturing yellow follicles, except for the germinal disc region. Localization of ZP2 in the germinal disc region of mature eggs, where sperm bind to the egg coat at high density, suggests some role for ZP2 in the preferential binding and penetration of sperm in the germinal disc region of bird eggs.	[Nishio, Shunsuke; Kohno, Yoshinori; Iwata, Yuki; Arai, Mayumi; Oshima, Kenzi; Nadano, Daita; Matsuda, Tsukasa] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Okumura, Hiroki] Meijo Univ, Fac Agr, Dept Appl Biol Chem, Tenpa Ku, Nagoya, Aichi, Japan	Matsuda, T (reprint author), Nagoya Univ, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	tmatsuda@agr.nagoya-u.ac.jp			KAKENHI from Japan Society for the Promotion of Science [22112510, 17380200]	This research was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) from The Japan Society for the Promotion of Science (grants 22112510 and 17380200 to T.M.). cDNA sequences ZP2 and ZP4 were registered originally in the DNA Data Bank of Japan as ZPA (AB197938) and ZPB (AB025428), respectively, and later revised to ZP2 (NM_001039098.1 [23]) and ZP4 (NM_204879.1), respectively.	Takeuchi Y, 2001, BIOL REPROD, V64, P822, DOI 10.1095/biolreprod64.3.822; Lefievre L, 2004, HUM REPROD, V19, P1580, DOI 10.1093/humrep/deh301; Waclawek M, 1998, BIOL REPROD, V59, P1230, DOI 10.1095/biolreprod59.5.1230; BLEIL JD, 1988, DEV BIOL, V128, P376, DOI 10.1016/0012-1606(88)90299-0; Inoue N, 2011, P NATL ACAD SCI USA, V108, P20008, DOI 10.1073/pnas.1116965108; Baibakov B, 2012, J CELL BIOL, V197, P897, DOI 10.1083/jcb.201203062; Rodler D, 2012, CELLS TISSUES ORGANS, V195, P330, DOI 10.1159/000327013; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Cosson J, 2008, REPRODUCTION, V136, P277, DOI 10.1530/REP-07-0522; PERRY MM, 1978, J ANAT, V127, P379; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; BAKST MR, 1977, BIOL REPROD, V17, P370, DOI 10.1095/biolreprod17.3.370; BRAMWELL RK, 1992, BIOL REPROD, V47, P1113, DOI 10.1095/biolreprod47.6.1113; Takeuchi Y, 1999, EUR J BIOCHEM, V260, P736, DOI 10.1046/j.1432-1327.1999.00203.x; Okumura H, 2007, BIOL REPROD, V76, P9, DOI 10.1095/biolreprod.106.056267; Burkart AD, 2012, J CELL BIOL, V197, P37, DOI 10.1083/jcb.201112094; BRAMWELL RK, 1995, POULTRY SCI, V74, P1875; BAKST MR, 1977, BIOL REPROD, V17, P361, DOI 10.1095/biolreprod17.3.361; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Okumura H, 2004, BIOCHEM J, V384, P191, DOI 10.1042/BJ20040299; Bausek N, 2000, J BIOL CHEM, V275, P28866, DOI 10.1074/jbc.275.37.28866; BLEIL JD, 1980, DEV BIOL, V76, P185, DOI 10.1016/0012-1606(80)90371-1; GREVE JM, 1985, J MOL BIOL, V181, P253, DOI 10.1016/0022-2836(85)90089-0; HOWARTH B, 1973, J REPROD FERTIL, V33, P123; Kinoshita M, 2010, REPRODUCTION, V139, P359, DOI 10.1530/REP-09-0222; Serizawa M, 2011, ANIM SCI J, V82, P227, DOI 10.1111/j.1740-0929.2010.00830.x; Smith J, 2005, MOL REPROD DEV, V70, P133, DOI 10.1002/mrd.20197; Yanagimachi R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105072	29	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	NOV 1	2014	91	5							107	10.1095/biolreprod.114.119826		10	Reproductive Biology	Reproductive Biology	AT4UC	WOS:000344937300009		
J	Tokuda, T; Takahashi, M; Uejima, K; Masuda, K; Kawamura, T; Ohta, Y; Motoyama, M; Noda, T; Sasagawa, K; Okitsu, T; Takeuchi, S; Ohta, J				Tokuda, Takashi; Takahashi, Masayuki; Uejima, Kazuhiro; Masuda, Keita; Kawamura, Toshikazu; Ohta, Yasumi; Motoyama, Mayumi; Noda, Toshihiko; Sasagawa, Kiyotaka; Okitsu, Teru; Takeuchi, Shoji; Ohta, Jun			CMOS image sensor-based implantable glucose sensor using glucose-responsive fluorescent hydrogel	BIOMEDICAL OPTICS EXPRESS			English	Article							SYSTEM; CHIP	A CMOS image sensor-based implantable glucose sensor based on an optical-sensing scheme is proposed and experimentally verified. A glucose-responsive fluorescent hydrogel is used as the mediator in the measurement scheme. The wired implantable glucose sensor was realized by integrating a CMOS image sensor, hydrogel, UV light emitting diodes, and an optical filter on a flexible polyimide substrate. Feasibility of the glucose sensor was verified by both in vitro and in vivo experiments. (C) 2014 Optical Society of America	[Tokuda, Takashi; Uejima, Kazuhiro; Masuda, Keita; Kawamura, Toshikazu; Ohta, Yasumi; Motoyama, Mayumi; Noda, Toshihiko; Sasagawa, Kiyotaka; Ohta, Jun] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan; [Takahashi, Masayuki] TERUMO Co, R&D Headquarters, Nakai, Kanagawa 2590151, Japan; [Okitsu, Teru; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Tokuda, T (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, 8916-5Takayama Cho, Ikoma, Nara 6300192, Japan.	tokuda@ms.naist.jp			Japan Society for the Promotion of Science (JSPS) [23360157]; VLSI Design and Education Centre (VDEC), The University of Tokyo; Cadence Design Systems, Inc.	This study was partly supported by Grant-in-Aid for Scientific Research (B) # 23360157 from Japan Society for the Promotion of Science (JSPS) and by the VLSI Design and Education Centre (VDEC), The University of Tokyo, in collaboration with Cadence Design Systems, Inc.	Ahmadi MM, 2009, IEEE T BIOMED CIRC S, V3, P169, DOI 10.1109/TBCAS.2009.2016844; Tamada JA, 2002, IEEE SPECTRUM, V39, P52, DOI 10.1109/6.993789; Heo YJ, 2011, P NATL ACAD SCI USA, V108, P13399, DOI 10.1073/pnas.1104954108; Newman JD, 2005, BIOSENS BIOELECTRON, V20, P2435, DOI 10.1016/j.bios.2004.11.012; Kobayashi T, 2012, BIOSENS BIOELECTRON, V38, P321, DOI 10.1016/j.bios.2012.06.035; SHULTS MC, 1994, IEEE T BIO-MED ENG, V41, P937, DOI 10.1109/10.324525; Rossetti P, 2010, SENSORS-BASEL, V10, P10936, DOI 10.3390/s101210936; Liao YT, 2012, IEEE J SOLID-ST CIRC, V47, P335, DOI 10.1109/JSSC.2011.2170633; Fossum ER, 1997, IEEE T ELECTRON DEV, V44, P1689, DOI 10.1109/16.628824; Shibata H, 2010, P NATL ACAD SCI USA, V107, P17894, DOI 10.1073/pnas.1006911107; Chu MX, 2011, TALANTA, V83, P960, DOI 10.1016/j.talanta.2010.10.055; Haruta M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EL05; Kawanishi T, 2004, J FLUORESC, V14, P499, DOI 10.1023/B:JOFL.0000039338.16715.48; Kobayashi T, 2014, BIOSENS BIOELECTRON, V53, P31, DOI 10.1016/j.bios.2013.09.033; Tokuda T, 2007, SENSOR ACTUAT A-PHYS, V135, P315, DOI 10.1016/j.sna.2006.08.027	15	2	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	NOV 1	2014	5	11					3859	3870		10.1364/BOE.5.003859		12	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	AT4UR	WOS:000344939400009		
J	Yoshida, K; Nishidate, I				Yoshida, Kenichiro; Nishidate, Izumi			Rapid calculation of diffuse reflectance from a multilayered model by combination of the white Monte Carlo and adding-doubling methods	BIOMEDICAL OPTICS EXPRESS			English	Article							OPTICAL-PROPERTIES; TURBID MEDIA; LIGHT-PROPAGATION; ABSORPTION; SIMULATION; TISSUES	To rapidly derive a result for diffuse reflectance from a multilayered model that is equivalent to that of a Monte-Carlo simulation (MCS), we propose a combination of a layered white MCS and the adding-doubling method. For slabs with various scattering coefficients assuming a certain anisotropy factor and without absorption, we calculate the transition matrices for light flow with respect to the incident and exit angles. From this series of precalculated transition matrices, we can calculate the transition matrices for the multilayered model with the specific anisotropy factor. The relative errors of the results of this method compared to a conventional MCS were less than 1%. We successfully used this method to estimate the chromophore concentration from the reflectance spectrum of a numerical model of skin and in vivo human skin tissue. (C) 2014 Optical Society of America	[Yoshida, Kenichiro; Nishidate, Izumi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan	Yoshida, K (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	inishi@cc.tuat.ac.jp					Nichols MG, 1997, APPL OPTICS, V36, P93, DOI 10.1364/AO.36.000093; Tseng SH, 2009, OPT EXPRESS, V17, P14599, DOI 10.1364/OE.17.014599; Sassaroli A, 1998, APPL OPTICS, V37, P7392, DOI 10.1364/AO.37.007392; JACQUES SL, 1991, PHOTOCHEM PHOTOBIOL, V53, P769; Kienle A, 1996, PHYS MED BIOL, V41, P2221, DOI 10.1088/0031-9155/41/10/026; Pifferi A, 1998, APPL OPTICS, V37, P2774, DOI 10.1364/AO.37.002774; Alerstam E, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950319; Thorn CE, 2011, AM J PHYSIOL-HEART C, V301, pH442, DOI 10.1152/ajpheart.01316.2010; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Martinelli M, 2011, OPT EXPRESS, V19, P19627, DOI 10.1364/OE.19.019627; Jacques S, 1998, SKIN OPTICS SUMMARY; Jacques S.L., 1996, ADV OPTICAL IMAGING, V2, P364; Nishidate I, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3613929; Nishidate I, 2004, J BIOMED OPT, V9, P700, DOI 10.1117/1.1756918; Nishidate I, 2003, OPT REV, V10, P427, DOI 10.1007/s10043-003-0427-7; Prahl S. A., 1999, OPTICAL ABSORPTION H; Prahl S.A., 1995, OPTICAL THERMAL RESP; VANGEMERT MJC, 1989, IEEE T BIO-MED ENG, V36, P1146, DOI 10.1109/10.42108; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wilson RH, 2009, PROC SPIE, V7175, DOI 10.1117/12.808423; Yamamoto S, 2012, OPT REV, V19, P361, DOI 10.1007/s10043-012-0058-y; Yoshida K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016009; Yudovsky D, 2011, APPL OPTICS, V50, P4237, DOI 10.1364/AO.50.004237	23	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	NOV 1	2014	5	11					3901	3920		10.1364/BOE.5.003901		20	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	AT4UR	WOS:000344939400012		
J	Inazu, M				Inazu, Masato			Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy	BIOPHARMACEUTICS & DRUG DISPOSITION			English	Review						choline; transporter; choline transporter-like protein; choline kinase; cancer; apoptosis	MAGNETIC-RESONANCE-SPECTROSCOPY; MAMMARY EPITHELIAL-CELLS; ORGANIC CATION TRANSPORTERS; H-1 MR SPECTROSCOPY; PROSTATE-CANCER; BREAST-CANCER; LUNG-CANCER; FUNCTIONAL-CHARACTERIZATION; PHOSPHOLIPID-METABOLISM; NONNEURONAL ACETYLCHOLINE	Choline is essential for the synthesis of the major membrane phospholipid phosphatidylcholine (PC), the methyl donor betaine and the neurotransmitter acetylcholine (ACh). Elevated levels of choline and up-regulated choline kinase activity have been detected in various cancers. Thus, the intracellular accumulation of choline through choline transporters is the rate-limiting step in phospholipid metabolism and a prerequisite for cancer cell proliferation. Previous studies have demonstrated abnormalities in choline uptake and choline phospholipid metabolism in cancer cells using the imaging of cancer with positron emission tomography (PET) and magnetic resonance spectroscopy (MRS). The aberrant choline metabolism in cancer cells is strongly correlated with their malignant progression. Using quantitative real-time PCR, the mRNA expression of choline transporters was measured, and it was found that choline transporter-like proteins CTLs/SLC44 family are highly expressed in various cancer cell lines. Choline uptake through CTLs is associated with cell viability, and the functional inhibition of CTLs could promote apoptotic cell death. Furthermore, non-neuronal cholinergic systems that include CTLs-mediated choline transport are associated with cell proliferation and their inhibition promotes apoptotic cell death in colon cancer, small cell lung cancer and human leukemic T-cells. The identification of this new CTLs-mediated choline transport system provides a potential new target for cancer therapy. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Inazu, Masato] Tokyo Med Univ, Inst Med Sci, Dept Mol Prevent Med, Shinjuku Ku, Tokyo 1608402, Japan	Inazu, M (reprint author), Tokyo Med Univ, Inst Med Sci, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	inazu@tokyo-med.ac.jp					Inazu M, 2013, PHARMACOL RES, V76, P119, DOI 10.1016/j.phrs.2013.07.011; Moller-Hartmann W, 2002, NEURORADIOLOGY, V44, P371, DOI 10.1007/s00234-001-0760-0; Meisamy S, 2005, RADIOLOGY, V236, P465, DOI 10.1148/radiol.2362040836; Jagannathan NR, 2001, BRIT J CANCER, V84, P1016, DOI 10.1054/bjoc.2001.1711; Gillies RJ, 2005, ANNU REV BIOMED ENG, V7, P287, DOI 10.1146/annurev.bioeng.7.060804.100411; Eliyahu G, 2007, INT J CANCER, V120, P1721, DOI 10.1002/ijc.22293; Song PF, 2013, J NEUROCHEM, V126, P451, DOI 10.1111/jnc.12298; Katz-Brull R, 2002, J NATL CANCER I, V94, P1197; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Treglia G, 2012, ANN NUCL MED, V26, P451, DOI 10.1007/s12149-012-0602-7; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/003-091; Ruvolo PP, 2001, LEUKEMIA, V15, P1153, DOI 10.1038/sj.leu.2402197; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Hara T, 2000, J NUCL MED, V41, P1507; Nakamura T, 2010, BIOL PHARM BULL, V33, P691; Fujii T, 2003, LIFE SCI, V72, P2131, DOI 10.1016/S0024-3205(03)00073-0; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Nair TS, 2004, J NEUROSCI, V24, P1772, DOI 10.1523/JNEUROSCI.5063-03.2004; Balassiano K, 2011, CANCER LETT, V311, P85, DOI 10.1016/j.canlet.2011.06.038; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Yuan ZF, 2006, PHYSIOL GENOMICS, V26, P76, DOI 10.1152/physiolgenomics.00107.2005; Song P, 2007, CANCER RES, V67, P3936, DOI 10.1158/0008-5472.CAN-06-2484; Song PF, 2003, CANCER RES, V63, P214; Kawashima K, 2012, ANN NY ACAD SCI, V1261, P7, DOI 10.1111/j.1749-6632.2012.06516.x; Kwee SA, 2006, J NUCL MED, V47, P262; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Keshari KR, 2011, NMR BIOMED, V24, P691, DOI 10.1002/nbm.1738; RUIZCABELLO J, 1992, NMR BIOMED, V5, P226, DOI 10.1002/nbm.1940050506; Fisher MC, 2001, TERATOLOGY, V64, P114, DOI 10.1002/tera.1053; Apparsundaram S, 2000, BIOCHEM BIOPH RES CO, V276, P862, DOI 10.1006/bbrc.2000.3561; Muller SA, 2009, EUR J NUCL MED MOL I, V36, P1434, DOI 10.1007/s00259-009-1117-x; Hara T, 1997, J NUCL MED, V38, P842; Kawashima K, 2000, PHARMACOL THERAPEUT, V86, P29, DOI 10.1016/S0163-7258(99)00071-6; McMaster CR, 1997, BBA-LIPID LIPID MET, V1348, P100, DOI 10.1016/S0005-2760(97)00097-0; Traiffort E, 2013, MOL ASPECTS MED, V34, P646, DOI 10.1016/j.mam.2012.10.011; Inazu M, 2005, J NEUROCHEM, V94, P1427, DOI 10.1111/j.1471-4159.2005.03299.x; Kommareddi PK, 2010, PROTEIN J, V29, P417, DOI 10.1007/s10930-010-9268-y; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Katz-Brull R, 2002, CANCER RES, V62, P1966; Zhang SX, 2010, ANTICANCER RES, V30, P97; Wisnivesky JP, 2012, CANCER-AM CANCER SOC, V118, P4478, DOI 10.1002/cncr.26585; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Fuccio C, 2011, EUR J RADIOL, V80, pE50, DOI 10.1016/j.ejrad.2010.07.023; Aboagye EO, 1999, CANCER RES, V59, P80; Hara T, 1998, J NUCL MED, V39, P990; Michel V, 2006, EXP BIOL MED, V231, P490; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Cheng KR, 2008, AM J PHYSIOL-GASTR L, V295, pG591, DOI 10.1152/ajpgi.00055.2008; ZEISEL SH, 1991, FASEB J, V5, P2093; O'Regan S, 2000, P NATL ACAD SCI USA, V97, P1835, DOI 10.1073/pnas.030339697; Kekuda R, 1998, J BIOL CHEM, V273, P15971, DOI 10.1074/jbc.273.26.15971; Reske SN, 2006, J NUCL MED, V47, P1249; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Machova E, 2009, J NEUROCHEM, V110, P1297, DOI 10.1111/j.1471-4159.2009.06218.x; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; Traiffort E, 2005, J NEUROCHEM, V92, P1116, DOI 10.1111/j.1471-4159.2004.02962.x; Yuan ZF, 2004, GENE, V341, P305, DOI 10.1016/j.gene.2004.07.042; Burckhardt G, 2000, AM J PHYSIOL-RENAL, V278, pF853; Glunde K, 2011, NMR BIOMED, V24, P673, DOI 10.1002/nbm.1751; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Greinacher A, 2010, NAT MED, V16, P45, DOI 10.1038/nm.2070; Ting YLT, 1996, ANTICANCER RES, V16, P1381; Ferguson SM, 2004, P NATL ACAD SCI USA, V101, P8762, DOI 10.1073/pnas.0401667101; Albright CD, 1996, FASEB J, V10, P510; Grundemann D, 1998, NAT NEUROSCI, V1, P349, DOI 10.1038/1557; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Mertens K, 2010, EUR J NUCL MED MOL I, V37, P2188, DOI 10.1007/s00259-010-1496-z; ROSS B, 1994, MAGN RESON QUART, V10, P191; Baek HM, 2009, RADIOLOGY, V251, P653, DOI 10.1148/radiol.2512080553; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Koepsell H, 2007, PHARM RES, V24, P1227, DOI 10.1007/s11095-9254-z; Beyer LA, 2011, HEARING RES, V282, P63, DOI 10.1016/j.heares.2011.09.004; Bezabeh T, 1996, ANTICANCER RES, V16, P1553; Bolan PJ, 2002, MAGNET RESON MED, V48, P215, DOI 10.1002/mrm.10224; Cais H, 1993, MOL CELL BIOL, V13, P7645; Glunde K, 2006, PHARMACOGENOMICS, V7, P1109, DOI 10.2217/14622416.7.7.1109; Glunde K, 2006, EXPERT REV MOL DIAGN, V6, P821, DOI 10.1586/14737159.6.6.821; Grundemann D, 1999, MOL PHARMACOL, V56, P1; Haberberger RV, 2002, J INVEST DERMATOL, V119, P943, DOI 10.1046/j.1523-1747.2002.00182.x; Hara T, 2003, J NEUROSURG, V99, P474, DOI 10.3171/jns.2003.99.3.0474; Hara T, 2006, MOL IMAGING, V5, P498, DOI 10.2310/7290.2006.00032; Inazus M, 2010, J PHARM SCI S, V112; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Katz-Brull R, 1996, ANTICANCER RES, V16, P1375; Kobori Oichiro, 1999, Cancer, V86, P1638, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1638::AID-CNCR4>3.0.CO;2-U; Kouji H, 2009, ARCH BIOCHEM BIOPHYS, V483, P90, DOI 10.1016/j.abb.2008.12.008; Kurhanewicz J, 1996, RADIOLOGY, V200, P489; Sandi AK, 2007, SEMIN NUCL MED, V37, P420, DOI 10.1053/j.semnuclmed.2007.07.003; Lius D, 2002, BRIT J CANCER, V87, P783; Nelson SJ, 2001, MAGNET RESON MED, V46, P228, DOI 10.1002/mrm.1183; Okuda M, 1996, BIOCHEM BIOPH RES CO, V224, P500, DOI 10.1006/bbrc.1996.1056; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; O'Regan S, 2003, NEUROCHEM RES, V28, P551, DOI 10.1023/A:1022877524469; Pfeil U, 2003, AM J RESP CELL MOL, V28, P473, DOI 10.1165/rcmb.2002-0190OC; Rinnab L, 2007, BJU INT, V99, P1421, DOI 10.1111/j.1464-410X.2007.06776.x; Rodriguez-Gonzalez A, 2004, ONCOGENE, V23, P8247, DOI 10.1038/sj.onc.1208045; Russo P, 2006, CURR MED CHEM, V13, P3493, DOI 10.2174/092986706779026192; Sanchez-Lopez E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.453; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Stanwell P, 2005, EUR RADIOL, V15, P1037, DOI 10.1007/s00330-004-2475-1; Sweet DH, 2001, J BIOL CHEM, V276, P41611, DOI 10.1074/jbc.M108472200; Takalkar A., 2008, INDIAN J RADIOL IMAG, V18, P17; Uchida Y, 2009, J PHARMACOL SCI, V109, P102, DOI 10.1254/jphs.08291FP; van Asten JJA, 2008, MAGN RESON MATER PHY, V21, P435, DOI 10.1007/s10334-008-0156-9; Vance JE, 2005, J BIOL CHEM, V280, P10877, DOI 10.1074/jbc.R400038200; Wang T, 2007, ACTA BIOCH BIOPH SIN, V39, P668, DOI 10.1111/j.1745-7270.2007.00323.x; Wus G, 2010, BIOCH CELL BIOL, V88, P559; Wus X, 1998, J BIOL CHEM, V273, P32776; Yabuki M, 2009, ARCH BIOCHEM BIOPHYS, V485, P88, DOI 10.1016/j.abb.2009.02.007; Yamada T, 2011, NEUROCHEM INT, V58, P354, DOI 10.1016/j.neuint.2010.12.011; Yens CL, 1999, FASEB J, V13, P135; Yens CL, 2001, FASEB J, V15, P1704; Yoshimoto M, 2004, NUCL MED BIOL, V31, P859, DOI 10.1016/j.nucmedbio.2004.05.002; Zeisel S H, 1997, Adv Pediatr, V44, P263	117	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2782	1099-081X		BIOPHARM DRUG DISPOS	Biopharm. Drug Dispos.	NOV	2014	35	8			SI		431	449		10.1002/bdd.1892		19	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT9BZ	WOS:000345224200001		
J	Nakanishi, T; Tamai, I				Nakanishi, Takeo; Tamai, Ikumi			Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers	BIOPHARMACEUTICS & DRUG DISPOSITION			English	Review						SLC transporter; OATP; hormone-refractory cancer; chemotherapy; breast cancer; prostate cancer	INDEPENDENT PROSTATE-CANCER; HUMAN BREAST-CARCINOMA; HEPATIC-UPTAKE; HUMAN LIVER; STEROID SULFATASE; MESSENGER-RNA; PANCREATIC-CANCER; SLCO1B3 GENE; IN-VITRO; FUNCTIONAL-CHARACTERIZATION	Transporter proteins classified into the solute carrier (SLC) transporter superfamily are essential for the import of nutrients required for cell survival in organisms. Various SLC transporters are differentially upregulated in cancer cells, and among them, polyspecific organic anion-transporting polypeptides (OATPs) have been proposed to have pathophysiological significance in cancer. This review will briefly introduce OATPs and summarize their proposed roles in cancer, focusing particularly on hormone-dependent breast and prostate cancers. Over the past two decades, compelling evidence has also accumulated that SLC transporters, including OATPs, interact with clinically important anticancer agents and influence their pharmacokinetics, particularly the processes of absorption, elimination and distribution. Therefore, a better understanding of not only the pathophysiological roles, but also the pharmacological effects of OATPs in cancer cells should be helpful in combating human malignant tumors. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Nakanishi, Takeo; Tamai, Ikumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa 9201192, Japan	Tamai, I (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tamai@p.kanazawa-u.ac.jp	Nakanishi, Takeo/C-3891-2015; TAMAI, Ikumi/D-8412-2015	Nakanishi, Takeo/0000-0002-6561-7138; 	Japan Society for the Promotion of Sceience [23590176]	This work has been supported by the Grant-in-Aid for Scientific Research No. 23590176 from Japan Society for the Promotion of Sceience. We thank Dr. Arakawa at Takasaki University of Health and Welfare, Takasaki, Japan for his kind adivices and technical helps.	Abes T, 1999, J BIOL CHEM, V274, P17159, DOI [10.1074/jbc.274.24.17159, DOI 10.1074/JBC.274.24.17159]; ABES T, 2001, GASTROENTEROLOGY, V120, P1689; Adachi H, 2003, AM J PHYSIOL-RENAL, V285, pF1188, DOI 10.1152/ajprenal.00402.2002; ALS SW, 2006, ANTICANCER RES, V26, P4985; Leonhardt M, 2010, DRUG METAB DISPOS, V38, P1024, DOI 10.1124/dmd.110.032862; Mandery K, 2010, BIOCHEM PHARMACOL, V80, P1746, DOI 10.1016/j.bcp.2010.08.008; Nakakariya M, 2008, DRUG METAB PHARMACOK, V23, P347, DOI 10.2133/dmpk.23.347; Grube M, 2006, CLIN PHARMACOL THER, V80, P607, DOI 10.1016/j.clpt.2006.09.010; Tsuboyama T, 2010, RADIOLOGY, V255, P824, DOI 10.1148/radiol.10091557; Vavricka SR, 2002, HEPATOLOGY, V36, P164, DOI 10.1053/jhep.2002.34133; Longcope C, 1995, ANN NY ACAD SCI, V774, P143, DOI 10.1111/j.1749-6632.1995.tb17378.x; Wang X, 2003, MOL PHARMACOL, V63, P65, DOI 10.1124/mol.63.1.65; Banerjee N, 2012, J PHARMACOL EXP THER, V342, P510, DOI 10.1124/jpet.112.192344; Pizzagalli F, 2002, MOL ENDOCRINOL, V16, P2283, DOI 10.1210/me.2001-0309; Nozawa T, 2005, DRUG METAB DISPOS, V33, P434, DOI 10.1124/dmd.104.001909; Takane H, 2009, CANCER CHEMOTH PHARM, V63, P1165, DOI 10.1007/s00280-008-0864-x; Wright JL, 2011, CANCER EPIDEM BIOMAR, V20, P619, DOI 10.1158/1055-9965.EPI-10-1023; Utsumi T, 2000, J STEROID BIOCHEM, V73, P141, DOI 10.1016/S0960-0760(00)00060-1; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; Bronger H, 2005, CANCER RES, V65, P11419, DOI 10.1158/0008-5472.CAN-05-1271; Kostakoglu L, 2003, RADIOGRAPHICS, V23, P315, DOI 10.1148/rg.232025705; Mitsuoka K, 2008, J NUCL MED, V49, P615, DOI 10.2967/jnumed.107.048231; Huber RD, 2007, AM J PHYSIOL-CELL PH, V292, pC795, DOI 10.1152/ajpcell.00597.2005; Hartkoorn RC, 2010, PHARMACOGENET GENOM, V20, P112, DOI 10.1097/FPC.0b013e328335b02d; Glaeser H, 2007, CLIN PHARMACOL THER, V81, P362, DOI 10.1038/sj.clpt.6100056; Yamaguchi H, 2008, CANCER LETT, V260, P163, DOI 10.1016/j.canlet.2007.10.040; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Nomura T, 2004, MOL PHARMACOL, V65, P973, DOI 10.1124/mol.65.4.973; Hamada A, 2008, CLIN CANCER RES, V14, P3312, DOI 10.1158/1078-0432.CCR-07-4118; Konig J, 2011, HANDB EXP PHARMACOL, V201, P1, DOI 10.1007/978-3-642-14541-4_1; Katz DA, 2006, CLIN PHARMACOL THER, V79, P186, DOI 10.1016/j.clpt.2005.11.003; Reed MJ, 2005, ENDOCR REV, V26, P171, DOI 10.1210/er.2004-0003; Yamada A, 2007, DRUG METAB DISPOS, V35, P2166, DOI 10.1124/dmd.107.017459; Nozawa T, 2004, J PHARMACOL EXP THER, V308, P438, DOI 10.1124/jpet.103.060194; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Vasuri F, 2011, VIRCHOWS ARCH, V459, P141, DOI 10.1007/s00428-011-1099-5; Ballestero MR, 2006, BIOCHEM PHARMACOL, V72, P729, DOI 10.1016/j.bcp.2006.06.007; Muto M, 2007, CANCER SCI, V98, P1570, DOI 10.1111/j.1349-7006.2007.00570.x; Letschert K, 2004, PHARMACOGENETICS, V14, P441, DOI 10.1097/01.fpc.0000114744.08559.92; Labrie F, 2011, NAT REV UROL, V8, P73, DOI 10.1038/nrurol.2010.231; Shirasaka Y, 2013, J ENDOCRINOL, V217, P265, DOI 10.1530/JOE-12-0339; Maeda T, 2010, J STEROID BIOCHEM, V122, P180, DOI 10.1016/j.jsbmb.2010.06.014; Nakanishi T, 1997, CANCER RES, V57, P4118; Arakawa H, 2012, BIOCHEM PHARMACOL, V84, P1070, DOI 10.1016/j.bcp.2012.07.026; McConathy J, 2008, CANCER METAST REV, V27, P555, DOI 10.1007/s10555-008-9154-7; Smith NF, 2005, CANCER BIOL THER, V4, P815; Okabe M, 2008, MOL CANCER THER, V7, P3081, DOI 10.1158/1535-7163.MCT-08-0539; Nakanishi T, 2012, DRUG METAB PHARMACOK, V27, P106, DOI 10.2133/dmpk.DMPK-11-RV-099; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Schiffer R, 2003, J INVEST DERMATOL, V120, P285, DOI 10.1046/j.1523-1747.2003.12031.x; Fujiwara K, 2001, ENDOCRINOLOGY, V142, P2005, DOI 10.1210/en.142.5.2005; Maeda K, 2006, CLIN PHARMACOL THER, V79, P427, DOI 10.1016/j.clpt.2006.01.011; Konig J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200; Nozawa T, 2004, J PHARMACOL EXP THER, V311, P1032, DOI 10.1124/jpet.104.071522; Narita M, 2009, J GASTROENTEROL, V44, P793, DOI 10.1007/s00535-009-0056-4; Nozawa T, 2005, PHARM RES, V22, P1634, DOI 10.1007/s11095-005-7096-0; Shirasaka Y, 2010, J PHARMACOL EXP THER, V332, P181, DOI 10.1124/jpet.109.159756; Groer C, 2013, J PHARMACEUT BIOMED, V85, P253, DOI 10.1016/j.jpba.2013.07.031; Gonzalez DE, 1998, CANCER RES, V58, P519; Kounnis V, 2011, ONCOTARGETS THER, V4, P27, DOI 10.2147/OTT.S16706; Tamai I, 2012, ADV DRUG DELIVER REV, V64, P508, DOI 10.1016/j.addr.2011.07.007; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; Thakkar N, 2013, MOL PHARMACEUT, V10, P406, DOI 10.1021/mp3005353; Yang M, 2011, J CLIN ONCOL, V29, P2565, DOI 10.1200/JCO.2010.31.2405; Miyoshi Y, 2003, CLIN CANCER RES, V9, P2288; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Vavricka SR, 2004, J HEPATOL, V40, P212, DOI 10.1016/j.jhep.2003.10.008; Okudaira H, 2011, J NUCL MED, V52, P822, DOI 10.2967/jnumed.110.086074; Hays A, 2013, PHARM RES-DORDR, V30, P2260, DOI 10.1007/s11095-012-0962-7; Wlcek K, 2011, CANCER BIOL THER, V11, P801, DOI 10.4161/cbt.11.9.15176; Miki Y, 2006, CANCER RES, V66, P535, DOI 10.1158/0008-5472.CAN-05-1070; Holla VR, 2008, CANCER PREV RES, V1, P93, DOI 10.1158/1940-6207.CAPR-07-0009; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Svoboda M, 2011, BIOMED PHARMACOTHER, V65, P417, DOI 10.1016/j.biopha.2011.04.031; Matsushima S, 2008, DRUG METAB DISPOS, V36, P663, DOI 10.1124/dmd.107.017814; Nagai M, 2012, BIOCHEM BIOPH RES CO, V418, P818, DOI 10.1016/j.bbrc.2012.01.115; Sato K, 2003, PLACENTA, V24, P144, DOI 10.1053/plac.2002.0907; Simonson SG, 2004, CLIN PHARMACOL THER, V76, P167, DOI 10.1016/j.clpt.2004.03.010; Pizzagalli F, 2003, J CLIN ENDOCR METAB, V88, P3902, DOI 10.1210/jc.2003-030174; Hirano M, 2004, J PHARMACOL EXP THER, V311, P139, DOI 10.1124/jpet.104.068056; Ismair MG, 2001, GASTROENTEROLOGY, V121, P1185, DOI 10.1053/gast.2001.28704; van de Steeg E, 2009, DRUG METAB DISPOS, V37, P277, DOI 10.1124/dmd.108.024315; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; Nakanishi T, 2000, INT J CANCER, V88, P274, DOI 10.1002/1097-0215(20001015)88:2<274::AID-IJC20>3.0.CO;2-5; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Baker SD, 2008, CLIN PHARMACOL THER, V85, P155; Banerjee N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064069; BAOS Y, 2002, AM J PHYSIOL-RENAL, V282, pF1103, DOI DOI 10.1152/AJPRENAL.00152.2001; Brawer Michael K, 2006, Rev Urol, V8 Suppl 2, pS35; CMIKKAICHIS T, 2004, P NATL ACAD SCI USA, V101, P3569, DOI DOI 10.1073/PNAS.0304987101.; CUIS Y, 2001, J BIOL CHEM, V276, P9626, DOI DOI 10.1074/JBC.M004968200; CUIS Y, 2003, LAB INVEST, V83, P527; FANS X, 2010, BIOCHEM PHARMACOL, V80, P811, DOI DOI 10.1016/J.BCP.2010.05.021; GAOS B, 2005, EXP EYE RES, V80, P61, DOI DOI 10.1016/J.EXER.2004.08.013; GAOS B, 2000, J PHARMACOL EXP THER, V294, P73; HANS S, 2013, BIOCHEM PHARMACOL, V86, P816, DOI DOI 10.1016/J.BCP.2013.07.020; HOS RH, 2006, GASTROENTEROLOGY, V130, P1793; IEDAUERS R, 2009, ONCOL REP, V22, P1485; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; Justenhoven C, 2011, BREAST CANCER RES TR, V125, P563, DOI 10.1007/s10549-010-1046-1; Kindla J, 2011, CANCER BIOL THER, V11, P584, DOI 10.4161/cbt.11.6.14533; Kleberg K, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-78; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156; Kullak-Ublick GA, 1998, FEBS LETT, V424, P173, DOI 10.1016/S0014-5793(98)00168-9; LeCluyse E, 2000, J BIOCHEM MOL TOXIC, V14, P177, DOI 10.1002/(SICI)1099-0461(2000)14:4<177::AID-JBT1>3.0.CO;2-4; LEES SY, 2004, CANC IMMUN, V4, P13; LEES W, 2008, CANCER RES, V68, P10315, DOI DOI 10.1158/0008-5472.CAN-08-1984.; Lockhart Albert Craig, 2008, Clin Exp Gastroenterol, V1, P1; LUS R, 1996, J CLIN INVEST, V98, P1142, DOI DOI 10.1172/JCI118897; Miki Y, 2002, J CLIN ENDOCR METAB, V87, P5760, DOI 10.1210/jc.2002-020670; Nakagomi-Hagihara R, 2006, DRUG METAB DISPOS, V34, P862, DOI 10.1124/dmd.105.008888; Nakanishi T, 2011, J PHARM SCI-US, V100, P3731, DOI 10.1002/jps.22576; Oba-Shinjo Sueli M, 2008, Cancer Immun, V8, P7; Olszewski-Hamilton U, 2011, Biomark Cancer, V3, P31, DOI 10.4137/BIC.S7151; Pressler H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020372; Puranen T, 1997, MOL ENDOCRINOL, V11, P77, DOI 10.1210/me.11.1.77; RUDER HJ, 1972, J CLIN INVEST, V51, P1020, DOI 10.1172/JCI106862; Schwabedissen HEMZ, 2008, CANCER RES, V68, P9338, DOI 10.1158/0008-5472.CAN-08-0265; Sebastian K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083257; Sreedharan S, 2011, GENE, V478, P11, DOI 10.1016/j.gene.2010.10.011; Stute P, 2012, MATURITAS, V71, P376, DOI 10.1016/j.maturitas.2011.12.020; Suzuki T, 2003, MOL ENDOCRINOL, V17, P1203, DOI 10.1210/me.2002-0304; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Wlcek Katrin, 2008, Cancer Biol Ther, V7, P1450, DOI 10.4161/cbt.7.9.6282; Yoshimura N, 2004, BREAST CANCER RES, V6, pR46, DOI 10.1186/bcr746	129	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2782	1099-081X		BIOPHARM DRUG DISPOS	Biopharm. Drug Dispos.	NOV	2014	35	8			SI		463	484		10.1002/bdd.1915		22	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT9BZ	WOS:000345224200003		
J	Yamada, M; Hara, S; Yamada, T; Katagiri, F; Hozumi, K; Nomizu, M				Yamada, Masanori; Hara, Sachiko; Yamada, Tetsuya; Katagiri, Fumihiko; Hozumi, Kentaro; Nomizu, Motoyoshi			Double-Stranded DNA Stereoselectively Promotes Aggregation of Amyloid-Like Fibrils and Generates Peptide/DNA Matrices	BIOPOLYMERS			English	Article						cell adhesion; DNA; laminin; peptide; scaffold	LAMININ ALPHA-1 CHAIN; CELL-BINDING SEQUENCES; IKVAV SEQUENCE; A-CHAIN; SYNTHETIC PEPTIDES; CHARGE-TRANSPORT; CONGO RED; IN-VITRO; IDENTIFICATION; EXPRESSION	An amyloidogenic LAM-L peptide (AASIKVAVSADR, all-L configuration) derived from laminin promoted cell adhesion, neurite outgrowth, and angiogenesis. Here, we prepared novel matrices using double-stranded DNA and the LAM-L peptide. Double-stranded DNA promoted aggregation of amyloid-like fibrils and generated a LAM-L/DNA matrix through electrostatic interactions between the phosphate groups of DNA and the amino groups of LAM-L. This formation of peptide/DNA matrix depends on the Ile-Lys-Val-Ala-Val (IKVAV) sequence in the peptide, since LAM-RM peptide (AASVVIAKSADR), which is scrambled peptide of LAM-L, did not form a matrix with DNA. Further, LAM-D (all-D configuration of LAM-L), which forms amyloid-like fibrils and promotes similar biological activities as LAM-L, did not form amyloid-like fibrils with DNA, suggesting that DNA selectively interacts with the L-configured peptide. Moreover, the LAM-L/DNA matrices showed stronger cell attachment activity compared with LAM-L alone, suggesting the LAM-L/DNA matrices have potential for use as a novel biomaterial in tissue engineering. (c) 2014 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 102: 465-472, 2014.	[Yamada, Masanori; Hara, Sachiko] Okayama Univ Sci, Dept Chem, Fac Sci, Kita Ku, Okayama 7000005, Japan; [Yamada, Tetsuya] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Katagiri, Fumihiko; Hozumi, Kentaro; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Yamada, M (reprint author), Okayama Univ Sci, Dept Chem, Fac Sci, Kita Ku, Okayama 7000005, Japan.	myamada@chem.ous.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25410195]; MEXT	Contract grant sponsor: the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Contract grant number: 25410195; Contract grant sponsor: The matching fund subsidy for private universities from MEXT	Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Liu XD, 2007, ADV POLYM SCI, V209, P149, DOI 10.1007/12_2006_106; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; GLENNER GG, 1972, J HISTOCHEM CYTOCHEM, V20, P821; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Yuan C, 2007, FEBS LETT, V581, P241, DOI 10.1016/j.febslet.2006.12.019; Liu XD, 2008, CHEM SOC REV, V37, P2745, DOI 10.1039/b801433g; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; TASHIRO K, 1989, J BIOL CHEM, V264, P16174; Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r; NOMIZU M, 1995, J BIOL CHEM, V270, P20583; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Genereux JC, 2010, CHEM REV, V110, P1642, DOI 10.1021/cr900228f; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Platt GW, 2009, FEBS LETT, V583, P2623, DOI 10.1016/j.febslet.2009.05.005; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Howie AJ, 2009, MICRON, V40, P285, DOI 10.1016/j.micron.2008.10.002; Bondy SC, 1999, NEUROSCI LETT, V267, P25, DOI 10.1016/S0304-3940(99)00307-9; COLOGNATO H, 2000, DEV DYNAM, V18, P13; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; GUILLAMEGENTIL O, 2009, ADV MATER, V22, P5443; Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107; KANEMOTO T, 1990, P NATL ACAD SCI USA, V87, P2279, DOI 10.1073/pnas.87.6.2279; Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t; Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565; KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; KLEINMAN HK, 1991, ARCH BIOCHEM BIOPHYS, V290, P320, DOI 10.1016/0003-9861(91)90547-V; Lendel C, 2010, BIOCHEMISTRY-US, V49, P1358, DOI 10.1021/bi902005t; Libby RT, 2000, J NEUROSCI, V20, P6517; Liu XD, 2009, ANAL BIOCHEM, V393, P67, DOI 10.1016/j.ab.2009.06.020; Luckey M, 2000, FEBS LETT, V468, P23, DOI 10.1016/S0014-5793(00)01184-4; Merino EJ, 2008, CURR OPIN CHEM BIOL, V12, P229, DOI 10.1016/j.cbpa.2008.01.046; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198; Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828; NOMIZU M, 1992, J BIOL CHEM, V267, P14118; NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O; OHGA Y, 2009, BIOMATERIALS, V35, P6731; SAENGER W, 1987, PRINCIPLES NUCL ACID; Simmel FC, 2005, SMALL, V1, P284, DOI 10.1002/smll.200400111; Yamada M, 2008, POLYMER, V49, P4658, DOI 10.1016/j.polymer.2008.08.027; Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L; Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8; Yamada M., 2009, ANAL CHIM ACTA, V674, P249; Yamada M, 2008, BIOMACROMOLECULES, V9, P3341, DOI 10.1021/bm800984p; Zhang LJ, 2007, SEP PURIF TECHNOL, V55, P388, DOI 10.1016/j.seppur.2006.12.016; Zou ZW, 2009, MAT SCI ENG C-MATER, V29, P2099, DOI 10.1016/j.msec.2009.04.009	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3525	1097-0282		BIOPOLYMERS	Biopolymers	NOV	2014	102	6					465	472		10.1002/bip.22571		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AU1EX	WOS:000345364900006		
J	Uehara, K; Yasunaga, H; Morizaki, Y; Horiguchi, H; Fushimi, K; Tanaka, S				Uehara, K.; Yasunaga, H.; Morizaki, Y.; Horiguchi, H.; Fushimi, K.; Tanaka, S.			Necrotising soft-tissue infections of the upper limb RISK FACTORS FOR AMPUTATION AND DEATH	BONE & JOINT JOURNAL			English	Article							PROCEDURE COMBINATION DATABASE; SPINAL-FUSION; MORTALITY; COMPLICATIONS; SURGERY; FASCIITIS; DETERMINANTS; OUTCOMES	Necrotising soft-tissue infections (NSTIs) of the upper limb are uncommon, but potentially life-threatening. We used a national database to investigate the risk factors for amputation of the limb and death. We extracted data from the Japanese Diagnosis Procedure Combination database on 116 patients (79 men and 37 women) who had a NSTI of the upper extremity between 2007 and 2010. The overall in-hospital mortality was 15.5%. Univariate analysis of in-hospital mortality showed that the significant variables were age (p = 0.015), liver dysfunction (p = 0.005), renal dysfunction (P < 0.001), altered consciousness (p = 0.049), and sepsis (p = 0.021). Logistic regression analysis showed that the factors associated with death in hospital were age over 70 years (Odds Ratio (OR) 6.6; 95% confidence interval (CI) 1.5 to 28.2; p = 0.011) and renal dysfunction (OR 15.4; 95% CI 3.8 to 62.8; p < 0.001). Univariate analysis of limb amputation showed that the significant variables were diabetes (p = 0.017) mellitus and sepsis (p = 0.001). Multivariable logistic regression analysis showed that the factors related to limb amputation were sepsis (OR 1.8; 95% CI 1.5 to 24.0; p = 0.013) and diabetes mellitus (OR 1.6; 95% CI 1.1 to 21.1; p = 0.038). For NSTIs of the upper extremity, advanced age and renal dysfunction are both associated with a higher rate of in-hospital mortality. Sepsis and diabetes mellitus are both associated with a higher rate of amputation.	[Uehara, K.; Yasunaga, H.; Morizaki, Y.; Horiguchi, H.; Fushimi, K.; Tanaka, S.] Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Tokyo, Japan	Morizaki, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	MORIZAKIY-ORT@h.u-tokyo.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H25-Policy-010]; Council for Science and Technology Policy, Japan [0301002001001]	This study was funded by a Grant-in-Aid for Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan (Grant number: H25-Policy-010), and by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from the Council for Science and Technology Policy, Japan (Grant number: 0301002001001).	Anaya DA, 2005, ARCH SURG-CHICAGO, V140, P151, DOI 10.1001/archsurg.140.2.151; Elliott DC, 1996, ANN SURG, V224, P672, DOI 10.1097/00000658-199611000-00011; Ogilvie CM, 2006, CLIN ORTHOP RELAT R, P179, DOI 10.1097/01.blo.0000218734.46376.89; Kuwabara K, 2010, J TRAUMA, V68, P463, DOI 10.1097/TA.0b013e3181a60275; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Angoules AG, 2007, INJURY, V38, pS19, DOI 10.1016/j.injury.2007.10.030; MCHENRY CR, 1995, ANN SURG, V221, P558, DOI 10.1097/00000658-199505000-00013; Kadono Y, 2010, J ORTHOP SCI, V15, P162, DOI 10.1007/s00776-009-1448-2; Boakye M, 2008, NEUROSURGERY, V62, P455, DOI [10.1227/01.neu.0000316013.97926.4c, 10.1227/01.NEU.0000297053.35400.E7]; Shen Y, 2009, J NEUROSURG ANESTH, V21, P21, DOI 10.1097/ANA.0b013e31818b47e9; Patil CG, 2007, CANCER, V110, P625, DOI 10.1002/cncr.22819; Golger A, 2007, PLAST RECONSTR SURG, V119, P1803, DOI 10.1097/01.prs.0000259040.71478.27; Wong CH, 2003, J BONE JOINT SURG AM, V85A, P1454; Liu Yuag-Meng, 2005, Journal of Microbiology Immunology and Infection, V38, P430; Majeski J, 1997, SOUTHERN MED J, V90, P1065, DOI 10.1097/00007611-199711000-00001; Sunderland IR, 2009, J HAND SURG-AM, V34A, P1900, DOI 10.1016/j.jhsa.2009.08.018; Yasunaga H, 2010, UROLOGY, V76, P548, DOI 10.1016/j.urology.2010.03.021	17	2	2	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	2049-4394			BONE JOINT J	Bone Joint J.	NOV	2014	96B	11					1530	1534		10.1302/0301-620X.96B11.34888		5	Orthopedics; Surgery	Orthopedics; Surgery	AT6CN	WOS:000345026600019		
J	Saito, T; Inoue, Y; Sato, K; Tsuruoka, Y; Shigefuku, R; Ikeda, H; Okuse, C; Takahashi, M; Miura, I				Saito, T.; Inoue, Y.; Sato, K.; Tsuruoka, Y.; Shigefuku, R.; Ikeda, H.; Okuse, C.; Takahashi, M.; Miura, I.			Improvement of high serum levels of biomarkers of endothelial injury after allogeneic hematopoietic SCT with pre-existing severe hepatitis using recombinant human soluble thrombomodulin	BONE MARROW TRANSPLANTATION			English	Letter							BONE-MARROW-TRANSPLANTATION; VENOOCCLUSIVE DISEASE		[Saito, T.; Inoue, Y.; Sato, K.; Tsuruoka, Y.; Takahashi, M.; Miura, I.] St Marianna Univ, Dept Internal Med, Div Hematol & Oncol, Kawasaki, Kanagawa, Japan; [Shigefuku, R.; Ikeda, H.; Okuse, C.] St Marianna Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan	Saito, T (reprint author), St Marianna Univ, Dept Internal Med, Div Hematol & Oncol, Kawasaki, Kanagawa, Japan.	ino-yasu@marianna-u.ac.jp					BEARMAN SI, 1995, BLOOD, V85, P3005; MCDONALD GB, 1984, HEPATOLOGY, V4, P116, DOI 10.1002/hep.1840040121; Carreras E, 2011, BONE MARROW TRANSPL, V46, P1495, DOI 10.1038/bmt.2011.65; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cutler C, 2010, BIOL BLOOD MARROW TR, V16, P1180, DOI 10.1016/j.bbmt.2010.02.016; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Nomura S, 2011, THROMB HAEMOSTASIS, V105, P1118, DOI 10.1160/TH10-12-0802; Ikezoe T, 2010, BONE MARROW TRANSPL, V45, P783, DOI 10.1038/bmt.2009.217; Richard S, 1996, BONE MARROW TRANSPL, V18, P955	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	NOV	2014	49	11					1444	1445		10.1038/bmt.2014.156		2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	AT4RC	WOS:000344927400019		
J	Watanabe, J; Sato, K; Fujikura, Y; Horiuchi, T; Kato, S; Hikota, R; Maekawa, T; Yamamura, T; Kobayashi, A; Kobayashi, S; Kawana, A; Kimura, F				Watanabe, J.; Sato, K.; Fujikura, Y.; Horiuchi, T.; Kato, S.; Hikota, R.; Maekawa, T.; Yamamura, T.; Kobayashi, A.; Kobayashi, S.; Kawana, A.; Kimura, F.			Tracheobronchomalacia after allogeneic BMT; pulmonary function test findings similar to those of bronchiolitis obliterans	BONE MARROW TRANSPLANTATION			English	Letter							AIRWAY COLLAPSE; CT		[Watanabe, J.; Sato, K.; Horiuchi, T.; Kato, S.; Hikota, R.; Maekawa, T.; Yamamura, T.; Kobayashi, A.; Kobayashi, S.; Kimura, F.] Natl Def Med Coll, Dept Internal Med, Div Haematol, Tokorozawa, Saitama 359, Japan; [Fujikura, Y.; Kawana, A.] Natl Def Med Coll, Dept Internal Med, Div Infect Dis & Pulm Med, Tokorozawa, Saitama 359, Japan	Watanabe, J (reprint author), Natl Def Med Coll, Dept Internal Med, Div Haematol, Tokorozawa, Saitama 359, Japan.	dri3001@ndmc.ac.jp					Baroni RH, 2005, RADIOLOGY, V235, P635, DOI 10.1148/radiol.2352040309; Carden KA, 2005, CHEST, V127, P984, DOI 10.1378/chest.127.3.984; Ernst A, 2009, CHEST, V135, P1024, DOI 10.1378/chest.08-1180; Sharma S, 2005, CHEST, V128, P1385, DOI 10.1378/chest.128.3.1385; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Murgu SD, 2006, RESPIROLOGY, V11, P388, DOI 10.1111/j.1400-1843.2006.00862.x; Gilkeson RC, 2001, AM J ROENTGENOL, V176, P205; Eugene MC, 2013, IMMUNOL ALLERGY CLIN, V33, P23; Loring SH, 2007, CHEST, V131, P1118, DOI 10.1378/chest.06-2556; Septimiu M, 2013, CLIN CHEST MED, V34, P527	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	NOV	2014	49	11					1450	1451		10.1038/bmt.2014.175		2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	AT4RC	WOS:000344927400022		
J	Brocklehurst, P; O'Malley, L; Hill, H; Ozaki, T; Nomura, M; Matsuda, R				Brocklehurst, P.; O'Malley, L.; Hill, H.; Ozaki, T.; Nomura, M.; Matsuda, R.			The development and piloting of a leadership questionnaire for general dental practitioners: preliminary results from the North West of England and Tokyo	BRITISH DENTAL JOURNAL			English	Article								Objectives Key reforms in England and Japan have called for greater clinical leadership from general dental practitioners to deliver improvements in the quality of care for patients. In England, the reorganisation of the National Health Service has led to the development of Local Professional Networks to ensure services are clinically led, patient and outcome focused. In Japan, the rapidly changing demographics have led to calls for general dental practitioners to become more active in meeting the emerging population health challenges. Both require engagement at a strategic and a local level. However, little is known about what is meant by clinical leadership in dentistry or what training needs exist. The aim of this study was to develop and pilot a questionnaire to understand what general dental practitioners feel is important about clinical leadership and how they rate themselves. Methods A 61-item questionnaire was developed from the literature, an earlier qualitative study and refined through cognitive interviews. Questionnaires were distributed to general dental practitioners across the North West of England and Tokyo, using random sequence generation. For each item, the participant had to record whether they thought the statement was an important component of clinical leadership and how they rated themselves. Both were rated using a seven-point Likert scale. Data reduction was undertaken using principal component analysis to examine for factor loadings within the questionnaire. Differences in mean scores were also used to highlight substantive differences in how general dental practitioners rated the different components of leadership and how they rated themselves. Results The response rate for the pilot was low (22.9% and 7.5% for North West and Tokyo respectively). The items that were considered to be important in leadership reduced to two components in the North West (accounting for 62.1% of the total variance): 'How to lead' and 'How not to lead'. In Tokyo, 56.4% of the total variance was explained by three components: 'Demonstrating personal qualities', 'Working with others' and 'How not to lead'. When the self-rated items were reduced, three factors were found to be important in the North West: 'Working with others', 'Setting direction' and 'Managing services' (55.1% of the variance). 'Working with others', 'Demonstrating personal qualities', 'Pragmatism', 'Setting direction' and 'Improving services' were found to be important in Tokyo (52.8% of the variance). The questionnaire items relating to integrity, team-working and having a positive attitude during difficult times were rated highly by both groups. Items relating to providing vision for team, being assertive and having a positive attitude had the greatest mean difference, suggesting possible areas of training need. Conclusion The nature of the pilot study and the poor response rate makes any conclusion difficult to infer. Among those that participated, leadership was understood to be more important at a practice level rather than at a strategic level. The questionnaire should be refined further based on the results of the pilot and the data reduction.	[Brocklehurst, P.; O'Malley, L.; Hill, H.] Univ Manchester, Dept Dent Publ Hlth, Manchester M13 9PL, Lancs, England; [Ozaki, T.] Nihon Univ, Sch Dent, Tokyo 102, Japan; [Matsuda, R.] Ritsumeikan Univ, Coll Social Sci, Kyoto, Japan	Brocklehurst, P (reprint author), Univ Manchester, Dept Dent Publ Hlth, Manchester M13 9PL, Lancs, England.	paul.brocklehurst@manchester.ac.uk					Brocklehurst P R, 2013, BR DENT J, V215, P1; Brocklehurst P R, 2013, COCHRANE DB SYST REV, V11; Brocklehurst P, 2013, COMMUNITY DENT HLTH, V30, P241, DOI 10.1922/CDH_3246Brocklehurst08; Bureau of Social Welfare and Public Health Tokyo Metropolitan Government, 2008, PRACT GUID HOM DENT; Cameron S, 2012, J ADV NURS, V68, P1469, DOI 10.1111/j.1365-2648.2011.05869.x; Carter S, 2007, HDB HLTH RES METHODS, P215; CHEN C, 1995, PSYCHOL SCI, V6, P170, DOI 10.1111/j.1467-9280.1995.tb00327.x; Cook M J, 2004, J NURS MANAG, V12, P436; Department of Health, 2008, HIGH QUALITY CARE AL; Faddy W. H., 1993, CONSTRUCTING QUESTIO; Hofstede G. H., 1980, CULTURES CONSEQUENCE; Mills I, 2011, BRIT DENT J, V211, DOI 10.1038/sj.bdj.2011.521; Ministry of Health Labour and Welfare, OUTL REV REIMB MED F; NHS Commissioning Board, 2013, SEC EXC COMM NHS DEN; NHS Institute for Innovation and Improvement, NHS LEAD QUAL FRAM; Rattray J, 2007, J CLIN NURS, V16, P234, DOI 10.1111/j.1365-2702.2006.01573.x; The King's Fund, 2009, FUT LEAD MAN NHS NO; The Kings Fund, 2012, LEAD ENG IMPR NHS; Willis GB, 1994, COGNITIVE INTERVIEWI	19	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0007-0610	1476-5373		BRIT DENT J	Br. Dent. J.	NOV	2014	217	9							E17	10.1038/sj.bdj.2014.980		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT5LW	WOS:000344985500019		
J	Brocklehurst, P; O'Malley, L; Hill, H; Ozaki, T; Nomura, M; Matsuda, R				Brocklehurst, P.; O'Malley, L.; Hill, H.; Ozaki, T.; Nomura, M.; Matsuda, R.			Summary of: The development and piloting of a leadership questionnaire for general dental practitioners: preliminary results from the North West of England and Tokyo	BRITISH DENTAL JOURNAL			English	Editorial Material								Objectives Key reforms in England and Japan have called for greater clinical leadership from general dental practitioners to deliver improvements in the quality of care for patients. In England, the reorganisation of the National Health Service has led to the development of Local Professional Networks to ensure services are clinically led, patient and outcome focused. In Japan, the rapidly changing demographics have led to calls for general dental practitioners to become more active in meeting the emerging population health challenges. Both require engagement at a strategic and a local level. However, little is known about what is meant by clinical leadership in dentistry or what training needs exist. The aim of this study was to develop and pilot a questionnaire to understand what general dental practitioners feel is important about clinical leadership and how they rate themselves. Methods A 61-item questionnaire was developed from the literature, an earlier qualitative study and refined through cognitive interviews. Questionnaires were distributed to general dental practitioners across the North West of England and Tokyo, using random sequence generation. For each item, the participant had to record whether they thought the statement was an important component of clinical leadership and how they rated themselves. Both were rated using a seven-point Likert scale. Data reduction was undertaken using principal component analysis to examine for factor loadings within the questionnaire. Differences in mean scores were also used to highlight substantive differences in how general dental practitioners rated the different components of leadership and how they rated themselves. Results The response rate for the pilot was low (22.9% and 7.5% for North West and Tokyo respectively). The items that were considered to be important in leadership reduced to two components in the North West (accounting for 62.1% of the total variance): 'How to lead' and 'How not to lead'. In Tokyo, 56.4% of the total variance was explained by three components: 'Demonstrating personal qualities', 'Working with others' and 'How not to lead'. When the self-rated items were reduced, three factors were found to be important in the North West: 'Working with others', 'Setting direction' and 'Managing services' (55.1% of the variance). 'Working with others', 'Demonstrating personal qualities', 'Pragmatism', 'Setting direction' and 'Improving services' were found to be important in Tokyo (52.8% of the variance). The questionnaire items relating to integrity, teamworking and having a positive attitude during difficult times were rated highly by both groups. Items relating to providing vision for team, being assertive and having a positive attitude had the greatest mean difference, suggesting possible areas of training need. Conclusion The nature of the pilot study and the poor response rate makes any conclusion difficult to infer. Among those that participated, leadership was understood to be more important at a practice level rather than at a strategic level. The questionnaire should be refined further based on the results of the pilot and the data reduction.	[Brocklehurst, P.; O'Malley, L.; Hill, H.] Univ Manchester, Dept Dent Publ Hlth, Manchester M13 9PL, Lancs, England; [Ozaki, T.] Nihon Univ, Sch Dent, Tokyo 101, Japan; [Nomura, M.] Healthcare Res Inc, Tokyo, Japan; [Matsuda, R.] Ritsumeikan Univ, Coll Social Sci, Kyoto, Japan	Brocklehurst, P (reprint author), Univ Manchester, Dept Dent Publ Hlth, Manchester M13 9PL, Lancs, England.	paul.brocklehurst@manchester.ac.uk						0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0007-0610	1476-5373		BRIT DENT J	Br. Dent. J.	NOV	2014	217	9					528	529		10.1038/sj.bdj.2014.978		2	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT5LW	WOS:000344985500014		
J	Kameda, T; Takahashi, K; Kim, R; Jiang, Y; Movahed, M; Park, EK; Rantanen, J				Kameda, Takashi; Takahashi, Ken; Kim, Rokho; Jiang, Ying; Movahed, Mehrnoosh; Park, Eun-Kee; Rantanen, Jorma			Asbestos: use, bans and disease burden in Europe	BULLETIN OF THE WORLD HEALTH ORGANIZATION			English	Article							GLOBAL BURDEN; MESOTHELIOMA; MORTALITY	Objective To analyse national data on asbestos use and related diseases in the European Region of the World Health Organization (WHO). Methods For each of the 53 countries, per capita asbestos use (kg/capita/year) and age-adjusted mortality rates (deaths/million persons/year) due to mesothelioma and asbestosis were calculated using the databases of the United States Geological Survey and WHO, respectively. Countries were further categorized by ban status: early-ban (ban adopted by 2000, n = 17), late-ban (ban adopted 2001-2013, n = 17), and no-ban (n = 19). Findings Between 1920-2012, the highest per capita asbestos use was found in the no-ban group. After 2000, early-ban and late-ban groups reduced their asbestos use levels to less than or equal to 0.1 kg/capita/year, respectively, while the no-ban group maintained a very high use at 2.2 kg/capita/year. Between 1994 and 2010, the European Region registered 106180 deaths from mesothelioma and asbestosis, accounting for 60% of such deaths worldwide. In the early-ban and late-ban groups, 16/17 and 15/17 countries, respectively, reported mesothelioma data to WHO, while only 6/19 countries in the no-ban group reported such data. The age-adjusted mortality rates for mesothelioma for the early-ban, late-ban and no-ban groups were 9.4, 3.7 and 3.2 deaths/million persons/year, respectively. Asbestosis rates for the groups were 0.8, 0.9 and 1.5 deaths/million persons/year, respectively. Conclusion Within the European Region, the early-ban countries reported most of the current asbestos-related deaths. However, this might shift to the no-ban countries, since the disease burden will likely increase in these countries due the heavy use of asbestos.	[Kameda, Takashi; Takahashi, Ken; Jiang, Ying; Movahed, Mehrnoosh] Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Inst Ind Ecol Sci, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan; [Kim, Rokho] WHO Western Pacific Reg Off, Suva, Fiji; [Park, Eun-Kee] Kosin Univ, Coll Med, Dept Med Humanities & Social Med, Pusan, South Korea; [Rantanen, Jorma] Univ Jyvaskyla, Jyvaskyla, Finland	Takahashi, K (reprint author), Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Inst Ind Ecol Sci, Yahatanishi Ku, Iseigaoka 1-1, Kitakyushu, Fukuoka 807, Japan.	ktaka@med.uoeh-u.ac.jp			Japan Society for the Promotion of Science; Asia-Africa Science Platform Program; University of Occupational and Environmental Health for the promotion of occupational health; project for the development of a toolkit for the elimination of asbestos-related diseases	This work was supported in part by the Japan Society for the Promotion of Science, the Asia-Africa Science Platform Program, an research grant from University of Occupational and Environmental Health for the promotion of occupational health, and a project for the development of a toolkit for the elimination of asbestos-related diseases, commissioned by the Rotterdam Convention Secretariat.	Ahmad OB, 2001, AGE STANDARDIZATION; Le GV, 2011, RESPIROLOGY, V16, P767, DOI 10.1111/j.1440-1843.2011.01975.x; [Anonymous], 1986, RAT C162 ASB CONV 16; Stayner L, 2013, ANNU REV PUBL HEALTH, V34, P205, DOI 10.1146/annurev-publhealth-031811-124704; LaDou J, 2004, ENVIRON HEALTH PERSP, V112, P285, DOI 10.1289/ehp.6704; Lin RT, 2007, LANCET, V369, P844, DOI 10.1016/S0140-6736(07)60412-7; Antao VCD, 2009, OCCUP ENVIRON MED, V66, P335, DOI 10.1136/oem.2008.039172; Park EK, 2011, ENVIRON HEALTH PERSP, V119, P514, DOI 10.1289/ehp.1002845; Tse LA, 2010, ENVIRON HEALTH PERSP, V118, P382, DOI 10.1289/ehp.0900868; Nishikawa K, 2008, ENVIRON HEALTH PERSP, V116, P1675, DOI 10.1289/ehp.11272; Fingerhut M, 2005, SCAND J WORK ENV HEA, P58; Tossavainen A, 2004, INT J OCCUP ENV HEAL, V10, P22; Driscoll T, 2005, AM J IND MED, V48, P432, DOI 10.1002/ajim.20210; Driscoll T, 2005, AM J IND MED, V48, P419, DOI 10.1002/ajim.20209; Harington JS, 1998, AM J IND MED, V33, P321, DOI 10.1002/(SICI)1097-0274(199804)33:4<321::AID-AJIM2>3.0.CO;2-X; *HOSP AUTH, 2014, HONG KONG CANC REGIS; *INT BAN ASB SECR, 2013, CURR ASB BANS RESTR; *INT BAN ASB SECR, 2013, CHRON NAT ASB BANS; *INT COMM OCC HLTH, 2014, HELS DECL MAN EL ASB; *INT LAB OFF, 2003, THIRTEEN SESSION OF; *INT LAB ORG WHO, 2007, OUTL DEV NAT PROGR E; International Agency on Research on Cancer, 2012, IARC MON EV CARC RIS, V100 E; LAHMEYER J, 2006, POPULATION STAT HIST; LEE U, 2010, LUNG CANCER, V68, P16; Ngoan le T, 2007, ASIAN PAC CANC PREV, V8, P535; RUEGGER M, 2007, MED INFORM, P64; *UN, 2008, REP C PART ROTT CONV; United States Census Bureau, 2012, INT DAT BAS; *US GEOL SURV, 2009, MIN IND SURV WORLD A; VIRTA RL, 2006, 1298 US GEOL SURV, P80; *WHO, 1992, INT STAT CLASS DIS H, V1; WHO, 2000, WORLD HLTH REP 2000; *WHO REG OFF EUR, 2013, HUM FIN BURD ASB WHO; WHO Regional Office for Europe, 2010, PARM DECL ENV HLTH; World Health Organization, 2006, EL ASB REL DIS; World Health Organization, 2012, HLTH STAT HLTH INF S	36	3	3	WORLD HEALTH ORGANIZATION	GENEVA 27	MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND	0042-9686	1564-0604		B WORLD HEALTH ORGAN	Bull. World Health Organ.	NOV	2014	92	11					790	797		10.2471/BLT.13.132118		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AT9SW	WOS:000345267300013		
J	Parks, CG; Miller, FW; Satoh, M; Chan, EKL; Andrushchenko, Z; Birnbaum, LS; Jusko, TA; Kissling, GE; Patel, MD; Rose, KM; Weinberg, C; Zeldin, DC; Sandler, DP				Parks, Christine G.; Miller, Frederick W.; Satoh, Minoru; Chan, Edward K. L.; Andrushchenko, Zhanna; Birnbaum, Linda S.; Jusko, Todd A.; Kissling, Grace E.; Patel, Mehul D.; Rose, Kathryn M.; Weinberg, Clarice; Zeldin, Darryl C.; Sandler, Dale P.			Reproductive and Hormonal Risk Factors for Antinuclear Antibodies (ANA) in a Representative Sample of US Women	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; BREAST-CANCER; AUTOIMMUNE-DISEASE; RHEUMATOID-ARTHRITIS; HEALTHY-INDIVIDUALS; UNITED-STATES; IMMUNE-SYSTEM; ADULT-ONSET; VITAMIN-D; AUTOANTIBODIES	Background: Autoantibodies are of growing interest in cancer research as potential biomarkers; yet, the determinants of autoimmunity are not well understood. Antinuclear antibodies (ANA) are common in the general population and are more prevalent in women and older adults. Here, we examined the relationship of ANA with reproductive and hormonal factors in a representative sample of U.S. women. Methods: We analyzed data on reproductive history and exogenous hormone use in relation to serum ANA in 2,037 females ages 12 years and older from the National Health and Nutrition Examination Survey (NHANES; 1999-2004). Estimated ANA prevalences were adjusted for sampling weights. Prevalence ORs (POR) and 95% confidence intervals (CI) were adjusted for age, race, and poverty-income ratio, and models were stratified by menopause status. Results: In premenopausal women ages 20 years and older, ANA prevalence was associated with parity (P < 0.001; parous vs. nulliparous POR -2.0; 95% CI, 1.2-3.4), but in parous women, ANAdid not vary by number of births, age at first birth, years since last birth, or breastfeeding. In postmenopausal women, ANA prevalence was associated with an older age at menarche (P = 0.019; age 16-20 vs. 10-12 years POR = 3.0; 95% CI, 1.6-5.9), but not with parity. Oral contraceptives and estrogen therapy were not associated with a higher ANA prevalence. Conclusions: Childbearing (having had one or more births) may explain age-associated elevations in ANA prevalence seen in premenopausal women. Impact: These findings highlight the importance of considering reproductive history in studies of autoimmunity and cancer in women. (C)2014 AACR.	[Parks, Christine G.; Birnbaum, Linda S.; Kissling, Grace E.; Weinberg, Clarice; Zeldin, Darryl C.; Sandler, Dale P.] NIEHS, NIH, Res Triangle Pk, NC 27599 USA; [Miller, Frederick W.] NIEHS, NIH, Bethesda, MD USA; [Satoh, Minoru] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan; [Chan, Edward K. L.] Univ Florida, Gainesville, FL USA; [Andrushchenko, Zhanna; Rose, Kathryn M.] Social & Sci Syst, Res Triangle Pk, NC USA; [Jusko, Todd A.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Patel, Mehul D.] Univ N Carolina, Chapel Hill, NC USA	Parks, CG (reprint author), NIEHS, Epidemiol Branch, A3-05,POB 12233, Res Triangle Pk, NC 27599 USA.	Parks1@mail.nih.gov			Intramural Program of the NIH, National Institute of Environmental Health Sciences [Z01ES-044005, Z01ES-101074]; NIH [K12 ES019852, P30 ES001247]	This work was supported by the Intramural Program of the NIH, National Institute of Environmental Health Sciences (Z01ES-044005 and Z01ES-101074), and NIH grant K12 ES019852 and P30 ES001247 (to T.A. Jusko).	Morris DH, 2010, BRIT J CANCER, V103, P1760, DOI 10.1038/sj.bjc.6605978; Parks CG, 2013, ANN RHEUM DIS, V72, P350, DOI 10.1136/annrheumdis-2011-201083; Njemini R, 2002, CLIN EXP IMMUNOL, V127, P99, DOI 10.1046/j.1365-2249.2002.01713.x; Hughes GC, 2012, AUTOIMMUN REV, V11, pA502, DOI 10.1016/j.autrev.2011.12.003; Moorman PG, 2011, OBSTET GYNECOL, V118, P1271, DOI 10.1097/AOG.0b013e318236fd12; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Gogal RA, 2008, J IMMUNOTOXICOL, V5, P413, DOI 10.1080/10408360802483201; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; Mariz HA, 2011, ARTHRITIS RHEUM-US, V63, P191, DOI 10.1002/art.30084; Lerchbaum E, 2012, EUR J ENDOCRINOL, V166, P765, DOI 10.1530/EJE-11-0984; Bellinger DL, 2008, J IMMUNOTOXICOL, V5, P419, DOI 10.1080/15476910802483415; Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002; D'Aloisio AA, 2013, EPIDEMIOLOGY, V24, P277, DOI 10.1097/EDE.0b013e31828062b7; Simard JF, 2008, ARTHRIT RHEUM-ARTHR, V59, P1155, DOI 10.1002/art.23930; Jorgensen KT, 2012, J AUTOIMMUN, V38, pJ81, DOI 10.1016/j.jaut.2011.06.004; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Clancy KBH, 2013, AM J HUM BIOL, V25, P389, DOI 10.1002/ajhb.22386; Chighizola C, 2012, AUTOIMMUN REV, V11, pA493, DOI 10.1016/j.autrev.2011.11.027; Craig WY, 1999, J RHEUMATOL, V26, P914; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Sakiani S, 2013, NAT REV ENDOCRINOL, V9, P56, DOI 10.1038/nrendo.2012.206; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Zaenker P, 2013, CANCER EPIDEM BIOMAR, V22, P2161, DOI 10.1158/1055-9965.EPI-13-0621; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; Cutolo M, 2008, RHEUMATOLOGY, V47, P2, DOI 10.1093/rheumatology/ken150; Fugazzola L, 2011, NAT REV ENDOCRINOL, V7, P89, DOI 10.1038/nrendo.2010.216; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Shelly S, 2012, AUTOIMMUN REV, V11, pA465, DOI 10.1016/j.autrev.2011.11.009; Cutolo M, 2014, ANN NY ACAD SCI, V1317, P39, DOI 10.1111/nyas.12432; Quintero OL, 2012, J AUTOIMMUN, V38, pJ109, DOI 10.1016/j.jaut.2011.10.003; Vella LA, 2009, P NATL ACAD SCI USA, V106, P14010, DOI 10.1073/pnas.0903225106; Walitt BT, 2008, J RHEUMATOL, V35, P811; Borchers AT, 2010, J AUTOIMMUN, V34, pJ287, DOI 10.1016/j.jaut.2009.11.015; Cunningham M, 2011, CLIN REV ALLERG IMMU, V40, P66, DOI 10.1007/s12016-010-8203-5; Boynton-Jarrett R, 2012, ANN EPIDEMIOL, V22, P731, DOI 10.1016/j.annepidem.2012.08.005; Bracci PM, 2012, CANCER-AM CANCER SOC, V118, P5384, DOI 10.1002/cncr.27538; Carp HJA, 2012, J AUTOIMMUN, V38, pJ266, DOI 10.1016/j.jaut.2011.11.016; Chan EKL, 2007, AUTOIMMUN REV, V6, P577, DOI 10.1016/j.autrev.2007.05.001; Chao T, 2013, PROTEOM CLIN APPL, V7, P327, DOI 10.1002/prca.201200058; Clemons M, 2001, NEW ENGL J MED, V344, P276; Cooper GS, 2002, ARTHRITIS RHEUM, V46, P1830, DOI 10.1002/art.10365; Eriksson C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3258; Gammill HS, 2010, BLOOD, V116, P2706, DOI 10.1182/blood-2010-02-270942; Ghosh M, 2014, J STEROID BIOCHEM, V142, P171, DOI 10.1016/j.jsbmb.2013.09.003; Hanash S, 2011, CANCER EPIDEM BIOMAR, V20, P569, DOI 10.1158/1055-9965.EPI-11-0183; Brix TH, 2001, THYROID, V11, P769, DOI 10.1089/10507250152484619; HOOPER B, 1972, CLIN EXP IMMUNOL, V12, P79; Ishikawa M, 2008, CLIN EXP NEPHROL, V12, P200, DOI 10.1007/s10157-008-0030-0; Jorgensen KT, 2012, J AUTOIMMUN, V38, pJ120, DOI 10.1016/j.jaut.2011.10.002; Khashan AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019658; Korn E. L., 1999, ANAL HLTH SURVEYS; Kwok MK, 2011, AM J EPIDEMIOL, V173, P1440, DOI 10.1093/aje/kwr028; Laustrup H, 2004, LUPUS, V13, P792, DOI 10.1191/0961203304lu2015oa; Li WH, 2006, PROTEOMICS, V6, P4781, DOI 10.1002/pmic.200500909; Mendola Pauline, 2008, Fertil Steril, V89, pe81, DOI 10.1016/j.fertnstert.2007.12.036; Navarra SV, 2011, LUPUS, V20, P537, DOI 10.1177/0961203310385164; Nolen B, 2009, J IMMUNOL METHODS, V344, P116, DOI 10.1016/j.jim.2009.03.017; Olsen NJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3927; Pike MC, 1998, AM J EPIDEMIOL, V147, P718; Pinheiro SP, 2010, CANCER EPIDEM BIOMAR, V19, P1595, DOI 10.1158/1055-9965.EPI-10-0068; Ramos PS, 2006, GENES IMMUN, V7, P417, DOI 10.1038/sj.gene.6364316; Rasch EK, 2003, ARTHRITIS RHEUM, V48, P917, DOI 10.1002/art.10897; Rockhill B, 2000, AM J EPIDEMIOL, V151, P404; Rosner B, 2011, ANN EPIDEMIOL, V21, P450, DOI 10.1016/j.annepidem.2011.02.010; Wiemels JL, 2013, AM J EPIDEMIOL, V177, P75, DOI 10.1093/aje/kws221; YADIN O, 1989, CLIN EXP IMMUNOL, V75, P402	66	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	NOV	2014	23	11					2492	2502		10.1158/1055-9965.EPI-14-0429		11	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	AT9YL	WOS:000345279600033		
J	Sun, Q; Luo, TZ; Ren, YX; Florey, O; Shirasawa, S; Sasazuki, T; Robinson, DN; Overholtzer, M				Sun, Qiang; Luo, Tianzhi; Ren, Yixin; Florey, Oliver; Shirasawa, Senji; Sasazuki, Takehiko; Robinson, Douglas N.; Overholtzer, Michael			Competition between human cells by entosis	CELL RESEARCH			English	Article						entosis; cell competition; cell cannibalism; cell-in-cell structure; tumor evolution; Kras; Rho GTPase	TRANSFORMED-CELLS; HUMAN CANCERS; MYOSIN-II; DROSOPHILA; ADHESION; GROWTH; DIFFERENTIATION; CANNIBALISM; ENGULFMENT; DEATH	Human carcinomas are comprised of complex mixtures of tumor cells that are known to compete indirectly for nutrients and growth factors. Whether tumor cells could also compete directly, for example by elimination of rivals, is not known. Here we show that human cells can directly compete by a mechanism of engulfment called entosis. By entosis, cells are engulfed, or cannibalized while alive, and subsequently undergo cell death. We find that the identity of engulfing ("winner") and engulfed ("loser") cells is dictated by mechanical deformability controlled by RhoA and actomyosin, where tumor cells with high deformability preferentially engulf and outcompete neighboring cells with low deformability in heterogeneous populations. We further find that activated Kras and Rac signaling impart winner status to cells by downregulating contractile myosin, allowing for the internalization of neighboring cells that eventually undergo cell death. Finally, we compute the energy landscape of cell-in-cell formation, demonstrating that a mechanical differential between winner and loser cells is required for entosis to proceed. These data define a mechanism of competition in mammalian cells that occurs in human tumors.	[Sun, Qiang] Inst Biotechnol, Lab Cell Engn, Beijing 100071, Peoples R China; [Sun, Qiang; Overholtzer, Michael] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Luo, Tianzhi; Ren, Yixin; Robinson, Douglas N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Florey, Oliver] Babraham Inst, Signalling Programme, Cambridge CB22 3AT, England; [Shirasawa, Senji] Fukuoka Univ, Sch Med, Dept Cell Biol, Fukuoka 8140180, Japan; [Sasazuki, Takehiko] Int Med Ctr Japan, Res Inst, Dept Pathol, Tokyo 1638655, Japan; [Overholtzer, Michael] Weill Cornell Med Coll, BCMB Allied Program, New York, NY 10065 USA	Overholtzer, M (reprint author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.	sungiang1975@126.com; overhoml@mskcc.org			NCI [CA154649]; NIGMS [GM66817]; Louis V Gerstner, Jr Young Investigators Fund; Benjamin Friedman Research Fund; Cancer Research UK fellowship [C47718/A16337]; National Basic Research Program of China [2015CB553704]; National Natural Science Foundation of China [30871364, 81472588]	We thank Drs Alan Hall, Xuejun Jiang and their lab members and members of the Overholtzer laboratory for reagents and discussions on the manuscript. We thank Drs Keith Burridge, Klaus Hahn, Marilyn Resh and Tingchao Chou for reagents. We thank Drs Elisa de Stanchina, Xiaodong Huang and Juan Qiu for help with animal experiments, and Ms Ning Fan for histology. This work was supported by the NCI (CA154649, MO), the NIGMS (GM66817, DNR), the Louis V Gerstner, Jr Young Investigators Fund (MO), the Benjamin Friedman Research Fund (MO), Cancer Research UK fellowship (C47718/A16337, OF), the National Basic Research Program of China (2015CB553704, QS), and the National Natural Science Foundation of China (30871364 and 81472588, QS).	ANDERSON KW, 1991, CELL BIOPHYS, V18, P81; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Krajcovic M, 2011, NAT CELL BIOL, V13, P324, DOI 10.1038/ncb2174; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Sharma N, 2011, DIAGN CYTOPATHOL, V39, P229, DOI 10.1002/dc.21402; Zhang Y, 2012, NUCLEIC ACIDS RES, V40, P9286, DOI 10.1093/nar/gks667; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Krajcovic M, 2013, MOL BIOL CELL, V24, P3736, DOI 10.1091/mbc.E13-07-0408; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Luo TZ, 2012, BIOPHYS J, V102, P238, DOI 10.1016/j.bpj.2011.12.020; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Krajcovic M, 2012, CANCER RES, V72, P1596, DOI 10.1158/0008-5472.CAN-11-3127; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Overholtzer M, 2008, NAT REV MOL CELL BIO, V9, P796, DOI 10.1038/nrm2504; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; Baker NE, 2008, CANCER RES, V68, P5505, DOI 10.1158/0008-5472.CAN-07-6348; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Lolo FN, 2012, CELL REPORTS, V2, P526, DOI 10.1016/j.celrep.2012.08.012; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Ren YX, 2009, CURR BIOL, V19, P1421, DOI 10.1016/j.cub.2009.07.018; WARD KA, 1991, BIORHEOLOGY, V28, P301; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Sun Qiang, 2013, Methods Mol Biol, V1004, P59, DOI 10.1007/978-1-62703-383-1_5; Sun Q, 2014, CELL RES, V24, P1288, DOI 10.1038/cr.2014.137; Sun Q, 2007, CANCER BIOL THER, V6, P668; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Xu XJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-77; Zhou QQ, 2010, CURR BIOL, V20, P1881, DOI 10.1016/j.cub.2010.09.048	49	15	15	INST BIOCHEMISTRY & CELL BIOLOGY	SHANGHAI	SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA	1001-0602	1748-7838		CELL RES	Cell Res.	NOV	2014	24	11					1299	1310		10.1038/cr.2014.138		12	Cell Biology	Cell Biology	AT5PC	WOS:000344993600007		
J	Ikeda, TM; Yanaka, M; Takata, K				Ikeda, Tatsuya M.; Yanaka, Mikiko; Takata, Kanenori			Comparison of Quality-Related Alleles Among Australian and North American Wheat Classes Exported to Japan	CEREAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; TRITICUM-AESTIVUM L.; BREAD-MAKING QUALITY; GLUTENIN SUBUNIT GENES; GRAIN HARDNESS; COMMON WHEAT; FLOUR QUALITY; PUROINDOLINE B; SDS-PAGE; STARCH	Grain hardness, amylose content, and glutenin subunit composition are critical determinants for end-use properties of wheat. To improve the end-use properties of domestic wheats, we studied these traits between the Australian and North American wheat classes exported to Japan in 2009 and 2011 by analyzing the corresponding alleles. Most hard classes had Pina-D1b or Pinb-D1b. A partial waxy allele (Wx-B1b) was found in all Australian Standard White (ASW) seeds in 2009 and two-thirds of ASW seeds in 2011. All or most American hard wheat seeds had Glu-D1d. Most U. S. Western White (WW) seeds had a null allele (Glu-A1c) or alleles that lacked one of the two Glu-B1 subunits. Most hard red winter (HRW) seeds had Glu-B3b or Glu-B3g. Quality characteristics of these classes seemed to be consistent with these results. In addition, we also found new Glu-1 and Glu-3 alleles in HRW and WW. These results suggested that although there are variations in its allelic composition from year to year, each class has unique quality-related alleles corresponding to its end use. We proposed two matrices for classification of starch properties on the basis of Pin and Wx allelic combinations and for classification of gluten strength on the basis of glutenin allelic combinations.	[Ikeda, Tatsuya M.; Yanaka, Mikiko; Takata, Kanenori] NARO, Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan	Ikeda, TM (reprint author), NARO, Western Reg Agr Res Ctr, 6-12-1 Nishifukatsu, Fukuyama, Hiroshima 7218514, Japan.	tmikeda@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	This work was supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Development of crop production technology for all year round multi-utilization of paddy field). We are also grateful to Kimiko Suginohara for her helpful technical assistance.	Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; Ikeda TM, 2002, THEOR APPL GENET, V104, P680, DOI 10.1007/s001220100756; Liang D, 2010, EUPHYTICA, V172, P235, DOI 10.1007/s10681-009-0054-x; D'Ovidio R, 1997, PLANT BREEDING, V116, P525, DOI 10.1111/j.1439-0523.1997.tb02184.x; Lillemo M, 2000, THEOR APPL GENET, V100, P1100, DOI 10.1007/s001220051392; SYMES KJ, 1965, AUST J AGR RES, V16, P113, DOI 10.1071/AR9650113; Nishio Z, 2009, CEREAL CHEM, V86, P313, DOI 10.1094/CCHEM-86-3-0313; Giroux MJ, 1997, THEOR APPL GENET, V95, P857, DOI 10.1007/s001220050636; Zeng M, 1997, CEREAL CHEM, V74, P63, DOI 10.1094/CCHEM.1997.74.1.63; Butow BJ, 2004, THEOR APPL GENET, V109, P1525, DOI 10.1007/s00122-004-1776-8; ANDERSON OD, 1989, NUCLEIC ACIDS RES, V17, P461, DOI 10.1093/nar/17.1.461; Nakamura T, 2002, GENOME, V45, P1150, DOI 10.1139/G02-090; GAUTIER MF, 1994, PLANT MOL BIOL, V25, P43, DOI 10.1007/BF00024197; Branlard G, 2003, GENET RESOUR CROP EV, V50, P669, DOI 10.1023/A:1025077005401; Yamamori M, 2000, THEOR APPL GENET, V100, P32, DOI 10.1007/s001220050005; Ikeda TM, 2005, J CEREAL SCI, V41, P1, DOI 10.1016/j.jcs.2004.10.002; MARCHYLO BA, 1992, J CEREAL SCI, V15, P29; JACKSON EA, 1983, THEOR APPL GENET, V66, P29, DOI 10.1007/BF00281844; Zhang W, 2004, THEOR APPL GENET, V108, P1409, DOI 10.1007/s00122-003-1558-8; Bekes F., 2008, GLUTEN COMPOSITION 2; Bekes F, 2006, EUR J AGRON, V25, P155, DOI 10.1016/j.eja.2006.04.008; Corona V., 2001, Journal of Genetics and Breeding, V55, P187; Eagles HA, 2004, AUST J AGR RES, V55, P1093, DOI 10.1071/AR04113; Geng HW, 2012, THEOR APPL GENET, V124, P1259, DOI 10.1007/s00122-011-1784-4; Gobaa S, 2007, PLANT BREEDING, V126, P1, DOI 10.1111/j.1439-0523.2006.01313.x; Ikeda T. M., 2009, 10 INT GLUT WORKSH, P180; Ikeda TM, 2006, THEOR APPL GENET, V112, P327, DOI 10.1007/s00122-005-0131-z; Ito M, 2011, BREEDING SCI, V61, P281, DOI 10.1270/jsbbs.61.281; Ito M, 2007, FOOD SCI TECHNOL RES, V13, P121, DOI 10.3136/fstr.13.121; Kang CS, 2012, CEREAL CHEM, V89, P296, DOI 10.1094/CCHEM-03-12-0034-R; Law C. N., 1978, Seed protein improvement by nuclear technique. Proceedings of the two Research Co-ordination Meetings, Baden, 28 March - 1 April 1977 and Vienna, 26-30 September 1977. Aneuploids in wheat protein improvement., P483; Li YL, 2010, J CEREAL SCI, V51, P127, DOI 10.1016/j.jcs.2009.10.008; Liu L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-124; LUKOW O M, 1992, Journal of Genetics and Breeding, V46, P187; Ma DY, 2009, J CEREAL SCI, V50, P126, DOI 10.1016/j.jcs.2009.03.006; Martin JM, 2001, CROP SCI, V41, P228; Martin JM, 2004, CEREAL CHEM, V81, P188, DOI 10.1094/CCHEM.2004.81.2.188; Mattern P. J., 1973, Proceedings of the Fourth International Wheat Genetics Symposium. Cytogenetics., P703; Maucher T, 2009, CEREAL CHEM, V86, P372, DOI 10.1094/CCHEM-86-4-0372; Nagamine T, 2003, J CEREAL SCI, V37, P337, DOI 10.1006/jcrs.2002.0505; Nakamura K, 2012, CEREAL CHEM, V89, P79, DOI 10.1094/CCHEM-07-11-0081; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Pena R. J., 2003, 8 GLUT WORKSH, P156; Redaelli R, 1997, PLANT BREEDING, V116, P429, DOI 10.1111/j.1439-0523.1997.tb01026.x; SINGH NK, 1991, J CEREAL SCI, V14, P203; Suzuki T., 2008, DNA MARKERS DISTINGU; Tabiki T, 2006, BREEDING SCI, V56, P131, DOI 10.1270/jsbbs.56.131; Takata K., 2008, Breeding Research, V10, P41, DOI 10.1270/jsbbr.10.41; Takata K, 1999, BREEDING SCI, V49, P221; Takata K, 2010, BREEDING SCI, V60, P228, DOI 10.1270/jsbbs.60.228; Wang LH, 2009, THEOR APPL GENET, V118, P525, DOI 10.1007/s00122-008-0918-9; Zhang XF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-243	52	1	1	AACC INTERNATIONAL	ST PAUL	3340 PILOT KNOB RD, ST PAUL, MN 55121-2097 USA	0009-0352	1943-3638		CEREAL CHEM	Cereal Chem.	NOV-DEC	2014	91	6					616	622		10.1094/CCHEM-01-14-0009-R		7	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AT9ZE	WOS:000345281900013		
J	Emura, M; Matsuda, H				Emura, Makoto; Matsuda, Hiroyuki			A Green and Sustainable Approach: Celebrating the 30th Anniversary of the Asymmetric l-Menthol Process	CHEMISTRY & BIODIVERSITY			English	Article							BINAP; COMPLEXES	Takasago has been devoted to producing l-menthol since 1954, and our long history of manufacturing this important aroma chemical is reviewed here. The current asymmetric catalytic process had its 30th anniversary in 2013. Our l-menthol process is considered carbon-neutral, and, therefore, 'green' and sustainable. It uses renewable myrcene obtained from gum rosin as a starting material. In addition, the Rh-BINAP (=2,2'-bis(diphenylphosphino)-1,1'-binaphthyl) catalytic system is highly efficient. This pathway not only leads l-menthol, but a variety of 100% biobased aroma chemical products as well. By measuring the 14C levels in a material, one can determine the percentage of carbon that is biobased. This biobased assay, described as the ratio plant-derived C/fossil-derived C, can clarify how renewable a product really is. This will be highlighted for several of Takasago's key aroma chemicals.	[Emura, Makoto; Matsuda, Hiroyuki] Takasago Int Corp, Corp Res & Dev Div 4 11, Hiratsuka, Kanagawa 2540073, Japan	Emura, M (reprint author), Takasago Int Corp, Corp Res & Dev Div 4 11, 1 Chome, Hiratsuka, Kanagawa 2540073, Japan.	makoto_emura@takasago.com					AKUTAGAWA S, 1995, APPL CATAL A-GEN, V128, P171, DOI 10.1016/0926-860X(95)00097-6; Norton GA, 2006, BIORESOURCE TECHNOL, V97, P2084, DOI 10.1016/j.biortech.2005.08.017; MIYASHITA A, 1980, J AM CHEM SOC, V102, P7932, DOI 10.1021/ja00547a020; TANI K, 1984, J AM CHEM SOC, V106, P5208, DOI 10.1021/ja00330a029; Emura M., 2006, Japan Patent, Patent No. 225643; Horiuchi R., 1929, Japan Patent, Patent No. 79323; Indo M., 1993, KORYO, V177, P33; Iwata T., 2001, Japan Patent, Patent No. 10527; Kaizer R., 1975, J AGR FOOD CHEM, V23, P943; Katsura S., 1957, Japan Patent, Patent No. 8875; Katsura S., 1957, Japan Patent, Patent No. 9869; Kenmochi H., 1999, Japan Patent, Patent No. 130710; KOPKE T, 1992, Z LEBENSM UNTERS FOR, V194, P372, DOI 10.1007/BF01193223; Kumobayashi H, 1996, RECL TRAV CHIM PAY B, V115, P201; Matsuda H., 1997, Japan Patent, Patent No. 169993; Mitsuhashi K., 2002, Japan Patent, Patent No. 190616; Nagashima H., 1982, Japan Patent, Patent No. 48051; Nagashima H., 1982, Japan Patent, Patent No. 53766; Ogura M., 1993, Japan Patent, Patent No. 112494	19	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1612-1872	1612-1880		CHEM BIODIVERS	Chem. Biodivers.	NOV	2014	11	11					1688	1699		10.1002/cbdv.201400063		12	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	AU0MF	WOS:000345316400002		
J	Saito, A; Hayashi, M; Takeshita, H; Matsuzawa, T				Saito, Aya; Hayashi, Misato; Takeshita, Hideko; Matsuzawa, Tetsuro			The Origin of Representational Drawing: A Comparison of Human Children and Chimpanzees	CHILD DEVELOPMENT			English	Article							PAN-TROGLODYTES; OBJECT MANIPULATION; INFANT CHIMPANZEES; CAVE; TASK; ART	To examine the evolutional origin of representational drawing, two experiments directly compared the drawing behavior of human children and chimpanzees. The first experiment observed free drawing after model presentation, using imitation task. From longitudinal observation of humans (N=32, 11-31months), the developmental process of drawing until the emergence of shape imitation was clarified. Adult chimpanzees showed the ability to trace a model, which was difficult for humans who had just started imitation. The second experiment, free drawing on incomplete facial stimuli, revealed the remarkable difference between two species. Humans (N=57, 6-38months) tend to complete the missing parts even with immature motor control, whereas chimpanzees never completed the missing parts and instead marked the existing parts or traced the outlines. Cognitive characteristics may affect the emergence of representational drawings.	[Saito, Aya] Chubu Gakuin Univ, Gifu 5040837, Japan; [Hayashi, Misato; Matsuzawa, Tetsuro] Kyoto Univ, Kyoto 6068501, Japan; [Takeshita, Hideko] Univ Shiga Prefecture, Hikone, Shiga, Japan	Saito, A (reprint author), Chubu Gakuin Univ, Fac Child Studies, 30-1 Nakaoida Cho, Gifu 5040837, Japan.	asaito@chubu-gu.ac.jp					Fagot J, 1999, J COMP PSYCHOL, V113, P3, DOI 10.1037/0735-7036.113.1.3; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Hayashi M, 2009, INTERACT STUD, V10, P130, DOI 10.1075/is.10.2.03hay; Hayashi M, 2003, ANIM COGN, V6, P225, DOI 10.1007/s10071-003-0185-8; Hayashi M, 2007, CORTEX, V43, P308, DOI 10.1016/S0010-9452(08)70457-X; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Humphrey N, 1998, CAMB ARCHAEOL J, V8, P165; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Arnheim R., 1954, ART VISUAL PERCEPTIO; Beltran A., 2000, CAVE ALTAMIRA; BOYSEN ST, 1987, J COMP PSYCHOL, V101, P82, DOI 10.1037//0735-7036.101.1.82; CHAUVET J.-M., 1996, CHAUVET CAVE DISCOVE; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Cox M. V., 1992, CHILDRENS DRAWINGS; desWaal F., 2001, APE SUSHI MASTER CUL; Eng H., 1954, PSYCHOL CHILDRENS DR; Freeman N. H., 1977, CHILDS REPRESENTATIO, P3; Freeman N H, 1972, Perception, V1, P123, DOI 10.1068/p010123; Gardner R A, 1978, Ann N Y Acad Sci, V309, P37, DOI 10.1111/j.1749-6632.1978.tb29441.x; Golomb C., 1973, GENETIC PSYCHOL MONO, V87, P107; Gombrich Ernst Hans, 1972, ART ILLUSION STUDY P, V4th; Goodnow J., 1977, CHILDRENS DRAWING; Guthrie S., 1993, FACES CLOUDS NEW THE; Hayashi M, 2009, ANIM COGN, V12, pS49, DOI 10.1007/s10071-009-0273-5; Ikuzawa M., 1985, KYOTO SCALE PSYCHOL; Imura T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03256; ITAKURA S, 1994, J GEN PSYCHOL, V121, P189; Iversen IH, 1997, JPN PSYCHOL RES, V39, P154, DOI 10.1111/1468-5884.00051; Iversen IH, 1996, JPN PSYCHOL RES, V38, P126; Kellog R., 1969, ANAL CHILDRENS ART; Kellogg WN, 1933, APE CHILD STUDY ENV; Ladygina-Kohts N., 2002, INFANT CHIMPANZEE HU; Lenain T., 1995, HUMAN EVOLUTION, V10, P205, DOI 10.1007/BF02438973; Lenain T., 1997, MONKEY PAINTING; Luquet G. H., 1927, LE DESSIN ENFANTIN; Matsuzawa T., 1990, WORLD EYES CHIMPANZE; MATSUZAWA T, 1985, NATURE, V315, P57, DOI 10.1038/315057a0; Matsuzawa T, 2009, ANIM COGN, V12, pS1, DOI 10.1007/s10071-009-0277-1; Matsuzawa T., 1995, CHIMPANZEES CHIMPAN; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; Matsuzawa T., 2000, CHIMPANZEES MIND; MATSUZAWA T, 1985, J HUM EVOL, V14, P283, DOI 10.1016/S0047-2484(85)80069-5; MATTHEWS J, 1984, Early Child Development and Care, V18, P1, DOI 10.1080/0300443840180101; Morris D., 1962, BIOL ART; Myowa-Yamakoshi M, 1999, J COMP PSYCHOL, V113, P128, DOI 10.1037/0735-7036.113.2.128; Patterson F., 1986, PRIMATES ROAD SELF S, DOI [10.1007/978-1-4612-4918-4_63, DOI 10.1007/978-1-4612-4918-4_63]; PREMACK D, 1975, SCIENCE, V188, P228, DOI 10.1126/science.1118724; Saito A, 2011, JPN PSYCHOL RES, V53, P379, DOI 10.1111/j.1468-5884.2011.00495.x; SCHILLER PH, 1951, J COMP PHYSIOL PSYCH, V44, P101, DOI 10.1037/h0053604; SMITH DA, 1973, J COMP PHYSIOL PSYCH, V82, P406, DOI 10.1037/h0034135; Takeshita H, 2009, INTERACT STUD, V10, P252, DOI 10.1075/is.10.2.08tak; Takeshita H, 2001, Anim Cogn, V4, P335, DOI 10.1007/s100710100089; Tanaka M, 2003, ANIM COGN, V6, P245, DOI 10.1007/s10071-003-0198-3; Tomasello M., 1999, CULTURAL ORIGINS HUM; Yamagata K, 2001, JPN PSYCHOL RES, V43, P130, DOI 10.1111/1468-5884.00169; Yamagata K, 1991, JAPANESE J ED PSYCHO, V39, P102	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-3920	1467-8624		CHILD DEV	Child Dev.	NOV-DEC	2014	85	6					2232	2246		10.1111/cdev.12319		15	Psychology, Educational; Psychology, Developmental	Psychology	AU0EH	WOS:000345295800010		
J	Qu, WW; Zhang, GL; Tanihata, I; Terashima, S; Guo, CL; Xiao-Yun, L; Sakaguchi, H				Qu Wei-Wei; Zhang Gao-Long; Tanihata, I.; Terashima, S.; Guo Chen-Lei; Le Xiao-Yun; Sakaguchi, H.			Simulation of beam optics for C-12+C-12 scattering of RCNP by using Monte Carlo method	CHINESE PHYSICS C			English	Article						achromatic matching; simulation; orbit4; datadesk; collimators		The Monte Carlo method is used to simulate the beam optics of the WS beam line of RCNP, Osaka University in order to know the effect of collimators on the beam line to control the beam spot. According to the simulation, we do not need to use the collimator to cut the beam and the beam angular resolution can be better than 0.05 degrees in achromatic mode. In the present paper, the actual beam condition during the beam adjustment is listed. The accelerator can provide a C-12 beam in achromatic mode and the angular resolution sigma=0.7775 mrad +/- 0.0030 mrad.	[Zhang Gao-Long] Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China; [Qu Wei-Wei; Zhang Gao-Long; Tanihata, I.; Terashima, S.; Guo Chen-Lei; Le Xiao-Yun] Beihang Univ, Sch Phys & Nucl Energy Engn, Beijing 100191, Peoples R China; [Qu Wei-Wei; Zhang Gao-Long; Tanihata, I.; Terashima, S.; Guo Chen-Lei; Le Xiao-Yun] Beihang Univ, Int Res Ctr Nuclei & Particles Cosmos, Beijing 100191, Peoples R China; [Tanihata, I.; Sakaguchi, H.] Osaka Univ, Nucl Phys Res Ctr, Osaka 5670047, Japan	Zhang, GL (reprint author), Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China.	zgl@buaa.edu.cn			National Nature Science Foundation of China [11035007, 11235002, 11175011]; State Key Laboratory of Software Development Environment [SKLSDE-2014ZX-08]; Key Laboratory of High Precision Nuclear Spectroscopy, Institute of Modern Physics, Chinese Academy of Sciences	Supported by National Nature Science Foundation of China (11035007, 11235002, 11175011) and State Key Laboratory of Software Development Environment (SKLSDE-2014ZX-08 as well as by the Key Laboratory of High Precision Nuclear Spectroscopy, Institute of Modern Physics, Chinese Academy of Sciences.)	Furumoto T, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.044614; Furumoto T, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.044612; Fujita H, 2002, NUCL INSTRUM METH A, V484, P17, DOI 10.1016/S0168-9002(01)01970-2; Furumoto T, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.011601; Wakasa T, 2002, NUCL INSTRUM METH A, V482, P79, DOI 10.1016/S0168-9002(01)01686-2; Yu L, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/2/024001	6	1	1	CHINESE PHYSICAL SOC	BEIJING	P O BOX 603, BEIJING 100080, PEOPLES R CHINA	1674-1137			CHINESE PHYS C	Chin. Phys. C	NOV	2014	38	11							116202	10.1088/1674-1137/38/11/116202		5	Physics, Nuclear; Physics, Particles & Fields	Physics	AT4LQ	WOS:000344911400009		
J	Earnestly, F; Lim, LW; Takeuchi, T				Earnestly, Femi; Lim, Lee Wah; Takeuchi, Toyohide			Eluent-Induced Separation of Inorganic Cations in Capillary Liquid Chromatography with Contactless Conductivity Detector	CHROMATOGRAPHIA			English	Article						Capillary ion chromatography; Hydrophobic stationary phase; Non-suppressed contactless conductivity detector; Methanesulfonic acid; Sodium dodecyl sulfate; Inorganic cations	ION CHROMATOGRAPHY; STATIONARY PHASES; COLUMN; ANIONS; SEAWATER; IODIDE; ELECTROPHORESIS; ETHER	A non-suppressed contactless conductivity detector has been used as a capillary detector in a capillary ion chromatograph, combining a reversed-phase C30 column permanently modified with ionic surfactant. The C30 column (100 x 0.32 mm. id) was modified with sodium dodecyl sulfate (SDS) for the separation of inorganic cations. Monovalent cations could be separated by the proposed system, in which methanesulfonic acid (MSA) and SDS were employed as the mobile phase component, but divalent cations could not be eluted under this condition. As for the case of SDS used as the eluent, an H+-cation-exchange column was placed before the sample injector to convert the Na+ from the eluent into H+, and when the mixture of MSA and dodecyl sulfuric acid was used as the eluent, the retention of cations was improved and baseline separation of the cations was achieved within 23 min. The effect of the eluent composition on the retention behavior of inorganic cations was investigated. The repeatability of retention time and peak height varied from 0.39 to 0.58 and 2.21 to 3.25 % as relative standard deviation, respectively.	[Earnestly, Femi; Lim, Lee Wah; Takeuchi, Toyohide] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Gifu 5011193, Japan; [Earnestly, Femi] Muhammadiyah Univ Sumatera Barat, Fac Forestry, Padang 25171, Indonesia	Takeuchi, T (reprint author), Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, 1-1 Yanagido, Gifu 5011193, Japan.	take-t@gifu-u.ac.jp	Lim, Lee Wah/A-8470-2015		Directorate General of Higher Education, Ministry of Education and Culture of the Republic Indonesia	Femi Earnestly gratefully acknowledges the Directorate General of Higher Education, the Ministry of Education and Culture of the Republic Indonesia for the Ph.D. scholarship in Gifu University, Japan.	Abad-Villar EM, 2005, ELECTROPHORESIS, V26, P3609, DOI 10.1002/elps.200500149; Amin M, 2005, ANAL BIOANAL CHEM, V381, P1426, DOI 10.1007/s00216-005-3073-z; TAKEUCHI T, 1981, J CHROMATOGR, V213, P25, DOI 10.1016/S0021-9673(00)80628-7; Rong L, 2013, ANAL SCI, V29, P31; Stahlberg J, 1999, J CHROMATOGR A, V855, P3, DOI 10.1016/S0021-9673(99)00176-4; Gillespie E, 2007, ANALYST, V132, P1238, DOI 10.1039/b711350a; Takeuchi T, 2011, ANAL SCI, V27, P1019; Rong L, 2013, MICROCHEM J, V108, P113, DOI 10.1016/j.microc.2012.10.008; Rong L, 2012, ANAL SCI, V28, P367; Shen DZ, 2011, TALANTA, V84, P42, DOI 10.1016/j.talanta.2010.12.010; Rong L, 2007, TALANTA, V72, P1625, DOI 10.1016/j.talanta.2007.03.017; Takeuchi T, 2009, ANAL SCI, V25, P851; SMALL H, 1975, ANAL CHEM, V47, P1801, DOI 10.1021/ac60361a017; Lee HS, 2001, J CHROMATOGR A, V913, P371, DOI 10.1016/S0021-9673(00)01029-3; Ueki Y, 2004, ANAL CHEM, V76, P7007, DOI 10.1021/ac040079g; Cook HA, 2003, J CHROMATOGR A, V997, P13, DOI 10.1016/S0021-9673(03)00063-3; Earnestly F, 2012, INT J CHEM, V1, P466; EDWARDS BR, 1995, J CHROMATOGR A, V706, P69, DOI 10.1016/0021-9673(94)01241-6; FRANSSON B, 1976, J CHROMATOGR, V125, P327, DOI 10.1016/S0021-9673(00)93829-9; Ito K, 1999, J CHROMATOGR A, V850, P247, DOI 10.1016/S0021-9673(99)00019-9; Kuban P, 2004, J SEP SCI, V27, P1441, DOI 10.1002/jssc.200401824; Mori M, 2006, J CHROMATOGR A, V1118, P51, DOI 10.1016/j.chroma.2006.02.083; Nesterenko PN, 2003, J CHROMATOGR A, V986, P263, DOI 10.1016/S0021-9673(02)02008-3; Rafi M, 2013, TALANTA, V103, P28, DOI 10.1016/j.talanta.2012.09.057; ROKUSHIKA S, 1983, J CHROMATOGR, V280, P69, DOI 10.1016/S0021-9673(00)91539-5; Sander LC, 2000, J CHROMATOGR A, V880, P189, DOI 10.1016/S0021-9673(00)00121-7; SANDER LC, 1987, ANAL CHEM, V59, P2309, DOI 10.1021/ac00145a020; Sedyohutomo A, 2008, J CHROMATOGR A, V1203, P239, DOI 10.1016/j.chroma.2008.07.055; Sprung C, 2008, SEP SCI TECHNOL, V15, P3856; Takeuchi T., 2005, CHROMATOGRAPHY, V26, P7; Unterholzner V, 2002, ANALYST, V127, P715, DOI 10.1039/b202765h; Xu Q, 2004, J CHROMATOGR A, V1023, P239, DOI 10.1016/j.chroma.2003.10.017; Zeng WF, 2006, J CHROMATOGR A, V1118, P68, DOI 10.1016/j.chroma.2006.01.065	33	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-5893	1612-1112		CHROMATOGRAPHIA	Chromatographia	NOV	2014	77	21-22					1539	1544		10.1007/s10337-014-2753-2		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AT5TK	WOS:000345004800017		
J	Isokawa, M; Funatsu, T; Tsunoda, M				Isokawa, Muneki; Funatsu, Takashi; Tsunoda, Makoto			Evaluation of the Effects of Sample Dilution and Volume in Hydrophilic Interaction Liquid Chromatography	CHROMATOGRAPHIA			English	Article						Column liquid chromatography; ZIC-HILIC; Peak shape; Thiol; Bioanalysis	MASS-SPECTROMETRY	The effects of sample dilution and volume on the peak shapes in hydrophilic interaction liquid chromatography (HILIC) were evaluated using fluorescence-labeled thiols as model compounds and ZIC-HILIC as the HILIC column. The content of acetonitrile, which was selected as the diluent of the aqueous samples in this study, was varied 0-95 % in the injection samples, and the numbers of theoretical plates (NTPs) and retention times were compared using a mobile phase composed of ammonium formate buffer/acetonitrile (25:75, v/v). Although the NTPs and retention times decreased with decreasing acetonitrile content, the peak shapes were acceptable for samples with acetonitrile contents down to 50 % based on asymmetry factor. Furthermore, the sample volume had a serious effect for samples with low acetonitrile contents. Although a high content of acetonitrile in samples is still recommended, the capacity for the aqueous solution in the injection samples under HILIC conditions should vary with the composition of the mobile phase and may be larger than previously thought. These findings should be helpful in deciding the sample composition under HILIC conditions, particularly in bioanalysis, where aqueous solution is often contained in the injection samples and the sample dilution with an organic solvent may decrease the detection sensitivity.	[Isokawa, Muneki; Funatsu, Takashi; Tsunoda, Makoto] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Tsunoda, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	makotot@mol.f.u-tokyo.ac.jp	Isokawa, Muneki/C-6512-2013	Isokawa, Muneki/0000-0003-4110-6322			Ruta J, 2010, J CHROMATOGR A, V1217, P8230, DOI 10.1016/j.chroma.2010.10.106; Zhou ZF, 2013, ANAL BIOANAL CHEM, V405, P6323, DOI 10.1007/s00216-013-7049-0; Chauve B, 2010, J SEP SCI, V33, P752, DOI 10.1002/jssc.200900749; Isokawa M, 2013, ANALYST, V138, P3802, DOI 10.1039/c3an00527e; Periat A, 2013, J CHROMATOGR A, V1312, P49, DOI 10.1016/j.chroma.2013.08.097; Kumar A, 2011, J CHROMATOGR A, V1218, P3854, DOI 10.1016/j.chroma.2011.04.034; Sanchez AC, 2012, J CHROMATOGR A, V1228, P338, DOI 10.1016/j.chroma.2012.01.038; Dejaegher B, 2010, J SEP SCI, V33, P698, DOI 10.1002/jssc.200900742; McCalley DV, 2007, J CHROMATOGR A, V1171, P46, DOI 10.1016/j.chroma.2007.09.047; Simon R, 2012, J CHROMATOGR A, V1264, P31, DOI 10.1016/j.chroma.2012.09.059; Isokawa M, 2014, BIOANALYSIS IN PRESS; Kokotou MG, 2012, CHROMATOGRAPHIA, V75, P457, DOI 10.1007/s10337-012-2228-2; Merck SeQuant AB, 2008, PRACT GUID HIL; Snyder L. R., 2011, INTRO MODERN LIQUID; Sriboonvorakul N, 2013, J CHROMATOGR B, V941, P116, DOI 10.1016/j.jchromb.2013.10.005	15	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-5893	1612-1112		CHROMATOGRAPHIA	Chromatographia	NOV	2014	77	21-22					1553	1556		10.1007/s10337-014-2748-z		4	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AT5TK	WOS:000345004800019		
J	Ishihara, K; Doi, Y; Uchiyama, M				Ishihara, Kaneyoshi; Doi, Yuriko; Uchiyama, Makoto			The reliability and validity of the Japanese version of the Children's ChronoType Questionnaire (CCTQ) in preschool children	CHRONOBIOLOGY INTERNATIONAL			English	Article						Chronotype; Children's ChronoType Questionnaire; CCTQ; reliability; validity	MORNINGNESS-EVENINGNESS; CIRCADIAN TYPOLOGY; SLEEP DISORDERS; SOCIAL JETLAG; HIGH-SCHOOL; ACTIGRAPHY; PATTERNS	We aimed to examine the reliability and validity of the Japanese version of the Children's ChronoType Questionnaire (CCTQ) in preschool children. The CCTQ consists of 16 items on sleep-wake parameters for scheduled and free days, a 10-item of the Morningness/Eveningness Scale (CCTQ-M/E), and a single item on chronotype. Out of 502 children aged 3-6 years living in Okayama Prefecture, we evaluated 346 (188 boys and 158 girls) between May and June 2012. Their parents filled out the questionnaires two times at an interval of two weeks. Cronbach's alpha of the CCTQ-M/E was 0.77. For test-retest reliability, Pearson's correlation coefficient of the CCTQ-M/E between the two observations was 0.898 (p < 0.001). Kruskal-Wallis test with post-hoc tests was used to compare sleep-wake parameters measured with the CCTQ among the three groups of children, morning (M)-type, neither (N)-type and evening (E)-type, who were classified according to the CCTQ-M/E score. Sleep-wake parameters in timing were significantly different among the children with M-type, N-type and E-type (p < 0.001). Post-hoc pairwise comparisons revealed that sleep-wake parameters in timing were significantly delayed from the M-type to the N-type children (p < 0.001), from the M-type to the E-type children (p < 0.001), and from the N-type to the E-type children (p < 0.001), except that wake-up time and get-up time were not significantly different between the children with N-type and E-type on scheduled days when their start time was regularly fixed. Out of these 346 children, we evaluated 72 (35 boys and 37 girls) to see the correlations between subjectively and objectively measured sleep-wake parameters from June to October 2012. Spearman's correlation coefficients between sleep-wake parameters measured with the CCTQ and an actigraph were 0.512-0.836 on scheduled days (p < 0.001) and 0.380-0.786 on free days (p < 0.001). Based on these findings we conclude that the Japanese version of the CCTQ is a reliable and valid measure for assessing chronotypes in preschool children.	[Ishihara, Kaneyoshi] Notre Dame Seishin Univ, Dept Child Welf, Okayama, Japan; [Doi, Yuriko] Natl Inst Publ Hlth, Area Epidemiol Res, Wako, Saitama 3510197, Japan; [Uchiyama, Makoto] Nihon Univ, Sch Med, Dept Psychiat, Tokyo, Japan	Doi, Y (reprint author), Natl Inst Publ Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	yuriko@niph.go.jp			Astellas Pharma; Eisai; Meijiseika Pharma; Mochida Pharmaceutical; MSD; Pfizer; Sanofi; Takeda Pharmaceutical; Yoshitomiyakuhin Corporation; JSPS KAKENHI [23390181]; Japan Society for Promoting Science and Technology Agency [22591301]	This was not an industry-supported study. Dr Uchiyama reports that his department received research support from: Astellas Pharma, Eisai, Meijiseika Pharma, Mochida Pharmaceutical, MSD, Pfizer, Sanofi, Takeda Pharmaceutical, and Yoshitomiyakuhin Corporation. He has provided consulting services to Eisai, Kao, MSD, Pfizer Japan, Sanofi, Taisho Pharmaceutical and Takeda Pharmaceutical. The other authors declare no conflicts of interest.; The authors alone are responsible for the contents and writing of the paper. This work was supported by JSPS KAKENHI Grant Number 23390181 and partly by a Research Grant from the Japan Society for Promoting Science and Technology Agency (22591301, 2011-2012).	Ancoli-Israel S, 2003, SLEEP, V26, P342; Reutrakul S, 2013, DIABETES CARE, V36, P2523, DOI 10.2337/dc12-2697; Sitnick SL, 2008, SLEEP, V31, P395; Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253; Preckel F, 2013, BRIT J EDUC PSYCHOL, V83, P114, DOI 10.1111/j.2044-8279.2011.02059.x; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; DEKONINCK J, 1992, SLEEP, V15, P143; Gaina A, 2004, J EPIDEMIOL, V14, P1, DOI 10.2188/jea.14.1; Werner H, 2009, CHRONOBIOL INT, V26, P992, DOI 10.1080/07420520903044505; Besoluk S, 2011, CHRONOBIOL INT, V28, P118, DOI 10.3109/07420528.2010.540729; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Morgenthaler T, 2007, SLEEP, V30, P519; CARSKADON MA, 1993, SLEEP, V16, P258; Mindell JA, 2013, SLEEP MED, V14, P1283, DOI 10.1016/j.sleep.2013.09.002; Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Wolfson AR, 2003, SLEEP, V26, P213; Tryon WW, 2004, SLEEP, V27, P158; SMITH CS, 1989, J APPL PSYCHOL, V74, P728, DOI 10.1037//0021-9010.74.5.728; Meltzer LJ, 2012, SLEEP MED REV, V16, P463, DOI 10.1016/j.smrv.2011.10.002; Belanger ME, 2013, J CLIN SLEEP MED, V9, P701, DOI 10.5664/jcsm.2844; KERKHOF GA, 1985, BIOL PSYCHOL, V20, P83, DOI 10.1016/0301-0511(85)90019-5; Sadeh A, 2004, PEDIATRICS, V113, pE570, DOI 10.1542/peds.113.6.e570; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Doi Y, 2013, JPN J SLEEP MED, V7, P486; Doi Y, 2014, CHRONOBIOL INT, V31, P328, DOI 10.3109/07420528.2013.852103; Jenni OG, 2005, PEDIATRICS, V115, P204, DOI 10.1542/peds.2004-0815B; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Schlarb AA, 2014, CHRONOBIOL INT, V31, P1, DOI 10.3109/07420528.2013.829846; Streiner D. L., 1995, HLTH MEASUREMENT SCA; Urbán Róbert, 2011, Chronobiol Int, V28, P238, DOI 10.3109/07420528.2010.549599	32	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	NOV	2014	31	9					947	953		10.3109/07420528.2014.933841		7	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	AT9HC	WOS:000345237600001		
J	Sasaki, H; Ohtsu, T; Ikeda, Y; Tsubosaka, M; Shibata, S				Sasaki, Hiroyuki; Ohtsu, Teiji; Ikeda, Yuko; Tsubosaka, Miku; Shibata, Shigenobu			Combination of meal and exercise timing with a high-fat diet influences energy expenditure and obesity in mice	CHRONOBIOLOGY INTERNATIONAL			English	Article						Circadian rhythm; exercise; obesity; timing of meal and exercise	FOOD-INTAKE; DIFFERENTIAL ROLES; PHYSICAL-EXERCISE; LIPID-METABOLISM; CIRCADIAN CLOCKS; CALORIC-INTAKE; WEIGHT-GAIN; LONG-TERM; RATS; BREAKFAST	In mice, obesity has been observed not only in those freely fed a high-fat diet (HFD) but also in those fed while physically inactive. In contrast, a HFD during physically active periods protects against obesity and the impairments in the circadian rhythm induced by free feeding of a HFD. Although exercise is known to be effective for obesity prevention and management, the optimal timing of exercise has not yet been determined. In the present experiments, we aimed to determine the best combination of daily timing of HFD consumption and exercise for the prevention of HFD-induced weight gain in mice. In this experiment, "morning" refers to the beginning of the active phase (the "morning" for nocturnal animals). Increases in body weight related to free feeding of a HFD was significantly reduced with 4 h of exercise during the late (evening) or middle (noon) active period compared to 4 h of exercise during the early (morning) active period or free access to exercise, which resulted in hours of exercise similar to that of morning exercise. These results suggested that eating in the morning or at noon followed by exercise in the evening could prevent weight gain more effectively than exercise in the morning followed by eating at noon or in the evening. The group fed a HFD for 4 h in the morning had lower body weight than the group fed a HFD for 4 h in the evening without exercise. The last group of experiments tested the hypothesis that there would be an interaction between mealtime and exercise time (i.e. time of day) versus order (i.e. which comes first) effects. We compared groups that exercised for 4 h at noon and were fed either in the morning or evening and groups that were fed for 4 h at noon and either exercised in the morning or evening. We found that the groups that were fed before exercise gained less body and fat weight and more skeletal muscle weight compared to the groups that exercised before eating. Corresponding to the body and fat weight changes, the respiratory exchange ratio (RER) was lower and energy expenditure was higher in the groups fed before exercise than in the groups fed after exercise, and these effects on energy metabolism were also observed in the early stage of HFD feeding before obesity. When obese mice fed a HFD for 12 weeks were exposed to a combination of feeding and exercise timing in an effort to reduce body weight, eating followed by exercise resulted in greater weight loss, similar to the experiments conducted to prevent weight gain. These results demonstrate that a combination of daily timing of eating and exercise may influence weight gain and that eating followed by exercise may be effective for minimizing increases in body and fat weight as well as maximizing increases in skeletal muscle weight.	[Sasaki, Hiroyuki; Ohtsu, Teiji; Ikeda, Yuko; Tsubosaka, Miku; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Dept Physiol & Pharmacol, Shinjuku Ku, Tokyo 1628480, Japan	Sasaki, H (reprint author), Waseda Univ, Sch Adv Sci & Engn, Dept Physiol & Pharmacol, Shinjuku Ku, Tokyo 1628480, Japan.	shibatas@waseda.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23300278]	This study was partially supported by a Grant-in-Aid for Scientific Research (B) (23300278) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.S.).	Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Allen DL, 2001, J APPL PHYSIOL, V90, P1900; Bensimhon DR, 2006, AM HEART J, V151, P598, DOI 10.1016/j.ahj.2005.03.005; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Zhang JQ, 1998, J APPL PHYSIOL, V85, P1516; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Coelho DF, 2011, BRAZ J MED BIOL RES, V44, P966, DOI 10.1590/S0100-879X2011007500107; Katsanos CS, 2004, CLIN J SPORT MED, V14, P33, DOI 10.1097/00042752-200401000-00006; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bennard P, 2006, APPL PHYSIOL NUTR ME, V31, P502, DOI 10.1139/H06-027; Paoli A, 2011, INT J SPORT NUTR EXE, V21, P48; Curioni CC, 2005, INT J OBESITY, V29, P1168, DOI 10.1038/sj.ijo.0803015; Cheng MHY, 2009, APPETITE, V52, P193, DOI 10.1016/j.appet.2008.09.015; Tahara Y, 2013, NEUROSCIENCE, V253, P78, DOI 10.1016/j.neuroscience.2013.08.049; Solomon TPJ, 2008, J APPL PHYSIOL, V104, P1313, DOI 10.1152/japplphysiol.00890.2007; Bray MS, 2013, INT J OBESITY, V37, P843, DOI 10.1038/ijo.2012.137; Barwell ND, 2009, METABOLISM, V58, P1320, DOI 10.1016/j.metabol.2009.04.016; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR771, DOI 10.1152/ajpregu.00650.2003; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Schutz Y, 2004, PHYSIOL BEHAV, V83, P557, DOI 10.1016/j.physbeh.2004.09.015; Borer KT, 2005, APPETITE, V45, P177, DOI 10.1016/j.appet.2005.01.012; Farah NMF, 2013, BRIT J NUTR, V109, P2297, DOI 10.1017/S0007114512004448; Fuse Yuta, 2012, J Circadian Rhythms, V10, P4, DOI 10.1186/1740-3391-10-4; Hardman A E, 1995, J Cardiovasc Risk, V2, P71, DOI 10.1097/00043798-199502000-00011; HEBERT JA, 1975, P SOC EXP BIOL MED, V148, P646; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Hsieh SD, 2011, INTERNAL MED, V50, P2499, DOI 10.2169/internalmedicine.50.5844; KLEIN L, 1992, ATHEROSCLEROSIS, V97, P37, DOI 10.1016/0021-9150(92)90049-M; Li Min-Dian, 2012, Yale Journal of Biology and Medicine, V85, P387; LOPEZS A, 1975, P SOC EXP BIOL MED, V148, P640; SCHLIERF G, 1987, METABOLISM, V36, P726, DOI 10.1016/0026-0495(87)90107-7; Schneiter P, 1995, AM J PHYSIOL-ENDOC M, V269, pE1031; Shibata S, 2010, ADV DRUG DELIVER REV, V62, P918, DOI 10.1016/j.addr.2010.06.003; Sugiura H, 2001, J APPL PHYSIOL, V90, P789; Wang XY, 2013, GENES NUTR, V8, P457, DOI 10.1007/s12263-013-0333-y; WELLE S, 1984, AM J CLIN NUTR, V40, P990; Wu T, 2011, CHRONOBIOL INT, V28, P890, DOI 10.3109/07420528.2011.622599	40	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	NOV	2014	31	9					959	975		10.3109/07420528.2014.935785		17	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	AT9HC	WOS:000345237600003		
J	Obayashi, K; Saeki, K; Kurumatani, N				Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio			Association between light exposure at night and insomnia in the general elderly population: The HEIJO-KYO cohort	CHRONOBIOLOGY INTERNATIONAL			English	Article						Actigraphy; circadian rhythms; insomnia; light at night; melatonin; sleep quality	HUMAN CIRCADIAN PACEMAKER; BRIGHT LIGHT; OLDER-ADULTS; DEPRESSIVE SYMPTOMS; SLEEP DISTURBANCES; FOLLOW-UP; MELATONIN; SENSITIVITY; ALERTNESS; INITIATION	Chronic circadian misalignment between the internal and environmental rhythms, which is typically related to night-shift work and clock-gene variants, is associated with disruption of suprachiasmatic nucleus function and increased risk of insomnia. Under controlled laboratory conditions, light at night (LAN) suppresses melatonin secretion, delays the internal biological rhythm, and reduces sleepiness. Therefore, LAN exposure may cause circadian misalignment and insomnia, though it remains unclear in real-life situations whether LAN exposure is associated with insomnia. To evaluate an association between LAN exposure and sleep quality in home settings, we conducted a cross-sectional community-based study in 857 elderly individuals (mean age, 72.2 years). We evaluated bedroom light intensity using a light meter and subjectively and objectively measured sleep quality using the Pittsburgh Sleep Quality Index and an actigraph, respectively, along with urinary 6-sulfatoxymelatonin excretion. Compared with the lowest quartile group of LAN intensity, the highest quartile group revealed a significantly higher odds ratio (OR) for subjective insomnia in a multivariate model adjusted for age, gender, body mass index, daytime physical activity, urinary 6-sulfatoxymelatonin excretion, bedtime, rising time, and day length (adjusted OR, 1.61, 95% confidence interval, 1.05-2.45, p = 0.029). In addition, higher OR for subjective insomnia was significantly associated with the increase in quartiles of LAN intensity (p(trend) = 0.043). Consistently, we observed significant association trends between the increase in quartiles of LAN intensity and poorer actigraphic sleep quality, including decreased sleep efficiency, prolonged sleep-onset latency, increased wake-after-sleep onset, shortened total sleep time, and delayed sleep-mid time in multivariate models adjusted for the covariates mentioned above (all p(trend) < 0.001). In conclusion, we demonstrated that LAN exposure in home settings is significantly associated with both subjectively and objectively measured sleep quality in a community-based elderly population.	[Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio] Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, Kashiharashi, Nara 6348521, Japan	Obayashi, K (reprint author), Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, 840 Shijocho, Kashiharashi, Nara 6348521, Japan.	obayashi@naramed-u.ac.jp			Department of Indoor Environmental Medicine, Nara Medical University; Ministry of Education, Culture, Sports, Science and Technology; Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Japan Science and Technology Agency	All authors report no conflicts of interest. This work was supported by Grants from the Department of Indoor Environmental Medicine, Nara Medical University; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology; Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; and the Japan Science and Technology Agency.	Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Paudel ML, 2008, J AM GERIATR SOC, V56, P1228, DOI 10.1111/j.1532-5415.2008.01753.x; Lockley SW, 2006, SLEEP, V29, P161; Allebrandt KV, 2010, BIOL PSYCHIAT, V67, P1040, DOI 10.1016/j.biopsych.2009.12.026; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; Chang AM, 2012, J PHYSIOL-LONDON, V590, P3103, DOI 10.1113/jphysiol.2011.226555; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; Boudreau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070813; Levenson JC, 2013, J CLIN SLEEP MED, V9, P125, DOI 10.5664/jcsm.2404; EAKER ED, 1992, AM J EPIDEMIOL, V135, P854; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Obayashi K, 2014, CHRONOBIOL INT, V31, P461, DOI 10.3109/07420528.2013.840647; Calem M, 2012, SLEEP, V35, P377, DOI 10.5665/sleep.1700; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Dew MA, 2003, PSYCHOSOM MED, V65, P63, DOI 10.1097/01.PSY.0000039756.23250.7C; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Fonken LK, 2012, J BIOL RHYTHM, V27, P319, DOI 10.1177/0748730412448324; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Obayashi K, 2012, J CLIN ENDOCR METAB, V97, P4166, DOI 10.1210/jc.2012-1873; Yokoyama E, 2010, SLEEP, V33, P1693; Walsh JK, 2011, SLEEP, V34, P997, DOI 10.5665/SLEEP.1150; Bedrosian TA, 2013, MOL PSYCHIATR, V18, P930, DOI 10.1038/mp.2012.96; Baskett JJ, 1998, J PINEAL RES, V24, P58, DOI 10.1111/j.1600-079X.1998.tb00366.x; Burgess Helen J, 2003, Behav Sleep Med, V1, P102, DOI 10.1207/S15402010BSM0102_3; Dijk DJ, 1997, J BIOL RHYTHM, V12, P627, DOI 10.1177/074873049701200618; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Maglione JE, 2012, J AM GERIATR SOC, V60, P635, DOI 10.1111/j.1532-5415.2012.03908.x; PRINZ PN, 1990, NEW ENGL J MED, V323, P520	31	6	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	NOV	2014	31	9					976	982		10.3109/07420528.2014.937491		7	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	AT9HC	WOS:000345237600004		
J	Osonoi, Y; Mita, T; Osonoi, T; Saito, M; Tamasawa, A; Nakayama, S; Someya, Y; Ishida, H; Kanazawa, A; Gosho, M; Fujitani, Y; Watada, H				Osonoi, Yusuke; Mita, Tomoya; Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Nakayama, Shiho; Someya, Yuki; Ishida, Hidenori; Kanazawa, Akio; Gosho, Masahiko; Fujitani, Yoshio; Watada, Hirotaka			Morningness-eveningness questionnaire score and metabolic parameters in patients with type 2 diabetes mellitus	CHRONOBIOLOGY INTERNATIONAL			English	Article						Biochemical parameters; morningness-eveningness questionnaire; type 2 diabetes mellitus	PHYSICAL-ACTIVITY QUESTIONNAIRE; SLEEP QUALITY INDEX; CIRCADIAN-RHYTHMS; FOOD-INTAKE; VALIDITY; RELIABILITY; RISK; VALIDATION; DURATION; OBESITY	"Morningness'' and "Eveningness'' represent lifestyle patterns including sleep-wake patterns. Although previous studies described a relationship between the morningness-eveningness trait and glycemic control in patients with type 2 diabetes mellitus (T2DM), the mechanism underlying this association remains unknown. The study participants comprised 725 Japanese T2DM outpatients free of history of cardiovascular diseases. Various lifestyles were analyzed using self-reported questionnaires, including morningness-eveningness questionnaire (MEQ). The relationships between morningness-eveningness trait and various biochemical parameters were investigated by linear regression analysis and logistic regression analysis. We classified the study patients into three groups, morning type (n = 117), neither type (n = 424) and evening type (n = 184). Subjects of the evening type had high levels of alanine aminotransferase, triglyceride, fasting blood glucose and HbA1c and low high-density lipoprotein-cholesterol level in a model adjusted for age and gender. Furthermore, multivariate analysis showed that the evening type was associated with high HbA1c and estimated glomerular filtration rate even after adjustment for other lifestyle factors known to affect metabolic control. The results suggest that T2DM patients with eveningness trait are under inadequate metabolic control independent of other lifestyle factors. Thus, the evening trait of T2DM patients represents an important target for intervention to ensure appropriate metabolic function.	[Osonoi, Yusuke; Mita, Tomoya; Nakayama, Shiho; Someya, Yuki; Kanazawa, Akio; Fujitani, Yoshio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Bunkyo Ku, Tokyo 1138421, Japan; [Mita, Tomoya; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Mol Diabetol, Tokyo 1138421, Japan; [Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Ishida, Hidenori] Naka Mem Clin, Naka, Ibaraki, Japan; [Kanazawa, Akio; Watada, Hirotaka] Juntendo Univ, Sch Med, Ctr Therapeut Innovat Diabet, Tokyo, Japan; [Gosho, Masahiko] Aichi Med Univ, Adv Med Res Ctr, Unit Biostat, Nagakute, Aichi 48011, Japan; [Fujitani, Yoshio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Beta Cell Biol & Regenerat, Tokyo 113, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Sportol Ctr, Bunkyo Ku, Tokyo 113, Japan	Mita, T (reprint author), Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	tom-m@juntendo.ac.jp			MSD; Takeda; Eli Lilly; Boehringer Ingelheim; Sanofi-Aventis; Ono Pharmaceutical Co.; Novo Nordisk Pharma; Kissei Pharma; Mitsubishi Tanabe Pharma; Novartis Pharmaceuticals; Sanwakagaku Kenkyusho; Daiichi Sankyo Inc.; Takeda Pharmaceutical Co.; Dainippon Sumitomo Pharm; Kowa Co.; Pfizer; Mochida Pharmaceutical Co.; Terumo Corp; Shionogi; Pharma; Astrazeneca	T.M. received research funds from MSD, Takeda and Eli Lilly. T.O. has received lecture fees from Boehringer Ingelheim, Sanofi-Aventis, Ono Pharmaceutical Co., Novo Nordisk Pharma, Kissei Pharma, Mitsubishi Tanabe Pharma, Novartis Pharmaceuticals, Sanwakagaku Kenkyusho, Daiichi Sankyo Inc., Takeda Pharmaceutical Co., MSD, Dainippon Sumitomo Pharm. and Kowa Co. and research funds from Novo Nordisk Pharma and Dainippon Sumitomo Pharma. A.K. has received lecture fees from Kissei Pharma, Sanofi-Aventis and Takeda Pharmaceutical Co. M.G. has received lecture fees from Novartis Pharmaceuticals. Y.F. has received lecture fees from Novartis Pharmaceuticals and Eli Lilly, research funds from Novartis Pharmaceuticals, MSD and Takeda Pharmaceutical Co. H.W. has received lecture fees from Boehringer Ingelheim, Sanofi-Aventis, Ono Pharmaceutical Co., Novo Nordisk Pharma, Novartis Pharmaceuticals, Eli Lilly, Sanwakagaku Kenkyusho, Daiichi Sankyo Inc., Takeda Pharmaceutical Co., MSD, Dainippon Sumitomo Pharm., Kowa Co. and research funds from Boehringer Ingelheim, Pfizer, Mochida Pharmaceutical Co., Sanofi-Aventis, Novo Nordisk Pharma, Novartis Pharmaceuticals, Sanwakagaku Kenkyusho, Terumo Corp. Eli Lilly, Mitsubishi Tanabe Pharma, Daiichi Sankyo Inc., Takeda Pharmaceutical Co., MSD, Shionogi, Pharma, Dainippon Sumitomo Pharma, Kissei Pharma and Astrazeneca.	Agency SaT, 2005, STAND TABL FOOD COMP; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Klerman EB, 2005, J BIOL RHYTHM, V20, P375, DOI 10.1177/0748730405278353; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Ohkuma T, 2013, DIABETES CARE, V36, P611, DOI 10.2337/dc12-0904; Reutrakul S, 2013, DIABETES CARE, V36, P2523, DOI 10.2337/dc12-2697; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Kojima M, 2002, PSYCHIAT RES, V110, P291, DOI 10.1016/S0165-1781(02)00106-3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Maeda Y, 2014, DIABETES CARE, V37, P2383, DOI 10.2337/dc13-1886; Baron KG, 2013, APPETITE, V60, P246, DOI 10.1016/j.appet.2012.09.026; Merikanto I, 2013, CHRONOBIOL INT, V30, P470, DOI 10.3109/07420528.2012.741171; Williams CJ, 2007, DIABETES CARE, V30, P1233, DOI 10.2337/dc06-2107; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Lee JH, 2014, CHRONOBIOL INT, V31, P479, DOI 10.3109/07420528.2013.867864; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Balkau B, 2004, DIABETOLOGIA, V47, P2118, DOI 10.1007/s00125-004-1574-5; Taillard J, 2004, J BIOL RHYTHM, V19, P76, DOI 10.1177/074830403259849; Beck A. T., 1996, MANUAL BECK DEPRESSI; Beliard S, 2012, ANN ENDOCRINOL-PARIS, V73, P523, DOI 10.1016/j.ando.2012.09.006; Broms U, 2011, ADDICTION, V106, P170, DOI 10.1111/j.1360-0443.2010.03112.x; Hone JA, 1976, INT J CHRONOBIOL, V4, P97; ISHIHARA K, 1986, JPN J PSYCHOL, V57, P87; Iwasaki M, 2013, J DIABETES INVEST, V4, P376, DOI 10.1111/jdi.12047; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200; Murase N, 2002, J HLTH WELFARE STAT, V49, P1; OSTBERG O, 1973, ERGONOMICS, V16, P203, DOI 10.1080/00140137308924497; Tsuchida Y, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-9; Wan Mahmood WA, 2013, INT J ENDOCRINOL, V2013	37	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	NOV	2014	31	9					1017	1023		10.3109/07420528.2014.943843		7	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	AT9HC	WOS:000345237600008		
J	Nagashima, H; Sakamoto, Y; Ogata, H; Miyamoto, J; Yazawa, M; Kishi, K				Nagashima, Hayato; Sakamoto, Yoshiaki; Ogata, Hisao; Miyamoto, Junpei; Yazawa, Masaki; Kishi, Kazuo			Evaluation of Bone Volume After Secondary Bone Grafting in Unilateral Alveolar Cleft Using Computer-Aided Engineering	CLEFT PALATE-CRANIOFACIAL JOURNAL			English	Article						alveolar cleft; computer-aided engineering; iliac bone; MDCT; secondary bone graft	PALATE PATIENTS; LIP; TOMOGRAPHY; EXPERIENCE; SCANS	The purpose of this study was to evaluate the initial defect and the outcome of bone grafts for unilateral alveolar cleft. To determine the absorption of the bone graft in patients with unilateral cleft, computer-aided engineering (CAE) with multi-detector row computed tomography (MDCT) was used. MDCT scans of 29 patients were taken immediately preoperatively and at 1 month and 6 months postoperatively. The patients underwent bone grafting between 8 and 14 years of age using iliac crest bone grafts. Three-dimensional models were created in each period, and the defect at the alveolar cleft and volume of the bone graft were determined in each patient using CAE. Cleft volume and success of alveolar bone grafting were significantly correlated (P < .01). Alveolar clefts with cleft palate required more bone volume than those without cleft palate (P < .01), but the resorption rate did not significantly differ between alveolar clefts with and without cleft palate (0.48 +/- 0.14 and 0.49 +/- 0.18, respectively; P = .93). In conclusion, three-dimensional reconstruction of bone grafts using CAE based on MDCT provides a valuable objective assessment of graft volume.	[Nagashima, Hayato; Sakamoto, Yoshiaki; Ogata, Hisao; Miyamoto, Junpei; Yazawa, Masaki; Kishi, Kazuo] Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 1608582, Japan	Sakamoto, Y (reprint author), Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Shinjuku Ward, 35 Shinanomachi, Tokyo 1608582, Japan.	ysakamoto@z8.keio.jp					Shirota T, 2010, INT J ORAL MAX SURG, V39, P904, DOI 10.1016/j.ijom.2010.04.050; BORSTLAP WA, 1990, J CRANIO MAXILL SURG, V18, P201, DOI 10.1016/S1010-5182(05)80411-1; TESSIER P, 1982, CLIN PLAST SURG, V9, P531; Kindelan JD, 1997, CLEFT PALATE-CRAN J, V34, P195, DOI 10.1597/1545-1569(1997)034<0195:RAOSAA>2.3.CO;2; Nakajima T, 2008, J PLAST RECONSTR AES, V61, P870, DOI 10.1016/j.bjps.2007.06.003; Rosenstein SW, 1997, CLEFT PALATE-CRAN J, V34, P199, DOI 10.1597/1545-1569(1997)034<0199:CODCFP>2.3.CO;2; Dempf R, 2002, CLEFT PALATE-CRAN J, V39, P18, DOI 10.1597/1545-1569(2002)039<0018:ABGIPW>2.0.CO;2; BOYNE PJ, 1972, J ORAL SURG, V30, P87; Bardach J, 1995, OPERATIVE TECHNIQUES, V2, P211, DOI [DOI 10.1016/S1071-0949(06)80034-X, 10.1016/51071-0949(06)80034-X]; Bergland O, 1986, CLEFT PALATE-CRAN J, V23, P75; Bongartz G, EUROPEAN GUIDELINES; BRATTSTROM V, 1992, SCAND J PLAST RECONS, V26, P197; ENEMARK H, 1985, INT J ORAL MAXILLOF, V14, P2, DOI 10.1016/S0300-9785(85)80003-X; Feichtinger M, 2008, BRIT J ORAL MAX SURG, V46, P278, DOI 10.1016/j.bjoms.2007.12.010; Kalaaji A, 2001, SCAND J PLAST RECONS, V35, P35; Newlands LC, 2000, BRIT J ORAL MAX SURG, V38, P488, DOI 10.1054/bjom.2000.0300; ROSENSTEIN S, 1991, PLAST RECONSTR SURG, V87, P644, DOI 10.1097/00006534-199104000-00006; SINDETPEDERSEN S, 1990, J ORAL MAXIL SURG, V48, P554; Van der Meij AJW, 2001, ORAL SURG ORAL MED O, V92, P136, DOI 10.1067/moe.2001.115274	19	1	1	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1545-1569	1055-6656		CLEFT PALATE-CRAN J	Cleft Palate-Craniofac. J.	NOV	2014	51	6					665	668		10.1597/13-045		4	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AT4UI	WOS:000344938100013		
J	Suzuki, A; Sasaguri, M; Hiura, K; Yasunaga, A; Mitsuyasu, T; Kubota, Y; Ninomiya, T; Takenoshita, Y				Suzuki, Akira; Sasaguri, Masaaki; Hiura, Kenji; Yasunaga, Atsushi; Mitsuyasu, Takeshi; Kubota, Yasutaka; Ninomiya, Tomohiro; Takenoshita, Yasuharu			Can Occlusal Evaluation of Children With Unilateral Cleft Lip and Palate Help Determine Future Maxillofacial Morphology?	CLEFT PALATE-CRANIOFACIAL JOURNAL			English	Article						cephalometrics; Goslon yardstick; maxillofacial growth; occlusal evaluation; prospective longitudinally study	DENTAL ARCH RELATIONSHIPS; ADVISORY GROUP CSAG; ONE-STAGE REPAIR; GOSLON YARDSTICK; SURGICAL TECHNIQUES; CRANIOFACIAL FORM; UNITED-KINGDOM; FACIAL GROWTH; PART 1; INFANT ORTHOPEDICS	Objective: To investigate the change in occlusal evaluations from the 5-year-olds' index to the Goslon Yardstick and to compare the relationship between the evaluations and maxillofacial growth in patients with complete unilateral cleft lip and palate (UCLP). Design: A prospective longitudinal study. Subjects: The sample consisted of 85 patients with complete UCLP who underwent surgery from 1969 to 1994 and were treated at the Kyushu University Hospital in Fukuoka, Japan. Subjects had two serial dental casts performed at the ages of 5 and 10 years. Furthermore, each patient had lateral cephalographs taken at the age of 5 years, 76 of 85 subjects had films taken at the age of 10 years, and 54 subjects also had lateral cephalograms taken after the age of 15 years. Methods: Every dental cast was evaluated by the 5-year-olds' index and the Goslon Yardstick, respectively. The lateral cephalographs were traced and digitized, and angular dimensions were calculated. Outcomes were compared using Spearman's rank-order correlation analysis and the Kruskal-Wallis analysis. Results and Conclusion: Dental arch relationships were evaluated and rated as 2.96 in the 5-year-olds' index and 2.85 in the Goslon Yardstick, respectively. Both groupings showed a significant relationship, and they showed no change in 36 out of 85 subjects (42.3%), significant improvement in 30 (35.3%), and deterioration in 19 (22.3%). Two occlusal groupings and maxillofacial morphology on the cephalographs indicated that the grouping reflected the anteroposterior position of the mandible. Moreover, both groupings showed some relation to previous maxillofacial growth, but they did not show any relationship with future growth. The Goslon Yardstick may not predict maxillofacial morphology in adulthood.	[Suzuki, Akira; Yasunaga, Atsushi] Kyushu Univ Hosp, Dept Orthodont, Fukuoka 8128582, Japan; [Sasaguri, Masaaki; Mitsuyasu, Takeshi; Kubota, Yasutaka; Ninomiya, Tomohiro; Takenoshita, Yasuharu] Kyushu Univ, Dept Oral & Maxillofacial Surg, Fukuoka 812, Japan; [Hiura, Kenji] Hiura Orthodont Clin, Fukuoka, Japan	Suzuki, A (reprint author), Kyushu Univ Hosp, Dept Orthodont, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	suzuki@dent.kyushu-u.ac.jp			Scientific Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology [21592598]	The main part of this study was supported by the Scientific Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology No. 21592598.	Alam MK, 2008, ORTHODONTIC WAVE, V67, P45, DOI 10.1016/j.odw.2007.12.001; Brattstrom V, 2005, CLEFT PALATE-CRAN J, V42, P69, DOI 10.1597/02-119.2.1; Lilja J, 2006, CLEFT PALATE-CRAN J, V43, P606, DOI 10.1597/05-069; Williams AC, 2001, CLEFT PALATE-CRAN J, V38, P24, DOI 10.1597/1545-1569(2001)038<0024:CLAPCI>2.0.CO;2; Sinko K, 2008, CLEFT PALATE-CRAN J, V45, P87, DOI 10.1597/06-118.1; Hsieh YJ, 2012, CLIN ORAL INVEST, V16, P1261, DOI 10.1007/s00784-011-0601-4; NOVERRAZ AEM, 1993, CLEFT PALATE-CRAN J, V30, P391, DOI 10.1597/1545-1569(1993)030<0391:TOHPCA>2.3.CO;2; Russell K, 2011, CLEFT PALATE-CRAN J, V48, P265, DOI 10.1597/09-187.1; Atack NE, 1997, CLEFT PALATE-CRAN J, V34, P242, DOI 10.1597/1545-1569(1997)034<0242:ANIFAS>2.3.CO;2; Hathaway R, 2011, CLEFT PALATE-CRAN J, V48, P244, DOI 10.1597/09-181.1; Williams AC, 2003, PLAST RECONSTR SURG, V111, P586, DOI 10.1097/01.PRS.0000041946.98451.FB; Semb G, 2005, CLEFT PALATE-CRAN J, V42, P64, DOI 10.1597/02-119.1.1; Sandy JR, 2001, CLEFT PALATE-CRAN J, V38, P20, DOI 10.1597/1545-1569(2001)038<0020:CLAPCI>2.0.CO;2; Love R, 2012, CLEFT PALATE-CRAN J, V49, P456, DOI 10.1597/10-111; Bongaarts CAM, 2004, CLEFT PALATE-CRAN J, V41, P633, DOI 10.1597/03-051.1; Nollet PJPM, 2005, CLEFT PALATE-CRAN J, V42, P512, DOI 10.1597/04-129.1; MARS M, 1987, CLEFT PALATE J, V24, P314; Bearn D, 2001, CLEFT PALATE-CRAN J, V38, P38, DOI 10.1597/1545-1569(2001)038<0038:CLAPCI>2.0.CO;2; TENNISON CW, 1952, PLAST RECONSTR SURG, V9, P115, DOI 10.1097/00006534-195202000-00005; MILLARD DR, 1958, AM J SURG, V95, P318, DOI 10.1016/0002-9610(58)90525-7; Long RE, 2011, CLEFT PALATE-CRAN J, V48, P239, DOI 10.1597/09-180.1; Friede H, 1998, ACTA ODONTOL SCAND, V56, P346, DOI 10.1080/000163598428293; BRATTSTROM V, 1991, SCAND J PLAST RECONS, V25, P259; Capelozza L, 1996, CLEFT PALATE-CRAN J, V33, P51, DOI 10.1597/1545-1569(1996)033<0051:IIOLAP>2.3.CO;2; Chan KT, 2003, CLEFT PALATE-CRAN J, V40, P511, DOI 10.1597/1545-1569(2003)040<0511:TEOAIO>2.0.CO;2; Choudhary S, 2003, PLAST RECONSTR SURG, V111, P576, DOI 10.1097/01.PRS.0000041945.51785.58; Cronin T D, 1966, Cleft Palate J, V3, P376; Daskalogiannakis J, 2011, CLEFT PALATE-CRAN J, V48, P252, DOI 10.1597/09-185.1; Daskalogiannakis J, 2006, CLEFT PALATE-CRAN J, V43, P471; FRIEDE H, 1982, SCAND J PLAST RECONS, V16, P41; FRIEDE H, 1994, SCAND J PLAST RECONS, V28, P113; Fudalej P, 2009, CLEFT PALATE-CRAN J, V46, P648, DOI 10.1597/09-010.1; Fudalej P, 2009, CLEFT PALATE-CRAN J, V46, P374, DOI 10.1597/07-242.1; Gaggl A, 2003, J CRANIO MAXILL SURG, V31, P20, DOI 10.1016/S1010-5182(02)00142-7; Gaukroger Maren J, 2002, J Orthod, V29, P113, DOI 10.1093/ortho/29.2.113; Hirano Y, 2007, J JPN CLEFT PALATE A, V32, P68; Johnston CD, 2004, CLEFT PALATE-CRAN J, V41, P42, DOI 10.1597/03-027; MARS M, 1992, CLEFT PALATE-CRAN J, V29, P405, DOI 10.1597/1545-1569(1992)029<0405:ASCISO>2.3.CO;2; MARS M, 1990, CLEFT PALATE J, V27, P7, DOI 10.1597/1545-1569(1990)027<0007:APSOFG>2.3.CO;2; Mlsted K, 2005, CLEFT PALATE-CRAN J, V42, P78; Mlsted K, 1992, CLEFT PALATE-CRAN J, V29, P398; MORRIS T, 1994, CLEFT PALATE-CRAN J, V31, P142, DOI 10.1597/1545-1569(1994)031<0142:IOAAOM>2.3.CO;2; Nollet PJPM, 2005, PLAST RECONSTR SURG, V116, P1255, DOI 10.1097/01.prs.0000181652.84855.a3; Okazaki M, 2002, J JPN CLEFT PALATE A, V27, P47; Onizuka T, 1975, STANDARD PLASTIC SUR, P213; PALMER CR, 1969, CAN J SURG, V12, P32; Peng Zhao-wei, 2008, Zhonghua Kou Qiang Yi Xue Za Zhi, V43, P414; Prahl-Andersen B, 2006, ANGLE ORTHOD, V76, P265; RANDALL P, 1959, Plast Reconstr Surg Transplant Bull, V23, P331, DOI 10.1097/00006534-195904000-00003; Renkielska A, 2005, ANN PLAS SURG, V54, P595, DOI 10.1097/01.sap.0000158067.17992.af; Ross RB, 1987, CLEFT PALATE J, V24, P71; SEMB G, 1991, CLEFT PALATE-CRAN J, V28, P40, DOI 10.1597/1545-1569(1991)028<0040:SSBAFG>2.3.CO;2; SHAW WC, 1992, CLEFT PALATE-CRAN J, V29, P393, DOI 10.1597/1545-1569(1992)029<0393:ASCISO>2.3.CO;2; SHAW WC, 1992, CLEFT PALATE-CRAN J, V29, P413, DOI 10.1597/1545-1569(1992)029<0413:ASCISO>2.3.CO;2; Shaw WC, 2005, CLEFT PALATE-CRAN J, V42, P93, DOI 10.1597/02-119.5.1; Singh GD, 2004, CLEFT PALATE-CRAN J, V41, P136, DOI 10.1597/02-166; Southall P, 2012, CLEFT PALATE-CRAN J, V49, P215, DOI 10.1597/10-096; Susami T, 2006, CLEFT PALATE-CRAN J, V43, P96, DOI 10.1597/04-117R.1; Suzuki A, 2007, CLEFT PALATE-CRAN J, V44, P434, DOI 10.1597/06-069.1; SUZUKI A, 1991, AM J ORTHOD DENTOFAC, V99, P107, DOI 10.1016/0889-5406(91)70113-B; Suzuki A, 1996, CLEFT PALATE-CRAN J, V33, P429, DOI 10.1597/1545-1569(1996)033<0429:CCOCMB>2.3.CO;2; Trenouth MJ, 1999, BRIT J ORAL MAX SURG, V37, P19, DOI 10.1054/bjom.1998.0423; Wardell WEM, 1937, BRIT J SURG, V25, P117, DOI 10.1002/bjs.1800259715; Yamanishi T, 2009, J ORAL MAXIL SURG, V67, P2210, DOI 10.1016/j.joms.2009.04.038; Zreaqat M, 2009, CLEFT PALATE-CRAN J, V46, P326, DOI 10.1597/07-210.1	65	0	0	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1545-1569	1055-6656		CLEFT PALATE-CRAN J	Cleft Palate-Craniofac. J.	NOV	2014	51	6					696	706		10.1597/12-103		11	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AT4UI	WOS:000344938100017		
J	Fukunaga, T; Honjo, T; Sakai, Y; Sasaki, K; Takano-Yamamoto, T; Yamashiro, T				Fukunaga, Tomohiro; Honjo, Tadashi; Sakai, Yuichi; Sasaki, Kiyo; Takano-Yamamoto, Teruko; Yamashiro, Takashi			A Case Report of Multidisciplinary Treatment of an Adult Patient With Bilateral Cleft Lip and Palate	CLEFT PALATE-CRANIOFACIAL JOURNAL			English	Article						BCLP; jaw movement; long-term stability; orthodontic treatment	RAPID MAXILLARY EXPANSION; ALVEOLAR CLEFT; ORTHODONTIC TREATMENT; RESIDUAL ALVEOLAR; CLINICAL REPORT; BONE; SECONDARY; MALOCCLUSION; PERFORMANCE; MANAGEMENT	This is a case report about the successful orthodontic treatment of a bilateral cleft lip and palate patient by using a combination of bone grafting and subsequent prosthodontic rehabilitation. An adult patient with a bilateral cleft lip and palate presented with a concave profile, anterior and lateral crossbite, a markedly deep overbite, and residual bilateral alveolar clefts. His jaw movement patterns were unstable and irregular due to his collapsed bite. Orthodontic treatment with bilateral bone grafting improved his concave profile by downward and backward rotation of the mandible within the freeway space, and optimum occlusion and functionally stable and smooth jaw movements were obtained. After a 6-year retention period, no skeletal relapse could be detected, and his occlusal stability was satisfactory.	[Fukunaga, Tomohiro; Sakai, Yuichi; Sasaki, Kiyo; Takano-Yamamoto, Teruko] Tohoku Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Sendai, Miyagi 980, Japan; [Honjo, Tadashi; Yamashiro, Takashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthodont & Dentofacial Orthoped, Okayama 7008525, Japan	Yamashiro, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthodont & Dentofacial Orthoped, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	yamataka@md.oakayama-u.ac.jp					ADLAM DM, 1989, BRIT J ORAL MAX SURG, V27, P265, DOI 10.1016/0266-4356(89)90037-5; AHLGREN J, 1967, ACTA ODONTOL SCAND, V25, P3, DOI 10.3109/00016356709072519; Bajaj AK, 2003, J CRANIOFAC SURG, V14, P840, DOI 10.1097/00001665-200311000-00005; Cohlmia JT, 1996, ANGLE ORTHOD, V66, P27; ABYHOLM FE, 1981, SCAND J PLAST RECONS, V15, P15; NICHOLSON PT, 1989, EUR J ORTHODONT, V11, P186; WILDING RJC, 1994, ARCH ORAL BIOL, V39, P333, DOI 10.1016/0003-9969(94)90125-2; RANTA R, 1986, AM J ORTHOD DENTOFAC, V90, P11, DOI 10.1016/0889-5406(86)90022-3; PIRTTINIEMI P, 1990, EUR J ORTHODONT, V12, P408; BERGLAND O, 1986, CLEFT PALATE J, V23, P175; BOYNE PJ, 1972, J ORAL SURG, V30, P87; BOYNE PJ, 1976, AM J ORTHOD DENTOFAC, V70, P20, DOI 10.1016/0002-9416(76)90258-X; BISHARA SE, 1977, ANGLE ORTHOD, V47, P34; CRONIN DG, 1980, CLEFT PALATE J, V17, P116; da Silva Filho O G, 2000, Angle Orthod, V70, P174; DAHL E, 1979, CLEFT PALATE J, V16, P34; Ehmer U, 1992, Int J Adult Orthodon Orthognath Surg, V7, P153; KALAAJI A, 1994, PLAST RECONSTR SURG, V93, P690, DOI 10.1097/00006534-199404000-00005; Kamakura S, 2003, CLEFT PALATE-CRAN J, V40, P449, DOI 10.1597/1545-1569(2003)040<0449:PROTSA>2.0.CO;2; LEE C, 1995, PLAST RECONSTR SURG, V96, P1534, DOI 10.1097/00006534-199512000-00004; Lilja J, 2000, CLEFT PALATE-CRAN J, V37, P98, DOI 10.1597/1545-1569(2000)037<0098:CBGADC>2.3.CO;2; Maki K, 2003, Orthod Craniofac Res, V6 Suppl 1, P52, DOI 10.1034/j.1600-0544.2003.235.x; Miyawaki S, 1997, CLEFT PALATE-CRAN J, V34, P533, DOI 10.1597/1545-1569(1997)034<0531:ICARUC>2.3.CO;2; Owens S, 2002, AM J ORTHOD DENTOFAC, V121, P602, DOI 10.1067/mod.2002.122829; Sawaki M, 2008, ACTA MED OKAYAMA, V62, P59; Scolozzi P, 2007, PLAST RECONSTR SURG, V119, P2200, DOI 10.1097/01.prs.0000260770.48769.dc; Shibusawa T., 2000, ORTHOD WAVES, V59, P237; SINDETPEDERSEN S, 1985, INT J ORAL MAXILLOF, V14, P389, DOI 10.1016/S0300-9785(85)80071-5; Susami T, 1996, CLEFT PALATE-CRAN J, V33, P445, DOI 10.1597/1545-1569(1996)033<0445:OTOACP>2.3.CO;2; Tokiwa H., 2001, J JPN SOC STOMATOGNA, V7, P13; Tuncer BB, 2009, J CRANIO MAXILL SURG, V37, P312, DOI 10.1016/j.jcms.2009.01.004; Ueda R, 1993, J JPN PROSTHODONT SO, p[37, 761]; Vojvodic D, 1996, J PROSTHET DENT, V76, P230, DOI 10.1016/S0022-3913(96)90163-8; Wada K, 1981, J KANAZAWA MED U, V6, P60; Wang DH, 2009, J ORAL MAXIL SURG, V67, P2238, DOI 10.1016/j.joms.2009.04.075; Watanabe I, 2005, J ORAL REHABIL, V32, P620, DOI 10.1111/j.1365-2842.2005.01468.x; Yamamoto I., 1988, J JPN CLEFT PALATE A, V13, P271; ZIMMER B, 1991, EUR J ORTHODONT, V13, P27	38	0	0	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1545-1569	1055-6656		CLEFT PALATE-CRAN J	Cleft Palate-Craniofac. J.	NOV	2014	51	6					711	721		10.1597/11-113		11	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AT4UI	WOS:000344938100019		
J	Kamatani, T; Shirota, T; Kondo, S; Shintani, S				Kamatani, T.; Shirota, T.; Kondo, S.; Shintani, S.			Ultrasound-Guided Surgery of Particulate Cancellous Bone and Marrow From the Iliac Crest for Cleft Palate	CLEFT PALATE-CRANIOFACIAL JOURNAL			English	Article						cleft palate; guided surgery; particulate cancellous bone and marrow; ultrasound echo	MORBIDITY	Minimally invasive procedures for treatment of disease have become increasingly popular and require specialized instruments and precise imaging guidance. We here propose a technique of minimally invasive surgery with ultrasound echo-guided procedures as a less traumatic and invasive procedure to get particulate cancellous bone and marrow from the iliac crest for cleft palate. This technique has been used successfully at our institutions. Our experience suggests that it can provide reliable ultrasound echo imaging-guided surgery.	[Kamatani, T.; Shirota, T.; Kondo, S.; Shintani, S.] Showa Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Ota, Tokyo 1458515, Japan	Kamatani, T (reprint author), Showa Univ, Sch Dent, 2-1-1 Kitasenzoku, Ota, Tokyo 1458515, Japan.	kamatani@dent.showa-u.ac.jp					Schaaf H, 2010, ORAL SURG ORAL MED O, V109, P52, DOI 10.1016/j.tripleo.2009.08.023; BOYNE PJ, 1976, AM J ORTHOD DENTOFAC, V70, P20, DOI 10.1016/0002-9416(76)90258-X; Samii VF, 1999, VET RADIOL ULTRASOUN, V40, P82, DOI 10.1111/j.1740-8261.1999.tb01843.x; TAYAPONGSAK P, 1994, ORAL SURG ORAL MED O, V78, P296, DOI 10.1016/0030-4220(94)90057-4	4	0	0	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1545-1569	1055-6656		CLEFT PALATE-CRAN J	Cleft Palate-Craniofac. J.	NOV	2014	51	6					743	744		10.1597/13-054		2	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AT4UI	WOS:000344938100024		
J	Yogi, A; Koga, T; Azama, K; Higa, D; Ogawa, K; Watanabe, T; Ishiuchi, S; Murayama, S				Yogi, Akira; Koga, Tomomi; Azama, Kimei; Higa, Daichi; Ogawa, Kazuhiko; Watanabe, Takashi; Ishiuchi, Shogo; Murayama, Sadayuki			Usefulness of the apparent diffusion coefficient (ADC) for predicting the consistency of intracranial meningiomas	CLINICAL IMAGING			English	Article						Meningioma; Consistency; DWI; ADC	ACOUSTIC STRAIN WAVES; PEDIATRIC BRAIN; GRADE; ECHO; MRI; CELLULARITY; ANISOTROPY; GLIOMAS; TUMORS	Meningioma consistency is an important factor for surgical treatment. Tumor cellularity and fibrous tissue contribute to the consistency of tumors, and it is proposed that the minimum apparent diffusion coefficient (ADC) value is significantly correlated with meningioma consistency. Twenty-seven consecutive patients with 28 meningiomas were retrospectively enrolled. Minimum ADC values in meningiomas with a hard consistency were significantly lower than those with a soft consistency. The minimum ADC value might have clinical use as a predictor of meningioma consistency. (C) 2014 Elsevier Inc. All rights reserved.	[Yogi, Akira; Koga, Tomomi; Azama, Kimei; Higa, Daichi; Ogawa, Kazuhiko; Murayama, Sadayuki] Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Okinawa 9030215, Japan; [Ogawa, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Osaka, Japan; [Watanabe, Takashi; Ishiuchi, Shogo] Univ Ryukyus, Grad Sch Med Sci, Okinawa 9030215, Japan	Yogi, A (reprint author), Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, 207 Uehara,Nishihara Cho, Okinawa 9030215, Japan.	jxo98ayg@med.u-ryukyu.ac.jp					Kashimura H, 2007, J NEUROSURG, V107, P784, DOI 10.3171/JNS-07/10/0784; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; EIS M, 1995, MAGN RESON MED, V34, P835, DOI 10.1002/mrm.1910340608; Holdsworth SJ, 2011, AM J NEURORADIOL, V32, P1274, DOI 10.3174/ajnr.A2481; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Castillo M, 2001, AM J NEURORADIOL, V22, P60; Higano S, 2006, RADIOLOGY, V241, P839, DOI 10.1148/radiol.2413051276; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Klaeboe L, 2005, INT J CANCER, V117, P996, DOI 10.1002/ijc.21255; Maiuri F, 1999, EUR J RADIOL, V31, P69, DOI 10.1016/S0720-048X(98)00083-7; Muthupillai R, 1996, MAGNET RESON MED, V36, P266, DOI 10.1002/mrm.1910360214; Mahmoud OM, 2011, EUR J RADIOL, V80, P412, DOI 10.1016/j.ejrad.2010.05.023; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Belinda A, 2009, AM J CLIN ONCOL-CANC, V32, P73; CHEN TC, 1992, NEUROSURGERY, V31, P1015; Dobes Martin, 2011, Surg Neurol Int, V2, P176, DOI 10.4103/2152-7806.90696; EIS M, 1994, ACT NEUR S, V60, P344; Fujimoto K, 2011, RADIOLOGY, V258, P739, DOI 10.1148/radiol.10100853; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449; Hiwatashi A, 2014, AM J NEURORADIOL, V35, P95, DOI 10.3174/ajnr.A3620; Hoffman SPJ, 2009, NEURO-ONCOLOGY, V8, P27; Hoover JM, 2011, SURG NEUROL INT, V2, P142, DOI [10.4103/2152-7806.85983, DOI 10.4103/2152-7806.85983]; Majda M, 2010, DIAGNOSTIC IMAGING B; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Sitthinamsuwan B, 2012, ACTA NEUROCHIR, V154, P1383, DOI 10.1007/s00701-012-1427-9; Tropine A, 2007, J MAGN RESON IMAGING, V25, P703, DOI 10.1002/jmri.20887; Yin B, 2012, EUR J RADIOL, V81, P4050, DOI 10.1016/j.ejrad.2012.06.002	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-7071	1873-4499		CLIN IMAG	Clin. Imaging	NOV-DEC	2014	38	6					802	807		10.1016/j.clinimag.2014.06.016		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT3MR	WOS:000344839400006		
J	Nakashima, T; Takayama, Y; Nishie, A; Asayama, Y; Baba, S; Yamashita, Y; Shirabe, K; Kubo, Y; Hida, T; Honda, H				Nakashima, Takaaki N; Takayama, Yukihisa; Nishie, Akihiro; Asayama, Yoshiki; Baba, Shingo; Yamashita, Youichi; Shirabe, Ken; Kubo, Yuichiro; Hida, Tomoyuki; Honda, Hiroshi			Hepatocellular adenoma showing high uptake of F-18-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2)	CLINICAL IMAGING			English	Article						Hepatocellular adenoma (HCA); HNF1 alpha-inactivated; F-18-FDG; Magnetic resonance imaging; Glucose transporter (GLUT)	F-18-FDG PET; TUMORS; MANAGEMENT; METABOLISM; CARCINOMA	Hepatocellular adenoma (HCA) is a benign liver neoplasm composed of hepatocytes. We experienced HCA demonstrating a high uptake of F-18-fluorodeoxyglucose (FOG) on positron emission tomography-computed tomography, mimicking a malignant tumor. The mechanism underlying the uptake of FOG has not been identified. Here, we discuss that an enhancement of glucose metabolism via an increased expression of glucose transporter 2 may have a role in the high uptake of FOG shown by HCAs. (C) 2014 Elsevier Inc. All rights reserved.	[Nakashima, Takaaki N; Nishie, Akihiro; Asayama, Yoshiki; Baba, Shingo; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Takayama, Yukihisa] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Higashi Ku, Fukuoka 8128582, Japan; [Yamashita, Youichi; Shirabe, Ken] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan; [Kubo, Yuichiro; Hida, Tomoyuki] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan	Nishie, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	anishie@radiol.med.kyushu-u.ac.jp					Paudyal B, 2008, INT J ONCOL, V33, P1047, DOI 10.3892/ijo_00000093; Karim S, 2012, WORLD J GASTROENTERO, V18, P6771, DOI 10.3748/wjg.v18.i46.6771; McIntosh AL, 2013, LIPIDS, V48, P435, DOI 10.1007/s11745-013-3777-3; van Aalten SM, 2011, RADIOLOGY, V261, P172, DOI 10.1148/radiol.11110023; Farges O, 2011, GUT, V60, P85, DOI 10.1136/gut.2010.222109; Kitamura K, 2011, J HEPATOL, V55, P846, DOI 10.1016/j.jhep.2011.01.038; Zhao ZH, 2013, J NUCL MED, V54, P499, DOI 10.2967/jnumed.112.113472; Bioulac-Sage P, 2007, HEPATOLOGY, V46, P740, DOI 10.1002/hep.21743; Shanbhogue AK, 2011, RADIOLOGY, V258, P673, DOI 10.1148/radiol.10100376; Bioulac-Sage P, 2010, WHO CLASSIFICATION T, P198; Chang CY, 2013, INT J HEPATOL, V2013, DOI DOI 10.1155/2013/604860; Hostetler HA, 2010, J LIPID RES, V51, P3103, DOI 10.1194/jlr.M005041; Lim D, 2013, WORLD J GASTROENTERO, V19, P4432, DOI 10.3748/wjg.v19.i27.4432; McIntosh AL, 2012, J LIPID RES, V53, P467, DOI 10.1194/jlr.M019919; Rebouissou S, 2007, J BIOL CHEM, V282, P14437, DOI 10.1074/jbc.M610725200; Sacks A, 2011, AM J ROENTGENOL, V197, pW260, DOI 10.2214/AJR.11.6995; Stephenson JA, 2011, CASE REPORTS HEPATOL; Sumiyoshi T, 2012, SURG TODAY, V42, P200, DOI 10.1007/s00595-011-0067-7; van Aalten SM, 2012, BRIT J SURG, V99, P911, DOI 10.1002/bjs.8762; Yasuda S, 2001, J NUCL MED, V42, P989	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-7071	1873-4499		CLIN IMAG	Clin. Imaging	NOV-DEC	2014	38	6					888	891		10.1016/j.clinimag.2014.06.005		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT3MR	WOS:000344839400022		
J	Kumagai, T; Nagayama, H; Ota, T; Nishiyama, Y; Mishina, M; Ueda, M				Kumagai, Tomoaki; Nagayama, Hiroshi; Ota, Tomohiro; Nishiyama, Yasuhiro; Mishina, Masahiro; Ueda, Masayuki			Sex Differences in the Pharmacokinetics of Levodopa in Elderly Patients With Parkinson Disease	CLINICAL NEUROPHARMACOLOGY			English	Review						Parkinson disease; levodopa; pharmacokinetics; sex difference	MENOPAUSAL TRANSITION; MOTOR FLUCTUATIONS; GENDER-DIFFERENCES; WEARING-OFF; ESTROGEN; DYSKINESIAS; WOMEN; BODY	Objectives: Levodopa (LD) is the most effective antiparkinsonian drug used in the treatment of Parkinson disease (PD). Sex differences in the bioavailability of LD have been shown previously. In addition, epidemiological sex differences in PD have been reported, suggesting an involvement of estrogen. In this study, we evaluated the pharmacokinetics of LD in elderly patients with PD to examine the influence of estrogen. Methods: After the oral administration of a tablet of LD 100 mg/carbidopa 10 mg in 128 PD patients (including 91 elderly patients; age at examination, 75 years or older), plasma LD concentrations were measured at 6 points until 180 minutes, and pharmacological parameters were calculated. Then, differences in these parameters between sex were compared. Results: The area under the curve (AUC) and the AUC adjusted for body weight were found to be significantly greater in the female subjects compared with the male subjects (P<0.0001 and P<0.0001, respectively). Furthermore, in the elderly patients, the AUC and the AUC adjusted for body weight were significantly greater among the female subjects (P < 0.0001 and P < 0.0001, respectively). Conclusions: Even in the elderly cohort, the women had a significantly greater bioavailability of LD. In conclusion, to avoid the development of motor complications during LD treatment, it is important to consider the sex differences in the bioavailability of LD.	[Kumagai, Tomoaki; Nagayama, Hiroshi; Ota, Tomohiro; Nishiyama, Yasuhiro; Mishina, Masahiro; Ueda, Masayuki] Nippon Med Sch, Dept Neurol Sci, Grad Sch Med, Tokyo 1138603, Japan	Nagayama, H (reprint author), Nippon Med Sch, Dept Neurol Sci, Grad Sch Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	nagayama@nms.ac.jp					Burger H, 2008, J SEX MED, V5, P2266, DOI 10.1111/j.1743-6109.2008.00921.x; Martinelli P, 2003, NEUROL SCI, V24, P192, DOI 10.1007/s10072-003-0125-z; MARSDEN CD, 1994, J NEUROL NEUROSUR PS, V57, P672, DOI 10.1136/jnnp.57.6.672; Burger HG, 1999, J CLIN ENDOCR METAB, V84, P4025, DOI 10.1210/jc.84.11.4025; Blanchet PJ, 1999, NEUROLOGY, V53, P91; Nyholm D, 2006, CLIN PHARMACOKINET, V45, P109, DOI 10.2165/00003088-200645020-00001; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; Deleu D, 2002, CLIN PHARMACOKINET, V41, P261, DOI 10.2165/00003088-200241040-00003; Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305; Morrish PK, 1998, J NEUROL NEUROSUR PS, V64, P314, DOI 10.1136/jnnp.64.3.314; Shulman LM, 2007, GENDER MED, V4, P8, DOI 10.1016/S1550-8579(07)80003-9; Kompoliti K, 2002, NEUROLOGY, V58, P1418; Schrag A, 2000, BRAIN, V123, P2297, DOI 10.1093/brain/123.11.2297; Tsang KL, 2000, NEUROLOGY, V54, P2292; Olanow CW, 2013, MOVEMENT DISORD, V28, P1064, DOI 10.1002/mds.25364; BOUDIKOVA B, 1990, CLIN PHARMACOL THER, V48, P381; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; KAAKKOLA S, 1985, ACTA NEUROL SCAND, V72, P385; KOLLER WC, 1982, NEUROLOGY, V32, P547; MCDERMOTT JL, 1994, EXP NEUROL, V125, P306, DOI 10.1006/exnr.1994.1034; Murata M, 1996, J NEURAL TRANSM, V103, P1177, DOI 10.1007/BF01271202; VANHARTESVELDT C, 1986, NEUROSCI BIOBEHAV R, V10, P1, DOI 10.1016/0149-7634(86)90029-1; Zappia M, 2002, CLIN NEUROPHARMACOL, V25, P79, DOI 10.1097/00002826-200203000-00004	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-5664	1537-162X		CLIN NEUROPHARMACOL	Clin. Neuropharmacol.	NOV-DEC	2014	37	6					173	176		10.1097/WNF.0000000000000051		4	Clinical Neurology; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	AT8BP	WOS:000345159100003		
J	Sano, T				Sano, T.			Refined abelian Stark conjectures and the equivariant leading term conjecture of Burns	COMPOSITIO MATHEMATICA			English	Article						refined abelian Stark conjecture; Rubin Stark conjecture; Gross's conjecture; Darmon's conjecture; equivariant Tamagawa number conjecture	DERIVATIVES	We formulate a conjecture which generalizes Darmon's 'refined class number formula'. We discuss relations between our conjecture and the equivariant leading term conjecture of Burns. As an application, we give another proof of the 'except 2-part' of Darmon's conjecture, which was first proved by Mazur and Rubin.	Keio Univ, Dept Math, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Sano, T (reprint author), Keio Univ, Dept Math, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	tkmc310@a2.keio.jp					Rubin K, 1996, ANN I FOURIER, V46, P33; Burns D., 2001, DOC MATH, V6, P501; Burns D, 2003, INVENT MATH, V153, P303, DOI 10.1007/s00222-003-0291-x; Burns D, 2007, INVENT MATH, V169, P451, DOI 10.1007/s00222-007-0052-3; DARMON H, 1995, CAN J MATH, V47, P302, DOI 10.4153/CJM-1995-016-6; Flach M, 2011, J REINE ANGEW MATH, V661, P1, DOI 10.1515/CRELLE.2011.082; Gross B., 1988, J FS U TOKYO, V35, P177; Hayward A, 2004, COMPOS MATH, V140, P99, DOI 10.1112/S0010437X03000265; KOLYVAGIN VA, 1990, GROTHENDIECK FESTSCH, V2, P435; Mazur B., 2013, PREPRINT; Mazur B., 2004, MEM AM MATH SOC, V168; Mazur B, 2011, COMPOS MATH, V147, P56, DOI 10.1112/S0010437X1000494X; Popescu C. D., 2011, IAS PARK CITY MATH S, V18, P45; Rubin K., 1990, GRAD TEXTS MATH, V121, P397; Rubin K., 2000, ANN MATH STUDIES, V147; Serre J-P, 1979, GRADUATE TEXTS MATH, V67; Tate J., 1984, PROGR MATH, V47	17	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0010-437X	1570-5846		COMPOS MATH	Compos. Math.	NOV	2014	150	11					1809	1835		10.1112/S0010437X14007416		27	Mathematics	Mathematics	AT8MY	WOS:000345188400002		
J	Jardim, M; Verbitsky, M				Jardim, Marcos; Verbitsky, Misha			Trihyperkahler reduction and instanton bundles on CP3	COMPOSITIO MATHEMATICA			English	Article						mathematical instanton; hyperkahler reduction; stable bundle; twistor space; hyperkahler manifold; spacial holonomy	MODULI SPACES; HYPERKAHLER METRICS; KAHLER-MANIFOLDS; VECTOR-BUNDLES; P-3; SHEAVES; IRREDUCIBILITY; CONSTRUCTION; RANK-2	A trisymplectic structure on a complex 2n-manifold is a three-dimensional space Q of closed holomorphic forms such that any element of Q has constant rank 2n, n or zero, and degenerate forms in Q belong to a non-degenerate quadric hypersurface. We show that a trisymplectic manifold is equipped with a holomorphic 3-web and the Chern connection of this 3-web is holomorphic, torsion-free, and preserves the three symplectic forms. We construct a trisymplectic structure on the moduli of regular rational curves in the twistor space of a hyperkahler manifold, and define a trisymplectic reduction of a trisymplectic manifold, which is a complexified form of a hyperkahler reduction. We prove that the trisymplectic reduction in the space of regular rational curves on the twistor space of a hyperkahler manifold M is compatible with the hyperkahler reduction on M. As an application of these geometric ideas, we consider the ADHM construction of instantons and show that the moduli space of rank r, charge c framed instanton bundles on CP3 is a smooth trisymplectic manifold of complex dimension 4rc. In particular, it follows that the moduli space of rank two, charge c instanton bundles on CP3 is a smooth complex manifold dimension 8c - 3, thus settling part of a 30-year-old conjecture.	[Jardim, Marcos] IMECC UNICAMP, Dept Matemat, BR-13083859 Campinas, SP, Brazil; [Verbitsky, Misha] NRU HSE, Lab Algebra Geometry, Fac Math, Moscow, Russia; [Verbitsky, Misha] Univ Tokyo, Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan	Jardim, M (reprint author), IMECC UNICAMP, Dept Matemat, Rua Sergio Buarque Holanda 651, BR-13083859 Campinas, SP, Brazil.	mbjardim@hotmail.com; verbit@verbit.ru	Jardim, Marcos/B-7683-2012	Jardim, Marcos/0000-0002-8419-7044	CNPq [302477/2010-1]; FAPESP [2011/01071-3, 2009/12576-9]; AG Laboratory SU-HSE; RF government [ag. 11.G34.31.0023]; RFBR [12-01-00944]; NRU-HSE Academic Fund Program [12-01-0179]; Simons-IUM	The first named author is partially supported by the CNPq grant number 302477/2010-1 and the FAPESP grant number 2011/01071-3. He thanks Amar Henni and Renato Vidal Martins for several discussions related to instanton bundles. The second named author was partially supported by the FAPESP grant number 2009/12576-9, AG Laboratory SU-HSE, RF government grant, ag. 11.G34.31.0023, RFBR grant 12-01-00944, NRU-HSE Academic Fund Program in 2013-2014, research grant 12-01-0179, and a Simons-IUM fellowship. We are grateful to Alexander Tikhomirov for his insight and comments, and to Andrei Soldatenkov for his suggestion to use the Clifford algebra in our treatment of trisymplectic structures. The referee's remarks were very valuable in straightening up the arguments, especially in 3.1.	Andrada A, 2006, COMMUN MATH PHYS, V262, P1, DOI 10.1007/s00220-005-1472-9; DONALDSON SK, 1984, COMMUN MATH PHYS, V93, P453, DOI 10.1007/BF01212289; HARTSHORNE R, 1978, MATH ANN, V238, P229, DOI 10.1007/BF01420250; SALAMON S, 1982, INVENT MATH, V67, P143, DOI 10.1007/BF01393378; Verbitsky M, 1999, COMMUN ANAL GEOM, V7, P355; HITCHIN NJ, 1987, COMMUN MATH PHYS, V108, P535, DOI 10.1007/BF01214418; ATIYAH MF, 1978, PHYS LETT A, V65, P185, DOI 10.1016/0375-9601(78)90141-X; Feix B, 2001, J REINE ANGEW MATH, V532, P33; Frenkel IB, 2008, J ALGEBRA, V319, P2913, DOI 10.1016/j.jalgebra.2008.01.016; Arnold VI, 2001, FUNCT ANAL APPL+, V35, P61, DOI 10.1023/A:1004176617816; ATIYAH MF, 1957, T AM MATH SOC, V85, P181, DOI 10.2307/1992969; Barth W., 1977, MATH ANN, V226, P125; BARTH W, 1981, MATH ANN, V258, P81, DOI 10.1007/BF01450348; BEAUVILLE A, 1983, J DIFFER GEOM, V18, P755; Besse A.L., 1987, EINSTEIN MANIFOLDS; Coanda I, 2003, INT J MATH, V14, P1, DOI 10.1142/S0129167X03001624; Dancer A, 2008, ESI LECT MATH PHYS, P97, DOI 10.4171/051-1/3; ELLINGSRUD G, 1981, MATH ANN, V255, P123, DOI 10.1007/BF01450561; GRAUERT H, 1958, ANN MATH, V68, P460, DOI 10.2307/1970257; Hauzer M, 2011, GLASGOW MATH J, V53, P51, DOI 10.1017/S0017089510000558; Henni A. A., 2012, GLASG MATH IN PRESS; Huybrechts D., 2005, UNIVERSITEXT; Jardim M, 2006, COLLECT MATH, V57, P69; Jardim M, 2008, CR MATH, V346, P427, DOI 10.1016/j.crma.2008.02.014; Jardim M, 2011, ADV MATH, V227, P1526, DOI 10.1016/j.aim.2011.03.012; Kaledin D., 2001, HYPERKAHLER MANIFOLD; Kaledin D., 1998, SELECTA MATH, V4, P279, DOI 10.1007/s000290050033; LePotier J, 1983, PROGR MATH, V37, P65; MACIOCIA A, 1991, COMMUN MATH PHYS, V135, P467, DOI 10.1007/BF02104116; Markushevich D., 2010, PREPRINT; MARUYAMA M, 1981, MATH ANN, V255, P317, DOI 10.1007/BF01450706; Mumford D., 1994, GEOMETRIC INVARIANT, V34; Nakajima H., 1999, LECT HILBERT SCHEMES	33	1	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0010-437X	1570-5846		COMPOS MATH	Compos. Math.	NOV	2014	150	11					1836	1868		10.1112/S0010437X14007477		33	Mathematics	Mathematics	AT8MY	WOS:000345188400003		
J	Saeung, A; Baimai, V; Thongsahuan, S; Otsuka, Y; Srisuka, W; Taai, K; Somboon, P; Suwonkerd, W; Sochanta, T; Choochote, W				Saeung, Atiporn; Baimai, Visut; Thongsahuan, Sorawat; Otsuka, Yasushi; Srisuka, Wichai; Taai, Kritsana; Somboon, Pradya; Suwonkerd, Wannapa; Sochanta, Tho; Choochote, Wej			Cytogenetic, cross-mating and molecular evidence of four cytological races of Anopheles crawfordi (Diptera: Culicidae) in Thailand and Cambodia	COMPTES RENDUS BIOLOGIES			English	Article						Anopheles crawfordi; Metaphase karyotypes; Cross-mating experiments; ITS2; COI; COII	SUBGENUS CELLIA DIPTERA; COMPLEX DIPTERA; HYRCANUS GROUP; GEOGRAPHIC-DISTRIBUTION; GENETIC COMPATIBILITY; METAPHASE KARYOTYPES; BRUGIA-MALAYI; MINIMUS GROUP; MEMBERS; PHYLOGENETICS	Twenty-nine isolines of Anopheles crawfordi were established from wild-caught females collected from cow-baited traps in Thailand and Cambodia. Three types of X (X-1, X-2, X-3) and four types of Y (Y-1, Y-2, Y-3, and Y-4) chromosomes were identified, according to differing amounts of extra heterochromatin. These sex chromosomes represent four metaphase karyotypes, i.e., Forms A (X-1, X-2, X-3, Y-1), B (X-1, X-2, X-3, Y-2), C (X-2, Y-3) and D (X-2, Y-4). Forms C and D are novel metaphase karyotypes confined to Thailand, whereas forms A and B appear to be common in both Thailand and Cambodia. Cross-mating experiments between the four karyotypic forms indicated genetic compatibility in yielding viable progenies and synaptic salivary gland polytene chromosomes. The results suggest that the forms are conspecific and A. crawfordi comprises four cytological races, which is further supported by very low intraspecific variation (mean genetic distance = 0.000-0.018) of the nucleotide sequences in ribosomal DNA (ITS2) and mitochondrial DNA sequences (COI, COII). (C) 2014 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.	[Saeung, Atiporn; Taai, Kritsana; Somboon, Pradya; Choochote, Wej] Chiang Mai Univ, Dept Parasitol, Fac Med, Chiang Mai 50200, Thailand; [Baimai, Visut] Mahidol Univ, Dept Biol, Fac Sci, Bangkok 10400, Thailand; [Baimai, Visut] Mahidol Univ, Ctr Vectors & Vector Borne Dis, Fac Sci, Bangkok 10400, Thailand; [Thongsahuan, Sorawat] Prince Songkla Univ, Fac Vet Sci Estab Project, Hat Yai 90110, Thailand; [Otsuka, Yasushi] Kagoshima Univ, Res Ctr Pacific Islands, Kagoshima 8908580, Japan; [Srisuka, Wichai] Queen Sirikit Bot Garden, Entomol Sect, Chiang Mai 50180, Thailand; [Suwonkerd, Wannapa] Minist Publ Hlth, Dept Dis Control, Off Dis Prevent & Control 10, Chiang Mai 50200, Thailand; [Sochanta, Tho] Natl Ctr Malaria Control Parasitol & Entomol, Phnom Penh 12302, Cambodia	Saeung, A (reprint author), Chiang Mai Univ, Dept Parasitol, Fac Med, Chiang Mai 50200, Thailand.	atsaeung@mail.med.cmu.ac.th			Thailand Research Fund [RTA5480006]; Diamond Research Grant of Faculty of Medicine, Chiang Mai University	This work was supported by the Thailand Research Fund (TRF Senior Research Scholar: RTA5480006) and the Diamond Research Grant of Faculty of Medicine, Chiang Mai University to Wej Choochote and Atiporn Saeung. The authors would like to thank Dr. Wattana Navacharoen, Dean of the Faculty of Medicine, Chiang Mai University, for his interest in this research.	Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Min GS, 2002, MOL CELLS, V14, P198; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Baimai V, 1998, ZOOL STUD, V37, P75; Park MH, 2008, J AM MOSQUITO CONTR, V24, P489, DOI 10.2987/08-5753.1; BEEBE NW, 1995, AM J TROP MED HYG, V53, P478; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; BAIMAI V, 1993, J AM MOSQUITO CONTR, V9, P59; BAIMAI V, 1987, P ENTOMOL SOC WASH, V89, P157; Chen B, 2003, SYST ENTOMOL, V28, P57, DOI 10.1046/j.1365-3113.2003.00200.x; Chen B, 2002, MED VET ENTOMOL, V16, P253, DOI 10.1046/j.1365-2915.2002.00373.x; Choochote W, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0110; Choochote Wej, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P29; Choochote Wej, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P841; Choochote W, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P57, DOI 10.5772/54853; Dusfour I, 2007, INFECT GENET EVOL, V7, P484, DOI 10.1016/j.meegid.2007.02.003; Garros C, 2005, J MED ENTOMOL, V42, P522, DOI 10.1603/0022-2585(2005)042[0522:MAAMPO]2.0.CO;2; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Harbach R.E., 2014, ANOPHELES CALSSIFICA; HARRISON B A, 1975, Contributions of the American Entomological Institute, V12, P1; Junkum A, 2005, J VECTOR ECOL, V30, P213; Kanda T., 1981, Japanese Journal of Sanitary Zoology, V32, P321; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Morgan K, 2009, MOL PHYLOGENET EVOL, V52, P588, DOI 10.1016/j.ympev.2009.01.022; Nanda N, 2013, INFECT GENET EVOL, V13, P218, DOI 10.1016/j.meegid.2012.09.018; Ngo CT, 2013, ACTA TROP, V128, P623, DOI 10.1016/j.actatropica.2013.09.004; Nylander J.A.A., 2004, MRMODELTEST V2; Paredes-Esquivel C, 2009, MOL PHYLOGENET EVOL, V50, P141, DOI 10.1016/j.ympev.2008.10.011; Park MH, 2008, GENES GENOM, V30, P245; Park SJ, 2003, MOL CELLS, V16, P354; Rattanarithikul Rampa, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 1, P1; REID JA, 1962, ANN TROP MED PARASIT, V56, P323; Reid JA, 1968, STUD I MED RES MALAY, V31, P1; Saeung A, 2008, PARASITOL RES, V102, P499, DOI 10.1007/s00436-007-0788-0; Saeung A, 2007, PARASITOL RES, V101, P1337, DOI 10.1007/s00436-007-0645-1; Saeung A, 2012, TROP BIOMED, V29, P613; Saeung A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sharpe RG, 2000, SYST ENTOMOL, V25, P263, DOI 10.1046/j.1365-3113.2000.00118.x; Somboon P, 2005, J AM MOSQUITO CONTR, V21, P5, DOI 10.2987/8756-971X(2005)21[5:CEOAMS]2.0.CO;2; Subbarao S. K, 1998, TECHNICAL PUBLICATIO, V18, P1; Suwannamit S, 2009, PARASITOL RES, V104, P905, DOI 10.1007/s00436-008-1272-1; Taai K, 2013, TROP BIOMED, V30, P238; Taai K, 2013, MEM I OSWALDO CRUZ, V108, P312, DOI 10.1590/S0074-02762013000300009; Thongsahuan S, 2009, MEM I OSWALDO CRUZ, V104, P558, DOI 10.1590/S0074-02762009000400004; Thongwat D, 2008, J AM MOSQUITO CONTR, V24, P194, DOI 10.2987/5668.1; WHARTON RH, 1963, ANN TROP MED PARASIT, V57, P235; Wilkerson RC, 2005, ANN ENTOMOL SOC AM, V98, P918, DOI 10.1603/0013-8746(2005)098[0918:MPONAN]2.0.CO;2	50	2	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1631-0691	1768-3238		CR BIOL	C. R. Biol.	NOV	2014	337	11					625	634		10.1016/j.crvi.2014.08.001		10	Biology	Life Sciences & Biomedicine - Other Topics	AT4KS	WOS:000344908900002		
J	Shigemitsu, R; Yoda, N; Ogawa, T; Kawata, T; Gunji, Y; Yamakawa, Y; Ikeda, K; Sasaki, K				Shigemitsu, Ryuji; Yoda, Nobuhiro; Ogawa, Toru; Kawata, Tetsuo; Gunji, Yoshinori; Yamakawa, Yuki; Ikeda, Kiyohiro; Sasaki, Keiichi			Biological-data-based finite-element stress analysis of mandibular bone with implant-supported overdenture	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Implant; Finite element method; Overdenture; Stress; Biological data	IN-VIVO; OSSEOINTEGRATED IMPLANTS; ELASTIC PROPERTIES; DENTAL PROSTHESES; ORAL IMPLANTS; BITE FORCE; LOAD; DIAMETER; TOOTH; PATTERNS	Background: This study aimed to evaluate the stress distribution in a mandibular bone with an implant-supported overdenture by a biological-data-based finite element analysis (FEA) utilizing personal CT images and in vivo loading data, and to evaluate the influence of the number and alignment of implants and bone conditions on the stress in pen-implant bone. Methods: FEA models of a mandible were constructed for two types of overdentures: 4 implants supported overdenture (4-OD) and 2 implants supported overdenture (2-OD). The geometry of these models was constructed from CT images of a subject, who wore an implant-supported overdenture. The magnitude and direction of the loads on the implants for two types of overdentures during the maximal voluntary clenching were measured with 3D force transducers. FEA using these loads was carried out to observe stress distributions in pen-implant bone. Results: Higher stress was observed in cortical bone around the implant neck. Stress in pen-implant bone for 4-OD was reduced in comparison with those for the 2-OD. For the 4-OD, notwithstanding such reduction of the stress, the stress concentrated at the cortical bone around the implant aligned with large deviation from load direction. Conclusions: In this study, biological data from a certain subject was successfully duplicated to the FEA models. The results demonstrate the mechanical prominence of using more implants. Even in 4 implants model, high stress was found around an implant with a large inclination and with thin cortical bone. This suffices to demonstrate the capability and usefulness of the biological-data-based FEA. (C) 2014 Elsevier Ltd. All rights reserved.	[Shigemitsu, Ryuji; Yoda, Nobuhiro; Ogawa, Toru; Kawata, Tetsuo; Gunji, Yoshinori; Sasaki, Keiichi] Tohoku Univ, Div Adv Prosthet Dent, Grad Sch Dent, Sendai, Miyagi 9808575, Japan; [Yamakawa, Yuki; Ikeda, Kiyohiro] Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Sendai, Miyagi 9893204, Japan	Shigemitsu, R (reprint author), Tohoku Univ, Div Adv Prosthet Dent, Grad Sch Dent, Sendai, Miyagi 9808575, Japan.	shigemitsu@dent.tohoku.ac.jp			Japan Society for the Promotion of Science [26462910]	This research was supported by a Grant-in-Aid for Scientific Research (No's 26462910) from the Japan Society for the Promotion of Science.	Weber HP, 2007, INT J ORAL MAX IMPL, V22, P140; Ogawa T, 2010, J ORAL REHABIL, V37, P525, DOI 10.1111/j.1365-2842.2010.02076.x; Hansson S, 2003, J BIOMECH, V36, P1247, DOI 10.1016/S0021-9290(03)00164-7; Baggi L, 2008, J PROSTHET DENT, V100, P422, DOI 10.1016/S0022-3913(08)60259-0; Karabuda C, 2008, IMPLANT DENT, V17, P74, DOI [10.1097/ID.0b013e318166d88b, 10.1097/lD.0b013e318166d88b]; Baggi L, 2008, SIMUL MODEL PRACT TH, V16, P971, DOI 10.1016/j.simpat.2008.05.009; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Demenko V, 2011, J DENT RES, V90, P1211, DOI 10.1177/0022034511417442; Ueda T, 2011, INT J ORAL MAX IMPL, V26, P365; Isidor F, 1996, CLIN ORAL IMPLAN RES, V7, P143, DOI 10.1034/j.1600-0501.1996.070208.x; Pessoa RS, 2010, CLIN IMPLANT DENT R, V12, P219, DOI 10.1111/j.1708-8208.2009.00155.x; Baggi L, 2013, J PROSTHET DENT, V109, P9, DOI 10.1016/S0022-3913(13)60004-9; Bozkaya D, 2004, J PROSTHET DENT, V92, P523, DOI 10.1016/j.prosdent.2004.07.024; Hannam AG, 2011, J ORAL REHABIL, V38, P217, DOI 10.1111/j.1365-2842.2010.02149.x; Duyck J, 2001, CLIN ORAL IMPLAN RES, V12, P207, DOI 10.1034/j.1600-0501.2001.012003207.x; Daas M, 2008, MED ENG PHYS, V30, P218, DOI 10.1016/j.medengphy.2007.02.005; Barbier L, 1998, J ORAL REHABIL, V25, P847, DOI 10.1046/j.1365-2842.1998.00318.x; KORIOTH TWP, 1994, J DENT RES, V73, P56, DOI 10.1177/00220345940730010801; Bonnet AS, 2009, MED ENG PHYS, V31, P806, DOI 10.1016/j.medengphy.2009.03.004; Geng JP, 2001, J PROSTHET DENT, V85, P585, DOI 10.1067/mpr.2001.115251; Herrmann I, 2005, INT J ORAL MAX IMPL, V20, P220; Yoda N, 2013, INT J PROSTHODONT, V26, P143, DOI 10.11607/ijp.3223; O'Mahony AM, 2000, CLIN ORAL IMPLAN RES, V11, P415, DOI 10.1034/j.1600-0501.2000.011005415.x; DECHOW PC, 1993, AM J PHYS ANTHROPOL, V90, P291, DOI 10.1002/ajpa.1330900304; Silva GC, 2010, INT J ORAL MAX IMPL, V25, P239; Tabata LF, 2010, J CRANIOFAC SURG, V21, P696, DOI 10.1097/SCS.0b013e3181d7f202; De Smet E, 2007, INT J ORAL MAX IMPL, V22, P580; Kawaguchi T, 2007, J BIOMECH, V40, P244, DOI 10.1016/j.jbiomech.2006.01.004; Kawata T, 2007, J ORAL REHABIL, V34, P259, DOI 10.1111/j.1365-2842.2007.01681.x; Koller B, 2011, INT J PROSTHODONT, V24, P109; Lekholm U, 1985, TISSUE INTEGRATED PR, P199; Lu SH, 2013, COMPUT BIOL MED, V43, P1949, DOI 10.1016/j.compbiomed.2013.08.019; Meijer H J, 1994, Int J Prosthodont, V7, P271; MericskeStern R, 1996, CLIN ORAL IMPLAN RES, V7, P378, DOI 10.1034/j.1600-0501.1996.070412.x; O'Mahony A.M., 2000, CLIN ORAL IMPLAN RES, V9, P648; Ogawa T, 2006, J ORAL REHABIL, V33, P729, DOI 10.1111/j.1365-2842.2006.01617.x; Ogawa T, 2010, INT J PROSTHODONT, V23, P566; Okumura Nobuaki, 2010, J Prosthodont Res, V54, P133, DOI 10.1016/j.jpor.2009.12.004; Pavlin D, 2001, CRIT REV ORAL BIOL M, V12, P414; Plesh O, 1996, J ORAL REHABIL, V23, P262, DOI 10.1111/j.1365-2842.1996.tb00851.x; Qian LH, 2009, INT J ORAL MAX IMPL, V24, P877; SASAKI K, 1989, J DENT RES, V68, P499, DOI 10.1177/00220345890680031401; Shigemitsu R, 2013, ODONTOLOGY, V101, P222, DOI 10.1007/s10266-012-0077-y; Shimizu Y, 2005, DENT MATER J, V24, P447; Suito Hideki, 2011, J Prosthodont Res, V55, P141, DOI 10.1016/j.jpor.2010.10.004; Takahashi Takeshi, 2010, J Prosthodont Res, V54, P179, DOI 10.1016/j.jpor.2010.04.004; Vairo G, 2013, COMPUT MATH METHOD M, V2013; Wakabayashi N, 2010, Int J Comput Dent, V13, P317	48	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	NOV 1	2014	54						44	52		10.1016/j.compbiomed.2014.08.018		9	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	AT8NM	WOS:000345189800006		
J	Li, BN; Shan, X; Xiang, K; An, N; Xu, JZ; Huang, WM; Kobayashi, E				Li, Bing Nan; Shan, Xiang; Xiang, Kui; An, Ning; Xu, Jinzhang; Huang, Weimin; Kobayashi, Etsuko			Evaluation of robust wave image processing methods for magnetic resonance elastography	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Directional filtering; Magnetic resonance elastography; Noise suppression; Phase unwrapping	MR ELASTOGRAPHY; IN-VIVO; BRAIN; ELASTICITY; TISSUE; INVERSION; MODEL; ECHO	Magnetic resonance elastography (MRE) is a promising modality for in vivo quantification and visualization of soft tissue elasticity. It involves three stages of processes for (1) external excitation, (2) wave imaging and (3) elasticity reconstruction. One of the important issues to be addressed in MRE is wave image processing and enhancement. In this study we approach it from three different ways including phase unwrapping, directional filtering and noise suppression. The relevant solutions were addressed briefly. Some of them were implemented and evaluated on both simulated and experimental MRE datasets. The results confirm that wave image enhancement is indispensable before carrying out MRE elasticity reconstruction. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Bing Nan; Shan, Xiang] Hefei Univ Technol, Dept Biomed Engn, Hefei, Peoples R China; [Xiang, Kui] Wuhan Univ Technol, Sch Automat, Wuhan 430070, Peoples R China; [An, Ning] Hefei Univ Technol, Sch Comp & Informat, Hefei, Peoples R China; [Xu, Jinzhang] Hefei Univ Technol, Sch Elect Engn & Automat, Hefei, Peoples R China; [Huang, Weimin] Inst Infocomm Res, Neural & Biomed Image Lab, Singapore, Singapore; [Kobayashi, Etsuko] Univ Tokyo, Dept Precis Engn, Tokyo, Japan	Li, BN (reprint author), Hefei Univ Technol, Dept Biomed Engn, POB 112,Tunxi Rd 193, Hefei, Peoples R China.	bingoon@ieee.org; xkarcher@126.com	LI, Bing Nan/E-7575-2010	LI, Bing Nan/0000-0002-4777-5773	National Natural Science Foundation of China [61271123, 61101022]; Department of Science and Technology of Anhui [1201B0403019]; Fundamental Research Funds for the Central Universities [2013HGCH0009]	The authors are grateful of technical supports from Dr. Tomokazu Numano, Dr. Toshikatsu Washio and Prof. Kazuhiro Homma from the National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba East, Japan. This works was supported by the National Natural Science Foundation of China (Grant nos: 61271123 and 61101022), the Department of Science and Technology of Anhui (Grant no: 1201B0403019), and the Fundamental Research Funds for the Central Universities (Grant no: 2013HGCH0009).	Manduca A, 2003, MED IMAGE ANAL, V7, P465, DOI 10.1016/S1361-8415(03)00038-0; Murphy MC, 2010, MAGN RESON IMAGING, V28, P1514, DOI 10.1016/j.mri.2010.06.016; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Beccani M, 2014, IEEE T BIO-MED ENG, V61, P353, DOI 10.1109/TBME.2013.2279337; Tse ZTH, 2009, P I MECH ENG H, V223, P497, DOI 10.1243/09544119JEIM529; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Bush K, 2014, MAGN RESON IMAGING, V32, P721, DOI 10.1016/j.mri.2014.03.002; Mariappan YK, 2009, MAGN RESON MED, V62, P1457, DOI 10.1002/mrm.22091; Buades A, 2010, SIAM REV, V52, P113, DOI 10.1137/090773908; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P698, DOI 10.1109/TIP.2006.888351; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Doyley MM, 2012, PHYS MED BIOL, V57, pR35, DOI 10.1088/0031-9155/57/3/R35; Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731; Kwon OI, 2009, IEEE T MED IMAGING, V28, P1526, DOI 10.1109/TMI.2009.2019823; Chaitow L, 2010, PALPATION ASSESSMENT; Fatemi M, 2003, P IEEE, V91, P1503, DOI 10.1109/JPROC.2003.817865; Ghiglia D. C., 1998, 2 DIMENSIONAL PHASE; Haacke M.E., 2004, MAGN RESON MED, V52, P612; Huwart L, 2008, EUR RADIOL, V18, P2535, DOI 10.1007/s00330-008-1051-5; Johnson CL, 2012, MAGN RESON IMAGING, V30, P205, DOI 10.1016/j.mri.2011.09.017; Kar J, 2014, ANN BIOMED ENG, V42, P541, DOI 10.1007/s10439-013-0931-2; Lee SY, 2011, COMPUT BIOL MED, V41, P123, DOI 10.1016/j.compbiomed.2011.01.001; Li BN, 2010, LECT NOTES COMPUT SC, V6326, P305; Li BN, 2012, MAGN RESON IMAGING, V20, P390, DOI 10.1016/j.mri.2011.09.015; Li B.N., 2013, P 2013 IEEE INT C RO, P2209; Maderwald S, 2006, J MAGN RESON IMAGING, V23, P774, DOI 10.1002/jmri.20570; Mansour MBA, 2013, COMPUT BIOL MED, V43, P405, DOI 10.1016/j.compbiomed.2013.02.005; McGarry M, 2013, IEEE T MED IMAGING, V32, P1901, DOI 10.1109/TMI.2013.2268978; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7; Xiang K, 2013, COMPUT BIOL MED, V43, P847, DOI 10.1016/j.compbiomed.2013.04.005	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	NOV 1	2014	54						100	108		10.1016/j.compbiomed.2014.08.024		9	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	AT8NM	WOS:000345189800012		
J	Nishiyama, M; Kawaguchi, J				Nishiyama, Megumi; Kawaguchi, Jun			Visual long-term memory and change blindness: Different effects of pre- and post-change information on one-shot change detection using meaningless geometric objects	CONSCIOUSNESS AND COGNITION			English	Article						Visual long-term memory; Change blindness; Recognition memory	PREVIOUSLY ATTENDED OBJECTS; NATURAL SCENES; WORKING-MEMORY; EYE-MOVEMENTS; REPRESENTATIONS; WORLD; SEARCH; RETRIEVAL; ATTENTION; TARGETS	To clarify the relationship between visual long-term memory (VLTM) and online visual processing, we investigated whether and how VLTM involuntarily affects the performance of a one-shot change detection task using images consisting of six meaningless geometric objects. In the study phase, participants observed pre-change (Experiment 1), post-change (Experiment 2), or both pre- and post-change (Experiment 3) images appearing in the subsequent change detection phase. In the change detection phase, one object always changed between pre- and post-change images and participants reported which object was changed. Results showed that VLTM of pre-change images enhanced the performance of change detection, while that of post-change images decreased accuracy. Prior exposure to both pre- and post-change images did not influence performance. These results indicate that pre-change information plays an important role in change detection, and that information in VLTM related to the current task does not always have a positive effect on performance. (C) 2014 Elsevier Inc. All rights reserved.	[Nishiyama, Megumi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Nishiyama, Megumi; Kawaguchi, Jun] Nagoya Univ, Grad Sch Environm Studies, Dept Social & Human Environm, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nishiyama, M (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	nishiyama.megumi@c.mbox.nagoya-u.ac.jp					Angelone BL, 2003, PERCEPTION, V32, P947, DOI 10.1068/p5079; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Konkle T, 2010, J EXP PSYCHOL GEN, V139, P558, DOI 10.1037/a0019165; Rensink RA, 2000, VIS COGN, V7, P17, DOI 10.1080/135062800394667; Konkle T, 2010, PSYCHOL SCI, V21, P1551, DOI 10.1177/0956797610385359; Beck MR, 2007, MEM COGNITION, V35, P610, DOI 10.3758/BF03193299; Hollingworth A, 2003, J EXP PSYCHOL HUMAN, V29, P388, DOI 10.1037/0096-1523.29.2.388; Henderson JM, 2003, PERCEPT PSYCHOPHYS, V65, P58, DOI 10.3758/BF03194783; Vierck E, 2008, ACTA PSYCHOL, V127, P309, DOI 10.1016/j.actpsy.2007.06.004; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Yeh YY, 2008, ACTA PSYCHOL, V127, P114, DOI 10.1016/j.actpsy.2007.03.002; Becker MW, 2002, PSYCHON B REV, V9, P744, DOI 10.3758/BF03196330; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Hayhoe MM, 1998, VISION RES, V38, P125, DOI 10.1016/S0042-6989(97)00116-8; Jackson MC, 2008, J EXP PSYCHOL HUMAN, V34, P556, DOI 10.1037/0096-1523.34.3.556; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939; Hollingworth A, 2001, PSYCHON B REV, V8, P761, DOI 10.3758/BF03196215; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Simons DJ, 1996, PSYCHOL SCI, V7, P301, DOI 10.1111/j.1467-9280.1996.tb00378.x; Simons DJ, 1998, PSYCHON B REV, V5, P644, DOI 10.3758/BF03208840; Levin DT, 2002, BRIT J PSYCHOL, V93, P289, DOI 10.1348/000712602760146224; Simons DJ, 2000, VIS COGN, V7, P1, DOI 10.1080/135062800394658; Hollingworth A, 2005, J EXP PSYCHOL LEARN, V31, P396, DOI 10.1037/0278-7393.31.3.396; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Simons DJ, 2002, CONSCIOUS COGN, V11, P78, DOI 10.1006/ecog.2001.0533; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; Hollingworth A, 2006, VIS COGN, V14, P781, DOI 10.1080/13506280500193818; O'Regan JK, 2000, VIS COGN, V7, P191; Hollingworth A, 2002, J EXP PSYCHOL HUMAN, V28, P113, DOI 10.1037//0096-1523.28.1.113; Williams P, 2000, VIS COGN, V7, P297; Werner S, 2000, VIS COGN, V7, P163; Busch NA, 2013, BRAIN RES, V1520, P107, DOI 10.1016/j.brainres.2013.05.014; Varakin DA, 2006, BRIT J PSYCHOL, V97, P51, DOI 10.1348/000712605X68906; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; Hollingworth A, 2004, J EXP PSYCHOL HUMAN, V30, P519, DOI 10.1037/0096-1523.30.3.519; Mitroff SR, 2004, PERCEPT PSYCHOPHYS, V66, P1268, DOI 10.3758/BF03194997; Beck MR, 2003, PERCEPT PSYCHOPHYS, V65, P458, DOI 10.3758/BF03194575; Beck MR, 2004, J EXP PSYCHOL HUMAN, V30, P778, DOI 10.1037/0096-1523.30.4.778; Beck MR, 2011, MEM COGNITION, V39, P433, DOI 10.3758/s13421-010-0033-4; Brady Timothy F, 2009, Commun Integr Biol, V2, P1; Castelhano MS, 2005, VIS COGN, V12, P1017, DOI 10.1080/13506280444000634; Droll J. A., 2007, J VISION, V7, P1, DOI DOI 10.1167/7.14.6; JACOBY LL, 1987, PERS SOC PSYCHOL B, V13, P314, DOI 10.1177/0146167287133003; Jiang YH, 2005, PERCEPT PSYCHOPHYS, V67, P1128, DOI 10.3758/BF03193546; Nishiyama M., 2013, JAPANESE J PSYCHOL, V83, P526; Silverman ME, 2006, CONSCIOUS COGN, V15, P409, DOI 10.1016/j.concog.2005.08.003; Takahashi K, 2008, PERCEPTION, V37, P324, DOI 10.1068/p5906; Ueda A., 2008, JAPANESE J COGNITIVE, V6, P35; Ueda A., 2010, JAPANESE J PSYCHOL, V81, P413; Williams CC, 2005, PERCEPT PSYCHOPHYS, V67, P816, DOI 10.3758/BF03193535; Yang CT, 2009, PSYCHOL RES-PSYCH FO, V73, P75, DOI 10.1007/s00426-008-0134-x; Yeh YY, 2009, CONSCIOUS COGN, V18, P91, DOI 10.1016/j.concog.2008.10.009	54	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8100	1090-2376		CONSCIOUS COGN	Conscious. Cogn.	NOV	2014	30						105	117		10.1016/j.concog.2014.09.001		13	Psychology, Experimental	Psychology	AT8PP	WOS:000345195100009		
J	Yamamizu, K; Schlessinger, D; Ko, MSH				Yamamizu, Kohei; Schlessinger, David; Ko, Minoru S. H.			SOX9 accelerates ESC differentiation to three germ layer lineages by repressing SOX2 expression through P21 (WAF1/CIP1)	DEVELOPMENT			English	Article						Embryonic stem cells; Sox9; Sox2; Cdkn1a; (P21/WAF1/CIP1)	EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR SOX9; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; SELF-RENEWAL; DEFINED FACTORS; CAMPOMELIC DYSPLASIA; DIRECT CONVERSION; UP-REGULATION; GENOME-WIDE	Upon removal of culture conditions that maintain an undifferentiated state, mouse embryonic stem cells (ESCs) differentiate into various cell types. Differentiation can be facilitated by forced expression of certain transcription factors (TFs), each of which can generally specify a particular developmental lineage. We previously established 137 mouse ESC lines, each of which carried a doxycycline-controllable TF. Among them, Sox9 has unique capacity: its forced expression accelerates differentiation of mouse ESCs into cells of all three germ layers. With the additional use of specific culture conditions, overexpression of Sox9 facilitated the generation of endothelial cells, hepatocytes and neurons from ESCs. Furthermore, Sox9 action increases formation of p21 (WAF1/CIP1), which then binds to the SRR2 enhancer of pluripotency marker Sox2 and inhibits its expression. Knockdown of p21 abolishes inhibition of Sox2 and Sox9-accelerated differentiation, and reduction of Sox2 2 days after the beginning of ESC differentiation can comparably accelerate mouse ESC formation of cells of three germ layers. These data implicate the involvement of the p21-Sox2 pathway in the mechanism of accelerated ESC differentiation by Sox9 overexpression. The molecular cascade could be among the first steps to program ESC differentiation.	[Yamamizu, Kohei; Schlessinger, David; Ko, Minoru S. H.] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; [Ko, Minoru S. H.] Keio Univ, Dept Syst Med, Sakaguchi Lab, Sch Med, Tokyo 1608582, Japan	Ko, MSH (reprint author), NIA, Genet Lab, NIH, Baltimore, MD 21224 USA.	kom@z7.keio.jp			Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging; Japan Science and Technology Agency (JST), CREST program; Research Center Network for Realization of Regenerative Medicine program; Kanae Foundation (Japan); Uehara Memorial Foundation (Japan); Naito Foundation (Japan); Japan Society for Promotion of Science (JSPS)	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging. This research was also supported in part by the Japan Science and Technology Agency (JST), CREST program and Research Center Network for Realization of Regenerative Medicine program. K.Y. was supported by the postdoctoral fellowships from the Kanae Foundation (Japan), Uehara Memorial Foundation (Japan), Naito Foundation (Japan) and the Japan Society for Promotion of Science (JSPS). Deposited in PMC for release after 12 months.	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Besson A, 2008, DEV CELL, V14, P159, DOI [10.1016/j.devcel.2008.01.013, 10.1016/j.devce1.2008.01.013]; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; [Anonymous], DEVELOPMENT; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Vidal VPI, 2008, J CUTAN PATHOL, V35, P373, DOI 10.1111/j.1600-0560.2007.00815.x; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Kanamori M, 2004, BIOCHEM BIOPH RES CO, V322, P787, DOI 10.1016/j.bbrc.2004.07.179; Yamamizu K, 2013, STEM CELL REP, V1, P545, DOI 10.1016/j.stemcr.2013.10.006; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Panda DK, 2001, J BIOL CHEM, V276, P41229, DOI 10.1074/jbc.M104231200; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Kordes U, 2006, J NEURO-ONCOL, V80, P151, DOI 10.1007/s11060-006-9180-7; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Jiang SS, 2010, CLIN CANCER RES, V16, P4363, DOI 10.1158/1078-0432.CCR-10-0138; Matheu A, 2012, CANCER RES, V72, P1301, DOI 10.1158/0008-5472.CAN-11-3660; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Yamamizu K, 2012, CELL STEM CELL, V10, P759, DOI 10.1016/j.stem.2012.02.022; Yamamizu K, 2009, BLOOD, V114, P3707, DOI 10.1182/blood-2008-12-195750; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Snykers S, 2009, STEM CELLS, V27, P577, DOI 10.1634/stemcells.2008-0963; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Kondoh H, 2010, INT J BIOCHEM CELL B, V42, P391, DOI 10.1016/j.biocel.2009.09.003; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Passeron T, 2009, J CLIN INVEST, V119, P954, DOI 10.1172/JCI34015; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Correa-Cerro LS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00167; Dolezalova D, 2012, STEM CELLS, V30, P1362, DOI 10.1002/stem.1108; Egozi D, 2007, FASEB J, V21, P2807, DOI 10.1096/fj.06-7758com; LEE JHW, 2013, J HYDRO ENVIRON RES, V0007; Moriguchi H, 2010, HEPATOLOGY, V51, P1088, DOI 10.1002/hep.23396; Nishiyama A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01390; Saegusa M, 2012, AM J PATHOL, V181, P684, DOI 10.1016/j.ajpath.2012.05.008; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; van den Bos C, 1998, CELL TISSUE RES, V293, P463, DOI 10.1007/s004410051138; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	68	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	NOV	2014	141	22					4254	4266		10.1242/dev.115436		13	Developmental Biology	Developmental Biology	AT6DN	WOS:000345029400006		
J	Morimoto-Suzki, N; Hirabayashi, Y; Tyssowski, K; Shinga, J; Vidal, M; Koseki, H; Gotoh, Y				Morimoto-Suzki, Nao; Hirabayashi, Yusuke; Tyssowski, Kelsey; Shinga, Jun; Vidal, Miguel; Koseki, Haruhiko; Gotoh, Yukiko			The polycomb component Ring1B regulates the timed termination of subcerebral projection neuron production during mouse neocortical development	DEVELOPMENT			English	Article						Neocortical development; Fezf2; Polycomb; Neural stem cell; Neural precursor cell	DEVELOPING CEREBRAL-CORTEX; GROUP PROTEINS RING1A/B; STEM-CELLS; PYRAMIDAL NEURONS; SELF-RENEWAL; IN-VIVO; LAMINAR IDENTITY; PROGENITOR CELLS; PRECURSOR CELLS; X-INACTIVATION	In the developing neocortex, neural precursor cells (NPCs) sequentially generate various neuronal subtypes in a defined order. Although the precise timing of the NPC fate switches is essential for determining the number of neurons of each subtype and for precisely generating the cortical layer structure, the molecular mechanisms underlying these switches are largely unknown. Here, we show that epigenetic regulation through Ring1B, an essential component of polycomb group (PcG) complex proteins, plays a key role in terminating NPC-mediated production of subcerebral projection neurons (SCPNs). The level of histone H3 residue K27 trimethylation at and Ring1B binding to the promoter of Fezf2, a fate determinant of SCPNs, increased in NPCs as Fezf2 expression decreased. Moreover, deletion of Ring1B in NPCs, but not in postmitotic neurons, prolonged the expression of Fezf2 and the generation of SCPNs that were positive for CTIP2. These results indicate that Ring1B mediates the timed termination of Fezf2 expression and thereby regulates the number of SCPNs.	[Morimoto-Suzki, Nao; Gotoh, Yukiko] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Morimoto-Suzki, Nao; Hirabayashi, Yusuke; Tyssowski, Kelsey; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Shinga, Jun; Vidal, Miguel; Koseki, Haruhiko] RIKEN, Ctr Allergy & Immunol, Kanagawa, Japan; [Vidal, Miguel] Ctr Invest Biol, Consejo Super Invest Cient, E-28006 Madrid, Spain	Hirabayashi, Y (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan.	yhira@iam.u-tokyo.ac.jp; ygotoh@mol.f.u-tokyo.ac.jp			Core Research for Evolutionary Science and Technology (CREST) of the Japan Science and Technology Agency; JSPS; Global Center of Excellence (COE) Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan)	N.M.-S. was a research fellow of the Japan Society for the Promotion of Science (JSPS). This work was supported by Core Research for Evolutionary Science and Technology (CREST) of the Japan Science and Technology Agency; and Grant-in-Aid for Scientific Research on Innovative Areas 'Neural Diversity and Neocortical Organization' for Scientific Research (A), for JSPS fellows from JSPS; and the Global Center of Excellence (COE) Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan).	De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Rouaux C, 2013, NAT CELL BIOL, V15, P214, DOI 10.1038/ncb2660; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Testa G, 2011, BIOESSAYS, V33, P519, DOI 10.1002/bies.201100021; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrcd1991; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Guo C, 2013, NEURON, V80, P1167, DOI 10.1016/j.neuron.2013.09.037; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Kohwi M, 2013, NAT REV NEUROSCI, V14, P823, DOI 10.1038/nrn3618; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Luis NM, 2012, CELL STEM CELL, V11, P16, DOI 10.1016/j.stem.2012.06.005; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Hirata T, 2004, DEV DYNAM, V230, P546, DOI 10.1002/dvdy.20068; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.10.021; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Sparmann A, 2013, EMBO J, V32, P1598, DOI 10.1038/emboj.2013.93; Desai AR, 2000, DEVELOPMENT, V127, P2863; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Maruoka H, 2011, J NEUROSCI, V31, P18522, DOI 10.1523/JNEUROSCI.3117-11.2011; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Aldiri I, 2012, DEV BIOL, V367, P91, DOI 10.1016/j.ydbio.2012.04.030; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Joshi PS, 2008, NEURON, V60, P258, DOI 10.1016/j.neuron.2008.08.006; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Cabianca Daphne S, 2012, Cell, V149, P819, DOI 10.1016/j.cell.2012.03.035; Calés Carmela, 2008, Mol Cell Biol, V28, P1018; Fishell G, 2008, NEURON, V57, P333, DOI [10.1016/j.neuron.2008.01.018, 10.1016/i.neuron.2008.01.018]; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Onoguchi M, 2012, P NATL ACAD SCI USA, V109, P16939, DOI 10.1073/pnas.1202956109; Polleux F, 1997, J COMP NEUROL, V385, P95; Touma JJ, 2012, DEVELOPMENT, V139, P657, DOI 10.1242/dev.071589	69	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	NOV	2014	141	22					4343	4353		10.1242/dev.112276		11	Developmental Biology	Developmental Biology	AT6DN	WOS:000345029400014		
J	Dejima, K; Kang, S; Mitani, S; Cosman, PC; Chisholm, AD				Dejima, Katsufumi; Kang, Sukryool; Mitani, Shohei; Cosman, Pamela C.; Chisholm, Andrew D.			Syndecan defines precise spindle orientation by modulating Wnt signaling in C. elegans	DEVELOPMENT			English	Article						Heparan sulfate; Proteoglycan; Embryo; Endocytosis; Dishevelled; C. elegans	HEPARAN-SULFATE PROTEOGLYCANS; CELL-DIVISION ORIENTATION; CAENORHABDITIS-ELEGANS; MITOTIC SPINDLE; CORE PROTEIN; EXTENSION MOVEMENTS; BETA-CATENIN; EMBRYOS; MORPHOGENESIS; EXPRESSION	Wnt signals orient mitotic spindles in development, but it remains unclear how Wnt signaling is spatially controlled to achieve precise spindle orientation. Here, we show that C. elegans syndecan (SDN-1) is required for precise orientation of a mitotic spindle in response to a Wnt cue. We find that SDN-1 is the predominant heparan sulfate (HS) proteoglycan in the early C. elegans embryo, and that loss of HS biosynthesis or of the SDN-1 core protein results in misorientation of the spindle of the ABar blastomere. The ABar and EMS spindles both reorient in response to Wnt signals, but only ABar spindle reorientation is dependent on a new cell contact and on HS and SDN-1. SDN-1 transiently accumulates on the ABar surface as it contacts C, and is required for local concentration of Dishevelled (MIG-5) in the ABar cortex adjacent to C. These findings establish a new role for syndecan in Wnt-dependent spindle orientation.	[Dejima, Katsufumi; Chisholm, Andrew D.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Dejima, Katsufumi; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1628666, Japan; [Kang, Sukryool; Cosman, Pamela C.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92037 USA	Chisholm, AD (reprint author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	chisholm@ucsd.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; Japan Society for the Promotion of Science (JSPS) Post Doctoral Fellowship for Research Abroad; National Institutes of Health [R01 GM054657]	The CGC is funded by the NIH Office of Research Infrastructure Programs [P40 OD010440]. K.D. was supported by a Japan Society for the Promotion of Science (JSPS) Post Doctoral Fellowship for Research Abroad. This work was supported by a grant [R01 GM054657] from the National Institutes of Health to A.D.C. Deposited in PMC for release after 12 months.	Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Morgan MR, 2013, DEV CELL, V24, P472, DOI 10.1016/j.devcel.2013.01.027; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Schwabiuk M, 2009, DEV BIOL, V334, P235, DOI 10.1016/j.ydbio.2009.07.020; Walston T, 2006, DEV BIOL, V298, P485, DOI 10.1016/j.ydbio.2006.06.053; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/nmeth.1318, 10.1038/NMETH.1318]; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Mizumoto K, 2007, DEV CELL, V12, P287, DOI 10.1016/j.devcel.2007.01.004; Kim S, 2013, P NATL ACAD SCI USA, V110, pE918, DOI 10.1073/pnas.1300769110; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Grana TM, 2010, DEV BIOL, V344, P731, DOI 10.1016/j.ydbio.2010.05.507; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Lu MS, 2013, DEVELOPMENT, V140, P1843, DOI 10.1242/dev.087627; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Sumiyoshi E, 2011, DEV BIOL, V355, P302, DOI 10.1016/j.ydbio.2011.04.034; Giurumescu CA, 2012, DEVELOPMENT, V139, P4271, DOI 10.1242/dev.086256; Noatynska A, 2012, J CELL BIOL, V199, P1025, DOI 10.1083/jcb.201209015; Strome S, 2001, MOL BIOL CELL, V12, P1751; Park FD, 2003, DEVELOPMENT, V130, P3547, DOI 10.1242/dev.00563; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; GOLDSTEIN B, 1995, J CELL BIOL, V129, P1071, DOI 10.1083/jcb.129.4.1071; Ohkawara B, 2003, DEVELOPMENT, V130, P2129, DOI 10.1242/dev.00435; Park FD, 2004, CURR BIOL, V14, P2252, DOI 10.1016/j.cub.2004.12.019; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Inaba M, 2012, CELL STEM CELL, V11, P461, DOI 10.1016/j.stem.2012.09.003; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; Walston T, 2004, DEV CELL, V7, P831, DOI 10.1016/j.devcel.2004.10.008; Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042; Cabello J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000297; Chanana B, 2009, P NATL ACAD SCI USA, V106, P11984, DOI 10.1073/pnas.0901148106; Eisenmann D. M., 2005, WORMBOOK, DOI 10.1895/wormbook.1.7.1; Eriksson AS, 2012, J HISTOCHEM CYTOCHEM, V60, P936, DOI 10.1369/0022155412460242; Hardin J, 2008, CURR OPIN GENET DEV, V18, P362, DOI 10.1016/j.gde.2008.06.006; Hudson ML, 2006, DEV BIOL, V294, P352, DOI 10.1016/j.ydbio.2006.02.036; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Kleinschmit A, 2013, J BIOL CHEM, V288, P5081, DOI 10.1074/jbc.M112.447029; Minniti AN, 2004, J CELL SCI, V117, P5179, DOI 10.1242/jcs.01394; Mullen GP, 1999, MOL BIOL CELL, V10, P3205; Niehrs C, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3134pe26; Pohl C, 2010, DEV CELL, V19, P402, DOI 10.1016/j.devcel.2010.08.014; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Sawa H., 2013, WORMBOOK, DOI [10.1895/wormbook.1.7.2, DOI 10.1895/WORMBOOK.1.7.2]; Singh D, 2014, DEV CELL, V28, P253, DOI 10.1016/j.devcel.2014.01.002; Wang QJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042883; Wu MF, 2007, DEV BIOL, V303, P650, DOI 10.1016/j.ydbio.2006.12.002; Zhao R, 2010, STEM CELL REV REP, V6, P345, DOI 10.1007/s12015-010-9128-3	64	3	3	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	NOV	2014	141	22					4354	4365		10.1242/dev.113266		12	Developmental Biology	Developmental Biology	AT6DN	WOS:000345029400015		
J	Yanagisawa, K; Ashihara, J; Obara, S; Wada, N; Takeuchi, M; Nishino, Y; Maeda, S; Ishibashi, Y; Yamagishi, S				Yanagisawa, Katsuyuki; Ashihara, Junya; Obara, Shinji; Wada, Norio; Takeuchi, Masayoshi; Nishino, Yuri; Maeda, Sayaka; Ishibashi, Yuji; Yamagishi, Sho-ichi			Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients	DIABETES-METABOLISM RESEARCH AND REVIEWS			English	Article						oxidative damage; glycation; RAGE	GLYCATION END-PRODUCTS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; OXYGEN SPECIES GENERATION; URINARY ALBUMIN EXCRETION; SOLUBLE FORM; SERUM-LEVELS; RAGE EXPRESSION; RENAL INJURY; FASTER ONSET; FOLLOW-UP	BackgroundBasal and bolus insulin therapy is required for strict blood control in diabetic patients, which could lead to prevention of vascular complications in diabetes. However, the optimal combination regimen is not well established. MethodsFifty-nine diabetic patients (49 type 1 and 10 type 2; 52.913.3years old) whose blood glucose levels were uncontrolled (HbA(1c)>6.2%) by combination treatment of basal insulin glargine with multiple daily pre-meal injections of bolus short-acting insulin [aspart (n=19), lispro (n=37) and regular human insulin (n=3)] for at least 8weeks were enrolled in this study. We examined whether glycaemic control and vascular injury were improved by replacement of short-acting insulin with glulisine. Patient satisfaction was assessed with Diabetes Treatment Satisfaction Questionnaire. ResultsAlthough bolus and basal insulin doses were almost unchanged before and after replacement therapy, switching to glulisine insulin for 24weeks significantly decreased level of HbA(1c), advanced glycation end products (AGEs), soluble receptor for AGEs (sRAGE), monocyte chemoattractant protein-1 (MCP-1) and urinary albumin excretion. In multiple stepwise regression analysis, change in MCP-1 values from baseline (MCP-1) was a sole determinant of log urinary albumin excretion. AGEs and sRAGE were independently correlated with each other. The relationship between MCP-1 and sRAGE was marginally significant (p=0.05). Replacement of short-acting insulin by glulisine significantly increased Diabetes Treatment Satisfaction Questionnaire scores. ConclusionsOur present study suggests that combination therapy of glargine with multiple daily pre-meal injections of glulisine might show superior efficacy in controlling blood glucose, preventing vascular damage and improving treatment satisfaction in diabetic patients. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Yanagisawa, Katsuyuki; Ashihara, Junya; Obara, Shinji; Wada, Norio] Sapporo City Gen Hosp, Dept Endocrinol & Diabet, Sapporo, Hokkaido, Japan; [Takeuchi, Masayoshi] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Kanazawa, Ishikawa, Japan; [Nishino, Yuri; Maeda, Sayaka; Ishibashi, Yuji; Yamagishi, Sho-ichi] Kurume Univ, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Sch Med, Kurume, Fukuoka 8300011, Japan	Yamagishi, S (reprint author), Kurume Univ, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	shoichi@med.kurume-u.ac.jp					Yamagishi S, 2005, CURR PHARM DESIGN, V11, P2279, DOI 10.2174/1381612054367300; Nakamura T, 2009, METABOLISM, V58, P1624, DOI 10.1016/j.metabol.2009.05.018; Heise T, 2007, DIABETES OBES METAB, V9, P746, DOI 10.1111/j.1463-1326.2007.00746.x; Yamagishi S, 2012, BBA-GEN SUBJECTS, V1820, P663, DOI 10.1016/j.bbagen.2011.03.014; Dailey G, 2004, DIABETES CARE, V27, P2363, DOI 10.2337/diacare.27.10.2363; Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8; Nakamura K, 2008, DIABETES-METAB RES, V24, P109, DOI 10.1002/dmrr.766; Rahbar S, 2005, ANN NY ACAD SCI, V1043, P9, DOI 10.1196/annals.1333.002; Ramasamy R, 2012, VASC PHARMACOL, V57, P160, DOI 10.1016/j.vph.2012.06.004; Chiarelli F, 2002, DIABETES CARE, V25, P1829, DOI 10.2337/diacare.25.10.1829; Kilhovd BK, 2007, DIABETOLOGIA, V50, P1409, DOI 10.1007/s00125-007-0687-z; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Yamagishi SI, 2008, CURR PHARM DESIGN, V14, P487, DOI 10.2174/138161208783597416; Nakamura K, 2008, MICROVASC RES, V76, P52, DOI 10.1016/j.mvr.2007.09.004; Chow FY, 2006, KIDNEY INT, V69, P73, DOI 10.1038/sj.ki.5000014; Stitt AW, 1997, ANN NY ACAD SCI, V811, P115, DOI 10.1111/j.1749-6632.1997.tb51994.x; Nakamura K, 2007, CLIN EXP MED, V7, P188, DOI 10.1007/s10238-007-0146-7; Ishibashi Y, 2011, METABOLISM, V60, P1271, DOI 10.1016/j.metabol.2011.01.010; Fujisawa K, 2013, ATHEROSCLEROSIS, V227, P425, DOI 10.1016/j.atherosclerosis.2013.01.016; Colhoun HM, 2011, DIABETES, V60, P2379, DOI 10.2337/db11-0291; Takebayashi K, 2006, J DIABETES COMPLICAT, V20, P98, DOI 10.1016/j.diacomp.2005.05.008; Nicolucci A, 2011, DIABETES CARE, V34, P2524, DOI 10.2337/dc11-0900; Ishibashi Y, 2012, HORM METAB RES, V44, P891, DOI 10.1055/s-0032-1321878; Nakamura K, 2007, MOL MED, V13, P185, DOI 10.2119/2006-00090.Nakamura; Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; Arnolds S, 2010, EXP CLIN ENDOCR DIAB, V118, P662, DOI 10.1055/s-0030-1252067; Aziz Kamran M A, 2012, Recent Pat Endocr Metab Immune Drug Discov, V6, P148; Becker RHA, 2008, CLIN PHARMACOKINET, V47, P7; Becker RHA, 2007, DIABETES TECHNOL THE, V9, P109, DOI 10.1089/dia.2006.0035; des Jongs PE, 2007, J NEPHROL, V20, P375; Gansevoort RT, 2010, CURR OPIN NEPHROL HY, V19, P513, DOI 10.1097/MNH.0b013e32833e4ce1; Gus L, 2006, NEPHROL DIAL TRANSPL, V21, P299; HIRSCH IB, 1990, DIABETES CARE, V13, P1265, DOI 10.2337/diacare.13.12.1265; Inagaki Y, 2003, DIABETOLOGIA, V46, P284, DOI 10.1007/s00125-002-1013-4; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Lindholm A, 1999, DIABETES CARE, V22, P801, DOI 10.2337/diacare.22.5.801; Nakamura T, 2012, J INT MED RES, V40, P798; Nins JW, 2010, DIABETES, V59, P2027; Nins JW, 2011, DIABETES CARE, V34, P442; Ogawa S, 2008, CLIN J AM SOC NEPHRO, V3, P362, DOI 10.2215/CJN.03450807; Raskin P, 2000, DIABETES CARE, V23, P1666, DOI 10.2337/diacare.23.11.1666; Witthaus E, 2001, DIABETIC MED, V18, P619, DOI 10.1046/j.1464-5491.2001.00529.x; Yamagishi S, 2007, ARTERIOSCL THROM VAS, V27, pE32, DOI 10.1161/ATVBAHA.107.139923; Yamagishi Sho-ichi, 2010, Front Biosci (Elite Ed), V2, P1184	45	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-7560			DIABETES-METAB RES	Diabetes-Metab. Res. Rev.	NOV	2014	30	8					693	700		10.1002/dmrr.2537		8	Endocrinology & Metabolism	Endocrinology & Metabolism	AU0CR	WOS:000345291300009		
J	Ueda, H; Perea, MP				Ueda, Hiroto; Perea, Maria-Pilar			The degree of union resulting from reaction points expressed in a diatopic table An application to a Catalan verb morphology database	DIALECTOLOGIA ET GEOLINGUISTICA			English	Article								For describing a particular area from a geolinguistic perspective, the basic procedure is to create a two-dimensional table with an axis showing forms or phenomena and another axis showing localities. In this table, observing the specific reaction in every cell will allow us to develop both co-occurrence and coefficient matrixes, as well as clustering and multivariate interpretation graphs. In this table, which is the starting point for multivariate analyses of geolinguistic data, certain convergences and divergences of the reaction points are revealed. Our interest is in a quantitative evaluation of the degree of convergence and divergence that takes the form of a rectangular linkage of the reacted points; that is to say, an analysis of the state of their continuity set out in rectangular plots. In order to evaluate properly the absolute values in numbers of unions (U) it is necessary to develop a mathematical function that will return the maximum number of unions (Umax) in a parameter with the number of reactions (n): Umax (n). Once the Umax function has been established, the desirable "Degree of Binding" will be formulated through the division of U by Umax(n). The aim of this paper is to put into practice this method with the data from La flexio verbal en els dialectes catalans ('Verbal Flexion') (1929-1932), by Antoni M. Alcover, previously analysed in Perea & Ueda (2010). The calculation of the Degree of Binding is applied to the data in both its forms: the original data and the patternized distribution of data (see Perea & Ueda 2010: 103-111). The result of our calculations gives rise to a new multivariate perspective of "isoglosses" for overcoming the problems of mismatched lines on the linguistic maps.	[Ueda, Hiroto] Univ Tokyo, Tokyo 1138654, Japan; [Perea, Maria-Pilar] Univ Barcelona, E-08007 Barcelona, Spain	Ueda, H (reprint author), Univ Tokyo, Tokyo 1138654, Japan.	uedahiroto@jcom.home.ne.jp; mpilar.perea@ub.edu					Anderberg M.R., 1973, CLUSTER ANAL APPL; Avila Raul, 2003, LINGUISTICA IBEROAME, V19; Bertin J., 1977, GRAPHIQUE TRAITEMENT; Chambers J. K., 1998, DIALECTOLOGY; Coseriu Eugenio, 1975, SPRACHGEOGRAPHIE; Fletcher Paul, 1986, STAT LANGUAGE STUDIE; Hartigan JA, 1975, CLUSTERING ALGORITHM; Hayashi Chikio, 1970, ZYOOHOOSYORI TO TOUK; Horst P., 1965, FACTOR ANAL DATA MAT; Perea MP, 2010, DIALECTOL GEOLINGUIS, V18, P99, DOI 10.1515/DIG.2010.006; Rietveld T., 1993, STAT TECHNIQUES STUD; Romesburg Charles H., 1989, CLUSTER ANAL RES; Yasumoto Biten, 1981, INSHI BUNSEKI HOU	13	0	0	DE GRUYTER MOUTON	BERLIN	GENTHINER STRASSE 13, 10785 BERLIN, GERMANY	0942-4040	1867-0903		DIALECTOL GEOLINGUIS	Dialectol. Geolinguist.	NOV	2014	22	1					16	38		10.1515/dialect-2014-0002		23	Linguistics; Language & Linguistics	Linguistics	AT7MB	WOS:000345120200002		
J	Irving, AA; Yoshimi, K; Hart, ML; Parker, T; Clipson, L; Ford, MR; Kuramoto, T; Dove, WF; Amos-Landgraf, JM				Irving, Amy A.; Yoshimi, Kazuto; Hart, Marcia L.; Parker, Taybor; Clipson, Linda; Ford, Madeline R.; Kuramoto, Takashi; Dove, William F.; Amos-Landgraf, James M.			The utility of Apc-mutant rats in modeling human colon cancer	DISEASE MODELS & MECHANISMS			English	Review						APC; Allelic series; Animal models; Colorectal cancer	ZINC-FINGER NUCLEASES; FAMILIAL ADENOMATOUS POLYPOSIS; COLORECTAL-CANCER; ULCERATIVE-COLITIS; TUMOR SUPPRESSION; KNOCKOUT RATS; MOUSE MODEL; SUSCEPTIBILITY LOCI; EFFECTOR NUCLEASES; ENU MUTAGENESIS	Prior to the advent of genetic engineering in the mouse, the rat was the model of choice for investigating the etiology of cancer. Now, recent advances in the manipulation of the rat genome, combined with a growing recognition of the physiological differences between mice and rats, have reignited interest in the rat as a model of human cancer. Two recently developed rat models, the polyposis in the rat colon (Pirc) and Kyoto Apc Delta (KAD) strains, each carry mutations in the intestinal-cancer-associated adenomatous polyposis coli (Apc) gene. In contrast to mouse models carrying Apc mutations, in which cancers develop mainly in the small intestine rather than in the colon and there is no gender bias, these rat models exhibit colonic predisposition and gender-specific susceptibility, as seen in human colon cancer. The rat also provides other experimental resources as a model organism that are not provided by the mouse: the structure of its chromosomes facilitates the analysis of genomic events, the size of its colon permits longitudinal analysis of tumor growth, and the size of biological samples from the animal facilitates multiplexed molecular analyses of the tumor and its host. Thus, the underlying biology and experimental resources of these rat models provide important avenues for investigation. We anticipate that advances in disease modeling in the rat will synergize with resources that are being developed in the mouse to provide a deeper understanding of human colon cancer.	[Irving, Amy A.; Clipson, Linda; Ford, Madeline R.; Dove, William F.; Amos-Landgraf, James M.] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Madison, WI 53792 USA; [Yoshimi, Kazuto; Kuramoto, Takashi] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto 6068501, Japan; [Yoshimi, Kazuto; Hart, Marcia L.; Parker, Taybor; Amos-Landgraf, James M.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	Amos-Landgraf, JM (reprint author), Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Madison, WI 53792 USA.	amoslandgrafj@missouri.edu	Amos-Landgraf, James/K-9288-2013	Amos-Landgraf, James/0000-0003-2535-7746	National Cancer Institute [R01 CA63677, R01 CA125591]; American Cancer Society Post-Doctoral Training Grant [PF-08-077-01-MGO]; National Institute of Environmental Health Sciences Pre-Doctoral Training Grant [T32ES007015-033]; Ministry of Health, Labour and Welfare [21300153]; Japan Society for the Promotion of Science [0233639]	This work was supported by grants from the National Cancer Institute (R01 CA63677 and R01 CA125591 to W. F. D.), an American Cancer Society Post-Doctoral Training Grant (PF-08-077-01-MGO to J.M.A.-L.), a National Institute of Environmental Health Sciences Pre-Doctoral Training Grant (T32ES007015-033 to A. A. I.), a Grant-in-aid for Cancer Research from the Ministry of Health, Labour and Welfare (21300153 to T. K.) and a Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (0233639 to K.Y.).	American Cancer Society, 2014, WHAT AR SURV RAT COL; American Cancer Society, 2014, WHAT AR KEY STAT COL; American Cancer Society, 2014, WHAT AR RISK FACT CO; Amos-Landgraf JM, 2012, P NATL ACAD SCI USA, V109, P2060, DOI 10.1073/pnas.1120753109; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Ladd JJ, 2012, CANCER PREV RES, V5, P655, DOI 10.1158/1940-6207.CAPR-11-0412; Pickhardt PJ, 2013, LANCET ONCOL, V14, P711, DOI 10.1016/S1470-2045(13)70216-X; Nieuwenhuis MH, 2007, CRIT REV ONCOL HEMAT, V61, P153, DOI 10.1016/j.critrevonc.2006.07.004; Kosten TA, 2014, DEV PSYCHOBIOL, V56, P392, DOI 10.1002/dev.21106; Li XM, 2013, CANCER RES, V73, P7176, DOI 10.1158/0008-5472.CAN-13-1528; Yamazaki K, 2004, J HUM GENET, V49, P664, DOI 10.1007/s10038-004-0204-x; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rutte C, 2007, PLOS BIOL, V5, P1421, DOI 10.1371/journal.pbio.0050196; Lidgard GP, 2013, CLIN GASTROENTEROL H, V11, P1313, DOI 10.1016/j.cgh.2013.04.023; Zeineldin M, 2013, CANCER RES, V73, P2389, DOI 10.1158/0008-5472.CAN-12-4607; Oshima H, 2012, J GASTROENTEROL, V47, P97, DOI 10.1007/s00535-011-0523-6; Kohler EM, 2008, HUM MOL GENET, V17, P1978, DOI 10.1093/hmg/ddn095; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Ivancic MM, 2013, J PROTEOME RES, V12, P4152, DOI 10.1021/pr400467c; Lin D, 2013, J PROTEOME RES, V12, P5996, DOI 10.1021/pr400877e; Irving AA, 2014, COMPARATIVE MED, V64, P128; Manna SK, 2014, GASTROENTEROLOGY, V146, P1313, DOI 10.1053/j.gastro.2014.01.017; Mashimo T, 2014, DEV GROWTH DIFFER, V56, P46, DOI 10.1111/dgd.12110; Zhao SY, 2004, GENOME RES, V14, P1851, DOI 10.1101/gr.2663304; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; Foote AL, 2007, CURR BIOL, V17, P551, DOI 10.1016/j.cub.2007.01.061; Amos-Landgraf JM, 2007, P NATL ACAD SCI USA, V104, P4036, DOI 10.1073/pnas.0611690104; Payne SR, 2005, CARCINOGENESIS, V26, P2031, DOI 10.1093/carcin/bgi223; Bhatia V, 2005, J GASTROEN HEPATOL, V20, P332, DOI 10.1111/j.1400-1746.2004.03508.x; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Mollersen L, 2004, ANTICANCER RES, V24, P2595; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Washington MK, 2013, GASTROENTEROLOGY, V144, P705, DOI 10.1053/j.gastro.2013.01.067; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Eisner R, 2013, BIOMED RES INT, DOI 10.1155/2013/303982; Murphy G, 2011, INT J CANCER, V128, P1668, DOI 10.1002/ijc.25481; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Ritchie KJ, 2009, P NATL ACAD SCI USA, V106, P20859, DOI 10.1073/pnas.0911351106; Nelson S, 2013, J CELL SCI, V126, P873, DOI 10.1242/jcs.100479; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Mikami T, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-30; Olson TJP, 2014, CANCER PREV RES, V7, P105, DOI 10.1158/1940-6207.CAPR-13-0163; Bikle DD, 2014, ENDOCRINE, V46, P29, DOI 10.1007/s12020-013-0146-1; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Irving AA, 2011, ARCH BIOCHEM BIOPHYS, V515, P64, DOI 10.1016/j.abb.2011.08.011; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Suzui M, 2002, CANCER LETT, V183, P31, DOI 10.1016/S0304-3835(02)00114-3; GARDNER EJ, 1962, AM J HUM GENET, V14, P376; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Barouei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046051; Burt RW, 2000, GASTROENTEROLOGY, V119, P837, DOI 10.1053/gast.2000.16508; Byun AJ, 2014, CANCER LETT, V347, P191, DOI 10.1016/j.canlet.2014.03.004; Centers for Disease Control and Prevention, 2014, COL CANC STAT; Crumeyrolle-Arias M, 2014, PSYCHONEUROENDOCRINO, V42, P207, DOI 10.1016/j.psyneuen.2014.01.014; Dove WF, 2014, G3-GENES GENOM GENET, V4, P1113, DOI 10.1534/g3.114.010595; Dutta N, 2009, EXP TOXICOL PATHOL, V61, P353, DOI 10.1016/j.etp.2008.10.003; EKER R, 1961, NATURE, V189, P858, DOI 10.1038/189858b0; Ferlay J, 2014, IARC CANCERBASE; GARDNER EJ, 1952, AM J HUM GENET, V4, P31; Gondo Y, 2013, ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE, P833, DOI 10.1016/B978-0-12-415894-8.00034-8; Grill J. I., 2014, MOL CANC RES; Guo XS, 2013, GENETICS, V194, P1017, DOI 10.1534/genetics.113.153049; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; HALBERG F, 1973, EXPERIENTIA, V29, P909, DOI 10.1007/BF01930381; HIRONO I, 1981, J NATL CANCER I, V66, P579; Howlader N, 2013, SEER CANC STAT REV 1; Huttlin EL, 2009, P NATL ACAD SCI USA, V106, P17235, DOI 10.1073/pnas.0909282106; Irving A. A., 2014, THESIS U WISCONSIN M; Ivancic MM, 2014, CANCER PREV RES, V7, P1160, DOI 10.1158/1940-6207.CAPR-14-0056; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kochi T., 2014, EUR J CANCER PREV, DOI [10.1097/CEJ.0000000000000063, DOI 10.1097/CEJ.0000000000000063]; Largaespada DA, 2001, J EXP MED, V193, pF15, DOI 10.1084/jem.193.4.F15; Larsson M, 1998, MAMM GENOME, V9, P479, DOI 10.1007/s003359900802; Mashimo T, 2008, NAT GENET, V40, P514, DOI 10.1038/ng0508-514; Mashimo T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01253; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Plawski A, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-15; Ponce de Leon V., 2014, PLOS ONE, V9; Preston SL, 2008, J PATHOL, V214, P294, DOI 10.1002/path.2294; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Valle L, 2008, SCIENCE, V321, P1361, DOI 10.1126/science.1159397; van Boxtel R, 2010, METHODS MOL BIOL, V597, P151, DOI 10.1007/978-1-60327-389-3_11; Weichert J. P., 2004, MOUSE MODELS HUMAN C, P339; WOLFE KH, 1993, J MOL EVOL, V37, P441; Wood PA, 2008, MOL CANCER RES, V6, P1786, DOI 10.1158/1541-7786.MCR-08-0196; Worthey EA, 2010, METHODS MOL BIOL, V597, P33, DOI 10.1007/978-1-60327-389-3_3; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yoshimi K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-448; Yoshimi K, 2009, CANCER SCI, V100, P2022, DOI 10.1111/j.1349-7006.2009.01287.x; Yoshimi K, 2013, AM J PATHOL, V182, P1263, DOI 10.1016/j.ajpath.2012.12.005; Young M, 2013, MOL ONCOL, V7, P178, DOI 10.1016/j.molonc.2013.02.006; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830; Zeineldin M, 2012, ONCOGENE, V31, P2423, DOI 10.1038/onc.2011.434; Zhang Tie Yuan, 2013, Neuropsychopharmacology, V38, P111, DOI 10.1038/npp.2012.149	107	4	4	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	NOV	2014	7	11					1215	1225		10.1242/dmm.016980		11	Cell Biology; Pathology	Cell Biology; Pathology	AT5UE	WOS:000345006800002		
J	Kalaee, MJ; Katoh, Y; Ono, T				Kalaee, Mohammad Javad; Katoh, Yuto; Ono, Takayuki			Effects of the Angle Between the Density Gradient and the External Magnetic Field on the Linear Mode Conversion and Resultant Beaming Angle of LO-Mode Radio Emissions	EARTH MOON AND PLANETS			English	Article						Density gradient; Mode conversion; Beaming angle; Radio emissions	PLASMA; WAVES; SIMULATION; RADIATION	Recent spacecraft's observations of kilometric continuum radiation showed that the linear mode conversion theory (LMCT) cannot explain the beaming angle of these observations; on the other hand satellite observations show some local fluctuation in the density gradient. In this research, we consider the mode conversion process from UHR-mode (slow Z- mode) to LO-mode (ordinary) waves, focusing on the effect of the angle between the density gradient and the external magnetic field on the efficiency of the LMCT and the resultant beaming angle of converted LO-mode waves; a comparison of the LMCT and simulation results are presented. We first consider a condition that the density gradient is perpendicular to the external magnetic field, corresponding to the condition assumed in the conventional LMCT. Next, we extend the discussion to the condition that the density gradient is oblique to the external magnetic field. Our aim here is to investigate a condition where the efficient mode conversion can occur and to study the deviation of the beaming angle from that estimated by LMCT. From the results of analyses, for both perpendicular and oblique cases, the highest conversion efficiency is obtained for a certain value of the wave normal angle (critical wave normal angle) of the incident slow Z-mode waves, corresponding to the case when two mode branches are matched. The simulation results show in the perpendicular case that the beaming angle is consistent with the conventional LMCT; but in the oblique case a critical wave normal angle becomes different from the perpendicular case and the beaming angle is different from the LMCT prediction.	[Kalaee, Mohammad Javad] Univ Tehran, Inst Geophys, Tehran, Iran; [Katoh, Yuto; Ono, Takayuki] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi 980, Japan	Kalaee, MJ (reprint author), Univ Tehran, Inst Geophys, Tehran, Iran.	mjkalaee@ut.ac.ir; yuto@stpp.gp.tohoku.ac.jp; ono@stpp.gp.tohoku.ac.jp	Katoh, Yuto/B-8007-2015	Katoh, Yuto/0000-0002-4318-0633	University of Tehran [28905/1/01]	The authors would like to acknowledge the financial support of University of Tehran for research under grant number 28905/1/01.	JONES D, 1976, NATURE, V260, P686, DOI 10.1038/260686a0; Grimald S, 2007, ANN GEOPHYS-GERMANY, V25, P823; Boardsen SA, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012319; Hashimoto K., 2006, LECT NOTE PHYS, V687, P33; Jones D., 1988, PLANETARY RADIO EMIS, P255; JONES D, 1980, NATURE, V288, P225, DOI 10.1038/288225a0; JONES D, 1987, NATURE, V328, P391, DOI 10.1038/328391a0; Kalaee MJ, 2010, ANN GEOPHYS-GERMANY, V28, P1289, DOI 10.5194/angeo-28-1289-2010; Kalaee MJ, 2009, EARTH PLANETS SPACE, V61, P1243; Mjplhus E., 1983, J PLASMA PHYS, V30, P179; Mjplhus E., 1990, RADIO SCI, V25, P1321; OYA H, 1971, RADIO SCI, V6, P1131, DOI 10.1029/RS006i012p01131; OYA H, 1974, PLANET SPACE SCI, V22, P687, DOI 10.1016/0032-0633(74)90140-8; PREINHAE.J, 1973, J PLASMA PHYS, V10, P1; Stix T.H., 1992, WAVES PLASMAS; WARREN ES, 1968, NATURE, V220, P466, DOI 10.1038/220466a0	16	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-9295	1573-0794		EARTH MOON PLANETS	Earth Moon Planets	NOV	2014	114	1-2					1	15		10.1007/s11038-014-9448-4		15	Astronomy & Astrophysics; Geosciences, Multidisciplinary	Astronomy & Astrophysics; Geology	AT6CT	WOS:000345027400001		
J	Motoki, H; Koyama, J; Izawa, A; Tomita, T; Miyashita, Y; Takahashi, M; Ikeda, U				Motoki, Hirohiko; Koyama, Jun; Izawa, Atsushi; Tomita, Takeshi; Miyashita, Yusuke; Takahashi, Masafumi; Ikeda, Uichi			Impact of Azelnidipine and Amlodipine on Left Ventricular Mass and Longitudinal Function in Hypertensive Patients with Left Ventricular Hypertrophy	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Article						left ventricular hypertrophy; left ventricular mass; strain-strain rate	HEART-FAILURE; DOPPLER-ECHOCARDIOGRAPHY; PROGNOSTIC IMPLICATIONS; CHAMBER QUANTIFICATION; DIASTOLIC DYSFUNCTION; TISSUE DOPPLER; SERIAL CHANGES; DISEASE; RECOMMENDATIONS; EVOLUTION	BackgroundThe impact of long-acting calcium channel blocker (CCB) administration on serial changes in left ventricular (LV) function and morphology in hypertensive patients with LV hypertrophy remains unclear. This study attempted to clarify this impact by comparing the effects of administration of azelnidipine with that of amlodipine using conventional and speckle tracking echocardiography. MethodsAn equal number (16) of 32 hypertensive patients was prospectively assigned to a group administered 5mg of amlodipine/day or a group administered 16mg of azelnidipine/day. LV function and morphology was examined by conventional and speckle tracking echocardiography at baseline and at 1, 3, 6, and 12months after treatment initiation. ResultsBoth groups were found to have experienced a significant decrease in systolic blood pressure by 1month after treatment initiation; a significant reduction in septal thickness and LV mass index at 6 and 12months. Transmitral flow E/A ratio and early diastolic mitral annular velocity at lateral wall significantly improved at 12months. On the other hand, a significant improvement of global longitudinal strain was observed earlier than the above indexes at 3, 6, and 12months. Ar-A duration difference was significantly decreased at 3months. The global circumferential strain improved significantly at 3months, but there were no significant changes in mid-/apical circumferential and radial strains throughout the study period. ConclusionAzelnidipine has beneficial effects on LV mass regression, transmitral flow, tissue Doppler, and LV longitudinal strain that are comparable to those of amlodipine on the same parameters.	[Motoki, Hirohiko; Koyama, Jun; Izawa, Atsushi; Tomita, Takeshi; Miyashita, Yusuke; Ikeda, Uichi] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano 3908621, Japan; [Takahashi, Masafumi] Jichi Med Univ, Div Bioimaging Sci, Ctr Mol Med, Shimotsuke, Japan	Koyama, J (reprint author), Shinshu Univ, Sch Med, Dept Cardiovasc Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	jkoyama@shinshu-u.ac.jp					DEVEREUX RB, 1993, CIRCULATION, V88, P1444; KOREN MJ, 1991, ANN INTERN MED, V114, P345; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; LEVY D, 1994, CIRCULATION, V90, P1786; Iacoviello M, 2013, ECHOCARDIOGR-J CARD, V30, P803, DOI 10.1111/echo.12142; SHEPHARD DAE, 1976, CAN MED ASSOC J, V115, P1191; Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Poulsen SH, 2003, J AM SOC ECHOCARDIOG, V16, P724, DOI 10.1016/S0894-7317(03)00403-6; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; BIKKINA M, 1994, JAMA-J AM MED ASSOC, V272, P33, DOI 10.1001/jama.272.1.33; Baltabaeva A, 2008, EUR J ECHOCARDIOGR, V9, P501, DOI 10.1016/j.euje.2007.08.004; Pavlopoulos H, 2008, EUR J ECHOCARDIOGR, V9, P772, DOI 10.1093/ejechocard/jen145; Rivas-Gotz C, 2003, AM J CARDIOL, V91, P780, DOI 10.1016/S0002-9149(02)03433-1; Devereux RB, 2001, CIRCULATION, V104, P1248, DOI 10.1161/hc3601.095927; Kasner M, 2007, CIRCULATION, V116, P637, DOI 10.1161/CIRCULATIONAHA.106.61983; Terpstra WF, 2001, J HYPERTENS, V19, P303, DOI 10.1097/00004872-200102000-00018; Verdecchia P, 1998, CIRCULATION, V97, P48; Ito H, 2009, HYPERTENS RES, V32, P1; Klein A L, 1991, J Am Soc Echocardiogr, V4, P379; Nishikawa N, 2001, J AM COLL CARDIOL, V38, P1539, DOI 10.1016/S0735-1097(01)01548-0; Park S, 2008, J AM SOC ECHOCARDIOG, V21, P246, DOI 10.1016/j.echo.2007.06.005; Schller NB, 1989, J AM SOC ECHOCARDIOG, V2, P358; Yamamoto E, 2006, J HYPERTENS, V24, P2057, DOI 10.1097/01.hjh.0000244956.47114.c1; Yamamoto K, 1997, J AM COLL CARDIOL, V30, P1819, DOI 10.1016/S0735-1097(97)00390-2	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	NOV	2014	31	10					1230	1238		10.1111/echo.12548		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT3ST	WOS:000344854600017		
J	Kijima, Y; Akagi, T; Nakagawa, K; Takaya, Y; Oe, H; Ito, H				Kijima, Yasufumi; Akagi, Teiji; Nakagawa, Koji; Takaya, Yoichi; Oe, Hiroki; Ito, Hiroshi			Three-Dimensional Echocardiography Guided Closure of Complex Multiple Atrial Septal Defects	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Article						three-dimensional echocardiography; atrial septal defect; transcatheter closure device	TRANSCATHETER CLOSURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; INTERATRIAL COMMUNICATIONS; PERCUTANEOUS CLOSURE; DEVICES	Mini-Abstract Transcatheter closure of complex multiple atrial septal defects (ASDs) remains a challenge. We describe our clinical experience with staged device deployment in a patient with multiple ASDs using four Amplatzer septal occluder devices. Three-dimensional transesophageal echocardiography imaging contributed not only to the therapeutic guidance of successful device deployment but also to the decision making for the staged device delivery approach in a case of morphologically complex multiple ASDs. Transcatheter closure of complex multiple atrial septal defects (ASDs) remains a challenge. We describe our clinical experience with staged device deployment in a patient with multiple ASDs using four Amplatzer septal occluder devices. Three-dimensional transesophageal echocardiography imaging contributed not only to the therapeutic guidance of successful device deployment but also to the decision making for the staged device delivery approach in a case of morphologically complex multiple ASDs.	[Kijima, Yasufumi; Nakagawa, Koji; Takaya, Yoichi; Oe, Hiroki; Ito, Hiroshi] Okayama Univ Hosp, Dept Cardiovasc Med, Okayama, Japan; [Akagi, Teiji] Okayama Univ Hosp, Div Cardiac Intens Care Unit, Okayama, Japan	Kijima, Y (reprint author), Okayama Univ Hosp, Dept Cardiovasc Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	kijima-y@cc.okayama-u.ac.jp					Cao QL, 2000, EUR HEART J, V21, P941, DOI 10.1053/euhj.1999.1909; Mahadevan VS, 2009, INT J CARDIOL, V133, P359, DOI 10.1016/j.ijcard.2008.01.027; Lander SR, 2004, CATHETER CARDIO INTE, V62, P526, DOI 10.1002/ccd.20099; Masseli J, 2013, CATHETER CARDIO INTE, V81, P825, DOI 10.1002/ccd.24329; Flachskampf FA, 2014, EUR HEART J-CARD IMG, V15, P353, DOI 10.1093/ehjci/jeu015; Butera G, 2010, CATHETER CARDIO INTE, V76, P121, DOI 10.1002/ccd.22435; Arcidiacono Carmelo, 2008, Circ Cardiovasc Imaging, V1, pe15, DOI 10.1161/CIRCIMAGING.108.774570; Bartel T, 2013, EUR HEART J-CARD IMG, V14, P618, DOI 10.1093/ehjci/jet048; Taniguchi M, 2013, INT J CARDIOVAS IMAG, V29, P1273, DOI 10.1007/s10554-013-0212-z	9	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	NOV	2014	31	10					E304	E306		10.1111/echo.12731		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT3ST	WOS:000344854600004		
J	Uchida, K; Ushimaru, A				Uchida, Kei; Ushimaru, Atushi			Biodiversity declines due to abandonment and intensification of agricultural lands: patterns and mechanisms	ECOLOGICAL MONOGRAPHS			English	Article						butterfly; diversity; land use change; landscape; Orthoptera; seminatural grassland; the intermediate disturbance hypothesis; the more individuals hypothesis	SPECIES RICHNESS; SEMINATURAL GRASSLANDS; PLANT DIVERSITY; INDIVIDUALS HYPOTHESIS; HABITAT FRAGMENTATION; ARTHROPOD DIVERSITY; GRAZING INTENSITY; FIELD EXPERIMENT; BODY-SIZE; COMMUNITIES	Declines in plants and herbivorous insects due to land use abandonment and intensification have been studied in agricultural areas worldwide. We tested four hypotheses, which were complementary rather than mutually exclusive, to understand the mechanisms driving biodiversity declines due to abandonment and intensification. These predict that biodiversity decline is caused by a decline in resource diversity, changes in disturbance regime, surrounding landscape conversion, and a decrease in biomass production. We compared plant richness and butterfly and orthopteran richness and diversity among three land use types in seminatural grasslands: abandoned, traditional, and intensified terraces. Then, we examined effects of changes in resource (plant) richness, frequency of disturbance (mowing), and surrounding landscapes on butterfly and orthopteran diversity to understand the mechanisms driving decline after land abandonment and intensification. Plant and herbivore richness and diversity were significantly lower in abandoned and intensified grasslands than in traditional grasslands. This trend was consistent throughout the seasons in both years of the study. Changes in mowing frequency and surrounding landscape explained plant richness declines as a consequence of land abandonment and intensification. Declines in herbivorous insects were explained by plant richness declines and changes in mowing frequency, but not by landscape changes. Plant and herbivore richness were maximized at an intermediate mowing frequency (approximately twice per year), which is typical practice on traditional terraces. This is the first report demonstrating that the intermediate disturbance hypothesis explained well the biodiversity declines in agricultural ecosystems. The richness and diversity responses of herbivore functional groups to plant richness, mowing frequency, and surrounding landscapes were generally inconsistent with predictions. We found significant trends in which butterfly and orthopteran species with low abundance in traditional terraces were lost in abandoned and/or intensive terraces. This may suggest that the number of individuals of most herbivorous species decreased randomly with respect to life-history traits following a decline in plant richness after changes in disturbance frequency. This study demonstrates that declines in herbivorous insects can be explained by multiple factors, and provides a unified explanation for biodiversity declines in both abandoned and intensified use of agricultural lands, which have often been studied separately.	[Uchida, Kei; Ushimaru, Atushi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo 6578501, Japan	Uchida, K (reprint author), Kobe Univ, Grad Sch Human Dev & Environm, 3-11 Tsurukabuto, Kobe, Hyogo 6578501, Japan.	k.uchida023@gmail.com			Japan Society for the Promotion of Science [13J03127, 23570024]	We sincerely appreciate Michael A. Huston and an anonymous reviewer for detailed comments that greatly improved the manuscript. We thank also Debra L. Wohl, Yasuoki Takami, Tatsuya Amano, Akira S. Mori, and Yoshiaki Takeda for their helpful comments and discussions on the draft of the manuscript. We also thank Emi Uchida, Yuko Nagata, Sogo Takahashi, Toshiki Izumisawa, Kumiko Michimoto, Shiori Maihara, Masayoshi K. Hiraiwa, Chihiro Fukada, Kotaro Nakamoto, Tomoya Shiotani, and Wataru Maruyama for their assistance in field surveys. This research was partly supported by grants-in-aid for K. Uchida (No. 13J03127) and A. Ushimaru (No. 23570024) from the Japan Society for the Promotion of Science.	Wettstein W, 1999, J APPL ECOL, V36, P363, DOI 10.1046/j.1365-2664.1999.00404.x; Kruess A, 2002, CONSERV BIOL, V16, P1570, DOI 10.1046/j.1523-1739.2002.01334.x; Hamback PA, 2010, ECOGRAPHY, V33, P1149, DOI 10.1111/j.1600-0587.2009.06125.x; Duffy JE, 2003, ECOL LETT, V6, P637; Uematsu Y, 2013, ECOL APPL, V23, P1357, DOI 10.1890/12-1939.1; Poyry J, 2009, OECOLOGIA, V160, P577, DOI 10.1007/s00442-009-1328-7; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Collinge SK, 2003, CONSERV BIOL, V17, P178, DOI 10.1046/j.1523-1739.2003.01315.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Joern A, 2005, ECOLOGY, V86, P861, DOI 10.1890/04-0135; Holland JD, 2005, OIKOS, V110, P101, DOI 10.1111/j.0030-1299.2005.13638.x; Huston MA, 2011, ECOL MONOGR, V81, P349, DOI 10.1890/10-1523.1; Ekroos J, 2010, J APPL ECOL, V47, P459, DOI 10.1111/j.1365-2664.2009.01767.x; Davies KF, 2000, ECOLOGY, V81, P1450, DOI 10.1890/0012-9658(2000)081[1450:WTOSPP]2.0.CO;2; Kuussaari M, 2007, AGR ECOSYST ENVIRON, V122, P366, DOI 10.1016/j.agee.2007.02.008; Aarssen LW, 2000, OIKOS, V89, P606, DOI 10.1034/j.1600-0706.2000.890321.x; Hamback PA, 2007, P NATL ACAD SCI USA, V104, P8368, DOI 10.1073/pnas.0611462104; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Bergman KO, 2004, ECOGRAPHY, V27, P619, DOI 10.1111/j.0906-7590.2004.03906.x; Uematsu Y, 2010, AGR ECOSYST ENVIRON, V135, P304, DOI 10.1016/j.agee.2009.10.010; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Kleijn D, 2011, TRENDS ECOL EVOL, V26, P474, DOI 10.1016/j.tree.2011.05.009; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Poyry J, 2006, OIKOS, V115, P401, DOI 10.1111/j.2006.0030-1299.15126.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Chiari C, 2010, J ANIM ECOL, V79, P366, DOI 10.1111/j.1365-2656.2009.01631.x; Petermann JS, 2010, J ANIM ECOL, V79, P709, DOI 10.1111/j.1365-2656.2010.01674.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Pykala J, 2004, PLANT ECOL, V175, P217; Baker HG., 1974, ANNU REV ECOL SYST, V5, P1, DOI DOI 10.1146/ANNUREV.ES.05.110174.000245; Begon M., 2006, ECOLOGY INDIVIDUALS; Di Giulio M, 2001, J APPL ECOL, V38, P310, DOI 10.1046/j.1365-2664.2001.00605.x; ElEla S. A., 2010, J THREATENED TAXA, V2, P849; Google, 2013, GOOGL MAPS 8 1 1; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Horn H. S., 1975, ECOLOGY EVOLUTION CO; Hubbell S. P., 2001, UNIFIED NEUTRAL THEO; Huston MA, 1994, BIOL DIVERSITY COEXI; Ichikawa A., 2006, ORTHOPTERA JAPANESE; Isley F. B., 1944, ANN ENTOMOL SOC AM, V37, P47; Kricheva J., 2000, OECOLOGIA, V125, P271; Matsumura T, 2010, APPL VEG SCI, V13, P336, DOI 10.1111/j.1654-109X.2010.01075.x; McNeely J.A., 1995, P711; Pautasso M, 2008, ANN BOT-LONDON, V101, P709, DOI 10.1093/aob/mcn010; Petterson B. D., 1984, AM MIDL NAT, V111, P296; Pollard E, 1994, MONITORING BUTTERFLI; R Development Core Team, 2008, R VERS 2 13 1; Rodriguez-Estrella R, 2007, DIVERS DISTRIB, V13, P877, DOI 10.1111/j.1472-4642.2007.00387.x; Shirouzu T., 2006, BUTTERFLIES JAPAN CO; Tabata H, 1997, SATOYAMA ITS CONSERV; Wootton JT, 1998, AM NAT, V152, P803, DOI 10.1086/286210; Yee DA, 2007, OECOLOGIA, V153, P153, DOI 10.1007/s00442-007-0707-1	65	7	7	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	0012-9615	1557-7015		ECOL MONOGR	Ecol. Monogr.	NOV	2014	84	4					637	658		10.1890/13-2170.1		22	Ecology	Environmental Sciences & Ecology	AT4PU	WOS:000344923500006		
J	Kobayashi, S; Usui, R; Nomoto, K; Ushirokita, M; Denda, T; Izawa, M				Kobayashi, Shun; Usui, Ryota; Nomoto, Kouta; Ushirokita, Mineyuki; Denda, Tetsuo; Izawa, Masako			Does egg dispersal occur via the ocean in the stick insect Megacrania tsudai (Phasmida: Phasmatidae)?	ECOLOGICAL RESEARCH			English	Article						Egg period; Hatching rate; Megacrania tsudai; Salinity tolerance; Seawater dispersal	HALOBATES HETEROPTERA; SALINITY TOLERANCE; MOSQUITOS; SELECTION; GERRIDAE; BIOLOGY	Although insects expand their distribution by various ways, generally only the adult phase has been taken into consideration in research on dispersal. In Megacrania tsudai, it has been proposed that eggs are dispersed through seawater. To test this hypothesis, eggs were treated under normal condition (NC) on wet cotton swabs, and marine condition (MC), floating on salt water for 30, 60, 90, and 365 days. In addition, eggs in the NC and MC treatment groups were dissected every 10 days to verify the developmental stage. The hatching rates in the NC and MC treatment groups were not significantly different among the five treatment groups. However, the egg period, time from laying to hatching, in the MC treatment group was significantly longer than that in any other treatment groups. The egg period was lengthened when the floating period on seawater was longer. The time of the start of egg development was similar in the NC and MC treatment groups, but the developmental speed was slower in the MC treatment group. These results support that M. tsudai can expand its distribution by dispersing its eggs through seawater, probably thanks to specific characteristics of eggs that allow their survival when they float in the sea.	[Kobayashi, Shun] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan; [Kobayashi, Shun] Japan Soc Promot Sci, Tokyo, Japan; [Usui, Ryota] Univ Ryukyus, Grad Sch Agr, Nishihara, Okinawa 9030213, Japan; [Nomoto, Kouta] Itami City Museum Insects, Itami, Hyogo 6640015, Japan; [Ushirokita, Mineyuki] Ecoplanning Res Co Ltd, Tokyo 1890013, Japan; [Denda, Tetsuo; Izawa, Masako] Univ Ryukyus, Fac Sci, Nishihara, Okinawa 9030213, Japan	Kobayashi, S (reprint author), Univ Ryukyus, Grad Sch Engn & Sci, Senbaru 1, Nishihara, Okinawa 9030213, Japan.	cheirotonus.jambar@gmail.com			Takeshi Sasaki of The University Museum (Fujukan); University of the Ryukyus; 'International Research Hub Project for Climate Change and Coral Reef/Island Dynamics' from University of the Ryukyus; KAIGIN Environment Fund	We appreciate Takeshi Sasaki of The University Museum (Fujukan), University of the Ryukyus for his valuable advices and support of this research. We also thank Yuki Yamakoshi, Keita Nakamura, and Hiromu Tanimoto for their help and two reviewers for their valuable comments. This study was partly supported by the 'International Research Hub Project for Climate Change and Coral Reef/Island Dynamics' from the University of the Ryukyus and The KAIGIN Environment Fund-managed by THE OKINAWA KAIHO BANK, LTD.	Andersen NM, 2004, OCEANOGR MAR BIOL, V42, P119; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Kiflawi M, 2003, ECOL ENTOMOL, V28, P168, DOI 10.1046/j.1365-2311.2003.00505.x; CHENG L, 1985, ANNU REV ENTOMOL, V30, P111; Azuma S., 2002, CHECK LIST INSECT RY; Basden EB, 1955, ENTOMOL MON MAG, V61, P201; BEAMENT JW, 1961, BIOL REV, V36, P281, DOI 10.1111/j.1469-185X.1961.tb01291.x; Bedford GO, 1976, AUST J ENTOMOL, V15, P389, DOI 10.1111/j.1440-6055.1976.tb01722.x; Bedford GO, 1978, ANNU REV ENTOMOL, V25, P129; CLARK JT, 1979, SYST ENTOMOL, V4, P325, DOI 10.1111/j.1365-3113.1979.tb00617.x; DEHGAN B, 1983, BOT GAZ, V144, P412, DOI 10.1086/337391; Foster WA, 2008, ZOOL J LINN SOC-LOND, V86, P391; Garcia-Gonzalez F, 2003, BEHAV ECOL SOCIOBIOL, V53, P385, DOI [10.1007/s00265-003-0591-6, 10.1007/s00265-003-0663-7]; Gibbs GW, 1996, NZ ENTOMOL, V4, P14; HINTON HE, 1969, ANNU REV ENTOMOL, V14, P343, DOI 10.1146/annurev.en.14.010169.002015; Hirsh H, 2002, BIOTROPICA, V34, P598, DOI 10.1111/j.1744-7429.2002.tb00579.x; Hsiung Chia-Chi, 2007, Journal of Orthoptera Research, V16, P207, DOI 10.1665/1082-6467(2007)16[207:ROTGMK]2.0.CO;2; Iwata Shu-ko, 2004, Japanese Journal of Entomology (New Series), V7, P133; Krebs C. J., 2001, ECOLOGY EXPT ANAL DI, P695; LEADER JP, 1972, J EXP BIOL, V57, P821; McLachlan A, 2006, ECOLOGY SANDY SHORES; Minakawa Noboru, 2001, Entomological Science, V4, P393; NAKANISHI H, 1988, Ecological Research, V3, P163, DOI 10.1007/BF02346937; Patrick ML, 2000, J EXP BIOL, V203, P821; Rikiishi K, 1974, J OCEANOGR SOC JPN, V30, P42, DOI DOI 10.1007/BF02112890; Roberts D, 1996, J MED ENTOMOL, V33, P525; STONE B C, 1967, Gardens' Bulletin (Singapore), V22, P231; Udvardy M. D. F., 1969, DYNAMIC ZOOGEOGRAPHY; Ueno S.-I., 1978, Memoirs of the National Science Museum (Tokyo), V11, P123; Ushirokita Mineyuki, 1998, Insectarium, V35, P108; Wang C-H, 1982, NTU PHYTOPATHOL ENTO, V9, P98; Williams DD, 1998, FRESHWATER BIOL, V39, P411, DOI 10.1046/j.1365-2427.1998.00285.x; Yamasaki T, 1991, P JAP SOC SYST, V44, P49	33	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	NOV	2014	29	6					1025	1032		10.1007/s11284-014-1188-4		8	Ecology	Environmental Sciences & Ecology	AT6EX	WOS:000345033000001		
J	Takigahira, T; Suwito, A; Kimura, MT				Takigahira, Tomohiro; Suwito, Awit; Kimura, Masahito T.			Assessment of fitness costs of resistance against the parasitoid Leptopilina victoriae in Drosophila bipectinata	ECOLOGICAL RESEARCH			English	Article						Artificial selection; Coevolution; Specificity; Trade-offs	LARVAL COMPETITIVE ABILITY; TRADE-OFF; FRUGIVOROUS DROSOPHILIDS; GEOGRAPHICAL VARIATION; MELANOGASTER LARVAE; HOST; COEVOLUTION; SUPPRESSION; VIRULENCE; ABUNDANCE	How insects evolve resistance or counter-resistance against antagonists is a basic issue in the study of host-parasitoid coevolution. One of the factors that affect their coevolution is fitness costs of resistance and counter-resistance. Here, we assess fitness costs of resistance against the parasitoid Leptopilina victoriae in Drosophila bipectinata on the basis of selection experiments. We made a base population by mixing three geographic fly populations that differed in resistance. The established base population was divided into four populations, two for selection of resistance against a L. victoriae population and two for control. Resistance increased rapidly in response to selection and reached a very high level within four generations in the selected populations, while resistance of the control populations remained low during 20 generations. High resistance of the selected populations was maintained at least for 10 generations after selection was stopped. Both selected populations had lower female longevity than the control populations, and at least one of the selected populations had shorter thorax length, lower female desiccation tolerance and adult heat tolerance than both or either of the control populations. On the other hand, the selected populations had higher male starvation tolerance and longevity than the control populations. There were no significant differences in resistance against another population of L. victoriae and two other parasitoid species between the selected and control populations. These results suggest that the resistance against the L. victoriae population in D. bipectinata may incur some but not so high costs and act parasitoid-species-and/or parasitoid-population-specifically.	[Takigahira, Tomohiro; Kimura, Masahito T.] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Suwito, Awit] LIPI, Biol Res Ctr, Museum Zool Bogoriense, Div Zool, Bogor, Indonesia	Takigahira, T (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan.	takigahira@ees.hokudai.ac.jp			Ministry of Education, Science, Sports, Culture and Technology of Japan [23370005]	We thank M. J. Toda, M. Kondo and M. B. Lakim who provided us with D. bipectinata and L. victoriae from Kota Kinabalu. We also thank T. I. Kohyama, K. W. Matsubayashi, F. Y. Nomano, B. Novkovic and N. Kasuya for their kind assistance. This study was supported by Grant-in-Aids from the Ministry of Education, Science, Sports, Culture and Technology of Japan (No. 23370005).	Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Shelby KS, 1999, J INSECT PHYSIOL, V45, P507, DOI 10.1016/S0022-1910(98)00144-9; Kimura MT, 2014, ENVIRON ENTOMOL, V43, P123, DOI 10.1603/EN13141; Mitsui H, 2010, EUR J ENTOMOL, V107, P535; Kimura MT, 2012, J NAT HIST, V46, P1947, DOI 10.1080/00222933.2012.707239; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Kraaijeveld AR, 1997, NATURE, V389, P278; Novkovic B, 2012, EUR J ENTOMOL, V109, P517; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; NORDLANDER G, 1980, ENTOMOL SCAND, V11, P428; Novkovic B, 2011, ENTOMOL SCI, V14, P333, DOI 10.1111/j.1479-8298.2011.00459.x; Doebeli M, 1997, J THEOR BIOL, V188, P109, DOI 10.1006/jtbi.1997.0454; EDSON KM, 1981, SCIENCE, V211, P582, DOI 10.1126/science.7455695; HOLM S, 1979, SCAND J STAT, V6, P65; Kopp A, 2005, GENET RES, V85, P23, DOI 10.1017/S0016672305007317; KRAAIJEVELD AR, 1994, PHYSIOL ENTOMOL, V19, P9, DOI 10.1111/j.1365-3032.1994.tb01068.x; Fellowes MDE, 1998, P ROY SOC B-BIOL SCI, V265, P1553; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.ento.40.1.31; Lemeunier F., 1986, P147; CARTON Y, 1992, HEREDITY, V69, P393; Development Core Team R., 2012, R LANG ENV STAT COMP; Dubuffet A, 2007, HEREDITY, V98, P21, DOI 10.1038/sj.hdy.6800893; Dubuffet A, 2009, ADV PARASIT, V70, P147, DOI 10.1016/S0065-308X(09)70006-5; Dupas S, 2009, ADV PARASIT, V70, P281, DOI 10.1016/S0065-308X(09)70011-9; Dupas S, 1998, J HERED, V89, P306, DOI 10.1093/jhered/89.4.306; Dupas S, 2003, HEREDITY, V90, P84, DOI 10.1038/sj.hdy.6800182; Dupas S, 1999, ECOGRAPHY, V22, P284, DOI 10.1111/j.1600-0587.1999.tb00504.x; Fellowes MDE, 1999, EVOLUTION, V53, P1302, DOI 10.2307/2640834; Hirai Yoshiyuki, 2000, Entomological Science, V3, P273; Hufbauer RA, 2001, ECOLOGY, V82, P717, DOI 10.1890/0012-9658(2001)082[0717:PAPIHP]2.0.CO;2; KRAAIJEVELD AR, 1995, EVOL ECOL, V9, P10, DOI 10.1007/BF01237692; Rolff J, 2003, P R SOC LOND BIOL S, V270, pS154; Sasaki A, 1999, P ROY SOC B-BIOL SCI, V266, P455; Therneau TM, 2014, PACKAGE SURVIVAL; Westfall P., 2013, PACKAGE MULTCOMP; Wheeler M.R., 1972, U TEXAS PUBL, V7213, P1	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	NOV	2014	29	6					1033	1041		10.1007/s11284-014-1190-x		9	Ecology	Environmental Sciences & Ecology	AT6EX	WOS:000345033000002		
J	Nanashima, A; Abo, T; Takagi, K; Arai, J; To, K; Kunizaki, M; Hidaka, S; Takeshita, H; Sawai, T; Nagayasu, T				Nanashima, A.; Abo, T.; Takagi, K.; Arai, J.; To, K.; Kunizaki, M.; Hidaka, S.; Takeshita, H.; Sawai, T.; Nagayasu, T.			Prognostic influence of the liver hanging maneuver for patients with hepatobiliary malignancies who underwent hepatic resections	EJSO			English	Article						Hepatectomy; Liver hanging maneuver; Major anatomic resection; Patient prognosis; Hepatobiliary malignancies	LARGE HEPATOCELLULAR-CARCINOMA; RIGHT HEPATECTOMY; ANTERIOR APPROACH; CAUDATE LOBE; HILAR CHOLANGIOCARCINOMA; TUMOR-CELLS; BLOOD-LOSS; BILE-DUCT; SURVIVAL; TRANSPLANTATION	Background: Prognostic influences of hepatic transection by. an anterior approach using the liver hanging maneuver (LHM) has not been fully clarified. Methods: We examined 233 patients who underwent major hepatectomy with the LHM (n = 75; hepatocellular carcinoma (HCC) in 35, colorectal liver metastasis (CLM) in 10, intrahepatic cholangiocarcinoma (ICC) in 14 and perihilar bile duct carcinoma (BDC) in 16) or without it (n = 158; HCC in 78, CLM in 21, ICC in 31 and BDC in 28). Results: In HCC patients, cancer-positive margin rate, blood loss, transection time and prevalence of posthepatectomy ascites in the LHM group were significantly lower than those in the non-LHM group (p < 0.05). In CLM, transection time in the LHM group was significantly lower than that in the non-LHM group (p < 0.05). In BDC patients, amount of blood loss, transection time and prevalence of ascites in the LHM group were significantly lower than those in the non-LHM group (p < 0.05). In CLM patients, tumor recurrence rate in the non-LHM group was significantly higher than that in the LHM group and disease-free survival in the LHM group was significantly better than that in the non-LHM group in CLM patients and, however, this difference was not observed in a large CLM exceeding 5 cm. However, significant, differences of posthepatectomy disease-free and overall survivals were not observed in HCC, ICC and BDC patients. Conclusions: Although advantages of LHM improving surgical records in major anatomical liver resections were clarified, oncological advantages in the long-term Survival of LHM was still uncertain in the hepatobiliary malignancies. (C) 2014 Elsevier Ltd. All rights reserved.	[Nanashima, A.; Abo, T.; Takagi, K.; Arai, J.; To, K.; Kunizaki, M.; Hidaka, S.; Takeshita, H.; Sawai, T.; Nagayasu, T.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki 8528501, Japan	Nanashima, A (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	a-nanasm@nagasaki-u.ac.jp					Lai ECS, 1996, WORLD J SURG, V20, P314; de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; Liu CL, 2006, BRIT J SURG, V93, P1488, DOI 10.1002/bjs.5482; YAMANAKA N, 1992, CANCER, V70, P2263, DOI 10.1002/1097-0142(19921101)70:9<2263::AID-CNCR2820700909>3.0.CO;2-M; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; Liu CL, 2006, ANN SURG, V244, P194, DOI 10.1097/01.sla.0000225095.18754.45; Spelt L, 2012, EJSO-EUR J SURG ONC, V38, P16, DOI 10.1016/j.ejso.2011.10.013; Wong IHN, 1999, CLIN CANCER RES, V5, P4021; Belghiti J, 2001, J AM COLL SURGEONS, V193, P109, DOI 10.1016/S1072-7515(01)00909-7; Ogata S, 2007, ANN SURG, V245, P31, DOI 10.1097/01.sla.0000224725.40979.0a; Aydin U, 2006, HPB OXF, V8, P35; Capussotti L, 2012, J GASTROINTEST SURG, V16, P1324, DOI 10.1007/s11605-012-1894-6; Emond JC, 1996, AM J SURG, V172, P29, DOI 10.1016/S0002-9610(96)00069-4; Endo I, 2012, J HEPATO-BIL-PAN SCI, V19, P216, DOI 10.1007/s00534-011-0481-7; Ettorre GM, 2004, J HEPATO-BILIARY-PAN, V11, P155, DOI 10.1007/s00534-004-0903-x; Gaujoux S, 2007, AM J SURG, V193, P488, DOI 10.1016/j.amjsurg.2006.04.006; Gruttadauria S, 2011, J SURG ONCOL, V103, P140, DOI 10.1002/jso.21796; Hirai I, 2003, CLIN ANAT, V16, P224, DOI 10.1002/ca.10092; Horino K, 2013, INT J CLIN ONCOL, V18, P829, DOI 10.1007/s10147-012-0451-3; Hwang S, 2008, J GASTROINTEST SURG, V12, P1288, DOI 10.1007/s11605-007-0420-8; Kim SH, 2007, ANN SURG, V245, P201, DOI 10.1097/01.sla.0000245516.10349.c5; Liddo G, 2009, HPB, V11, P296, DOI 10.1111/j.1477-2574.2009.00068.x; Makuuchi M, 2009, GEN RULES CLIN PATHO, P17; Makuuchi Masatoshi, 2013, Int J Surg, V11 Suppl 1, pS47, DOI 10.1016/S1743-9191(13)60015-1; Miyazaki M, 2013, GEN RULES CLIN PATHO, P11; Mutoh T, 2006, GEN RULES CLIN PATHO, P14; Nanashima A, 2011, SURG TODAY, V41, P453, DOI 10.1007/s00595-010-4291-3; Nanashima A, 2008, J SURG ONCOL, V98, P535, DOI 10.1002/jso.21142; Nanashima A, 2013, SURG TODAY, V43, P485, DOI 10.1007/s00595-012-0374-7; Nanashima A, 2009, HEPATO-GASTROENTEROL, V56, P498; Nanashima A, 2009, HPB, V11, P529, DOI 10.1111/j.1477-2574.2009.00098.x; Nanashima A, 2011, ANTICANCER RES, V31, P4545; Nanashima A, 2008, WORLD J SURG, V32, P2070, DOI 10.1007/s00268-008-9606-9; Nanashima A, 2009, EJSO-EUR J SURG ONC, V35, P326, DOI 10.1016/j.ejso.2008.01.023; Nanashima A, 2013, INT J SURG, V11, P891, DOI 10.1016/j.ijsu.2013.07.012; Shindoh J, 2011, J GASTROINTEST SURG, V15, P988, DOI 10.1007/s11605-011-1499-5; Wang CC, 2010, WORLD J SURG, V34, P1874, DOI 10.1007/s00268-010-0546-9; Wu TJ, 2010, BRIT J SURG, V97, P1070, DOI 10.1002/bjs.7083	39	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	NOV	2014	40	11					1540	1549		10.1016/j.ejso.2014.06.013		10	Oncology; Surgery	Oncology; Surgery	AT3HE	WOS:000344825600022		
J	Cao, JY; Liu, LQ; Hashimoto, A; Ye, JH				Cao, Junyu; Liu, Lequan; Hashimoto, Ayako; Ye, Jinhua			Hematite photo-electrodes with multiple ultrathin SiOx interlayers towards enhanced photoelectrochemical properties	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Multiple-layer; Hematite; Photo-electrode; Ultrathin interlayer; Water splitting	WATER; PHOTOANODES	Fe2O3 photo-electrodes with multiple ultrathin SiOx interlayers were prepared by a pulsed laser deposition method. The as-prepared photo-electrode showed a high photocurrent density of 1.13 mA/cm(2) at 0.6 V vs. Ag/AgCl under a simulated solar irradiation (AM 1.5, 75 mW/cm(2) at 350 nm-800 nm). The enhancement of the photoelectrochemical properties should be due to the improved electron-hole migration inside the photo-electrode, which is caused by the import of multiple ultrathin SiOx interlayers. (C) 2014 Elsevier B.V. All rights reserved.	[Cao, Junyu; Ye, Jinhua] Natl Inst Mat Sci, Environm Remediat Mat Unit, Tsukuba, Ibaraki, Japan; [Liu, Lequan; Ye, Jinhua] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki, Japan; [Hashimoto, Ayako] Natl Inst Mat Sci, Surface Phys & Struct Unit, Tsukuba, Ibaraki, Japan; [Hashimoto, Ayako] Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki, Japan; [Hashimoto, Ayako] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Ye, Jinhua] Tianjin Univ, Sch Mat Sci & Engn, TU NIMS Joint Res Ctr, Tianjin 300072, Peoples R China	Ye, JH (reprint author), Natl Inst Mat Sci, Environm Remediat Mat Unit, 1-1 Namiki, Tsukuba, Ibaraki, Japan.				World Premier International Research Center Initiative on Materials Nanoarchitectonics; Center of Materials Research for Low Carbon Emission, Japan; MEXT	This work was partially supported by the World Premier International Research Center Initiative on Materials Nanoarchitectonics, MEXT, and Center of Materials Research for Low Carbon Emission, Japan.	Chen XQ, 2011, ACS NANO, V5, P4310, DOI 10.1021/nn200100v; Cao JY, 2013, LANGMUIR, V29, P3116, DOI 10.1021/la304377z; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Zhong DK, 2010, J AM CHEM SOC, V132, P4202, DOI 10.1021/ja908730h; Zou ZG, 2001, NATURE, V414, P625, DOI 10.1038/414625a; Tong H, 2012, ADV MATER, V24, P229, DOI 10.1002/adma.201102752; Cesar I, 2006, J AM CHEM SOC, V128, P4582, DOI 10.1021/ja060292p; Cao JY, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/32/325101; Cao JY, 2012, CHEM COMMUN, V48, P8649, DOI 10.1039/c2cc33662f; Dotan H, 2013, NAT MATER, V12, P158, DOI [10.1038/nmat3477, 10.1038/NMAT3477]; Kleiman-Shwarsctein A, 2010, CHEM MATER, V22, P510, DOI 10.1021/cm903135j; Walter M.G., 2010, CHEM REV, V11, P6446	12	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	NOV	2014	48						17	20		10.1016/j.elecom.2014.07.030		4	Electrochemistry	Electrochemistry	AT8UT	WOS:000345208000005		
J	Iio, A; Ikeda, H; Anggraini, SA; Miura, N				Iio, Ayumi; Ikeda, Hiroshi; Anggraini, Sri Ayu; Miura, Norio			Potentiometric YSZ-based oxygen sensor using BaFeO3 sensing-electrode	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Oxygen sensor; Potentiometric sensor; YSZ; Perovskite oxide	LOW-TEMPERATURE OPERATION; EXHAUST-GAS SENSORS; SOLID-ELECTROLYTE; CONCENTRATION CELLS; OXIDE ELECTRODES; PEROVSKITE; BEHAVIOR; KINETICS; CERIA	Various metal oxides were examined for a sensing-electrode (SE) material of potentiometric yttria-stabilized zirconia (YSZ)-based oxygen sensors. Among the oxides tested, perovskite-type oxides of BaxSr1-xFeO3 (x = 1.0, 0.9, 0.5, 0.1, 0) were found to give low responses to various gases (NH3, H-2, C3H6, C3H8, CH4, NO2, NO, and CO, 100 ppm each) at 600 degrees C. Particularly, BaFeO3-SE gave the most insensitive behavior to all the gases tested even in the temperature range of 500-600 degrees C, as the conventional Pt-SE did. Furthermore, the sensor using this inexpensive BaFeO3-SE was found to be quite sensitive to oxygen in the concentration range of 0.05-21 vol.% at temperatures of 500-600 degrees C, as similar to the case of an expensive Pt-SE. At 600 degrees C, the number of electron (n) involved in the electrochemical reaction of oxygen for the sensors using each of BaFeO3-SE and Pt-SE was estimated to be 4.2, which was obtained from the slope of linear correlation between potential response and the logarithm of oxygen concentration. The estimated n value was in good agreement with the theoretical value (n = 4). The present sensor using BaFeO3-SE was also confirmed to work well as a. (lambda) sensor at 600 degrees C, showing similar behavior as the sensor using Pt-SE did. (C) 2014 Elsevier B.V. All rights reserved.	[Iio, Ayumi] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan; [Ikeda, Hiroshi; Anggraini, Sri Ayu; Miura, Norio] Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Fukuoka 8168580, Japan	Miura, N (reprint author), Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Fukuoka 8168580, Japan.	miurano@astec.kyushu-u.ac.jp	Ikeda, Hiroshi/K-3378-2012	Ikeda, Hiroshi/0000-0002-7187-1722	JSPS KAKENHI [25288109]	This work was partially supported by JSPS KAKENHI Grant No. 25288109.	IHARADA T, 1991, SOLID STATE IONICS, V48, P257, DOI 10.1016/0167-2738(91)90040-I; Fergus JW, 2007, SENSOR ACTUAT B-CHEM, V122, P683, DOI 10.1016/j.snb.2006.06.024; Ramamoorthy R, 2003, J MATER SCI, V38, P4271, DOI 10.1023/A:1026370729205; INOUE T, 1990, J ELECTROCHEM SOC, V137, P2523, DOI 10.1149/1.2086980; Miura N, 2014, IONICS, V20, P901, DOI 10.1007/s11581-014-1140-1; Moos R, 2005, INT J APPL CERAM TEC, V2, P401, DOI 10.1111/j.1744-7402.2005.02041.x; Riegel J, 2002, SOLID STATE IONICS, V152, P783, DOI 10.1016/S0167-2738(02)00329-6; Cho HS, 2005, SENSOR ACTUAT B-CHEM, V108, P335, DOI 10.1016/j.snb.2004.10.043; Cho HS, 2005, SENSOR ACTUAT B-CHEM, V109, P307, DOI 10.1016/j.snb.2004.12.062; EGUCHI K, 1993, SENSOR ACTUAT B-CHEM, V13, P38, DOI 10.1016/0925-4005(93)85317-4; INOUE T, 1988, CHEM LETT, P1939, DOI 10.1246/cl.1988.1939; Pikalova EY, 2010, RUSS J ELECTROCHEM+, V46, P820, DOI 10.1134/S1023193510070165; Ramamoorthy R, 2006, SENSOR ACTUAT B-CHEM, V113, P162, DOI 10.1016/j.snb.2005.02.043; Ramirez-Salgado J, 2002, SENSOR ACTUAT B-CHEM, V82, P34, DOI 10.1016/S0925-4005(01)00986-8	14	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	NOV	2014	48						134	137		10.1016/j.elecom.2014.09.004		4	Electrochemistry	Electrochemistry	AT8UT	WOS:000345208000034		
J	Tie, J; Uchigasaki, S				Tie, Jian; Uchigasaki, Seisaku			Detection of short tandem repeat polymorphisms from human nails using direct polymerase chain reaction method	ELECTROPHORESIS			English	Article						Direct multiplex PCR; Forensic identification; Human fingernail; STR polymorphisms	DIRECT PCR; HUMAN REMAINS; DNA; IDENTIFICATION; BONE; POPULATIONS	Human nail is an important forensic material for parental testing and individual identification in large-scale disasters. Detection of STR polymorphism from hard tissues generally requires DNA purification, which is technically complicated and time consuming. In the present study, we attempted to detect STR polymorphisms from untreated human nail samples by direct PCR amplification method using the primer mixture supplied with the GenePrint (R) SilverSTR (R) III System or the AmpFlSTR (R) Identifiler (R) PCR Amplification Kit, and Tks Gflex DNA polymerase known to be effective for amplification from crude samples. A nail fragment measuring approximately 1.5 mm in breadth and 0.5 mm in length was placed directly into a PCR tube, and various PCR conditions were tested. The PCR products were analyzed by denaturing acrylamide gel electrophoresis or CE. Multiple STR polymorphisms were detected successfully. This method that detects STR polymorphisms not only from fresh human fingernails, but also from old nail fragments stored at room temperature for up to 10 years is expected to become a novel DNA analytical method in forensic medicine and genetic studies.	[Tie, Jian; Uchigasaki, Seisaku] Nihon Univ, Sch Med, Div Legal Med, Dept Social Med, Tokyo 1738610, Japan	Tie, J (reprint author), Nihon Univ, Sch Med, Div Legal Med, Dept Social Med, Tokyo 1738610, Japan.	tetsu.ken@nihon-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [24590867]	This work was supported by Japan Society for the Promotion of Science KAKENHI, Great-in-Aid for Scientific Research (C) number 24590867.	Allouche M, 2008, FORENSIC SCI INT-GEN, V3, P46, DOI 10.1016/j.fsigen.2008.07.008; Verheij S, 2012, FORENSIC SCI INT-GEN, V6, P167, DOI 10.1016/j.fsigen.2011.03.014; Gaibar M, 2012, ANN HUM BIOL, V39, P297, DOI 10.3109/03014460.2012.697578; Aboud M, 2013, ELECTROPHORESIS, V34, P1539, DOI 10.1002/elps.201200570; Barta JL, 2013, FORENSIC SCI INT, V231, P340, DOI 10.1016/j.forsciint.2013.06.004; Davis C, 2013, FORENSIC SCI INT-GEN, V7, P204, DOI 10.1016/j.fsigen.2012.06.005; Adler CJ, 2011, J ARCHAEOL SCI, V38, P956, DOI 10.1016/j.jas.2010.11.010; Campos PF, 2012, ANN ANAT, V194, P7, DOI 10.1016/j.aanat.2011.07.003; Linacre A, 2010, FORENSIC SCI INT-GEN, V4, P137, DOI 10.1016/j.fsigen.2009.07.006; Higgins D, 2013, SCI JUSTICE, V53, P433, DOI 10.1016/j.scijus.2013.06.001; Swaran YC, 2012, FORENSIC SCI INT-GEN, V6, P407, DOI 10.1016/j.fsigen.2011.08.007; Chavez-Briones MD, 2013, J FORENSIC SCI, V58, P248, DOI 10.1111/j.1556-4029.2012.02279.x; Harder M, 2012, CROAT MED J, V53, P416, DOI 10.3325/cmj.2012.53.416; Nakanishi Akinori, 2003, Leg Med (Tokyo), V5 Suppl 1, pS194, DOI 10.1016/S1344-6223(02)00109-8; Park Joshua, 2012, J Prev Med Public Health, V45, P235, DOI 10.3961/jpmph.2012.45.4.235; Piccinini A., 2006, INT CONGR SER, V1288, P586, DOI 10.1016/j.ics.2005.08.029; Purzycka J. K., 2006, INT C SER, V1288, P719, DOI 10.1016/j.ics.2005.09.073; Quincey D, 2013, SCI JUSTICE, V53, P253, DOI 10.1016/j.scijus.2013.04.003; Sim JE, 2013, J FORENSIC SCI, V58, P989, DOI 10.1111/1556-4029.12166; Tie JA, 2010, ELECTROPHORESIS, V31, P2411, DOI 10.1002/elps.200900754; Uchida K., 1996, BLOOD, V87, P4015; Uchigasaki S, 2013, MOL BIOL REP, V40, P3193, DOI 10.1007/s11033-012-2394-1	22	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	NOV	2014	35	21-22			SI		3188	3192		10.1002/elps.201400061		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AT9UP	WOS:000345272200022		
J	Sgambi, L; Garavaglia, E; Basso, N; Bontempi, F				Sgambi, L.; Garavaglia, E.; Basso, N.; Bontempi, F.			Monte Carlo simulation for seismic analysis of a long span suspension bridge	ENGINEERING STRUCTURES			English	Article						Monte Carlo simulation; Seismic analysis; Long span suspension bridge; Uncertainties	EARTHQUAKE GROUND MOTIONS; CABLE-STAYED BRIDGES; SPATIAL VARIABILITY; RISK-ASSESSMENT; GENERATION; ACCELEROGRAMS; BUILDINGS; TRANSFORM; SPECTRUM; DESIGN	The seismic analysis of long-span cable suspended bridges is undoubtedly a problem in structural analysis that involves a high number of uncertain parameters. In this work, through a probabilistic approach (Monte Carlo simulation) seismic analysis is carried out able to take into account the variability of certain factors relating to the seismic input. Displacement time histories, necessary to define seismic scenarios, are built artificially based on the response spectrum of the site. The analysis is carried out using a 3D numerical model built using one-dimensional finite elements using ADINA software code. This model has been developed in conjunction with a purpose-built program in FORTRAN language to conduct the Monte Carlo simulations. The results expressed in terms of displacements and stresses are described by their average value and their variance. (C) 2014 Elsevier Ltd. All rights reserved.	[Sgambi, L.; Garavaglia, E.] Politecn Milan, Dept Civil & Environm Engn, I-20133 Milan, Italy; [Basso, N.] Tokyo Denki Univ, Dept Architecture, Tokyo 101, Japan; [Bontempi, F.] Univ Roma La Sapienza, Dept Struct & Geotech Engn, I-00185 Rome, Italy	Sgambi, L (reprint author), Politecn Milan, Dept Civil & Environm Engn, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.	luca.sgambi@polimi.it					Abdel Raheem S.E., 2009, J STRUCT ENG, V55A, p709 ; Raheem SEA, 2011, EARTHQ ENG ENG VIB, V10, P37, DOI 10.1007/s11803-011-0045-5; Alvarez JJ, 2012, ENG STRUCT, V34, P69, DOI 10.1016/j.engstruct.2011.09.013; Soyluk K, 2000, ENG STRUCT, V22, P435, DOI 10.1016/S0141-0296(98)00126-6; Boore DM, 2005, SOIL DYN EARTHQ ENG, V25, P93, DOI 10.1016/j.soildyn.2004.10.007; Barbato M, 2013, STRUCT SAF, V45, P24, DOI 10.1016/j.strusafe.2013.07.002; Douglas J, 2003, B EARTHQ ENG, V1, P141, DOI 10.1023/A:1024861528201; Ni SH, 2013, STRUCT SAF, V42, P45, DOI 10.1016/j.strusafe.2013.01.008; Kiureghian AD, 2009, STRUCT SAF, V31, P105, DOI 10.1016/j.strusafe.2008.06.020; Ciampoli M, 2012, PROBABILIST ENG MECH, V28, P75, DOI 10.1016/j.probengmech.2011.08.013; Pergalani F, 2008, SOIL DYN EARTHQ ENG, V28, P964, DOI 10.1016/j.soildyn.2008.05.004; SIMON HA, 1973, ARTIF INTELL, V4, P181, DOI 10.1016/0004-3702(73)90011-8; Barbato M, 2013, EARTHQ ENG STRUCT D, V42, P1203, DOI 10.1002/eqe.2267; Sgambi L, 2014, COMPUT CONCRETE, V13, P389; Bathe K-J, 1982, FINITE ELEMENT PROCE; Beer Michael, 2009, International Journal of Reliability and Safety, V3, DOI 10.1504/IJRS.2009.026840; BOISSIERES HP, 1995, SOIL DYN EARTHQ ENG, V14, P23, DOI 10.1016/0267-7261(94)00027-E; Bommer JJ, 2000, SOIL DYN EARTHQ ENG, V19, P219, DOI 10.1016/S0267-7261(00)00012-9; Bontempi F, 2006, BRIDGE 2006; Borsoi L, 1985, P 8 SMIRT C BRUSS; Cacciola P, 2012, SOIL DYN EARTHQ ENG, V31, P351; Camossi G, 2010, BRIDGE MAINTENANCE S, P1372; Di Capua G, 2014, ANN GEOPHYS-ITALY, V57, DOI 10.4401/ag-6363; Dordoni S, 2010, BRIDGE MAINTENANCE S, P1388; Ferreira MP, 2006, STRUCT ENG MECH, V23, P233; Garavaglia E, 2013, STRUCT ENG MECH, V46, P533, DOI 10.12989/sem.2013.46.4.533; Garavaglia E, 2015, STRUCT INFRASTRUCT E, V11, P683, DOI 10.1080/15732479.2014.896022; Gasparini D., 1976, R764 MIT DEP CIV ENG; Ghaffarzadeh H, 2013, EARTHQ STRUCT, V4, P509, DOI 10.12989/eas.2013.4.5.509; Amiri GG, 2009, J EARTHQ ENG, V13, P899, DOI 10.1080/13632460802687728; LIU WL, 2012, GEOLOGOS, V18, P197, DOI DOI 10.2478/v10118-012-0010-4; Lualdi M, 2013, GEOPHYS J INT, V196, P818; Lualdi M, 2013, NDT&E INT, V60, P87, DOI 10.1016/j.ndteint.2013.07.013; Malerba PG, 2012, BRIDGE MAINTENANCE, SAFETY, MANAGEMENT, RESILIENCE AND SUSTAINABILITY, P1771; Musil M, 2002, STUD GEOPHYS GEOD, P115; Petrini F, 2012, P 3 INT S LIF CVCL C; Petrini F, 2010, STRUCT ENG MECH, V36, P599; Rofooei FR, 2001, ENG STRUCT, V23, P827, DOI 10.1016/S0141-0296(00)00093-6; Sgambi L., 2005, P 10 INT C CIV STRUC; Sgambi L, 2004, P 13 WORLD C EARTHQ; Sgambi L, 2004, COMPUT STRUCT, V82, P1067, DOI 10.1016/j.compstruc.2004.03.016; Sgambi L, 2012, COMPUT-AIDED CIV INF, V27, P655, DOI 10.1111/j.1467-8667.2012.00780.x; Shama AA, 2007, ENG STRUCT, V29, P248, DOI 10.1016/j.engstruct.2006.04.018; Wang J, 1999, SOIL DYN EARTHQ ENG, V18, P297, DOI 10.1016/S0267-7261(99)00002-0; Yongxin Wu, 2011, Earthquake Engineering and Engineering Vibration, V10, DOI 10.1007/s11803-011-0055-3	45	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-0296	1873-7323		ENG STRUCT	Eng. Struct.	NOV 1	2014	78						100	111		10.1016/j.engstruct.2014.08.051		12	Engineering, Civil	Engineering	AT8KB	WOS:000345181200010		
J	Hara-Kudo, Y; Kumagai, S				Hara-Kudo, Y.; Kumagai, S.			Impact of seafood regulations for Vibrio parahaemolyticus infection and verification by analyses of seafood contamination and infection	EPIDEMIOLOGY AND INFECTION			English	Review						Infection; regulation; seafood; Vibrio parahaemolyticus	POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; COASTAL ENVIRONMENT; UNITED-STATES; O3-K6; OYSTERS; TDH; TRH; AMPLIFICATION; VULNIFICUS	Consumption of seafood contaminated with Vibrio parahaemolyticus causes foodborne infections, which are on the rise owing to increased consumption of raw seafood in Asia, Europe, North America, and other regions. V. parahaemolyticus infections have been common in Japan since the 1960s. Following an epidemic in 1997, the Japanese Ministry of Health, Labour, and Welfare instituted regulations for seafood in 1999, which appear to be reducing V. parahaemolyticus infections. In this review, we describe the scientific findings for these regulations. Analyses of the V. parahaemolyticus serotypes and isolate characteristics in samples from infected patients and contaminated seafood are discussed. In addition, based on the results of a survey, we show that new food safety regulations have led to improvements in food hygiene at many seafood retail shops, food service facilities, and restaurants. This example from Japan could be of immense help to control foodborne infections in other countries.	[Hara-Kudo, Y.] Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, Tokyo 1588501, Japan; [Kumagai, S.] Food Safety Commiss, Minato Ku, Tokyo, Japan	Hara-Kudo, Y (reprint author), Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	ykudo@nihs.go.jp					Akahane S, 1984, B SHIZUOKA PREFECTUR, V27, P89; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Chiou CS, 2000, J CLIN MICROBIOL, V38, P4621; Bag PK, 1999, J CLIN MICROBIOL, V37, P2354; Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; Martinez-Urtaza J, 2005, EMERG INFECT DIS, V11, P1319; Nordstrom JL, 2007, APPL ENVIRON MICROB, V73, P5840, DOI 10.1128/AEM.00460-07; Vuddhakul V, 2000, APPL ENVIRON MICROB, V66, P2685, DOI 10.1128/AEM.66.6.2685-2689.2000; Daniels NA, 2000, JAMA-J AM MED ASSOC, V284, P1541, DOI 10.1001/jama.284.12.1541; Jones JL, 2012, FOOD MICROBIOL, V30, P105, DOI 10.1016/j.fm.2011.12.011; Hara-Kudo Y, 2003, APPL ENVIRON MICROB, V69, P3883, DOI 10.1128/AEM.69.7.3883-3891.2003; Newton A, 2012, CLIN INFECT DIS, V54, pS391, DOI 10.1093/cid/cis243; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Gendel SM, 2001, J FOOD PROTECT, V64, P1617; Wong HC, 2000, APPL ENVIRON MICROB, V66, P3981, DOI 10.1128/AEM.66.9.3981-3986.2000; Bilung LM, 2005, FEMS MICROBIOL LETT, V252, P85, DOI 10.1016/j.femsle.2005.08.053; Committee of Milk Meat and Seafood in Food Sanitation Investigation Council, 2000, C MAT NO 3; Committee of Milk Meat and Seafood in Food Sanitation Investigation Council, 2000, C MAT NO 3 3; Committee of Milk Meat and Seafood in Food Sanitation Investigation Council, 2000, C MAT NO 3 2; Dileep V, 2003, LETT APPL MICROBIOL, V36, P423, DOI 10.1046/j.1472-765X.2003.01333.x; Food and Agriculture Organization of the United Nations and the World Health Organization, 2011, MICR RISK ASS SER FO, V16; FUJINO T., 1953, MED JOUR OSAKA UNIV, V4, P299; Fukushima Hiroshi, 2007, Kansenshogaku Zasshi, V81, P138; Gonzalez-Escalona N, 2005, EMERG INFECT DIS, V11, P129; Hara-Kudo, 2012, INT J FOOD MICROBIOL, V157, P95; Hara-Kudo Y, 2003, JAPANESE J FOOD MICR, V24, P165; International Commission on Microbiological Specification for Foods, 1996, MICR FOODS, P426; Kirs M, 2011, INT J FOOD MICROBIOL, V147, P149, DOI 10.1016/j.ijfoodmicro.2011.03.012; Kumagai S, 2010, STUDIES PREVENTION M, P87; Kumagai S, 2000, OCCURRENCE VIBRIO PA, P4; Kumagai S, 2000, RES USE HYGIENIC SEA, P14; Miwai N, 2006, J FOOD HYG SOC JPN, V47, P41, DOI 10.3358/shokueishi.47.41; National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division Ministry of Health Labour and Welfare, 1999, INFECT AGENTS SURVEI, V20, P159; National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division Ministry of Health Labour and Welfare, 2008, INFECT AGENTS SURVEI, V29, P213; Ottaviani D, 2008, J CLIN MICROBIOL, V46, P2144, DOI 10.1128/JCM.00683-08; Shimada T, 2000, RES VIBRIO PARAHAEMO, P233; Sugiyama K, 2000, DETECTION TDH PRODUC, P202; TADA J, 1992, MOL CELL PROBE, V6, P477, DOI 10.1016/0890-8508(92)90044-X; Terzi G, 2009, LETT APPL MICROBIOL, V49, P757, DOI 10.1111/j.1472-765X.2009.02736.x; U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition, 2005, VIBR PAR RISK ASS; Ward LN, 2006, APPL ENVIRON MICROB, V72, P2031, DOI 10.1128/AEM.72.3.2031-2042.2006	41	4	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	NOV	2014	142	11					2237	2247		10.1017/S0950268814001897		11	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	AT4OZ	WOS:000344921000001		
J	Minami, K				Minami, Kazuhiko			Equivalence between the two-dimensional Ising model and the quantum XY chain with randomness and with open boundary	EPL			English	Article							RANDOM IMPURITIES; TRANSFER-MATRIX; SOLUBLE MODELS; GROUND STATE; SPIN SYSTEMS; FERROMAGNET; BEHAVIOR	The equivalence between the two-dimensional Ising model and the one-dimensional quantum XY model is generalized to the cases with alternating/random interactions and with periodic/free boundary conditions. It is proved that the eigenstate for the maximum eigenvalue of the transfer matrix of the two-dimensional Ising model corresponds to the ground state of the Hamiltonian of the one-dimensional XY model, which certifies direct relations between the physical quantities of the two models. Copyright (C) EPLA, 2014	Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan	Minami, K (reprint author), Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan.						ABRAHAM D, 1971, LETT NUOVO CIMENTO, V2, P143, DOI 10.1007/BF02772738; ABRAHAM DB, 1974, PHYS REV LETT, V33, P377, DOI 10.1103/PhysRevLett.33.377; ABRAHAM DB, 1971, STUD APPL MATH, V50, P71; Onsager L, 1944, PHYS REV, V65, P117, DOI 10.1103/PhysRev.65.117; SUZUKI M, 1985, PHYS REV B, V31, P2957, DOI 10.1103/PhysRevB.31.2957; FISHER DS, 1995, PHYS REV B, V51, P6411, DOI 10.1103/PhysRevB.51.6411; Kuznetsova EI, 2006, J EXP THEOR PHYS+, V102, P882, DOI 10.1134/S1063776106060021; KATSURA S, 1962, PHYS REV, V127, P1508, DOI 10.1103/PhysRev.127.1508; Fel'dman EB, 2005, JETP LETT+, V81, P47, DOI 10.1134/1.1887913; FEL'DMAN E. B., 2006, J PHYS A, V39, P1039; FISHER ME, 1967, PHYS REV LETT, V19, P169, DOI 10.1103/PhysRevLett.19.169; GRIFFITH.RB, 1969, PHYS REV LETT, V23, P17, DOI 10.1103/PhysRevLett.23.17; Igloi F, 1996, J PHYS A-MATH GEN, V29, P4803, DOI 10.1088/0305-4470/29/16/007; KRINSKY S, 1972, PHYS LETT A, VA 39, P169, DOI 10.1016/0375-9601(72)90691-3; LIEB E, 1961, ANN PHYS-NEW YORK, V16, P407, DOI 10.1016/0003-4916(61)90115-4; MCCOY BM, 1968, PHYS REV, V176, P631, DOI 10.1103/PhysRev.176.631; MCCOY BM, 1969, PHYS REV LETT, V23, P383, DOI 10.1103/PhysRevLett.23.383; McKenzie RH, 1996, PHYS REV LETT, V77, P4804, DOI 10.1103/PhysRevLett.77.4804; NAMBU Y, 1950, PROG THEOR PHYS, V5, P1; NIEMEIJE.T, 1967, PHYSICA, V36, P377, DOI 10.1016/0031-8914(67)90235-2; ONSAGER L., 1971, CRITICAL PHENOMENA A, P3; PESCHEL I, 1985, PHYS LETT A, V110, P313, DOI 10.1016/0375-9601(85)90780-7; SCHULTZ TD, 1964, REV MOD PHYS, V36, P856, DOI 10.1103/RevModPhys.36.856; SHANKAR R, 1987, PHYS REV B, V36, P536, DOI 10.1103/PhysRevB.36.536; SHANKAR R, 1987, PHYS REV B, V35, P3671, DOI 10.1103/PhysRevB.35.3671; STEPHEN MJ, 1972, J MATH PHYS, V13, P1944, DOI 10.1063/1.1665938; SUZUKI M, 1971, PROG THEOR PHYS, V46, P1337, DOI 10.1143/PTP.46.1337; SUZUKI M, 1971, PHYS LETT A, VA 34, P94, DOI 10.1016/0375-9601(71)90218-0; SUZUKI M, 1976, PROG THEOR PHYS, V56, P1454, DOI 10.1143/PTP.56.1454	29	1	1	EPL ASSOCIATION, EUROPEAN PHYSICAL SOCIETY	MULHOUSE	6 RUE DES FRERES LUMIERE, MULHOUSE, 68200, FRANCE	0295-5075	1286-4854		EPL-EUROPHYS LETT	EPL	NOV	2014	108	3							30001	10.1209/0295-5075/108/30001		6	Physics, Multidisciplinary	Physics	AT4ML	WOS:000344913400001		
J	Zargar, R; Russo, J; Schall, P; Tanaka, H; Bonn, D				Zargar, R.; Russo, J.; Schall, P.; Tanaka, H.; Bonn, D.			Disorder and excess modes in hard-sphere colloidal systems	EPL			English	Article							BOSON PEAK; VIBRATIONAL-MODES; GLASS; SOLIDS; ORIGIN; MICROSCOPY; TRANSITION; LIQUIDS; ENERGY; STATES	The anomalous thermodynamic properties of glasses remain incompletely understood, notably the anomalous peak in the heat capacity at low temperatures; it is believed to be due to an excess of low-frequency vibrational modes and a manifestation of the structural disorder in these systems. We study the thermodynamics and vibrational dynamics of colloidal glasses and (defected) crystals. The experimental determination of the vibrational density of states allows us to directly observe a strong enhancement of low-frequency modes. Using a novel method (ZARGAR R. et al., Phys. Rev. Lett. 110 (2013) 258301) to determine the free energy, we also determine the entropy and the specific heat experimentally. It follows that the emergence of the excess modes and high values of the specific heat are directly related and are specific to the glass: even for solids containing a very large amount of defects, both the low-frequency density of states and the specific heat are significantly smaller than for the glass. Copyright (C) EPLA, 2014	[Zargar, R.; Schall, P.; Bonn, D.] Univ Amsterdam, Inst Phys, NL-1098 XH Amsterdam, Netherlands; [Russo, J.; Tanaka, H.] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Zargar, R (reprint author), Univ Amsterdam, Inst Phys, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.		Tanaka, Hajime/A-9653-2008	Tanaka, Hajime/0000-0002-4444-1890	Stichting voor Fundamenteel Onderzoek der Materie (FOM); Shell; JSPS	We thank M. SCHINDLER, A. C. MAGGS for helpful discussions. We would like to thank the Stichting voor Fundamenteel Onderzoek der Materie (FOM) and Shell for financial support. This study was partly supported by Grants-in-Aid for Scientific Research (S) and Specially Promoted Research from JSPS.	Anderson P W, 1995, Science, V267, P1615, DOI 10.1126/science.267.5204.1615-e; ANGELL CA, 1924, SCIENCE, V267, P1995; Wyart M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051306; FRICK B, 1995, SCIENCE, V267, P1939, DOI 10.1126/science.267.5206.1939; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Schreck CF, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.078301; Mari R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.025701; Chen K, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022315; Chumakov AI, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.025502; Ghosh A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.248305; DeGiuli E, 2014, SOFT MATTER, V10, P5628, DOI 10.1039/c4sm00561a; Chen K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.025501; Watanabe K, 2011, NAT MATER, V10, P512, DOI [10.1038/nmat3034, 10.1038/NMAT3034]; HALL KR, 1972, J CHEM PHYS, V57, P2252, DOI 10.1063/1.1678576; Shintani H, 2008, NAT MATER, V7, P870, DOI 10.1038/nmat2293; Greaves GN, 2007, ADV PHYS, V56, P1, DOI 10.1080/00018730601147426; Wyart M, 2005, EUROPHYS LETT, V72, P486, DOI 10.1209/epl/i2005-10245-5; Goodrich CP, 2014, NAT PHYS, V10, P578, DOI 10.1038/NPHYS3006; Xu N, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.175502; Kaya D, 2010, SCIENCE, V329, P656, DOI 10.1126/science.1187988; Poon WCK, 2012, SOFT MATTER, V8, P21, DOI 10.1039/c1sm06083j; Royall CP, 2013, SOFT MATTER, V9, P17, DOI 10.1039/c2sm26245b; ASCHCROFT NW, 1976, SOLID STATE PHYS; Derlet PM, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20902-0; Dullens RPA, 2006, P NATL ACAD SCI USA, V103, P529, DOI 10.1073/pnas.0507052103; Ghosh A, 2010, SOFT MATTER, V6, P3082, DOI 10.1039/c0sm00265h; Ghosh A., 2011, PHYSICA A, V139, P3061; Gratale MD, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052301; Henkes S, 2012, SOFT MATTER, V8, P6092, DOI 10.1039/c2sm07445a; Kamien RD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.155501; Kittel Charles, 1953, INTRO SOLID STATE PH; Leonforte F, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.224206; Lerner E., 2013, ARXIV13122146; Marruzzo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01407; Mizuno H, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/56001; Phillips W A, 1981, AMORPHOUS SOLIDS LOW; Russo J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00505; Tan P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.095501; Yannopoulos SN, 2006, J NON-CRYST SOLIDS, V352, P4541, DOI [10.1016/j.jnoncrysol.2006.02.164, 10.1016/j.noncrysol.2006.02.164]; Zargar R., 2014, ARXIV14032770; Zargar R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.258301	41	0	0	EPL ASSOCIATION, EUROPEAN PHYSICAL SOCIETY	MULHOUSE	6 RUE DES FRERES LUMIERE, MULHOUSE, 68200, FRANCE	0295-5075	1286-4854		EPL-EUROPHYS LETT	EPL	NOV	2014	108	3							38002	10.1209/0295-5075/108/38002		6	Physics, Multidisciplinary	Physics	AT4ML	WOS:000344913400037		
J	Kumbhani, DJ; Steg, PG; Cannon, CP; Eagle, KA; Smith, SC; Goto, S; Ohman, EM; Elbez, Y; Sritara, P; Baumgartner, I; Banerjee, S; Creager, MA; Bhatt, DL				Kumbhani, Dharam J.; Steg, Ph Gabriel; Cannon, Christopher P.; Eagle, Kim A.; Smith, Sidney C., Jr.; Goto, Shinya; Ohman, E. Magnus; Elbez, Yedid; Sritara, Piyamitr; Baumgartner, Iris; Banerjee, Subhash; Creager, Mark A.; Bhatt, Deepak L.		REACH Registry Investigators	Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry	EUROPEAN HEART JOURNAL			English	Article						Statins; Peripheral vascular disease; Claudication; Morbidity; Registry	ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENT RATES; LOWER-EXTREMITY; TASK-FORCE; NUTRITION EXAMINATION; PRACTICE GUIDELINES; NATIONAL-HEALTH; COMPETING RISK; FOLLOW-UP; MORTALITY	Aims Due to a high burden of systemic cardiovascular events, current guidelines recommend the use of statins in all patients with peripheral artery disease (PAD). We sought to study the impact of statin use on limb prognosis in patients with symptomatic PAD enrolled in the international REACH registry. Methods Statin use was assessed at study enrolment, as well as a time-varying covariate. Rates of the primary adverse limb outcome (worsening claudication/new episode of critical limb ischaemia, new percutaneous/surgical revascularization, or amputation) at 4 years and the composite of cardiovascular death/myocardial infarction/stroke were compared among statin users vs. non-users. Results A total of 5861 patients with symptomatic PAD were included. Statin use at baseline was 62.2%. Patients who were on statins had a significantly lower risk of the primary adverse limb outcome at 4 years when compared with those who were not taking statins [22.0 vs. 26.2%; hazard ratio (HR), 0.82; 95% confidence interval (CI), 0.72-0.92; P = 0.0013]. Results were similar when statin use was considered as a time-dependent variable (P = 0.018) and on propensity analysis (P < 0.0001). The composite of cardiovascular death/myocardial infarction/stroke was similarly reduced (HR, 0.83; 95% CI, 0.73-0.96; P = 0.01). Conclusion Among patients with PAD in the REACH registry, statin use was associated with an similar to 18% lower rate of adverse limb outcomes, including worsening symptoms, peripheral revascularization, and ischaemic amputations. These findings suggest that statin therapy not only reduces the risk of adverse cardiovascular events, but also favourably affects limb prognosis in patients with PAD.	[Kumbhani, Dharam J.; Banerjee, Subhash] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Steg, Ph Gabriel; Elbez, Yedid] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Steg, Ph Gabriel; Elbez, Yedid] INSERM, U1148, Paris, France; [Steg, Ph Gabriel; Elbez, Yedid] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, F-75877 Paris, France; [Steg, Ph Gabriel] Royal Brompton Hosp, ICMS, NHLI Imperial Coll, London SW3 6LY, England; [Cannon, Christopher P.; Creager, Mark A.; Bhatt, Deepak L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Cannon, Christopher P.; Creager, Mark A.; Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Cannon, Christopher P.; Bhatt, Deepak L.] TIMI Study Grp, Boston, MA USA; [Eagle, Kim A.] Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Smith, Sidney C., Jr.] Univ N Carolina, Ctr Cardiovasc Sci & Med, Chapel Hill, NC USA; [Goto, Shinya] Tokai Univ, Sch Med, Dept Med, Isehara, Kanagawa 25911, Japan; [Ohman, E. Magnus] Duke Univ, Div Cardiol, Durham, NC USA; [Sritara, Piyamitr] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand; [Baumgartner, Iris] Univ Hosp Bern, Swiss Cardiovasc Ctr Bern, Bern, Switzerland; [Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA USA	Kumbhani, DJ (reprint author), Univ Texas SW Med Ctr Dallas, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dharam@post.harvard.edu					Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; McDermott MM, 1997, J GEN INTERN MED, V12, P209, DOI 10.1007/s11606-006-5042-4; Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Abola MTB, 2012, ATHEROSCLEROSIS, V221, P527, DOI 10.1016/j.atherosclerosis.2012.01.002; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Ardati AK, 2012, CIRC-CARDIOVASC INTE, V5, P850, DOI 10.1161/CIRCINTERVENTIONS.112.975862; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Chen J, 2000, AM J MED, V108, P460, DOI 10.1016/S0002-9343(00)00331-4; Mohler ER, 2003, CIRCULATION, V108, P1481, DOI 10.1161/01.CIR.0000090686.57897.F5; Pedersen TR, 1998, AM J CARDIOL, V81, P333, DOI 10.1016/S0002-9149(97)00904-1; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hankey GJ, 2006, JAMA-J AM MED ASSOC, V295, P547, DOI 10.1001/jama.295.5.547; Alberts MJ, 2009, EUR HEART J, V30, P2318, DOI 10.1093/eurheartj/ehp355; Garber MC, 2004, MED CARE, V42, P649, DOI 10.1097/01.mlr.0000129496.05898.02; McDermott MM, 2003, CIRCULATION, V107, P757, DOI 10.1161/01.CIR.0000050380.64025.07; Pande RL, 2011, CIRCULATION, V124, P17, DOI 10.1161/CIRCULATIONAHA.110.003954; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197; Berger JS, 2012, CIRCULATION, V126, P491, DOI 10.1161/CIRCULATIONAHA.111.033886; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V303, P2188, DOI 10.1001/jama.2010.743; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; O'Hare AM, 2004, CIRCULATION, V109, P320, DOI 10.1161/01.CIR.0000114519.75433.DD; Linnemann B, 2014, J AM COLL CARDIOL, V63, P1529, DOI 10.1016/j.jacc.2013.05.059; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; Brevetti G, 2007, J GEN INTERN MED, V22, P639, DOI 10.1007/s11606-007-0162-z; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; de Lemos JA, 2014, J AM COLL CARDIOL, V63, P1539, DOI 10.1016/j.jacc.2013.05.063; Giri J, 2006, J AM COLL CARDIOL, V47, P998, DOI 10.1016/j.jacc.2005.10.052; Heart Protection Study Collaborative Group, 2007, J VASC SURG, V45, P645, DOI DOI 10.1016/J.JVS.2006.12.054; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Kumbhani DJ, 2013, AM J MED, V126, p74e1; Lin G, ANAL SURVIVAL DATA C; Ohman EM, 2006, AM HEART J, V151; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197	40	12	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0195-668X	1522-9645		EUR HEART J	Eur. Heart J.	NOV 1	2014	35	41			SI		2864	2872		10.1093/eurheartj/ehu080		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU1FS	WOS:000345367100006		
J	Tanaka, A; Suzuki, K; Inoue, N; Meguro, T				Tanaka, Akiko; Suzuki, Kenji; Inoue, Naoto; Meguro, Taiichiro			Optical coherence tomography images of iliac artery fibromuscular dysplasia	EUROPEAN HEART JOURNAL			English	Editorial Material									[Tanaka, Akiko; Suzuki, Kenji; Inoue, Naoto; Meguro, Taiichiro] Sendai Kousei Hosp, Ctr Cardiovasc, Aoba Ku, Sendai, Miyagi 9800873, Japan	Tanaka, A (reprint author), Sendai Kousei Hosp, Ctr Cardiovasc, Aoba Ku, 4-15 Hirosemachi, Sendai, Miyagi 9800873, Japan.	akihende@yahoo.co.jp						0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0195-668X	1522-9645		EUR HEART J	Eur. Heart J.	NOV 1	2014	35	41			SI		2872	2872		10.1093/eurheartj/ehu233		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU1FS	WOS:000345367100007		
J	Ohno, Y; Attizzani, GF; Capodanno, D; Cannata, S; Dipasqua, F; Imme, S; Barbanti, M; Ministeri, M; Caggegi, A; Pistritto, AM; Chiaranda, M; Ronsivalle, G; Giaquinta, S; Farruggio, S; Mangiafico, S; Scandura, S; Tamburino, C; Capranzano, P; Grasso, C				Ohno, Yohei; Attizzani, Guilherme F.; Capodanno, Davide; Cannata, Stefano; Dipasqua, Fabio; Imme, Sebastiano; Barbanti, Marco; Ministeri, Margherita; Caggegi, Anna; Pistritto, Anna M.; Chiaranda, Marta; Ronsivalle, Giuseppe; Giaquinta, Sandra; Farruggio, Silvia; Mangiafico, Sarah; Scandura, Salvatore; Tamburino, Corrado; Capranzano, Piera; Grasso, Carmelo			Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING			English	Article						Mitral regurgitation; Percutaneous mitral valve repair; Tricuspid regurgitation; MitraClip	NATIVE VALVULAR REGURGITATION; LEFT-VENTRICULAR DYSFUNCTION; HEART-FAILURE; EUROPEAN ASSOCIATION; SECONDARY; THERAPY; IMPACT; RECOMMENDATIONS; MANAGEMENT; SEVERITY	Aim The aim of this study was to evaluate the association of baseline tricuspid regurgitation (TR) on the outcomes after percutaneous mitral valve repair (PMVR) with the MitraClip system. Methods and results Data from 146 consecutive patients with functional mitral regurgitation (MR) were obtained. Two different groups, dichotomized according to the degree of pre-procedural TR (moderate/severe, n = 47 and none/mild, n = 99), had their clinical and echocardiographic outcomes through 12-month compared. At 30-day, the primary safety endpoint was significantly higher inmoderate/severe TR compared with none/mild TR(10.6 vs. 2.0%, P = 0.035). Marked reduction in MR grades observed post-procedure were maintained through 12 months. Although NYHA functional class significantly improved in both groups compared with baseline, it was impaired in moderate/severeTRcompared with the none/mild TR group (NYHA > II at 30 day: 33.3 vs. 9.2%, P < 0.001; at 1 year: 38.5 vs. 12.3%, respectively, P = 0.006). Left ventricle reverse remodelling and ejection fraction improvement were revealed in both groups. The primary efficacy endpoint at 12-month determined by freedom from death, surgery for mitral valve dysfunction, or grade >= 3+MR was comparable between groups, but combined death and re-hospitalization for heart failure rates were higher in the moderate/severe TR group. Multivariable Cox regression analysis demonstrated that baseline moderate/severe TR and chronic kidney disease were independent predictors of this combined endpoint. Conclusions Although PMVR with MitraClip led to improvement in MR, TR, and NYHA functional class in patients with baseline moderate/severe TR, the primary safety endpoint at 30-day was impaired, while moderate/severe TR independently predicted death and re-hospitalization for heart failure at 12-month.	[Ohno, Yohei; Attizzani, Guilherme F.; Capodanno, Davide; Cannata, Stefano; Dipasqua, Fabio; Imme, Sebastiano; Barbanti, Marco; Ministeri, Margherita; Caggegi, Anna; Pistritto, Anna M.; Chiaranda, Marta; Ronsivalle, Giuseppe; Giaquinta, Sandra; Farruggio, Silvia; Mangiafico, Sarah; Scandura, Salvatore; Tamburino, Corrado; Capranzano, Piera; Grasso, Carmelo] Univ Catania, Ferrarotto Hosp, Dept Cardiol, I-95124 Catania, Italy; [Ohno, Yohei] Tokai Univ, Sch Med, Dept Cardiol, Isehara, Kanagawa 25911, Japan; [Attizzani, Guilherme F.] Univ Hosp Cleveland, Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA; [Attizzani, Guilherme F.] Pitangueiras Hosp, Dept Intervent Cardiol, Jundiai, Brazil; [Capodanno, Davide; Tamburino, Corrado; Capranzano, Piera] Excellence Newest Adv ETNA Fdn, Catania, Italy	Grasso, C (reprint author), Univ Catania, Ferrarotto Hosp, Dept Cardiol, Via Citelli 29, I-95124 Catania, Italy.	melfat75@gmail.com			Japan Heart Foundation; Bayer Yakuhin Research Grant Abroad	Dr Ohno is supported by a grant from the Japan Heart Foundation and Bayer Yakuhin Research Grant Abroad.	Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; Gaemperli O, 2013, CIRCULATION, V127, P1018, DOI 10.1161/CIRCULATIONAHA.112.135061; Agricola E, 2009, EUR J HEART FAIL, V11, P581, DOI 10.1093/eurjhf/hfp051; Grasso C, 2013, AM J CARDIOL, V111, P1482, DOI 10.1016/j.amjcard.2013.01.300; Mihaljevic T, 2007, J AM COLL CARDIOL, V49, P2191, DOI 10.1016/j.jacc.2007.02.043; Franzen O, 2011, EUR J HEART FAIL, V13, P569, DOI 10.1093/eurjhf/hfr029; Shiran A, 2009, J AM COLL CARDIOL, V53, P401, DOI 10.1016/j.jacc.2008.09.048; Calafiore AM, 2011, J THORAC CARDIOV SUR, V142, P308, DOI 10.1016/j.jtcvs.2010.04.047; ROSEN SE, 1994, AM J CARDIOL, V74, P374, DOI 10.1016/0002-9149(94)90406-5; Tamburino C, 2010, EUR HEART J, V31, P1382, DOI 10.1093/eurheartj/ehq051; Laule M, 2013, J AM COLL CARDIOL, V61, P1929, DOI 10.1016/j.jacc.2013.01.070; Whitlow PL, 2012, J AM COLL CARDIOL, V59, P130, DOI 10.1016/j.jacc.2011.08.067; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Grayburn PA, 2013, CIRCULATION, V128, P1667, DOI 10.1161/CIRCULATIONAHA.112.001039; Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P611, DOI 10.1093/ehjci/jet105; Hoffmann R, 2014, AM J CARDIOL, V113, P1228, DOI 10.1016/j.amjcard.2013.12.035; Boudjemline Y, 2005, J AM COLL CARDIOL, V46, P360, DOI 10.1016/j.jacc.2005.01.062; Franzen O, 2010, EUR HEART J, V31, P1373, DOI 10.1093/eurheartj/ehq050; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Cosyns B, 2013, EUR HEART J-CARD IMG, V14, P837, DOI 10.1093/ehjci/jet140; Neuhold S, 2013, EUR HEART J, V34, P844, DOI 10.1093/eurheartj/ehs465; Matsuyama K, 2003, ANN THORAC SURG, V75, P1826, DOI 10.1016/S0003-4975(03)00028-6; Matsunaga A, 2005, CIRCULATION, V112, pI453, DOI 10.1161/CIRCULATIONAHA.104.524421; Nath J, 2004, J AM COLL CARDIOL, V43, P405, DOI 10.1016/j.jacc.2003.09.036; Ribichini F, 2013, AM J CARDIOL, V112, P1051, DOI 10.1016/j.amjcard.2013.05.043; De Bonis M, 2008, EUR J CARDIO-THORAC, V33, P600, DOI 10.1016/j.ejcts.2008.01.011; Dreyfus GD, 2005, ANN THORAC SURG, V79, P127, DOI 10.1016/j.athoracsur.2004.06.057; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Di Mauro M, 2009, EUR J CARDIO-THORAC, V35, P635, DOI 10.1016/j.ejcts.2008.12.040; Goel SS, 2014, J AM COLL CARDIOL, V63, P185, DOI 10.1016/j.jacc.2013.08.723; Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094; McCarthy Patrick M, 2007, Semin Thorac Cardiovasc Surg, V19, P121, DOI 10.1053/j.semtcvs.2007.06.002; Nishimura RA, 2014, CIRCULATION; Sadeghi HM, 2004, J AM COLL CARDIOL, V44, P126, DOI 10.1016/j.jacc.2003.12.058; Scandura S, 2012, J AM SOC ECHOCARDIOG, V25, P1099, DOI 10.1016/j.echo.2012.07.015; Ussia GP, 2014, J CARDIOVASC MED	36	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-2404	2047-2412		EUR HEART J-CARD IMG	Eur. Heart J.-Cardiovasc. Imaging	NOV	2014	15	11					1246	1255		10.1093/ehjci/jeu114		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT8NC	WOS:000345188800013		
J	Nishimura, S; Ehara, S; Hanatani, A; Yoshiyama, M				Nishimura, Satoshi; Ehara, Shoichi; Hanatani, Akihisa; Yoshiyama, Minoru			Chronic active Epstein-Barr virus infection complicated with multiple artery aneurysms	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING			English	Editorial Material									[Nishimura, Satoshi; Ehara, Shoichi; Hanatani, Akihisa; Yoshiyama, Minoru] Osaka City Univ, Grad Sch Med, Dept Cardiovasc Med, Abeno Ku, Osaka 5458585, Japan	Nishimura, S (reprint author), Osaka City Univ, Grad Sch Med, Dept Cardiovasc Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	satoshirx8@yahoo.co.jp						0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-2404	2047-2412		EUR HEART J-CARD IMG	Eur. Heart J.-Cardiovasc. Imaging	NOV	2014	15	11					1255	1255		10.1093/ehjci/jeu119		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT8NC	WOS:000345188800014		
J	Yamasaki, Y; Nagao, M; Sakamoto, I; Yonezawa, M; Honda, H				Yamasaki, Yuzo; Nagao, Michinobu; Sakamoto, Ichiro; Yonezawa, Masato; Honda, Hiroshi			Prosthetic valve dysfunction in repaired tetralogy of Fallot: assessment by FDG-PET and 256-slice 4D-CT	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING			English	Editorial Material									[Yamasaki, Yuzo; Yonezawa, Masato; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Nagao, Michinobu] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Fukuoka 8128582, Japan; [Sakamoto, Ichiro] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan	Yamasaki, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yyama@radiol.med.kyushu-u.ac.jp						0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-2404	2047-2412		EUR HEART J-CARD IMG	Eur. Heart J.-Cardiovasc. Imaging	NOV	2014	15	11					1303	1303		10.1093/ehjci/jeu108		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT8NC	WOS:000345188800024		
J	Fujita, T; Kobayashi, J; Hata, H; Seguchi, O; Murata, Y; Yanase, M; Nakatani, T				Fujita, Tomoyuki; Kobayashi, Junjiro; Hata, Hiroki; Seguchi, Osamu; Murata, Yoshihiro; Yanase, Masanobu; Nakatani, Takeshi			Right heart failure and benefits of adjuvant tricuspid valve repair in patients undergoing left ventricular assist device implantation	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article; Proceedings Paper	27th Annual Meeting of the European-Association-for-Cardio-Thoracic-Surgery	OCT 05-09, 2013	Vienna, AUSTRIA	European Assoc Cardio Thorac Surg		Tricuspid valve repair; Left ventricular assist device; Right heart failure	CLINICAL IMPACT; RISK-FACTOR; PREDICTORS; SUPPORT; REGURGITATION; DYSFUNCTION; MANAGEMENT; RECIPIENTS	Although right heart failure (RVF) is an important issue in the management of patients with left ventricular assist devices (LVADs), the benefits of performing tricuspid valve repair in conjunction with LVAD implantation have not been demonstrated. We retrospectively reviewed the records of 141 patients who received LVAD implantation as a bridge to transplant from May 1999 to January 2013. We assessed short- and long-term right heart function in 69 of these patients who underwent tricuspid valve repair because of moderate-to-severe tricuspid regurgitation (TR) or severe dilatation of the tricuspid annulus. RVF was defined as the need for a right ventricular assist device or > 30 days of intravenous inotropic support. TR was graded from 0 to 4, while fibrosis in myocardial biopsy samples was graded pathologically from 0 to 3. The average duration of LVAD support was 595 days. Twenty-seven patients developed RVF and their survival rate was significantly worse than that of patients who did not develop RVF (65 vs 91% at 1 year). RVF was significantly related to high preoperative ratio of central venous pressure (CVP) to pulmonary capillary wedge pressure, high total bilirubin, high fibrosis score and high TR grade. In patients who underwent tricuspid valve repair, the TR grade was significantly reduced from 2.6 to 1.0, and this decrease was maintained for 2 years. Although patients who underwent tricuspid valve repair had significantly higher TR grades, ratios of CVP to pulmonary capillary wedge pressure and fibrosis scores preoperatively, no survival impairment was seen. Tricuspid valve repair is a useful and durable adjuvant procedure for restoring deteriorated right ventricular function in patients requiring LVAD implantation.	[Fujita, Tomoyuki; Kobayashi, Junjiro; Hata, Hiroki] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka 5658565, Japan; [Seguchi, Osamu; Murata, Yoshihiro; Yanase, Masanobu; Nakatani, Takeshi] Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, Suita, Osaka 5658565, Japan	Fujita, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	tomofujita@nifty.com	Kobayashi, Junjiro/J-8547-2015				Puwanant S, 2008, J HEART LUNG TRANSPL, V27, P1102, DOI 10.1016/j.healun.2008.07.022; Potapov EV, 2008, J HEART LUNG TRANSPL, V27, P1275, DOI 10.1016/j.healun.2008.08.012; Mangi AA, 2011, CARDIOL CLIN, V29, P629, DOI 10.1016/j.ccl.2011.08.003; Matsumiya G, 2005, J THORAC CARDIOV SUR, V130, P699, DOI 10.1016/j.jtcvs.2005.05.016; Kirklin JK, 2013, J HEART LUNG TRANSPL, V32, P141, DOI 10.1016/j.healun.2012.12.004; Dang NC, 2006, J HEART LUNG TRANSPL, V25, P1, DOI 10.1016/j.healun.2005.07.008; Kavarana MN, 2002, ANN THORAC SURG, V73, P745, DOI 10.1016/S0003-4975(01)03406-3; Morgan JA, 2004, ANN THORAC SURG, V77, P859, DOI 10.1016/j.athoracsur.2003.09.048; Kormos RL, 2010, J THORAC CARDIOV SUR, V139, P1316, DOI 10.1016/j.jtcvs.2009.11.020; Peura JL, 2012, CIRCULATION, V126, P2648, DOI 10.1161/CIR.0b013e3182769a54; Nath J, 2004, J AM COLL CARDIOL, V43, P405, DOI 10.1016/j.jacc.2003.09.036; Atluri P, 2013, ANN THORAC SURG, V96, P857, DOI 10.1016/j.athoracsur.2013.03.099; Atrache ME, 2012, J AM COLL CARDIOL, V59, pE881; Moon MR, 1997, CIRCULATION, V95, P1320; Ochiai Y, 2002, CIRCULATION, V106, pI198, DOI 10.1161/01.cir.0000032906.33237.1c; Jeevanandam V, 2011, ANN THORAC SURG, V92, P1418; Piacentino V, 2012, J THORAC CARDIOV SUR, V144, P1217, DOI 10.1016/j.jtcvs.2012.07.064; Piacentino V, 2011, ANN THORAC SURG, V92, P1414, DOI 10.1016/j.athoracsur.2011.05.084; Piacentino V, 2011, ANN THORAC SURG, V91, P1342, DOI 10.1016/j.athoracsur.2011.01.053; Pinney SP, 2012, CURR OPIN CARDIOL, V27, P288, DOI 10.1097/HCO.0b013e3283512051; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455	22	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2014	46	5					802	807		10.1093/ejcts/ezu040		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AT5FD	WOS:000344968700011		
J	Cho, Y; Shimura, S; Aki, A; Furuya, H; Odagiri, S; Okada, K; Ueda, T				Cho, Yasunori; Shimura, Shinichiro; Aki, Akira; Furuya, Hidekazu; Odagiri, Shigeto; Okada, Kimiaki; Ueda, Toshihiko			Non-heart transplant surgical approaches with left ventricular restoration and mitral valve operation for advanced ischaemic cardiomyopathy	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article; Proceedings Paper	27th Annual Meeting of the European-Association-for-Cardio-Thoracic-Surgery	OCT 05-09, 2013	Vienna, AUSTRIA	European Assoc Cardio Thorac Surg		Non-heart transplant approaches; Left ventricular restoration; Mitral valve operation; INTERMACS profiles; Long-term outcomes	DOR PROCEDURE; STICH TRIAL; RECONSTRUCTION; REGURGITATION; FAILURE; MORTALITY; OUTCOMES; SURGERY; IMPACT; VOLUME	The aim of this study was to assess long-term outcomes of non-heart transplant surgical approaches to advanced ischaemic cardiomyopathy (ICM), including left ventricular restoration (LVR) and mitral valve operation. Since September 2002, 102 consecutive patients (mean age 65, 18 females) with advanced ICM [ejection fraction (EF) < 40%, left ventricular end-systolic volume index (LVESVI) > 60 ml/m(2)] were treated using non-heart transplant procedures. A total of 84 patients with asynergy of large scar exceeding 35% of left ventricular (LV) perimeter underwent LVR, and 30 patients with greater than or equal to moderate mitral regurgitation (MR) underwent mitral valve operation such as annuloplasty (n = 23) and valve replacement (n = 7). Patients were divided into four groups according to their interagency registry for mechanically assisted circulatory support (INTERMACS) profiles: Profile 1-2 (the highest levels of clinical compromise; n = 9), Profile 3-4 (n = 40), Profile 5-6 (n = 32) and Profile a parts per thousand yen7 (n = 21). We compared the four groups, looking at survival, major adverse cardiac and cerebrovascular event (MACCE), New York Heart Association (NYHA) status, LV volume and function. The overall 8-year survival including 3 hospital deaths (2.9%) was 64.3% without sudden death due to arrhythmia. Ninety-nine survivors showed significant improvement in the mean NYHA status, from 2.9 to 1.4, and the mean EF (33.2-41.7%) (P < 0.0001). The mean LVESVI was significantly reduced from 104.1 to 61.4 ml/m(2) (41% volume reduction) (P < 0.0001). Seven-year survival in patients with Profiles 1-2, 3-4, 5-6 and a parts per thousand yen7 were 50.0, 57.2, 60.3 and 95.2%, respectively (P = 0.13). Freedom from MACCE at 5 years in patients with Profiles 1-2, 3-4, 5-6 and a parts per thousand yen7 were 29.6, 47.0, 67.2 and 95.2%, respectively (P = 0.0067). The improvements in NYHA status were significantly greater in patients with higher levels of clinical compromise (P < 0.0001), although, there was no significant difference in LV volume reduction and functional improvement among the four groups. Patients with Profile a parts per thousand yen7 had significantly better survival at 7 years (hazard ratio (HR): 0.11, P = 0.046) and freedom from MACCE at 5 years (HR: 0.053, P = 0.0066) compared with patients with Profiles 1-2. Our non-heart transplant surgical approaches using LVR and mitral valve operation for advanced ICM yielded excellent long-term outcomes in terms of survival and NYHA status, even in patients who are potential candidates for heart transplantation or LV assist devices; and are encouraging in a very particular situation where heart transplantation is limited due to organ storage.	[Cho, Yasunori; Shimura, Shinichiro; Aki, Akira; Furuya, Hidekazu; Odagiri, Shigeto; Okada, Kimiaki; Ueda, Toshihiko] Tokai Univ, Sch Med, Dept Cardiovasc Surg, Isehara, Kanagawa 2591193, Japan	Cho, Y (reprint author), Tokai Univ, Sch Med, Dept Cardiovasc Surg, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	ynoricho@tokai-u.jp					Stevenson LW, 2009, J HEART LUNG TRANSPL, V28, P535, DOI 10.1016/j.healun.2009.02.015; Kirklin JK, 2011, J HEART LUNG TRANSPL, V30, P115, DOI 10.1016/j.healun.2010.12.001; Wever-Pinzon O, 2013, CIRCULATION, V127, P452, DOI 10.1161/CIRCULATIONAHA.112.100123; Wu AH, 2005, J AM COLL CARDIOL, V45, P381, DOI 10.1016/j.jacc.2004.09.073; Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Cho Y, 2012, EUR J CARDIO-THORAC, V42, P462, DOI 10.1093/ejcts/ezs363; Buckberg G, 2012, EUR J CARDIO-THORAC, V42, P393, DOI 10.1093/ejcts/ezs374; Buckberg GD, 2009, J THORAC CARDIOV SUR, V138, P1060, DOI 10.1016/j.jtcvs.2009.07.015; Di Donato M, 2001, J THORAC CARDIOV SUR, V121, P91, DOI 10.1067/mtc.2001.111379; DOR V, 1994, EUR HEART J, V15, P1063; DOR V, 1985, Journal of Cardiovascular Surgery, V26, P73; Dor V, 2004, J THORAC CARDIOV SUR, V128, P17, DOI 10.1016/j.jtcvs.2004.02.026; Dor V, 2011, J THORAC CARDIOV SUR, V141, P905, DOI 10.1016/j.jtcvs.2010.10.026; Gummert JF, 2003, EUR J CARDIO-THORAC, V23, P1017, DOI 10.1016/S1010-7940(03)00148-9; Isomura T, 2011, EUR J HEART FAIL, V13, P423, DOI 10.1093/eurjhf/hfq227; Isomura Tadashi, 2011, Gen Thorac Cardiovasc Surg, V59, P315, DOI 10.1007/s11748-010-0742-4; Jeevanandam Valluvan, 2012, Semin Thorac Cardiovasc Surg, V24, P8, DOI 10.1053/j.semtcvs.2012.04.003; Kitamura Soichiro, 2012, Gen Thorac Cardiovasc Surg, V60, P639, DOI 10.1007/s11748-012-0110-7; Mandegar Mohammad Hossein, 2006, Interact Cardiovasc Thorac Surg, V5, P81, DOI 10.1510/icvts.2005.118430; Matsui Y, 2004, J THORAC CARDIOV SUR, V127, P1221, DOI 10.1016/j.jtcvs.2003.10.044; Menicanti L, 2002, J THORAC CARDIOV SUR, V124, P886, DOI 10.1067/mtc.2002.129140; Mickleborough LL, 2004, J THORAC CARDIOV SUR, V128, P27, DOI 10.1016/j.jtcvs.2003.08.013; Suma H, 2001, SEMIN THORAC CARDIOV, V13, P190; Wakasa S, 2013, INTERACT CARDIOV TH, V16, P785, DOI 10.1093/icvts/ivt096	25	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2014	46	5					849	856		10.1093/ejcts/ezu011		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AT5FD	WOS:000344968700018		
J	Okita, Y; Yamanaka, K; Okada, K; Matsumori, M; Inoue, T; Fukase, K; Sakamoto, T; Miyahara, S; Shirasaka, T; Izawa, N; Ohara, T; Nomura, Y; Nakai, H; Gotake, Y; Kano, H				Okita, Yutaka; Yamanaka, Katsuhiro; Okada, Kenji; Matsumori, Masamichi; Inoue, Takeshi; Fukase, Keigo; Sakamoto, Toshihito; Miyahara, Shunsuke; Shirasaka, Tomonori; Izawa, Naoto; Ohara, Taimi; Nomura, Yoshikatsu; Nakai, Hidekazu; Gotake, Yasuko; Kano, Hiroya			Strategies for the treatment of aorto-oesophageal fistula	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article; Proceedings Paper	27th Annual Meeting of the European-Association-for-Cardio-Thoracic-Surgery	OCT 05-09, 2013	Vienna, AUSTRIA	European Assoc Cardio Thorac Surg		Aorto-oesophageal fistula; Thoracic endovascular aortic repair; Infected aneurysm	SUCCESSFUL SURGICAL-TREATMENT; ENDOVASCULAR AORTIC REPAIR; ANEURYSM; GRAFT	Presenting a surgical strategy for aorto-oesophageal fistula (AEF). From October 1999 to August 2013, 16 patients with AEF were treated at Kobe University Hospital. The mean age was 65.5 +/- 10.2 years, and the male/female ratio was 13/3. Eight patients had non-dissecting thoracic aneurysm, 3 had chronic aortic dissection, 5 had oesophageal cancer and 1 had fish bone penetration. Five patients were in shock. Four patients had previous thoracic endovascular aortic repair (TEVAR) in the descending aorta and 1 had hemi-arch replacement. As treatment for AEF, 8 patients underwent TEVAR, 2 had a bridge TEVAR to open surgery, 2 had extra-anatomical bypass (EAB) and 5 had in situ reconstruction of the descending aorta. The oesophagus was resected in 8 patients, and an omental flap was installed in 7 patients. For the 4 most recent cases, simultaneous resection of the aorta and oesophagus, in situ reconstruction of the descending aorta using rifampicin-soaked Dacron graft and omental flap installation were performed. Hospital mortality was noted in 4 patients (25.0%; persistent sepsis n = 3 and pneumonia n = 1). However, since 2007, only 1 of 5 patients died (pneumonia). All patients with oesophageal cancer died during follow-up. Two patients underwent oesophageal reconstruction using a pedicled colon graft and one is on the waiting list for oesophageal reconstruction. Bridging TEVAR is a useful adjunct in treating AEF patients with shock. One-stage surgery consisting of resection of the aneurysm and oesophagus, in situ reconstruction of the descending aorta and omental flap installation provided a better outcome in the AEF surgical strategy compared with conservative treatment.	[Okita, Yutaka; Yamanaka, Katsuhiro; Okada, Kenji; Matsumori, Masamichi; Inoue, Takeshi; Fukase, Keigo; Sakamoto, Toshihito; Miyahara, Shunsuke; Shirasaka, Tomonori; Izawa, Naoto; Ohara, Taimi; Nomura, Yoshikatsu; Nakai, Hidekazu; Gotake, Yasuko; Kano, Hiroya] Kobe Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Surg, Kobe, Hyogo 6500017, Japan	Okita, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Surg,Div Cardiovasc Surg, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yokita@med.kobe-u.ac.jp					Vallabhajosyula P, 2012, J THORAC CARDIOV SUR, V144, P1266, DOI 10.1016/j.jtcvs.2012.07.084; COSELLI JS, 1990, J VASC SURG, V12, P269, DOI 10.1067/mva.1990.22359; Fatima J, 2013, J VASC SURG, V58, P371, DOI 10.1016/j.jvs.2013.01.047; VOGT P, 1995, J THORAC CARDIOV SUR, V109, P589, DOI 10.1016/S0022-5223(95)70294-6; vonSegesser LK, 1997, EUR J CARDIO-THORAC, V12, P195, DOI 10.1016/S1010-7940(97)00142-5; Baril DT, 2006, J VASC SURG, V44, P250, DOI 10.1016/j.jvs.2006.04.031; Czerny M, 2011, ANN THORAC SURG, V92, P1657, DOI 10.1016/j.athoracsur.2011.06.073; HOLLANDER JE, 1991, AM J MED, V91, P279, DOI 10.1016/0002-9343(91)90129-L; Chiari H, 1914, BERLIN KLIN WSCHR, V51, P7; Czerny M, 2014, EUR J CARDIO-THORAC, V45, P452, DOI 10.1093/ejcts/ezt393; da Silva ES, 1999, J VASC SURG, V30, P1150, DOI 10.1016/S0741-5214(99)70056-X; Kitayama J, 2006, AM J SURG, V192, P130, DOI 10.1016/j.amjsurg.2005.09.011; Kubota Suguru, 2013, Gen Thorac Cardiovasc Surg, V61, P560, DOI 10.1007/s11748-013-0280-y; Marone EM, 2010, TEX HEART I J, V37, P722; Munakata H, 2013, J THORAC CARDIOV SUR, V146, P235, DOI 10.1016/j.jtcvs.2013.02.064; SNYDER DM, 1983, J THORAC CARDIOV SUR, V85, P457; Yonago R H, 1969, Ann Thorac Surg, V7, P235	17	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2014	46	5					894	900		10.1093/ejcts/ezu094		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AT5FD	WOS:000344968700025		
J	Takeuchi, D; Asagai, S; Ishihara, K; Nakanishi, T				Takeuchi, Daiji; Asagai, Seiji; Ishihara, Kazuaki; Nakanishi, Toshio			Successful Fontan conversion combined with cardiac resynchronization therapy for a case of failing Fontan circulation with ventricular dysfunction	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Editorial Material						Failing Fontan; Fontan conversion; Cardiac resynchronization therapy		Although Fontan conversion combined with cardiac resynchronization therapy appears to be an effective surgical solution for the management of failing Fontan circulation with refractory atrial arrhythmia and cardiac dysfunction due to dyssynchronous ventricular wall motion, limited data are available on the mid- to long-term results of this treatment. We report our successful experience with Fontan conversion combined with cardiac resynchronization therapy in a male patient with failing Fontan circulation who showed favourable outcomes 5 years after the operation.	[Takeuchi, Daiji; Asagai, Seiji; Nakanishi, Toshio] Tokyo Womens Med Univ, Inst Heart, Dept Pediat Cardiol, Tokyo 1618666, Japan; [Ishihara, Kazuaki] Tokyo Womens Med Univ, Inst Heart, Dept Cardiovasc Surg, Tokyo 1618666, Japan	Takeuchi, D (reprint author), Tokyo Womens Med Univ, Inst Heart, Dept Pediat Cardiol, Shinjuku Ku, Kawadacho 1-8, Tokyo 1618666, Japan.	0220teamdaiji@gmail.com					Deal BJ, 2012, HEART, V98, P1098, DOI 10.1136/heartjnl-2011-301133; Hiramatsu T, 2011, EUR J CARDIO-THORAC, V40, P1007, DOI 10.1016/j.ejcts.2011.01.022; Michielon G, 2003, CIRCULATION, V108, P140, DOI 10.1161/01.cir.0000087442.82569.51; Bacha EA, 2004, ANN THORAC SURG, V78, P1678, DOI 10.1016/j.athoracsur.2004.04.065; Mavroudis C, 2008, EUR J CARDIO-THORAC, V34, P1034, DOI 10.1016/j.ejcts.2008.04.024	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2014	46	5					913	915		10.1093/ejcts/ezu084		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AT5FD	WOS:000344968700028		
J	Suematsu, Y; Morizumi, S; Enomoto, T				Suematsu, Yoshihiro; Morizumi, Sei; Enomoto, Tsuyoshi			Off-pump coronary artery bypass grafting in a patient with neurofibromatosis I	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Editorial Material						Neurofibromatosis; Coronary disease; Off-pump coronary artery bypass grafting		Neurofibromatosis, otherwise known as von Recklinghausen disease, is a congenital hereditary disorder involving tissues of neuroectodermal or mesodermal origin. Involvement of the coronary arteries is, however, extremely rare. To the best of our knowledge, this represents the first report of off-pump coronary artery bypass grafting using the bilateral internal mammary arteries for coronary arterial vasculopathy in a patient with neurofibromatosis and of the longest reported follow-up of such a case after bypass surgery.	[Suematsu, Yoshihiro; Morizumi, Sei] Tsukuba Mem Hosp, Dept Cardiovasc Surg, Tsukuba, Ibaraki 3002622, Japan; [Enomoto, Tsuyoshi] Tsukuba Mem Hosp, Dept Cardiol, Tsukuba, Ibaraki 3002622, Japan	Suematsu, Y (reprint author), Tsukuba Mem Hosp, Dept Cardiovasc Surg, 1187-299 Kaname, Tsukuba, Ibaraki 3002622, Japan.	suematsu@tf7.so-net.ne.jp					BRASFIEL.RD, 1972, ANN SURG, V175, P86; Conlon NP, 2007, ANN THORAC SURG, V84, P1021, DOI 10.1016/j.athoracsur.2007.04.024; Evrengul H, 2013, CARDIOL YOUNG, V23, P454, DOI 10.1017/S1047951112000984; GREENE JF, 1974, AM J CLIN PATHOL, V62, P481; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2014	46	5					916	918		10.1093/ejcts/ezu071		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AT5FD	WOS:000344968700029		
J	Miura, K; Eguchi, T; Saito, G; Yoshida, K				Miura, Kentaro; Eguchi, Takashi; Saito, Gaku; Yoshida, Kazuo			Hilar lymph node metastasis of amelanotic malignant melanoma of unknown origin	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Editorial Material						Amelanotic malignant melanoma; Lymph node metastasis; Pneumonectomy		We report a case of hilar lymph node metastasis of amelanotic malignant melanoma of unknown origin. A left pulmonary nodule was detected during a check-up in a 58-year old woman. Chest computed tomography indicated a large left hilar mass located between the upper and lower lobes. She underwent left pneumonectomy with mediastinal lymph node dissection, and the tumour was diagnosed as hilar lymph node metastasis of an amelanotic malignant melanoma; however, the primary lesion could not be detected. Thus, the possibility of spontaneous regression of the primary lesion and the amelanotic subtype of malignant melanomas should be considered in clinical practice.	[Miura, Kentaro; Eguchi, Takashi; Saito, Gaku; Yoshida, Kazuo] Shinshu Univ, Div Thorac Surg, Matsumoto, Nagano 3908621, Japan	Eguchi, T (reprint author), Shinshu Univ, Div Thorac Surg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tks1976@shinshu-u.ac.jp					GIULIANO AE, 1982, SEMIN ONCOL, V9, P442; SMITH JL, 1965, CANCER, V18, P1399, DOI 10.1002/1097-0142(196511)18:11<1399::AID-CNCR2820181104>3.0.CO;2-R; Koch SE, 2000, J AM ACAD DERMATOL, V42, P731, DOI 10.1067/mjd.2000.103981; Petersen RP, 2007, J THORAC CARDIOV SUR, V133, P104, DOI 10.1016/j.jtcvs.2006.08.065; TABOADA C F, 1972, Chest, V62, P629	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2014	46	5					919	920		10.1093/ejcts/ezu105		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AT5FD	WOS:000344968700030		
J	Mihara, W; Matsushita, A; Atarashi, K; Aoki, N				Mihara, Wahei; Matsushita, Akihito; Atarashi, Kentaro; Aoki, Naoto			Simultaneous mobile thrombi of the aortic valve and thoracic aorta	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Editorial Material						Mobile thrombi; Aortic valve; Thoracic aorta			[Mihara, Wahei; Matsushita, Akihito] Chiba Cent Med Ctr, Dept Cardiovasc Surg, Chiba 2640017, Japan; [Atarashi, Kentaro; Aoki, Naoto] Chiba Cent Med Ctr, Dept Cardiol, Chiba 2640017, Japan	Matsushita, A (reprint author), Chiba Cent Med Ctr, Dept Cardiovasc Surg, Wakaba Ku, 1835-1 Kasori Cho, Chiba 2640017, Japan.	akihito.matsu@gmail.com						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2014	46	5					923	923		10.1093/ejcts/ezu063		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AT5FD	WOS:000344968700033		
J	Shishido, T; Hachisuka, M; Ryuzaki, K; Miura, Y; Tanabe, A; Tamura, Y; Kusayanagi, T; Takeuchi, T; Kamisuki, S; Sugawara, F; Sahara, H				Shishido, Tatsuya; Hachisuka, Masami; Ryuzaki, Kai; Miura, Yuko; Tanabe, Atsushi; Tamura, Yasuaki; Kusayanagi, Tomoe; Takeuchi, Toshifumi; Kamisuki, Shinji; Sugawara, Fumio; Sahara, Hiroeki			EpsinR, a target for pyrenocine B, role in endogenous MHC-II-restricted antigen presentation	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Antigen presentation; Epsin R; MHC class II; Pyrenocine B; SNARE	DENDRITIC CELLS; ENTH-DOMAIN; IN-VIVO; COMPLEX; PROTEINS; ADAPTER; MOLECULES; FUSION; MATURATION; PEPTIDES	While the presentation mechanism of antigenic peptides derived from exogenous proteins by MHC class II molecules is well understood, relatively little is known about the presentation mechanism of endogenous MHC class II-restricted antigens. We therefore screened a chemical library of 200 compounds derived from natural products to identify inhibitors of the presentation of endogenous MHC class II-restricted antigens. We found that pyrenocine B, a compound derived from the fungus Pyrenochaeta terrestris, inhibits presentation of endogenous MHC class II-restricted minor histocompatibility antigen IL-4 inducible gene 1 (IL4I1) by primary dendritic cells (DCs). Phage display screening and surface plasmon resonance (SPR) analysis were used to investigate the mechanism of suppressive action by pyrenocine B. EpsinR, a target molecule for pyrenocine B, mediates endosomal trafficking through binding of soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs). Lentiviral-mediated short hairpin (sh) RNA downregulation of EpsinR expression in DCs resulted in a decrease in the responsiveness of CD4(+) T cells. Our data thus suggest that EpsinR plays a role in antigen presentation, which provides insight into the mechanism of presentation pathway of endogenous MHC class II-restricted antigen.	[Shishido, Tatsuya; Hachisuka, Masami; Ryuzaki, Kai; Miura, Yuko; Tanabe, Atsushi; Sahara, Hiroeki] Azabu Univ, Sch Vet Med, Biol Lab, Sagamihara, Kanagawa, Japan; [Tamura, Yasuaki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Kusayanagi, Tomoe; Takeuchi, Toshifumi; Kamisuki, Shinji; Sugawara, Fumio] Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba, Japan	Sahara, H (reprint author), Azabu Univ, Sch Vet Med, Biol Lab, Sagamihara, Kanagawa, Japan.	sahara@azabu-u.ac.jp			Azabu University	This research was supported by a research project grant awarded by the Azabu University. We thank Dr. Nilabh Shastri for the generous gift of T-cell hybridoma and are grateful to Dr. Hisashi Arase for providing us invaluable tools for our study.	Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; MALNATI MS, 1992, NATURE, V357, P702, DOI 10.1038/357702a0; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Matsuki K, 2012, CANCER SCI, V103, P1546, DOI 10.1111/j.1349-7006.2012.02333.x; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; WEISS S, 1991, CELL, V64, P767, DOI 10.1016/0092-8674(91)90506-T; Imai A, 2007, EUR J IMMUNOL, V37, P1730, DOI 10.1002/eji.200636392; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; SANDERSON S, 1995, P NATL ACAD SCI USA, V92, P7217, DOI 10.1073/pnas.92.16.7217; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Dorfel D, 2005, BLOOD, V105, P3199, DOI 10.1182/blood-2004-09-3556; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Dugast M, 2005, J BIOL CHEM, V280, P19656, DOI 10.1074/jbc.M501357200; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; SPARACE SA, 1987, CAN J MICROBIOL, V33, P327; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Costantino CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029805; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kuramochi K, 2005, BIOCONJUGATE CHEM, V16, P97, DOI 10.1021/bc0497970; Morohashi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018285; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Sahara H, 2003, J EXP MED, V197, P375, DOI 10.1084/jem.20021961; Shiratori J., 2004, J EXP MED, V199, P525	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	NOV	2014	44	11					3220	3231		10.1002/eji.201444475		12	Immunology	Immunology	AT9CG	WOS:000345225000008		
J	Muhammad, K; Alrefai, H; Marienfeld, R; Pham, DAT; Murti, K; Patra, AK; Avots, A; Bukur, V; Sahin, U; Kondo, E; Klein-Hessling, S; Serfling, E				Muhammad, Khalid; Alrefai, Hani; Marienfeld, Ralf; Duong Anh Thuy Pham; Murti, Krisna; Patra, Amiya K.; Avots, Andris; Bukur, Valesca; Sahin, Ugur; Kondo, Eisaku; Klein-Hessling, Stefan; Serfling, Edgar			NF-kappa B factors control the induction of NFATc1 in B lymphocytes	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Chromatin; Induction; Lymphocytes; Nfatc1 gene; NF-B; Transcription	NUCLEAR-FACTOR; TRANSCRIPTION FACTORS; INTERLEUKIN-2 GENE; RESPONSE ELEMENT; CELL DEVELOPMENT; MOLECULE CD28; UP-REGULATION; MICE LACKING; T-CELLS; ACTIVATION	In peripheral lymphocytes, the transcription factors (TFs) NF-B, NFAT, and AP-1 are the prime targets of signals that emerge from immune receptors. Upon activation, these TFs induce gene networks that orchestrate the growth, expansion, and effector function of peripheral lymphocytes. NFAT and NF-B factors share several properties, such as a similar mode of induction and architecture in their DNA-binding domain, and there is a subgroup of B-like DNA promoter motifs that are bound by both types of TFs. However, unlike NFAT and AP-1 factors that interact and collaborate in binding to DNA, NFAT, and NF-B seem neither to interact nor to collaborate. We show here that NF-B1/p50 and c-Rel, the most prominent NF-B proteins in BCR-induced splenic B cells, control the induction of NFATc1/A, a prominent short NFATc1 isoform. In part, this is mediated through two composite B/NFAT-binding sites in the inducible Nfatc1 P1 promoter that directs the induction of NFATc1/A by BCR signals. In concert with coreceptor signals that induce NF-B factors, BCR signaling induces a persistent generation of NFATc1/A. These data suggest a tight connection between NFATc1 and NF-B induction in B lymphocytes contributing to the effector function of peripheral B cells.	[Muhammad, Khalid; Alrefai, Hani; Duong Anh Thuy Pham; Murti, Krisna; Patra, Amiya K.; Avots, Andris; Klein-Hessling, Stefan; Serfling, Edgar] Univ Wurzburg, Dept Mol Pathol, Inst Pathol, D-97070 Wurzburg, Germany; [Muhammad, Khalid; Alrefai, Hani; Duong Anh Thuy Pham; Murti, Krisna; Patra, Amiya K.; Avots, Andris; Klein-Hessling, Stefan; Serfling, Edgar] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [Marienfeld, Ralf] Univ Ulm, Inst Pathol, D-89069 Ulm, Germany; [Bukur, Valesca; Sahin, Ugur] Johannes Gutenberg Univ Mainz, Med Ctr, TRON GGmbH Translat Oncol, D-55122 Mainz, Germany; [Sahin, Ugur] Johannes Gutenberg Univ Mainz, Med Ctr GGmbH, D-55122 Mainz, Germany; [Kondo, Eisaku] Aichi Canc Ctr, Res Inst, Div Oncol Pathol, Nagoya, Aichi 464, Japan	Serfling, E (reprint author), Univ Wurzburg, Dept Mol Pathol, Inst Pathol, D-97070 Wurzburg, Germany.	serfling.e@mail.uni-wuerzburg.de			Deutsche Forschungsgemeinschaft [TRR52]; Wilhelm-Sander foundation; Scheel foundation	We are very much indebted to Doris Michel and Ilona Pietrowski for technical support. For mouse lines and reagents we wish to thank Drs. M. Busslinger (Vienna), L. Glimcher (New York), M. Pasparakis (Cologne), A. Rao (San Diego), and M. Reth (Freiburg). We thank Dr. A. Rosenwald for his kind support. The work was supported by the Deutsche Forschungsgemeinschaft, grant TRR52 (to E. S. and A. A.), the Wilhelm-Sander foundation (to E. S. and S.K.-H.), and the Scheel foundation (to E. S. and A.A.).	DURAND DB, 1988, MOL CELL BIOL, V8, P1715; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Pham LV, 2005, BLOOD, V106, P3940, DOI 10.1182/blood-2005-03-1167; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Bhattacharyya S, 2011, J EXP MED, V208, P823, DOI 10.1084/jem.20100945; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Vaeth M, 2012, P NATL ACAD SCI USA, V109, P16258, DOI 10.1073/pnas.1203870109; Giffin MJ, 2003, NAT STRUCT BIOL, V10, P800, DOI 10.1038/nsb981; SERFLING E, 1989, EMBO J, V8, P465; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Hock M, 2013, J IMMUNOL, V190, P2345, DOI 10.4049/jimmunol.1201591; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Banerjee A, 2008, BLOOD, V112, P5063, DOI 10.1182/blood-2007-10-120832; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; FRUMAN DA, 1995, MOL CELL BIOL, V15, P3857; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Gilmore Thomas D, 2011, Genes Cancer, V2, P695, DOI 10.1177/1947601911421925; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Huang DB, 2001, STRUCTURE, V9, P669, DOI 10.1016/S0969-2126(01)00635-9; Jin L, 2003, NAT STRUCT BIOL, V10, P807, DOI 10.1038/nsb975; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Oh-hora M, 2013, IMMUNITY, V38, P881, DOI 10.1016/j.immuni.2013.02.008; PIERCE JW, 1988, P NATL ACAD SCI USA, V85, P1482, DOI 10.1073/pnas.85.5.1482; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Serfling E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-16; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Snapper CM, 1996, J IMMUNOL, V156, P183; Suhasini M, 1997, ONCOGENE, V15, P1859, DOI 10.1038/sj.onc.1201530; TOTH CR, 1995, J BIOL CHEM, V270, P7661; Ueda T, 2001, FEBS LETT, V491, P40, DOI 10.1016/S0014-5793(01)02145-7; VERWEIJ CL, 1991, J BIOL CHEM, V266, P14179; Wolfe SA, 1997, NATURE, V385, P172, DOI 10.1038/385172a0; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Zhang BC, 2007, BLOOD, V110, P743, DOI 10.1182/blood-2006-11-058446; Zhou P, 1998, CELL, V92, P687, DOI 10.1016/S0092-8674(00)81136-8	48	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	NOV	2014	44	11					3392	3402		10.1002/eji.201444756		11	Immunology	Immunology	AT9CG	WOS:000345225000023		
J	Ishikawa, Y; Usui, T; Shiomi, A; Shimizu, M; Murakami, K; Mimori, T				Ishikawa, Yuki; Usui, Takashi; Shiomi, Aoi; Shimizu, Masakazu; Murakami, Kosaku; Mimori, Tsuneyo			Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL-2R gamma(-/-) mice	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Animal models; Antibodies; Autoimmunity; Immune responses; Memory cells	BLOOD MONONUCLEAR-CELLS; RHEUMATOID-ARTHRITIS; NOG MICE; IMMUNE-RESPONSES; GAMMA-CHAIN; DISEASE; MOUSE; DIFFERENTIATION; MOLECULES; SYSTEM	NOD/LtSzscid/IL-2R(-/-) (NSG) mice have advantages in establishing humanized mouse models. However, transferring human PBMCs into these mice often causes lethal GVH disease. In this study, we discovered an improved method for the engraftment of normal or pathological human PBMCs into NSG mice and examined the subsequent induction of specific immune responses. We sequentially transferred human CD4(+) memory T (Tm) and B cells obtained from PBMCs of healthy adults or patients with autoimmune diseases into NSG mice. Removing naive CD4(+) Tcells from the transferred PBMCs allowed successful engraftment without lethal GVH disease. The transferred Tm cells were found to reside mainly in the spleen and the lymphoid nodules, where they expressed MHC class II molecules and produced cytokines, including IL-21. Surprisingly, the transferred B cells were also well maintained in the lymphoid organs, underwent de novo class-switch recombination, and secreted all isotypes of human Igs at significant levels. Moreover, transferring patient-derived Tm and B cells resulted in sustained production of IgM-rheumatoid factor and antiaminoacyl transfer RNA synthetase Abs in these mice. These results suggest that transfer of Tm and B cells derived from human PBMCs into NSG mice could be a useful method for the study of human autoimmune mechanisms.	[Ishikawa, Yuki; Usui, Takashi; Shiomi, Aoi; Shimizu, Masakazu; Murakami, Kosaku; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan	Usui, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.	takausui@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [18591106, 20591168, 18390290, 22390201]	This work was supported by a grant-in-aid for scientific research (18591106 and 20591168 to T. U. and 18390290 and 22390201 to T. M.) from the Japan Society for the Promotion of Science. DNA sequencing analysis was performed at the Medical Research Support Center, Graduate School of Medicine, Kyoto University. We are grateful for the essential collaboration of the patients who participated in this study.	Andrade D, 2011, ARTHRITIS RHEUM-US, V63, P2764, DOI 10.1002/art.30424; Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Ito R, 2008, CURR TOP MICROBIOL, V324, P95; Oxelius VA, 2013, CLIN IMMUNOL, V149, P475, DOI 10.1016/j.clim.2013.10.003; Covassin L, 2013, CLIN EXP IMMUNOL, V174, P372, DOI 10.1111/cei.12180; Saito N, 2013, J ALLERGY CLIN IMMUN, V131, P434, DOI 10.1016/j.jaci.2012.09.014; Ohbo K, 1996, BLOOD, V87, P956; Suzuki M, 2012, INT IMMUNOL, V24, P243, DOI 10.1093/intimm/dxs045; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Mahler M, 2014, AUTOIMMUN REV, V13, P367, DOI 10.1016/j.autrev.2014.01.022; Cerutti A, 1998, J IMMUNOL, V160, P2145; Aletaha D, 2013, ANN RHEUM DIS, V72, P875, DOI 10.1136/annrheumdis-2012-201517; Jin H, 2014, P NATL ACAD SCI USA, V111, P3787, DOI 10.1073/pnas.1401105111; Dorner T, 2004, CURR OPIN RHEUMATOL, V16, P246; Katsumata Y, 2007, J AUTOIMMUN, V29, P174, DOI 10.1016/j.jaut.2007.07.005; Pino S, 2010, METHODS MOL BIOL, V602, P105, DOI 10.1007/978-1-60761-058-8_7; Pene J, 2004, J IMMUNOL, V172, P5154; Berglund LJ, 2013, BLOOD, V122, P3940, DOI 10.1182/blood-2013-06-506865; Collado JA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00442; Currier J. R., 2001, CURR PROTOC IMMUNOL, V172, P5154; Hajj Hiba El, 2012, Front Microbiol, V3, P333, DOI 10.3389/fmicb.2012.00333; Koenen HJPM, 2003, J IMMUNOL, V171, P6431; Kuwana Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026630; Matsuki F, 2013, BIOCHEM BIOPH RES CO, V438, P778, DOI 10.1016/j.bbrc.2013.05.120; Mimori Tsuneyo, 2007, Rinsho Shinkeigaku, V47, P855; Nakamura M, 2008, CURR TOP MICROBIOL, V324, P167; Nakashima R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085062; Nischang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038853; Nolte T, 2013, CLIN EXP IMMUNOL, V172, P349, DOI 10.1111/cei.12057; Qin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029141; Tobon GJ, 2013, AUTOIMMUNE DIS, V2013, DOI DOI 10.1155/2013/827254	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	NOV	2014	44	11					3453	3463		10.1002/eji.201444729		11	Immunology	Immunology	AT9CG	WOS:000345225000028		
J	Horie, M; Watanabe, K; Bepari, AK; Nashimoto, J; Araki, K; Sano, H; Chiken, S; Nambu, A; Ono, K; Ikenaka, K; Kakita, A; Yamamura, K; Takebayashi, H				Horie, Masao; Watanabe, Keisuke; Bepari, Asim K.; Nashimoto, Jun-ichiro; Araki, Kimi; Sano, Hiromi; Chiken, Satomi; Nambu, Atsushi; Ono, Katsuhiko; Ikenaka, Kazuhiro; Kakita, Akiyoshi; Yamamura, Ken-ichi; Takebayashi, Hirohide			Disruption of actin-binding domain-containing Dystonin protein causes dystonia musculorum in mice	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						autonomic neuropathy; dystonia; gene trap mutant; hereditary sensory; neurodegeneration	BULLOUS-PEMPHIGOID ANTIGEN-1; DEVELOPING SPINAL-CORD; MUTANT MICE; NEUROLOGIC DEGENERATION; NEURONAL-ACTIVITY; NERVOUS-SYSTEM; BPAG1 LOCUS; MOUSE MODEL; DT MICE; EXPRESSION	The Dystonin gene (Dst) is responsible for dystonia musculorum (dt), an inherited mouse model of hereditary neuropathy accompanied by progressive motor symptoms such as dystonia and cerebellar ataxia. Dst-a isoforms, which contain actin-binding domains, are predominantly expressed in the nervous system. Although sensory neuron degeneration in the peripheral nervous system during the early postnatal stage is a well-recognised phenotype in dt, the histological characteristics and neuronal circuits in the central nervous system responsible for motor symptoms remain unclear. To analyse the causative neuronal networks and roles of Dst isoforms, we generated novel multipurpose Dst gene trap mice, in which actin-binding domain-containing isoforms are disrupted. Homozygous mice showed typical dt phenotypes with sensory degeneration and progressive motor symptoms. The gene trap allele (Dst(Gt)) encodes a mutant Dystonin-LacZ fusion protein, which is detectable by X-gal (5-bromo-4-chloro-3-indolyl--D-galactoside) staining. We observed wide expression of the actin-binding domain-containing Dystonin isoforms in the central nervous system (CNS) and peripheral nervous system. This raised the possibility that not only secondary neuronal defects in the CNS subsequent to peripheral sensory degeneration but also cell-autonomous defects in the CNS contribute to the motor symptoms. Expression analysis of immediate early genes revealed decreased neuronal activity in the cerebellar-thalamo-striatal pathway in the homozygous brain, implying the involvement of this pathway in the dt phenotype. These novel Dst(Gt) mice showed that a loss-of-function mutation in the actin-binding domain-containing Dystonin isoforms led to typical dt phenotypes. Furthermore, this novel multipurpose Dst(Gt) allele offers a unique tool for analysing the causative neuronal networks involved in the dt phenotype.	[Horie, Masao; Watanabe, Keisuke; Bepari, Asim K.; Nashimoto, Jun-ichiro; Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata 9518510, Japan; [Araki, Kimi; Yamamura, Ken-ichi] Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto, Japan; [Sano, Hiromi; Chiken, Satomi; Nambu, Atsushi] Natl Inst Physiol Sci, Div Syst Neurophysiol, Okazaki, Aichi 444, Japan; [Ono, Katsuhiko] Kyoto Prefectural Univ Med, Dept Biol, Kyoto, Japan; [Ikenaka, Kazuhiro] Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 444, Japan; [Kakita, Akiyoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 9518510, Japan; [Takebayashi, Hirohide] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	Takebayashi, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Asahimachi Chuo Ku, Niigata 9518510, Japan.	takebaya@med.niigata-u.ac.jp	Bepari, Asim/D-4001-2013	Bepari, Asim/0000-0001-5656-1833	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Nakabayashi Trust for ALS Research Foundation; Tsukada Medical Foundation; Yujin Memorial Grant; Kato Memorial Trust for Nambyo Research; Kanehara Ichiro Foundation; Cooperative Study Program of the National Institute for Physiological Sciences	This study was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (H. T. and M. H.), Grant-in-Aid for Scientific Research on Innovative Areas ('Glial assembly') (H. T.), Takeda Science Foundation (H. T.), Nakabayashi Trust for ALS Research Foundation (H. T.), Tsukada Medical Foundation (M. H.), Yujin Memorial Grant (H. T.), Kato Memorial Trust for Nambyo Research (H. T.), Kanehara Ichiro Foundation (H. T.) and the Cooperative Study Program of the National Institute for Physiological Sciences (H. T., M. H. and A.N.). We thank Dr Kenji Sakimura, Dr Masayoshi Mishina, and Dr Kenji F. Tanaka for materials; Dr Daisuke Koga, Dr Hiroaki Tsukano, Dr Yukiko Mori, Dr Noriyoshi Usui, Ms Mari Miyamoto, Mr Masaki Tominaga, Ms Junko Takasaki, Ms Chieko Tanda, and Ms Sayoko Fujimura for technical assistance; and Dr Takayoshi Shimohata, and Dr Thomas Floss for discussion. The authors have declared that no competing interests exist.	MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; Zhuang P, 2004, CLIN NEUROPHYSIOL, V115, P2542, DOI 10.1016/j.clinph.2004.06.006; Farmer SF, 1998, BRAIN, V121, P801, DOI 10.1093/brain/121.5.801; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; Neychev VK, 2011, NEUROBIOL DIS, V42, P185, DOI 10.1016/j.nbd.2011.01.026; Pizoli CE, 2002, J NEUROSCI, V22, P7825; Calderon DP, 2011, NAT NEUROSCI, V14, P357, DOI 10.1038/nn.2753; Bepari AK, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-140; Watanabe K, 2006, DEVELOPMENT, V133, P1379, DOI 10.1242/dev.02312; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.050227310; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5; Sano H, 2013, J NEUROSCI, V33, P7583, DOI 10.1523/JNEUROSCI.4932-12.2013; Takebayashi H, 2008, GENESIS, V46, P775, DOI 10.1002/dvg.20461; Horie M, 2003, EUR J NEUROSCI, V17, P49, DOI 10.1046/j.1460-9568.2003.02424.x; Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; Zoons E, 2011, NEUROIMAGE, V56, P1011, DOI 10.1016/j.neuroimage.2011.02.045; Chiken S, 2008, J NEUROSCI, V28, P13967, DOI 10.1523/JNEUROSCI.3834-08.2008; Lenz FA, 1998, J NEUROL NEUROSUR PS, V65, P767, DOI 10.1136/jnnp.65.5.767; Vitek JL, 2002, MOVEMENT DISORD, V17, pS49, DOI 10.1002/mds.10142; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; Sadnicka A, 2012, CLIN NEUROPHYSIOL, V123, P65, DOI 10.1016/j.clinph.2011.04.027; Bernier G, 1998, DEVELOPMENT, V125, P2135; Bernier G, 1995, MOL CELL NEUROSCI, V6, P509, DOI 10.1006/mcne.1995.0003; BROWN LL, 1995, BRAIN RES, V686, P207, DOI 10.1016/0006-8993(95)00457-2; CAMPBELL RM, 1992, NEURON, V9, P693, DOI 10.1016/0896-6273(92)90032-9; Carbon M, 2004, NEUROLOGY, V62, P1384; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; DesRepentigny Y., 2011, PLOS ONE, V6; Ding L, 2005, DEV DYNAM, V234, P622, DOI 10.1002/dvdy.20545; Douglas DS, 2009, NEUROCHEM RES, V34, P124, DOI 10.1007/s11064-008-9719-4; Dowling J, 1997, DEV BIOL, V187, P131, DOI 10.1006/dbio.1997.8567; Duchen L. W., 1963, J PHYSL, V165, P7; DUCHEN LW, 1964, BRAIN, V87, P367, DOI 10.1093/brain/87.2.367; Edvardson S, 2012, ANN NEUROL, V71, P569, DOI 10.1002/ana.23524; Ferrier A, 2014, HUM MOL GENET, V23, P2694, DOI 10.1093/hmg/ddt663; Groves RW, 2010, J INVEST DERMATOL, V130, P1551, DOI 10.1038/jid.2010.19; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; Ichikawa H, 2008, BRAIN RES, V1226, P33, DOI 10.1016/j.brainres.2008.05.063; Ichinohe N, 2000, BRAIN RES, V880, P191, DOI 10.1016/S0006-8993(00)02744-X; JANOTA I, 1972, BRAIN, V95, P529, DOI 10.1093/brain/95.3.529; Jefferson JJ, 2006, EXP CELL RES, V312, P2712, DOI 10.1016/j.yexcr.2006.04.025; Komagata S, 2011, J NEUROSCI, V31, P4896, DOI 10.1523/JNEUROSCI.6753-10.2011; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Lalonde R, 2005, PHYSIOL BEHAV, V86, P46, DOI 10.1016/j.physbeh.2005.06.028; LeDoux M S, 1998, Adv Neurol, V78, P63; Leung CL, 2001, J CELL BIOL, V154, P691, DOI 10.1083/jcb.200012098; Liu XG, 2004, MOVEMENT DISORD, V19, P336, DOI 10.1002/mds.10655; MESSER A, 1980, NEUROSCIENCE, V5, P543, DOI 10.1016/0306-4522(80)90051-2; Obseo J. A., 1983, NEUROLOGY, V33, P825; Okumura M, 2002, J BIOL CHEM, V277, P6682, DOI 10.1074/jbc.M109209200; Pool M, 2005, MAMM GENOME, V16, P909, DOI 10.1007/s00335-005-0073-4; Sillitoe RV, 2014, BRAIN STRUCT FUNCT, V219, P35, DOI 10.1007/s00429-012-0482-6; SOTELO C, 1988, NEUROSCIENCE, V27, P403, DOI 10.1016/0306-4522(88)90277-1; Taniwaki T, 2005, DEV GROWTH DIFFER, V47, P163; Tseng KW, 2006, J NEUROPATH EXP NEUR, V65, P336, DOI 10.1097/01.jnen.0000218448.39944.f1; Tseng KW, 2008, J COMP NEUROL, V507, P1053, DOI 10.1002/ene.21606; Young KG, 2007, CELL MOTIL CYTOSKEL, V64, P897, DOI 10.1002/cm.20235	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	NOV	2014	40	10					3458	3471		10.1111/ejn.12711		14	Neurosciences	Neurosciences & Neurology	AU0GT	WOS:000345302400004		
J	Okazaki, M; Adachi, N; Akanuma, N; Hara, K; Ito, M; Kato, M; Onuma, T				Okazaki, Mitsutoshi; Adachi, Naoto; Akanuma, Nozomi; Hara, Koichiro; Ito, Masumi; Kato, Masaaki; Onuma, Teiichi			Do antipsychotic drugs increase seizure frequency in epilepsy patients?	EUROPEAN NEUROPSYCHOPHARMACOLOGY			English	Article						Epilepsy; Seizure; Antipsychotic drugs; Psychosis; Treatment	INTERICTAL PSYCHOTIC EPISODES; RISK; ANTIDEPRESSANTS; MEDICATION; OLANZAPINE; DISORDERS; DURATION	To investigate whether addition of antipsychotic drugs (APD) would increase seizure frequency in epilepsy patients who were already treated with anti-epileptic drugs (AED), we compared a one-year seizure control outcome in 150 epilepsy patients with APD treatment for psychiatric conditions and 309 epilepsy patients without APD treatment matched for ages at epilepsy onset and the baseline evaluation and types of epilepsy. The seizure frequency was recorded at the baseline (immediately before the start of APD) and after the 1st, 3rd, 6th and 12th months. The seizure outcome at each of the four follow-up points was compared with the baseline. The seizure outcome was compared between the two groups as a whole and according to the types of epilepsy (idiopathic generalized and partial epilepsies). In the APD group, the seizure outcome was also analyzed according to the types of APD (first and second generation APD and combination of first and second generation APD) and the types of psychiatric conditions (psychosis and non-psychosis). The seizure outcome was significantly better in the APD group than control group at all the four follow-up points. According to the epilepsy types, the improvement in the seizure outcome was only observed in the patients with partial epilepsy. Of the APD group, there was no significant difference in the seizure outcome according to the types of APD or the psychiatric conditions. In epilepsy patients who are already treated with AED, APD treatment seems safe in seizure control outcome for treatment of psychiatric conditions. (C) 2014 Elsevier B.V. and ECNP. All rights reserved.	[Okazaki, Mitsutoshi; Adachi, Naoto; Ito, Masumi; Kato, Masaaki; Onuma, Teiichi] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Kodaira, Tokyo, Japan; [Adachi, Naoto] Adachi Mental Clin, Sapporo, Hokkaido 0040867, Japan; [Akanuma, Nozomi] South London & Maudsley NHS Fdn Trust, London, England; [Hara, Koichiro] Asai Hosp, Togane, Japan; [Ito, Masumi] Jozen Clin, Sapporo, Hokkaido, Japan; [Kato, Masaaki; Onuma, Teiichi] Musashino Kokubunji Clin, Kokubunji, Tokyo, Japan	Adachi, N (reprint author), Adachi Mental Clin, Kitano 7-5-12, Sapporo, Hokkaido 0040867, Japan.	adacchan@tky2.3web.ne.jp					Adachi N, 1998, EPILEPSIA, V39, P628, DOI 10.1111/j.1528-1157.1998.tb01431.x; Adachi N., 2005, JPN J PSYCHIAT TRE S, V20, pS370; Adachi N, 2013, EPILEPSIA, V54, P19, DOI 10.1111/epi.12102; Adachi N, 2012, EPILEPSIA, V53, P1088, DOI 10.1111/j.1528-1167.2012.03438.x; Haddad PM, 2007, CNS DRUGS, V21, P911; Alldredge BK, 1999, NEUROLOGY, V53, pS68; Kerr MP, 2011, EPILEPSIA, V52, P2133, DOI 10.1111/j.1528-1167.2011.03276.x; Monte-Silva K, 2011, NEUROPSYCHOPHARMACOL, V36, P2097, DOI 10.1038/npp.2011.100; OJEMANN LM, 1987, NEUROLOGY, V37, P1525; Okazaki M, 2011, EPILEPSY BEHAV, V22, P331, DOI 10.1016/j.yebeh.2011.07.016; Gross A, 2000, J NEUROPSYCH CLIN N, V12, P458, DOI 10.1176/appi.neuropsych.12.4.458; Hedges D, 2003, DRUGS TODAY, V39, P551, DOI 10.1358/dot.2003.39.7.799445; Alper K, 2007, BIOL PSYCHIAT, V62, P345, DOI 10.1016/j.biopsych.2006.09.023; Karouni M, 2010, EUR J CLIN PHARMACOL, V66, P1151, DOI 10.1007/s00228-010-0861-y; Behere RV, 2009, CLIN NEUROPHARMACOL, V32, P297, DOI 10.1097/WNF.0b013e3181a7fd00; Commission on Classification and Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389; Fitzgerald Paul B., 2002, Psychopharmacology, V162, P74, DOI 10.1007/s00213-002-1068-4; Gardner D.M., 2012, AM J PSYCHIAT, V167, P686; Gudmundsson G., 1966, ACTA NEUROL SCAN S25, V43, pS1; Hara K, 2013, EPILEPSY BEHAV, V27, P342, DOI 10.1016/j.yebeh.2013.02.025; Itil T.M., 1980, JAMA-J AM MED ASSOC, V244, P1960; Koch-Stoecker S., 2002, EPILEPSIA S2, V43, pS19; Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P69, DOI 10.1016/j.seizure.2009.11.005; Lamgguth B., 2008, PSYCHOPHARMACOLOGY, V196, P623; Lertxundi U, 2013, SEIZURE-EUR J EPILEP, V22, P141, DOI 10.1016/j.seizure.2012.10.009; LOGOTHET.J, 1967, NEUROLOGY, V17, P869; MARKOWITZ JC, 1987, GEN HOSP PSYCHIAT, V9, P135, DOI 10.1016/0163-8343(87)90025-9; Melduram B.S., 1988, PSYCHOPHARMACOLOGY, P107; Nitsche M.A., 2008, J NEUROSCI, V29, P2648; OLIVER AP, 1982, ARCH GEN PSYCHIAT, V39, P206; Onuma T., 1987, JPN J PSYCHIAT TREAT, V2, P553; PAUIG PM, 1961, AM J PSYCHIAT, V117, P832; REMICK RA, 1979, J CLIN PSYCHIAT, V40, P78; Toru M., 2001, PSYCHOTROPIC DRUG MA; Trimble M. R., 2008, EPILEPSY COMPREHENSI, P2215; Woolley J, 2001, BRIT J PSYCHIAT, V178, P85; World Health Organization, 1992, ICD 10 CLASS MENT BE	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-977X	1873-7862		EUR NEUROPSYCHOPHARM	Eur. Neuropsychopharmacol.	NOV	2014	24	11					1738	1744		10.1016/j.euroneuro.2014.09.012		7	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AT8UB	WOS:000345206200003		
J	Mine, S; Kado, Y; Watanabe, M; Fukuda, Y; Abe, Y; Ueda, T; Kawarabayasi, Y; Inoue, T; Ishikawa, K				Mine, Shouhei; Kado, Yuji; Watanabe, Masahiro; Fukuda, Yohta; Abe, Yoshito; Ueda, Tadashi; Kawarabayasi, Yutaka; Inoue, Tsuyoshi; Ishikawa, Kazuhiko			The structure of hyperthermophilic beta-N-acetylglucosaminidase reveals a novel dimer architecture associated with the active site	FEBS JOURNAL			English	Article						chitin; crystal structure; N-acetylglucosamine; thermostable enzyme; -N-acetylglucosaminidase	ESCHERICHIA-COLI; INHIBITORS; MECHANISM; HYDROLASES; MAD	The -N-acetylglucosaminidase from the hyperthermophilic bacteria Thermotogamaritima (NagA) hydrolyzes chitooligomers into monomer -N-acetylglucosamine. Although NagA contains a highly conserved sequence motif found in glycoside hydrolase (GH) family 3, it can be distinguished from other GH family 3 -N-acetylglucosaminidases by its substrate specificity and biological assembly. To investigate its unique structure around the active site, we determined the crystal structure of NagA at a resolution of 2.43 angstrom. The NagA forms a dimer structure in which the monomer structure consists of an N- and a C-terminal domain. The dimer structure exhibits high solvation free energy for dimer formation. From mutagenesis analyses, the catalytic nucleophile and general acid-base residues were supposed to be Asp245 and His173, respectively. The most striking characteristic of NagA was that it forms the active site cleft from the N-terminal domain and the C-terminal domain of the next polypeptide chain, whereas the other two-domain GH family 3 enzymes form the site within the same molecule. Another striking feature is that the loops located around the active site show high flexibility. One of the flexible loops contains the general acid-base His173 and was thought to be involved in substrate distortion during catalysis. In addition, a loop in close contact with the active site, which comes from the C-terminal domain of the next polypeptide chain, contains a region of high B-factor values, indicating the possibility that the C-terminal domain is involved in catalysis. These results suggest that the dimer structure of NagA is important for its activity and thermostability. DatabaseStructural data are available in the Protein Data Bank under accession number . Structured digital abstract <list list-type="bulleted" id="febs13049-list-0001"> andby() <doi origin="wiley" registered="yes">10.1111/(ISSN)1742-4658</doi	[Mine, Shouhei; Kawarabayasi, Yutaka] Natl Inst Adv Ind Sci & Technol, Amagasaki, Hyogo 9549, Japan; [Kado, Yuji] Osaka Univ, Interdisciplinary Program Biomed Sci, Inst Acad Initiat, Osaka, Japan; [Kado, Yuji; Fukuda, Yohta; Inoue, Tsuyoshi] Osaka Univ, Grad Sch Engn, Osaka, Japan; [Watanabe, Masahiro; Ishikawa, Kazuhiko] AIST, Biomass Refinery Res Ctr, Hiroshima 7390046, Japan; [Abe, Yoshito; Ueda, Tadashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Kawarabayasi, Yutaka] Kyushu Univ, Fac Agr, Fukuoka 812, Japan	Mine, S (reprint author), Natl Inst Adv Ind Sci & Technol, 3-11-46 Nakoji, Amagasaki, Hyogo 9549, Japan.	s-mine@aist.go.jp; kazu-ishikawa@aist.go.jp	Abe, Yoshito/D-8370-2012	Abe, Yoshito/0000-0002-0016-8490	Japan Society for the Promotion of Sciences [25450143]; Institute for Fermentation, Osaka (IFO)	The authors are grateful to Dr T. Nakamura (AIST) for diffraction data collection of NagA crystals. The authors are grateful to Drs Y. Yoshida (AIST) and T. Sato (AIST) for their support throughout these studies. This work was supported in part by a Grant-in-Aid for Scientific Research (Grant Number 25450143) to S. Mine from the Japan Society for the Promotion of Sciences. Y. Kawarabayasi was partially supported by the Institute for Fermentation, Osaka (IFO). Synchrotron experiments were performed at SPring-8 under the approval of the Japan Synchrotron Radiation Research Institute (Proposal nos. 2012B1098 and 2014A6953).	Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Stubbs KA, 2007, J BIOL CHEM, V282, P21382, DOI 10.1074/jbc.M700084200; BEER D, 1990, HELV CHIM ACTA, V73, P1918, DOI 10.1002/hlca.19900730714; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; HENDRICKSON WA, 1990, EMBO J, V9, P1665; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Davies GJ, 1997, BIOCHEM J, V321, P557; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cheng QM, 2000, J BACTERIOL, V182, P4836, DOI 10.1128/JB.182.17.4836-4840.2000; Choi KH, 2009, J BIOSCI BIOENG, V108, P455, DOI 10.1016/j.jbiosc.2009.06.003; DeLano WL., 2002, PYMOL MOL GRAPHIC SY; Mine S, 2014, FEBS J, V281, P2584, DOI 10.1111/febs.12805; Mondon M, 2013, CHEM COMMUN, V49, P10983, DOI 10.1039/c3cc46646a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	NOV	2014	281	22					5092	5103		10.1111/febs.13049		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT2WW	WOS:000344795900011		
J	Ushijima, Y; Ohniwa, RL; Maruyama, A; Saito, S; Tanaka, Y; Morikawa, K				Ushijima, Yuri; Ohniwa, Ryosuke L.; Maruyama, Atsushi; Saito, Shinji; Tanaka, Yoshikazu; Morikawa, Kazuya			Nucleoid compaction by MrgA(Asp56Ala/Glu60Ala) does not contribute to staphylococcal cell survival against oxidative stress and phagocytic killing by macrophages	FEMS MICROBIOLOGY LETTERS			English	Article						Staphylococcus aureus; MrgA; nucleoid; oxidative stress; Dps	DNA PROTECTION; AUREUS; MICROSCOPY; FERRITINS; DAMAGE; DPS	Staphylococcus aureus MrgA (encoded by mrgA) belongs to the Dps family of proteins, which play important roles in coping with various stresses. The staphylococcal mrgA gene is specifically expressed under oxidative stress conditions and is one of the most highly induced genes during phagocytic killing by macrophages. We previously reported that mrgA is essential for oxidative stress resistance, and can cause nucleoid compaction. However, whether nucleoid compaction by itself would contribute to oxidative stress resistance was hard to determine, because Dps family proteins generally have ferroxidase activity to prevent hydroxyl radical formation via the Fenton reaction. In this study, we resolved the crystal structure of MrgA and conducted mutation analysis of Asp56 and Glu60, which are located at the expected ferroxidase centre. In the strain expressing Asp56Ala/Glu60Ala MrgA (termed MrgA*), MrgA* retained dodecamer formation and nucleoid compaction ability. By contrast, the ferroxidase activity of MrgA* decreased by about half. Viability of the mrgA* strain was as low as the mrgA null mutant in oxidative stress and phagocytic killing assays. These results suggest that nucleoid compaction by itself is insufficient for oxidative stress resistance, and Asp56 and Glu60 constitute essential molecular sites in MrgA for oxidative stress resistance and survival against phagocytic killing.	[Ushijima, Yuri] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Ohniwa, Ryosuke L.; Maruyama, Atsushi; Saito, Shinji; Morikawa, Kazuya] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Maruyama, Atsushi] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan; [Tanaka, Yoshikazu] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan	Morikawa, K (reprint author), Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan.	morikawa.kazuya.ga@u.tsukuba.ac.jp			Ichiro Kanehara Foundation [09KI202]; Program to Disseminate Tenure Tracking System, MEXT, Japan	We thank Mr Calros Neves Takashi Ohmura for his experimental help. This work was supported by The Ichiro Kanehara Foundation 09KI202 (K. M.), and by Program to Disseminate Tenure Tracking System, MEXT, Japan (http://ttweb.sec.tsukuba.ac.jp/e_aisatsu.html; RLO).	Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; ROBINOW C, 1994, MICROBIOL REV, V58, P211; Rimsky S, 2011, CURR OPIN MICROBIOL, V14, P136, DOI 10.1016/j.mib.2011.01.003; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Crichton RR, 2010, BBA-GEN SUBJECTS, V1800, P706, DOI 10.1016/j.bbagen.2010.03.019; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; Wolf SG, 1999, NATURE, V400, P83; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; LEVI S, 1988, J BIOL CHEM, V263, P18086; Arnold AR, 2013, J AM CHEM SOC, V135, P15726, DOI 10.1021/ja408760w; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ingmer H, 2010, BACTERIAL CHROMATIN, P175, DOI 10.1007/978-90-481-3473-1_9; Jeong KC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-181; Maruyama A, 2003, MICROBIOL-SGM, V149, P389, DOI 10.1099/mic.0.25796-0; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; Ohniwa RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072954; Ohniwa RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019172; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Tsai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-13; Yoshimura SH, 2003, J ELECTRON MICROSC, V52, P415, DOI 10.1093/jmicro/52.4.415	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0378-1097	1574-6968		FEMS MICROBIOL LETT	FEMS Microbiol. Lett.	NOV	2014	360	2					144	151		10.1111/1574-6968.12598		8	Microbiology	Microbiology	AU2OG	WOS:000345457200009		
J	Oshiro, S; Takagi, H				Oshiro, Satoshi; Takagi, Hiroshi			The transcriptional activator Pog1 controls cell cycle, and its phosphorylated form is downregulated by the ubiquitin ligase Dma2 in Saccharomyces cerevisiae	FEMS YEAST RESEARCH			English	Article						Saccharomyces cerevisiae; transcriptional activator Pog1; ubiquitin ligase Dma2; phosphorylation; ubiquitination; cell cycle	DEPENDENT KINASE; YEAST; DEGRADATION; PROTEINS; GENE	The POG1 gene in Saccharomyces cerevisiae is suggested to encode the transcriptional activator that promotes growth in the presence of a mating pheromone. We previously showed that the overexpression of POG1 conferred tolerance to high concentrations of LiCl and sugar on laboratory and baker's yeast strains, respectively. Here, the overexpression of POG1 was shown to induce cell cycle delay at the G1 phase and morphological abnormality. In addition, by yeast two-hybrid screening, the really interesting new gene (RING)-type ubiquitin ligase Dma2, which is involved in cell cycle regulation, was identified as the protein interacting with Pog1. The gene mutation and deletion analysis revealed that the interaction between Pog1 and Dma2 requires the phosphorylation of Thr253 in Pog1 and the forkhead-associated domain in Dma2. The phosphorylation status of Pog1 changed along with progression of the cell cycle. Interestingly, our results showed that Pog1 might be ubiquitinated by Dma2, but a dephosphorylation-mimic mutation in POG1 increased the cellular Pog1 level possibly due to the failure of ubiquitination. Furthermore, growth of the dma1/2-disrupted strain was greatly inhibited by the overexpression of POG1. These results suggest that Pog1 controls the cell cycle and its phosphorylated form is downregulated by Dma2.	[Oshiro, Satoshi; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	Takagi, H (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	hiro@bs.naist.jp			Global COE Program in Nara Institute of Science and Technology from the Ministry of Education, Science, Culture, Sports and Technology of Japan; Public Foundation of Elizabeth Arnold-Fuji	We thank Y. Fukao and M. Kurata (Nara Institute of Science and Technology) for analyzing the phosphorylation sites of Pog1. We also thank J. Nikawa (Kyushu Institute of Technology), M. Kitabatake (Kyoto Univeristy), and T. Kishi (Institute of Physical and Chemical Research) for providing plasmids pAD4, pMyc-UBi/323, and two-hybrid assay plasmids (pGilda, pSH18-34, and pJG4-5-cDNA), respectively. The helpful comments of M. Kitajima, T. Sasaki, D. Watanabe, I. Ohtsu, and N. Yoshida of our laboratory are greatly appreciated. This work was also supported in part by Global COE Program in Nara Institute of Science and Technology (Frontier Bio-sciences: strategies for survival and adaptation in a changing global environment) from the Ministry of Education, Science, Culture, Sports and Technology of Japan and the Public Foundation of Elizabeth Arnold-Fuji to H.T.	Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Kishi T, 2007, P NATL ACAD SCI USA, V104, P17418, DOI 10.1073/pnas.0704951104; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Hoshikawa C, 2003, P NATL ACAD SCI USA, V100, P11505, DOI 10.1073/pnas.1933153100; Fujii K, 2012, EMBO J, V31, P2579, DOI 10.1038/emboj.2012.85; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Brooks L, 2008, CELL MOL LIFE SCI, V65, P3458, DOI 10.1007/s00018-008-8220-1; Cassani C, 2013, CELL CYCLE, V12, P2794, DOI 10.4161/cc.25869; Demae M, 2007, FEMS MICROBIOL LETT, V277, P70, DOI 10.1111/j.1574-6968.2007.00947.x; Kishi T, 2008, P NATL ACAD SCI USA, V105, P14497, DOI 10.1073/pnas.0806253105; Leza MA, 1999, GENETICS, V151, P531; Merlini L, 2012, PLOS GENET, V8, P531, DOI 10.1371/journal.pgen.1002670; Nishizawa M, 1999, J BIOL CHEM, V274, P33859, DOI 10.1074/jbc.274.48.33859; Rspelli E, 2011, MOL BIOL CELL, V22, P2185; Sambrook J, 2001, MOL CLONING LAB MANU; Sasano Y, 2013, INT J FOOD MICROBIOL, V165, P241, DOI 10.1016/j.ijfoodmicro.2013.05.015; vansWerven FJ, 2012, CELL, V150, P1170	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1567-1356	1567-1364		FEMS YEAST RES	FEMS Yeast Res.	NOV	2014	14	7					1015	1027		10.1111/1567-1364.12190		13	Biotechnology & Applied Microbiology; Microbiology; Mycology	Biotechnology & Applied Microbiology; Microbiology; Mycology	AT4OF	WOS:000344918500003		
J	Yoritsune, K; Higuchi, Y; Matsuzawa, T; Takegawa, K				Yoritsune, Ken-ichi; Higuchi, Yujiro; Matsuzawa, Tomohiko; Takegawa, Kaoru			Functional analysis of putative phosphoenolpyruvate transporters localized to the Golgi apparatus in Schizosaccharomyces pombe	FEMS YEAST RESEARCH			English	Article						Golgi apparatus; N-glycan; oligosaccharide; phosphoenolpyruvate; Schizosaccharomyces pombe; transporter	FISSION YEAST; GALACTOSE; OLIGOSACCHARIDES; FLOCCULATION; GLYCANS; GROWTH; GENES	The cell surface of Schizosaccharomyces pombe is negatively charged due to the presence of pyruvylated oligosaccharides, which is important for cell-cell recognition. However, the mechanism of pyruvate supply to oligosaccharides is not clearly understood. Here, we analyzed three putative phosphoenolpyruvate (PEP) transporter genes (pet1(+), pet2(+), and pet3(+)) in S.pombe, identified by sequence homology search against the Arabidopsis thaliana PEP transporter AtPPT1. Schizosaccharomyces pombe strain carrying a disruption in pet1(+) (pet1) or in pet2(+) (pet2), but not the strain carrying a disruption in pet3(+) (pet3), showed reduced pyruvate level on the cell surface. This reduction in pyruvate level was restored to the control level by expressing green fluorescent protein (GFP)-tagged Pet1p and Pet2p in respective disruptants. Fluorescence microscope studies revealed that GFP-tagged Pet1p and Pet2p were localized to the Golgi apparatus. Although expression of neither AtPPT1 nor AtPPT2 suppressed the pet1 phenotype, that of chimeric constructs, where the N-terminal regions of AtPPT1 and AtPPT2 were replaced by the N-terminal region of Pet1p, partially suppressed the pet1 phenotype. Furthermore, the reduction in cell surface negative charge in pet1 cells was restored by incubating these cells with recombinant Pvg1p and PEP. Thus, Pet1p and Pet2p are likely involved in transporting PEP from the cytoplasm into the Golgi.	[Yoritsune, Ken-ichi; Higuchi, Yujiro; Matsuzawa, Tomohiko; Takegawa, Kaoru] Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Fukuoka 8128581, Japan	Takegawa, K (reprint author), Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	takegawa@agr.kyushu-u.ac.jp			Ministry of Education, Science, and Culture of Japan	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (K.T.). The authors declare that they have no conflict of interest.	Alfa C, 1993, EXPT FISSION YEAST; Andreishcheva EN, 2004, J BIOL CHEM, V279, P35644, DOI 10.1074/jbc.M403574200; Parolis LAS, 1996, CARBOHYD RES, V293, P101, DOI 10.1016/0008-6215(96)00190-5; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Knappe S, 2003, PLANT J, V36, P411, DOI 10.1046/j.1365-313X.2003.01888.x; Matsuzawa T, 2011, MOL MICROBIOL, V82, P1531, DOI 10.1111/j.1365-2958.2011.07908.x; Fischer K, 1997, PLANT CELL, V9, P453, DOI 10.1105/tpc.9.3.453; Odani T, 1997, FEBS LETT, V420, P186, DOI 10.1016/S0014-5793(97)01513-5; Gemmill TR, 1998, GLYCOBIOLOGY, V8, P1087, DOI 10.1093/glycob/8.11.1087; Gemmill TR, 1996, J BIOL CHEM, V271, P25945; Matsuzawa T, 2012, EUKARYOT CELL, V11, P151, DOI 10.1128/EC.05276-11; Mukai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P82, DOI 10.1271/bbb.100571; Nakase M, 2010, J CELL SCI, V123, P1578, DOI 10.1242/jcs.059139; SPILLMANN D, 1993, J BIOL CHEM, V268, P13378; Tabuchi M, 1997, BIOCHEM BIOPH RES CO, V232, P121, DOI 10.1006/bbrc.1997.6239; Tanaka N, 2001, TRENDS GLYCOSCI GLYC, V13, P519; Yoritsune K, 2013, FEBS LETT, V587, P917, DOI 10.1016/j.febslet.2013.02.016	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1567-1356	1567-1364		FEMS YEAST RES	FEMS Yeast Res.	NOV	2014	14	7					1101	1109		10.1111/1567-1364.12207		9	Biotechnology & Applied Microbiology; Microbiology; Mycology	Biotechnology & Applied Microbiology; Microbiology; Mycology	AT4OF	WOS:000344918500011		
J	Nagayoshi, Y; Miyazaki, T; Minematsu, A; Yamauchi, S; Takazono, T; Nakamura, S; Imamura, Y; Izumikawa, K; Kakeya, H; Yanagihara, K; Kohno, S				Nagayoshi, Yohsuke; Miyazaki, Taiga; Minematsu, Asuka; Yamauchi, Shunsuke; Takazono, Takahiro; Nakamura, Shigeki; Imamura, Yoshifumi; Izumikawa, Koichi; Kakeya, Hiroshi; Yanagihara, Katsunori; Kohno, Shigeru			Contribution of the Slt2-regulated transcription factors to echinocandin tolerance in Candida glabrata	FEMS YEAST RESEARCH			English	Article						cell wall integrity; Swi4; Swi6; Swi4-Swi6 cell cycle box binding factor; Candida glabrata; echinocandin	INTEGRITY SIGNALING PATHWAY; CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; KINASE PATHWAY; CASPOFUNGIN; SLT2; CALCINEURIN; RESISTANCE; ALBICANS	Echinocandin-class antifungals, including micafungin, are considered as the first-line treatment for Candida glabrata infections. However, recent epidemiological surveys have revealed an increasing number of C.glabrata isolates exhibiting decreased echinocandin susceptibilities. The Slt2 mitogen-activated protein kinase pathway is important for maintenance of cell wall integrity in fungi. Rlm1 and Swi4-Swi6 cell cycle box binding factor (SBF) are transcription factors downstream of Slt2. While Slt2 and Rlm1 play important roles in response to cell wall stresses, such as micafungin exposure, little is known about SBF in C.glabrata. Here, we generated C.glabrata strains lacking or overexpressing SWI4 and SWI6 and evaluated their susceptibilities to micafungin. Micafungin tolerance considerably decreased in the swi4 strain, whereas it increased in the strains overexpressing SWI4. On the other hand, deletion of SWI6 slightly impaired micafungin tolerance, but overexpression of SWI6 had no effect. These results suggest that, although Swi4 and Swi6 form a protein complex, Swi4 is involved in micafungin tolerance more predominantly than Swi6 in C.glabrata. Furthermore, the overexpression of RLM1 induced increased micafungin tolerance in the wild-type background but not in the swi4 and swi6 strains, suggesting that Rlm1 and SBF function interdependently in response to micafungin exposure.	[Nagayoshi, Yohsuke; Miyazaki, Taiga; Minematsu, Asuka; Yamauchi, Shunsuke; Takazono, Takahiro; Nakamura, Shigeki; Imamura, Yoshifumi; Izumikawa, Koichi; Kakeya, Hiroshi; Kohno, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 8528501, Japan; [Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 8528501, Japan	Miyazaki, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	taiga-m@nagasaki-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [24791027, 21390305]; Ministry of Health, Labour and Welfare [H25-shinko-ip-pan-006]	We thank Hironobu Nakayama for providing C. glabrata strains 2001T and 2001HT and plasmids pCgACT and pCgACH and Brendan Cormack for providing pGRB2.2. This work was supported by the Grant-in-Aid for Scientific Research (no. 24791027 to TM and no. 21390305 to SK) from the Japanese Ministry of Education, Culture, Sports, Science and Technology and by a grant from the Ministry of Health, Labour and Welfare (H25-shinko-ip-pan-006 to TM and SK). The authors declare no financial or other conflict of interests relevant to the subject of this article.	Barchiesi F, 2005, ANTIMICROB AGENTS CH, V49, P4989, DOI 10.1128/AAC.49.12.4989-4992.2005; Kraus PR, 2003, MOL MICROBIOL, V48, P1377, DOI 10.1046/j.1365-2958.2003.03508.x; Clancy CJ, 2006, ANTIMICROB AGENTS CH, V50, P2569, DOI 10.1128/AAC.00291-06; Chandrasekar PH, 2006, CLIN INFECT DIS, V42, P1171, DOI 10.1086/501020; Cota JM, 2008, ANTIMICROB AGENTS CH, V52, P1144, DOI 10.1128/AAC.01542-07; Igual JC, 1996, EMBO J, V15, P5001; Cormack BP, 1999, GENETICS, V151, P979; Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Baetz K, 2001, MOL CELL BIOL, V21, P6515, DOI 10.1128/MCB.21.19.6515-6528.2001; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Miyazaki T, 2010, FEMS YEAST RES, V10, P343, DOI 10.1111/j.1567-1364.2010.00611.x; Bruno VM, 2006, PLOS PATHOG, V2, P204, DOI 10.1371/journal.ppat.0020021; Delgado-Silva Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086270; Espinel-Ingroff Ana, 2003, Revista Iberoamericana de Micologia, V20, P121; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Kim KY, 2010, YEAST, V27, P541, DOI 10.1002/yea.1782; Kitada K, 1996, GENE, V175, P105, DOI 10.1016/0378-1119(96)00132-1; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Miyazaki T, 2011, FEMS YEAST RES, V11, P621, DOI 10.1111/j.1567-1364.2011.00751.x	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1567-1356	1567-1364		FEMS YEAST RES	FEMS Yeast Res.	NOV	2014	14	7					1128	1131		10.1111/1567-1364.12204		4	Biotechnology & Applied Microbiology; Microbiology; Mycology	Biotechnology & Applied Microbiology; Microbiology; Mycology	AT4OF	WOS:000344918500015		
J	Limsuwanchote, S; Wungsintaweekul, J; Keawpradub, N; Putalun, W; Morimoto, S; Tanaka, H				Limsuwanchote, Supattra; Wungsintaweekul, Juraithip; Keawpradub, Niwat; Putalun, Waraporn; Morimoto, Satoshi; Tanaka, Hiroyuki			Development of indirect competitive ELISA for quantification of mitragynine in Kratom (Mitragyna speciosa (Roxb.) Korth.)	FORENSIC SCIENCE INTERNATIONAL			English	Article						Electrofusion; icELISA; Kratom; Mitragynine; Monoclonal antibody	LINKED-IMMUNOSORBENT-ASSAY; INDOLE ALKALOIDS; OPIOID RECEPTOR; MONOCLONAL-ANTIBODIES; MASS-SPECTROMETRY; MICE; IDENTIFICATION; PHARMACOLOGY; THAILAND; SERUM	Monoclonal antibody (MAb) against mitragynine (MG), an analgesic alkaloid from Kratom leaves (Mitragyna speciosa), was produced. MG was coupled to carrier proteins employing either 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS), a zero-length cross linker or a 5-carbon length glutaraldehyde cross linker. To confirm the immunogenicity, the hapten numbers were determined usingmatrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Preparation of the MAb was accomplished by the electrofusion method. Hybridoma 1A6 that was constructed from the fusion between splenocytes of EDC/NHS conjugate immunized mice and SP2/0-Ag14 myeloma cells was selected, cloned twice and expanded. The cross-reactivities (CRs) of this MAb 1A6 with a series of indole alkaloids were 30.54%, 24.83% and 8.63% for speciogynine, paynantheine and mitraciliatine, respectively. Using this MAb, an indirect competitive enzyme-linked immunosorbent assay (icELISA) was developed with a measurement range of 32.92-250 mg/mL. Quantitative analysis of the MG contents in plant samples by icELISA correlated well with the standard high performance liquid chromatography method (R-2 = 0.994). The MAb against mitragynine provided a tool for detection of MG in Kratom preparations. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Limsuwanchote, Supattra; Wungsintaweekul, Juraithip; Keawpradub, Niwat] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmacognosy & Pharmaceut Bot, Hat Yai 90112, Songkhla, Thailand; [Putalun, Waraporn] Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen 40002, Thailand; [Morimoto, Satoshi; Tanaka, Hiroyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacognosy, Fukuoka 8128582, Japan	Wungsintaweekul, J (reprint author), Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmacognosy & Pharmaceut Bot, Hat Yai 90112, Songkhla, Thailand.	juraithip.w@psu.ac.th			Royal Golden Jubilee Ph.D Program; Thailand Research Fund [PHD/0311/2550]; National Research Council of Thailand [PHA560010S]	This study was supported by the Royal Golden Jubilee Ph.D Program, the Thailand Research Fund (PHD/0311/2550) and the National Research Council of Thailand (PHA560010S). We thank to Associate Prof. Dr. Anuchit Plubrukarn for his advices on hapten synthesis and Associate Prof. Dr. Tripetch Kanajanaphoom for his kindness of providing mitraphylline, secoxyloganin, carbomethoxystrictosidine. We also thank Dr. Brian Hodgson for his assistance with the English.	Adkins JE, 2011, CURR TOP MED CHEM, V11, P1165; JANSEN KLR, 1988, J ETHNOPHARMACOL, V23, P115, DOI 10.1016/0378-8741(88)90121-3; PONGLUX D, 1994, PLANTA MED, V60, P580, DOI 10.1055/s-2006-959578; Philipp AA, 2009, J MASS SPECTROM, V44, P1249, DOI 10.1002/jms.1607; Kikura-Hanajiri R, 2009, FORENSIC TOXICOL, V27, P67, DOI 10.1007/s11419-009-0070-5; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; SUWANLERT S, 1975, B NARCOTICS, V27, P21; Takayama H, 2004, CHEM PHARM BULL, V52, P916, DOI 10.1248/cpb.52.916; Idayu NF, 2011, PHYTOMEDICINE, V18, P402, DOI 10.1016/j.phymed.2010.08.011; Philipp AA, 2011, ANAL BIOANAL CHEM, V400, P127, DOI 10.1007/s00216-010-4464-3; Watanabe K, 1997, LIFE SCI, V60, P933, DOI 10.1016/S0024-3205(97)00023-4; Thongpradichote S, 1998, LIFE SCI, V62, P1371, DOI 10.1016/S0024-3205(98)00075-7; de Moraes NV, 2009, J CHROMATOGR B, V877, P2593, DOI 10.1016/j.jchromb.2009.06.023; CIBOTTI MC, 1990, PHYTOCHEMISTRY, V29, P2109, DOI 10.1016/0031-9422(90)83016-T; Sheleg SV, 2011, J ADDICT MED, V5, P300, DOI 10.1097/ADM.0b013e318221fbfa; Matsumoto K, 1996, EUR J PHARMACOL, V317, P75, DOI 10.1016/S0014-2999(96)00714-5; McWhirter L, 2010, EUR ADDICT RES, V16, P229, DOI 10.1159/000320288; Grewal KS, 1932, J PHARMACOL EXP THER, V46, P251; WEILER EW, 1976, PHYTOCHEMISTRY, V15, P1537, DOI 10.1016/S0031-9422(00)88933-5; Parthasarathy S, 2009, MOLECULES, V14, P3964, DOI 10.3390/molecules14103964; SHOYAMA Y, 1993, ORG MASS SPECTROM, V28, P987, DOI 10.1002/oms.1210280910; ARENS H, 1978, PLANTA MED, V34, P37; Chan K B, 2005, Bull Narc, V57, P249; Chaudhry MQ, 2000, PRACT APPROACH SER, P165; Dewen T., 2007, AM J AGR BIO SCI, V2, P88; Erlanger B F, 1980, Methods Enzymol, V70, P85; GEFFARD M, 1985, J NEUROCHEM, V44, P1221, DOI 10.1111/j.1471-4159.1985.tb08747.x; HOUGHTON PJ, 1991, PHYTOCHEMISTRY, V30, P347, DOI 10.1016/0031-9422(91)84152-I; Janchawee B, 2007, BIOMED CHROMATOGR, V21, P176, DOI 10.1002/bmc.731; LI QX, 1991, J AGR FOOD CHEM, V39, P1537, DOI 10.1021/jf00008a034; Matsumoto K, 1996, LIFE SCI, V59, P1149, DOI 10.1016/0024-3205(96)00432-8; Shaik Mossadeq W M, 2009, Med Princ Pract, V18, P378, DOI 10.1159/000226292; Onishi K., 1987, J IMMUNOL METHODS, V100, P181; Schütz Harald, 2006, Forensic Sci Med Pathol, V2, P75, DOI 10.1385/FSMP:2:2:75; Szurdoki F., 1995, NEW FRONTIERS AGROCH, P39; Tsuchiya S, 2002, EUR J PHARMACOL, V443, P185, DOI 10.1016/S0014-2999(02)01588-1; Utar Z, 2011, J ETHNOPHARMACOL, V136, P75, DOI [10.1016/j.jep.2011.04.011, 10.1016/j.jep.2011.04.0011]; Wungsintaweekul J, 2012, BIOTECHNOL LETT, V34, P1945, DOI 10.1007/s10529-012-0968-6; Yang TB, 2006, J PINEAL RES, V40, P350, DOI 10.1111/j.1600-079X.2006.00314.x; Zhang HT, 2011, J ZHEJIANG UNIV-SC B, V12, P884, DOI 10.1631/jzus.B1100076	40	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	NOV	2014	244						70	77		10.1016/j.forsciint.2014.08.011		8	Medicine, Legal	Legal Medicine	AT5YY	WOS:000345017000023		
J	Takahashi, Y; Sano, R; Nakajima, T; Kominato, Y; Kubo, R; Takahashi, K; Ohshima, N; Hirano, T; Kobayashi, S; Shimada, T; Tokue, H; Awata, S; Hirasawa, S; Ishige, T				Takahashi, Yoichiro; Sano, Rie; Nakajima, Tamiko; Kominato, Yoshihiko; Kubo, Rieko; Takahashi, Keiko; Ohshima, Noriyasu; Hirano, Tohko; Kobayashi, Susumu; Shimada, Takehiro; Tokue, Hiroyuki; Awata, Sachiko; Hirasawa, Satoshi; Ishige, Takashi			Combination of postmortem mass spectrometry imaging and genetic analysis reveals very long-chain acyl-CoA dehydrogenase deficiency in a case of infant death with liver steatosis	FORENSIC SCIENCE INTERNATIONAL			English	Article						Sudden infant death; Liver steatosis; Fatty acid oxidation; Imaging mass spectrometry	ACID OXIDATION DISORDERS; UNEXPECTED DEATH; SUDDEN; AUTOPSY; DISEASE	Case history: A 3-month-old infant was found dead in his bed. A postmortem computed tomography (CT) scan suggested fatty attenuation in the liver parenchyma, but no other potentially fatal changes were found. To clarify the cause of death, a medicolegal autopsy was carried out. Autopsy findings: Internal examination confirmed the presence of liver steatosis as well as hepatomegaly. There were no other significant findings including encephalitis or brain edema. Mass spectrometry analysis: To clarify the mechanism underlying lipid accumulation in the liver, matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) analysis was conducted. This indicated a significant accumulation of C14:1 acylcarnitine in the liver of the deceased, suggesting very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. Genetic analysis: To find the cause of the VLCAD deficiency, genetic analysis of the responsible gene, acyl-CoA dehydrogenase, very long chain (ACADVL), was performed. This revealed two novel mutations that may have accounted for the disease. Conclusion: A combination of these data revealed that the liver steatosis in this case might have been caused by VLCAD deficiency based on geneticmutations of ACADVL. Thus, the deceased might have been vulnerable to energy crisis and sudden infant death. The present findings show that MALDI-IMS analysis as well as genetic analysis can be useful for elucidating the cause of death. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Takahashi, Yoichiro; Sano, Rie; Nakajima, Tamiko; Kominato, Yoshihiko; Kubo, Rieko; Takahashi, Keiko] Gunma Univ, Grad Sch Med, Dept Legal Med, Maebashi, Gumma 3718511, Japan; [Ohshima, Noriyasu] Gunma Univ, Grad Sch Med, Dept Biochem, Maebashi, Gumma 3718511, Japan; [Hirano, Tohko] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Lab Analyt Instruments, Maebashi, Gumma 3718511, Japan; [Kobayashi, Susumu; Shimada, Takehiro; Tokue, Hiroyuki; Awata, Sachiko; Hirasawa, Satoshi] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gumma 3718511, Japan; [Ishige, Takashi] Gunma Univ Hosp, Dept Pediat, Maebashi, Gumma 3718511, Japan	Kominato, Y (reprint author), Gunma Univ, Grad Sch Med, Dept Legal Med, Maebashi, Gumma 3718511, Japan.	kominato@gunma-u.ac.jp			Japan Society for the Promotion of Science [25460861, 25860486, 26293161]	This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (25460861 to T.N., 25860486 to Y.T., 26293161 to Y.K.).	Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; Schiff M, 2013, MOL GENET METAB, V109, P21, DOI 10.1016/j.ymgme.2013.02.002; Chace DH, 2001, CLIN CHEM, V47, P1166; Bean LJH, 2013, HUM MUTAT, V34, P1183, DOI 10.1002/humu.22364; Andresen BS, 1996, J INHERIT METAB DIS, V19, P169, DOI 10.1007/BF01799421; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Merritt JL, 2014, MOL GENET METAB, V111, P484, DOI 10.1016/j.ymgme.2014.01.009; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; BENNETT MJ, 1994, HUM PATHOL, V25, P742, DOI 10.1016/0046-8177(94)90241-0; Boles RG, 1998, J PEDIATR-US, V132, P924, DOI 10.1016/S0022-3476(98)70385-3; Ernst LM, 2006, J PEDIATR-US, V148, P779, DOI 10.1016/j.jpeds.2006.01.040; Lundemose J. B., 1997, Molecular Pathology, V50, P212, DOI 10.1136/mp.50.4.212; Sharef Sharef Waadallah, 2013, Oman Med J, V28, P354, DOI 10.5001/omj.2013.101; Wilcox RL, 2002, J PEDIATR-US, V141, P833, DOI 10.1067/mpd.2002.130259; Yamamoto T, 2011, MOL GENET METAB, V102, P399, DOI 10.1016/j.ymgme.2010.12.004	15	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	NOV	2014	244						E34	E37		10.1016/j.forsciint.2014.08.031		4	Medicine, Legal	Legal Medicine	AT5YY	WOS:000345017000007		
J	Goto, M; Shinmura, K; Matsushima, Y; Ishino, K; Yamada, H; Totsuka, Y; Matsuda, T; Nakagama, H; Sugimura, H				Goto, Masanori; Shinmura, Kazuya; Matsushima, Yoshitaka; Ishino, Kousuke; Yamada, Hidetaka; Totsuka, Yukari; Matsuda, Tomonari; Nakagama, Hitoshi; Sugimura, Haruhiko			Human DNA glycosylase enzyme TDG repairs thymine mispaired with exocyclic etheno-DNA adducts	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Lipid peroxidation; Etheno-DNA adducts; Base excision repair enzyme; TDG; 3N(4)-Ethenocytosine	BASE EXCISION-REPAIR; HIGHLY MUTAGENIC ADDUCT; HUMAN CELL-EXTRACTS; LIPID-PEROXIDATION; ESCHERICHIA-COLI; GASTRIC-CANCER; VINYL-CHLORIDE; SUBSTRATE-SPECIFICITY; MISMATCH REPAIR; MAMMALIAN DNA	Lipid peroxidation directly reacts with DNA and produces various exocyclic etheno-base DNA adducts, some of which are considered to contribute to carcinogenesis. However, the system for repairing them in humans is largely unknown. We hypothesized that etheno-DNA adducts are repaired by base excision repair initiated by DNA glycosylase. To test this hypothesis, we examined the activities of the DNA glycosylase proteins OGG1, SMUG1, TDG, NEIL1, MUTYH, NTH1, MPG, and UNG2 against double-stranded oligonucleotides containing 1,N-6-ethenoadenine (epsilon A), 3,N-4-ethenocytosine (epsilon C), butanone-ethenocytosine (B epsilon C), butanone-ethenoguanine (B epsilon G), heptanone-ethenocytosine (H epsilon C), or heptanone-ethenoguanine (H epsilon G) using a DNA cleavage assay. We found that TDG is capable of removing thymine that has mispaired with epsilon C, B epsilon C, B epsilon G, H epsilon C, or H epsilon G in vitro. We next examined the effect of TDG against etheno-DNA adducts in human cells. TDG-knockdown cells exhibited the following characteristics: (a) higher resistance to cell death caused by the induction of etheno-DNA adducts; (b) lower repair activity for epsilon C; and (c) a modest acceleration of mutations caused by epsilon C, compared with the rate in control cells. All these characteristics suggest that TDG exerts a repair activity against etheno-DNA adducts in human cells. These results suggest that TDG has novel repair activities toward etheno-DNA adducts. (C) 2014 Elsevier Inc. All rights reserved.	[Goto, Masanori; Ishino, Kousuke; Totsuka, Yukari; Nakagama, Hitoshi] Natl Canc Ctr, Div Canc Dev Syst, Chuo Ku, Tokyo 1040045, Japan; [Goto, Masanori; Shinmura, Kazuya; Yamada, Hidetaka; Sugimura, Haruhiko] Hamamatsu Univ, Sch Med, Dept Tumor Pathol, Higashi Ward, Hamamatsu, Shizuoka 4313192, Japan; [Matsushima, Yoshitaka] Hamamatsu Univ, Sch Med, Dept Chem, Higashi Ward, Hamamatsu, Shizuoka 4313192, Japan; [Ishino, Kousuke] Nippon Med Sch, Dept Pathol, Bunkyo Ku, Tokyo 1138602, Japan; [Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga 5200811, Japan	Shinmura, K (reprint author), Hamamatsu Univ, Sch Med, Dept Tumor Pathol, Higashi Ward, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kzshinmu@hama-med.ac.jp; hsugimur@hama-med.ac.jp	Shinmura, Kazuya /K-8940-2012	Shinmura, Kazuya /0000-0003-4963-746X	Ministry of Health, Labour, and Welfare [21-1]; Japan Society for the Promotion of Science [122790378, 25460476, 22659072, 24659161]; Ministry of Education, Culture, Sports, Science, and Technology [22659072, 20014007, 221S0001]; Japanese Ministry of Health [23120201, 10103838]; Takeda Science Foundation; Center of Innovation Program of JST, Japan; Hamamatsu Foundation for Science and Technology Promotion; U.S.-Japan Cooperative Medical Science Program; National Cancer Center Research and Development Fund; Smoking Research Foundation	This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour, and Welfare (21-1), from the Japan Society for the Promotion of Science 122790378, 25460476, 22659072, 24659161], from the Ministry of Education, Culture, Sports, Science, and Technology [20014007, 22659072, 221S0001], for Cancer Research from the Japanese Ministry of Health [23120201, 10103838], from the Takeda Science Foundation, from Center of Innovation Program of JST, Japan, from the Hamamatsu Foundation for Science and Technology Promotion, for the U.S.-Japan Cooperative Medical Science Program, National Cancer Center Research and Development Fund, and the Smoking Research Foundation.	Shinmura K, 2004, CARCINOGENESIS, V25, P2311, DOI 10.1093/carcin/bgh267; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Fu D, 2012, DNA REPAIR, V11, P46, DOI 10.1016/j.dnarep.2011.10.004; Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012; Pollack M, 2003, CHEM RES TOXICOL, V16, P893, DOI 10.1021/tx030009p; Fahrer J, 2013, CARCINOGENESIS, V34, P2435, DOI 10.1093/carcin/bgt275; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Turco E, 2013, NUCLEIC ACIDS RES, V41, P4093, DOI 10.1093/nar/gkt130; Li WQ, 2013, CARCINOGENESIS, V34, P1536, DOI 10.1093/carcin/bgt094; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; Kasai H, 2008, MUTAT RES-REV MUTAT, V659, P56, DOI 10.1016/j.mrrev.2008.02.003; Shinmura K, 1997, MUTAT RES-DNA REPAIR, V385, P75, DOI 10.1016/S0921-8777(97)00041-4; Wolfe AE, 2009, BIOCHEMISTRY-US, V48, P11357, DOI 10.1021/bi9015082; Gueraud F, 2010, FREE RADICAL RES, V44, P1098, DOI 10.3109/10715762.2010.498477; Matsuda T, 2013, CARCINOGENESIS, V34, P121, DOI 10.1093/carcin/bgs327; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Lari SU, 2002, BIOCHEMISTRY-US, V41, P9248, DOI 10.1021/bi020239n; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Chou PH, 2010, CHEM RES TOXICOL, V23, P1442, DOI 10.1021/tx100047d; Goto M, 2010, HUM MUTAT, V31, pE1861, DOI 10.1002/humu.21363; Schmutte C, 1997, CANCER RES, V57, P3010; An Q, 2007, CANCER RES, V67, P940, DOI 10.1158/0008-5772.CAN-06-2960; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Lv LN, 2013, NUCLEIC ACIDS RES, V41, P10312, DOI 10.1093/nar/gkt793; Goto M, 2009, CARCINOGENESIS, V30, P1345, DOI 10.1093/carcin/bgp108; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Maciejewska AM, 2010, MUTAT RES-FUND MOL M, V684, P24, DOI 10.1016/j.mrfmmm.2009.11.005; Boffetta P, 2003, SCAND J WORK ENV HEA, V29, P220; Maekawa M, 2006, CHEM RES TOXICOL, V19, P130, DOI 10.1021/tx050236m; Barbin A, 1998, ACTA BIOCHIM POL, V45, P145; Bartsch H, 2000, TOXICOLOGY, V153, P105, DOI 10.1016/S0300-483X(00)00307-3; BASU AK, 1993, BIOCHEMISTRY-US, V32, P12793, DOI 10.1021/bi00210a031; BASU AK, 1987, BIOCHEMISTRY-US, V26, P5626, DOI 10.1021/bi00392a007; FOILES PG, 1993, CARCINOGENESIS, V14, P113, DOI 10.1093/carcin/14.1.113; Gros L, 2003, MUTAT RES-FUND MOL M, V531, P219, DOI 10.1016/j.mrfmmm.2003.07.008; Johnson KA, 1999, J BIOL CHEM, V274, P27112, DOI 10.1074/jbc.274.38.27112; Kato T, 2013, NANOTOXICOLOGY, V7, P452, DOI 10.3109/17435390.2012.674571; Kawai K, 2006, MUTAT RES-GEN TOX EN, V603, P186, DOI 10.1016/j.mrgentox.2005.11.012; Kim EJ, 2008, BIOCHEM BIOPH RES CO, V377, P838, DOI 10.1016/j.bbrc.2008.10.058; Kim MY, 2007, CHEM RES TOXICOL, V20, P1075, DOI 10.1021/tx700167v; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Lari SU, 2001, NUCLEIC ACIDS RES, V29, P2409, DOI 10.1093/nar/29.11.2409; Lee SH, 2007, CHEM RES TOXICOL, V20, P1665, DOI 10.1021/tx700130p; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Molatore S, 2010, HUM MUTAT, V31, P159, DOI 10.1002/humu.21158; MORIYA M, 1994, P NATL ACAD SCI USA, V91, P11899, DOI 10.1073/pnas.91.25.11899; Pollack M, 2006, CHEM RES TOXICOL, V19, P1074, DOI 10.1021/tx0600503; Raboisson P, 2002, J MED CHEM, V45, P962, DOI 10.1021/jm0104062; Rentel C, 2005, J ORG CHEM, V70, P7841, DOI 10.1021/jo050767f; Roberts DW, 2001, ANAL CHEM, V73, P303, DOI 10.1021/ac000866n; Ruczinski I, 2012, CARCINOGENESIS, V33, P1692, DOI 10.1093/carcin/bgs170; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; Shibata T, 2011, J BIOL CHEM, V286, P19943, DOI 10.1074/jbc.M110.187047; Shinmura K, 2011, J PATHOL, V225, P414, DOI 10.1002/path.2953; Speina E, 2003, CANCER RES, V63, P4351; Speina E, 2001, J BIOL CHEM, V276, P21821, DOI 10.1074/jbc.M100998200; Talhaoui I, 2013, NUCLEIC ACIDS RES, V41, P912, DOI 10.1093/nar/gks1149; Ward E, 2001, EPIDEMIOLOGY, V12, P710, DOI 10.1097/00001648-200111000-00021; Yamane A, 2003, CARCINOGENESIS, V24, P1031, DOI 10.1093/carcin/bgg056	64	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	NOV	2014	76						136	146		10.1016/j.freeradbiomed.2014.07.044		11	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	AT9NW	WOS:000345254800015		
J	Ayris, PM; Delmelle, P; Cimarelli, C; Maters, EC; Suzuki, YJ; Dingwell, DB				Ayris, Paul M.; Delmelle, Pierre; Cimarelli, Corrado; Maters, Elena C.; Suzuki, Yujiro J.; Dingwell, Donald B.			HCl uptake by volcanic ash in the high temperature eruption plume: Mechanistic insights	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article							SILICATE-GLASSES; ALUMINOSILICATE GLASSES; STRATOSPHERIC CHLORINE; FALL DEPOSITS; SURFACE; TEPHRA; WATER; GEOCHEMISTRY; INJECTION; CORROSION	The injection of HCl into the stratosphere by large volcanic eruptions has long been considered to be of minor importance. This is due to the widespread assumption that any HCl will be efficiently taken up by hydrometeors in the cooling plume. However, this assumption does not account for the possibility that prior scavenging processes can act within the high temperature core of the eruption plume. The adsorption of HCl onto ash surfaces to form soluble -Cl salts is a hitherto unconstrained scavenging mechanism, and their fate within the atmosphere and environment is uncertain. Here, we investigate the capacity of volcanic glasses of tephrite, phonolite, dacite and rhyolite composition to adsorb HCl. The experiments are conducted in the presence of He-SO2-CO2 mixtures at temperatures of 200-800 degrees C. Our experimental findings show that only the tephrite and phonolite glasses exhibit significant reactivity to HCl, which show optimal efficiency of uptake at 400600 degrees C. The primary reaction product formed during adsorption is halite (NaCl), in addition to minor quantities of Ca-, K-, Al- and Fe-bearing chlorides. Uptake of HCl by glass surfaces is sustained by the outward diffusion of Na+ and other Cl- reactive cations via exchange with H+. Simple mathematical models can be used to yield Na diffusion coefficients for the four experimental glasses, and suggest that a varying structural role for Na within the glass network governs the capacity for HCl retention. The uptake of HCl under experimental conditions is limited above 500 degrees C by a Cl-induced dehydroxylation process, but the presence of H2O in the hydrous plume may sustain or even enhance adsorption. The present experimental data, combined with cooling gradients obtained from established plume evolution models, lead us to conclude that HCl adsorption within the eruption plume core can be a more significant scavenging mechanism in large explosive eruptions than previously considered. We additionally highlight the importance of magma composition in dictating volatile adsorption, and suggest that HCl adsorption by peralkaline ash may be highly effective as an HCl sink. The fate of adsorbed HCl is variable; some may be removed from the plume within pyroclastic flows, whereas any chloride-coated ash ejected into the stratosphere could promote the formation of reactive Cl species. Our study also suggests that HCl adsorption could emplace Fe-and Cl-bearing salts on ash surfaces within the plume cores of large explosive eruptions. The ocean fertilising potential of such eruptions could therefore be greater than that inferred from ash from smaller, compositionally similar events. (C) 2014 Elsevier Ltd. All rights reserved.	[Ayris, Paul M.; Delmelle, Pierre; Maters, Elena C.] Catholic Univ Louvain, Earth & Life Inst, Louvain La Neuve, Belgium; [Ayris, Paul M.; Cimarelli, Corrado; Dingwell, Donald B.] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Suzuki, Yujiro J.] Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan	Ayris, PM (reprint author), Sect Mineral Petr & Geochem, Dept Earth & Environm Sci, Theresienstr 41, D-80333 Munich, Bayern, Germany.	paul.ayris@min.uni-muenchen.de			FNRS (MIS-Ulysse Grant) [326.F.6001.11]; AXA; ERI Cooperative Research Program; JPSP KAKENHI [25750142, 24244069]; ERC [247076]	P.A. was funded by an FNRS (MIS-Ulysse Grant 326.F.6001.11) Grant with P. D. and E. M. P. A., C. C. and D. D. were supported by AXA Research Grant "Risk from volcanic ash in the Earth system". Y.J.S. was funded by the ERI Cooperative Research Program and JPSP KAKENHI Grant Numbers 25750142, 24244069. The numerical simulations were performed by the Earth Simulator at ESC of JAMSTEC and the PRIMERGY CX400 at RI2T of Kyushu University. D. D. acknowledges the support of ERC Advanced Investigator Grant No. 247076 (EVOKES). We thank Anne Iseterentent and Claudine Givon for their analytical expertise and diligence at LLN. We are indebted to Mike Ward at the LEMAS facility in Leeds for providing access to TEM facilities, and for his input in interpreting the data. We benefitted from the generosity of Piergiorgio Scarlato in permitting access to SEM facilities at INGV Rome, and of David Damby, who analysed additional samples by SEM at University of Durham. We gratefully acknowledge the IAVCEI Tephra Commission for providing access to particle size distribution data. We thank Michel Rossi and Felix Von Aulock for thought-provoking discussion and careful review of the manuscript. We are grateful to two named reviewers, Thomas Giachetti and Morgan Jones, for their constructive comments, and to Lawrence Anovitz for his efforts as assigned editor. This work was inspired by preliminary experiments conducted by S. Shutkevar, an undergraduate student under supervision of P. A. and P. D. at University of York, while P. D. benefited from a Vice-Chancellor University Anniversary Lectureship.	AHMED AA, 1980, J NON-CRYST SOLIDS, V41, P57, DOI 10.1016/0022-3093(80)90191-X; Achterberg EP, 2013, GEOPHYS RES LETT, V40, P921, DOI 10.1002/grl.50221; Rose WI, 2009, J VOLCANOL GEOTH RES, V186, P32, DOI 10.1016/j.jvolgeores.2009.01.010; Roberts JM, 2008, SCIENCE, V321, P1059, DOI 10.1126/science.1158777; Lee KH, 1998, MICROPOR MESOPOR MAT, V23, P211, DOI 10.1016/S1387-1811(98)00118-8; Hamme RC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044629; Hamilton JP, 1997, J NON-CRYST SOLIDS, V222, P167, DOI 10.1016/S0022-3093(97)90110-1; Van Eaton AR, 2012, B VOLCANOL, V74, P1963, DOI 10.1007/s00445-012-0634-9; Ayris PM, 2012, B VOLCANOL, V74, P1905, DOI 10.1007/s00445-012-0654-5; McGrail BP, 2001, J NON-CRYST SOLIDS, V296, P10, DOI 10.1016/S0022-3093(01)00890-0; Langmann B, 2010, ATMOS CHEM PHYS, V10, P3891; Ruggieri F, 2011, ENVIRON CHEM, V8, P236, DOI 10.1071/EN10097; VAREKAMP JC, 1984, J VOLCANOL GEOTH RES, V23, P39, DOI 10.1016/0377-0273(84)90056-8; DelMelle P, 2007, EARTH PLANET SC LETT, V259, P159, DOI 10.1016/j.epsl.2007.04.052; Cronin SJ, 2003, J VOLCANOL GEOTH RES, V121, P271, DOI 10.1016/S0377-0273(02)00465-1; Suzuki YJ, 2012, J VOLCANOL GEOTH RES, V221, P1, DOI 10.1016/j.jvolgeores.2012.01.013; ROSE WI, 1977, GEOLOGY, V5, P621, DOI 10.1130/0091-7613(1977)5<621:SOVABA>2.0.CO;2; Mekki A, 1996, J NON-CRYST SOLIDS, V208, P267, DOI 10.1016/S0022-3093(96)00523-6; Ayris PM, 2013, GEOCHIM COSMOCHIM AC, V110, P58, DOI 10.1016/j.gca.2013.02.018; TABAZADEH A, 1993, SCIENCE, V260, P1082, DOI 10.1126/science.260.5111.1082; Olgun N, 2013, MAR ECOL PROG SER, V488, P81, DOI 10.3354/meps10403; Jones MT, 2008, GEOCHIM COSMOCHIM AC, V72, P3661, DOI 10.1016/j.gca.2008.05.030; BUNKER BC, 1994, J NON-CRYST SOLIDS, V179, P300, DOI 10.1016/0022-3093(94)90708-0; de Hoog JCM, 2001, J VOLCANOL GEOTH RES, V108, P55, DOI 10.1016/S0377-0273(00)00278-X; Frogner P, 2001, GEOLOGY, V29, P487, DOI 10.1130/0091-7613(2001)029<0487:FPOVAI>2.0.CO;2; Textor C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002987; Rossi MJ, 2003, CHEM REV, V103, P4823, DOI 10.1021/cr020507n; GILBERT JS, 1994, B VOLCANOL, V56, P398, DOI 10.1007/BF00326465; Mastin LG, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001455; Anthony EJ, 2003, ENERG FUEL, V17, P363, DOI 10.1021/ef020124s; CAREY S, 1989, B VOLCANOL, V51, P28, DOI 10.1007/BF01086759; STOLARSK.RS, 1974, CAN J CHEM, V52, P1610, DOI 10.1139/v74-233; Crank J., 1979, MATH DIFFUSION; Cruguel H, 2003, J ELECTRON SPECTROSC, V128, P271, DOI 10.1016/S0368-2048(02)00304-3; CRUTZEN P J, 1974, Ambio, V3, P201; Damby DE, 2013, J VOLCANOL GEOTH RES, V261, P376, DOI 10.1016/j.jvolgeores.2012.09.001; Durant AJ, 2012, PHYS CHEM EARTH, V45-46, P50, DOI 10.1016/j.pce.2011.09.004; Ehlmer T. H., 1981, J AM CERAM SOC, V64, P150; ELMER TH, 1963, J PHYS CHEM-US, V67, P2219, DOI 10.1021/j100804a059; Heiken G., 1974, ATLAS VOLCANIC ASH, P101; Koenderink GH, 2000, J NON-CRYST SOLIDS, V262, P80, DOI 10.1016/S0022-3093(99)00704-8; Kojima G, 2001, J NON-CRYST SOLIDS, V292, P50, DOI 10.1016/S0022-3093(01)00861-4; Lee Joseph, 2012, Frontiers of Chemical Science and Engineering, V6, DOI 10.1007/s11705-011-1162-4; Lowenstern JB, 2012, B VOLCANOL, V74, P2303, DOI 10.1007/s00445-012-0663-4; Molina M. J., 1974, NATURE, V249, P811; NEWHALL CG, 1982, J GEOPHYS RES-OC ATM, V87, P1231, DOI 10.1029/JC087iC02p01231; Pyle DM, 2000, ENCY VOLCANOES, P263; Risacher F, 2001, J VOLCANOL GEOTH RES, V109, P319, DOI 10.1016/S0377-0273(01)00198-6; Rose W., 1973, B VOLCANOL, V37, P338, DOI DOI 10.1007/BF02597633; ROSE WI, 1978, J VOLCANOL GEOTH RES, V4, P3, DOI 10.1016/0377-0273(78)90027-6; Rose WI, 2008, B VOLCANOL, V70, P1043, DOI 10.1007/s00445-007-0187-5; Schultz-Munzenberg C, 1998, J NON-CRYST SOLIDS, V238, P83, DOI 10.1016/S0022-3093(98)00580-8; Self S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020925; skarsson O N, 1980, J VOLCANOL GEOTH RES, V8, P251; SMITH DB, 1982, J VOLCANOL GEOTH RES, V13, P1, DOI 10.1016/0377-0273(82)90017-8; Sparks R.S.J., 1997, VOLCANIC PLUMES, P574; SPRENGER D, 1990, J NON-CRYST SOLIDS, V126, P111, DOI 10.1016/0022-3093(90)91029-Q; Sung H. J., 2008, ENVIRON SCI TECHNOL, V43, P47; Suzuki YJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003460; TAYLOR PS, 1973, GEOL SOC AM BULL, V84, P1031, DOI 10.1130/0016-7606(1973)84<1031:SMOAFA>2.0.CO;2	60	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-7037	1872-9533		GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	NOV 1	2014	144						188	201		10.1016/j.gca.2014.08.028		14	Geochemistry & Geophysics	Geochemistry & Geophysics	AT4XM	WOS:000344945600012		
J	Joswiak, DJ; Nakashima, D; Brownlee, DE; Matrajt, G; Ushikubo, T; Kita, NT; Messenger, S; Ito, M				Joswiak, D. J.; Nakashima, D.; Brownlee, D. E.; Matrajt, G.; Ushikubo, T.; Kita, N. T.; Messenger, S.; Ito, M.			Terminal particle from Stardust track 130: Probable Al-rich chondrule fragment from comet Wild 2	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article							UNEQUILIBRATED ORDINARY CHONDRITES; INTERPLANETARY DUST PARTICLES; MICROCHONDRULE-BEARING CLAST; OXYGEN-ISOTOPE SYSTEMATICS; CH CARBONACEOUS CHONDRITES; EARLY SOLAR-SYSTEM; FERROMAGNESIAN CHONDRULES; AL-26-MG-26 SYSTEMATICS; ION MICROPROBE; FEO-RICH	A 4 x 6 mu m terminal particle from Stardust track 130, named Bidi, is composed of a refractory assemblage of Fo(97) olivine, Al- and Ti-bearing clinopyroxene and anorthite feldspar (An(97)). Mineralogically, Bidi resembles a number of components found in primitive chondritic meteorites including Al-rich chondrules, plagioclase-bearing type I ferromagnesian chondrules and amoeboid olivine aggregates (AOAs). Measured widths of augite/pigeonite lamellae in the clinopyroxene indicate fast cooling rates suggesting that Bidi is more likely to be a chondrule fragment than an AOA. Bulk element concentrations, including an Al2O3 content of 10.2 wt%, further suggests that Bidi is more akin to Al-rich rather than ferromagnesian chondrules. This is supported by high anorthite content of the plagioclase feldspar, overall bulk composition and petrogenetic analysis using a cosmochemical Al2O3-Ca2SiO4-Mg2SiO4 phase diagram. Measured minor element abundances of individual minerals in Bidi generally support an Al-rich chondrule origin but are not definitive between any of the object types. Oxygen isotope ratios obtained from olivine (+minor high-Ca pyroxene) fall between the TF and CCAM lines and overlap similar minerals from chondrules in primitive chondrites but are generally distinct from pristine AOA minerals. Oxygen isotope ratios are similar to some minerals from both Al-rich and type I ferromagnesian chondrules in unequilibrated carbonaceous, enstatite and ordinary chondrites. Although no single piece of evidence uniquely identifies Bidi as a particular object type, the preponderance of data, including mineral assemblage, bulk composition, mineral chemistry, inferred cooling rates and oxygen isotope ratios, suggest that Bidi is more closely matched to Al-rich chondrules than AOAs or plagioclase-bearing type I ferromagnesian chondrules and likely originated in a chondrule-forming region in the inner solar system. (C) 2014 Elsevier Ltd. All rights reserved.	[Joswiak, D. J.; Brownlee, D. E.; Matrajt, G.] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Nakashima, D.; Ushikubo, T.; Kita, N. T.] Tohoku Univ, Grad Sch Sci, Div Earth & Planetary Mat Sci, Lab Early Solar Syst Evolut, Sendai, Miyagi 9808578, Japan; [Messenger, S.] ARES, Johnson Space Ctr, Robert M Walker Lab Space Sci, Houston, TX 77058 USA; [Ito, M.] JAMSTEC, Kochi Inst Core Sample Res, Nankoku Ku, Kochi 7838502, Japan	Joswiak, DJ (reprint author), Univ Washington, Dept Astron, Seattle, WA 98195 USA.	joswiak@astro.washington.edu			NASA [NNX10AI89GS01, NNX09AC30G]; NSF-EAR [0319230, 0516725, 0744079, 1053466]	We wish to thank the Discovery and Cosmochemistry programs at NASA for support of the Stardust mission, funding of instrumentation and sample procurement. Special thanks to Hanson Fong of the Materials Science and Engineering Department, University of Washington, for FESEM assistance with obtaining backscatter images. We thank Trevor Ireland and two additional reviewers for constructive comments which improved the manuscript. This work was supported by NASA Grants NNX10AI89GS01 and NNX09AC30G. The WiscSIMS lab is partially funded by NSF-EAR (0319230, 0516725, 0744079, 1053466).	Aleon J, 2002, METEORIT PLANET SCI, V37, P1729; Anderson W. W., 1998, NASACR1998207766, P23; Maruyama S, 2003, GEOCHIM COSMOCHIM AC, V67, P3943, DOI 10.1016/S0016-7037(03)00172-8; RUBIN AE, 1982, GEOCHIM COSMOCHIM AC, V46, P1763, DOI 10.1016/0016-7037(82)90116-8; Rudraswami NG, 2011, GEOCHIM COSMOCHIM AC, V75, P7596, DOI 10.1016/j.gca.2011.09.035; Cuzzi JN, 2008, ASTROPHYS J, V687, P1432, DOI 10.1086/591239; Guan Y, 2006, METEORIT PLANET SCI, V41, P33; Ushikubo T, 2012, GEOCHIM COSMOCHIM AC, V90, P242, DOI 10.1016/j.gca.2012.05.010; Ciesla FJ, 2007, SCIENCE, V318, P613, DOI 10.1126/science.1147273; Krot AN, 2004, GEOCHIM COSMOCHIM AC, V68, P2167, DOI 10.1016/j.gca.2003.10.025; Krot AN, 2002, METEORIT PLANET SCI, V37, P91; Jones RH, 1996, GEOCHIM COSMOCHIM AC, V60, P3115, DOI 10.1016/0016-7037(96)00152-4; Simon SB, 2008, METEORIT PLANET SCI, V43, P1861; Kita NT, 2010, GEOCHIM COSMOCHIM AC, V74, P6610, DOI 10.1016/j.gca.2010.08.011; WASSON JT, 1993, METEORITICS, V28, P14; LaTourrette T, 1998, EARTH PLANET SC LETT, V158, P91, DOI 10.1016/S0012-821X(98)00048-X; Burchell MJ, 2008, METEORIT PLANET SCI, V43, P23; Tenner TJ, 2013, GEOCHIM COSMOCHIM AC, V102, P226, DOI 10.1016/j.gca.2012.10.034; Joswiak DJ, 2012, METEORIT PLANET SCI, V47, P471, DOI 10.1111/j.1945-5100.2012.01337.x; Kurahashi E, 2008, GEOCHIM COSMOCHIM AC, V72, P3865, DOI 10.1016/j.gca.2008.05.038; Krot AN, 1997, GEOCHIM COSMOCHIM AC, V61, P463, DOI 10.1016/S0016-7037(96)00342-0; Grossman JN, 2005, METEORIT PLANET SCI, V40, P87; CLIFF G, 1975, J MICROSC-OXFORD, V103, P203; Tronche EJ, 2007, GEOCHIM COSMOCHIM AC, V71, P3361, DOI 10.1016/j.gca.2007.03.037; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; RUBIN AE, 1989, METEORITICS, V24, P191; Weisberg MK, 2011, GEOCHIM COSMOCHIM AC, V75, P6556, DOI 10.1016/j.gca.2011.08.040; Krot AN, 2002, METEORIT PLANET SCI, V37, P155; STOLPER E, 1986, GEOCHIM COSMOCHIM AC, V50, P1785, DOI 10.1016/0016-7037(86)90139-0; Kita NT, 2000, GEOCHIM COSMOCHIM AC, V64, P3913, DOI 10.1016/S0016-7037(00)00488-9; Matzel JEP, 2010, SCIENCE, V328, P483, DOI 10.1126/science.1184741; Kita NT, 2009, CHEM GEOL, V264, P43, DOI 10.1016/j.chemgeo.2009.02.012; Russell SS, 2000, EARTH PLANET SC LETT, V184, P57, DOI 10.1016/S0012-821X(00)00309-5; Itoh S, 2007, METEORIT PLANET SCI, V42, P1241, DOI 10.1111/j.1945-5100.2007.tb00571.x; MacPherson GJ, 2005, GEOCHIM COSMOCHIM AC, V69, P3099, DOI 10.1016/j.gca.2004.12.022; Rubin AE, 2010, GEOCHIM COSMOCHIM AC, V74, P4807, DOI 10.1016/j.gca.2010.05.018; Schmitz S, 2009, GEOCHIM COSMOCHIM AC, V73, P5483, DOI 10.1016/j.gca.2009.06.008; Heck PR, 2010, GEOCHIM COSMOCHIM AC, V74, P497, DOI 10.1016/j.gca.2009.10.027; Makide K, 2009, GEOCHIM COSMOCHIM AC, V73, P5018, DOI 10.1016/j.gca.2009.01.042; Leroux H, 2008, AM MINERAL, V93, P1933, DOI 10.2138/am.2008.3048; Bridges JC, 2012, EARTH PLANET SC LETT, V341, P186, DOI 10.1016/j.epsl.2012.06.011; Keller C, 2004, ASTRON ASTROPHYS, V415, P1177, DOI 10.1051/0004-6361:20034629; Joswiak DJ, 2009, METEORIT PLANET SCI, V44, P1561, DOI 10.1111/j.1945-5100.2009.tb01192.x; Fagan TJ, 2004, GEOCHIM COSMOCHIM AC, V68, P2591, DOI 10.1016/j.gca.2003.10.033; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; Nakamura T, 2008, SCIENCE, V321, P1664, DOI 10.1126/science.1160995; BISCHOFF A, 1984, GEOCHIM COSMOCHIM AC, V48, P693, DOI 10.1016/0016-7037(84)90096-6; Jones RH, 2004, GEOCHIM COSMOCHIM AC, V68, P3423, DOI 10.1016/j.gca.2004.01.013; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; Horz F, 2006, SCIENCE, V314, P1716, DOI 10.1126/science.1135705; Nagahara H, 2008, GEOCHIM COSMOCHIM AC, V72, P1442, DOI 10.1016/j.gca.2007.12.020; WEISBERG MK, 1993, GEOCHIM COSMOCHIM AC, V57, P1567, DOI 10.1016/0016-7037(93)90013-M; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842; Brownlee D, 2012, METEORIT PLANET SCI, V47, P453, DOI 10.1111/j.1945-5100.2012.01339.x; Bayliss P, 1980, JCPDS MINERAL POWDER; Bigolski J. N., 2013, 44 LUN PLAN SCI C, P2239; Brearley A. J., 1998, REV MINERALOGY, V36; BRIGHAM CA, 1986, GEOCHIM COSMOCHIM AC, V50, P1655, DOI 10.1016/0016-7037(86)90128-6; Dobrica E., 2013, 44 LUN PLAN SCI C, P2701; Franchi IA, 2008, REV MINERAL GEOCHEM, V68, P345, DOI 10.2138/rmg.2008.68.13; Gainsforth Z., 2010, 73 ANN M MET SOC H S, P5428; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Hewins R. H., 1996, CHONDRULES PROTOPLAN, P3; Hezel DC, 2003, METEORIT PLANET SCI, V38, P1199; Hiyagon H, 1999, SCIENCE, V283, P828, DOI 10.1126/science.283.5403.828; Imai H, 2003, GEOCHIM COSMOCHIM AC, V67, P765, DOI 10.1016/S0016-7037(02)01174-2; Ishi H., 2010, 41 LUN PLAN SCI C, P2317; Jones R. H., 1989, P 19 LUN PLAN SCI C, P523; Jones R. H., 2005, 36 LUN PLAN SCI C, P1813; Joswiak D. J., 2010, 41 LUN PLAN SCI C, P2119; Joswiak D. J., 2013, 76 ANN M MET SOC EDM, P5136; KITAMURA M, 1977, CONTRIB MINERAL PETR, V61, P299, DOI 10.1007/BF00376703; Komatsu M, 2009, POLAR SCI, V3, P31, DOI 10.1016/j.polar.2009.03.002; Komatsu M, 2001, METEORIT PLANET SCI, V36, P629; Krot AN, 2004, CHEM ERDE-GEOCHEM, V64, P185, DOI 10.1016/j.chemer.2004.05.001; Krot AN, 2000, METEORIT PLANET SCI, V35, P1249; Krot AN, 2006, CHEM ERDE-GEOCHEM, V66, P249, DOI 10.1016/j.chemer.2006.07.002; Krot AN, 2002, SCIENCE, V295, P1051, DOI 10.1126/science.1068200; Leitner J., 2010, 41 LUN PLAN SCI C, P1609; Lofgren G. E., 1996, CHONDRULES PROTOPLAN, P187; Matrajt G., 2006, METEORIT PLANET SCI, V41, P1695; Matrajt G, 2008, Meteoritics & Planetary Science, V43; Messenger S., 2009, 40 LUN PLAN SCI C, P1790; Misawa K., 1996, CHONDRULES PROTOPLAN, P99; Miyamoto M., 2009, 40 LUN PLAN SCI C, P1143; Nakamura-Messenger K, 2011, METEORIT PLANET SCI, V46, P1033, DOI 10.1111/j.1945-5100.2011.01211.x; Nakashima D, 2012, METEORIT PLANET SCI, V47, P197, DOI [10.1111/J.1945-5100.2011.01319.x, 10.1111/j.1945-5100.2011.01319.x]; Nakashima D, 2011, METEORIT PLANET SCI, V46, P857, DOI 10.1111/j.1945-5100.2011.01198.x; Ogliore R. C., 2012, ASTROPHYS J LETT, V745, P1; Palme H., 2003, METEORITES COMETS PL, V1, P41, DOI [10.1016/B0-08-043751-6/01060-4, DOI 10.1016/B0-08-043751-6/01060-4]; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Scott ERD, 2005, TREATISE GEOCHEM, V1, P143; Scott ERD, 2005, ASTROPHYS J, V623, P571, DOI 10.1086/428606; Sheng Y. J., 1992, THESIS CALTECH; Stodolna J., 2012, 43 LUN PLAN SCI C, P1214; Tenner T. J., 2012, 43 LUN PLAN SCI C; Valley J.W., 2009, MINERALOGICAL ASS CA, V41, P19; WASSON JT, 1994, EARTH PLANET SC LETT, V122, P403, DOI 10.1016/0012-821X(94)90011-6; WEINBRUCH S, 1995, GEOCHIM COSMOCHIM AC, V59, P3221, DOI 10.1016/0016-7037(95)00210-Q; Weisberg M. K., 2008, 39 LUN PLAN SCI C, P1981; Weisberg M. K., 2007, 38 LUN PLAN SCI C, P1588; Weisberg MK, 2004, METEORIT PLANET SCI, V39, P1741; Westphal AJ, 2004, METEORIT PLANET SCI, V39, P1375; Wick MJ, 2012, GEOCHIM COSMOCHIM AC, V98, P140, DOI 10.1016/j.gca.2012.09.027	105	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-7037	1872-9533		GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	NOV 1	2014	144						277	298		10.1016/j.gca.2014.08.017		22	Geochemistry & Geophysics	Geochemistry & Geophysics	AT4XM	WOS:000344945600017		
J	Kawasaki, T				Kawasaki, Toshisuke			Obituary: An appreciation of Gilbert G. Ashwell - A pioneer of Glycobiology	GLYCOCONJUGATE JOURNAL			English	Biographical-Item									Ritsumeikan Univ, Res Ctr Glycobiotechnol, Kusatsu, Shiga 5258577, Japan	Kawasaki, T (reprint author), Ritsumeikan Univ, Res Ctr Glycobiotechnol, Kusatsu, Shiga 5258577, Japan.	tkawasak@fc.ritsumei.ac.jp					ASHWELL GG, PUBLICATION LIST	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	NOV	2014	31	8					545	546		10.1007/s10719-014-9552-8		2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT7TW	WOS:000345141000001		
J	Suzuki, A				Suzuki, A.			Obituary: Dr. Yoshitaka Nagai (1931-2014)	GLYCOCONJUGATE JOURNAL			English	Biographical-Item									Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 2591292, Japan	Suzuki, A (reprint author), Tokai Univ, Inst Glycosci, 1117 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	akmszk@tokai-u.jp					NAGAI Y, PUBLICATION LIST	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	NOV	2014	31	8					547	548		10.1007/s10719-014-9553-7		2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT7TW	WOS:000345141000002		
J	Urashima, T; Fujita, S; Fukuda, K; Nakamura, T; Saito, T; Cowan, P; Messer, M				Urashima, Tadasu; Fujita, Saori; Fukuda, Kenji; Nakamura, Tadashi; Saito, Tadao; Cowan, Phil; Messer, Michael			Chemical characterization of milk oligosaccharides of the common brushtail possum (Trichosurus vulpecula) (vol 31, pg 387, 2014)	GLYCOCONJUGATE JOURNAL			English	Correction									[Urashima, Tadasu; Fujita, Saori; Fukuda, Kenji] Obihiro Univ Agr & Vet Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan; [Nakamura, Tadashi] Obihiro Univ Agr & Vet Med, Dept Food Sci, Obihiro, Hokkaido 0808555, Japan; [Saito, Tadao] Tohoku Univ, Grad Sch Agr, Sendai, Miyagi 9818555, Japan; [Cowan, Phil] Landcare Res, Wildlife Ecol & Management, Lincoln 7640, New Zealand; [Messer, Michael] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	Urashima, T (reprint author), Obihiro Univ Agr & Vet Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan.	urashima@obihiro.ac.jp					Urashima T, 2014, GLYCOCONJUGATE J, V31, P387, DOI 10.1007/s10719-014-9533-y	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	NOV	2014	31	8					603	603		10.1007/s10719-014-9537-7		1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT7TW	WOS:000345141000009		
J	Nakatani, S				Nakatani, Satoshi			Almanac 2014: cardiovascular imaging	HEART			English	Review							CORONARY-ARTERY-DISEASE; OPTICAL COHERENCE TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; LONGITUDINAL SYSTOLIC STRAIN; FRACTIONAL FLOW RESERVE; HEART-FAILURE; COMPUTED-TOMOGRAPHY; ATRIAL-FIBRILLATION; PROGNOSTIC VALUE; DIAGNOSTIC PERFORMANCE	The 'Almanac' Reviews provide an overview of articles on a specific topic published in Heart over the past 2 years, put in the context of advances in the field, including publications from several other journals. The focus of this Almanac article is Cardiovascular imaging - as a general cardiology journal, the imaging research in Heart tends to be clinically oriented and often will impact our clinical practice.	Osaka Univ, Grad Sch Med, Dept Hlth Sci, Suita, Osaka 5650871, Japan	Nakatani, S (reprint author), Osaka Univ, Grad Sch Med, Dept Hlth Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	nakatani@sahs.med.osaka-u.ac.jp					Aldrovandi A, 2009, EUR RADIOL, V19, P1653, DOI 10.1007/s00330-009-1344-3; Uemura S, 2012, EUR HEART J, V33, P78, DOI 10.1093/eurheartj/ehr284; Bezerra HG, 2009, JACC-CARDIOVASC INTE, V2, P1035, DOI 10.1016/j.jcin.2009.06.019; Fairbairn TA, 2013, HEART, V99, P1185, DOI 10.1136/heartjnl-2013-303927; Messroghli DR, 2003, J CARDIOV MAGN RESON, V5, P353, DOI 10.1081/JCMR-120019418; Jang SJ, 2013, HEART, V99, P17, DOI 10.1136/heartjnl-2012-301980; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Bull S, 2013, HEART, V99, P932, DOI 10.1136/heartjnl-2012-303052; Hadamitzky M, 2009, JACC-CARDIOVASC IMAG, V2, P404, DOI 10.1016/j.jcmg.2008.11.015; Jacobson AF, 2010, J AM COLL CARDIOL, V55, P2212, DOI 10.1016/j.jacc.2010.01.014; Brix G, 2014, EUR J NUCL MED MOL I, V41, pS125, DOI 10.1007/s00259-013-2543-3; Miller TD, 2002, AM J MED, V112, P290, DOI 10.1016/S0002-9343(01)01111-1; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Zakeri R, 2014, CIRC-HEART FAIL, V7, P123, DOI 10.1161/CIRCHEARTFAILURE.113.000568; Hachamovitch R, 2011, EUR HEART J, V32, P1012, DOI 10.1093/eurheartj/ehq500; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Kwong RY, 2011, JACC-CARDIOVASC IMAG, V4, P157, DOI 10.1016/j.jcmg.2010.12.004; Kim HJ, 2010, ANN BIOMED ENG, V38, P3195, DOI 10.1007/s10439-010-0083-6; Greif M, 2013, HEART, V99, P1004, DOI 10.1136/heartjnl-2013-303794; Marshall A, 2012, HEART, V98, P1359, DOI 10.1136/heartjnl-2012-302321; Bellavia D, 2008, AM J CARDIOL, V101, P1039, DOI 10.1016/j.amjcard.2007.11.047; Bamberg F, 2010, EUR RADIOL, V20, P1168, DOI 10.1007/s00330-010-1715-9; Phelan D, 2012, HEART, V98, P1442, DOI 10.1136/heartjnl-2012-302353; Kim KJ, 2013, HEART, V99, P1113, DOI 10.1136/heartjnl-2013-303631; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Nakata T, 2013, JACC-CARDIOVASC IMAG, V6, P772, DOI 10.1016/j.jcmg.2013.02.007; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Tian JW, 2012, HEART, V98, P1504, DOI 10.1136/heartjnl-2012-302445; Nakazato R, 2013, CIRC-CARDIOVASC IMAG, V6, P881, DOI 10.1161/CIRCIMAGING.113.000297; Sun JP, 2009, AM J CARDIOL, V103, P411, DOI 10.1016/j.amjcard.2008.09.102; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; George RT, 2007, INVEST RADIOL, V42, P815; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Su HM, 2013, HEART, V99, P1588, DOI 10.1136/heartjnl-2013-304561; Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012; Koyama J, 2010, JACC-CARDIOVASC IMAG, V3, P333, DOI 10.1016/j.jcmg.2009.11.013; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Cho GY, 2009, J AM COLL CARDIOL, V54, P618, DOI 10.1016/j.jacc.2009.04.061; Choi JH, 2011, JACC-CARDIOVASC IMAG, V4, P1149, DOI 10.1016/j.jcmg.2011.09.006; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Guan J, 2012, AM J PHYSIOL-HEART C, V302, pH544, DOI 10.1152/ajpheart.00815.2011; Kusunose K, 2012, J AM SOC ECHOCARDIOG, V25, P953, DOI 10.1016/j.echo.2012.06.009; Lee CS, 2012, J AM SOC ECHOCARDIOG, V25, P945, DOI 10.1016/j.echo.2012.06.006; Min JK, 2013, HEART, V99, P661, DOI 10.1136/heartjnl-2012-302039; Nakauchi Y, 2012, HEART, V98, P566, DOI 10.1136/heartjnl-2011-300915; Grundy SM, 2002, CIRCULATION, V106, P3143; Schaap J, 2013, HEART, V99, P188, DOI 10.1136/heartjnl-2012-302761; Yiu KH, 2012, HEART, V98, P232, DOI 10.1136/heartjnl-2011-300038	51	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1355-6037	1468-201X		HEART	Heart	NOV	2014	100	21					1661	1666		10.1136/heartjnl-2014-306024		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT6CS	WOS:000345027300006		
J	Ito, H; Motoyama, S; Sarai, M; Kawai, H; Harigaya, H; Kan, S; Kato, S; Anno, H; Takahashi, H; Naruse, H; Ishii, J; Narula, J; Ozaki, Y				Ito, Hajime; Motoyama, Sadako; Sarai, Masayoshi; Kawai, Hideki; Harigaya, Hiroto; Kan, Shino; Kato, Shigeru; Anno, Hirofumi; Takahashi, Hiroshi; Naruse, Hiroyuki; Ishii, Junichi; Narula, Jagat; Ozaki, Yukio			Characteristics of plaque progression detected by serial coronary computed tomography angiography	HEART AND VESSELS			English	Article						Coronary computed tomography angiography; Coronary artery disease; Plaque progression	INTERNATIONAL MULTICENTER REGISTRY; ARTERY-DISEASE; CLINICAL-OUTCOMES; DIAGNOSTIC PERFORMANCE; SYMPTOMATIC PATIENTS; PROGNOSTIC VALUE; MORTALITY RISK; ATHEROSCLEROSIS; CT; THERAPY	We previously reported that serial coronary computed tomography angiography (CTA) had a potential to evaluate the interval change of plaque morphology of coronary arteries. The aim of this study was to evaluate variables associated with the plaque progression by serial CTA. We included 148 patients (age 66.3 +/- 9.8 years, male 81.1 %, median scan interval 12 months) with coronary artery disease undergoing serial CTA. Each coronary artery was compared visually between baseline and follow-up CTA to detect plaque progression. Baseline characteristics between progression and nonprogression patients did not demonstrate any significant differences. Logistic analysis revealed that only low-density lipoprotein cholesterol (LDL-C) a parts per thousand yen100 mg/dl at follow-up was associated with plaque progression (odds ratio 2.59, 95 % confidence interval 1.12-6.34, P = 0.0263). Cutoff value of LDL-C for plaque progression at follow-up was 103.0 mg/dl based on receiver-operator characteristic curves analyses. Of the 36 progressive lesions in 32 patients, plaque composition at baseline included 13 lesions (36.1 %) of noncalcified plaque, 1 lesion (2.8 %) of calcified plaque, 12 lesions (33.3 %) of partially calcified plaque, and the remaining 10 lesions (27.8 %) had no plaque at baseline and revealed de novo plaques at follow-up. There were 9 lesions (25 %) with high-risk plaque (HRP) characteristics at baseline and 18 lesions (50 %) with HRP at follow-up. Plaque progression of coronary arteries by serial CTA was associated with LDL-C a parts per thousand yen100 mg/dl at follow-up regardless of baseline LDL-C level. There was no specific finding to predict plaque progression on the baseline plaque characteristics.	[Ito, Hajime; Motoyama, Sadako; Sarai, Masayoshi; Kawai, Hideki; Harigaya, Hiroto; Kan, Shino; Kato, Shigeru; Naruse, Hiroyuki; Ishii, Junichi; Ozaki, Yukio] Fujita Hlth Univ, Dept Cardiol, Toyoake, Aichi 4701192, Japan; [Anno, Hirofumi] Fujita Hlth Univ, Dept Radiol, Toyoake, Aichi 4701192, Japan; [Takahashi, Hiroshi] Fujita Hlth Univ, Div Med Stat, Toyoake, Aichi 4701192, Japan; [Narula, Jagat] Mt Sinai Sch Med, Zena & Michael A Weiner Cardiovasc Inst, New York, NY USA	Motoyama, S (reprint author), Fujita Hlth Univ, Dept Cardiol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	sadakom@fujita-hu.ac.jp					Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Chow BJW, 2011, CIRC-CARDIOVASC IMAG, V4, P463, DOI 10.1161/CIRCIMAGING.111.964155; Inoue K, 2010, JACC-CARDIOVASC IMAG, V3, P691, DOI 10.1016/j.jcmg.2010.04.011; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Kristensen TS, 2011, J AM COLL CARDIOL, V58, P502, DOI 10.1016/j.jacc.2011.01.058; Kataoka Y, 2012, J AM COLL CARDIOL, V59, P1592, DOI 10.1016/j.jacc.2012.03.012; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P45; Nicholls SJ, 2011, NEW ENGL J MED, V365, P2078, DOI 10.1056/NEJMoa1110874; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Lin FY, 2011, J AM COLL CARDIOL, V58, P510, DOI 10.1016/j.jacc.2010.11.078; Tobaru T, 2013, HEART VESSELS, V28, P39, DOI 10.1007/s00380-012-0243-8; Hulten EA, 2011, J AM COLL CARDIOL, V57, P1237, DOI 10.1016/j.jacc.2010.10.011; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Villines TC, 2011, J AM COLL CARDIOL, V58, P2533, DOI 10.1016/j.jacc.2011.10.851; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Lehman SJ, 2009, JACC-CARDIOVASC IMAG, V2, P1262, DOI 10.1016/j.jcmg.2009.07.007; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Ueda H, 2012, HEART VESSELS, V27, P128, DOI 10.1007/s00380-011-0128-2	24	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					743	749		10.1007/s00380-013-0420-4		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200003		
J	Iwama, M; Tanaka, S; Noda, T; Segawa, T; Kawasaki, M; Nishigaki, K; Minagawa, T; Watanabe, S; Minatoguchi, S				Iwama, Makoto; Tanaka, Shinichiro; Noda, Toshiyuki; Segawa, Tomonori; Kawasaki, Masanori; Nishigaki, Kazuhiko; Minagawa, Taro; Watanabe, Sachiro; Minatoguchi, Shinya			Impact of tissue characteristics on luminal narrowing of mild angiographic coronary stenosis: assessment of integrated backscatter intravascular ultrasound	HEART AND VESSELS			English	Article						Coronary artery disease; Progression; Tissue characterization; Integrated backscatter	RANDOMIZED CONTROLLED-TRIAL; VIRTUAL HISTOLOGY; PLAQUE PROGRESSION; STATIN THERAPY; ATHEROSCLEROSIS; DISEASE; TOMOGRAPHY	Integrated backscatter intravascular ultrasound (IB-IVUS) is a useful method for analyzing coronary plaque tissue. We evaluated whether tissue composition determined using IB-IVUS is associated with the progression of stenosis in coronary angiography. Sixty-three nontarget coronary lesions in 63 patients with stable angina were evaluated using conventional IVUS and IB-IVUS. IB-IVUS images were analyzed at 1-mm intervals for a length of 10 mm. After calculating the relative areas of the tissue components using the IB-IVUS system, fibrous volume (FV) and lipid volume (LV) were calculated through integration of the slices, after which percentages of per-plaque volume (%FV/PV, %LV/PV) and per-vessel volume (%FV/VV, %LV/VV) were calculated. Progression of coronary stenosis was interpreted from the increase in percent diameter stenosis (%DS) from baseline to the follow-up period (6-9 months) using quantitative coronary angiography. %DS was 24.1 +/- 12.8 % at baseline and 23.2 +/- 13.7 % at follow-up. Using IB-IVUS, LV was 31.7 +/- 10.5 mm(3), and %LV/PV and %LV/VV were 45.6 +/- 10.3 % and 20.2 +/- 6.0 %, respectively. FV, %FV/PV, and %FV/VV were 35.5 +/- 12.1 mm(3), 52.1 +/- 9.5 %, and 23.4 +/- 7.1 %, respectively. The change in %DS was -0.88 +/- 7.25 % and correlated closely with %LV/VV (r = 0.27, P = 0.03) on simple regression. Multivariate regression after adjustment for potentially confounding risk factors showed %LV/VV to be correlated independently with changes in %DS (r = 0.42, P = 0.02). Logistic regression analysis after adjusting for confounding coronary risk factors showed LV (odds ratio 1.08; 95 % confidence interval 1.01-1.16; P = 0.03) and %LV/VV (odds ratio 1.13; 95 % confidence interval 1.01-1.28; P = 0.03) to be independent predictors of the progression of angiographic coronary stenosis. Our findings suggest that angiographic luminal narrowing of the coronary artery is likely associated with tissue characteristics. IB-IVUS may provide information about the natural progression of luminal narrowing in coronary stenosis.	[Iwama, Makoto; Tanaka, Shinichiro; Noda, Toshiyuki; Watanabe, Sachiro] Gifu Prefectural Gen Med Ctr, Dept Cardiol, Gifu, Japan; [Tanaka, Shinichiro; Kawasaki, Masanori; Nishigaki, Kazuhiko; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Internal Med 2, Gifu 5011194, Japan; [Tanaka, Shinichiro; Minagawa, Taro] Gifu Cardiovasc Inst, Gifu, Japan; [Segawa, Tomonori] Asahi Univ, Murakami Mem Hosp, Dept Cardiovasc Med, Gifu, Japan	Minatoguchi, S (reprint author), Gifu Univ, Grad Sch Med, Dept Internal Med 2, 1-1 Yanagido, Gifu 5011194, Japan.	minatos@gifu-u.ac.jp					Ando H, 2011, CIRC J, V75, P383, DOI 10.1253/circj.CJ-10-0815; Okubo M, 2008, CIRC J, V72, P1631, DOI 10.1253/circj.CJ-07-0936; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Kubo T, 2010, J AM COLL CARDIOL, V55, P1590, DOI 10.1016/j.jacc.2009.07.078; Burke AP, 2001, CIRCULATION, V103, P934; de Graaf MA, 2013, HEART VESSELS, V28, P166, DOI 10.1007/s00380-012-0236-7; Amano T, 2007, J AM COLL CARDIOL, V49, P1149, DOI 10.1016/j.jacc.2006.12.028; Brown BG, 2007, CIRCULATION, V115, P1824, DOI 10.1161/CIRCULATIONAHA.106.689968; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Kawasaki M, 2010, CIRC J, V74, P2641, DOI 10.1253/circj.CJ-10-0547; Okubo M, 2008, ULTRASOUND MED BIOL, V34, P655, DOI 10.1016/j.ultrasmedbio.2007.09.015; Kawasaki M, 2005, J AM COLL CARDIOL, V45, P1946, DOI 10.1016/j.jacc.2004.09.081; Amano T, 2011, ATHEROSCLEROSIS, V218, P110, DOI 10.1016/j.atherosclerosis.2011.05.030; Amano T, 2011, CIRC J, V75, P157, DOI 10.1253/circj.CJ-10-0612; Takayama T, 2009, CIRC J, V73, P2110; Berry C, 2007, CIRCULATION, V115, P1851, DOI 10.1161/CIRCULATIONAHA.106.655654; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Kaneko H, 2014, HEART VESSELS, V29, P437, DOI 10.1007/s00380-013-0382-6; Fujii K, 2005, AM J CARDIOL, V96, P1476, DOI 10.1016/j.amjcard.2005.07.054; Inaba S, 2012, EUR HEART J-CARD IMG, V13, P717, DOI 10.1093/ehjci/jes033; Ishihara Y, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-32; Lehman SJ, 2009, JACC-CARDIOVASC IMAG, V2, P1262, DOI 10.1016/j.jcmg.2009.07.007; Miyoshi T, 2014, HEART VESSELS, V29, P178, DOI 10.1007/s00380-013-0343-0; Nozue T, 2014, HEART VESSELS, V29, P456, DOI 10.1007/s00380-013-0387-1; Tanaka S, 2013, HEART VESSELS, V28, P415, DOI 10.1007/s00380-012-0266-1	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					750	760		10.1007/s00380-013-0428-9		11	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200004		
J	Kumagai, S; Takashima, H; Waseda, K; Ando, H; Suzuki, A; Uetani, T; Harada, K; Yoshida, T; Kunimura, A; Shimbo, Y; Kitagawa, K; Harada, K; Ishii, H; Yoshikawa, D; Matsubara, T; Murohara, T; Amano, T				Kumagai, Soichiro Z.; Takashima, Hiroaki; Waseda, Katsuhisa; Ando, Hirohiko; Suzuki, Akihiro; Uetani, Tadayuki; Harada, Ken; Yoshida, Tomohiro; Kunimura, Ayako; Shimbo, Yusaku; Kitagawa, Katsuhide; Harada, Kazuhiro; Ishii, Hideki; Yoshikawa, Daiji; Matsubara, Tatsuaki; Murohara, Toyoaki; Amano, Tetsuya			Prognostic impact of lipid contents on the target lesion in patients with drug eluting stent implantation	HEART AND VESSELS			English	Article						Intravascular ultrasound; Drug-eluting stent; Coronary artery disease; Lipid profiles	BACKSCATTER INTRAVASCULAR ULTRASOUND; 5-YEAR CLINICAL-OUTCOMES; CORONARY PLAQUES; TISSUE CHARACTERIZATION; MYOCARDIAL-INFARCTION; TRIALS; EVENTS; ARTERY	We sought to determine the morphologic predictors of major adverse cardiac events (MACEs) after successful percutaneous coronary intervention (PCI) with drug-eluting stents (DES), using integrated backscatter intravascular ultrasound (IB-IVUS). Conventional IVUS and IB-IVUS were performed in 260 consecutive patients who underwent PCI with DES. Three-dimensional analyses were performed to determine plaque volume and the volume of each plaque component (lipid, fibrous, and calcification). Patients were divided into two groups according to the median lipid volume (LV) in the target lesion. MACEs were defined as death, nonfatal myocardial infarction, and any repeat revascularization. The median follow-up interval was 1285 days. MACEs were observed in 64 patients (24.6 %). Patients having a larger LV compared with their counterparts had worse long-term clinical outcomes regarding mortality (3.8 vs. 0 %, P = 0.02) and MACEs (31.5 vs. 17.7 %, P = 0.008) by log-rank test. After adjustment for confounders, large LV (odds ratio 1.95, 95 % confidence interval 1.14-3.33, P = 0.02) was significantly and independently associated with MACEs. The assessment of coronary plaque characteristics in the target lesion may be useful to predict long-term outcome following successful coronary intervention.	[Kumagai, Soichiro Z.; Takashima, Hiroaki; Waseda, Katsuhisa; Ando, Hirohiko; Suzuki, Akihiro; Amano, Tetsuya] Aichi Med Univ, Dept Cardiol, Nagakute, Aichi 4801195, Japan; [Uetani, Tadayuki; Harada, Ken; Yoshida, Tomohiro; Kunimura, Ayako; Shimbo, Yusaku; Kitagawa, Katsuhide; Harada, Kazuhiro] Chubu Rosai Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Ishii, Hideki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Yoshikawa, Daiji] Japanese Red Cross Nagoya Daiichi Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Matsubara, Tatsuaki] Aichi Gakuin Univ, Sch Dent, Dept Internal Med, Nagoya, Aichi 464, Japan	Kumagai, S (reprint author), Aichi Med Univ, Dept Cardiol, 1-1 Karimata, Nagakute, Aichi 4801195, Japan.	kumagais@aichi-med-u.ac.jp	Murohara, Toyoaki/M-4958-2014				Ambroes JA, 2010, AM J MED, V123, P10; Anderson Jeffrey L, 2007, J Am Coll Cardiol, V50, pe1, DOI 10.1016/j.jacc.2007.02.013; Ando H, 2011, CIRC J, V75, P383, DOI 10.1253/circj.CJ-10-0815; Roy P, 2008, EUR HEART J, V29, P1851, DOI 10.1093/eurheartj/ehn249; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; DEFEYTER PJ, 1995, CIRCULATION, V92, P1408; Kimura T, 2002, CIRCULATION, V105, P2986, DOI 10.1161/01.CIR.0000019743.11941.3B; Amano T, 2007, J AM COLL CARDIOL, V49, P1149, DOI 10.1016/j.jacc.2006.12.028; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Waxman S, 2006, CIRCULATION, V114, P2390, DOI 10.1161/CIRCULATIONAHA.105.540013; Wright RS, 2011, CIRCULATION, V123, P2022, DOI 10.1161/CIR.0b013e31820f2f3e; Miyagi M, 2010, NEPHROL DIAL TRANSPL, V25, P175, DOI 10.1093/ndt/gfp423; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Okubo M, 2008, ULTRASOUND MED BIOL, V34, P655, DOI 10.1016/j.ultrasmedbio.2007.09.015; Kawasaki M, 2005, J AM COLL CARDIOL, V45, P1946, DOI 10.1016/j.jacc.2004.09.081; Amano T, 2011, ATHEROSCLEROSIS, V218, P110, DOI 10.1016/j.atherosclerosis.2011.05.030; Amano T, 2011, CIRC J, V75, P157, DOI 10.1253/circj.CJ-10-0612; Fitzgerald PJ, 2000, CIRCULATION, V102, P523; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Kaneko H, 2014, HEART VESSELS, V29, P437, DOI 10.1007/s00380-013-0382-6; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B; FUSTER V, 1992, NEW ENGL J MED, V326, P242; Kaneko H, 2014, HEART VESSELS, V29, P21, DOI 10.1007/s00380-013-0325-2; Lee TT, 2006, AM J CARDIOL, V98, P718, DOI 10.1016/j.amjcard.2006.03.059; Min JK, 2010, INT J CARDIOVAS IMAG, V26, P721, DOI 10.1007/s10554-010-9613-4; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Takaoka N, 2014, HEART VESSELS, V29, P584, DOI 10.1007/s00380-013-0401-7	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					761	768		10.1007/s00380-013-0430-2		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200005		
J	Nabeta, T; Inomata, T; Iida, Y; Ikeda, Y; Iwamoto, M; Ishii, S; Sato, T; Watanabe, I; Naruke, T; Shinagawa, H; Koitabashi, T; Takeuchi, I; Nishii, M; Inoue, Y; Izumi, T				Nabeta, Takeru; Inomata, Takayuki; Iida, Yuichiro; Ikeda, Yuki; Iwamoto, Miwa; Ishii, Shunsuke; Sato, Takanori; Watanabe, Ichiro; Naruke, Takashi; Shinagawa, Hisahito; Koitabashi, Toshimi; Takeuchi, Ichiro; Nishii, Mototsugu; Inoue, Yusuke; Izumi, Tohru			Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy	HEART AND VESSELS			English	Article						Fibrosis; Magnetic resonance imaging; Biopsy; Dilated cardiomyopathy	DECOMPENSATED HEART-FAILURE; MYOCARDIAL FIBROSIS; NONISCHEMIC CARDIOMYOPATHY; RESYNCHRONIZATION THERAPY; BLOCKER THERAPY; PREVALENCE; EXPRESSION; SCINTIGRAPHY; OUTPATIENTS; MARKER	Endomyocardial biopsy (EMB) and late gadolinium enhancement cardiovascular magnetic resonance (LGE-CMR) imaging performed at baseline are both used to evaluate the extent of myocardial fibrosis. However, no study has directly compared the effectiveness of these diagnostic tools in the prediction of left ventricular reverse remodeling (LVRR) and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy (IDCM). Seventy-five patients with newly diagnosed IDCM who were undergoing optimal therapy were assessed at baseline using LGE-CMR imaging and EMB; the former measured LGE area and the latter measured collagen volume fraction (CVF) as possible predictive indices of LVRR and cardiac event-free survival. Among all the baseline primary candidate factors with P < 0.2 as per univariate analysis, multivariate analysis indicated that only LGE area was an independent predictor of subsequent LVRR (beta = 0.44; 95 % confidence interval (CI) 0.87-2.53; P < 0.001), as indicated by decreasing left ventricular end-systolic volume index over the 1-year follow-up. Kaplan-Meier curves indicated significantly lower cardiac event-free survival rates in patients with LGE at baseline than in patients without (P < 0.01). By contrast, there was no significant difference in prognosis between patients with CVF values above (severe fibrosis) and below (mild fibrosis) the median of 4.9 %. Cox proportional hazard analysis showed that LGE area was an independent predictor of subsequent cardiac events (hazard ratio 1.06; 95 % CI 1.02-1.10; P a parts per thousand currency sign 0.01). The degree of myocardial fibrosis estimated by baseline LGE-CMR imaging, but not that estimated by baseline EMB, can predict LVRR and cardiac event-free survival in response to therapy in patients with newly diagnosed IDCM.	[Nabeta, Takeru; Inomata, Takayuki; Iida, Yuichiro; Ikeda, Yuki; Iwamoto, Miwa; Ishii, Shunsuke; Sato, Takanori; Watanabe, Ichiro; Naruke, Takashi; Shinagawa, Hisahito; Koitabashi, Toshimi; Takeuchi, Ichiro; Nishii, Mototsugu; Izumi, Tohru] Kitasato Univ, Sch Med, Dept Cardioangiol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Inoue, Yusuke] Kitasato Univ, Sch Med, Dept Diagnost Radiol, Sagamihara, Kanagawa 2520374, Japan	Nabeta, T (reprint author), Kitasato Univ, Sch Med, Dept Cardioangiol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	srfaimx@yahoo.co.jp			Vehicle Racing Commemorative Foundation	We thank Dr Keika Hoshi, Kitasato Clinical Research Center, for outstanding assistance with statistical analysis, and Hiroyuki Hata, Department of Radiology, Kitasato University Hospital, for technical assistance with analysis of LGE-CMR imaging. This study was supported in part by a grant-in-aid for scientific research from The Vehicle Racing Commemorative Foundation.	Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Kasama S, 2007, EUR HEART J, V28, P989, DOI 10.1093/eurheartj/ehm048; Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636; Hoshikawa E, 2011, AM J CARDIOL, V107, P1065, DOI 10.1016/j.amjcard.2010.11.033; YAMADA T, 1993, J AM COLL CARDIOL, V21, P628; Yu CM, 2005, CIRCULATION, V112, P1580, DOI 10.1161/CIRCULATIONAHA.105.538272; Nishii M, 2008, J AM COLL CARDIOL, V51, P2329, DOI 10.1016/j.jacc.2007.11.085; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Baldasseroni S, 2002, AM HEART J, V143, P398, DOI 10.1067/mhj.2002.121264; Aoki T, 2011, CIRC J, V75, P2605, DOI 10.1253/circj.CJ-11-0568; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Jellis C, 2010, J AM COLL CARDIOL, V56, P89, DOI 10.1016/j.jacc.2010.02.047; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Merlo M, 2011, J AM COLL CARDIOL, V57, P1468, DOI 10.1016/j.jacc.2010.11.030; Messroghli DR, 2006, RADIOLOGY, V238, P1004, DOI 10.1148/radiol.2382041903; Leong DP, 2012, EUR HEART J, V33, P640, DOI 10.1093/eurheartj/ehr391; Heling A, 2000, CIRC RES, V86, P846; Croisille P, 2006, EUR RADIOL, V16, P1951, DOI 10.1007/s00330-006-0244-z; Suwa M, 1997, AM HEART J, V133, P353, DOI 10.1016/S0002-8703(97)70232-1; Chintanaboina J, 2013, KOREAN J INTERN MED, V28, P300, DOI 10.3904/kjim.2013.28.3.300; Lehrke S, 2011, HEART, V97, P727, DOI 10.1136/hrt.2010.205542; Choi JO, 2013, CIRC J, V77, P462, DOI 10.1253/circj.CJ-12-0507; Delnoij T, 2009, EUR HEART J, V30, P2492, DOI 10.1093/eurheartj/ehp319; Díez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Francis GS, 2003, AM HEART J, V145, P200, DOI 10.1067/mhj.2003.106; Franzen E, 2013, HEART VESSELS, V28, P626, DOI 10.1007/s00380-012-0289-7; Fukui S, 2008, J CARDIOVASC PHARM, V51, P317, DOI 10.1097/FJC.0b013e31816533b7; Ishii S, 2014, HEART VESSELS, V29, P88, DOI 10.1007/s00380-013-0335-0; Kawai K, 1999, AM J CARDIOL, V84, P671, DOI 10.1016/S0002-9149(99)00414-2; Ohshima K, 2011, INT HEART J, V52, P366; Schalla S, 2010, EUR J HEART FAIL, V12, P227, DOI 10.1093/eurjhf/hfq004; SCHOFER J, 1988, J AM COLL CARDIOL, V12, P1252; Sugihara N, 1988, J Cardiol, V18, P353; Sinagra G, 1996, CARDIOVASC PATHOL, V5, P21, DOI 10.1016/1054-8807(95)00056-9; Sutton MGS, 2003, CIRCULATION, V107, P1985, DOI 10.1161/01.CIR.0000065226.24159.E9; Tsukada B, 2009, HUM PATHOL, V40, P1015, DOI 10.1016/j.humpath.2008.12.017	38	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					784	792		10.1007/s00380-013-0415-1		9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200008		
J	Kaneko, H; Suzuki, S; Uejima, T; Kano, H; Matsuno, S; Otsuka, T; Takai, H; Oikawa, Y; Yajima, J; Koike, A; Nagashima, K; Kirigaya, H; Sagara, K; Tanabe, H; Sawada, H; Aizawa, T; Yamashita, T				Kaneko, Hidehiro; Suzuki, Shinya; Uejima, Tokuhisa; Kano, Hiroto; Matsuno, Shunsuke; Otsuka, Takayuki; Takai, Hideaki; Oikawa, Yuji; Yajima, Junji; Koike, Akira; Nagashima, Kazuyuki; Kirigaya, Hajime; Sagara, Koichi; Tanabe, Hiroaki; Sawada, Hitoshi; Aizawa, Tadanori; Yamashita, Takeshi			Prevalence and the long-term prognosis of functional mitral regurgitation in Japanese patients with symptomatic heart failure	HEART AND VESSELS			English	Article						Functional mitral regurgitation; Heart failure; Prognosis; Japanese	CARDIAC RESYNCHRONIZATION THERAPY; VENTRICULAR SYSTOLIC DYSFUNCTION; EJECTION FRACTION; HOSPITALIZED-PATIENTS; PROSPECTIVE COHORT; SEVERITY; REPAIR; OUTCOMES; IMPACT	Functional mitral regurgitation (FMR) is a common and critical condition in patients with heart failure (HF); however, the prevalence and clinical outcome of FMR in Japanese real-world clinical practice remain unclear. Within a single hospital-based cohort in the Shinken Database 2004-2011, which comprised all new patients (n = 17,517) who visited the Cardiovascular Institute, we followed symptomatic HF patients. A total of 1,701 patients were included: 104 FMR patients (who had moderate to severe FMR) and 1,597 non-FMR patients (who had none or mild FMR). FMR patients had lower rates of hypertension and dyslipidemia, but higher rates of dilated cardiomyopathy, atrial fibrillation, and New York Heart Association functional class III/IV. FMR patients had higher levels of brain natriuretic peptide and lower left ventricular function. Use of cardiovascular drugs was more common among FMR patients. Kaplan-Meier curves revealed that the incidences of all-cause death, cardiovascular death, and admission for HF were significantly higher in FMR patients. The adjusted Cox regression analysis showed that significant FMR was associated with higher incidences of all-cause death [hazard ratio (HR) 2.179, 95 % confidence interval (CI) 1.266-3.751; P = 0.005], cardiovascular death (HR 2.371, 95 % CI 1.157-4.858; P = 0.018), and admission for HF (HR 1.819, 95 % CI 1.133-2.920; P = 0.013). FMR was common in Japanese symptomatic HF patients and was associated with adverse long-term outcomes. Establishing optimal therapeutic strategies for FMR is warranted.	[Kaneko, Hidehiro; Suzuki, Shinya; Uejima, Tokuhisa; Kano, Hiroto; Matsuno, Shunsuke; Otsuka, Takayuki; Takai, Hideaki; Oikawa, Yuji; Yajima, Junji; Koike, Akira; Nagashima, Kazuyuki; Kirigaya, Hajime; Sagara, Koichi; Tanabe, Hiroaki; Sawada, Hitoshi; Aizawa, Tadanori; Yamashita, Takeshi] Cardiovasc Inst, Dept Cardiovasc Med, Minato Ku, Tokyo 1060031, Japan	Kaneko, H (reprint author), Cardiovasc Inst, Dept Cardiovasc Med, Minato Ku, 3-2-19 Nishiazabu, Tokyo 1060031, Japan.	h-kaneko@cvi.or.jp					Feldman T, 2009, J AM COLL CARDIOL, V54, P686, DOI 10.1016/j.jacc.2009.03.077; ENRIQUEZSARANO M, 1993, J AM COLL CARDIOL, V21, P1211; Mihaljevic T, 2007, J AM COLL CARDIOL, V49, P2191, DOI 10.1016/j.jacc.2007.02.043; van Bommel RJ, 2011, CIRCULATION, V124, P912, DOI 10.1161/CIRCULATIONAHA.110.009803; Di Biase L, 2011, EUROPACE, V13, P829, DOI 10.1093/europace/eur047; Feldman T, 2005, J AM COLL CARDIOL, V46, P2134, DOI 10.1016/j.jacc.2005.07.065; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Trichon BH, 2003, AM J CARDIOL, V91, P538, DOI 10.1016/S0002-9149(02)03301-5; Tsutsui H, 2001, AM J CARDIOL, V88, P530, DOI 10.1016/S0002-9149(01)01732-5; Rossi A, 2011, HEART, V97, P1675, DOI 10.1136/hrt.2011.225789; Breithardt OA, 2003, J AM COLL CARDIOL, V41, P765, DOI 10.1016/S0735-1097(02)02937-6; Grayburn PA, 2013, CIRCULATION, V128, P1667, DOI 10.1161/CIRCULATIONAHA.112.001039; Kaneko H, 2013, J CARDIOL, V62, P18, DOI 10.1016/j.jjcc.2013.02.009; Suzuki S, 2008, CIRC J, V72, P914, DOI 10.1253/circj.72.914; Dickstein K, 2010, EUR HEART J, V31, P2677, DOI 10.1093/eurheartj/ehq337; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Kaneko H, 2014, HEART VESSELS, V29, P156, DOI 10.1007/s00380-013-0339-9; Auricchio A, 2011, J AM COLL CARDIOL, V58, P2183, DOI 10.1016/j.jacc.2011.06.061; Neuss M, 2013, EUR J HEART FAIL, V15, P786, DOI 10.1093/eurjhf/hfs214; Koelling TM, 2002, AM HEART J, V144, P524, DOI 10.1067/mhj.2002.123575; Kaneko H, 2013, J CARDIOL, V62, P102, DOI 10.1016/j.jjcc.2013.03.013; Kaneko H, 2012, J CARDIOL, V59, P359, DOI 10.1016/j.jjcc.2012.01.004; Kaneko H, 2014, HEART VESSELS, V29, P21, DOI 10.1007/s00380-013-0325-2; Ramadan MM, 2008, INT HEART J, V49, P459, DOI 10.1536/ihj.49.459; Shiba Nobuyuki, 2008, Vasc Health Risk Manag, V4, P103, DOI 10.2147/vhrm.2008.04.01.103; Tsuchihashi-Makaya M, 2009, CIRC J, V73, P1893; VanDantzig JM, 1996, AM HEART J, V131, P865, DOI 10.1016/S0002-8703(96)90166-0	27	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					801	807		10.1007/s00380-013-0448-5		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200010		
J	Irie, T; Kaneko, Y; Nakajima, T; Ota, M; Iijima, T; Tamura, M; Iizuka, T; Tamura, S; Saito, A; Kurabayashi, M				Irie, Tadanobu; Kaneko, Yoshiaki; Nakajima, Tadashi; Ota, Masaki; Iijima, Takafumi; Tamura, Mio; Iizuka, Takashi; Tamura, Shuntaro; Saito, Akihiro; Kurabayashi, Masahiko			Electroanatomically estimated length of slow pathway in atrioventricular nodal reentrant tachycardia	HEART AND VESSELS			English	Article						Atrioventricular nodal reentrant tachycardia; Slow pathway; Koch's triangle; Atrioventricular node; Radiofrequency ablation; Electroanatomic mapping	SELECTIVE RADIOFREQUENCY ABLATION; CORONARY-SINUS MORPHOLOGY; CATHETER ABLATION; KOCHS TRIANGLE; ELECTROPHYSIOLOGICAL CHARACTERISTICS; JUNCTIONAL RHYTHM; CONDUCTION; SITE; CIRCUIT; ENERGY	The length of the slow pathway (SP-L) in atrioventricular (AV) nodal reentrant tachycardia (NRT) has never been measured clinically. We studied the relationship among (a) SP-L, i.e., the distance between the most proximal His bundle (H) recording and the most posterior site of radiofrequency (RF) delivery associated with a junctional rhythm, (b) the length of Koch's triangle (Koch-L), (c) the conduction time over the slow pathway (SP-T), measured by the AH interval during AVNRT at baseline, and (d) the distance between H and the site of successful ablation (SucABL-L) in 26 women and 20 men (mean age 64.6 +/- 11.6 years), using a stepwise approach and an electroanatomic mapping system (EAMS). SP-L (15.0 +/- 5.8 mm) was correlated with Koch-L (18.6 +/- 5.6 mm; R (2) = 0.1665, P < 0.005), SP-T (415 +/- 100 ms; R (2) = 0.3425, P = 0.036), and SucABL-L (11.6 +/- 4.7 mm; R (2) = 0.5243, P < 0.0001). The site of successful ablation was located within 10 mm of the posterior end of the SP in 38 patients (82.6 %). EAMS-guided RF ablation, using a stepwise approach, revealed individual variations in SP-L related to the size of Koch's triangle and AH interval during AVNRT. Since the site of successful ablation was also correlated with SP-L and was usually located near the posterior end of the SP, ablating anteriorly, away from the posterior end, is not a prerequisite for the success of ablation procedures.	[Irie, Tadanobu; Kaneko, Yoshiaki; Nakajima, Tadashi; Ota, Masaki; Iijima, Takafumi; Tamura, Mio; Iizuka, Takashi; Tamura, Shuntaro; Saito, Akihiro; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gumma 3718511, Japan	Kaneko, Y (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	kanekoy@gunma-u.ac.jp					Inoue S, 1998, CIRCULATION, V97, P188; Calkins H, 1999, CIRCULATION, V99, P262; THAKUR RK, 1993, J AM COLL CARDIOL, V22, P1706; Dagres N, 2006, HEART, V92, P115, DOI 10.1136/hrt.2004.054056; DOIG JC, 1995, CIRCULATION, V92, P436; Geller JC, 2004, PACE, V27, P1347; Goldberg CS, 1999, AM J CARDIOL, V83, pA9; HAISSAGUERRE M, 1992, CIRCULATION, V85, P2162; Hayashi M, 2001, PACE, V24, P1187, DOI 10.1046/j.1460-9592.2001.01187.x; Hsieh MH, 1998, CIRCULATION, V98, P2296; HUMMEL JD, 1995, J CARDIOVASC ELECTR, V6, P681, DOI 10.1111/j.1540-8167.1995.tb00444.x; Inoue S, 1998, PACE, V21, P1553, DOI 10.1111/j.1540-8159.1998.tb00242.x; JACKMAN WM, 1992, NEW ENGL J MED, V327, P313, DOI 10.1056/NEJM199207303270504; JAZAYERI MR, 1992, CIRCULATION, V85, P1318; JENTZER JH, 1994, CIRCULATION, V90, P2820; Josephson ME, 2008, CLIN CARDIAC ELECTRO, P175; KALBFLEISCH SJ, 1994, J AM COLL CARDIOL, V23, P716; Kawabata M, 1999, JPN CIRC J, V63, P427, DOI 10.1253/jcj.63.427; KAY GN, 1992, CIRCULATION, V85, P1675; Kopelman HA, 2003, EUROPACE, V5, P171, DOI 10.1053/eupc.2002.0296; Markowitz SM, 1996, CIRCULATION, V94, P2856; MCGUIRE MA, 1992, AM J CARDIOL, V70, P829, DOI 10.1016/0002-9149(92)90574-I; Nagamoto Y, 2012, HEART VESSELS, V27, P174, DOI 10.1007/s00380-011-0126-4; Nikoski V, 2001, CIRC RES, V88, pE23; Okumura Y, 2004, J CARDIOVASC ELECTR, V15, P269, DOI 10.1046/j.1540-8167.2004.03114.x; Otomo K, 2007, HEART RHYTHM, V4, P421, DOI 10.1016/j.hrthm.2006.12.035; Otomo K, 2006, J CARDIOVASC ELECTR, V17, P1177, DOI 10.1111/j.1540-8167.2006.00598.x; Suenari K, 2013, HEART VESSELS, V28, P360, DOI 10.1007/s00380-012-0253-6; Sumitomo N, 2007, CIRC J, V71, P1918, DOI 10.1253/circj.71.1918; Tai CT, 1996, J AM COLL CARDIOL, V28, P725, DOI 10.1016/0735-1097(96)00217-3; Thibault B, 1998, J CARDIOVASC ELECTR, V9, P631, DOI 10.1111/j.1540-8167.1998.tb00946.x; Ueng KC, 1996, J CARDIOVASC ELECTR, V7, P1017, DOI 10.1111/j.1540-8167.1996.tb00477.x; WANG CC, 1994, AM HEART J, V128, P219, DOI 10.1016/0002-8703(94)90471-5; WATHEN M, 1992, AM J CARDIOL, V70, P886, DOI 10.1016/0002-9149(92)90732-E; WU DL, 1993, J AM COLL CARDIOL, V21, P1612; Yamabe H, 1999, CIRCULATION, V100, P621; Yamane T, 1999, J CARDIOVASC ELECTR, V10, P529, DOI 10.1111/j.1540-8167.1999.tb00709.x	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					817	824		10.1007/s00380-013-0424-0		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200012		
J	Masutani, S; Saiki, H; Kurishima, C; Kuwata, S; Tamura, M; Senzaki, H				Masutani, Satoshi; Saiki, Hirofumi; Kurishima, Clara; Kuwata, Seiko; Tamura, Masanori; Senzaki, Hideaki			Assessment of ventricular relaxation and stiffness using early diastolic mitral annular and inflow velocities in pediatric patients with heart disease	HEART AND VESSELS			English	Article						Diastolic function; Stiffness; Relaxation; Tissue Doppler; Echo	ATRIAL SEPTAL-DEFECT; TISSUE DOPPLER; ISOVOLUMIC RELAXATION; NATRIURETIC PEPTIDE; PLASMA-LEVELS; REPAIRED TETRALOGY; FILLING PRESSURES; TIME CONSTANT; ECHOCARDIOGRAPHY; FAILURE	This study was undertaken to test the hypothesis that noninvasive echocardiographic indexes obtained using early diastolic mitral annular and inflow velocities reflect diastolic function in children. We included in this study 61 consecutive pediatric patients (age 0.4-13 years) who underwent cardiac catheterization for various heart diseases with biventricular circulation. Left ventricular (LV) pressure was measured using a high-fidelity manometer to obtain the time constant of relaxation (tau) and LV chamber stiffness (K). Echocardiography was simultaneously performed during catheterization. Data acquisition was repeated after the administration of dobutamine. The peak early mitral annular velocity (e') and tau showed a significant inverse correlation (r = -0.42). Receiver-operating characteristic (ROC) analysis to determine the 90th percentile of tau yielded an area under the curve (AUC) of 0.86 for a septal e' < 6.2 cm/s, with sensitivity and specificity of 0.83. The dobutamine-induced changes in e' closely correlated with those in tau (r = -0.69). The deceleration time (DT) showed a significant but weak negative correlation with K (r = -0.35), and ROC analysis to determine the 90th percentile of Ie yielded an AUC of 0.82 for a DT < 100 ms, with sensitivity of 0.80 and specificity of 0.77. The ratio of peak early mitral inflow velocity (E) to e' (E/e') significantly correlated with LV end-diastolic pressure (EDP; r = 0.48, P < 0.0005), and ROC analysis to determine the 90th percentile of EDP (> 12.96 mmHg) yielded an AUC of 0.81 for an E/e' > 16.4, with sensitivity of 0.71 and specificity of 0.93. The e', DT, and E/e' values in our study reflect the diastolic function in our pediatric population. However, the weak correlations between these indexes and invasive measures of diastolic function suggest that these indexes are useful in detecting diastolic dysfunction but not in determining the absolute values of diastolic dysfunction. Therefore, a future study is warranted to develop an efficient algorithm for systematic noninvasive evaluation of LV diastolic function in children.	[Masutani, Satoshi; Saiki, Hirofumi; Kurishima, Clara; Kuwata, Seiko; Tamura, Masanori; Senzaki, Hideaki] Saitama Med Univ, Saitama Med Ctr, Dept Pediat Cardiol, Kawagoe, Saitama 3508550, Japan	Senzaki, H (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Pediat Cardiol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	hsenzaki@saitama-med.ac.jp			Japan Society for the Promotion of Science and Medical Research [8025127]; Nipro Corporation; Kawano Memorial Foundation; Tenshindo Medical Institution; Saitama Medical University	We thank our university colleagues who performed the catheterization studies. This study was supported by a national grant (no. 8025127) from the Japan Society for the Promotion of Science and Medical Research; grants from Nipro Corporation, Kawano Memorial Foundation, and Tenshindo Medical Institution; and an internal grant from Saitama Medical University.	Amano H, 2013, HEART VESSELS, V28, P505, DOI 10.1007/s00380-012-0272-3; GIANNUZZI P, 1994, J AM COLL CARDIOL, V23, P1630; Senzaki H, 2001, J THORAC CARDIOV SUR, V122, P535, DOI 10.1067/mtc.2001.115424; Ommen SR, 2000, CIRCULATION, V102, P1788; Nagueh SF, 2001, J AM COLL CARDIOL, V37, P278, DOI 10.1016/S0735-1097(00)01056-1; Eidem BW, 2004, J AM SOC ECHOCARDIOG, V17, P212, DOI 10.1067/j.echo.2003.12.005; Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032; Masutani S, 2008, CIRCULATION, V117, P1550, DOI 10.1161/CIRCULATIONAHA.107.730564; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8; Little WC, 2009, CIRCULATION, V120, P802, DOI 10.1161/CIRCULATIONAHA.109.869602; McMahon CJ, 2004, CIRCULATION, V109, P1756, DOI 10.1161/01.CIR.0000124723.16433.31; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; SCHNITTGER I, 1983, J AM COLL CARDIOL, V2, P934; MATSUBARA H, 1995, CIRCULATION, V92, P2318; LITTLE WC, 1995, CIRCULATION, V92, P1933; Mullens W, 2009, CIRCULATION, V119, P62, DOI 10.1161/CIRCULATIONAHA.108.779223; RAFF GL, 1981, CIRC RES, V48, P813; Border WL, 2003, J AM SOC ECHOCARDIOG, V16, P988, DOI 10.1016/S0894-7317(03)00511-X; Florianczyk T, 2011, CLIN RES CARDIOL, V100, P493, DOI 10.1007/s00392-010-0272-1; FRAIS MA, 1990, CIRCULATION, V81, P1071; Goldberg DJ, 2011, PEDIATR TRANSPLANT, V15, P488, DOI 10.1111/j.1399-3046.2011.01503.x; Lee N, 2013, HEART VESSELS, V28, P76, DOI 10.1007/s00380-011-0212-7; Harada K, 2001, AM J CARDIOL, V88, P927, DOI 10.1016/S0002-9149(01)01912-9; Lu JC, 2012, PEDIATR CARDIOL, V33, P618, DOI 10.1007/s00246-012-0189-8; Masutani S, 2012, HEART VESSELS, V27, P71, DOI 10.1007/s00380-011-0122-8; Masutani S, 2009, AM J CARDIOL, V104, P1732, DOI 10.1016/j.amjcard.2009.07.058; Mori K, 2002, PEDIATR CARDIOL, V23, P160, DOI 10.1007/s00246-001-0040-0; Oyamada J, 2008, ECHOCARDIOGR-J CARD, V25, P270, DOI 10.1111/j.1540-8175.2007.00594.x; Quinones MA, 2005, PROG CARDIOVASC DIS, V47, P340, DOI 10.1016/j.pcad.2005.02.009; Senzaki H, 2010, CIRC-HEART FAIL, V3, P268, DOI 10.1161/CIRCHEARTFAILURE.109.865592; Senzaki H, 1999, J AM COLL CARDIOL, V34, P1529, DOI 10.1016/S0735-1097(99)00362-9; Smiseth OA, 2001, CAN J CARDIOL, V17, P1167; Solomon SD, 2009, CIRCULATION, V119, P13, DOI 10.1161/CIRCULATIONAHA.108.823591	36	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					825	833		10.1007/s00380-013-0422-2		9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200013		
J	Endo, T; Tomita, H; Higuma, T; Abe, N; Kushibiki, M; Saitoh, S; Yamada, M; Yokota, T; Echizen, T; Yokoyama, H; Tateyama, S; Suzuki, A; Ishida, Y; Murakami, K; Osanai, T; Okumura, K				Endo, Tomohide; Tomita, Hirofumi; Higuma, Takumi; Abe, Naoki; Kushibiki, Motoi; Saitoh, Shin; Yamada, Masahiro; Yokota, Takashi; Echizen, Takashi; Yokoyama, Hiroaki; Tateyama, Shunta; Suzuki, Akiko; Ishida, Yuji; Murakami, Kazuo; Osanai, Tomohiro; Okumura, Ken			Low serum eicosapentaenoic acid level is a risk for ventricular arrhythmia in patients with acute myocardial infarction: a possible link to J-waves	HEART AND VESSELS			English	Article						Eicosapentaenoic acid; Acute myocardial infarction; Ventricular arrhythmia; J-wave	POLYUNSATURATED FATTY-ACIDS; CORONARY-ARTERY-DISEASE; EARLY REPOLARIZATION; CARDIAC-ARREST; FIBRILLATION; PREVENTION; ISCHEMIA; EVENTS; PHASE; JELIS	Eicosapentaenoic acid (EPA) has antiarrhythmic effects. The J-wave on an electrocardiogram is associated with a high incidence of ventricular tachycardia/fibrillation (VT/VF). We evaluated relationships between EPA and J-waves, and their involvement in the occurrence of VT/VF in acute myocardial infarction (AMI). Two hundred consecutive patients undergoing successful percutaneous coronary intervention within 12 h after AMI onset were enrolled. Serum EPA level and J-waves at admission were evaluated. The patients were divided into two groups according to the optimal cutoff value (2.94) of serum EPA level (% of total fatty acids): LOW (< 2.94, 61 +/- 11 years, n = 103) and HIGH groups (a parts per thousand yen2.94, 70 +/- 13 years, n = 81). J-waves were observed more frequently in the LOW (36/103, 35 %) than in HIGH group (16/81, 20 %) (P = 0.020). The 30-day incidence of VT/VF including those occurring before admission was higher in the LOW (19.5 %) than in HIGH group (6.2 %) (P = 0.009). The patients with J-waves showed a higher incidence of VT/VF (23.1 %) than those without J-waves (9.9 %) (P = 0.019). Kaplan-Meier analysis showed that the highest incidence of VT/VF was observed in the LOW with J-wave group (27.8 %), followed by the LOW without J-wave (15.0 %), HIGH with J-wave (12.5 %), and HIGH without J-wave (4.6 %) (P = 0.013). Cox proportional hazard analysis revealed that Killip grade and low serum EPA level or presence of J-waves were significantly associated with the incidence of VT/VF. Low serum EPA level is a risk for incidence of VT/VF in the acute phase of myocardial infarction. Involvement of the J-wave and its possible link with EPA in the pathogenesis of ischemia-induced VT/VF are suggested.	[Endo, Tomohide; Tomita, Hirofumi; Higuma, Takumi; Abe, Naoki; Kushibiki, Motoi; Saitoh, Shin; Yamada, Masahiro; Yokota, Takashi; Echizen, Takashi; Yokoyama, Hiroaki; Tateyama, Shunta; Suzuki, Akiko; Ishida, Yuji; Murakami, Kazuo; Osanai, Tomohiro; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol, Hirosaki, Aomori 0368562, Japan	Okumura, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Cardiol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	okumura@cc.hirosaki-u.ac.jp					Aarsetoy H, 2008, RESUSCITATION, V78, P258, DOI 10.1016/j.resuscitation.2008.04.007; Matsuzaki M, 2009, CIRC J, V73, P1283; Antzelevitch C, 2012, CIRC J, V76, P1054, DOI 10.1253/circj.CJ-12-0284; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Patel RB, 2010, CIRC-ARRHYTHMIA ELEC, V3, P489, DOI 10.1161/CIRCEP.109.921130; VENKATESH N, 1991, CIRC RES, V69, P623; Nakayama M, 2013, EUROPACE, V15, P109, DOI 10.1093/europace/eus259; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Yan GX, 2004, CIRCULATION, V110, P1036, DOI 10.1161/01.CIR.0000140258.09964.19; Ueeda M, 2011, HEART VESSELS, V26, P145, DOI 10.1007/s00380-010-0038-8; Naruse Y, 2012, CIRC-ARRHYTHMIA ELEC, V5, P506, DOI 10.1161/CIRCEP.111.966952; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; [Anonymous], 1999, LANCET, V354, P447; Rudic B, 2012, HEART RHYTHM, V9, P1295, DOI 10.1016/j.hrthm.2012.03.006; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Chen YC, 2014, HEART VESSELS, V29, P249, DOI 10.1007/s00380-013-0352-z; Jastrzebski M, 2009, HEART RHYTHM, V6, P829, DOI 10.1016/j.hrthm.2009.02.036; KINOSHITA I, 1994, JPN CIRC J, V58, P903; Myojo T, 2012, PACE, V35, pe27, DOI 10.1111/j.1540-8159.2010.02874.x; Schrepf R, 2004, LANCET, V363, P1441, DOI 10.1016/S0140-6736(04)16105-9; Tomita T, 2012, HEART VESSELS, V28, P497; Tsuburaya R, 2011, J MOL CELL CARDIOL, V51, P329, DOI 10.1016/j.yjmcc.2011.05.018; Wilde AAM, 2012, HEART RHYTHM, V9, P556, DOI 10.1016/j.hrthm.2012.01.002; WILDE AAM, 1994, CARDIOVASC RES, V28, P16, DOI 10.1093/cvr/28.1.16	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					847	854		10.1007/s00380-013-0435-x		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200015		
J	Okamoto, Y; Yamamoto, K; Sugimoto, T; Asami, F; Nagasawa, A; Shiraiwa, S; Nakamura, N; Yoshii, S				Okamoto, Yuki; Yamamoto, Kazuo; Sugimoto, Tsutomu; Asami, Fuyuki; Nagasawa, Ayako; Shiraiwa, Satoru; Nakamura, Norihito; Yoshii, Shinpei			Descending aorta-external iliac artery bypass for middle aortic syndrome	HEART AND VESSELS			English	Article						Middle aortic syndrome; Hypertension; Renal artery stenosis	THORACIC AORTA; REVASCULARIZATION	We encountered a surgical case of middle aortic syndrome (MAS) in a 56-year-old man who had resistant hypertension. Computed tomography showed severe stenosis of the abdominal aorta from below the superior mesenteric artery to above the inferior mesenteric artery. Although bilateral renal artery stenosis was confirmed, renal function was within normal limits. A 10-mm vascular prosthetic graft was used to perform a descending aorta to left external iliac artery bypass. His hypertension was well controlled without medication. This extra-anatomic bypass may be a simple and useful approach for treating MAS if it is not necessary to reconstruct the renal artery or visceral artery.	[Okamoto, Yuki; Yamamoto, Kazuo; Sugimoto, Tsutomu; Asami, Fuyuki; Nagasawa, Ayako; Shiraiwa, Satoru; Nakamura, Norihito; Yoshii, Shinpei] Tachikawa Med Ctr, Dept Cardiovasc Surg, Nagaoka, Niigata 9400052, Japan	Okamoto, Y (reprint author), Tachikawa Med Ctr, Dept Cardiovasc Surg, 3-2-11 Kanda Cho, Nagaoka, Niigata 9400052, Japan.	yamanashimedical@yahoo.co.jp					Stanley JC, 2008, J VASC SURG, V48, P1073, DOI 10.1016/j.jvs.2008.05.078; Kallistratos MS, 2012, HEART VESSELS, V27, P46, DOI 10.1007/s00380-010-0115-z; CRIADO E, 1992, J VASC SURG, V15, P550; Daimon S, 1964, JPN HEART J, V82, P562; Delis Konstantinos T, 2005, Perspect Vasc Surg Endovasc Ther, V17, P187, DOI 10.1177/153100350501700302; Hetzer R, 2013, ANN THORAC SURG, V96, P183, DOI 10.1016/j.athoracsur.2013.03.025; MESSINA LM, 1986, ANN SURG, V204, P331, DOI 10.1097/00000658-198609000-00012; Passman MA, 1999, J VASC SURG, V29, P249, DOI 10.1016/S0741-5214(99)70378-2; POULIAS GE, 1990, EUR J VASC SURG VOL, P75; Saito S, 2012, HEART VESSELS, V27, P594, DOI 10.1007/s00380-011-0195-4; SEN PK, 1963, BRIT HEART J, V25, P610	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					864	866		10.1007/s00380-013-0441-z		3	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200017		
J	Sakamoto, N; Sato, N; Goto, M; Kobayashi, M; Takehara, N; Takeuchi, T; Talib, AK; Sugiyama, E; Minoshima, A; Tanabe, Y; Akasaka, K; Kawabe, J; Kawamura, Y; Doi, A; Hasebe, N				Sakamoto, Naka; Sato, Nobuyuki; Goto, Masahide; Kobayashi, Motoi; Takehara, Naofumi; Takeuchi, Toshiharu; Talib, Ahmed Karim; Sugiyama, Eitaro; Minoshima, Akiho; Tanabe, Yasuko; Akasaka, Kazumi; Kawabe, Junichi; Kawamura, Yuichiro; Doi, Atsushi; Hasebe, Naoyuki			Three cases of corticosteroid therapy triggering ventricular fibrillation in J-wave syndromes	HEART AND VESSELS			English	Article						Corticosteroid therapy; J-wave syndrome; Prednisolone; Ventricular fibrillation	EARLY REPOLARIZATION; BRUGADA-SYNDROME; METHYLPREDNISOLONE; RAT; HYPOKALEMIA; CHANNELS; CURRENTS	We describe three cases of J-wave syndrome in which ventricular fibrillation (VF) was probably induced by corticosteroid therapy. The patients involved were being treated with prednisolone for concomitant bronchial asthma. One of the three patients had only one episode of VF during her long follow-up period (14 years). Two patients had hypokalemia during their VF episodes. Corticosteroids have been shown to induce various types of arrhythmia and to modify cardiac potassium channels. We discuss the possible association between corticosteroid therapy and VF in J-wave syndrome based on the cases we have encountered.	[Sakamoto, Naka; Sato, Nobuyuki; Goto, Masahide; Kobayashi, Motoi; Takehara, Naofumi; Takeuchi, Toshiharu; Talib, Ahmed Karim; Sugiyama, Eitaro; Minoshima, Akiho; Tanabe, Yasuko; Akasaka, Kazumi; Kawabe, Junichi; Kawamura, Yuichiro; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Cardiol, Asahikawa, Hokkaido 0788510, Japan; [Doi, Atsushi] Asahikawa Red Cross Hosp, Dept Cardiol, Asahikawa, Hokkaido, Japan	Sato, N (reprint author), Asahikawa Med Univ, Dept Cardiol, Midorigaoka Higashi 2-1-1, Asahikawa, Hokkaido 0788510, Japan.	nsato@asahikawa-med.ac.jp					Watanabe H, 2011, CIRC-ARRHYTHMIA ELEC, V4, P874, DOI 10.1161/CIRCEP.111.963983; Takehara N, 2004, J INTERN MED, V255, P137, DOI 10.1046/j.0954-6820.2003.01247.x; Antzelevitch C, 2012, CIRC J, V76, P1054, DOI 10.1253/circj.CJ-12-0284; Wang L, 1999, CIRC RES, V85, P168; Akikusa JD, 2007, PEDIATRICS, V119, pE778, DOI 10.1542/peds.2006-0029; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Araki T, 2003, CIRC J, V67, P93, DOI 10.1253/circj.67.93; Bendahhou S, 2007, HUM MOL GENET, V16, P900, DOI 10.1093/hmg/ddm034; Capuano V, 2002, MOL CELL BIOCHEM, V237, P1, DOI 10.1023/A:1016518920693; Chen YC, 2014, HEART VESSELS, V29, P249, DOI 10.1007/s00380-013-0352-z; COULOMBE A, 1994, PFLUG ARCH EUR J PHY, V427, P47, DOI 10.1007/BF00585941; FUJIMOTO S, 1990, AM J NEPHROL, V10, P231, DOI 10.1159/000168087; Kawashiri M, 2014, HEART VESSELS, V29, P129, DOI 10.1007/s00380-013-0391-5; Myojo T, 2012, PACE, V35, pe234, DOI 10.1111/j.1540-8159.2012.03460.x; Seebohm G, 2012, FASEB J, V26, P513, DOI 10.1096/fj.11-189126; Shimoni Y, 2005, BRIT J PHARMACOL, V146, P280, DOI 10.1038/sj.bjp.0706314; Takeuchi T, 2003, PACE, V26, P632, DOI 10.1046/j.1460-9592.2003.00106.x; Vasheghani-Farahani A, 2011, J NEUROL SCI, V309, P75, DOI 10.1016/j.jns.2011.07.018	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					867	872		10.1007/s00380-013-0443-x		6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200018		
J	Kato, H; Shumiya, T; Yamauchi, M; Miyamoto, J; Nakano, A; Tsukamoto, H; Okumura, K				Kato, Hiroo; Shumiya, Takanori; Yamauchi, Masaki; Miyamoto, Junko; Nakano, Akinobu; Tsukamoto, Hideto; Okumura, Kenji			Rapidly progressive symptom development of pulmonary arterial hypertension: a case report of Trousseau syndrome	HEART AND VESSELS			English	Article						Trousseau syndrome; Signet-ring cell; Pulmonary arterial hypertension; Mucin-producing adenocarcinoma	TUMOR THROMBOTIC MICROANGIOPATHY; CARCINOMA; METASTASIS; MECHANISMS	Trousseau syndrome is most commonly defined as a hypercoagulability syndrome associated with mucin-producing adenocarcinoma. We report here a rare case of Trousseau syndrome presenting as pulmonary arterial hypertension. The patient complained of cough and increasing exertional dyspnea. Rapidly progressive symptom development of pulmonary arterial hypertension accompanied by right heart failure was observed, and the patient died on hospital day 2. An autopsy revealed Krukenberg tumors on both ovaries and a signet-ring cell gastric carcinoma. In the lungs there was tumor embolism with signet-ring cells to some extent, but the peripheral pulmonary arteries were occupied primarily by pulmonary embolism with platelets, fibroblasts, and fibrotic organized thrombi.	[Kato, Hiroo; Shumiya, Takanori; Yamauchi, Masaki; Tsukamoto, Hideto; Okumura, Kenji] Toki Municipal Gen Hosp, Dept Cardiol, Gifu 5095193, Japan; [Miyamoto, Junko; Nakano, Akinobu] Toki Municipal Gen Hosp, Dept Pathol, Toki, Gifu, Japan	Okumura, K (reprint author), Toki Municipal Gen Hosp, Dept Cardiol, 703-24 Tokiguchi,Tokitsu Cho, Gifu 5095193, Japan.	kenji@med.nagoya-u.ac.jp					Amano H, 2013, HEART VESSELS, V28, P505, DOI 10.1007/s00380-012-0272-3; Rickles FR, 2006, PATHOPHYSIOL HAEMO T, V35, P103, DOI 10.1159/000093551; Wahrenbrock M, 2003, J CLIN INVEST, V112, P853, DOI 10.1172/JCI200318882; Kim YS, 1996, GLYCOCONJUGATE J, V13, P693, DOI 10.1007/BF00702333; Varki NM, 2002, SEMIN THROMB HEMOST, V28, P53, DOI 10.1055/s-2002-20564; Donati MB, 2009, BEST PRACT RES CL HA, V22, P3, DOI 10.1016/j.beha.2009.01.005; Bick RL, 2003, NEW ENGL J MED, V349, P109, DOI 10.1056/NEJMp030086; Dammacco F, 2013, CLIN EXP MED, V13, P85, DOI 10.1007/s10238-013-0230-0; Chinen K, 2010, PATHOL RES PRACT, V206, P682, DOI 10.1016/j.prp.2010.05.002; Varki A, 2007, BLOOD, V110, P1723, DOI 10.1182/blood-2006-10-053736; CARRAWAY KL, 1992, J CELL SCI, V103, P299; Denko NC, 2001, CANCER RES, V61, P795; Ladizinski B, 2013, CAN MED ASSOC J, V185, P1063, DOI 10.1503/cmaj.121344; Leong DP, 2011, INTERN MED J, V41, P289, DOI 10.1111/j.1445-5994.2011.02427.x; Tachihara M, 2012, INTERNAL MED, V51, P1099, DOI 10.2169/internalmedicine.51.6453; Ueda A, 2011, INTERNAL MED, V50, P2807, DOI 10.2169/internalmedicine.50.6113	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	NOV	2014	29	6					873	877		10.1007/s00380-013-0446-7		5	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7WM	WOS:000345145200019		
J	Miyaji, K; Shahrizaila, N; Umapathi, T; Chan, YC; Hirata, K; Yuki, N				Miyaji, Kazuki; Shahrizaila, Nortina; Umapathi, Thirugnanam; Chan, Yee-Cheun; Hirata, Koichi; Yuki, Nobuhiro			Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?	HUMAN IMMUNOLOGY			English	Article						Acute inflammatory demyelinating polyneuropathies; Chronic inflammatory demyelinating polyneuropathies; Ezrin; Radixin; Moesin	GUILLAIN-BARRE-SYNDROME; MEDICAL PROGRESS; POLYNEUROPATHY; MOESIN; EZRIN; POLYRADICULONEUROPATHY; ANTIBODIES; RADIXIN	Ezrin, radixin and moesin, which are strongly expressed in the Schwann cell microvilli, are putative targets for autoantibodies in acute or chronic inflammatory demyelinating polyneuropathy (AIDP or CIDP). An association between anti-moesin IgG antibodies and cytomegalovirus-related AIDP has been postulated. None of 41 AIDP patients, including 8 cytomegalovirus-related AIDP patients, and 23 CIDP had IgG or IgM antibodies to ezrin, radixin and moesin; whereas, one patient with cytomegalovirus-related AIDP had anti-ezrin IgM antibodies. Ezrin, radixin and moesin are unlikely targets for autoantibodies in AIDP and CIDP, and the association of anti-moesin antibodies with cytomegalovirus-related AIDP was not confirmed. (C) 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.	[Miyaji, Kazuki; Yuki, Nobuhiro] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117599, Singapore; [Shahrizaila, Nortina] Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia; [Umapathi, Thirugnanam] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore; [Chan, Yee-Cheun] Natl Univ Singapore Hosp, Dept Med, Singapore 117548, Singapore; [Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan; [Yuki, Nobuhiro] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117599, Singapore	Yuki, N (reprint author), Natl Univ Singapore, Dept Med, Ctr Translat Med, Unit 09 01, 14 Med Dr, Singapore 117599, Singapore.	mdcyuki@nus.edu.sg	SHAHRIZAILA, NORTINA /B-9402-2010				KHALILISHIRAZI A, 1993, J NEUROIMMUNOL, V46, P245, DOI 10.1016/0165-5728(93)90255-W; Sawai S, 2014, NEUROLOGY, V83, P113, DOI 10.1212/WNL.0000000000000566; Querol L, 2013, ANN NEUROL, V73, P370, DOI 10.1002/ana.23794; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x; Kuwahara M, 2011, J NEUROIMMUNOL, V239, P87, DOI 10.1016/j.jneuroim.2011.08.016; Kaida K, 2008, NEUROLOGY, V71, P196, DOI 10.1212/01.wnl.0000317093.57106.33; Kokubun N, 2010, BRAIN, V133, P2897, DOI 10.1093/brain/awq260; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; EVERETT AW, 1990, J HISTOCHEM CYTOCHEM, V38, P1137; Hafer-Macko C. E., 1996, Annals of Neurology, V39, P625, DOI 10.1002/ana.410390512; Koller H, 2005, NEW ENGL J MED, V352, P1343, DOI 10.1056/NEJMra041347; Melendez-Vasquez CV, 2001, P NATL ACAD SCI USA, V98, P1235, DOI 10.1073/pnas.98.3.1235; Scherer SS, 2001, J NEUROSCI RES, V65, P150, DOI 10.1002/jnr.1138	15	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0198-8859	1879-1166		HUM IMMUNOL	Hum. Immunol.	NOV	2014	75	11					1089	1091		10.1016/j.humimm.2014.09.010		3	Immunology	Immunology	AT9NZ	WOS:000345255100003		
J	Kaneko, M; Hu, WH; Hayashi, K; Sakai, H				Kaneko, Megumi; Hu, Wenhao; Hayashi, Kazunori; Sakai, Hideaki			Compressed Sensing-Based Tag Identification Protocol for a Passive RFID System	IEEE COMMUNICATIONS LETTERS			English	Article						Compressed sensing; RFID system; tag identification protocols		We propose a novel tag identification protocol based on compressed sensing (CS) in a radio frequency identification (RFID) system. Unlike the existing Buzz protocol based on CS, our protocol does not require arbitrary restriction of the initially huge ID search space size. Moreover, by also making use of CS techniques for reducing the ID search space, our protocol significantly decreases the amount of required bits for successful identification as well as computational complexity compared to state-of-the-art protocols with ideal parameters.	[Kaneko, Megumi; Hu, Wenhao; Hayashi, Kazunori; Sakai, Hideaki] Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan	Kaneko, M (reprint author), Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan.	meg@i.kyoto-u.ac.jp; hu.wenhao@i.kyoto-u.ac.jp; kazunori@i.kyoto-u.ac.jp; hsakai@i.kyoto-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [23760334, 26820143, 24560457, 24560490]	This work was supported by the Grants-in-Aid for Scientific Research no. 23760334, 26820143, 24560457 and 24560490 from the Ministry of Education, Science, Sports, and Culture of Japan. The associate editor coordinating the review of this paper and approving it for publication was K. Witrisal.	Chen WT, 2009, IEEE T AUTOM SCI ENG, V6, P9, DOI 10.1109/TASE.2008.917093; Wang J, 2012, ACM SIGCOMM COMP COM, V42, P61, DOI 10.1145/2377677.2377685; [Anonymous], 2005, EPC RADIO FREQUENCY; Bletsas A, 2012, IEEE T COMMUN, V60, P756, DOI 10.1109/TCOMM.2011.020612.110212; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Elad M, 2010, SPARSE AND REDUNDANT REPRESENTATIONS, P3, DOI 10.1007/978-1-4419-7011-4_1; Zhang Y., 2010, RFID SENSOR NETWORKS	7	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1089-7798	1558-2558		IEEE COMMUN LETT	IEEE Commun. Lett.	NOV	2014	18	11					2023	2026		10.1109/LCOMM.2014.2360684		4	Telecommunications	Telecommunications	AT6SR	WOS:000345069700039		
J	Tanaka, T				Tanaka, Toshikatsu			Report on IEEE/IEEJ Workshop on Computer Simulation in Polymer Dielectrics Held in Conjunction With ISEIM 2014 Niigata, Japan, on June 1, 2014	IEEE ELECTRICAL INSULATION MAGAZINE			English	Article							AMORPHOUS POLYETHYLENE; STATES; TRANSPORT; ALKANES		[Tanaka, Toshikatsu] Waseda Univ, Tokyo, Japan	Tanaka, T (reprint author), Waseda Univ, Tokyo, Japan.						Taleb M, 2013, IEEE T DIELECT EL IN, V20, P311, DOI 10.1109/TDEI.2013.6451372; Boufayed F, 2006, J APPL PHYS, V100, DOI 10.1063/1.2375010; Baudoin F, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871377; Cubero D, 2003, CHEM PHYS LETT, V370, P21, DOI 10.1016/S0009-2614(03)00046-0; Cubero D, 2004, J CHEM PHYS, V120, P7772, DOI 10.1063/1.1667471; Cubero D, 2003, J CHEM PHYS, V119, P2669, DOI 10.1063/1.1587130; Le Roy S., 2013, JACABLE HVDC 2013; Le Roy S, 2006, J PHYS D APPL PHYS, V39, P1427, DOI 10.1088/0022-3727/39/7/014; Oakes W. G., 1949, P IEE 1, V6, P37; Sun Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4755841; Sun Y., 2013, 2013 ICSD BOL IT JUN; Sun Y., 2014, IEEE T DIEL IN PRESS; Takada T., 2013, IEEE ANN REPORT CEID, P246; Unge M, 2012, C ELECT INSUL DIEL P, P525, DOI 10.1109/CEIDP.2012.6378835; Unge M, 2013, IEEE INT C SOL DIEL, P935; Unge M., CHEM PHYS LETT UNPUB; Vu T. T. N., 2013, JACABLE HVDC 2013, pP12; Vu TTN, 2013, IEEE INT C SOL DIEL, P413; Wang CC, 2014, POLYMER, V55, P979, DOI 10.1016/j.polymer.2013.12.069; Wang Y, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869831	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0883-7554	1558-4402		IEEE ELECTR INSUL M	IEEE Electr. Insul. Mag.	NOV-DEC	2014	30	6					34	42				9	Engineering, Electrical & Electronic	Engineering	AT5OT	WOS:000344992800010		
J	Tsuru, M; Nishida, K; Kawakami, K; Yamaguchi, D; Komaki, M; Taniguchi, E; Hieda, M				Tsuru, Masaomi; Nishida, Kazuhiro; Kawakami, Kenji; Yamaguchi, Daisuke; Komaki, Masahiko; Taniguchi, Eiji; Hieda, Morishige			Formulation of a Dual-Tapped Microstrip Resonator VCO	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Dual tapped; microstrip; resonators; voltage-controlled oscillators (VCOs)	LOW-PHASE-NOISE; CMOS VCO; BAND; OSCILLATOR; DESIGN; GHZ; POWER	This paper provides a formulation of the dual-tapped microstrip resonator. The formulation derives the Q-factor of the resonator, and the maximum value of the Q-factor while still satisfying oscillation conditions. It is shown that the optimized Q-factor can be determined without changing the resonant frequency bandwidth. The phase-noise performance of a voltage-controlled oscillator (VCO) using a dual-tapped microstrip resonator can therefore be designed independent of the design of the oscillation bandwidth. This feature results in simple design of low phase-noise VCOs while maintaining the desired oscillation bandwidth. Experimental results of an X-band VCO employing the dual-tapped microstrip resonator verify the theoretical findings. The fabricated X-band VCO achieves an oscillation bandwidth of 11.86-12.09 GHz and phase noise lower than -114.4 dBc/Hz at 100-kHz offset from the carrier. This VCO is one of the most low phase-noise planar X-band VCOs published to date.	[Tsuru, Masaomi; Nishida, Kazuhiro; Kawakami, Kenji; Yamaguchi, Daisuke; Komaki, Masahiko; Taniguchi, Eiji; Hieda, Morishige] Mitsubishi Electr Corp, Kamakura, Kanagawa 2478501, Japan	Tsuru, M (reprint author), Mitsubishi Electr Corp, Kamakura, Kanagawa 2478501, Japan.	Tsuru.Masaomi@eb.MitsubishiElectric.co.jp					ABE H, 1978, IEEE T MICROW THEORY, V26, P156, DOI 10.1109/TMTT.1978.1129336; Lan X, 2006, IEEE MICROW WIREL CO, V16, P425, DOI 10.1109/LMWC.2006.877128; Garner PJ, 1998, IEEE T MICROW THEORY, V46, P1531, DOI 10.1109/22.721161; LEESON DB, 1966, PR INST ELECTR ELECT, V54, P329, DOI 10.1109/PROC.1966.4682; Chen Z, 2013, IEEE MICROW WIREL CO, V23, P43, DOI 10.1109/LMWC.2012.2234088; Bao MQ, 2005, IEEE MICROW WIREL CO, V15, P751, DOI 10.1109/LMWC.2005.858983; Boyd D. A., 1987, IEEE MTT S INT MICR, V2, P587; Cantu H. I., 2006, The Institution of Engineering and Technology Seminar on MM-Wave Products and Technologies, DOI 10.1049/ic:20060112; Chakraborty A., 2013, IEEE BIP BICMOS CIRC, P195; Collin R. E., 1992, FDN MICROWAVE ENG, P329; Dussopt L, 2003, IEEE MICROW WIREL CO, V13, P4, DOI 10.1109/LMWC.2002.807699; ELKAMALI W, 1986, IEEE T MICROW THEORY, V34, P1059, DOI 10.1109/TMTT.1986.1133495; Gourdon C., 2006, 36 EUR MICR C SEP, P91; Ha KW, 2014, IEEE MICROW WIREL CO, V24, P418, DOI 10.1109/LMWC.2014.2313582; Hamano S, 2003, IEEE MTT S INT MICR, P2189, DOI 10.1109/MWSYM.2003.1210598; Hosoya K, 2000, IEEE MTT-S, P47, DOI 10.1109/MWSYM.2000.860882; Hu K, 2010, IEEE INT SYMP CIRC S, P1899; Hwang CG, 2003, IEEE MICROW WIREL CO, V13, P229, DOI 10.1109/LMWC.2003.814595; Ikematsu H., 1998, APMC98, P143; Jaewon C., 2010, AS PAC MICR C DEC, P394; Jaewon Choi, 2008, IEEE Transactions on Microwave Theory and Techniques, V56, DOI 10.1109/TMTT.2008.2007363; Jung D, 2009, APMC: 2009 ASIA PACIFIC MICROWAVE CONFERENCE, VOLS 1-5, P1707; Makon RE, 2005, ELECTRON LETT, V41, P961, DOI 10.1049/el:20050986; Matsuzuka T., 2003, IEEE MTT S INT MICR, V2, P725; Nick M., 2011, IEEE MTT S INT MICR, P1; Poddar A. K., 2011, JOINT IEEE INT FREQ, P1; Rohde U. L., 2008, IEEE SARN S APR, P1; Rohde U.L., 2006, IEEE INT FREQ CONTR, P432; Souares R., 1988, GAAS MESFET CIRCUIT, P345; Starzer F, 2012, PROCEEDINGS OF THE 2012 IEEE 14TH ELECTRONICS PACKAGING TECHNOLOGY CONFERENCE, P326; Sun Y., 2012, IEEE RAD FREQ INT CI, P79; TAJIMA K, 1997, IEEE MTTS INT, V3, P1217; Tanji K., 1998, 28 EUR MICR P OCT, V1, P47; Tseng CH, 2012, IEEE T MICROW THEORY, V60, P3151, DOI 10.1109/TMTT.2012.2210441; Tsuru M, 2010, EUR MICROW INTEGRAT, P460; Wang TP, 2011, IEEE T ULTRASON FERR, V58, P1307, DOI 10.1109/TUFFC.2011.1951; Wang Y., 2012, IEEE T BROADCAST, P1, DOI DOI 10.1111/J.1744-7402.2011.02733.X; Zirath H., 2004, IEEE Compound Semiconductor Integrated Circuit Symposium. 2004 IEEE CISC Symposium (IEEE Cat. No.04CH37591); Zou Q, 2012, IEEE T CIRCUITS-II, V59, P262, DOI 10.1109/TCSII.2012.2190855	39	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	NOV	2014	62	11			SI		2733	2742		10.1109/TMTT.2014.2360682		10	Engineering, Electrical & Electronic	Engineering	AT5NY	WOS:000344990700025		
J	Nakaharai, S; Iijima, T; Ogawa, S; Li, SL; Tsukagoshi, K; Sato, S; Yokoyama, N				Nakaharai, Shu; Iijima, Tomohiko; Ogawa, Shinichi; Li, Song-Lin; Tsukagoshi, Kazuhito; Sato, Shintaro; Yokoyama, Naoki			Electrostatically Reversible Polarity of Dual-Gated Graphene Transistors	IEEE TRANSACTIONS ON NANOTECHNOLOGY			English	Article						Nanoelectronics; thin-film transistors		We developed dual-gated graphene transistors in which the transistor polarity (n-type or p-type) is electrostatically reversible by the gate bias of one of the top gates. In this device, a channel is defined as the region between a pair of top gates, where graphene is irradiated by an accelerated helium ion beam to form a defect-induced transport gap. This device features not only a large current ON-OFF ratio of four orders of magnitude but also unipolarity of transistors, which would otherwise be ambipolar. We also show how these polarity-reversible transistors can be used in logic circuits.	[Nakaharai, Shu; Sato, Shintaro; Yokoyama, Naoki] Natl Inst Adv Ind Sci & Technol, Green Nanoelect Ctr, Tsukuba, Ibaraki 3058569, Japan; [Iijima, Tomohiko] Natl Inst Adv Ind Sci & Technol, Tsukuba Innovat Arena Headquarters, Tsukuba, Ibaraki 3058569, Japan; [Ogawa, Shinichi] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058569, Japan; [Li, Song-Lin] Natl Inst Mat Sci, World Premier Int Ctr Mat Nanoarchitecton, Ctr Young Scientists, Tsukuba, Ibaraki 3050044, Japan	Nakaharai, S (reprint author), Natl Inst Mat Sci, World Premier Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan.	Nakaharai.Shu@nims.go.jp; iijima.tomohiko@aist.go.jp; ogawa.shinichi@aist.go.jp; LI.Songlin@nims.go.jp; kazuhito@nims.go.jp; shintaro.sato@aist.go.jp; yokoyama.naoki@aist.go.jp	TSUKAGOSHI, Kazuhito/H-2688-2011; Li, Songlin/F-3059-2010	Li, Songlin/0000-0002-3995-9580	Japan Society for the Promotion of Science; Council for Science and Technology Policy	This work was supported by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy. The review of this paper was arranged by Associate Editor P.-E. Gaillardon.	Banhart F, 2011, ACS NANO, V5, P26, DOI 10.1021/nn102598m; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Ben-Jamaa MH, 2011, IEEE T COMPUT AID D, V30, P242, DOI 10.1109/TCAD.2010.2085250; Han MY, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.056801; Bell DC, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455301; Lemme M. C., 2008, ACS NANO, V3, P2674; Lherbier A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.075402; Miyazaki H., 2011, SEMICOND SCI TECH, V30; Morozov S. V., 2010, PHYS REV LETT, V9; Nakaharai S., 2012, APPL PHYS EXP, V5, P60; Nakaharai S., ACS NANO, P5694; Schwierz F., NAT NANO IN PRESS, P487	12	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-125X	1941-0085		IEEE T NANOTECHNOL	IEEE Trans. Nanotechnol.	NOV	2014	13	6					1039	1043		10.1109/TNANO.2014.2313134		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	AT7AJ	WOS:000345087900004		
J	Jiang, WH; Sugiyama, H; Tokuchi, A				Jiang, Weihua; Sugiyama, Hiroka; Tokuchi, Akira			Pulsed Power Generation by Solid-State LTD	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Power electronics; power metal-oxide-semiconductor field-effect transistors (MOSFETs); pulse generation; pulsed power systems	COMPACT; NANOSECOND; MODULATOR; MOSFETS; SWITCH	A solid-state linear transformer driver stack has been developed to demonstrate pulsed power generation and output pulse shaping. It consists of 30 modules each using 24 power metal-oxide-semiconductor field-effect transistors as switches. The output voltage of the stack is the superposition of the voltage pulse of each module no matter if the modules are switched synchronously or not. In synchronous operation, the output voltages of all modules are added up to reach an output voltage up to similar to 29 kV with a maximum output current of similar to 240 A. The pulsewidth is variable in the range of 50-170 ns. On the other hand, by carrying out separate switching of different modules, the output waveform can be varied by performing pulse shaping. The control signals for pulse shaping experiment are generated using an field-programmable gate array board that allows potentially automatic waveform optimization.	[Jiang, Weihua; Sugiyama, Hiroka; Tokuchi, Akira] Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan; [Tokuchi, Akira] Pulsed Power Japan Lab Ltd, Kusatsu, Shiga 5250032, Japan	Jiang, WH (reprint author), Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan.	jiang@nagaokaut.ac.jp; h_sugiyama@etigo.nagaokaut.ac.jp; tokuchi@etigo.nagaokaut.ac.jp			Japan Society for the Promotion of Science [24360105]	This work was supported by the Grants-in-Aid for Scientific Research Program through the Japan Society for the Promotion of Science under Grant 24360105.	Mazarakis MG, 2009, PHYS REV SPEC TOP-AC, V12, DOI 10.1103/PhysRevSTAB.12.050401; Akiyama H, 2007, IEEE T DIELECT EL IN, V14, P1051, DOI 10.1109/TDEI.2007.4339465; Schamiloglu E, 2004, P IEEE, V92, P1014, DOI 10.1109/JPROC.2004.829058; Jiang WH, 2012, IEEE T PLASMA SCI, V40, P2625, DOI 10.1109/TPS.2012.2200048; Jayaram SH, 2000, IEEE ELECTR INSUL M, V16, P17, DOI 10.1109/57.887601; Jang SR, 2011, IEEE T DIELECT EL IN, V18, P1242, DOI 10.1109/TDEI.2011.5976122; Biela J, 2009, IEEE T DIELECT EL IN, V16, P1093, DOI 10.1109/TDEI.2009.5211860; Buttram M, 2002, IEEE T PLASMA SCI, V30, P262, DOI 10.1109/TPS.2002.1003869; Jiang WH, 2004, P IEEE, V92, P1180, DOI 10.1109/JPROC.2004.829003; Jiang WH, 2010, IEEE T PLASMA SCI, V38, P2730, DOI 10.1109/TPS.2010.2051042; Kim JH, 2007, IEEE T DIELECT EL IN, V14, P921, DOI 10.1109/TDEI.2007.4286526; Kim A. A., 2009, PHYS REV SPECIAL TOP, V12; Koval'chuk B. M., 1997, Russian Physics Journal, V40, DOI 10.1007/BF02524302; MARTIN JCC, 1992, P IEEE, V80, P934, DOI 10.1109/5.149456; Mesyats GA, 2004, P IEEE, V92, P1166, DOI [10.1109/JPROC.2004.829005, 10.1109/JPROC.2004.82905]; Novac BM, 2006, IEEE T PLASMA SCI, V34, P1814, DOI 10.1109/TPS.2006.876533; Rossi JO, 2011, IEEE T PLASMA SCI, V39, P3033, DOI 10.1109/TPS.2011.2157841; Sack M, 2013, IEEE T PLASMA SCI, V41, P2630, DOI 10.1109/TPS.2013.2267395; SPAHN E, 1995, IEEE T MAGN, V31, P78, DOI 10.1109/20.364724; Sun Y, 2007, IEEE T DIELECT EL IN, V14, P863, DOI 10.1109/TDEI.2007.4286517; Zorngiebel V, 2009, IEEE T MAGN, V45, P531, DOI 10.1109/TMAG.2008.2008511	21	0	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	NOV	2014	42	11					3603	3608		10.1109/TPS.2014.2358627		6	Physics, Fluids & Plasmas	Physics	AT6RZ	WOS:000345067700022		
J	Sakugawa, T; Iwaishi, T; Hosseini, SHR; Akiyama, H				Sakugawa, Takashi; Iwaishi, Takumi; Hosseini, Sayed Hammid Reza; Akiyama, Hidenori			Investigation of Preionization Effects in Atmospheric Pulsed Discharge	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Dielectric barrier discharge; preionization; streamer discharge	LASER	Preionization for atmospheric pressure discharge plasma has been employed in several pulse gas lasers, while dielectric barrier discharge has often been utilized for ozone generators. A single ozone-generating device combining both preionization discharge and dielectric barrier discharge is investigated in this paper. The preionizing electrode configuration consisted of a wire-dielectric-plate with a 1.5-mm-thick aluminum oxide (Al2O3) barrier with relative permittivity er of about 10. Wire electrodes (0.8-mm diameter) and plate electrodes were all made of stainless steel. A barrier discharge was generated by applying a pulse voltage between the plate electrode and the wire electrodes across the dielectric, which was served as a preionizer. The main discharge was produced immediately after preionization by applying a high-voltage pulse between the wire-plate electrodes with a gap distance of 10 mm. This paper examines the temporal and spatial evolution of the discharge with and without preionization. Results from a high-speed framing camera indicate that preionization increases the volume of the main discharge, resulting in a streamer-like discharge system with preionization, which is an effective method for ozone generation.	[Sakugawa, Takashi; Iwaishi, Takumi; Hosseini, Sayed Hammid Reza; Akiyama, Hidenori] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan	Sakugawa, T (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	sakugawa@cs.kumamoto-u.ac.jp; pplab.iwaishi@gmail.com; hosseini@kumamoto-u.ac.jp; akiyama@cs.kumamoto-u.ac.jp			Japan Society for the Promotion of Science [23560331]	This work was supported by the Grant-in Aid for Scientific Research (C), Japan Society for the Promotion of Science, under Grant 23560331.	Zhao L, 2012, IEEE T PLASMA SCI, V40, P802, DOI 10.1109/TPS.2011.2181538; Wang F, 2005, IEEE T PLASMA SCI, V33, P844, DOI 10.1109/TPS.2005.845251; Hegeler F, 1997, IEEE T PLASMA SCI, V25, P1158, DOI 10.1109/27.649640; CHAMPAGNE LF, 1987, J APPL PHYS, V62, P1576, DOI 10.1063/1.339605; LACOUR B, 1987, J APPL PHYS, V62, P754, DOI 10.1063/1.339728; Ono R., 2007, INT J PLASMA ENV SCI, V1, P123; Takahashi E., 2011, J PHYS D, V44; Wang DY, 2004, IEEE T PLASMA SCI, V32, P2038, DOI 10.1109/TPS.2004.835447	8	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	NOV	2014	42	11					3633	3638		10.1109/TPS.2014.2333053		6	Physics, Fluids & Plasmas	Physics	AT6RZ	WOS:000345067700026		
J	Zhang, MH; Wei, YY; Shi, XB; Yue, LN; Wei, WH; Xu, J; Zhao, GQ; Huang, MZ; Wang, ZL; Gong, YB; Wang, WX; Li, DZ				Zhang, Minghao; Wei, Yanyu; Shi, Xianbao; Yue, Lingna; Wei, Wanghe; Xu, Jin; Zhao, Guoqing; Huang, Minzhi; Wang, Zhanliang; Gong, Yubin; Wang, Wenxiang; Li, Dazhi			A Modified Slow-Wave Structure for Backward-Wave Oscillator Design in THz Band	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Backward-wave oscillator (BWO); quasi-parallelplate (QPP); slow-wave structure (SWS); terahertz (THz) source	HIGH-POWER; GUIDE; BEAM; BWO; AMPLIFIER	In this paper, a novel slow-wave structure (SWS), called quasi-parallel-plate (QPP), is proposed for terahertz (THz) backward-wave oscillator BWO design. Compared with the conventional SWSs, the novel SWS has a wider "cold" bandwidth and higher interaction impedance. The Particle-in-cell (PIC) results show that the BWO can produce over 0.82 W output power in the operating frequency range from 0.82 to 1 THz by utilizing an operating voltage range from 5 to 10 kV. The interaction efficiency over the entire operating frequency band is above 2.8%. This SWS, which employing a circular electron beam of 3 mA, can be considered as a promising THz SWS for BWO design with characteristics of moderate operating voltage, wide tunable bandwidth, high efficiency, and compact structure.	[Zhang, Minghao; Wei, Yanyu; Shi, Xianbao; Yue, Lingna; Wei, Wanghe; Xu, Jin; Zhao, Guoqing; Huang, Minzhi; Wang, Zhanliang; Gong, Yubin; Wang, Wenxiang] Univ Elect Sci & Technol China, Sch Phys Elect, Vacuum Elect Natl Lab, Chengdu 610054, Peoples R China; [Li, Dazhi] Inst Laser Technol, Suita, Osaka 5650871, Japan	Zhang, MH (reprint author), Univ Elect Sci & Technol China, Sch Phys Elect, Vacuum Elect Natl Lab, Chengdu 610054, Peoples R China.	yywei@uestc.edu.cn; Dazhi_li@hotmail.com			National Natural Science Foundation of China [61271029]; National Science Fund for Distinguished Young Scholars of China [61125103]; Fundamental research funds for the central universities [ZYGX2013Z002]; Research Foundation for Opto-Science and Technology, KAKENHI [24560057]	This work was supported in part by the National Natural Science Foundation of China under Grant 61271029, by the National Science Fund for Distinguished Young Scholars of China under Grant 61125103, by the Fundamental research funds for the central universities under Grant ZYGX2013Z002, and by the Research Foundation for Opto-Science and Technology, KAKENHI under Grant 24560057.	Aksenchyk A. V., 2007, P IEEE IVEC, P1; Mineo M, 2010, IEEE T ELECTRON DEV, V57, P3169, DOI 10.1109/TED.2010.2071876; Booske JH, 2011, IEEE T THZ SCI TECHN, V1, P54, DOI 10.1109/TTHZ.2011.2151610; Maestrini A, 2012, IEEE T THZ SCI TECHN, V2, P177, DOI 10.1109/TTHZ.2012.2183740; Wang ZL, 2013, IEEE T ELECTRON DEV, V60, P471, DOI 10.1109/TED.2012.2226587; Joye CD, 2014, IEEE T ELECTRON DEV, V61, P1672, DOI 10.1109/TED.2014.2300014; Xu X, 2011, IEEE ELECTR DEVICE L, V32, P1152, DOI 10.1109/LED.2011.2158060; Xu X, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3677889; Mineo M, 2010, IEEE T ELECTRON DEV, V57, P1481, DOI 10.1109/TED.2010.2045678; SWEGLE JA, 1987, PHYS FLUIDS, V30, P1201, DOI 10.1063/1.866269; Liu G, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/34/345102; Baughman WE, 2013, IEEE T THZ SCI TECHN, V3, P387, DOI 10.1109/TTHZ.2013.2267416; CST Corp, CST MWS TUT; CST Corporation, CST PS TUT; Feng JJ, 2014, IEEE T ELECTRON DEV, V61, P1721, DOI 10.1109/TED.2014.2307476; Gong HR, 2013, IEEE T ELECTRON DEV, V60, P482, DOI 10.1109/TED.2012.2227751; Joye CD, 2013, IEEE T ELECTRON DEV, V60, P506, DOI 10.1109/TED.2012.2226591; Komandin GA, 2013, IEEE T THZ SCI TECHN, V3, P440, DOI 10.1109/TTHZ.2013.2255914; Lai JQ, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/6/068403; Liu QL, 2013, IEEE T ELECTRON DEV, V60, P1463, DOI 10.1109/TED.2013.2246868; Ogura K., 2004, J PLASMA FUSION RES, V6, P703; Ostmann T. K., 2014, IEEE T THZ SCI TECHN, V4, P12; Otsuji T., 2014, J PHYS D, V47; Sharma R, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/30/305107; Shin Y., 2008, APPL PHYS LETT, V93; Shin Y. M., 2006, P IEEE IVEC, P419; Suen JY, 2014, IEEE T THZ SCI TECHN, V4, P86, DOI 10.1109/TTHZ.2013.2294018; Zhang MH, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.036201; Zhang YB, 2014, IEEE T PLASMA SCI, V42, P1502, DOI 10.1109/TPS.2014.2301719; Zheng XD, 1998, J PHYS SOC JPN, V67, P1466, DOI 10.1143/JPSJ.67.1466	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2014	4	6					741	748		10.1109/TTHZ.2014.2360778		8	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AT5MY	WOS:000344988200014		
J	Taira, Y; Tripathi, SR; Murate, K; Hayashi, S; Nawata, K; Minamide, H; Kawase, K				Taira, Yusuke; Tripathi, Saroj R.; Murate, Kosuke; Hayashi, Shin'ichiro; Nawata, Kouji; Minamide, Hiroaki; Kawase, Kodo			A Terahertz Wave Parametric Amplifier With a Gain of 55 dB	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Nonlinear crystal; parametric sources; terahertz (THz) wave	HIGH-POWER; GENERATION; LINBO3	We report a terahertz (THz) wave amplifier based on optical parametric processes in magnesium-oxide-doped lithium niobate (MgO : LiNbO3) crystals. The amplifier operates at room temperature and has a gain of 55 dB. The non-linear crystals used for the purposes of emission and amplification of the THz waves are pumped separately using a microchip laser, which leads to an enhancement of the gain in comparison with existing approaches.	[Taira, Yusuke; Tripathi, Saroj R.; Murate, Kosuke; Kawase, Kodo] Nagoya Univ, Dept Elect Engn, Nagoya, Aichi 4648603, Japan; [Hayashi, Shin'ichiro; Nawata, Kouji; Minamide, Hiroaki; Kawase, Kodo] RIKEN, Sendai, Miyagi 9800845, Japan	Taira, Y (reprint author), Nagoya Univ, Dept Elect Engn, Nagoya, Aichi 4648603, Japan.	tripathi@nuee.nagoya-u.ac.jp			Collaborative Research Based on Industrial Demand of the Japan Science and Technology Agency (JST)	This work was supported in part by the Collaborative Research Based on Industrial Demand of the Japan Science and Technology Agency (JST).	Kawase K, 2002, APPL PHYS LETT, V80, P195, DOI 10.1063/1.1429299; Kawase K, 1996, APPL PHYS LETT, V68, P2483, DOI 10.1063/1.115828; Hayashi S, 2012, OPT EXPRESS, V20, P2881, DOI 10.1364/OE.20.002881; Koenig S, 2013, NAT PHOTONICS, V7, P977, DOI [10.1038/nphoton.2013.275, 10.1038/NPHOTON.2013.275]; Hebling J, 2008, J OPT SOC AM B, V25, pB6, DOI 10.1364/JOSAB.25.0000B6; Kawase K, 2003, OPT EXPRESS, V11, P2549, DOI 10.1364/OE.11.002549; Sakai H, 2008, OPT EXPRESS, V16, P19891, DOI 10.1364/OE.16.019891; Shoji I, 1997, J OPT SOC AM B, V14, P2268, DOI 10.1364/JOSAB.14.002268; Hauri C. P., 2011, APPL PHYS LETT, V99; Hayashi S., 2014, SCI REP, V5; Hirori, 2011, APPL PHYS LETT, V98; Murate K, 2014, IEEE T THZ SCI TECHN, V4, P523, DOI 10.1109/TTHZ.2014.2326298; Pickwell E, 2006, J PHYS D APPL PHYS, V39, pR301, DOI 10.1088/0022-3727/39/17/R01; Tripathi S. R., 2013, APPL PHYS EXPRESS, V6; Tripathi SR, 2014, OPT LETT, V39, P1649, DOI 10.1364/OL.39.001649	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2014	4	6					753	755		10.1109/TTHZ.2014.2355179		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AT5MY	WOS:000344988200016		
J	Kinoshita, M; Iida, H; Shimada, Y				Kinoshita, Moto; Iida, Hitoshi; Shimada, Yozo			Frequency Calibration of Terahertz Time-Domain Spectrometer Using Air-Gap Etalon	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Time-domain analysis; frequency; air gaps; interferometers; calibration	SPECTROSCOPY; RESOLUTION; REGION	Although various terahertz (THz) technologies have been rapidly developed in recent years, their metrology standards are yet to be established. We have developed a simple calibration method for the frequency of a THz time-domain spectrometer (TDS) using an optically transparent THz air-gap etalon (OT-TAGE). The OT-TAGE can be used in both the near-infrared (NIR) and THz regions. Therefore, a frequency measurement using THz waves can be directly compared with one using NIR light via the OT-TAGE. In this study, the frequency of a commercial THz-TDS was calibrated by referring to the NIR wavelength was demonstrated. The obtained frequency errors were within +/- 3 GHz, with relative uncertainties within 1%.	[Kinoshita, Moto; Iida, Hitoshi; Shimada, Yozo] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan NMIJ, Tsukuba, Ibaraki, Japan	Kinoshita, M (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan NMIJ, Tsukuba, Ibaraki, Japan.	moto-kinoshita@aist.go.jp; h-iida@aist.go.jp; yozo.shi-mada@aist.go.jp					Iida H, 2013, IEEE T INSTRUM MEAS, V62, P1801, DOI 10.1109/TIM.2012.2225927; Yasui T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209718; Naftaly M, 2009, OPT LETT, V34, P674, DOI 10.1364/OL.34.000674; Naftaly M, 2009, J OPT SOC AM B, V26, P1357, DOI 10.1364/JOSAB.26.001357; Naftaly M, 2010, OPT COMMUN, V283, P1849, DOI 10.1016/j.optcom.2009.12.025; Iida H., OPT LETT, V39, P1609; Kinoshita M., 2013, OTST 2013, P192; Kinoshita M., 2012, P 37 IRMMW THZ; PENNDORF R, 1957, J OPT SOC AM, V47, P176, DOI 10.1364/JOSA.47.000176; Steck Daniel A., 2008, CESIUM D LINE DATA; Werner L, 2009, METROLOGIA, V46, pS160, DOI 10.1088/0026-1394/46/4/S05; Yasui T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2008379	12	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	NOV	2014	4	6					756	759		10.1109/TTHZ.2014.2357895		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AT5MY	WOS:000344988200017		
J	Hasegawa, H; Kanai, H				Hasegawa, Hideyuki; Kanai, Hiroshi			Effect of Subaperture Beamforming on Phase Coherence Imaging	IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL			English	Article							ARTERY-WALL STRAIN; TRANSIENT ELASTOGRAPHY; PLANE-WAVE; BLOOD-FLOW; ULTRASOUND	High-frame-rate echocardiography using unfocused transmit beams and parallel receive beamforming is a promising method for evaluation of cardiac function, such as imaging of rapid propagation of vibration of the heart wall resulting from electrical stimulation of the myocardium. In this technique, high temporal resolution is realized at the expense of spatial resolution and contrast. The phase coherence factor has been developed to improve spatial resolution and contrast in ultrasonography. It evaluates the variance in phases of echo signals received by individual transducer elements after delay compensation, as in the conventional delay-and-sum beamforming process. However, the phase coherence factor suppresses speckle echoes because phases of speckle echoes fluctuate as a result of interference of echoes. In the present study, the receiving aperture was divided into several subapertures, and conventional delay-and-sum beamforming was performed with respect to each subaperture to suppress echoes from scatterers except for that at a focal point. After subaperture beamforming, the phase coherence factor was obtained from beamformed RF signals from respective subapertures. By means of this procedure, undesirable echoes, which can interfere with the echo from a focal point, can be suppressed by subaperture beamforming, and the suppression of the phase coherence factor resulting from phase fluctuation caused by such interference can be avoided. In the present study, the effect of subaperture beamforming in high-frame-rate echocardiography with the phase coherence factor was evaluated using a phantom. By applying subaperture beamforming, the average intensity of speckle echoes from a diffuse scattering medium was significantly higher (-39.9 dB) than that obtained without subaperture beamforming (-48.7 dB). As for spatial resolution, the width at half-maximum of the lateral echo amplitude profile obtained without the phase coherence factor was 1.06 mm. By using the phase coherence factor, spatial resolution was improved significantly, and subaperture beamforming achieved a better spatial resolution of 0.75 mm than that of 0.78 mm obtained without subaperture beamforming.	[Hasegawa, Hideyuki] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan; [Hasegawa, Hideyuki] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Kanai, Hiroshi] Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi 980, Japan; [Kanai, Hiroshi] Tohoku Univ, Grad Sch Engn, Dept Elect Engn, Sendai, Miyagi 980, Japan	Hasegawa, H (reprint author), Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan.	hasegawa@ecei.tohoku.ac.jp					Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Montaldo G, 2009, IEEE T ULTRASON FERR, V56, P489, DOI 10.1109/TUFFC.2009.1067; GREENLEAF JF, 1983, P IEEE, V71, P330, DOI 10.1109/PROC.1983.12591; Hasegawa H, 2008, IEEE T ULTRASON FERR, V55, P2626, DOI 10.1109/TUFFC.2008.978; LOUPAS T, 1995, IEEE T ULTRASON FERR, V42, P672, DOI 10.1109/58.393110; Sutherland GR, 2004, J AM SOC ECHOCARDIOG, V17, P788, DOI 10.1016/j.echo.2004.03.027; Cheng JQ, 2006, IEEE T ULTRASON FERR, V53, P880; Dahl JJ, 2008, ULTRASONIC IMAGING, V30, P1; Bercoff J, 2003, ULTRASOUND MED BIOL, V29, P1387, DOI 10.1016/S0301-5629(03)00978-5; Holfort IK, 2009, IEEE T ULTRASON FERR, V56, P314, DOI 10.1109/TUFFC.2009.1040; Tanter M, 2002, IEEE T ULTRASON FERR, V49, P1363, DOI 10.1109/TUFFC.2002.1041078; Kanai H, 2009, ULTRASOUND MED BIOL, V35, P936, DOI 10.1016/j.ultrasmedbio.2008.12.013; Hasegawa H, 2011, J MED ULTRASON, V38, P129, DOI 10.1007/s10396-011-0304-0; Camacho J, 2009, IEEE T ULTRASON FERR, V56, P958, DOI 10.1109/TUFFC.2009.1128; Heimdal A, 1998, J AM SOC ECHOCARDIOG, V11, P1013, DOI 10.1016/S0894-7317(98)70151-8; Synnevag JF, 2007, IEEE T ULTRASON FERR, V54, P1606, DOI 10.1109/TUFFC.2007.431; Li PC, 2003, IEEE T ULTRASON FERR, V50, P128; Tong L, 2012, IEEE T ULTRASON FERR, V59, P1654, DOI 10.1109/TUFFC.2012.2371; Couade M., 2009, P IEEE INT ULTR S, P515; Cramer H., 1946, MATH METHODS STAT; Hasegawa H., 2014, P 2014 SPRING M AC S, P488; Hasegawa H, 2012, IEEE T ULTRASON FERR, V59, P2569, DOI 10.1109/TUFFC.2012.2490; Hasegawa H, 2008, IEEE T ULTRASON FERR, V55, P1921, DOI 10.1109/TUFFC.884; Hyun DW, 2012, IEEE INT ULTRA SYM, P117, DOI 10.1109/ULTSYM.2012.0029; Kanai H, 1997, IEEE T ULTRASON FERR, V44, P752, DOI 10.1109/58.655190; Katz A. M., 2001, PHYSL HEART; Morse P. M., 1968, THEORETICAL ACOUSTIC; NAGAI K, 1985, IEEE T SON ULTRASON, V32, P531; Provost J, 2011, PHYS MED BIOL, V56, pL1, DOI 10.1088/0031-9155/56/22/F01; Rao C.R., 1945, Bulletin of the Calcutta Mathematical Society, V37; Sutherland G R, 1994, J Am Soc Echocardiogr, V7, P441; Kanai H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.07HA01; Zipes DP, 2005, BRAUNWALDS HEART DIS, V7th	33	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-3010	1525-8955		IEEE T ULTRASON FERR	IEEE Trans. Ultrason. Ferroelectr. Freq. Control	NOV	2014	61	11					1779	1790		10.1109/TUFFC.2014.006365		12	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	AT6ZN	WOS:000345085700002		
J	Uno, M; Kukita, A				Uno, Masatoshi; Kukita, Akio			Single-Switch Single-Transformer Cell Voltage Equalizer Based on Forward-Flyback Resonant Inverter and Voltage Multiplier for Series-Connected Energy Storage Cells	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Battery; equalizer; forward-flyback inverter (FFI); supercapacitor (SC); voltage imbalance; voltage multiplier	ION BATTERY STRINGS; CHARGE EQUALIZATION; REGENERATIVE SNUBBER; CONVERTER; SYSTEM; DESIGN; PERFORMANCE	Cell voltage equalization is inevitable to ensure years of safe operation of series-connected energy storage cells, such as lithium-ion batteries and supercapacitors (SCs). Although various kinds of cell voltage equalizers have been proposed, most equalizer topologies require multiple switches and/or a multiwinding transformer, resulting in complex circuitry and poor modularity. In this paper, a single-switch single-transformer equalizer using a forward-flyback resonant inverter (FFRI) with a voltage multiplier is proposed. The required switch count of the proposed equalizer is the minimum without impairing modularity due to the single-switch circuitry with no need for a multiwinding transformer. An experimental equalization test performed for eight SCs connected in series successfully demonstrated the equalization performance of the proposed equalizer. The FFRI can be extended as a "resonant input cell," and by combining one of resonant input cells and a voltage multiplier, a single-switch resonant equalization charger that is basically a charger with an equalization function is also derived. An experimental charging test using the resonant equalization charger was also performed, and its equalization-charging performance was demonstrated.	[Uno, Masatoshi; Kukita, Akio] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki 3058505, Japan	Uno, M (reprint author), Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki 3058505, Japan.	uno.masatoshi@jaxa.jp; Kukita.akio@jaxa.jp					Chuang YC, 2008, IEEE T IND ELECTRON, V55, P3030, DOI 10.1109/TIE.2008.921218; Uno M, 2011, IEEE T VEH TECHNOL, V60, P3635, DOI 10.1109/TVT.2011.2165229; Kimball JW, 2007, 2007 IEEE VEHICLE POWER AND PROPULSION CONFERENCE, VOLS 1 AND 2, P323, DOI 10.1109/VPPC.2007.4544145; Abramovitz A, 2010, IEEE T POWER ELECTR, V25, P667, DOI 10.1109/TPEL.2009.2033275; KUTKUT NH, 1995, IEEE T IND APPL, V31, P562, DOI 10.1109/28.382117; Xu AG, 2009, IEEE T VEH TECHNOL, V58, P3981, DOI 10.1109/TVT.2009.2028148; Lu RG, 2007, IEEE T MAGN, V43, P254, DOI 10.1109/TMAG.2006.887652; Einhorn M, 2011, IEEE T VEH TECHNOL, V60, P2448, DOI 10.1109/TVT.2011.2153886; Cassani PA, 2010, IEEE T IND ELECTRON, V57, P3956, DOI 10.1109/TIE.2010.2050750; Einhorn M, 2011, IEEE T VEH TECHNOL, V60, P4227, DOI 10.1109/TVT.2011.2168988; Pascual C, 1997, APPL POWER ELECT CO, P848, DOI 10.1109/APEC.1997.575744; Uno M, 2008, IEEE POWER ELECTRON, P755, DOI 10.1109/PESC.2008.4592020; Lee YS, 2006, IEEE T POWER ELECTR, V21, P1213, DOI 10.1109/TPEL.2006.880349; Lee YS, 2005, IEEE T IND ELECTRON, V52, P1297, DOI 10.1109/TIE.2005.855673; Baughman AC, 2008, IEEE T IND ELECTRON, V55, P2277, DOI [10.1109/TIE.2008.918401, 10.1109/TIE.2007.918401]; [Anonymous], 2006, AN4147; Kim CH, 2013, IEEE T POWER ELECTR, V28, P3779, DOI 10.1109/TPEL.2012.2227810; Cassani PA, 2009, IEEE T VEH TECHNOL, V58, P3938, DOI 10.1109/TVT.2009.2031553; Abramovitz A, 2013, IEEE T POWER ELECTR, V28, P5323, DOI 10.1109/TPEL.2013.2243845; Kim J, 2012, IEEE T POWER ELECTR, V27, P411, DOI 10.1109/TPEL.2011.2158553; Park HS, 2009, IEEE T VEH TECHNOL, V58, P3216, DOI 10.1109/TVT.2009.2015331; Uno M, 2011, IEEE T VEH TECHNOL, V60, P1505, DOI 10.1109/TVT.2011.2127500; Chuang YC, 2010, IEEE T IND ELECTRON, V57, P2463, DOI 10.1109/TIE.2009.2035459; Kutkut NH, 1999, IEEE T IND APPL, V35, P28, DOI 10.1109/28.740842; Baronti F, 2013, IEEE T IND INFORM, V9, P1139, DOI 10.1109/TII.2012.2223479; Cao J., 2008, P IEEE VEH POW PROP, P1; Guo K. Z., 2006, P IEEE POW EL SPEC C, P1; Huber L, 1999, IEEE T POWER ELECTR, V14, P184, DOI 10.1109/63.737607; Imtiaz AM, 2013, IEEE T POWER ELECTR, V28, P5960, DOI 10.1109/TPEL.2013.2257861; Kim C. H., 2011, P 8 INT C POW EL ECC, P304; Kim CH, 2012, IEEE T POWER ELECTR, V27, P3764, DOI 10.1109/TPEL.2012.2185248; Kim M. Y., 2011, P 8 INT C POW EL ECC, P2248; Kim M.-Y., 2011, P 8 INT C POW EL ECC, P310; Kutkut NH, 1998, IEEE T AERO ELEC SYS, V34, P235, DOI 10.1109/7.640281; Nishijima K, 2000, IEEE POWER ELECTRON, P517; Uno M., 2008, P IEEE INT C SUST EN, P999; Uno M, 2013, IEEE T IND ELECTRON, V60, P3227, DOI 10.1109/TIE.2012.2203776; Uno M, 2014, IEEE T POWER ELECTR, V29, P812, DOI 10.1109/TPEL.2013.2257867; Uno M, 2012, IEEE T VEH TECHNOL, V61, P3920, DOI 10.1109/TVT.2012.2215892; WEST S, 2000, P IEEE INT TEL EN C, P439; Yu WS, 2012, 2012 IEEE ENERGY CONVERSION CONGRESS AND EXPOSITION (ECCE), P3549; Yuanmao Y., 2012, IEEE T POWER ELECTR, V27, P3234	42	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	NOV	2014	63	9					4232	4247		10.1109/TVT.2014.2312381		16	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	AT6RX	WOS:000345067500007		
J	Li, Z; Guo, S; Zeng, DZ; Barnawi, A; Stojmenovic, I				Li, Zhuo; Guo, Song; Zeng, Deze; Barnawi, Ahmed; Stojmenovic, Ivan			Joint Resource Allocation for Max-Min Throughput in Multicell Networks	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Channel assignment; load balancing; multicell networks; power allocation; resource management; user association	FEMTOCELL NETWORKS; OPTIMIZATION; WIRELESS; SYSTEMS	We investigate the resource-allocation problem in multicell networks targeting the max-min throughput of all cells. A joint optimization over power control, channel allocation, and user association is considered, and the problem is then formulated as a nonconvex mixed-integer nonlinear problem (MINLP). To solve this problem, we proposed an alternating-optimization-based algorithm, which applies branch-and-bound and simulated annealing in solving subproblems at each optimization step. We also demonstrate the convergence and efficiency of the proposed algorithms by thorough numerical experiments. The experimental results show that joint optimization over all resources outperforms the restricted optimization over individual resources significantly.	[Li, Zhuo] Beijing Informat Sci & Technol Univ, Beijing Key Lab Internet Culture & Digital Dissem, Beijing 100101, Peoples R China; [Li, Zhuo] Nanjing Univ, State Key Lab Novel Software Technol, Nanjing 210023, Jiangsu, Peoples R China; [Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima 9658580, Japan; [Zeng, Deze] China Univ Geosci, Sch Comp Sci, Wuhan 430074, Peoples R China; [Barnawi, Ahmed; Stojmenovic, Ivan] King Abdulaziz Univ, Jeddah 22254, Saudi Arabia; [Stojmenovic, Ivan] Deakin Univ, Sch Informat Technol, Melbourne, Vic 3125, Australia; [Stojmenovic, Ivan] Univ Ottawa, Sch Elect Engn & Comp Sci, Ottawa, ON K1N 6N5, Canada	Li, Z (reprint author), Beijing Informat Sci & Technol Univ, Beijing Key Lab Internet Culture & Digital Dissem, Beijing 100101, Peoples R China.	lizhuo@bistu.edu.cn; sguo@u-aizu.ac.jp; dazzae@gmail.com; ambarnawi@kau.edu.sa; stojmenovic@gmail.com			National Natural Science Foundation of China [61202417, 61370065]; General Program of Science and Technology Development Project of the Beijing Municipal Education Commission [KM201411232013]; Fundamental Research Funds for the Central Universities; China University of Geosciences, Wuhan [CUG140615]; Natural Sciences and Engineering Research Council of Canada	This work was supported in part by the National Natural Science Foundation of China under Grant 61202417 and Grant 61370065, by the General Program of Science and Technology Development Project of the Beijing Municipal Education Commission under Grant KM201411232013, by the Fundamental Research Funds for the Central Universities, China University of Geosciences, Wuhan, under Grant CUG140615, and by the Natural Sciences and Engineering Research Council of Canada Discovery Grant. The review of this paper was coordinated by Prof. J. Tang.	Andrews J., 2008, IEEE COMMUN MAG, V46, P59; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Borst SC, 2014, IEEE ACM T NETWORK, V22, P674, DOI 10.1109/TNET.2013.2257181; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Lopez-Perez D, 2009, IEEE COMMUN MAG, V47, P41, DOI 10.1109/MCOM.2009.5277454; Horst R, 1999, J OPTIMIZ THEORY APP, V103, P1, DOI 10.1023/A:1021765131316; Torregoza JPM, 2010, EURASIP J WIREL COMM, P1, DOI 10.1155/2010/285714; Gur G, 2010, IEEE WIREL COMMUN, V17, P62, DOI 10.1109/MWC.2010.5547923; Fooladivanda D, 2011, 2011 IEEE 22ND INTERNATIONAL SYMPOSIUM ON PERSONAL INDOOR AND MOBILE RADIO COMMUNICATIONS (PIMRC), P384, DOI 10.1109/PIMRC.2011.6139988; Broustis I, 2010, IEEE ACM T NETWORK, V18, P722, DOI 10.1109/TNET.2009.2031971; KIRKPATRICK S, 1984, J STAT PHYS, V34, P975, DOI 10.1007/BF01009452; Lopez-Perez D, 2008, 2008 11TH IEEE SINGAPORE INTERNATIONAL CONFERENCE ON COMMUNICATION SYSTEMS (ICCS), VOLS 1-3, P1579, DOI 10.1109/ICCS.2008.4737449; Bejerano Y, 2007, IEEE ACM T NETWORK, V15, P560, DOI 10.1109/TNET.2007.893680; Ashraf I., 2010, P IEEE WIR COMM NETW, P1; Benmesbah L., 2010, P INT S COMM SYST NE, P881; Bezakova I., 2005, ACM SIGECOM EXCHANGE, V5, P11, DOI 10.1145/1120680.1120683; Bezdek J. C., 2002, P AFSS INT C FUZZ SY, P288; Cheng CH, 2011, PEDIATR INFECT DIS J, V30, P309, DOI 10.1097/INF.0b013e3181ff84ff; Chen J., 2009, P IEEE GLOBECOM, P1; FALLGREN M, 2011, P IEEE INT C COMM WO, P1; GRANVILLE V, 1994, IEEE T PATTERN ANAL, V16, P652, DOI 10.1109/34.295910; Horst R., 1991, J GLOBAL OPTIM, V1, P183, DOI 10.1007/BF00119991; Hou IH, 2013, IEEE J SEL AREA COMM, V31, P937, DOI 10.1109/JSAC.2013.130512; Jarinen M., 2009, THESIS HELSINKI U TE; Karp R., 1972, COMPLEXITY COMPUTER, P85, DOI DOI 10.1007/978-1-4684-2001-2_; Lee T., 2010, P IEEE VPPC LILL FRA, P1; Pierce J. R., 1980, INTRO INFORM THEORY; Xu W., 2011, P IEEE INT C EL MACH, P1; Xu W., 2010, P IEEE ICC, P1; Yun J.-H., 2010, P ACM INT C MOB COMP, P61, DOI 10.1145/1859995.1860003	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	NOV	2014	63	9					4546	4559		10.1109/TVT.2014.2317235		14	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	AT6RX	WOS:000345067500030		
J	Miura, N; Kucho, K; Noguchi, M; Miyoshi, N; Uchiumi, T; Kawaguchi, H; Tanimoto, A				Miura, Naoki; Kucho, Ken-Ichi; Noguchi, Michiko; Miyoshi, Noriaki; Uchiumi, Toshiki; Kawaguchi, Hiroaki; Tanimoto, Akihide			Comparison of the Genomic Sequence of the Microminipig, a Novel Breed of Swine, with the Genomic Database for Conventional Pig	IN VIVO			English	Article						Genomic sequence; porcine; minipig; microminipig	CHOLESTEROL DIET; ANIMAL-MODEL; ATHEROSCLEROSIS; VALUES; PARAMETERS	The microminipig, which weighs less than 10 kg at an early stage of maturity, has been reported as a potential experimental model animal. Its extremely small size and other distinct characteristics suggest the possibility of a number of differences between the genome of the microminipig and that of conventional pigs. In this study, we analyzed the genomes of two healthy microminipigs using a next-generation sequencer SOLiD (TM) system. We then compared the obtained genomic sequences with a genomic database for the domestic pig (Sus scrofa). The mapping coverage of sequenced tag from the microminipig to conventional pig genomic sequences was greater than 96% and we detected no clear, substantial genomic variance from these data. The results may indicate that the distinct characteristics of the microminipig derive from small-scale alterations in the genome, such as Single Nucleotide Polymorphisms or translational modifications, rather than large-scale deletion or insertion polymorphisms. Further investigation of the entire genomic sequence of the microminipig with methods enabling deeper coverage is required to elucidate the genetic basis of its distinct phenotypic traits.	[Miura, Naoki] Kagoshima Univ, Joint Fac Vet Med, Dept Vet Histopathol, Kagoshima 8900065, Japan; [Miyoshi, Noriaki; Kawaguchi, Hiroaki] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Histopathol, Kagoshima 8900065, Japan; [Noguchi, Michiko] Kagoshima Univ, Joint Fac Vet Med, Lab Domest Anim Internal Med, Kagoshima 8900065, Japan; [Kucho, Ken-Ichi; Uchiumi, Toshiki] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Tanimoto, Akihide] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Pathol, Sakuragaoka, Kagoshima, Japan	Kawaguchi, H (reprint author), Kagoshima Univ, Joint Fac Vet Med, Dept Vet Histopathol, 1-21-35 Korimoto, Kagoshima 8900065, Japan.	k3038952@kadai.jp; akit09@m3.kufm.kagoshima-u.ac.jp			Ministry of Health, Labour and Welfare of Japan [33361105]; Ministry of Education Culture, Sports, Science and Technology of Japan [AS2316907E]	This work was partly supported by Health Labour Sciences Research Grant (No. 33361105) from the Ministry of Health, Labour and Welfare of Japan (to AT and HK), Adaptable and Seamless Technology Transfer Program (A-Step No. AS2316907E) from the Ministry of Education Culture, Sports, Science and Technology of Japan (to AT and HK). We are also grateful to Mrs. Yuu Kucho for SOLiD sequencing and Mr. H. Smith (Shin Nippon Biomedical Laboratories, Ltd. Kagoshima, Japan) for their valuable assistance.	Kawaguchi H, 2011, J PHARMACOL SCI, V115, P115, DOI 10.1254/jphs.10R17FM; Akioka K, 2014, IN VIVO, V28, P81; Svendsen O, 2006, EXP TOXICOL PATHOL, V57, P335, DOI 10.1016/j.etp.2006.03.003; Sugiyama A, 2011, J PHARMACOL SCI, V115, P122, DOI 10.1254/jphs.10R21FM; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Kaneko N, 2011, J PHARMACOL SCI, V115, P112, DOI 10.1254/jphs.10R16FM; Murayama N, 2009, DRUG METAB PHARMACOK, V24, P404; Bollen P J A, 2010, LAB SWINE, P1; Jorgensen KD, 1998, SCAND J LAB ANIM SCI, V25, P181; Kakimoto T, 2014, IN VIVO, V28, P579; Kawaguchi H, 2012, J VET MED SCI, V74, P933, DOI 10.1292/jvms.11-0571; Kawaguchi H, 2013, IN VIVO, V27, P617; Kawaguchi H, 2014, J ATHEROSCLER THROMB, V21, P186; Miura N, 2013, IN VIVO, V27, P357; Miyoshi N, 2010, IN VIVO, V24, P671; RISPAT G, 1993, LAB ANIM, V27, P368, DOI 10.1258/002367793780745561; Takeishi K, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/472982; TUMBELSO.ME, 1972, J ANIM SCI, V35, P48; Yoshikawa T, 2013, TOXICOL PATHOL, V41, P109, DOI 10.1177/0192623312452489	19	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0258-851X	1791-7549		IN VIVO	In Vivo	NOV-DEC	2014	28	6					1107	1111				5	Medicine, Research & Experimental	Research & Experimental Medicine	AT9CK	WOS:000345225400015		
J	Numazaki, K; Ichikawa, M				Numazaki, Kei; Ichikawa, Maho			Clinical and Virological Characteristics of Rotavirus Gastroenteritis and Prevalence of Strains in Tochigi, Japan	IN VIVO			English	Article						Rotavirus gastroenteritis; endemic strain; genotype; G6P [9]; rotavirus vaccine	AGED LESS-THAN-5 YEARS; G12 HUMAN ROTAVIRUSES; GROUP-A ROTAVIRUSES; MOLECULAR EPIDEMIOLOGY; CHILDREN; DIARRHEA; ADULTS; INFECTION; GENOTYPE; NEPAL	Aim: Rotavirus infection is a serious gastrointestinal infection that is usually prevalent during winter months and often seen in infants and young children. Studies on genotypes of prevalent rotavirus strains are important for preventing infection, developing vaccines, and its evaluation. The purpose of this study was to make an investigation of a rotavirus infection in the Nasu Region of Tochigi, Japan and to compare findings to those of other regions. Materials and Methods: We examined the clinical findings in 147 patients who attended the Department of Pediatrics at International University of Health and Welfare Hospital in the Nasu-shiobara City, Tochigi Prefecture, Japan during April 1, 2008 to March 31, 2010. Results: We analyzed the clinical findings of 37 patients with a fecal sample positive for rotavirus antigen. Furthermore, viral genotypes were determined using rotavirus-positive samples from 27 of these 37 patients. The genotypes were determined as G1P [8] in 5 samples, G3P [8] in 5 samples, G9P [8] in 3 samples, and G6P [9] in 2 samples. We were able to analyze the phylogenetic trees of these genotypes. Conclusion: Of particular note, we detected G6P [9] which were extremely rare in humans but common in cattle. Studies on changes in prevalent strains after vaccine introduction need to be conducted.	[Numazaki, Kei; Ichikawa, Maho] Int Univ Hlth & Welf, Grad Sch Hlth & Welf, Div Int Infect Dis, Nasushiobara, Tochigi 3292763, Japan	Numazaki, K (reprint author), Int Univ Hlth & Welf, Univ Hosp, Div Int Infect Dis, Grad Sch,Dept Pediat, 537-3 Iguchi, Nasushiobara, Tochigi 3292763, Japan.	numazaki@iuhw.ac.jp					Santos N, 1998, J CLIN MICROBIOL, V36, P2727; Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412; NAKAGOMI T, 1990, MICROBIOL IMMUNOL, V34, P77; Pun SB, 2007, EMERG INFECT DIS, V13, P482; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Nordgren J, 2012, EMERG INFECT DIS, V18, P589, DOI 10.3201/eid1804.110973; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Banerjee I, 2007, J MED VIROL, V79, P1413, DOI 10.1002/jmv.20872; Wakuda M, 2003, J CLIN MICROBIOL, V41, P5764, DOI 10.1128/JCM.41.12.5764-5769.2003; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; NISHIMURA S, 1993, BRAIN DEV-JPN, V15, P457, DOI 10.1016/0387-7604(93)90088-P; Uchida R, 2006, J CLIN MICROBIOL, V44, P3499, DOI 10.1128/JCM.01089-06; Castello AA, 2009, J MED VIROL, V81, P371, DOI 10.1002/jmv.21384; Dennehy PH, 2008, CLIN MICROBIOL REV, V2, P1198; Dey SK, 2009, INFECT GENET EVOL, V9, P955, DOI 10.1016/j.meegid.2009.06.017; Duan ZJ, 2007, J CLIN MICROBIOL, V45, P1614, DOI 10.1128/JCM.00032-07; Goto T, 2007, SCAND J INFECT DIS, V39, P1067, DOI 10.1080/00365540701466249; Kamiya H, 2011, JPN J INFECT DIS, V64, P482; Khamrin P, 2009, INFECT GENET EVOL, V9, P1394, DOI 10.1016/j.meegid.2009.08.006; Nakajima H, 2001, LANCET, V357, P1950, DOI 10.1016/S0140-6736(00)05086-8; Schmacher RF, 1999, KLIN PEDIAT, V211, P61; Sherchand JB, 2009, J INFECT DIS, V200, pS182, DOI 10.1086/605046; El Sherif M, 2011, INFECT GENET EVOL, V11, P1436, DOI 10.1016/j.meegid.2011.05.012; Steele AD, 2009, J INFECT DIS, V200, pS57, DOI 10.1086/605027; Tajiri H, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-83; Wang YH, 2009, J MED VIROL, V81, P382, DOI 10.1002/jmv.21387; Wang YH, 2007, ARCH VIROL, V152, P669, DOI 10.1007/s00705-006-0904-y; Yamamoto D, 2011, VIRUS GENES, V43, P215, DOI 10.1007/s11262-011-0624-6; Yoshinaga M, 2006, ARCH VIROL, V151, P183, DOI 10.1007/s00705-005-0604-z	30	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0258-851X	1791-7549		IN VIVO	In Vivo	NOV-DEC	2014	28	6					1141	1147				7	Medicine, Research & Experimental	Research & Experimental Medicine	AT9CK	WOS:000345225400021		
J	Nakabayashi, Y; Nakamura, H; Kubota, Y; Morimoto, M; Kawasaki, T; Nakai, M; Yamauchi, O				Nakabayashi, Yasuo; Nakamura, Hitomi; Kubota, Yuya; Morimoto, Mika; Kawasaki, Tomotaka; Nakai, Misaki; Yamauchi, Osamu			DNA interaction with dipolar ruthenium(II) ammine complexes containing 4,4 '-bipyridinium as photochemotherapeutic agents	INORGANICA CHIMICA ACTA			English	Article						Dipolar ruthenium(II) ammine complexes; 4,4 '-bipyridinium cations; Intercalation; Electrostatic binding; Photochemotherapeutic agents	LIGHT INDUCED PHOTOCLEAVAGE; CALF THYMUS DNA; COVALENT BINDING; RU(II) COMPLEXES; SINGLET OXYGEN; CYTOTOXICITY; CLEAVAGE; LIGANDS; PHOTOCYTOTOXICITY; COBALT(III)	The interaction of DNA with dipolar ruthenium(II) ammine complexes containing 4,4'-bipyridinium cations L+, [Ru(L+)(NH3)(5)](3+), has been investigated by spectroscopic and electrochemical methods. These ruthenium(II) complexes undergo strong stacking interactions of L+ with the base-pairs of DNA duplex in addition to the electrostatic and hydrogen binding modes. The phbp(+) ([2](3+)) and pymbp(+) ([3](3+)) complexes bind to DNA more strongly than the mebp(+) ([1](3+)) complex, due to the presence of extended planar aromatic ligands. [3](3+) which exhibited the strongest interaction with DNA can bind to supercoiled plasmid pBR322 DNA following photoinduced loss of ligands pymbp(+) and NH3. The finding led to the photoc-leavage of supercoiled plasmid pBR322 DNA by [3](3+) with visible light under aerobic and unaerobic conditions. Since similar photolysis of [1](3+) and [2](3+) has been observed, all the dipolar ruthenium(II) ammine complexes bearing 4,4'-bipyridinium cations can function as O-2-independent photochemotherapeutic agents. (C) 2014 Elsevier B.V. All rights reserved.	[Nakabayashi, Yasuo; Nakamura, Hitomi; Kubota, Yuya; Morimoto, Mika; Kawasaki, Tomotaka; Nakai, Misaki; Yamauchi, Osamu] Kansai Univ, Dept Chem & Mat Engn, Suita, Osaka 5648680, Japan	Nakabayashi, Y (reprint author), Kansai Univ, Dept Chem & Mat Engn, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	yasuon@kansai-u.ac.jp			Organization for Research and Development of Innovative Science and Technology (ORDIST) in Kansai University	We thank Organization for Research and Development of Innovative Science and Technology (ORDIST) in Kansai University for financial support.	Angeles-Boza AM, 2005, INORG CHEM, V44, P7262, DOI 10.1021/ic0500715; Angeles-Boza AM, 2004, INORG CHEM, V43, P8510, DOI 10.1021/ic049091h; Holder AA, 2004, INORG CHEM, V43, P303, DOI 10.1021/ic035029t; HAQ I, 1995, J AM CHEM SOC, V117, P4788, DOI 10.1021/ja00122a008; Holder AA, 2007, INORG CHEM, V46, P4760, DOI 10.1021/ic0619916; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; GUPTA N, 1992, ANGEW CHEM INT EDIT, V31, P1048, DOI 10.1002/anie.199210481; NOVAKOVA O, 1995, BIOCHEMISTRY-US, V34, P12369, DOI 10.1021/bi00038a034; Allardyce CS, 2001, PLATIN MET REV, V45, P62; Muller P, 2003, ANGEW CHEM INT EDIT, V42, P335, DOI 10.1002/anie.200390110; HIORT C, 1993, J AM CHEM SOC, V115, P3448, DOI 10.1021/ja00062a007; Bradley PM, 2004, INORG CHEM, V43, P2450, DOI 10.1021/ic035424j; Erkkila KE, 1999, CHEM REV, V99, P2777, DOI 10.1021/cr9804341; Maheswari PU, 2004, J INORG BIOCHEM, V98, P219, DOI 10.1016/j.jinorgbio.2003.09.003; Selvi PT, 2002, INORG CHIM ACTA, V337, P420, DOI 10.1016/S0020-1693(02)01112-X; WYATT MD, 1994, ANTI-CANCER DRUG DES, V9, P511; Galanski M, 2003, CURR PHARM DESIGN, V9, P2078, DOI 10.2174/1381612033454180; Clarke MJ, 1999, CHEM REV, V99, P2511, DOI 10.1021/cr9804238; Sathyaraj G, 2010, EUR J MED CHEM, V45, P284, DOI 10.1016/j.ejmech.2009.10.008; JURIS A, 1988, COORDIN CHEM REV, V84, P85, DOI 10.1016/0010-8545(88)80032-8; BARTON JK, 1985, J AM CHEM SOC, V107, P708, DOI 10.1021/ja00289a035; Levina A, 2009, METALLOMICS, V1, P458, DOI 10.1039/b904071d; GROVER N, 1992, J AM CHEM SOC, V114, P3390, DOI 10.1021/ja00035a034; CURTIS JC, 1983, INORG CHEM, V22, P224, DOI 10.1021/ic00144a009; CARTER MT, 1989, J AM CHEM SOC, V111, P8901, DOI 10.1021/ja00206a020; CARTER MT, 1987, J AM CHEM SOC, V109, P7528, DOI 10.1021/ja00258a046; Swavey S, 2002, INORG CHEM, V41, P6196, DOI 10.1021/ic0257726; Singh TN, 2004, INORG CHEM, V43, P7260, DOI 10.1021/ic049075k; GROVER N, 1994, INORG CHEM, V33, P3544, DOI 10.1021/ic00094a018; BAGULEY BC, 1984, BIOCHEMISTRY-US, V23, P937, DOI 10.1021/bi00300a022; Liu Y, 2009, INORG CHEM, V48, P375, DOI 10.1021/ic801636u; SAVA G, 1992, CLIN EXP METASTAS, V10, P273; Kostova I, 2006, CURR MED CHEM, V13, P1085, DOI 10.2174/092986706776360941; Zhao M, 1999, J BIOL INORG CHEM, V4, P325, DOI 10.1007/s007750050319; Bard A.J., 1980, ELECTROCHEMICAL METH, P194; Benites PJ, 2003, J AM CHEM SOC, V125, P6434, DOI 10.1021/ja020939f; Boener L.J.K., 2005, CURR OPIN BIOL, V9, P135; Coe BJ, 1998, INORG CHEM, V37, P3391, DOI 10.1021/ic971411s; Dyson PJ, 2006, DALTON T, P1929, DOI 10.1039/b601840h; Elias B, 2006, COORDIN CHEM REV, V250, P1627, DOI 10.1016/j.ccr.2005.11.011; Farrer NJ, 2009, DALTON T, P10690, DOI 10.1039/b917753a; Frasca D, 1996, Met Based Drugs, V3, P197, DOI 10.1155/MBD.1996.197; Fu PKL, 2002, INORG CHEM, V41, P3808, DOI 10.1021/ic020136t; Genereux C., 2010, CHEM REV, V110, P1642; Greer A, 2006, ACCOUNTS CHEM RES, V39, P797, DOI 10.1021/ar050191g; Heffeter P, 2010, J BIOL INORG CHEM, V15, P737, DOI 10.1007/s00775-010-0642-1; Kankia BI, 2001, NUCLEIC ACIDS RES, V29, P2795, DOI 10.1093/nar/29.13.2795; Lutterman DA, 2006, J AM CHEM SOC, V128, P738, DOI 10.1021/ja057620q; Manikandamathavan VM, 2013, EUR J MED CHEM, V68, P244, DOI 10.1016/j.ejmech.2013.07.051; Mrtcalfe C., 2003, CHEM SOC REV, V32, P215; Nakabayashi Y, 2006, INORG CHEM COMMUN, V9, P935, DOI 10.1016/j.inoche.2006.05.024; Rajendiran V, 2008, DALTON T, P148, DOI 10.1039/b710578a; Salassa L, 2011, EUR J INORG CHEM, P4931, DOI 10.1002/ejic.201100376; Schatzschneider U, 2010, EUR J INORG CHEM, P1451, DOI 10.1002/ejic.201000003; WELCH TW, 1995, J PHYS CHEM-US, V99, P11757, DOI 10.1021/j100030a021; WELLS R D, 1970, Journal of Molecular Biology, V54, P465, DOI 10.1016/0022-2836(70)90121-X; Zeglis BM, 2007, CHEM COMMUN, P4565, DOI 10.1039/b710949k	57	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693	1873-3255		INORG CHIM ACTA	Inorg. Chim. Acta	NOV 1	2014	423		A				109	114		10.1016/j.ica.2014.07.071		6	Chemistry, Inorganic & Nuclear	Chemistry	AT7KS	WOS:000345115900016		
J	Han, J; Gao, Q; Yu, Z; He, X; Quan, CY; Munakata, M				Han, Jing; Gao, Qi; Yu, Zhong; He, Xiang; Quan, Chun-yan; Munakata, Megumu			Syntheses, structures and guest-adsorption properties of Ag(I) coordination polymers with 1,4-dicyanobenzene	INORGANICA CHIMICA ACTA			English	Article						1,4-Dicyanobenzene; Silver(I) complex; Trifluoroacetate; Guest adsorption	XYLENE ISOMERS; COMPLEXES; LIGANDS; ANION; ETHYLBENZENE; SEPARATION; NITRILE; 4-AMINOBENZONITRILE; BENZONITRILE; FRAMEWORKS	Complexes {[Ag-5(CF3COO)(5)(1,4-dcb)(2)]center dot 2(C6H6)}(n) (1) and [Ag-2(CF3SO3) (2)(1,4-dcb)(2)(mu-H2O)](n) (2) were synthesized by reaction of 1,4-dicyanobenzene (1,4-dcb) with AgX (X=CF3COO- or CF3SO3-). Both of them have been characterized by FT-IR, elemental analysis and single-crystal X-ray diffraction. Complex 1 forms 2-D sheets which are constructed from cross-linked 1,4-dcb and 1-D silver(I) chains connecting through trifluoroacetate anions. Benzenes are intercalated as guests between the sheets of complex 1. Complex 2 forms double-strand chains which are built on bimetal centers bridged by a mu-H2O and double bridging 1,4-dcb ligands coordinating via terminal N-donors. Interestingly, the framework of 1 reversibly responds to the removal and inclusion of benzenes. In addition, benzene-eliminated 1 could adsorb toluene and shows a preferential adsorption of m-xylene over other xylene isomers. (C) 2014 Elsevier B.V. All rights reserved.	[Han, Jing; Gao, Qi; Quan, Chun-yan] Xian Univ Technol, Dept Mat Phys & Chem, Xian 710048, Shaanxi, Peoples R China; [Yu, Zhong] Xian Univ Technol, Dept Chem, Xian 710048, Shaanxi, Peoples R China; [He, Xiang] Shanghai Univ, Dept Chem, Shanghai 200444, Peoples R China; [Munakata, Megumu] Kinki Univ, Dept Chem, Higashiosaka, Osaka 5778502, Japan	Han, J (reprint author), 5 South Jinhua Rd, Xian 710048, Shaanxi Provinc, Peoples R China.	hanj@xaut.edu.cn			Natural Science Foundation of China [21101125, 21203117]; Scientific Research Foundation of State Education Ministry for the Returned Overseas Chinese Scholars; Shaanxi Natural Science Foundation [2010JM2008]; Scientific Research Project for Shaanxi Provincial Department of Education [12JK0614, 12JK0621]	This work is supported by a grant for Natural Science Foundation of China (Nos. 21101125 and 21203117), Scientific Research Foundation of State Education Ministry for the Returned Overseas Chinese Scholars (Han Jing and Yu Zhong), Shaanxi Natural Science Foundation (No. 2010JM2008) and Scientific Research Project for Shaanxi Provincial Department of Education (Nos. 12JK0614 and 12JK0621).	Zhang JP, 2008, J AM CHEM SOC, V130, P6010, DOI 10.1021/ja800550a; Fan J, 2003, CHEM-EUR J, V9, P3965, DOI 10.1002/chem.200204298; Alaerts L, 2007, ANGEW CHEM INT EDIT, V46, P4293, DOI 10.1002/anie.200700056; Carlucci L, 2003, COORDIN CHEM REV, V246, P247, DOI 10.1016/S0010-8545(03)00126-7; Wan CQ, 2010, INORG CHEM, V49, P97, DOI 10.1021/ic901521j; Lamann-Glees A, 2012, CRYST GROWTH DES, V12, P854, DOI 10.1021/cg201244y; Zhang JA, 2011, INORG CHIM ACTA, V374, P269, DOI 10.1016/j.ica.2011.02.073; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Notash B, 2010, INORG CHEM, V49, P11415, DOI 10.1021/ic101387c; Cordiner RL, 2005, J ORGANOMET CHEM, V690, P4908, DOI 10.1016/j.jorganchem.2005.08.002; Yuan GZ, 2009, J AM CHEM SOC, V131, P10452, DOI 10.1021/ja901154p; Hung-Low F, 2009, POLYHEDRON, V28, P407, DOI 10.1016/j.poly.2008.11.040; Gu ZY, 2010, ANGEW CHEM INT EDIT, V49, P1477, DOI 10.1002/anie.200906560; FUJITA M, 1994, J AM CHEM SOC, V116, P1151, DOI 10.1021/ja00082a055; Beurskens P.T., 1994, TECHN REP CRYSTALLOG; Byrne P, 2008, CHEM COMMUN, P3720, DOI 10.1039/b806060f; Chen CL, 2003, INORG CHEM, V42, P3738, DOI 10.1021/ic0341035; Cromer D. T., 1974, INT TABLES XRAY CRYS, V4; Drock U., 1978, ACTA CRYSTALLOGR B, V34, P3095; Fillaut JL, 2006, J ORGANOMET CHEM, V691, P5610, DOI 10.1016/j.jorganchem.2006.09.008; Fortin D, 2000, INORG CHEM, V39, P2758, DOI 10.1021/ic990975o; Gu ZY, 2010, J PHYS CHEM C, V114, P311, DOI 10.1021/jp9063017; Guo HM, 2011, POLYHEDRON, V30, P1982, DOI 10.1016/j.poly.2011.05.006; Huang XC, 2005, CHEM COMMUN, P2232, DOI 10.1039/b501071c; Janiak C, 2000, J CHEM SOC DALTON, P3885, DOI 10.1039/b003010o; Kilway KV, 2006, PURE APPL CHEM, V78, P855, DOI 10.1351/pac200678040855; Kubiak R, 1996, ACTA CHEM SCAND, V50, P1164, DOI 10.3891/acta.chem.scand.50-1164; Kuznetsov ML, 2004, J MOL STRUC-THEOCHEM, V674, P33, DOI 10.1016/j.theochem.2003.12.042; Kuznetsov ML, 2003, DALTON T, P738, DOI 10.1039/b210394j; Kuznetsov ML, 2004, J MOL STRUC-THEOCHEM, V671, P229, DOI 10.1016/j.theochem.2003.11.004; Molecular Structure Corporation, 1992, CRYST STRUCT ANAL PA; Munakata M, 2004, INORG CHEM, V43, P633, DOI 10.1021/ic0302433; Munakata M, 2006, INORG CHIM ACTA, V359, P4281, DOI 10.1016/j.ica.2006.06.010; NAKASHIMA M, 1985, B CHEM SOC JPN, V58, P968, DOI 10.1246/bcsj.58.968; Nasser N, 2011, CHEM COMMUN, V47, P2808, DOI 10.1039/c0cc05411a; Niu CY, 2009, ACTA CRYSTALLOGR E, V65, pM1029, DOI 10.1107/S1600536809029183; Stoll I, 2010, CHEM MATER, V22, P4749, DOI 10.1021/cm101193g; Sun D, 2011, CRYSTENGCOMM, V13, P5661, DOI 10.1039/c1ce05622k; Venkataraman D, 1996, ACTA CRYSTALLOGR C, V52, P2416, DOI 10.1107/S0108270196006099; Wan CQ, 2011, CRYST GROWTH DES, V11, P832, DOI 10.1021/cg101490a; Wang L, 2011, CRYSTENGCOMM, V13, P747, DOI 10.1039/c0ce00689k; Zhao CQ, 2008, DALTON T, P1243, DOI 10.1039/b716035f	42	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693	1873-3255		INORG CHIM ACTA	Inorg. Chim. Acta	NOV 1	2014	423		A				340	347		10.1016/j.ica.2014.08.035		8	Chemistry, Inorganic & Nuclear	Chemistry	AT7KS	WOS:000345115900047		
J	Chen, Y; Yang, W; Sha, R; Fu, RD; Sun, WH				Chen, Yan; Yang, Wenhong; Sha, Ren; Fu, Ru-De; Sun, Wen-Hua			Correlating net charges and the activity of bis(imino)pyridylcobalt complexes in ethylene polymerization	INORGANICA CHIMICA ACTA			English	Article						Density functional theory; QEq method; Effective net charge; Polymerization activity; Cobalt complex	CATALYTIC-ACTIVITY; IRON; COBALT	A series of unsymmetrical bis(imino)pyridylcobalt complexes was investigated by DFT-QEq method to correlate the net charges of cobalt center and their catalytic activities. The effective net charge values on cobalt atom, calculated by QEq method at doublet spin state, reflected the influences of substituents within their ligands. The catalytic activities of these cobalt complexes in ethylene polymerization continuously increase along with higher values of the effective net charges on cobalt atom. The energy differences at doublet and quartet states kept the constant tendency for the cobalt complexes without the steric influences of substituents within ligands. (C) 2014 Elsevier B.V. All rights reserved.	[Chen, Yan; Sha, Ren] Inner Mongolia Normal Univ, Dept Chem & Environm Sci, Hohhot 010020, Inner Mongolia, Peoples R China; [Chen, Yan; Yang, Wenhong; Sun, Wen-Hua] Chinese Acad Sci, Inst Chem, Key Lab Engn Plast, Beijing 100190, Peoples R China; [Chen, Yan; Yang, Wenhong; Sun, Wen-Hua] Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China; [Fu, Ru-De] Tokyo Jogakkan Coll, Dept Int Liberal Arts, Machida, Tokyo 1940004, Japan	Sha, R (reprint author), Inner Mongolia Normal Univ, Dept Chem & Environm Sci, Hohhot 010020, Inner Mongolia, Peoples R China.	whsun@iccas.ac.cn	Sun, Wen-Hua /C-9995-2010	Sun, Wen-Hua /0000-0002-6614-9284	National Science Foundation of China [21204092, U1362204]; "One-Three-Five'' Strategic Planning of ICCAS	This work was financially supported by National Science Foundation of China (Nos. 21204092 and U1362204) and "One-Three-Five'' Strategic Planning of ICCAS.	Guo DW, 2001, MACROMOL THEOR SIMUL, V10, P75, DOI 10.1002/1521-3919(20010201)10:2<75::AID-MATS75>3.0.CO;2-7; Zhang TZ, 2004, J MOL CATAL A-CHEM, V218, P119, DOI 10.1016/j.molcata.2004.03.034; Xiao LW, 2009, ORGANOMETALLICS, V28, P2225, DOI 10.1021/om801141n; JOHNSON LK, 1995, J AM CHEM SOC, V117, P6414, DOI 10.1021/ja00128a054; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Sun WH, 2013, ADV POLYM SCI, V258, P163, DOI 10.1007/12_2013_212; Duan BG, 2010, CHEM J CHINESE U, V31, P343; Guo DW, 2000, J POLYM SCI POL CHEM, V38, P2232, DOI 10.1002/(SICI)1099-0518(20000615)38:12<2232::AID-POLA110>3.3.CO;2-T; Zhang TZ, 2004, J POLYM SCI POL CHEM, V42, P4765, DOI 10.1002/pola.20242; Zhang WJ, 2013, DALTON T, V42, P8988, DOI 10.1039/c2dt32337k; RAPPE AK, 1991, J PHYS CHEM-US, V95, P3358, DOI 10.1021/j100161a070; Zhang XF, 2009, SCI CHINA SER B, V52, P48, DOI 10.1007/s11426-008-0112-6; Sun WH, 2007, ORGANOMETALLICS, V26, P2720, DOI 10.1021/om0700819; BECKE AD, 1988, J CHEM PHYS, V88, P2547, DOI 10.1063/1.454033; BROOKHART M, 1983, J ORGANOMET CHEM, V250, P395, DOI 10.1016/0022-328X(83)85065-7; Guo DW, 2002, MACROMOL THEOR SIMUL, V11, P1006, DOI 10.1002/1521-3919(200211)11:9<1006::AID-MATS1006>3.0.CO;2-7; ALELYUNAS YW, 1991, ORGANOMETALLICS, V10, P1406, DOI 10.1021/om00051a036; Britovsek GJP, 1998, CHEM COMMUN, P849, DOI 10.1039/a801933i; Cruz VL, 2005, ORGANOMETALLICS, V24, P5095, DOI 10.1021/om050458f; JORDAN RF, 1988, J CHEM EDUC, V65, P285; Ma J, 2014, INORG CHEM FRONT, V1, P14, DOI 10.1039/c3qi00028a; MOHRING PC, 1992, J MOL CATAL, V77, P41, DOI 10.1016/0304-5102(92)80183-H; Niu SQ, 2000, CHEM REV, V100, P353, DOI 10.1021/cr980404y; Small BL, 1998, J AM CHEM SOC, V120, P4049, DOI 10.1021/ja9802100; Wang SL, 2013, DALTON T, V42, P9188, DOI 10.1039/c3dt00011g; Yang W., J BRAZ CHEM IN PRESS; Yang W., MACROMOL CH IN PRESS	27	3	3	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693	1873-3255		INORG CHIM ACTA	Inorg. Chim. Acta	NOV 1	2014	423		A				450	453		10.1016/j.ica.2014.09.011		4	Chemistry, Inorganic & Nuclear	Chemistry	AT7KS	WOS:000345115900059		
J	Campbell, J				Campbell, Joel			Nuclear disaster at Fukushima Daiichi: social, political and environmental issues	INTERNATIONAL AFFAIRS			English	Book Review									[Campbell, Joel] Troy Univ, Okinawa, Japan	Campbell, J (reprint author), Troy Univ, Global Campus, Okinawa, Japan.						Hindmarsh R., 2013, NUCL DISASTER FUKUSH	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-5850	1468-2346		INT AFF	Int. Aff.	NOV	2014	90	6					1477	1479				3	International Relations	International Relations	AT2WD	WOS:000344794000029		
J	Kazamori, D; Aoi, H; Sugimoto, K; Ueshima, T; Amano, H; Itoh, K; Kuramoto, Y; YazakiDrug, A				Kazamori, Daichi; Aoi, Hiroshi; Sugimoto, Kaori; Ueshima, Taichi; Amano, Hirotaka; Itoh, Kenji; Kuramoto, Yasuhiro; YazakiDrug, Akira			In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Article						WQ-3810; Fluoroquinolones; Antimicrobial resistance	URINARY-TRACT-INFECTIONS; GRAM-NEGATIVE BACILLI; INTENSIVE-CARE UNITS; ANTIMICROBIAL SUSCEPTIBILITY; ACINETOBACTER-BAUMANNII; PSEUDOMONAS-AERUGINOSA; NEISSERIA-GONORRHOEAE; QUINOLONE RESISTANCE; DNA GYRASE; TOPOISOMERASES	The aim of this study was to examine the in vitro antibacterial activity of WQ-3810, a new fluoroquinolone, against clinically relevant pathogens such as Acinetobacter baumannii, Escherichia coli and Streptococcus pneumoniae, including multidrug-resistant (MDR) and fluoroquinolone-resistant (FQR) isolates, compared with those of ciprofloxacin, levofloxacin, moxifloxacin and gemifloxacin. WQ-3810 demonstrated the most potent activity against the antimicrobial-resistant pathogens tested. Against A. baumannii, including MDR isolates, the potency of WQ-3810 [minimum inhibitory concentration for 90% of the organisms (MIC90)= 1 mg/L] was more than eight-fold higher than that of ciprofloxacin (64 mg/L) and levofloxacin (8 mg/L). Against E. coli and S. pneumoniae, including FQR isolates, WQ-3810 (MIC90 = 4 mg/L and 0.06 mg/L, respectively) was also more active than ciprofloxacin (64 mg/L and 2 mg/L) and levofloxacin (32 mg/L and 2 mg/L). Furthermore, WQ-3810 was the most potent among the fluoroquinolones tested against meticillin-resistant Staphylococcus aureus (MRSA) and Neisseria gonorrhoeae, including FQR isolates. In particular, WQ-3810 demonstrated highly potent activity against FQR isolates of A. baumannii, E. coli and S. pneumoniae with amino acid mutation(s) in the quinolone resistance-determining region of DNA gyrase and/or topoisomerase IV, which are the target enzymes of fluoroquinolones. An enzyme inhibition study performed using FQR E. coli DNA gyrase suggested that the potent antibacterial activity of WQ-3810 against drug-resistant isolates partly results from the strong inhibition of the target enzymes. In conclusion, this study demonstrated that WQ-3810 exhibits extremely potent antibacterial activity over the existing fluoroquinolones, particularly against MDR and FQR pathogens. (C) 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.	[Kazamori, Daichi; Aoi, Hiroshi; Sugimoto, Kaori; Ueshima, Taichi; Amano, Hirotaka; Itoh, Kenji; Kuramoto, Yasuhiro; YazakiDrug, Akira] Wakunaga Pharmaceut Co Ltd, Drug Discovery Lab, Akitakata Shi, Hiroshima 7391195, Japan	Kazamori, D (reprint author), Wakunaga Pharmaceut Co Ltd, Drug Discovery Lab, 1624 Shimokotachi, Akitakata Shi, Hiroshima 7391195, Japan.	kazamori_d@wakunaga.co.jp			Wakunaga Pharmaceutical Co., Ltd. (Osaka, Japan)	This research was funded by Wakunaga Pharmaceutical Co., Ltd. (Osaka, Japan).	Amano H, 2012, 52 INT C ANT AG CHEM; Tabah A, 2012, INTENS CARE MED, V38, P1930, DOI 10.1007/s00134-012-2695-9; Lindgren PK, 2003, ANTIMICROB AGENTS CH, V47, P3222, DOI 10.1128/AAC.47.10.3222-3232.2003; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Fukuda H, 1998, ANTIMICROB AGENTS CH, V42, P1917; Akasaka T, 1998, ANTIMICROB AGENTS CH, V42, P1284; KOGA H, 1980, J MED CHEM, V23, P1358, DOI 10.1021/jm00186a014; Fisher L. Mark, 2008, V142, P11, DOI 10.1007/978-1-59745-246-5_2; Kuramoto Y, 2003, J MED CHEM, V46, P1905, DOI 10.1021/jm0205090; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377; Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Morata L, 2012, ANTIMICROB AGENTS CH, V56, P4833, DOI 10.1128/AAC.00750-12; Nagayama Ariaki, 2008, Journal of Infection and Chemotherapy, V14, P383, DOI 10.1007/s10156-008-0634-z; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI; Deane J, 2012, 52 INT C ANT AG CHEM; Dent LL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-196; Donegan EA, 2006, SEX TRANSM DIS, V33, P625, DOI 10.1097/01.olq.0000216012.83990.bd; Eckburg PB, 2012, 52 INT C ANT AG ICAA; Hooper DC, 1998, CLIN INFECT DIS, V27, pS54; Hooper DC, 2001, EMERG INFECT DIS, V7, P337; Linhares I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-19; Northwood JB, 2010, CLIN MICROBIOL INFEC, V16, pS494; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; Yang Y, 2006, J ANTIMICROB CHEMOTH, V58, P868, DOI 10.1093/jac/dkl301; Yau W, 2009, J INFECTION, V58, P138, DOI 10.1016/j.jinf.2008.11.002; Zhanel GG, 2008, DIAGN MICR INFEC DIS, V62, P67, DOI 10.1016/j.diagmicrobio.2008.04.012	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	NOV	2014	44	5					443	449		10.1016/j.ijantimicag.2014.07.017		7	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	AT4UM	WOS:000344938800011		
J	Yamada, T; Kubota, T; Nakamura, M; Ochiai, M; Yonezawa, M; Yano, T; Kawashiri, T; Egashira, N; Hara, T; Masuda, S				Yamada, Takaaki; Kubota, Toshio; Nakamura, Masako; Ochiai, Masayuki; Yonezawa, Mahoro; Yano, Takahisa; Kawashiri, Takehiro; Egashira, Nobuaki; Hara, Toshiro; Masuda, Satohiro			Evaluation of teicoplanin concentrations and safety analysis in neonates	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Article						Teicoplanin; Neonates; Safety analysis; Therapeutic drug monitoring	RESISTANT STAPHYLOCOCCUS-AUREUS; PHARMACOKINETICS; INFECTIONS	The aims of this study were (i) to evaluate the relationship between teicoplanin (TEIC) dosage and subsequent trough concentration, (ii) to investigate factors that affect TEIC serum concentration fluctuations and (iii) to examine the association between serum concentration of TEIC and adverse reactions in neonates. A total of 37 eligible neonates (< 28 days of age) treated with TEIC from 2008-2012 were included in this study. The median trough concentration in the loading dose regimen of > 12-16 mg/kg on Day 1, followed by > 6-8 mg/kg every 24 h (q24 h) was 19.6 mu g/mL on Day 3 or 4, and the median trough concentration in the maintenance dose regimen of > 6-8 mg/kg q24 h was 18.5 mu g/mL at steady-state. There were significant correlations between serum creatinine and concentration/dose (C/D) ratio (r = 0.475, P = 0.019), body weight and C/D ratio (r = -0.425, P = 0.038) and corrected gestational age and C/D ratio (r = -0.482, P = 0.017) after administering the loading dose. The incidence of hepatic dysfunction, renal impairment and thrombocytopenia was 14.8%, 20.0% and 14.8%, respectively. There was no significant difference in the incidence of adverse reactions between the trough concentration < 20 mu g/mL and >= 20 mu g/mL groups. These data suggest that the recommended TEIC dosage for neonates is appropriate to achieve and maintain a trough concentration range of 15-30 mu g/mL, and it is possible to set the target trough concentration at >= 20 mu g/mL for deep-seated infections such as endocarditis, bone and joint infections, and osteomyelitis. (C) 2014 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.	[Yamada, Takaaki; Kubota, Toshio; Yano, Takahisa; Kawashiri, Takehiro; Egashira, Nobuaki; Masuda, Satohiro] Kyushu Univ, Dept Pharm, Fukuoka 812, Japan; [Kubota, Toshio; Nakamura, Masako; Yonezawa, Mahoro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm & Pharmaceut Care, Fukuoka 812, Japan; [Ochiai, Masayuki; Hara, Toshiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 812, Japan; [Egashira, Nobuaki; Masuda, Satohiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Biopharmaceut, Fukuoka 812, Japan	Kubota, T (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm & Pharmaceut Care, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	t-kubota@pharm.med.kyushu-u.ac.jp	Masuda, Satohiro/E-6691-2010	Masuda, Satohiro/0000-0002-3589-5989			Kimura T, 2004, ANTIMICROB AGENTS CH, V48, P1159, DOI 10.1128/AAC.48.4.1159-1167.2004; Alcorn J, 2003, ADV DRUG DELIVER REV, V55, P667, DOI 10.1016/S0169-409X(03)00030-9; Gemmell CG, 2006, J ANTIMICROB CHEMOTH, V57, P589, DOI 10.1093/jac/dkl017; Fanos V, 1997, EUR J PEDIATR, V156, P423, DOI 10.1007/s004310050629; Matthews PC, 2014, J INFECTION, V68, P43, DOI 10.1016/j.jinf.2013.08.018; Sanchez A, 1999, J ANTIMICROB CHEMOTH, V44, P407, DOI 10.1093/jac/44.3.407; AWNI WM, 1991, THER DRUG MONIT, V13, P511, DOI 10.1097/00007691-199111000-00008; FRYE RF, 1992, PHARMACOTHERAPY, V12, P240; Healy CM, 2004, CLIN INFECT DIS, V39, P1460, DOI 10.1086/425321; Matthews PC, 2007, J INFECTION, V55, P408, DOI 10.1016/j.jinf.2007.07.012; Seki Masafumi, 2012, Clin Pharmacol, V4, P71, DOI 10.2147/CPAA.S37528; Sweetman SC, 2009, MARTINDALE COMPLETE, P344; Ueda T, 2012, J INFECT CHEMOTHER, V18, P296, DOI 10.1007/s10156-011-0325-z; Watanabe A, 2011, J INFECT CHEMOTHER, V17, P139, DOI 10.1007/s10156-010-0183-0; Wilson APR, 1997, TEICOPLANIN 1 DECADE, P137	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	NOV	2014	44	5					458	462		10.1016/j.ijantimicag.2014.07.005		5	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	AT4UM	WOS:000344938800013		
J	Cacchione, T; Indino, M; Fujita, K; Itakura, S; Matsuno, T; Schaub, S; Amici, F				Cacchione, Trix; Indino, Marcello; Fujita, Kazuo; Itakura, Shoji; Matsuno, Toyomi; Schaub, Simone; Amici, Federica			Universal ontology: Attentive tracking of objects and substances across languages and over development	INTERNATIONAL JOURNAL OF BEHAVIORAL DEVELOPMENT			English	Article						cross cultural differences; multiple-object tracking; linguistic relativity; object-substance distinction	LINGUISTIC RELATIVITY; WILLIAMS-SYNDROME; CORE KNOWLEDGE; MULTIPLE; INFANTS; PERCEPTION; CHILDREN; SYNTAX; CLASSIFIERS; PERSISTENCE	Previous research has demonstrated that adults are successful at visually tracking rigidly moving items, but experience great difficulties when tracking substance-like pouring items. Using a comparative approach, we investigated whether the presence/absence of the grammatical count-mass distinction influences adults and children's ability to attentively track objects versus substances. More specifically, we aimed to explore whether the higher success at tracking rigid over substance-like items appears universally or whether speakers of classifier languages (like Japanese, not marking the object-substance distinction) are advantaged at tracking substances as compared to speakers of non-classifier languages (like Swiss German, marking the object-substance distinction). Our results supported the idea that language has no effect on low-level cognitive processes such as the attentive visual processing of objects and substances. We concluded arguing that the tendency to prioritize objects is universal and independent of specific characteristics of the language spoken.	[Cacchione, Trix; Indino, Marcello; Schaub, Simone] Univ Zurich, CH-8006 Zurich, Switzerland; [Fujita, Kazuo; Itakura, Shoji; Matsuno, Toyomi] Kyoto Univ, Kyoto 6068501, Japan; [Amici, Federica] Max Planck Inst Evolutionary Anthropol, D-04107 Leipzig, Germany	Amici, F (reprint author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04107 Leipzig, Germany.	abbepu@yahoo.it					SOJA NN, 1991, COGNITION, V38, P179, DOI 10.1016/0010-0277(91)90051-5; Scholl BJ, 2001, COGNITION, V80, P1, DOI 10.1016/S0010-0277(00)00152-9; Spelke ES, 2000, AM PSYCHOL, V55, P1233, DOI 10.1037/0003-066X.55.11.1233; Hespos SJ, 2012, CHILD DEV, V83, P554, DOI 10.1111/j.1467-8624.2011.01703.x; Berent I, 2007, COGNITION, V104, P591, DOI 10.1016/j.cognition.2006.05.015; Scholl BJ, 2007, MIND LANG, V22, P563, DOI 10.1111/j.1468-0017.2007.00321.x; Scholl BJ, 1999, COGNITIVE PSYCHOL, V38, P259, DOI 10.1006/cogp.1998.0698; Scholl BJ, 2001, COGNITION, V80, P159, DOI 10.1016/S0010-0277(00)00157-8; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037//0033-295X.99.4.605; Regier T, 2009, TRENDS COGN SCI, V13, P439, DOI 10.1016/j.tics.2009.07.001; Prasada S, 2002, COGNITION, V83, P141, DOI 10.1016/S0010-0277(01)00173-1; Huntley-Fenner G, 2002, COGNITION, V85, P203, DOI 10.1016/S0010-0277(02)00088-4; Subrahmanyam K, 1999, LANG COGNITIVE PROC, V14, P249; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; SPELKE E, 1994, COGNITION, V50, P431, DOI 10.1016/0010-0277(94)90039-6; Chiang WC, 2000, COGNITION, V77, P169, DOI 10.1016/S0010-0277(00)00091-3; Wolff P, 2011, WIRES COGN SCI, V2, P253, DOI 10.1002/wcs.104; Leslie AM, 1998, TRENDS COGN SCI, V2, P10, DOI 10.1016/S1364-6613(97)01113-3; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; vanMarle K, 2003, PSYCHOL SCI, V14, P498, DOI 10.1111/1467-9280.03451; Cacchione T, 2013, COGNITION, V128, P397, DOI 10.1016/j.cognition.2013.05.006; Cacchione T, 2010, COGNITION, V116, P193, DOI 10.1016/j.cognition.2010.05.002; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Mahajan N, 2009, DEVELOPMENTAL SCI, V12, P920, DOI 10.1111/j.1467-7687.2009.00842.x; Cheries EW, 2008, DEVELOPMENTAL SCI, V11, P427, DOI 10.1111/j.1467-7687.2008.00687.x; Trick LM, 2005, COGNITIVE DEV, V20, P373, DOI 10.1016/j.cogdev.2005.05.009; Samuelson LK, 1999, COGNITION, V73, P1, DOI 10.1016/S0010-0277(99)00034-7; Cacchione T, 2013, ANIM COGN, V16, P1, DOI 10.1007/s10071-012-0545-3; Imai M, 1997, COGNITION, V62, P169, DOI 10.1016/S0010-0277(96)00784-6; Bahrami B, 2003, VIS COGN, V10, P949, DOI 10.1080/13506280344000158; Bloom P., 2000, CHILDREN LEARN MEANI; Bowerman M., 2001, LANG ACQUIS, P475, DOI DOI 10.1017/CBO9780511620669.018; Carey S, 2001, COGNITION, V80, P179, DOI 10.1016/S0010-0277(00)00154-2; Davidoff J., 1999, NATURE, V398, P2003; Gao Y., 2009, LANG COGNITIVE PROC, V24, P1124; Hall G., 1996, COGNITIVE DEV, V11, P229; Hespos SJ, 2009, PSYCHOL SCI, V20, P603, DOI 10.1111/j.1467-9280.2009.02331.x; Imai M, 2007, COGNITIVE SCI, V31, P385, DOI 10.1080/15326900701326436; Imai M., 2003, LANGUAGE MIND ADV IS, P430; LANDAU B, 1992, COGNITION, V43, P85, DOI 10.1016/0010-0277(92)90033-E; Li P, 2009, COGNITIVE PSYCHOL, V58, P487, DOI 10.1016/j.cogpsych.2008.12.001; Lucy J. A., 2001, LANG ACQUIS, P257, DOI 10.1017/CBO9780511620669.011; Lucy John, 1992, GRAMMATICAL CATEGORI; Muramoto Y, 2009, ASIAN J SOC PSYCHOL, V12, P199, DOI 10.1111/j.1467-839X.2009.01285.x; O'Hearn K, 2005, PSYCHOL SCI, V16, P905, DOI 10.1111/j.1467-9280.2005.01635.x; O'Hearn K, 2010, DEVELOPMENTAL SCI, V13, P430, DOI 10.1111/j.1467-7687.2009.00893.x; Pinker S, 1997, NATURE, V387, P547, DOI 10.1038/42347; Prasada S, 1999, LANGUAGE, LOGIC, AND CONCEPTS, P119; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Quine W.V., 1960, WORD OBJECT; Quine W.V.O., 1969, ONTOLOGICAL RELATIVI; Robertson D., 2010, WORDS MIND WORDS CAP, P183; Saalbach H, 2007, J EXP PSYCHOL GEN, V136, P485, DOI 10.1037/0096-3445.136.3.485; Saalbach H, 2012, LANG COGNITIVE PROC, V27, P381, DOI 10.1080/01690965.2010.546585; SOJA NN, 1992, COGNITIVE DEV, V7, P29, DOI 10.1016/0885-2014(92)90003-A; SOJA NN, 1992, COGNITION, V45, P101, DOI 10.1016/0010-0277(92)90025-D; vanMarle K, 2011, DEVELOPMENTAL SCI, V14, P502, DOI 10.1111/j.1467-7687.2010.00998.x; Zhang S, 1998, J EXP PSYCHOL-APPL, V4, P375, DOI 10.1037/1076-898X.4.4.375	58	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0165-0254	1464-0651		INT J BEHAV DEV	Int. J. Behav. Dev.	NOV	2014	38	6					481	486		10.1177/0165025414544233		6	Psychology, Developmental	Psychology	AU0HY	WOS:000345305300001		
J	Saitou, M				Saitou, Masatoshi			Characterization of Electrodeposited Ni and Ni-Mo Thin Films by X-ray Diffraction	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						Ni thin film; Ni-Mo thin film; X-ray diffraction; atomic pair distribution function; Williamson-Hall technique; nanocrystal	ALLOYS; LIQUID; AMORPHOUS/NANOCRYSTALLINE; MERCURY; SILVER	Electrodeposited Ni and Ni-Mo films were investigated by X-ray diffraction (XRD) and electron probe microanalysis (EPMA). Using a Williamson-Hall technique by X-ray diffraction, the Ni thin film, which shows four Bragg diffraction peaks in the XRD chart, is estimated to have a mean grain size of 30 nm. The Ni-Mo film having a Mo content of 9.6 to 10.6 at. % indicates that the Bragg peaks that exist in the XRD pattern of the Ni thin film disappear in the XRD pattern except for a broad diffraction from a (111) crystallographic plane. An atomic pair distribution function (PDF) calculated from the XRD pattern reveals that the Ni-Mo film has a long-range structural order and contains Mo as a solute atom that substitutes for a Ni atom. The electrodeposited Ni-Mo film is concluded to have a nanocrystalline characteristic comprising a Ni-Ni atomic bond and Ni-Mo atomic bond.	Univ Ryukyus, Dept Mech Syst Engn, Okinawa 9030213, Japan	Saitou, M (reprint author), Univ Ryukyus, Dept Mech Syst Engn, 1 Senbaru Nishihara Cho, Okinawa 9030213, Japan.	saitou@tec.u-ryukyu.ac.jp					Abadias G, 2010, J APPL PHYS, V107, DOI 10.1063/1.3284079; WAGNER CNJ, 1978, J NON-CRYST SOLIDS, V31, P1, DOI 10.1016/0022-3093(78)90097-2; Mihailov L, 2011, J MATER SCI, V46, P7068, DOI 10.1007/s10853-011-5436-5; Billinge SJL, 2004, Z KRISTALLOGR, V219, P117, DOI 10.1524/zkri.219.3.117.29094; Gingrich NS, 1943, REV MOD PHYS, V15, P0090, DOI 10.1103/RevModPhys.15.90; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6; LANGFORD JI, 1978, J APPL CRYSTALLOGR, V11, P102, DOI 10.1107/S0021889878012844; Allahyarzadeh MH, 2011, ELECTROCHIM ACTA, V56, P10210, DOI 10.1016/j.electacta.2011.09.011; KAPLOW R, 1965, PHYS REV, V138, P1336; Biju V, 2008, J MATER SCI, V43, P1175, DOI 10.1007/s10853-007-2300-8; Beltowska-Lehman E, 2012, THIN SOLID FILMS, V520, P2046, DOI 10.1016/j.tsf.2011.10.024; Beltowska-Lehman E, 2012, SURF COAT TECH, V211, P67, DOI 10.1016/j.surfcoat.2011.10.011; Birkholz M, 2006, THIN FILM ANALYSIS BY X-RAY SCATTERING, P1; Chassaing E, 2004, J APPL ELECTROCHEM, V34, P1085, DOI 10.1007/s10800-004-2460-z; Donten M, 2005, ELECTROCHIM ACTA, V50, P1405, DOI 10.1016/j.electacta.2004.08.028; Kirk DW, 1997, INT J HYDROGEN ENERG, V22, P493, DOI 10.1016/S0360-3199(96)00129-2; Luoa J. K., 2004, MATER LETT, V58, P2306; Macgillavry C. H., 1985, INT TABLES XRAY CRYS, V3; Mousavi R, 2008, INT J MOD PHYS B, V22, P3060, DOI 10.1142/S0217979208047924; Sagel K., 1958, TABELLEN RONTGENSTRU; Saitou M, 2003, J ELECTROCHEM SOC, V150, pC140, DOI 10.1149/1.1545459; Sanches L. S., 2004, ELECTROCHEM COMMUM, V6, P548; WAGNER CNJ, 1965, Z NATURFORSCH PT A, VA 20, P325; Waseda Y., 1980, STRUCTURE NONCRYSTAL; Zhang Q, 2000, J APPL PHYS, V87, P4147, DOI 10.1063/1.373044	25	1	1	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	NOV	2014	9	11					6033	6042				10	Electrochemistry	Electrochemistry	AT9QQ	WOS:000345261800015		
J	Reshak, AH; Tan, ST; Naumar, FY; Umar, AA; Oyama, M; Alahmed, ZA; Kamarudin, H; Kityk, IV				Reshak, A. H.; Tan, Sin Tee; Naumar, Fitri Yeni; Umar, A. A.; Oyama, M.; Alahmed, Z. A.; Kamarudin, H.; Kityk, I. V.			Photoinduced Nonlinear Optical Second -Order Optical Effects in the Ag-ZnO Nanorods	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						synthesis of ZnO nanorods; silver nanoprticles. Optical properties	MEDIATED GROWTH METHOD; THIN-FILMS; NANOPARTICLES; NANOWIRES; SURFACES; ARRAY	ZnO nanorods with controlled-surface density have been successfully obtained by simply varying the concentration of the growth solution. It was found that the variation in the growth solution concentration may vary the surface density of the ZnO nanorods arrays grown on the surface. The lowest concentration produces the lowest nanorods surface density. The photoinduced second harmonic generation was studied for the nanosecond Er: glass lasers at wavelength 1540 nm and induced by bicolour treatment at 1540/770 nm wavelengths. The nonlinear dependence on the Ag NP presence was observed. And it s was substantially higher than for the pure ZnO nanoparticles.	[Reshak, A. H.] Univ W Bohemia, New Technol Res Ctr, Plzen 30614, Czech Republic; [Reshak, A. H.; Kamarudin, H.] Univ Malaysia Perlis, Sch Mat Engn, Ctr Excellence Geopolymer & Green Technol, Kangar 01007, Perlis, Malaysia; [Reshak, A. H.] CENAKVA South Bohemia Univ CB, FFPW, Inst Complex Syst, Nove Hrady 37333, Czech Republic; [Tan, Sin Tee; Naumar, Fitri Yeni; Umar, A. A.] Univ Kebangsaan Malaysia, Inst Microengn & Nanoelect, Ukm Bangi 43600, Selangor, Malaysia; [Oyama, M.] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158520, Japan; [Alahmed, Z. A.] King Saud Univ, Dept Phys & Astron, Riyadh 11451, Saudi Arabia; [Kityk, I. V.] Eastern Ukrainian Natl Univ, Dept Phys, UA-43025 Lutsk, Ukraine	Reshak, AH (reprint author), Univ W Bohemia, New Technol Res Ctr, Univ 8, Plzen 30614, Czech Republic.	maalidph@yahoo.co.uk	Alahmed, Zeyad/F-1683-2013; Kityk, Iwan/M-4032-2015; Tan, Sin Tee/N-4791-2014; Oyama, Munetaka/D-6541-2014; 	Alahmed, Zeyad/0000-0001-7304-8118; Tan, Sin Tee/0000-0002-6845-6608; hussin, kamarudin/0000-0001-9644-4244; Oyama, Munetaka/0000-0001-7422-9914; Reshak, A/0000-0001-9426-8363	CENTEM project [CZ.1.05/2.1.00/03.0088]; ERDF, Ministry of Education, Youth and Sports OP RDI program	The result was developed within the CENTEM project, reg. no. CZ.1.05/2.1.00/03.0088, co-funded by the ERDF as part of the Ministry of Education, Youth and Sports OP RDI program. Computational resources were provided by MetaCentrum (LM2010005) and CERIT-SC (CZ.1.05/3.2.00/08.0144) infrastructures.	Xie W, 2010, J PHOTOCH PHOTOBIO A, V216, P149, DOI 10.1016/j.jphotochem.2010.06.032; Wang G, 2002, APPL PHYS LETT, V80, P401, DOI 10.1063/1.1435065; Vayssieres L, 2001, CHEM MATER, V13, P4395, DOI 10.1021/cm011160s; Vayssieres L, 2003, ADV MATER, V15, P464, DOI 10.1002/adma.200390108; Min SK, 2009, J KOREAN PHYS SOC, V55, P1005; Zhang XQ, 2003, J PHYS-CONDENS MAT, V15, P5191, DOI 10.1088/0953-8984/15/30/301; Ozga K, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/18/185709; Ibrahim AA, 2012, TALANTA, V93, P257, DOI 10.1016/j.talanta.2012.02.030; Umar AA, 2007, CRYST GROWTH DES, V7, P2404, DOI 10.1021/cg0602008; Neumann U, 2004, APPL PHYS LETT, V84, P170, DOI 10.1063/1.1639939; Demortiere A, 2008, J PHYS CHEM B, V112, P14583, DOI 10.1021/jp802081n; Ebothe J, 2006, APPL SURF SCI, V253, P1626, DOI 10.1016/j.apsusc.2006.02.055; Ozga K, 2011, J ALLOY COMPD, V509, pS424, DOI 10.1016/j.jallcom.2010.12.107; Tan S., 2013, J PHYS C SERIES, P12001; Tan ST, 2013, SCI ADV MATER, V5, P803, DOI 10.1166/sam.2013.1521; Umar A. A., 2011, NANOSCALE RES LETT, V6, P1; Umar AA, 2005, CRYST GROWTH DES, V5, P599, DOI 10.1021/cg049711p; Umar AA, 2006, APPL SURF SCI, V253, P2196, DOI 10.1016/j.apsusc.2006.04.033; Si X, 2008, CHINESE PHYS B, V17, P1291, DOI 10.1088/1674-1056/17/4/024; Yang YQ, 2013, CRYSTENGCOMM, V15, P2608, DOI 10.1039/c2ce26429c	20	2	2	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	NOV	2014	9	11					6352	6358				7	Electrochemistry	Electrochemistry	AT9QQ	WOS:000345261800040		
J	Yu, Z; Shi, G; Ju, DY				Yu, Zhan; Shi, Gang; Ju, Dongying			Electrochemical Properties Evaluation of a Novel Mg Alloy Anode on Mg-1 Air Batteries	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						Magnesium alloy anode; Magnesium air battery; Magnesium button battery; Magnesium fuel cell vehicle	ORGANIC SOLUTIONS; MAGNESIUM; ELECTRODEPOSITION; METALS	Magnesium alloy is considered an environmentally friendly material that contains none of mercury, lead and chromate. (2)This study aims to evaluate the performance of the new magnesium (Mg-Zn-InSn) alloy by adding elements Zn-In-Sn in AZ91 which are established by orthogonal design and manufactured by two roll continue casting methods, in order to improve the electrochemical properties of magnesium alloy, and then determine the application of Mg-Zn-In-Sn alloy on the air batteries. The electrochemical properties of magnesium air battery are measured to investigate the practical use of Mg-Zn-In-Sn alloy anode. Magnesium and zinc mixed button battery, as a kind of magnesium air battery is developed to measure the continuous discharge curves. And the discharge voltage is calculated by the concentrations of magnesium ion, which are measured via inductively coupled plasma (ICP) analysis and FACSIMILE software simulation. The comparison of pure magnesium, AZ31, AZ91 and Mg-Zn-In-Sn alloy anodes used in the magnesium fuel cell vehicle model were performed. The results show that Mg-Zn-In-Sn alloy anode has the most negative and stable open circuit potential used on the air battery. The stable discharge of magnesium and zinc mixed button battery is more than 60 hours. And the mechanism of corrosion reactions in magnesium and zinc mixed button battery is certificated by electrochemical calculation. Furthermore the speed of magnesium fuel cell vehicle model with Mg-Zn-In-Sn alloy anode is higher than the one with other alloy anodes. It is investigated that Mg-Zn-In-Sn alloy anode is suitable to use on the air batteries by this paper.	[Yu, Zhan; Shi, Gang] Saitama Inst Technol, Grad Sch, Saitama 3690293, Japan; [Ju, Dongying] Saitama Inst Technol, Dept Mat Sci & Engn, Saitama 3690293, Japan; [Ju, Dongying] Univ Sci & Technol Liaoning, Dept Mat Sci & Engn, Anshan 114051, Peoples R China	Yu, Z (reprint author), Saitama Inst Technol, Grad Sch, Fusaiji 1690, Saitama 3690293, Japan.	d8002dle@sit.ac.jp; dyju@sit.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	This work was partially supported by the "Nano Project" for Private Universities: 2011-2014 matching fund subsidy from Ministry of Education, Culture, Sports, Science and Technology.	GREGORY TD, 1990, J ELECTROCHEM SOC, V137, P775, DOI 10.1149/1.2086553; Gaddum LW, 1927, J AM CHEM SOC, V49, P1295, DOI 10.1021/ja01404a020; Winther-Jensen B, 2008, ELECTROCHIM ACTA, V53, P5881, DOI 10.1016/j.electacta.2008.04.005; Novak P, 1999, ELECTROCHIM ACTA, V45, P351, DOI 10.1016/S0013-4686(99)00216-9; CONNOR JH, 1957, J ELECTROCHEM SOC, V104, P38, DOI 10.1149/1.2428492; Sheha E, 2008, J POWER SOURCES, V185, P1509, DOI 10.1016/j.jpowsour.2008.09.046; Aurbach D., 2000, NATURE, V407, P72; Blomgren GE, 2000, NATURE, V407, P681, DOI 10.1038/35037687; BRENNER A, 1956, J ELECTROCHEM SOC, V103, P652, DOI 10.1149/1.2430185; Donahue J. F., 1963, DISCUSSION SILVER CH; Honer H N., 1976, U.S. Patent, Patent No. 19763966970; Hu X. D., 2007, THESIS SAITAMA U JAP; Koontz R. F., 1980, U.S. Patent, Patent No. 19804192197; Linden D., 2002, HDB BATTERIES; Nelson J.M., 1917, Journal of the American Chemical Society, V39, DOI 10.1021/ja02246a009; Yu K, 2012, T NONFERR METAL SOC, V22, P2184, DOI 10.1016/S1003-6326(11)61447-7; Yu Z, 2010, T NONFERROUS METALS, V20, P318	17	0	0	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	NOV	2014	9	11					6668	6676				9	Electrochemistry	Electrochemistry	AT9QQ	WOS:000345261800067		
J	Okada, A				Okada, Akira			The stationary equilibrium of three-person coalitional bargaining games with random proposers: a classification	INTERNATIONAL JOURNAL OF GAME THEORY			English	Article						Non-cooperative bargaining; Coalitional game; Three-person game; Random proposer; Core; Marginal contribution		We present a classification of all stationary subgame perfect equilibria of the random proposer model for a three-person cooperative game according to the level of efficiency. The efficiency level is characterized by the number of "central" players who join all equilibrium coalitions. The existence of a central player guarantees asymptotic efficiency. The marginal contributions of players to the grand coalition play a critical role in their expected equilibrium payoffs.	Hitotsubashi Univ, Grad Sch Econ, Tokyo 1868601, Japan	Okada, A (reprint author), Hitotsubashi Univ, Grad Sch Econ, 2-1 Naka, Tokyo 1868601, Japan.	aokada@econ.hit-u.ac.jp			Japan Society for the Promotion of Science [20223001]	I am grateful to two anonymous referees for helpful comments. I would also like to thank Takeshi Nishimura for excellent assistance with this research. Financial support from the Japan Society for the Promotion of Science under Grant No. (S) 20223001 is gratefully acknowledged.	Okada A, 1996, GAME ECON BEHAV, V16, P97, DOI 10.1006/game.1996.0076; BARON DP, 1989, AM POLIT SCI REV, V83, P1181, DOI 10.2307/1961664; Okada A, 2011, GAME ECON BEHAV, V73, P227, DOI 10.1016/j.geb.2011.01.008; Compte O, 2010, ECONOMETRICA, V78, P1593, DOI 10.3982/ECTA7883; Montero M, 2006, GAME ECON BEHAV, V54, P380, DOI 10.1016/j.geb.2005.01.001; Montero M, 2002, GAME ECON BEHAV, V41, P309, DOI 10.1016/S0899-8256(02)00501-8; Morgenstern O., 1944, THEORY GAMES EC BEHA; Nash JF, 2008, INT GAME THEORY REV, V10, P539; Okada A, 2000, JPN ECON REV, V51, P34, DOI 10.1111/1468-5876.00137; Okada A, 2010, J ECON THEORY, V145, P2356, DOI 10.1016/j.jet.2010.07.001; Ray D., 2007, GAME THEORETIC PERSP; Seidmann DJ, 1998, REV ECON STUD, V65, P793, DOI 10.1111/1467-937X.00069; Yan H, 2002, INT J GAME THEORY, V31, P527	13	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-7276	1432-1270		INT J GAME THEORY	Int. J. Game Theory	NOV	2014	43	4					953	973		10.1007/s00182-014-0413-2		21	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Statistics & Probability	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	AU0DM	WOS:000345293700012		
J	Harter, P; Johnson, T; Berton-Rigaud, D; Park, SY; Friedlander, M; del Campo, JM; Shimada, M; Forget, F; Mirza, MR; Colombo, N; Zamagni, C; Chan, JK; Imhof, M; Herzog, TJ; O'Donnell, D; King, K; Stinnett, S; Barrett, C; Jobanputra, M; Chun-Fang, X; du Bois, A				Harter, P.; Johnson, T.; Berton-Rigaud, D.; Park, S. Y.; Friedlander, M.; del Campo, J. M.; Shimada, M.; Forget, F.; Mirza, M. R.; Colombo, N.; Zamagni, C.; Chan, J. K.; Imhof, M.; Herzog, T. J.; O'Donnell, D.; King, K.; Stinnett, S.; Barrett, C.; Jobanputra, M.; Chun-Fang, X.; du Bois, A.			BRCA1/2 MUTATIONS ASSOCIATED WITH PROGRESSION FREE SURVIVAL IN OVARIAN CANCER PATIENTS WHO RECEIVED PAZOPANIB OR PLACEBO IN THE AGO-OVAR16 STUDY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Harter, P.; du Bois, A.] Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany; [Johnson, T.; Chun-Fang, X.] GlaxoSmithKline, Oncol, Stevenage, Herts, England; [Berton-Rigaud, D.] ICO Ctr Rene Gauducheau, Nantes, France; [Friedlander, M.] Prince Wales Canc Ctr, Randwick, NSW, Australia; [del Campo, J. M.] Vall dHebron Univ Hosp, Barcelona, Spain; [Shimada, M.] Tottori Univ Hosp, Dept Obstet & Gynecol, Nishimachi Yonago, Japan; [Forget, F.] CHA, Libramont, Belgium; [Mirza, M. R.] Univ Copenhagen Hosp, Rigshosp, DK-2100 Copenhagen, Denmark; [Colombo, N.] European Inst Oncol, Milan, Italy; [Zamagni, C.] Azienda Osped Univ Bologna Policlin, Dipartimento Ematol Oncol & Med Lab, Bologna, Italy; [Chan, J. K.] Palo Alto Med Fdn, San Francisco, CA USA; [Imhof, M.] Gen Publ Teaching Hosp Korneuburg, Dept Obstet & Gynaecol, Korneuburg, Austria; [Herzog, T. J.] Columbia Univ, New York, NY USA; [Herzog, T. J.] Irving Comprehens Canc Ctr, New York, NY USA; [O'Donnell, D.] St James Hosp, Dublin 8, Ireland; [King, K.; Stinnett, S.] GlaxoSmithKline, Genet, Res Triangle Pk, NC USA; [Barrett, C.; Jobanputra, M.] GlaxoSmithKline, Oncol, Uxbridge, Middx, England								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0971	40	41				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500032		
J	Yokoyama, Y; Matsushita, Y; Shigeto, T; Futagami, M; Mizunuma, H				Yokoyama, Y.; Matsushita, Y.; Shigeto, T.; Futagami, M.; Mizunuma, H.			DECREASED ARID1A EXPRESSION IS CORRELATED WITH CHEMO-RESISTANCE IN EPITHELIAL OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yokoyama, Y.; Matsushita, Y.; Shigeto, T.; Futagami, M.; Mizunuma, H.] Hirosaki Univ Grad Sch Med, Hirosaki, Aomori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0081	59	59				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500047		
J	Kato, K; Omatsu, K; Usami, T; Taniguchi, T; Yamamoto, A; Ushioda, N; Nomura, H; Matoda, M; Okamoto, S; Kondo, E; Umayahara, K; Takeshima, N				Kato, K.; Omatsu, K.; Usami, T.; Taniguchi, T.; Yamamoto, A.; Ushioda, N.; Nomura, H.; Matoda, M.; Okamoto, S.; Kondo, E.; Umayahara, K.; Takeshima, N.			POSITIVE PERITONEAL CYTOLOGY AT THE TIME OF INTERVAL DEBULKING SURGERY IS HIGHLY PREDICTIVE OF PROGNOSIS IN ADVANCED-STAGE OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kato, K.; Omatsu, K.; Usami, T.; Taniguchi, T.; Yamamoto, A.; Ushioda, N.; Nomura, H.; Matoda, M.; Okamoto, S.; Kondo, E.; Umayahara, K.; Takeshima, N.] Japanese Fdn Canc Res, Dept Gynecol, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0111	66	66				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500053		
J	Muraji, M; Fukuda, Y; Tokugawa, Y; Tsukahara, C; Iwata, N; Kashihara, H; Hisamoto, K; Kunishige, I; Nishio, Y; Tsujimoto, M				Muraji, M.; Fukuda, Y.; Tokugawa, Y.; Tsukahara, C.; Iwata, N.; Kashihara, H.; Hisamoto, K.; Kunishige, I.; Nishio, Y.; Tsujimoto, M.			THE CYTOLOGICAL ANALYSIS FROM ENDOMETRIUM IS USEFUL FOR EARLY DETECTION OF PELVIC SEROUS CARCINOMA ASSOCIATED WITH TUBAL INTRAEPITHELIAL CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Muraji, M.; Fukuda, Y.; Tokugawa, Y.; Tsukahara, C.; Iwata, N.; Kashihara, H.; Hisamoto, K.; Kunishige, I.; Nishio, Y.; Tsujimoto, M.] Osaka Police Hosp, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0112	67	67				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500054		
J	Maruyama, Y; Miyagi, E; Numazaki, R; Nakanishi, T; Kataoka, F; Saruki, N; Yamamoto, H; Shinhara, A; Muramatsu, T; Takasu, M; Ito, N; Yoshida, N; Yamakado, M; Aoki, D; Hirahara, F				Maruyama, Y.; Miyagi, E.; Numazaki, R.; Nakanishi, T.; Kataoka, F.; Saruki, N.; Yamamoto, H.; Shinhara, A.; Muramatsu, T.; Takasu, M.; Ito, N.; Yoshida, N.; Yamakado, M.; Aoki, D.; Hirahara, F.			USEFULNESS OF A NOVEL BIOMARKER BASED ON PLASMA AMINO ACID PROFILE FOR EARLY DETECTION OF OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Maruyama, Y.; Miyagi, E.; Numazaki, R.; Hirahara, F.] Yokohama City Univ Sch Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan; [Nakanishi, T.; Ito, N.; Yoshida, N.] Aichi Canc Ctr Hosp, Dept Gynecol, Nagoya, Aichi, Japan; [Kataoka, F.; Aoki, D.] Sch Med Keio Univ, Dept Obstet & Gynecol, Tokyo, Japan; [Saruki, N.] Gunma Prefectural Canc Ctr, Dept Anesthesia, Ohta, Gumma, Japan; [Yamamoto, H.; Shinhara, A.; Muramatsu, T.; Takasu, M.] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan; [Yamakado, M.] Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Tokyo 101, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0191	76	76				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500063		
J	Sakurai, M; Satoh, T; Matsumoto, K; Shikama, A; Michikami, H; Tasaka, N; Nakamura, Y; Nakao, S; Ochi, H; Onuki, M; Minaguchi, T; Yoshikawa, H				Sakurai, M.; Satoh, T.; Matsumoto, K.; Shikama, A.; Michikami, H.; Tasaka, N.; Nakamura, Y.; Nakao, S.; Ochi, H.; Onuki, M.; Minaguchi, T.; Yoshikawa, H.			HIGH PRETREATMENT PLASMA D-DIMER LEVELS ARE ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH OVARIAN CANCER INDEPENDENTLY OF VENOUS THROMBOEMBOLISM AND TUMOUR EXTENSION.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Sakurai, M.; Satoh, T.; Matsumoto, K.; Shikama, A.; Michikami, H.; Tasaka, N.; Nakamura, Y.; Nakao, S.; Ochi, H.; Onuki, M.; Minaguchi, T.; Yoshikawa, H.] Univ Tsukuba, Tsukuba, Ibaraki, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0203	80	81				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500067		
J	Mariya, T; Hirohashi, Y; Asano, T; Kuroda, T; Mizuuchi, M; Torigoe, T; Saito, T; Sato, N				Mariya, T.; Hirohashi, Y.; Asano, T.; Kuroda, T.; Mizuuchi, M.; Torigoe, T.; Saito, T.; Sato, N.			MMP10 REGULATES STEMNESS OF OVARIAN CANCER STEM CELLS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Mariya, T.; Hirohashi, Y.; Asano, T.; Kuroda, T.; Mizuuchi, M.; Torigoe, T.; Saito, T.; Sato, N.] Sapporo Med Univ, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0269	98	98				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500083		
J	Shibata, K; Mizuno, M; Sekiya, R; Mitui, H; Suzuki, S; Kajiyama, H; Kikkawa, F				Shibata, K.; Mizuno, M.; Sekiya, R.; Mitui, H.; Suzuki, S.; Kajiyama, H.; Kikkawa, F.			EFFECTIVENESS AND IMMNUNOLOGICAL ANALYSIS IN A PHASE II CLINICAL TRIAL OF THE GPC3 DERIVED PEPTIDE VACCINE FOR OVARIAN CLEAR CELL ADENOCARCINOMA PATIENTS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Shibata, K.; Mizuno, M.; Sekiya, R.; Mitui, H.; Suzuki, S.; Kajiyama, H.; Kikkawa, F.] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0276	99	99				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500084		
J	Yoneyama, K; Yamamoto, A; Tsunoda, Y; Kawase, R; Yamada, T; Kurose, K; Doi, D; Kamoi, S; Takeshita, T				Yoneyama, K.; Yamamoto, A.; Tsunoda, Y.; Kawase, R.; Yamada, T.; Kurose, K.; Doi, D.; Kamoi, S.; Takeshita, T.			PREOPERATIVE DIAGNOSIS OF SQUAMOUS CELL CARCINOMA ARISING FROM MATURE CYSTIC TERATOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yoneyama, K.; Yamamoto, A.; Tsunoda, Y.; Kawase, R.; Yamada, T.; Kurose, K.; Doi, D.; Kamoi, S.; Takeshita, T.] Nippon Med Sch, Tokyo 113, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0318	105	105				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500090		
J	Tanaka, A; Ugaki, H; Masuda, T; Yamada, M; Ouchi, Y; Maenaka, T; Tanaka, E; Oyama, T; Komoto, Y; Endo, M; Takemura, M				Tanaka, A.; Ugaki, H.; Masuda, T.; Yamada, M.; Ouchi, Y.; Maenaka, T.; Tanaka, E.; Oyama, T.; Komoto, Y.; Endo, M.; Takemura, M.			TRANSITIONAL CELL CARCINOMA (TCC) OF THE OVARY THAT HAS ACHIEVED LONG-TERM SURVIVAL: A CASE REPORT	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Tanaka, A.; Ugaki, H.; Masuda, T.; Yamada, M.; Ouchi, Y.; Maenaka, T.; Tanaka, E.; Oyama, T.; Komoto, Y.; Endo, M.; Takemura, M.] Osaka Gen Med Ctr, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0340	112	112				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500095		
J	Suzuki, S; Mitsui, H; Sekiya, R; Mizuno, M; Kajiyama, H; Shibata, K; Kikkawa, F				Suzuki, S.; Mitsui, H.; Sekiya, R.; Mizuno, M.; Kajiyama, H.; Shibata, K.; Kikkawa, F.			CLINICAL AND IMMUNOLOGICAL ANALYSIS IN CLINICAL STUDY OF GLYPICAN-3 PEPTIDE VACCINE FOR PATIENTS WITH OVARIAN CLEAR CELL CARCINOMA IN FIRST CLINICAL REMISSION	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Suzuki, S.; Mitsui, H.; Sekiya, R.; Mizuno, M.; Kajiyama, H.; Shibata, K.; Kikkawa, F.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0372	118	118				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500101		
J	Morimoto, A; Nagao, S; Kogiku, A; Yamamoto, K; Miwa, M; Wakahashi, S; Ichida, K; Sudo, T; Yamaguchi, S; Fujiwara, K				Morimoto, A.; Nagao, S.; Kogiku, A.; Yamamoto, K.; Miwa, M.; Wakahashi, S.; Ichida, K.; Sudo, T.; Yamaguchi, S.; Fujiwara, K.			THE CLINICAL CHARACTERISTICS IN DETERMINING THE OPTIMUM TIMING OF INTERVAL DEBULKING SURGERY IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Morimoto, A.; Nagao, S.; Kogiku, A.; Yamamoto, K.; Miwa, M.; Wakahashi, S.; Ichida, K.; Sudo, T.; Yamaguchi, S.; Fujiwara, K.] Hyogo Canc Ctr, Akashi, Hyogo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0419	131	131				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500111		
J	Mitsui, H; Shibata, K; Teshigawara, T; Sekiya, R; Suzuki, S; Mizuno, M; Kajiyama, H; Kikkawa, F				Mitsui, H.; Shibata, K.; Teshigawara, T.; Sekiya, R.; Suzuki, S.; Mizuno, M.; Kajiyama, H.; Kikkawa, F.			INTERACTION BETWEEN PERITONEAL MESOTHELIAL CELLS AND OVARIAN CANCER CELLS IN PERITONEAL DISSEMINATION	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Mitsui, H.; Shibata, K.; Teshigawara, T.; Sekiya, R.; Suzuki, S.; Mizuno, M.; Kajiyama, H.; Kikkawa, F.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0477	144	145				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500121		
J	Mizuno, M; Shibata, K; Mitsui, H; Sekiya, R; Suzuki, S; Kikkawa, F				Mizuno, M.; Shibata, K.; Mitsui, H.; Sekiya, R.; Suzuki, S.; Kikkawa, F.			PROGNOSTIC IMPACT OF HISTOLOGICAL TYPE IN STAGE IV OVARIAN CARCINOMA: A RETROSPECTIVE ANALYSIS OF 219 PATIENTS.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Mizuno, M.; Shibata, K.; Mitsui, H.; Sekiya, R.; Suzuki, S.; Kikkawa, F.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0492	149	149				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500124		
J	Furusawa, A; Uno, M; Mori, M; Kino, N; Ozaki, Y; Kubota, T; Yasugi, T				Furusawa, A.; Uno, M.; Mori, M.; Kino, N.; Ozaki, Y.; Kubota, T.; Yasugi, T.			CLINICAL BENEFITS OF SECONDARY DEBULKING SURGERY FOR RECURRENT OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Furusawa, A.; Kubota, T.] Tokyo Med & Dent Univ, Grad Sch, Tokyo, Japan; [Uno, M.; Mori, M.; Kino, N.; Ozaki, Y.; Yasugi, T.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Gynecol, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0498	151	151				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500126		
J	Imai, K; Fukuda, T; Kawanishi, M; Wada, T; Yamauchi, M; Kasai, M; Hashiguchi, Y; Ichimura, T; Yasui, T; Sumi, T				Imai, K.; Fukuda, T.; Kawanishi, M.; Wada, T.; Yamauchi, M.; Kasai, M.; Hashiguchi, Y.; Ichimura, T.; Yasui, T.; Sumi, T.			SAFETY AND EFFICACY OF DOCETAXEL PLUS CARBOPLATIN IN MENOPAUSAL PATIENTS WITH MULLERIAN CARCINOMA.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Imai, K.] Izumiotsu Municipal Hosp, Izumiotsu, Japan; [Fukuda, T.; Wada, T.; Yamauchi, M.; Kasai, M.; Hashiguchi, Y.; Ichimura, T.; Yasui, T.; Sumi, T.] Osaka City Univ, Grad Sch Med, Osaka 558, Japan; [Kawanishi, M.] Kishiwada City Hosp, Kishiwada, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0561	164	164				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500134		
J	Asai-Sato, M; Maruyama, K; Kawano, A; Mogami, T; Matsunaga, T; Hirahara, F; Miyagi, E				Asai-Sato, M.; Maruyama, K.; Kawano, A.; Mogami, T.; Matsunaga, T.; Hirahara, F.; Miyagi, E.			METASTATIC SITE PREDICTS PROGNOSIS OF FIGO STAGE IV EPITHELIAL OVARIAN CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Asai-Sato, M.; Maruyama, K.; Kawano, A.; Mogami, T.; Matsunaga, T.; Hirahara, F.; Miyagi, E.] Yokohama City Univ, Yokohama, Kanagawa 232, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0585	171	171				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500139		
J	Takaishi, K; Saito, F; Motohara, T; Tashiro, H; Katabuchi, H				Takaishi, K.; Saito, F.; Motohara, T.; Tashiro, H.; Katabuchi, H.			A CLINICOPATHOLOGICAL ANALYSIS OF 48 MALIGNANT OVARIAN GERM CELL TUMOR CASES	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Takaishi, K.; Saito, F.; Motohara, T.; Tashiro, H.; Katabuchi, H.] Kumamoto Univ, Fac Life Sci, Kumamoto, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0587	173	173				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500141		
J	Iwase, H; Ono, S; Takada, T; Arai, T; Arai, M; Onda, T				Iwase, H.; Ono, S.; Takada, T.; Arai, T.; Arai, M.; Onda, T.			EFFICACY OF MULTILINE CHEMOTHERAPY FOR PLATINUM-REFRACTORY OR - RESISTANT RECURRENT OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Iwase, H.; Ono, S.; Takada, T.; Arai, T.; Arai, M.; Onda, T.] Kitasato Univ, Sch Med, Sagamihara, Kanagawa 228, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0664	194	194				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500156		
J	Imai, Y; Hasegawa, K; Ichikawa, D; Sato, S; Yano, Y; Miyasaka, A; Yabuno, A; Nishikawa, T; Kurosaki, A; Yoshida, H; Fujiwara, K				Imai, Y.; Hasegawa, K.; Ichikawa, D.; Sato, S.; Yano, Y.; Miyasaka, A.; Yabuno, A.; Nishikawa, T.; Kurosaki, A.; Yoshida, H.; Fujiwara, K.			RETROSPECTIVE ANALYSIS OF INTRAPERITONEAL CARBOPLATIN COMBINED WITH INTRAVENOUS DOSE-DENSE PACLITAXEL IN PATIENTS WITH OVARIAN CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Imai, Y.; Hasegawa, K.; Ichikawa, D.; Sato, S.; Yano, Y.; Miyasaka, A.; Yabuno, A.; Nishikawa, T.; Kurosaki, A.; Yoshida, H.; Fujiwara, K.] Saitama Med Univ Int Med Ctr, Hidaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0671	196	196				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500158		
J	Yamada, Y; Miyamoto, T; Ando, H; Takatsu, A; Higuchi, S; Kobara, H; Shiozawa, T				Yamada, Y.; Miyamoto, T.; Ando, H.; Takatsu, A.; Higuchi, S.; Kobara, H.; Shiozawa, T.			LIPOCALIN2 ENHANCES INVASION AND SURVIVAL AGAINST OXIDATIVE STRESS OF OVARIAN CLEAR CELL CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yamada, Y.; Miyamoto, T.; Ando, H.; Takatsu, A.; Higuchi, S.; Kobara, H.; Shiozawa, T.] Shinshu Univ, Matsumoto, Nagano 390, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0675	199	199				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500160		
J	Higuchi, S; Miyamoto, T; Kobayashi, A; Tanaka, Y; Kasuga, H; Nakajima, M; Kobara, H; Tachibana, R; Shiozawa, T				Higuchi, S.; Miyamoto, T.; Kobayashi, A.; Tanaka, Y.; Kasuga, H.; Nakajima, M.; Kobara, H.; Tachibana, R.; Shiozawa, T.			A CASE OF SPONTANEOUS REGRESSION OF RECURRENT OVARIAN SEROUS ADENOCARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Higuchi, S.; Miyamoto, T.; Kobayashi, A.; Tanaka, Y.; Kasuga, H.; Nakajima, M.; Kobara, H.; Tachibana, R.; Shiozawa, T.] Shinshu Univ, Matsumoto, Nagano 390, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0709	214	214				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500171		
J	Matsumoto, K; Boku, S; Takase, N; Shibata, Y; Onoe, T; Negoro, S				Matsumoto, K.; Boku, S.; Takase, N.; Shibata, Y.; Onoe, T.; Negoro, S.			EARLY MORTALITY AND MORBIDITY OF ELDERLY PATIENTS WITH OVARIAN CANCER RECEIVING DOSE DENSE TC REGIMEN	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Matsumoto, K.; Boku, S.; Takase, N.; Shibata, Y.; Onoe, T.; Negoro, S.] Hyogo Canc Ctr, Akashi, Hyogo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0712	215	215				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500172		
J	Hasegawa, K; Oe, S; Torii, Y; Udagawa, Y; Fukasawa, I				Hasegawa, K.; Oe, S.; Torii, Y.; Udagawa, Y.; Fukasawa, I.			PODOPLANIN EXPRESSION PLAYS AN IMPORTANT ROLE IN CELL CYCLE REGULATION IN OVARIAN CLEAR CELL ADENOCARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Hasegawa, K.; Udagawa, Y.; Fukasawa, I.] Dokkyo Med Univ, Dept Obstet & Gynecol, Mibumachi, Japan; [Oe, S.] Nagoya Higashi Home Care Clin, Nagoya, Aichi, Japan; [Torii, Y.] Fujita Hlth Univ, Sch Med, Dept Obstet & Gynecol, Toyoake, Aichi 47011, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0722	222	222				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500177		
J	Fujiwara, K; Monk, BJ; Park, SY; Takeuchi, S; Nakanishi, T; Lim, BK; Kato, H; Yoshikawa, H; Fujiwara, Y; Hirashima, Y; Tassoudji, M; Warner, D; Bae, DS				Fujiwara, K.; Monk, B. J.; Park, S. Y.; Takeuchi, S.; Nakanishi, T.; Lim, B. K.; Kato, H.; Yoshikawa, H.; Fujiwara, Y.; Hirashima, Y.; Tassoudji, M.; Warner, D.; Bae, D. S.			A SUBGROUP ANALYSIS OF TRINOVA-1: WEEKLY TREBANANIB OR PLACEBO PLUS PACLITAXEL IN ASIAN WOMEN WITH RECURRENT OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Fujiwara, K.] Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka, Japan; [Monk, B. J.] Univ Arizona, Ctr Canc, St Josephs Hosp & Med Ctr, Dept Obstet & Gynecol, Phoenix, AZ USA; [Park, S. Y.] Natl Canc Ctr, Res Inst & Hosp, Goyang Si, South Korea; [Takeuchi, S.] Iwate Med Univ Hosp, Dept Obstet & Gynecol, Morioka, Iwate, Japan; [Nakanishi, T.] Aichi Canc Ctr Hosp, Dept Gynecol, Nagoya, Aichi 464, Japan; [Lim, B. K.] Univ Malaya, Dept Obstet & Gynecol, Med Ctr, Kuala Lumpur, Malaysia; [Kato, H.] Natl Hosp Org, Hokkaido Canc Ctr, Div Gynecol Oncol, Sapporo, Hokkaido, Japan; [Yoshikawa, H.] Tsukuba Univ Hosp, Dept Obstet & Gynecol, Tsukuba, Ibaraki, Japan; [Fujiwara, Y.] Natl Canc Ctr, Dept Med Oncol, Chuo Ku, Tokyo, Japan; [Tassoudji, M.] Amgen Inc, Dept Biostat, Thousand Oaks, CA 91320 USA; [Warner, D.] Amgen Inc, Dept Clin Dev, Thousand Oaks, CA 91320 USA; [Bae, D. S.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0756	231	232				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500184		
J	Hashimoto, K; Sasaki, K; Horibe, Y; Fukagawa, F; Akizawa, Y; Ishitani, K; Hirai, Y; Matsui, H				Hashimoto, K.; Sasaki, K.; Horibe, Y.; Fukagawa, F.; Akizawa, Y.; Ishitani, K.; Hirai, Y.; Matsui, H.			TOLERANCE AND OUTCOME OF PRIMARY CHEMOTHERAPY WITH CARBOPLATIN AND OCETAXEL IN ELDERLY OVARIAN CANCER PATIENTS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Hashimoto, K.; Sasaki, K.; Horibe, Y.; Fukagawa, F.; Akizawa, Y.; Ishitani, K.; Hirai, Y.; Matsui, H.] Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0795	254	254				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500198		
J	Odagiri, T; Nozaki, A; Kanno, M; Nomura, E				Odagiri, T.; Nozaki, A.; Kanno, M.; Nomura, E.			TUMOR DORMANCY AFTER IRRADIATION IN PLATINUM-RESISTANT OVARIAN CANCER LESIONS: ANALYSIS OF SUVMAX CHANGES OF IRRADIATED TUMORS BY PET/CT AND PATHOLOGICAL CONFIRMATION OF TUMOR BED EFFECT	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Odagiri, T.; Nozaki, A.; Kanno, M.; Nomura, E.] Oji Gen Hosp, Tomakomai, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0823	268	269				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500206		
J	Yamamoto, A; Ikeda, M; Kamoi, S; Shimada, M; Kurose, K; Kawase, R; Takeshita, T				Yamamoto, A.; Ikeda, M.; Kamoi, S.; Shimada, M.; Kurose, K.; Kawase, R.; Takeshita, T.			CYLINDROMA ORIGINATING FROM OVARIAN MATURE CYSTIC TERATOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yamamoto, A.; Ikeda, M.; Kamoi, S.; Shimada, M.; Kurose, K.; Kawase, R.; Takeshita, T.] Nippon Med Sch, Tokyo 113, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0835	271	272				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500208		
J	Tanaka, N; Suzuka, K; Kim, A; Kusanishi, T; Ijiri, M; Oosaki, T				Tanaka, N.; Suzuka, K.; Kim, A.; Kusanishi, T.; Ijiri, M.; Oosaki, T.			IMMATURE TERATOMA OF THE OVARY WITH SPINAL BONE METASTASIS: A CASE REPORT	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Tanaka, N.; Suzuka, K.; Kim, A.; Kusanishi, T.; Ijiri, M.; Oosaki, T.] Chiba Canc Ctr, Chiba 2608717, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0885	290	290				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500219		
J	Kitagawa, M; Watari, H; Mitamura, T; Tanaka, S; Sakuragi, N				Kitagawa, M.; Watari, H.; Mitamura, T.; Tanaka, S.; Sakuragi, N.			CABOZANTIB HAS ANTI-TUMOR EFFECT FOR OVARIAN CLEAR CELL CARCINOMA CELLS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kitagawa, M.; Watari, H.; Mitamura, T.; Tanaka, S.; Sakuragi, N.] Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0890	292	292				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500220		
J	Sugita, K; Takada, S; Yamamoto, T				Sugita, K.; Takada, S.; Yamamoto, T.			ONE CASE OF OVARIAN SQUAMOUS CELL CARCINOMA (SCC) PRESENT IN THE RENAL LEVEL (EPIGASTRIUM), ACCORDING TO DIAGNOSTIC IMAGING, AND DIAGNOSED AS A SUSPECTED MESENTERIC CYSTOMA.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Sugita, K.; Takada, S.; Yamamoto, T.] Nihon Univ, Sch Med, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1032	361	361				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500258		
J	Kaneda, H; Fujino, K; Ujihira, T; Kusunoki, S; Kimura, M; Terao, Y; Takeda, S				Kaneda, H.; Fujino, K.; Ujihira, T.; Kusunoki, S.; Kimura, M.; Terao, Y.; Takeda, S.			THREE CASES OF PRIMARY OVARIAN NEUROENDOCRINE CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kaneda, H.; Fujino, K.; Ujihira, T.; Kusunoki, S.; Kimura, M.; Terao, Y.; Takeda, S.] Juntendo Univ, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1078	380	380				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500269		
J	Takano, M; Ikeda, Y; Kouta, H; Sasaki, N; Goto, T; Kudoh, K; Kita, T; Kikuchi, R; Furuya, K; Kikuch, Y				Takano, M.; Ikeda, Y.; Kouta, H.; Sasaki, N.; Goto, T.; Kudoh, K.; Kita, T.; Kikuchi, R.; Furuya, K.; Kikuch, Y.			COMBINATION THERAPY WITH BEVACIZUMAB AND GEMOX FOR PATIENTS WITH RECURRENT OVARIAN CANCERS: A PHASE II STUDY.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Takano, M.; Sasaki, N.; Goto, T.; Furuya, K.] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan; [Ikeda, Y.] Univ Tokyo, Tokyo, Japan; [Kouta, H.; Kikuch, Y.] Ohki Mem Kikuchi Canc Ctr Women, Tokorozawa, Saitama, Japan; [Kudoh, K.] Nishisaitama Chuo Natl Hosp, Tokorozawa, Saitama, Japan; [Kita, T.] Nara Med Ctr, Tokorozawa, Saitama, Japan; [Kikuchi, R.] Sasaki Inst Kyoundo Hosp, Kanda Surugadai, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1079	381	382				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500270		
J	Shimokawa, M; Ohki, M; Kaku, T				Shimokawa, M.; Ohki, M.; Kaku, T.			CORRELATION OF PROGRESSION-FREE AND POST-PROGRESSION SURVIVAL WITH OVERALL SURVIVAL IN PHASE III TRIALS OF FIRST-LINE CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Shimokawa, M.] Kyushu Natl Canc Ctr, Clin Res Ctr, Fukuoka, Japan; [Ohki, M.; Kaku, T.] Kyushu Univ, Dept Hlth Sci, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1100	393	393				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500278		
J	Amano, Y; Yamaguchi, K; Matsumura, N; Baba, T; Hamanishi, J; Konishi, I; Mandai, M				Amano, Y.; Yamaguchi, K.; Matsumura, N.; Baba, T.; Hamanishi, J.; Konishi, I.; Mandai, M.			HNF1BETA CONFERS RESISTANCE TO OXIDATIVE STRESS OF OVARIAN CLEAR CELL CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Amano, Y.; Yamaguchi, K.; Matsumura, N.; Baba, T.; Hamanishi, J.; Konishi, I.] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Mandai, M.] Kinki Univ, Sch Med, Sayama, Osaka 589, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1108	394	394				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500279		
J	Koh, I; Hirata, E; Nosaka, S; Urabe, S; Nobuzane, T; Miyoshi, H; Kudo, Y				Koh, I.; Hirata, E.; Nosaka, S.; Urabe, S.; Nobuzane, T.; Miyoshi, H.; Kudo, Y.			KINETICS OF CDX2 AND MDR1 PROTEIN IN OVARIAN MUCINOUS ADENOCARCINOMA CELL LINES	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Koh, I.; Nosaka, S.] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Programs Appl Biomed, Hiroshima, Japan; [Hirata, E.; Urabe, S.; Nobuzane, T.; Miyoshi, H.; Kudo, Y.] Hiroshima Univ Hosp, Hiroshima, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1132	398	399				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500282		
J	Hamanishi, J; Mandai, M; Matsumura, N; Abiko, K; Baba, T; Yamaguchi, K; Ueda, M; Horikawa, N; Murakami, R; Koshiyama, M; Konishi, I				Hamanishi, J.; Mandai, M.; Matsumura, N.; Abiko, K.; Baba, T.; Yamaguchi, K.; Ueda, M.; Horikawa, N.; Murakami, R.; Koshiyama, M.; Konishi, I.			A PHASE II CLINICAL TRIAL OF IMMUNOTHERAPY WITH ANTI-PD-1 ANTIBODY (NIVOLUMAB) IN ADVANCED/RELAPSED, PLATINUM-RESISTANT OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Hamanishi, J.; Matsumura, N.; Abiko, K.; Baba, T.; Yamaguchi, K.; Ueda, M.; Horikawa, N.; Murakami, R.; Koshiyama, M.; Konishi, I.] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Mandai, M.] Kinki Univ, Grad Sch Med, Kyoto, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1133	400	401				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500283		
J	Yoshihara, M; Uno, K; Tano, S; Mayama, M; Ukai, M; Kondo, S; Kokabu, T; Harada, T; Kishigami, Y; Oguchi, H				Yoshihara, M.; Uno, K.; Tano, S.; Mayama, M.; Ukai, M.; Kondo, S.; Kokabu, T.; Harada, T.; Kishigami, Y.; Oguchi, H.			TWO CASES OF OVARIAN MIXED-EPITHELIAL PAPILLARY CYSTADENOMA OF BORDERLINE MALIGNANCY OF MULLERIAN TYPE WITH SQUAMOUS OVERGROWTH	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yoshihara, M.; Uno, K.; Tano, S.; Mayama, M.; Ukai, M.; Kondo, S.; Kokabu, T.; Harada, T.; Kishigami, Y.; Oguchi, H.] Toyota Mem Hosp, Toyota, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1152	406	406				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500287		
J	Asano, H; Yamada, K; Hanley, S; Nishi, S; Nomura, E				Asano, H.; Yamada, K.; Hanley, S.; Nishi, S.; Nomura, E.			RADIATION THERAPY FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER DETECTED BY FDG-PET/CONTRAST ENHANCED CT	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Asano, H.; Nishi, S.] Ebetsu City Hosp, Ebetsu, Hokkaido, Japan; [Yamada, K.; Nomura, E.] Oji Hosp, Tomakomai, Japan; [Hanley, S.] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1199	422	423				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500298		
J	Teshigawara, T; Mizuno, M; Shibata, K; Kikkawa, F				Teshigawara, T.; Mizuno, M.; Shibata, K.; Kikkawa, F.			THE EFFICACY OF 5-AMINOLEVULINIC ACID MEDIATED-PHOTODYNAMIC DIAGNOSIS AND PHOTODYNAMIC THERAPY FOR IN VIVO OVARIAN CANCER DISSEMINATION MODELS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Teshigawara, T.; Mizuno, M.; Shibata, K.; Kikkawa, F.] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1345	488	488				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500337		
J	Tanigawa, T; Matoda, M; Usami, T; Abe, A; Yamamoto, A; Nomura, H; Okamoto, S; Omatsu, K; Kondo, E; Kato, K; Umayahara, K; Takeshima, N				Tanigawa, T.; Matoda, M.; Usami, T.; Abe, A.; Yamamoto, A.; Nomura, H.; Okamoto, S.; Omatsu, K.; Kondo, E.; Kato, K.; Umayahara, K.; Takeshima, N.			CLINICAL USEFULNESS OF S-1 FOR ADVANCED OR RECURRENT CERVICAL CANCER.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Tanigawa, T.; Matoda, M.; Usami, T.; Abe, A.; Yamamoto, A.; Nomura, H.; Okamoto, S.; Omatsu, K.; Kondo, E.; Kato, K.; Umayahara, K.; Takeshima, N.] Canc Inst Hosp, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0120	504	504				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500348		
J	Mizunuma, M; Yokoyama, Y; Mizunuma, H				Mizunuma, M.; Yokoyama, Y.; Mizunuma, H.			PRETREATMENT NEUTROPHIL-TO-LYMPHOCYTE RATIO PREDICTS THERAPEUTIC RESPONSE OF RADIATION THERAPY AND CONCURRENT CHEMORADIATION THERAPY IN CERVICAL CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Mizunuma, M.; Yokoyama, Y.; Mizunuma, H.] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0137	510	510				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500352		
J	Yamashita, T; Utsu, H; Kim, M; Hanley, SJB; Katayama, H				Yamashita, T.; Utsu, H.; Kim, M.; Hanley, S. J. B.; Katayama, H.			LAPAROSCOPIC NERVE SPARING RADICAL HYSTERECTOMY AS A MINIMALLY INVASIVE FUNCTION-PRESERVING SURGERY IN EARLY STAGE CERVICAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yamashita, T.; Utsu, H.; Kim, M.] Hakodate Municipal Hosp, Hakodate, Hokkaido, Japan; [Hanley, S. J. B.] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Katayama, H.] Asahikawa Med Coll, Asahikawa, Hokkaido 078, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0161	517	518				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500357		
J	Nagao, S; Miwa, M; Maeda, N; Kogiku, A; Yamamoto, K; Morimoto, A; Wakahashi, S; Ichida, K; Sudo, T; Yamaguchi, S; Fujiwara, K; Sakuma, Y				Nagao, S.; Miwa, M.; Maeda, N.; Kogiku, A.; Yamamoto, K.; Morimoto, A.; Wakahashi, S.; Ichida, K.; Sudo, T.; Yamaguchi, S.; Fujiwara, K.; Sakuma, Y.			TREATMENT STRATEGIES FOR NEUROENDOCRINE CARCINOMA OF THE CERVIX: A CLINICAL REVIEW OF A SINGLE INSTITUTION	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Nagao, S.; Miwa, M.; Maeda, N.; Kogiku, A.; Yamamoto, K.; Morimoto, A.; Wakahashi, S.; Ichida, K.; Sudo, T.; Yamaguchi, S.; Fujiwara, K.; Sakuma, Y.] Hyogo Canc Ctr, Akashi, Hyogo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0209	531	531				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966500365		
J	Matsuura, Y; Oka, H; Yamagata, K; Kikuchi, J; Inoue, I; Ohkubo, N; Toki, N; Kawagoe, T; Hachisuga, T; Kashimura, M				Matsuura, Y.; Oka, H.; Yamagata, K.; Kikuchi, J.; Inoue, I.; Ohkubo, N.; Toki, N.; Kawagoe, T.; Hachisuga, T.; Kashimura, M.			UTERINE CERVICAL CANCER SCREENING IN KITAKYUSHU CITY : THE EFFICACY OF FREE COUPONS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Matsuura, Y.] Univ Occupat & Environm Hlth, Dept Nursing Human Broad Dev, Kitakyushu, Fukuoka 807, Japan; [Oka, H.; Yamagata, K.; Kikuchi, J.; Inoue, I.; Ohkubo, N.; Kashimura, M.] Kitakyushu Med Assoc, Dept Uterine Cerv Canc Screening Surveilla, Kitakyushu, Fukuoka, Japan; [Toki, N.] Kyushu Rosai Hosp, Dept Obstet & Gynecol, Kitakyushu, Fukuoka, Japan; [Kawagoe, T.; Hachisuga, T.] Univ Occupat & Environm Hlth, Dept Obstet & Gynecol, Kitakyushu, Fukuoka 807, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0237	536	537				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501002		
J	Neyatani, N; Osaka, Y; Waseda, T; Sasagawa, T; Makinoda, S				Neyatani, N.; Osaka, Y.; Waseda, T.; Sasagawa, T.; Makinoda, S.			ADVANTAGES AND EFFECTIVENESS OF INTENSITY-MODULATED RADIATION THERAPY (IMRT) FOR RECURRENT GYNECOLOGIC CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Neyatani, N.; Osaka, Y.; Waseda, T.; Sasagawa, T.; Makinoda, S.] Kanazawa Med Univ, Uchinada, Ishikawa 92002, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0254	542	542				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501005		
J	Yamauchi, M; Fukuda, T; Wada, T; Kawanishi, M; Imai, K; Teramae, M; Tasaka, R; Kasai, M; Hashiguchi, Y; Ichimura, T; Yasui, T; Sumi, T				Yamauchi, M.; Fukuda, T.; Wada, T.; Kawanishi, M.; Imai, K.; Teramae, M.; Tasaka, R.; Kasai, M.; Hashiguchi, Y.; Ichimura, T.; Yasui, T.; Sumi, T.			EXPRESSION OF SIRTUIN 1 PREDICTS THE EFFICACY OF NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED UTERINE CERVICAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yamauchi, M.; Fukuda, T.; Wada, T.; Kawanishi, M.; Imai, K.; Teramae, M.; Tasaka, R.; Kasai, M.; Hashiguchi, Y.; Ichimura, T.; Yasui, T.; Sumi, T.] Osaka City Univ, Grad Sch Med, Osaka 558, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0262	545	545				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501007		
J	Nishimura, M; Tanimura, N; Takiguchi, E; Kawakita, T; Yoshida, K; Irahara, M				Nishimura, M.; Tanimura, N.; Takiguchi, E.; Kawakita, T.; Yoshida, K.; Irahara, M.			SRC IS ACTIVATED IN CERVICAL ADENOCARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Nishimura, M.; Tanimura, N.; Takiguchi, E.; Kawakita, T.; Yoshida, K.; Irahara, M.] Univ Tokushima, Tokushima 770, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0290	561	561				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501018		
J	Togami, S; Kamio, M; Yanazume, S; Kobayashi, H; Douchi, T				Togami, S.; Kamio, M.; Yanazume, S.; Kobayashi, H.; Douchi, T.			IS IT POSSIBLE TO PERFORM LESS RADICAL SURGERY FOR INVASIVE UTERINE CERVICAL CANCER?	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Togami, S.; Kamio, M.; Yanazume, S.; Kobayashi, H.; Douchi, T.] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0328	568	568				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501023		
J	Ugaki, H; Masuda, T; Tanaka, A; Yamada, M; Ouchi, Y; Maenaka, T; Tanaka, E; Oyama, T; Komoto, Y; Endo, M; Takemura, M				Ugaki, H.; Masuda, T.; Tanaka, A.; Yamada, M.; Ouchi, Y.; Maenaka, T.; Tanaka, E.; Oyama, T.; Komoto, Y.; Endo, M.; Takemura, M.			A SUCCESSFUL TREATMENT BY LONG-TERM ANTIBIOTICS THERAPY FOR A CASE OF INTRAPLEVIC ABSCESS AFTER HIGH-DOSE-RATE INTERSTITIAL BRACHYTHERAPY (HDR-ISBT) FOR CERVICAL CANCER RECURRENCE	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Ugaki, H.; Masuda, T.; Tanaka, A.; Yamada, M.; Ouchi, Y.; Maenaka, T.; Tanaka, E.; Oyama, T.; Komoto, Y.; Endo, M.; Takemura, M.] Osaka Gen Med Ctr, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0337	572	573				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501026		
J	Kurose, Y; Nagai, T; Sato, S; Uotani, T; Hanaoka, T; Akahori, T; Takai, Y; Saito, M; Baba, K; Seki, H				Kurose, Y.; Nagai, T.; Sato, S.; Uotani, T.; Hanaoka, T.; Akahori, T.; Takai, Y.; Saito, M.; Baba, K.; Seki, H.			POSTPARTUM CONSERVATIVE MANAGEMENT OF CIN3 DIAGNOSED DURING PREGNANCY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kurose, Y.; Nagai, T.; Sato, S.; Uotani, T.; Hanaoka, T.; Akahori, T.; Takai, Y.; Saito, M.; Baba, K.; Seki, H.] Saitama Med Univ, Saitama Meda Ctr, Kawagoe, Saitama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0355	579	579				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501031		
J	Akahori, T; Nagai, T; Sato, S; Uotani, T; Hanaoka, T; Takai, Y; Seki, H				Akahori, T.; Nagai, T.; Sato, S.; Uotani, T.; Hanaoka, T.; Takai, Y.; Seki, H.			EFFICACY AND SAFETY OF CONCURRENT CHEMORADIATION THERAPY (CCRT) WITH WEEKLY CDGP (NEDAPLATIN) FOR ADVANCED CERVICAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Akahori, T.; Nagai, T.; Sato, S.; Uotani, T.; Hanaoka, T.; Takai, Y.; Seki, H.] Saitama Med Univ, Saitama Med Ctr, Kawagoe, Saitama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0360	582	582				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501033		
J	Miyagi, E; Sukegawa, A; Motoki, Y; Asai-Sato, M; Hirahara, F; Taguri, M; Ohshige, K; Wark, JD; Garland, SM				Miyagi, E.; Sukegawa, A.; Motoki, Y.; Asai-Sato, M.; Hirahara, F.; Taguri, M.; Ohshige, K.; Wark, J. D.; Garland, S. M.			SURVEYS ON ATTITUDES FOR HPV VACCINATION AMONG YOUNG WOMEN IN KANAGAWA PREFECTURE, JAPAN	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Miyagi, E.; Sukegawa, A.; Motoki, Y.; Asai-Sato, M.; Hirahara, F.; Taguri, M.] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Ohshige, K.] Yokohama Natl Univ, Ctr Hlth Serves Sci, Yokohama, Kanagawa 240, Japan; [Wark, J. D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Garland, S. M.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0385	587	587				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501036		
J	Shimada, C; Katoh, T; Watari, H; Yamaguchi, M; Kimura, K; Fukumoto, S; Mitamura, T; Konno, Y; Hosaka, Y; Kobayashi, N; Takeda, M; Kudoh, M; Sakuragi, N				Shimada, C.; Katoh, T.; Watari, H.; Yamaguchi, M.; Kimura, K.; Fukumoto, S.; Mitamura, T.; Konno, Y.; Hosaka, Y.; Kobayashi, N.; Takeda, M.; Kudoh, M.; Sakuragi, N.			DISTRIBUTION OF LYMPH NODE METASTASIS SITES IN CERVICAL CANCER UNDERGOING SYSTEMATIC LYMPHADENECTOMY-TOWARD OPTIMAL LYMPHADENECTOMY-	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Shimada, C.; Katoh, T.; Watari, H.; Yamaguchi, M.; Kimura, K.; Fukumoto, S.; Mitamura, T.; Konno, Y.; Hosaka, Y.; Kobayashi, N.; Takeda, M.; Kudoh, M.; Sakuragi, N.] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0411	595	595				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501042		
J	Nagano, H; Kawakami, M; Itai, Y; Ueno, M; Kawahara, K; Morita, Y; Muraoka, M; Takagi, K				Nagano, H.; Kawakami, M.; Itai, Y.; Ueno, M.; Kawahara, K.; Morita, Y.; Muraoka, M.; Takagi, K.			ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH STAGE IB AND II CERVICAL CANCER: A RETROSPECTIVE STUDY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Nagano, H.; Kawakami, M.; Itai, Y.; Ueno, M.; Kawahara, K.; Morita, Y.; Muraoka, M.; Takagi, K.] Tokyo Womens Med Univ, Med Ctr East, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0427	600	600				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501045		
J	Onuki, M; Matsumoto, K; Nakao, S; Sakurai, M; Ochi, H; Minaguchi, T; Satoh, T; Yoshikawa, H				Onuki, M.; Matsumoto, K.; Nakao, S.; Sakurai, M.; Ochi, H.; Minaguchi, T.; Satoh, T.; Yoshikawa, H.			HUMAN PAPILLOMAVIRUS (HPV) TESTING FOR WOMEN TREATED FOR CIN2/3 PREDICTS RECURRENT OR RESIDUAL DISEASES	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Onuki, M.; Matsumoto, K.; Sakurai, M.; Ochi, H.; Minaguchi, T.; Satoh, T.; Yoshikawa, H.] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Nakao, S.] Tsukuba Gakuen Hosp, Tsukuba, Ibaraki, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0459	607	607				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501050		
J	Kawano, K; Kato, H; Nishio, S; Tsuda, N; Sonoda, G; Komai, K; Ushijima, K				Kawano, K.; Kato, H.; Nishio, S.; Tsuda, N.; Sonoda, G.; Komai, K.; Ushijima, K.			OPTIMAL CONE LENGTH TO AVOID MARGIN POSITIVE STATUS OF CERVICAL INTRAEPITHELIAL NEOPLASIA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kawano, K.; Kato, H.; Nishio, S.; Tsuda, N.; Sonoda, G.; Komai, K.; Ushijima, K.] Kurume Univ, Kurume, Fukuoka 830, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0494	620	620				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501056		
J	Sekiyama, K				Sekiyama, K.			NERVE-SPARING OKABAYASHI'S RADICAL HYSTERECTOMY WITHOUT RADIOTHERAPY FOR STAGE IB1 TO IIB CERVICAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Sekiyama, K.] Kyoto Med Ctr, Dept Obstet & Gynecol, Kyoto, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0517	624	624				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501059		
J	Ando, H; Miyamoto, T; Takatsu, A; Yamada, Y; Higuchi, S; Tachibana, R; Kashima, H; Kobara, H; Shiozawa, T				Ando, H.; Miyamoto, T.; Takatsu, A.; Yamada, Y.; Higuchi, S.; Tachibana, R.; Kashima, H.; Kobara, H.; Shiozawa, T.			PREOPERATIVE DIAGNOSIS AND THE TREATMENT OF 84 CASES PRESENTING WITH MULTI-CYSTIC LESIONS OF THE UTERINE CERVIX	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Ando, H.; Miyamoto, T.; Takatsu, A.; Yamada, Y.; Higuchi, S.; Tachibana, R.; Kashima, H.; Kobara, H.; Shiozawa, T.] Shinshu Univ, Matsumoto, Nagano 390, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0531	626	626				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501061		
J	Nishio, S; Coleman, RL; Hosaka, M; Kodama, M; Miyake, TM; Westin, SN; Soliman, PT; Brown, J; Kamura, T; Ushijima, K				Nishio, S.; Coleman, R. L.; Hosaka, M.; Kodama, M.; Miyake, T. M.; Westin, S. N.; Soliman, P. T.; Brown, J.; Kamura, T.; Ushijima, K.			PROGNOSTIC FACTORS FOR 266 PATIENTS WITH STAGE IVB CERVICAL CANCER. -MD ANDERSON CANCER CENTER EXPERIENCE-S.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Nishio, S.; Kamura, T.; Ushijima, K.] Kurume Univ, Kurume, Fukuoka 830, Japan; [Coleman, R. L.; Hosaka, M.; Kodama, M.; Miyake, T. M.; Westin, S. N.; Soliman, P. T.; Brown, J.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0540	631	632				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501064		
J	Uotani, T; Nagai, T; Sato, S; Hanaoka, T; Ishida, H; Akahori, T; Takai, Y; Seki, H				Uotani, T.; Nagai, T.; Sato, S.; Hanaoka, T.; Ishida, H.; Akahori, T.; Takai, Y.; Seki, H.			RETROSPECTIVE STUDY OF CONCURRENT CHEMORADIOTHERAPY WITH WEEKLY PACLITAXEL AND CARBOPLATIN FOR ADVANCED NON-SQUAMOUS CELL CARCINOMA OF UTERINE CERVIX.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Uotani, T.; Nagai, T.; Sato, S.; Hanaoka, T.; Ishida, H.; Akahori, T.; Takai, Y.; Seki, H.] Saitama Med Univ, Saitama Med Ctr, Kawagoe, Saitama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0543	637	638				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501067		
J	Wada, T; Fukuda, T; Kawanishi, M; Imai, K; Yamauchi, M; Hashiguchi, Y; Kasai, M; Ichimura, T; Yasui, T; Sumi, T				Wada, T.; Fukuda, T.; Kawanishi, M.; Imai, K.; Yamauchi, M.; Hashiguchi, Y.; Kasai, M.; Ichimura, T.; Yasui, T.; Sumi, T.			CLINICAL ANALYSIS OF RECURRENT UTERINE CERVICAL CANCER AFTER SURGERY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Wada, T.; Fukuda, T.; Yamauchi, M.; Hashiguchi, Y.; Kasai, M.; Ichimura, T.; Yasui, T.; Sumi, T.] Osaka City Univ, Grad Sch Med, Osaka 558, Japan; [Kawanishi, M.] Kishiwada City Hosp, Kishiwada, Japan; [Imai, K.] Izumiotsu Municipal Hosp, Izumiotsu, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0559	644	645				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501071		
J	Kawanishi, M; Fukuda, T; Wada, T; Imai, K; Yamauchi, M; Kasai, M; Hashiguchi, Y; Ichimura, T; Yasui, T; Sumi, T				Kawanishi, M.; Fukuda, T.; Wada, T.; Imai, K.; Yamauchi, M.; Kasai, M.; Hashiguchi, Y.; Ichimura, T.; Yasui, T.; Sumi, T.			CLINICAL ANALYSIS OF STAGE I TO II ADENOSQUAMOU CARCINOMA OF UTERINE CERVIX	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kawanishi, M.] Kishiwada City Hosp, Kishiwada, Japan; [Fukuda, T.; Wada, T.; Yamauchi, M.; Kasai, M.; Hashiguchi, Y.; Ichimura, T.; Yasui, T.; Sumi, T.] Osaka City Univ, Grad Sch Med, Osaka 558, Japan; [Imai, K.] Izumiotsu Municipal Hosp, Izumiotsu, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0564	648	648				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501073		
J	Kashiwagi, H; Shida, M; Amatsu, S; Narayama, C; Asai, S; Tajima, T; Ikeda, M; Hirasawa, T; Ishimoto, H; Izumi, S; Mikami, M				Kashiwagi, H.; Shida, M.; Amatsu, S.; Narayama, C.; Asai, S.; Tajima, T.; Ikeda, M.; Hirasawa, T.; Ishimoto, H.; Izumi, S.; Mikami, M.			SIGNIFICANCE OF SUPRACLAVICULAR LYMPH NODE BIOPSY FOR CERVICAL CANCER WITH PARA-AORTIC LYMPH NODE METASTASIS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kashiwagi, H.; Shida, M.; Amatsu, S.; Narayama, C.; Asai, S.; Tajima, T.; Ikeda, M.; Hirasawa, T.; Ishimoto, H.; Izumi, S.; Mikami, M.] Tokai Univ, Sch Med, Dept Obstet & Gynecol, Isehara, Kanagawa 25911, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0595	657	657				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501079		
J	Kato, T; Kaneuchi, M; Yamaguchi, M; Shimada, C; Fukumoto, S; Mitamura, T; Konno, Y; Hosaka, M; Kobayashi, N; Takeda, M; Watari, H; Kudo, M; Sakuragi, N				Kato, T.; Kaneuchi, M.; Yamaguchi, M.; Shimada, C.; Fukumoto, S.; Mitamura, T.; Konno, Y.; Hosaka, M.; Kobayashi, N.; Takeda, M.; Watari, H.; Kudo, M.; Sakuragi, N.			SURVIVAL OUTCOME OF HOKKAIDO-METHOD OF NERVE-SPARING RADICAL HYSTERECTOMY FOR CERVICAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kato, T.; Yamaguchi, M.; Shimada, C.; Fukumoto, S.; Mitamura, T.; Konno, Y.; Hosaka, M.; Kobayashi, N.; Takeda, M.; Watari, H.; Kudo, M.; Sakuragi, N.] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Kaneuchi, M.] Nagasaki Univ, Nagasaki 852, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0605	660	661				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501081		
J	Fujiwara, K; Kanao, H; Andou, M				Fujiwara, K.; Kanao, H.; Andou, M.			SEXUAL DYSFUNCTION AFTER TOTAL LAPAROSCOPIC RADICAL HYSTERECTOMY FOR EARLY-STAGE CERVICAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Fujiwara, K.; Kanao, H.; Andou, M.] Kurashiki Med Ctr, Kurashiki, Okayama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0617	669	669				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501085		
J	Motoki, Y; Mizushima, S; Taguri, M; Asai-Sato, M; Hirahara, F; Miyagi, E				Motoki, Y.; Mizushima, S.; Taguri, M.; Asai-Sato, M.; Hirahara, F.; Miyagi, E.			INCREASING CERVICAL CANCER MORTALITY AMONG YOUNG JAPANESE WOMEN; ANALYSIS OF KANAGAWA CANCER REGISTRY, 1985-2012	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Motoki, Y.; Hirahara, F.] Yokohama City Univ Grad Sch Med, Dept Obstet Gynecol & Mol Reprod Sci, Yokohama, Kanagawa, Japan; [Mizushima, S.] Yokohama City Univ Grad Sch Med, Dept Publ Hlth, Yokohama, Kanagawa, Japan; [Taguri, M.] Yokohama City Univ Grad Sch, Dept Biostat & Epidemiol, Yokohama, Kanagawa, Japan; [Asai-Sato, M.; Miyagi, E.] Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0634	674	674				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501089		
J	Abe, A; Masato, N; Higashimoto, A; Yoshida, K; Irahara, M				Abe, A.; Masato, N.; Higashimoto, A.; Yoshida, K.; Irahara, M.			ANALYSIS OF 29CASES WITH CERVICAL CANCER IN WOMEN UNDER 35 YEARS OLD	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Abe, A.; Masato, N.; Higashimoto, A.; Yoshida, K.; Irahara, M.] Univ Tokushima, Tokushima 770, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0666	684	684				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501097		
J	Kawase, R; Ishiwata, T; Takeshita, T; Naito, Z				Kawase, R.; Ishiwata, T.; Takeshita, T.; Naito, Z.			FIBROBLAST GROWTH FACTOR RECEPTOR2 IIIC IN CERVICAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kawase, R.; Ishiwata, T.; Takeshita, T.; Naito, Z.] Nippon Med Sch Hpspital, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0695	692	692				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501101		
J	Takatsu, A; Miyamoto, T; Ando, H; Yamada, Y; Higuchi, S; Asaka, R; Ohira, S; Shiozawa, T				Takatsu, A.; Miyamoto, T.; Ando, H.; Yamada, Y.; Higuchi, S.; Asaka, R.; Ohira, S.; Shiozawa, T.			THE CASES WITH PREGNANCY IN WOMEN WITH LEGH-LIKE LESION	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Takatsu, A.; Miyamoto, T.; Ando, H.; Yamada, Y.; Higuchi, S.; Asaka, R.; Ohira, S.; Shiozawa, T.] Shinshu Univ, Matsumoto, Nagano 390, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0706	694	694				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501103		
J	Kato, H; Todo, Y; Okamoto, K				Kato, H.; Todo, Y.; Okamoto, K.			IMPROVEMENT OF DETECTION OF SENTINEL LYMPH NODES (SN) BY PDE AND TISSUE RINSE LIQUID-BASED CYTOLOGY (TRLBC).	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kato, H.; Todo, Y.; Okamoto, K.] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0711	698	699				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501105		
J	Matsumoto, Y; Mabuchi, S; Kawano, M; Sasano, T; Takahashi, R; Kuroda, H; Hashimoto, K; Isobe, A; Sawada, K; Sakata, M; Kimura, T				Matsumoto, Y.; Mabuchi, S.; Kawano, M.; Sasano, T.; Takahashi, R.; Kuroda, H.; Hashimoto, K.; Isobe, A.; Sawada, K.; Sakata, M.; Kimura, T.			MDSC TARGETING THERAPY FOR UTERINE CERVICAL CANCER DISPLAYING TRL	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Matsumoto, Y.; Mabuchi, S.; Kawano, M.; Sasano, T.; Takahashi, R.; Kuroda, H.; Hashimoto, K.; Isobe, A.; Sawada, K.; Sakata, M.; Kimura, T.] Osaka Univ Grad Sch Med, Dept Obstet & Gynecol, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0745	713	713				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501113		
J	Yamamoto, A; Ikeda, M; Kamoi, S; Yamada, T; Yoneyama, K; Kawase, E; Kurose, K; Takeshita, T				Yamamoto, A.; Ikeda, M.; Kamoi, S.; Yamada, T.; Yoneyama, K.; Kawase, E.; Kurose, K.; Takeshita, T.			PERFORMANCE OF THE AUTONOMIC NERVE-SPARING METHOD IN RADICAL HYSTERECTOMY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yamamoto, A.; Ikeda, M.; Kamoi, S.; Yamada, T.; Yoneyama, K.; Kawase, E.; Kurose, K.; Takeshita, T.] Nippon Med Sch, Tokyo 113, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0838	730	731				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501123		
J	Tenjimbayashi, Y; Minaguchi, T; Matsumoto, K; Sakurai, M; Onuki, M; Ochi, H; Obata, M; Satoh, T; Hamada, H; Yoshikawa, H				Tenjimbayashi, Y.; Minaguchi, T.; Matsumoto, K.; Sakurai, M.; Onuki, M.; Ochi, H.; Obata, M.; Satoh, T.; Hamada, H.; Yoshikawa, H.			DELIVERY DELAY WITH NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH FIGO STAGE IB1 CERVICAL CANCER DURING PREGNANCY: A REPORT OF TWO CASES	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Tenjimbayashi, Y.; Minaguchi, T.; Matsumoto, K.; Sakurai, M.; Onuki, M.; Ochi, H.; Obata, M.; Satoh, T.; Hamada, H.; Yoshikawa, H.] Univ Tsukuba, Tsukuba, Ibaraki, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0843	733	733				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501125		
J	Hanawa, S; Mitsuhashi, A; Usui, H; Yamamoto, N; Tate, S; Nishikimi, K; Uehara, T; Uno, T; Shozu, M				Hanawa, S.; Mitsuhashi, A.; Usui, H.; Yamamoto, N.; Tate, S.; Nishikimi, K.; Uehara, T.; Uno, T.; Shozu, M.			DAILY LOW-DOSE CISPLATIN-BASED CONCURRENT CHEMORADIOTHERAPY FOR THE TREATMENT OF CERVICAL CANCER IN PATIENTS AGED 70 YEARS OR OLDER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Hanawa, S.; Mitsuhashi, A.; Usui, H.; Yamamoto, N.; Tate, S.; Nishikimi, K.; Uehara, T.; Uno, T.; Shozu, M.] Chiba Univ, Grad Sch Med, Chiba, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0881	745	746				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501132		
J	Iida, A; Yoneyama, K; Kato, M; Kawase, R; Kurose, K; Doi, D; Peng, W; Naito, Y; Takeshita, T				Iida, A.; Yoneyama, K.; Kato, M.; Kawase, R.; Kurose, K.; Doi, D.; Peng, W.; Naito, Y.; Takeshita, T.			A CASE OF CERVICAL ADENOCARCINOMA ASSOCIATED WITH PEUTZ-JEGHERS SYNDROME	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Iida, A.; Yoneyama, K.; Kato, M.; Kawase, R.; Kurose, K.; Doi, D.; Peng, W.; Naito, Y.; Takeshita, T.] Nippon Med Sch, Tokyo 113, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0889	754	754				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501137		
J	Kurose, K; Kato, M; Iwasaki, N; Yamamoto, A; Kawase, R; Yamada, T; Doi, D; Yoneyama, K; Kamoi, S; Takeshita, T				Kurose, K.; Kato, M.; Iwasaki, N.; Yamamoto, A.; Kawase, R.; Yamada, T.; Doi, D.; Yoneyama, K.; Kamoi, S.; Takeshita, T.			ATYPICAL GLANDULAR CELLS (AGC) OF CERVICAL CYTOLOGY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kurose, K.; Kato, M.; Iwasaki, N.; Yamamoto, A.; Kawase, R.; Yamada, T.; Doi, D.; Yoneyama, K.; Kamoi, S.; Takeshita, T.] Nippon Med Sch, Tokyo 113, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1033	783	783				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501154		
J	Inamine, M; Ohishi, S; Nakamoto, T; Wakayama, A; Kudaka, W; Nagai, Y; Kinjo, T; Masamoto, H; Aoki, Y				Inamine, M.; Ohishi, S.; Nakamoto, T.; Wakayama, A.; Kudaka, W.; Nagai, Y.; Kinjo, T.; Masamoto, H.; Aoki, Y.			RADICAL ABDOMINAL TRACHELECTOMY FOR IB1 CERVICAL CANCER AT 17WEEKS OF GESTATION	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Inamine, M.] Okinawa Red Cross Hosp, Naha City, Japan; [Ohishi, S.; Nakamoto, T.; Wakayama, A.; Kudaka, W.; Nagai, Y.; Kinjo, T.; Masamoto, H.; Aoki, Y.] Univ Ryukyus, Nishihara, Okinawa 90301, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1107	806	807				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501170		
J	Kudaka, W; Kinjo, Y; Taira, Y; Arakaki, Y; Himura, M; Taira, R; Miyagi, M; Nakamoto, T; Wakayama, A; Inamine, M; Nagai, Y; Aoki, Y				Kudaka, W.; Kinjo, Y.; Taira, Y.; Arakaki, Y.; Himura, M.; Taira, R.; Miyagi, M.; Nakamoto, T.; Wakayama, A.; Inamine, M.; Nagai, Y.; Aoki, Y.			LONG-TERM RESULTS AND PROGNOSTIC FACTORS IN PATIENTS WITH STAGE III-IVA SQUAMOUS CELL CARCINOMA OF THE CERVIX TREATED WITH CONCURRENT CHEMORADIOTHERAPY FROM A SINGLE INSTITUTION STUDY.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kudaka, W.; Kinjo, Y.; Taira, Y.; Arakaki, Y.; Himura, M.; Taira, R.; Miyagi, M.; Nakamoto, T.; Wakayama, A.; Inamine, M.; Nagai, Y.; Aoki, Y.] Univ Ryukyus, Nishihara, Okinawa 90301, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1115	810	810				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501172		
J	Ida, T; Nakamura, H; Koike, K; Taniguchi, Y; Kohyama, A				Ida, T.; Nakamura, H.; Koike, K.; Taniguchi, Y.; Kohyama, A.			OUTCOME OF PLANNED TREATMENT DELAY IN PATIENTS WITH INVASIVE CERVICAL CANCER DURING PREGNANCY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Ida, T.; Nakamura, H.; Koike, K.; Taniguchi, Y.; Kohyama, A.] Tokyo Metropolitan Tama Med Ctr, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1181	823	823				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501181		
J	Nagai, Y; Wakayama, A; Nakamoto, T; Kudaka, W; Inamine, M; Toita, T; Aoki, Y				Nagai, Y.; Wakayama, A.; Nakamoto, T.; Kudaka, W.; Inamine, M.; Toita, T.; Aoki, Y.			CONCURRENT CHEMORADIOTHERAPY FOR NONBULKY STAGE IB/II CERVICAL CANCER WITHOUT PELVIC NODE ENLARGEMENT	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Nagai, Y.; Wakayama, A.; Nakamoto, T.; Kudaka, W.; Toita, T.; Aoki, Y.] Univ Ryukyus, Nishihara, Okinawa 90301, Japan; [Inamine, M.] Okinawa Red Cross Hosp, Naha, Okinawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1191	826	826				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501183		
J	Sekine, M; Nishino, K; Serikawa, T; Kashima, K; Kato, M; Adachi, S; Kodama, S; Maruhashi, T; Enomoto, T				Sekine, M.; Nishino, K.; Serikawa, T.; Kashima, K.; Kato, M.; Adachi, S.; Kodama, S.; Maruhashi, T.; Enomoto, T.			INFLUENCE OF DIFFERENT TREATMENT MODALITIES ON THE PROGNOSIS OF LOCALLY ADVANCED UTERINE CERVICAL CANCER IN EGOG(ECHIGO GYNECOLOGIC ONCOLOGY GROUP) STUDY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Sekine, M.; Nishino, K.; Serikawa, T.; Kashima, K.; Enomoto, T.] Niigata Univ Med & Dent Hosp, Niigata, Japan; [Kato, M.] Nagaoka Cent Hosp, Nagaoka, Niigata, Japan; [Adachi, S.] Nagaoka Red Cross Hosp, Nagaoka, Niigata, Japan; [Kodama, S.] Niigata Canc Ctr, Niigata, Japan; [Maruhashi, T.] Niigata Cent Hosp, Joetsu, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1214	829	829				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501185		
J	Futagami, M; Yokoyama, Y; Shoji, T; Sugiyama, T; Tokunaga, H; Takano, T; Yaegashi, N; Sato, N; Terada, Y; Ohta, T; Fujimori, K; Tase, T; Mizunuma, H				Futagami, M.; Yokoyama, Y.; Shoji, T.; Sugiyama, T.; Tokunaga, H.; Takano, T.; Yaegashi, N.; Sato, N.; Terada, Y.; Ohta, T.; Fujimori, K.; Tase, T.; Mizunuma, H.			INVESTIGATION OF THE CLINICOPATHOLOGICAL FEATURES OF THE SQUAMOUS CELL CARCINOMA OF THE VULVA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Futagami, M.; Yokoyama, Y.; Mizunuma, H.] Hirosaki Univ, Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori 036, Japan; [Shoji, T.; Sugiyama, T.] Iwate Med Univ, Sch Med, Dept Obstet & Gynecol, Morioka, Iwate 020, Japan; [Tokunaga, H.; Takano, T.; Yaegashi, N.] Tohoku Univ, Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Sato, N.; Terada, Y.] Akita Univ, Sch Med, Dept Obstet & Gynecol, Akita 010, Japan; [Ohta, T.] Yamagata Univ, Sch Med, Dept Obstet & Gynecol, Yamagata 99023, Japan; [Fujimori, K.] Fukushima Med Univ, Sch Med, Dept Obstet & Gynecol, Fukushima, Japan; [Tase, T.] Miyagi Canc Ctr, Dept Gynecol, Fukushima, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0108	882	883				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501221		
J	Okamoto, K; Todo, Y; Sudo, S; Kato, H				Okamoto, K.; Todo, Y.; Sudo, S.; Kato, H.			PRIMARY MALIGNANT MELANOMA OF THE VAGINA FOLLOWING SURGERY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Okamoto, K.; Todo, Y.; Sudo, S.; Kato, H.] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0571	913	913				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501239		
J	Tamura, R; Yokoyama, Y; Mizunuma, H				Tamura, R.; Yokoyama, Y.; Mizunuma, H.			4-METHYLUMBELLIFERONE INHIBITS OVARIAN CANCER GROWTH BY DOWN-REGULATING EXPRESSION OF THYMIDINE PHOSPHORYLASE	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Tamura, R.; Yokoyama, Y.; Mizunuma, H.] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0115	944	944				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501256		
J	Hirasawa, T; Miyazawa, M; Asai, S; Ikeda, M; Shida, M; Muramatsu, T; Mikami, M				Hirasawa, T.; Miyazawa, M.; Asai, S.; Ikeda, M.; Shida, M.; Muramatsu, T.; Mikami, M.			INHIBITION OF HDAC7 MAY SUPPRESS HIF-1 ACTIVATION IN OVARIAN CLEAR CELL ADENOCARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Hirasawa, T.; Miyazawa, M.; Asai, S.; Ikeda, M.; Shida, M.; Muramatsu, T.; Mikami, M.] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0119	946	946				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501257		
J	Matsumura, Y; Yokoyama, Y; Mizunuma, H				Matsumura, Y.; Yokoyama, Y.; Mizunuma, H.			TRADITIONAL JAPANESE MEDICINE, GOSHAJINKIGAN, PREVENTS PACLITAXEL-INDUCED PERIPHERAL NERVE DISORDER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Matsumura, Y.; Yokoyama, Y.; Mizunuma, H.] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0135	950	950				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501259		
J	Osawa, Y; Yokoyama, Y; Kobayashi, A; Shigeto, T; Futagami, M; Mizunuma, H				Osawa, Y.; Yokoyama, Y.; Kobayashi, A.; Shigeto, T.; Futagami, M.; Mizunuma, H.			DECREASED EXPRESSION OF CARBONYL REDUCTASE1 PROMOTES PROLIFERATION AND GROWTH OF OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Osawa, Y.; Yokoyama, Y.; Kobayashi, A.; Shigeto, T.; Futagami, M.; Mizunuma, H.] Hirosaki Univ Grad Sch Med, Hirosaki, Aomori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0148	951	951				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501260		
J	Sekiya, R; Kajiyama, H; Mitsui, H; Suzuki, S; Mizuno, M; Shibata, K; Kikkawa, F				Sekiya, R.; Kajiyama, H.; Mitsui, H.; Suzuki, S.; Mizuno, M.; Shibata, K.; Kikkawa, F.			PLAGL2 REGULATES ACTIN CYTOSKELETAL ARCHITECTURE AND CELL MIGRATION	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Sekiya, R.; Kajiyama, H.; Mitsui, H.; Suzuki, S.; Mizuno, M.; Shibata, K.; Kikkawa, F.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0185	954	954				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501262		
J	Matsushita, Y; Yokoyama, Y; Shigeto, T; Futagami, M; Mizunuma, H				Matsushita, Y.; Yokoyama, Y.; Shigeto, T.; Futagami, M.; Mizunuma, H.			EXPRESSION LEVEL OF RECQL1 IS A PROGNOSTIC FACTOR IN EPITHELIAL OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Matsushita, Y.; Yokoyama, Y.; Shigeto, T.; Futagami, M.; Mizunuma, H.] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0306	957	957				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501264		
J	Yamaguchi, N; Yanaihara, N; Ueda, K; Hirata, Y; Saito, M; Yoshida, K; Okamoto, A				Yamaguchi, N.; Yanaihara, N.; Ueda, K.; Hirata, Y.; Saito, M.; Yoshida, K.; Okamoto, A.			DYRK2 REGULATES EMT THROUGH SNAIL DEGRADATION IN OVARIAN SEROUS ADENOCARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yamaguchi, N.; Yanaihara, N.; Ueda, K.; Hirata, Y.; Saito, M.; Yoshida, K.; Okamoto, A.] Jikei Univ Sch Med, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0476	970	970				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501272		
J	Kisu, I; Banno, K; Adachi, M; Umene, K; Aoki, D				Kisu, I.; Banno, K.; Adachi, M.; Umene, K.; Aoki, D.			A PRELIMINARY ALLOGENEIC UTERINE TRANSPLANTATION STUDY IN NON-HUMAN PRIMATES MODELS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kisu, I.; Banno, K.; Adachi, M.; Umene, K.; Aoki, D.] Keio Univ Sch Med, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0534	976	976				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501276		
J	Kawano, M; Mabuchi, S; Matsumoto, Y; Sasano, T; Takahashi, R; Kuroda, H; Hashimoto, K; Isobe, A; Sawada, K; Sakata, M				Kawano, M.; Mabuchi, S.; Matsumoto, Y.; Sasano, T.; Takahashi, R.; Kuroda, H.; Hashimoto, K.; Isobe, A.; Sawada, K.; Sakata, M.			MECHANISM RESPONSIBLE FOR THE CHEMORESISTANCE OF UTERINE CERVICAL CANCER DISPLAYING TUMOR-RELATED LEUKOCYTOSIS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kawano, M.; Mabuchi, S.; Matsumoto, Y.; Sasano, T.; Takahashi, R.; Kuroda, H.; Hashimoto, K.; Isobe, A.; Sawada, K.; Sakata, M.] Osaka Univ, Suita, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0678	979	979				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501278		
J	Hiramatsu, K; Enomoto, T; Serada, S; Yoshihara, K; Hori, Y; Fujimoto, M; Ueda, Y; Yoshino, K; Fujita, M; Morii, E; Naka, T; Kimura, T				Hiramatsu, K.; Enomoto, T.; Serada, S.; Yoshihara, K.; Hori, Y.; Fujimoto, M.; Ueda, Y.; Yoshino, K.; Fujita, M.; Morii, E.; Naka, T.; Kimura, T.			A PROTEOMIC ANALYSIS DEMONSTRATES SIMILAR EXPRESSION PATTERN BETWEEN OVARIAN AND ENDOMETRIAL HIGH-GRADE SEROUS CARCINOMA BEYOND AN ORGAN	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Hiramatsu, K.; Hori, Y.; Ueda, Y.; Yoshino, K.; Fujita, M.; Morii, E.; Kimura, T.] Osaka Univ, Suita, Osaka, Japan; [Enomoto, T.; Yoshihara, K.] Niigata Univ, Niigata, Japan; [Serada, S.; Fujimoto, M.; Naka, T.] Natl Inst Biomed Innovat, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0741	986	986				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501282		
J	Tsubamoto, H; Inoue, K; Sonoda, T				Tsubamoto, H.; Inoue, K.; Sonoda, T.			IMPACT OF ITRACONAZOLE ON THE SURVIVAL OF HEAVILY PRETREATED PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Tsubamoto, H.; Inoue, K.] Hyogo Coll Med, Dept Obstet & Gynecol, Nishinomiya, Hyogo 6638501, Japan; [Sonoda, T.] Kohnan Hosp, Dept Med Oncol, Kobe, Hyogo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0632	1036	1036				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966501313		
J	Miura, R; Futagami, M; Shigetou, T; Yokoyama, Y; Mizunuma, H				Miura, R.; Futagami, M.; Shigetou, T.; Yokoyama, Y.; Mizunuma, H.			EFFICACIOUS USAGE OF 18-FDG PET/CT IN PATIENTS WITH OVARIAN CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Miura, R.; Futagami, M.; Shigetou, T.; Yokoyama, Y.; Mizunuma, H.] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0316	1104	1104				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502023		
J	Motoshima, S; Kumagai, S; Wroblewski, J; Okura, N; Tashiro, Y				Motoshima, S.; Kumagai, S.; Wroblewski, J.; Okura, N.; Tashiro, Y.			FEATURES OF OVARIAN FIBROMA ON MAGNETIC RESONANCE IMAGES	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Motoshima, S.; Kumagai, S.; Wroblewski, J.; Okura, N.; Tashiro, Y.] Kokura Med Ctr, Kitakyushu, Fukuoka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0598	1112	1112				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502028		
J	Toba, M; Miyasaka, N; Oshima, N; Wakana, K; Wakabayashi, A; Toshiro, K				Toba, M.; Miyasaka, N.; Oshima, N.; Wakana, K.; Wakabayashi, A.; Toshiro, K.			DIFFERENCES IN APPARENT DIFFUSION COEFFICIENTS BETWEEN MALIGNANT AND LOW MALIGNANT POTENTIAL SOLID OVARIAN TUMORS.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Toba, M.; Miyasaka, N.; Oshima, N.; Wakana, K.; Wakabayashi, A.; Toshiro, K.] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0810	1115	1116				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502030		
J	Osaka, Y; Takagi, H; Neyatani, N; Makinoda, S				Osaka, Y.; Takagi, H.; Neyatani, N.; Makinoda, S.			RELATIONSHIP BETWEEN HISTOLOGIC GRADING AND STANDARDIZED UPTAKE VALUES (SUV) OF PET/CT IN ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Osaka, Y.; Takagi, H.; Neyatani, N.; Makinoda, S.] Kanazawa Med Univ, Dept Obstet & Gynecol, Uchinada, Ishikawa 92002, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0858	1117	1117				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502031		
J	Matsuda, Y; Sugimori, Y; Murata, K; Sato, A; Ichiyama, T; Sakamoto, S; Yata, S; Nagata, R; Ota, T; Ogishima, D				Matsuda, Y.; Sugimori, Y.; Murata, K.; Sato, A.; Ichiyama, T.; Sakamoto, S.; Yata, S.; Nagata, R.; Ota, T.; Ogishima, D.			A PHASE II STUDY TO EVALUATE EFFICACY OF APREPITANT IN PREVENTING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Matsuda, Y.; Sugimori, Y.; Murata, K.; Sato, A.; Ichiyama, T.; Sakamoto, S.; Yata, S.; Nagata, R.; Ota, T.; Ogishima, D.] Juntendo Nerima Hosp, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0804	1179	1180				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502065		
J	Kobayashi, A; Futagami, M; Yokoyama, Y; Osawa, Y; Shigetou, T; Mizunuma, H				Kobayashi, A.; Futagami, M.; Yokoyama, Y.; Osawa, Y.; Shigetou, T.; Mizunuma, H.			THE ROLE OF CYTOREDUCTIVE SURGERY IN THE RELAPSE OF GYNECOLOGICAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kobayashi, A.; Futagami, M.; Yokoyama, Y.; Osawa, Y.; Shigetou, T.; Mizunuma, H.] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0186	1194	1195				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502076		
J	Yamagami, W; Susumu, N; Kataoka, F; Ninomiya, T; Wada, M; Takigawa, A; Nomura, H; Tanaka, K; Tominaga, E; Banno, K; Kameyama, K; Nakahara, T; Aoki, D				Yamagami, W.; Susumu, N.; Kataoka, F.; Ninomiya, T.; Wada, M.; Takigawa, A.; Nomura, H.; Tanaka, K.; Tominaga, E.; Banno, K.; Kameyama, K.; Nakahara, T.; Aoki, D.			RADIO-ISOTOPE METHOD WITH HYSTEROSCOPIC SUBENDOMETRIAL INJECTION AND ICG FLUORESCENCE IMAGING METHOD WITH SUBSEROSAL INJECTION MIGHT BE SUITABLE TO DETECT SENTINEL LYMPH NODE IN ENDOMETRIAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yamagami, W.; Susumu, N.; Kataoka, F.; Ninomiya, T.; Wada, M.; Takigawa, A.; Nomura, H.; Tanaka, K.; Tominaga, E.; Banno, K.; Kameyama, K.; Nakahara, T.; Aoki, D.] Keio Univ, Sch Med, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0194	1197	1198				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502078		
J	Machida, H; Yamada, M; Nishio, M; Yamamoto, K; Koyasu, Y				Machida, H.; Yamada, M.; Nishio, M.; Yamamoto, K.; Koyasu, Y.			DOES TUMOR SIZE HAVE AN EFFECT ON LAPAROSCOPIC MANAGEMENT OF LARGE OVARIAN TUMORS?	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Machida, H.; Yamada, M.; Nishio, M.; Yamamoto, K.; Koyasu, Y.] Yotuya Mec Cube, Womens Ctr, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0472	1218	1218				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502093		
J	Takahashi, N; Kasamatsu, Y; Komeda, S; Oi, T; Kuji, S; Tanaka, A; Abe, M; Takekuma, M; Hirashima, Y				Takahashi, N.; Kasamatsu, Y.; Komeda, S.; Oi, T.; Kuji, S.; Tanaka, A.; Abe, M.; Takekuma, M.; Hirashima, Y.			IS ROUTINE RETROPERITONEAL DRAINAGE AFTER RETROPERITONEAL LYMPHADENECTOMY FOR GYNECOLOGIC ONCOLOGICAL TUMORS USEFUL?	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Takahashi, N.; Kasamatsu, Y.; Komeda, S.; Oi, T.; Kuji, S.; Tanaka, A.; Abe, M.; Takekuma, M.; Hirashima, Y.] Shizuoka Canc Centar, Shizuoka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0479	1219	1219				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502094		
J	Enomoto, T; Kashima, K; NIshikawa, N; Yoshino, K				Enomoto, T.; Kashima, K.; NIshikawa, N.; Yoshino, K.			ABDOMINAL RADICAL TRACHELECTOMY DURING PREGNANCY FOR EARLY STAGE CERVICAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Enomoto, T.; Kashima, K.; NIshikawa, N.] Niigata Univ, Med & Dent Hosp, Niigata, Japan; [Yoshino, K.] Osaka Univ Hosp, Osaka 553, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0897	1231	1232				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502100		
J	Furukawa, N; Yoshida, S; Kanayama, S; Kawaguchi, R; Ito, F; Tanase, Y; Kobayashi, H				Furukawa, N.; Yoshida, S.; Kanayama, S.; Kawaguchi, R.; Ito, F.; Tanase, Y.; Kobayashi, H.			PALONOSETRON IN COMBINATION WITH 1-DAY VERSUS 3-DAYS DEXAMETHASONE TO PREVENT NAUSEA AND VOMITING IN PATIENTS RECEIVING PACLITAXEL AND CARBOPLATIN.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Furukawa, N.; Yoshida, S.; Kanayama, S.; Kawaguchi, R.; Ito, F.; Tanase, Y.; Kobayashi, H.] Nara Med Univ, Kashihara, Nara 634, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0037	1259	1259				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502118		
J	Oshima-Sudo, N; Furusawa, A; Wakana, K; Wakabayashi, A; Terauchi, M; Obayashi, S; Kubota, T				Oshima-Sudo, N.; Furusawa, A.; Wakana, K.; Wakabayashi, A.; Terauchi, M.; Obayashi, S.; Kubota, T.			EFFECT OF HERBAL MEDICINE DAIKENCHUTO FOR THE PREVENTION OF POSTOPERATIVE ILEUS IN GYNECOLOGIC CANCERS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Oshima-Sudo, N.; Furusawa, A.; Wakana, K.; Wakabayashi, A.; Terauchi, M.; Obayashi, S.; Kubota, T.] Tokyo Med & Dent Univ, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0082	1263	1263				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502120		
J	Watanabe, M; Shibuya, H; Kobayashi, Y; Iwashita, M				Watanabe, M.; Shibuya, H.; Kobayashi, Y.; Iwashita, M.			EFFICACY AND SAFETY OF FONDAPARINUX (FPX) FOR PREVENTION OF POSTOPERATIVE VENOUS THROMBOEMBOLISM (VTE) IN GYNECOLOGIC CANCER PATIENTS.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Watanabe, M.; Shibuya, H.; Kobayashi, Y.; Iwashita, M.] Kyorin Univ, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0104	1267	1267				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502122		
J	Abe, M; Kasamatsu, Y; Ooi, T; Komeda, S; Kuji, S; Tanaka, A; Takahashi, N; Takekuma, M; Hirashima, Y				Abe, M.; Kasamatsu, Y.; Ooi, T.; Komeda, S.; Kuji, S.; Tanaka, A.; Takahashi, N.; Takekuma, M.; Hirashima, Y.			CLINICAL RESEARCH OF OLANZAPINE FOR PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING RESISTANT TO STANDARD ANTIEMETIC THERAPY FOR HIGHLY EMETOGENIC CHEMOTHERAPY.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Abe, M.; Kasamatsu, Y.; Ooi, T.; Komeda, S.; Kuji, S.; Tanaka, A.; Takahashi, N.; Takekuma, M.; Hirashima, Y.] Shizuoka Canc Centar, Shizuoka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0200	1271	1271				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502125		
J	Yamada, Y; Furukawa, N; Ito, F; Yoshida, S; Kanayama, S; Kawaguchi, R; Tanase, Y; Kobayashi, H				Yamada, Y.; Furukawa, N.; Ito, F.; Yoshida, S.; Kanayama, S.; Kawaguchi, R.; Tanase, Y.; Kobayashi, H.			EVALUATION OF PALONOSETRON AND DEXAMETHASONE FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENTS RECEIVING MULTIPLE CYCLES OF PACLITAXEL AND CARBOPLATIN	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yamada, Y.; Furukawa, N.; Ito, F.; Yoshida, S.; Kanayama, S.; Kawaguchi, R.; Tanase, Y.; Kobayashi, H.] Nara Med Univ, Nara, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0248	1272	1273				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502126		
J	Ikeda, M; Amatsu, S; Narayama, C; Kashiwagi, H; Asai, T; Tajima, T; Shida, M; Hirasawa, T; Ogushi, Y; Mikami, M				Ikeda, M.; Amatsu, S.; Narayama, C.; Kashiwagi, H.; Asai, T.; Tajima, T.; Shida, M.; Hirasawa, T.; Ogushi, Y.; Mikami, M.			PREDICTING PERIOPERATIVE VENOUS THROMBOEMBOLISM IN JAPANESE GYNECOLOGICAL PATIENTS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Ikeda, M.; Amatsu, S.; Narayama, C.; Kashiwagi, H.; Asai, T.; Tajima, T.; Shida, M.; Hirasawa, T.; Ogushi, Y.; Mikami, M.] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0264	1274	1275				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502127		
J	Tozawa, A; Abe, Y; Nakazawa, H; Takeuchi, J; Kondo, A; Yokomichi, N; Yoshida, A; Hosonuma, S; Yoshioka, N; Kondo, H; Ohara, T; Kiguchi, K; Suzuki, N				Tozawa, A.; Abe, Y.; Nakazawa, H.; Takeuchi, J.; Kondo, A.; Yokomichi, N.; Yoshida, A.; Hosonuma, S.; Yoshioka, N.; Kondo, H.; Ohara, T.; Kiguchi, K.; Suzuki, N.			CLINICAL EFFICACY OF ARTERIAL INJECTION CHEMOTHERAPY FOR RECURRENT GYNECOLOGICAL MALIGNANCIES	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Tozawa, A.; Abe, Y.; Nakazawa, H.; Takeuchi, J.; Kondo, A.; Yokomichi, N.; Yoshida, A.; Hosonuma, S.; Yoshioka, N.; Kondo, H.; Ohara, T.; Kiguchi, K.; Suzuki, N.] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0338	1276	1277				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502128		
J	Inoue, K; Tsubamoto, H; Ito, K; Hori, K; Ito, Y; Furukawa, N				Inoue, K.; Tsubamoto, H.; Ito, K.; Hori, K.; Ito, Y.; Furukawa, N.			INTRAPERITONEAL AND INTRAPLEURAL ADMINISTRATIONS OF TRIAMCINOLONE ACETONIDE EFFECTIVE FOR CONTROL OF MALIGNANT ASCITES AND PLEURAL EFFUSION. (KCOG-G-1102)	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Inoue, K.; Tsubamoto, H.; Ito, Y.] Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; [Ito, K.; Hori, K.] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan; [Furukawa, N.] Nara Med Univ, Nara, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0529	1280	1280				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502130		
J	Nishikawa, R; Itani, Y; Arakawa, A; Tsubamoto, H; Ito, K; Inoue, K; Kita, T; Sugiura, A; Toyoda, S; Kuritani, K; Shichido-Yamamoto, S; Miyagi, Y; Furukawa, N				Nishikawa, R.; Itani, Y.; Arakawa, A.; Tsubamoto, H.; Ito, K.; Inoue, K.; Kita, T.; Sugiura, A.; Toyoda, S.; Kuritani, K.; Shichido-Yamamoto, S.; Miyagi, Y.; Furukawa, N.			MENTAL MOOD OF GYNECOLOGIC CANCER PATIENTS ASSESSED BY DIT (DISTRESS AND IMPACT THERMOMETER) AND HADS (HOSPITAL ANXIETY AND DEPRESSION SCALE) DURING THE TREATMENT: KCOG-G1103 STUDY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Nishikawa, R.; Arakawa, A.] Nagoya City Univ Hosp, Nagoya, Aichi, Japan; [Itani, Y.; Kita, T.; Sugiura, A.; Toyoda, S.] Nara Prefecture Gen Med Ctr, Nara, Japan; [Tsubamoto, H.] Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; [Ito, K.; Kuritani, K.; Shichido-Yamamoto, S.] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan; [Inoue, K.] Meiwa Gen Hosp, Nishinomiya, Hyogo, Japan; [Miyagi, Y.] Okayama Ohfuku Clin, Okayama, Japan; [Furukawa, N.] Nara Med Univ, Kashihara, Nara 634, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0754	1285	1286				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502133		
J	Takeuchi, J; Yoshioka, N; Abe, Y; Nakazawa, H; Kondo, A; Yokomichi, N; Yoshida, A; Hosonuma, S; Kondo, H; Ohara, T; Tozawa-Ono, A; Suzuki, N				Takeuchi, J.; Yoshioka, N.; Abe, Y.; Nakazawa, H.; Kondo, A.; Yokomichi, N.; Yoshida, A.; Hosonuma, S.; Kondo, H.; Ohara, T.; Tozawa-Ono, A.; Suzuki, N.			EFFICACY AND THE SAFETY OF ANTICOAGULANT THERAPY USING THE XA INHIBITOR IN VENOUS THROMBOEMBOLISM ASSOCIATED WITH GYNECOLOGICAL MALIGNANCIES	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Takeuchi, J.; Yoshioka, N.; Abe, Y.; Nakazawa, H.; Kondo, A.; Yokomichi, N.; Yoshida, A.; Hosonuma, S.; Kondo, H.; Ohara, T.; Tozawa-Ono, A.; Suzuki, N.] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0836	1287	1288				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502134		
J	Takano, M; Goto, T; Miyamoto, M; Kato, M; Sasaki, N; Aoyama, T; Soyama, H; Shibutani, T; Matsuura, H; Hirata, J; Sasa, H; Furuya, K				Takano, M.; Goto, T.; Miyamoto, M.; Kato, M.; Sasaki, N.; Aoyama, T.; Soyama, H.; Shibutani, T.; Matsuura, H.; Hirata, J.; Sasa, H.; Furuya, K.			IS GENOTYPING OF UGT1A1 REALLY NEEDED FOR GYNECOLOGIC CANCER PATIENTS TREATED WITH IRINOTECAN-BASED CHEMOTHERAPY?	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Takano, M.; Goto, T.; Miyamoto, M.; Kato, M.; Sasaki, N.; Aoyama, T.; Soyama, H.; Shibutani, T.; Matsuura, H.; Hirata, J.; Sasa, H.; Furuya, K.] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1059	1294	1294				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502138		
J	Todo, Y; Hidenori, KATO; Kazuhira, O; Shinichiro, M; Sakuragi, N				Todo, Y.; Hidenori, K. A. T. O.; Kazuhira, O.; Shinichiro, M.; Sakuragi, N.			ISOLATED TUMOR CELLS AND MICROMETASTASES IN REGIONAL LYMPH NODES IN ENDOMETRIAL CANCER WITH DEEP MYOMETRIAL INVASION: A PRELIMINARY REPORT	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Todo, Y.; Hidenori, K. A. T. O.; Kazuhira, O.; Shinichiro, M.] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan; [Sakuragi, N.] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0102	1315	1316				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502151		
J	Hachisuga, T; Sho, T; Nguyen, TT; Urabe, R; Kurita, T; Kagami, S; Kawagoe, T; Matsuura, Y				Hachisuga, T.; Sho, T.; Nguyen, T. T.; Urabe, R.; Kurita, T.; Kagami, S.; Kawagoe, T.; Matsuura, Y.			EXPRESSION OF ESTROGEN RECEPTOR-ALPHA AS A PROGNOSTIC FACTOR IN PATIENTS WITH UTERINE SEROUS CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Hachisuga, T.; Sho, T.; Nguyen, T. T.; Urabe, R.; Kurita, T.; Kagami, S.; Kawagoe, T.; Matsuura, Y.] Univ Occupat & Environm Hlth, Dept Obstet & Gynecol, Kitakyushu, Fukuoka 807, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0103	1317	1317				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502152		
J	Umayahara, K; Usami, T; Taniguchi, T; Yamamoto, A; Ushioda, N; Nomura, H; Matoda, M; Okamoto, S; Kondo, E; Omatsu, K; Kato, K; Takeshima, N				Umayahara, K.; Usami, T.; Taniguchi, T.; Yamamoto, A.; Ushioda, N.; Nomura, H.; Matoda, M.; Okamoto, S.; Kondo, E.; Omatsu, K.; Kato, K.; Takeshima, N.			CORRELATIONS BETWEEN THE NUMBER AND DISTRIBUTION OF METASTATIC LYMPH-NODES OF ENDOMETRIAL CANCER PATIENTS IN SYSTEMATIC PELVIC AND PARA-AORTIC LYMPHADENECTOMY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Umayahara, K.; Usami, T.; Taniguchi, T.; Yamamoto, A.; Ushioda, N.; Nomura, H.; Matoda, M.; Okamoto, S.; Kondo, E.; Omatsu, K.; Kato, K.; Takeshima, N.] Japanese Fdn Canc Res, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0127	1318	1318				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502153		
J	Sueoka, K; Umayahara, K; Abe, A; Usami, T; Yamamoto, A; Nomura, H; Matoda, M; Okamoto, S; Omatsu, K; Kondo, E; Kato, K; Takeshima, N				Sueoka, K.; Umayahara, K.; Abe, A.; Usami, T.; Yamamoto, A.; Nomura, H.; Matoda, M.; Okamoto, S.; Omatsu, K.; Kondo, E.; Kato, K.; Takeshima, N.			PROGNOSIS FOR ENDOMETRIAL CANCER PATIENTS TREATED WITH SYSTEMATIC PELVIC AND PARA-AORTIC LYMPHADENECTOMY FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Sueoka, K.; Umayahara, K.; Abe, A.; Usami, T.; Yamamoto, A.; Nomura, H.; Matoda, M.; Okamoto, S.; Omatsu, K.; Kondo, E.; Kato, K.; Takeshima, N.] Canc Inst Hosp, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0285	1356	1356				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502177		
J	Watari, H; Mitamura, T; Tanaka, S; Sakuragi, N				Watari, H.; Mitamura, T.; Tanaka, S.; Sakuragi, N.			MICRORNA 31 FUNCTIONS AS AN ENDOMETRIAL CANCER ONCOGENE BY SUPPRESSING HIPPO TUMOR SUPPRESSOR PATHWAY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Watari, H.; Mitamura, T.; Sakuragi, N.] Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan; [Tanaka, S.] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0310	1368	1368				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502183		
J	Ito, F; Furukawa, N; Tanase, Y; Haruta, S; Kawaguchi, R; Yoshida, S; Kobayashi, H				Ito, F.; Furukawa, N.; Tanase, Y.; Haruta, S.; Kawaguchi, R.; Yoshida, S.; Kobayashi, H.			THE PROGNOSTIC FACTOR OF MODERATE AND HIGH RISK ENDOMETRIAL CANCER RECEIVING ADJUVANT TAXANE-PLATINUM CHEMOTHERAPY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Ito, F.; Furukawa, N.; Tanase, Y.; Haruta, S.; Kawaguchi, R.; Yoshida, S.; Kobayashi, H.] Nara Med Univ, Kashihara, Nara 634, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0313	1370	1370				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502184		
J	Goto, T; Takano, M; Shibutani, T; Matsuura, H; Aoyama, T; Miyamoto, M; Kato, M; Sasaki, N; Hirata, J; Yoshida, A; Sasa, H; Furuya, K				Goto, T.; Takano, M.; Shibutani, T.; Matsuura, H.; Aoyama, T.; Miyamoto, M.; Kato, M.; Sasaki, N.; Hirata, J.; Yoshida, A.; Sasa, H.; Furuya, K.			A ROLE OF NEOADJUVANT CHEMOTHERAPY (NAC) FOR ADVANCED ENDOMETRIAL CANCER (EC) IN COMPARISON WITH ADVANCED OVARIAN CANCER (OC)	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Goto, T.; Takano, M.; Shibutani, T.; Matsuura, H.; Aoyama, T.; Miyamoto, M.; Kato, M.; Sasaki, N.; Hirata, J.; Yoshida, A.; Sasa, H.; Furuya, K.] Natl Def Med Coll, Saitama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0335	1374	1375				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502186		
J	Yamaguchi, M; Watari, H; Odagiri, T; Shimada, C; Fukumoto, S; Mitamura, T; Konno, Y; Kato, T; Hosaka, M; Kobayashi, N; Takeda, M; Kudo, M; Sakuragi, N				Yamaguchi, M.; Watari, H.; Odagiri, T.; Shimada, C.; Fukumoto, S.; Mitamura, T.; Konno, Y.; Kato, T.; Hosaka, M.; Kobayashi, N.; Takeda, M.; Kudo, M.; Sakuragi, N.			DISTRIBUTION OF LYMPH NODE METASTASIS SITES IN ENDOMETRIAL CANCER UNDERGOING SYSTEMATIC PELVIC AND PARA-AORTIC LYMPHADENECTOMY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yamaguchi, M.; Watari, H.; Shimada, C.; Fukumoto, S.; Mitamura, T.; Konno, Y.; Kato, T.; Hosaka, M.; Kobayashi, N.; Takeda, M.; Kudo, M.; Sakuragi, N.] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan; [Odagiri, T.] Oji Gen Hosp, Dept Obstet & Gynecol, Tomakomai, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0416	1394	1395				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502197		
J	Fukumoto, S; Watari, H; Mitamura, T; Yamaguchi, M; Kimura, K; Shimada, C; Kato, T; Konno, Y; Hosaka, M; Todo, Y; Kobayashi, N; Takeda, M; Kudo, M; Sakuragi, N				Fukumoto, S.; Watari, H.; Mitamura, T.; Yamaguchi, M.; Kimura, K.; Shimada, C.; Kato, T.; Konno, Y.; Hosaka, M.; Todo, Y.; Kobayashi, N.; Takeda, M.; Kudo, M.; Sakuragi, N.			LYMPHADENECTOMY CAN BE OMITTED FOR LOW-RISK ENDOMETRIAL CANCER BASED ON PREOPERATIVE ASSESSMENTS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Fukumoto, S.; Watari, H.; Mitamura, T.; Yamaguchi, M.; Kimura, K.; Shimada, C.; Kato, T.; Konno, Y.; Hosaka, M.; Kobayashi, N.; Takeda, M.; Kudo, M.; Sakuragi, N.] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Todo, Y.] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0417	1396	1396				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502198		
J	Saito, F; Yamaguchi, M; Takaishi, K; Honda, R; Tashiro, H; Ohba, T; Katabuchi, H				Saito, F.; Yamaguchi, M.; Takaishi, K.; Honda, R.; Tashiro, H.; Ohba, T.; Katabuchi, H.			CLINICAL IMPLICATION OF PROLACTIN IN ENDOMETRIAL CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Saito, F.; Yamaguchi, M.; Takaishi, K.; Honda, R.; Tashiro, H.; Ohba, T.; Katabuchi, H.] Kumamoto Univ, Sch Med, Kumamoto 860, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0432	1400	1400				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502200		
J	Sugihara, T; Nakagawa, S; Sasajima, Y; Ichinose, T; Takeshita, S; Ayabe, T				Sugihara, T.; Nakagawa, S.; Sasajima, Y.; Ichinose, T.; Takeshita, S.; Ayabe, T.			OBESITY AS A PROGNOSTIC INDICATOR IN ENDOMETRIAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Sugihara, T.; Nakagawa, S.; Sasajima, Y.; Ichinose, T.; Takeshita, S.; Ayabe, T.] Teikyo Univ, Tokyo 173, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0445	1401	1402				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502201		
J	Ichinose, T; Nakagawa, S; Sasajima, Y; Sugihara, T; Takeshita, H; Ayabe, T				Ichinose, T.; Nakagawa, S.; Sasajima, Y.; Sugihara, T.; Takeshita, H.; Ayabe, T.			FUNCTIONAL ANALYSIS OF UBIQUITIN-PROTEIN LIGASE CHIP(CARBOXYL TERMINUS OF HSC70-INTERRACTING PROTEIN), WHICH TARGETS SRC-3 AND ERBB2 (HER-2/NEU) FOR UBIQUITIN-MEDIATED DEGRADATION IN ENDOMETRIAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Ichinose, T.; Nakagawa, S.; Sasajima, Y.; Sugihara, T.; Takeshita, H.; Ayabe, T.] Teikyo Univ, Tokyo 173, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0480	1408	1410				3	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502206		
J	Kanno, M; Nomura, E; Odagiri, T; Nozaki, A; Kudo, M; Mitsube, K				Kanno, M.; Nomura, E.; Odagiri, T.; Nozaki, A.; Kudo, M.; Mitsube, K.			LAPAROSCOPIC LYMPHADENECTOMY OF EARLY-STAGE ENDOMETRIAL CANCER: UP TO THE LEVEL OF RENAL VEINS VS. THE INFERIOR MESENTERIC ARTERY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kanno, M.; Nomura, E.; Odagiri, T.; Nozaki, A.] Oji Gen Hosp, Tomakomai, Japan; [Kudo, M.] Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan; [Kudo, M.] Hokkaido Unvers Grad Sch Med, Sapporo, Hokkaido, Japan; [Mitsube, K.] Asahikawa Kosei Gen Hosp, Asahikawa, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0493	1412	1413				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502208		
J	Yasuda, M; Katoh, T; Ogane, N; Nakayama, H				Yasuda, M.; Katoh, T.; Ogane, N.; Nakayama, H.			RECONSIDERATION OF FIGO IIIA, "POSITIVE PERITONEAL CYTOLOGY ALONE", IN ENDOMETRIAL CARCINOMA: SIGNIFICANCE OF IMMUNOCYTOCHEMISTRY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yasuda, M.; Katoh, T.] Saitama Med Univ, Int Med Ctr, Hidaka, Japan; [Ogane, N.; Nakayama, H.] Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0495	1414	1414				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502209		
J	Kawai, Y; Sekiya, R; Mitsui, H; Suzuki, S; Mizuno, M; Kajiyama, H; Shibata, K; Kikkawa, F				Kawai, Y.; Sekiya, R.; Mitsui, H.; Suzuki, S.; Mizuno, M.; Kajiyama, H.; Shibata, K.; Kikkawa, F.			CLINICOPATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH SYNCHRONOUS PRIMARY ENDOMETRIAL AND OVARIAN CANCERS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kawai, Y.; Sekiya, R.; Mitsui, H.; Suzuki, S.; Mizuno, M.; Kajiyama, H.; Shibata, K.; Kikkawa, F.] Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0533	1437	1437				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502222		
J	Suzuka, K; Kusanishi, T; Ijiri, M; Oosaki, T; Tanaka, N				Suzuka, K.; Kusanishi, T.; Ijiri, M.; Oosaki, T.; Tanaka, N.			THE EFFECT OF MEDROXYPROGESTERONE ACETATE (MPA) THERAPY FOR ENDOMETRIAL STROMAL SARCOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Suzuka, K.; Kusanishi, T.; Ijiri, M.; Oosaki, T.; Tanaka, N.] Chiba Canc Ctr Inst, Chiba, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0547	1440	1440				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502224		
J	Miyamoto, T; Yamada, Y; Ando, H; Kobara, H; Takatsu, A; Higuchi, S; Kashima, H; Shiozawa, T				Miyamoto, T.; Yamada, Y.; Ando, H.; Kobara, H.; Takatsu, A.; Higuchi, S.; Kashima, H.; Shiozawa, T.			LIPOCALIN2 INCREASES CISPLATIN RESISTANCE VIA ELEVATED EXPRESSION OF CD44V8-10 AND CD133	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Miyamoto, T.; Yamada, Y.; Ando, H.; Kobara, H.; Takatsu, A.; Higuchi, S.; Kashima, H.; Shiozawa, T.] Shinshu Univ, Matsumoto, Nagano 390, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0548	1441	1441				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502225		
J	Nakamura, K; Kobayashi, Y; Banno, K; Nomura, H; Adachi, M; Iida, M; Masuda, K; Kisu, I; Ueki, A; Yamagami, W; Kataoka, F; Hirasawa, A; Tominaga, E; Susumu, N; Aoki, D				Nakamura, K.; Kobayashi, Y.; Banno, K.; Nomura, H.; Adachi, M.; Iida, M.; Masuda, K.; Kisu, I.; Ueki, A.; Yamagami, W.; Kataoka, F.; Hirasawa, A.; Tominaga, E.; Susumu, N.; Aoki, D.			CLINICOPATHOLOGIC FEATURES AND DNA MISMATCH REPAIR PROTEIN EXPRESSION IN 32 CASES OF SYNCHRONOUS PRIMARY ENDOMETRIAL AND OVARIAN CANCERS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Nakamura, K.; Kobayashi, Y.; Banno, K.; Nomura, H.; Adachi, M.; Iida, M.; Masuda, K.; Kisu, I.; Ueki, A.; Yamagami, W.; Kataoka, F.; Hirasawa, A.; Tominaga, E.; Susumu, N.; Aoki, D.] Keio Univ, Dept Obstet & Gynecol, Shinjyuku Ku, Tokyo 108, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0588	1451	1452				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502230		
J	Doi, D; Iida, A; Kakisu, M; Asakura, H; Takeshita, T				Doi, D.; Iida, A.; Kakisu, M.; Asakura, H.; Takeshita, T.			LEIOMYOSARCOMA ARISE FROM ATYPICAL POLYPOID ADENOMYOMA OF THE UTERUS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Doi, D.; Iida, A.; Kakisu, M.; Asakura, H.; Takeshita, T.] Nippon Med Sch, Musashikosugi Hosp, Kawasaki, Kanagawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0705	1474	1474				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502243		
J	Kiyohara, Y; Yoshino, K; Hiramatsu, K; Takata, T; Matsuzaki, S; Kimura, T; Kobayashi, E; Ueda, Y; Fujita, M; Inoue, M; Kimura, T				Kiyohara, Y.; Yoshino, K.; Hiramatsu, K.; Takata, T.; Matsuzaki, S.; Kimura, T.; Kobayashi, E.; Ueda, Y.; Fujita, M.; Inoue, M.; Kimura, T.			PREPARATION OF PRIMARY CULTURE CELLS FROM A LCNEC OF UTERINE CORPUS USING CTOS (CANCER TISSUE-ORIGINATED SPHEROID) METHOD	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kiyohara, Y.; Yoshino, K.; Hiramatsu, K.; Takata, T.; Matsuzaki, S.; Kimura, T.; Kobayashi, E.; Ueda, Y.; Fujita, M.; Kimura, T.] Osaka Univ, Suita, Osaka, Japan; [Inoue, M.] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0714	1475	1476				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502244		
J	Motooka, Y; Motohara, T; Takaishi, K; Saito, F; Honda, R; Tashiro, H; Ohba, T; Katabuchi, H				Motooka, Y.; Motohara, T.; Takaishi, K.; Saito, F.; Honda, R.; Tashiro, H.; Ohba, T.; Katabuchi, H.			CLINICOPATHOLOGICAL STUDY OF PROGNOSTIC FACTORS IN UTERINE CARCINOSARCOMA: A COMPARISON WITH GRADE 3 ENDOMETRIOID ADENOCARCINOMA OF THE UTERUS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Motooka, Y.; Motohara, T.; Takaishi, K.; Saito, F.; Honda, R.; Tashiro, H.; Ohba, T.; Katabuchi, H.] Kumamoto Univ, Dept Obstet & Gynecol, Kumamoto, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0716	1477	1478				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502245		
J	Yokota, N; Imai, K; Iida, T; Matsuhashi, T; Konnai, K; Onose, R; Kato, H				Yokota, N.; Imai, K.; Iida, T.; Matsuhashi, T.; Konnai, K.; Onose, R.; Kato, H.			SMALL CELL CARCINOMA OF THE ENDOMETRIUM (SCCE): A RETROSPECTIVE STUDY OF SIX CASES	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Yokota, N.; Imai, K.; Iida, T.; Matsuhashi, T.; Konnai, K.; Onose, R.; Kato, H.] Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0718	1479	1479				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502246		
J	Kotani, Y; Yasuda, Y; Koike, E; Shiota, M; Obata, K; Mandai, M				Kotani, Y.; Yasuda, Y.; Koike, E.; Shiota, M.; Obata, K.; Mandai, M.			IN UTERINE CANCERS, HIGH EXPRESSION RATIO OF AROMATASE TO ERYTHROPOIETIN MRNA LEVELS MAY BE PATHOGNOMONIC.	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kotani, Y.; Yasuda, Y.; Koike, E.; Mandai, M.] Kinki Univ, Fac Med, Osaka, Japan; [Shiota, M.] Kawasaki Med Univ, Kurashiki, Okayama, Japan; [Obata, K.] Kinki Univ, Nara Hosp, Fac Med, Ikoma, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0736	1481	1482				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502247		
J	Takahashi, R; Mabuchi, S; Kuroda, H; Sasano, T; Kawano, M; Matsumoto, Y; Hashimoto, K; Isobe, A; Sawada, K; Sakata, M; Kimura, T				Takahashi, R.; Mabuchi, S.; Kuroda, H.; Sasano, T.; Kawano, M.; Matsumoto, Y.; Hashimoto, K.; Isobe, A.; Sawada, K.; Sakata, M.; Kimura, T.			PROGNOSTIC SIGNIFICANCE OF PRETREATMENT LEUKOCYTOSIS AND NEUTROPHILIA IN ENDOMETRIAL CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Takahashi, R.; Mabuchi, S.; Kuroda, H.; Sasano, T.; Kawano, M.; Matsumoto, Y.; Hashimoto, K.; Isobe, A.; Sawada, K.; Sakata, M.; Kimura, T.] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0742	1484	1484				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502249		
J	Matsuzaki, S; Yoshino, K; Hori, Y; Matsuzaki, S; Takata, T; Kobayashi, E; Kimura, T; Ueda, Y; Fujita, M; Morii, E; Kimura, T				Matsuzaki, S.; Yoshino, K.; Hori, Y.; Matsuzaki, S.; Takata, T.; Kobayashi, E.; Kimura, T.; Ueda, Y.; Fujita, M.; Morii, E.; Kimura, T.			ABNORMAL CERVICAL CYTOLOGY FREQUENTLY APPEARS AND HELPS EARLIER DIAGNOSIS OF UTERINE PAPILLARY SEROUS CARCINOMA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Matsuzaki, S.; Yoshino, K.; Matsuzaki, S.; Takata, T.; Kobayashi, E.; Kimura, T.; Ueda, Y.; Fujita, M.; Kimura, T.] Osaka Univ, Suita, Osaka, Japan; [Hori, Y.; Morii, E.] Osaka Univ, Dept Pathol, Suita, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0755	1487	1487				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502251		
J	Aihara, S; Nishiyama, S; Hashiguchi, M; Ookuma, E; Nakao, Y; Yokoyama, M				Aihara, S.; Nishiyama, S.; Hashiguchi, M.; Ookuma, E.; Nakao, Y.; Yokoyama, M.			MAY DIAGNOSIS OF ENDOMETRIAL CANCER BE A SENTINEL EVENT IN JAPAN?	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Aihara, S.; Nishiyama, S.; Hashiguchi, M.; Ookuma, E.; Nakao, Y.; Yokoyama, M.] Saga Univ, Fac Med, Saga 840, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0794	1491	1491				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502254		
J	Ninomiya, T; Wada, M; Yokota, M; Ichikawa, Y; Susumu, N; Yamagami, W; Nomura, H; Kataoka, F; Hirasawa, A; Suzuki, A; Tominaga, E; Banno, K; Aoki, D				Ninomiya, T.; Wada, M.; Yokota, M.; Ichikawa, Y.; Susumu, N.; Yamagami, W.; Nomura, H.; Kataoka, F.; Hirasawa, A.; Suzuki, A.; Tominaga, E.; Banno, K.; Aoki, D.			SUCCESSFUL PREGNANCIES IN 54 PATIENTS FOLLOWING FERTILITY-PRESERVING HORMONAL THERAPY FOR ENDOMETRIAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Ninomiya, T.; Wada, M.; Yokota, M.; Ichikawa, Y.; Susumu, N.; Yamagami, W.; Nomura, H.; Kataoka, F.; Hirasawa, A.; Suzuki, A.; Tominaga, E.; Banno, K.; Aoki, D.] Keio Univ, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0855	1497	1497				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502258		
J	Uehara, T; Mitsuhashi, A; Hanawa, S; Yamamoto, N; Nishikimi, K; Tate, S; Usui, H; Shozu, M				Uehara, T.; Mitsuhashi, A.; Hanawa, S.; Yamamoto, N.; Nishikimi, K.; Tate, S.; Usui, H.; Shozu, M.			POLYCYSTIC OVARY SYNDROME PREDICTS PROGNOSIS IN ENDOMETRIAL CANCER PATIENTS	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Uehara, T.; Mitsuhashi, A.; Hanawa, S.; Yamamoto, N.; Nishikimi, K.; Tate, S.; Usui, H.; Shozu, M.] Chiba Univ, Grad Sch Med, Chiba, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0927	1508	1508				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502265		
J	Otsuka, I; Matsuura, T; Enmi, S; Suemitsu, T; Suzuki, Y; Teraoka, K; Furusawa, Y; Shimizu, Y; Kameda, S				Otsuka, I.; Matsuura, T.; Enmi, S.; Suemitsu, T.; Suzuki, Y.; Teraoka, K.; Furusawa, Y.; Shimizu, Y.; Kameda, S.			ENDOMETRIOID ENDOMETRIAL CARCINOMA WITH LYMPH NODE METASTASIS TREATED WITH ADJUVANT PACLITAXEL/CARBOPLATIN CHEMOTHERAPY	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Otsuka, I.; Matsuura, T.; Enmi, S.; Suemitsu, T.; Suzuki, Y.; Teraoka, K.; Furusawa, Y.; Shimizu, Y.; Kameda, S.] Kameda Med Ctr, Kamogawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1139	1539	1539				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502290		
J	Furukawa, S; Iwase, H; Ono, S; Takada, T; Arai, T; Arai, M; Onda, T				Furukawa, S.; Iwase, H.; Ono, S.; Takada, T.; Arai, T.; Arai, M.; Onda, T.			CLINICO-PATHOLOGICAL FEATURES OF UTERINE SEROUS CARCINOMA: A SINGLE-INSTITUTION EXPERIENCE	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Furukawa, S.; Iwase, H.; Ono, S.; Takada, T.; Arai, T.; Arai, M.; Onda, T.] Kitasato Univ, Sch Med, Sagamihara, Kanagawa 228, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1164	1547	1547				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502296		
J	Kataoka, F; Susumu, N; Yamagami, W; Ninomiya, T; Takigawa, A; Wada, M; Nakadaira, N; Iwasa, N; Hashimoto, S; Nomura, H; Banno, K; Nakahara, T; Kameyama, K; Aoki, D				Kataoka, F.; Susumu, N.; Yamagami, W.; Ninomiya, T.; Takigawa, A.; Wada, M.; Nakadaira, N.; Iwasa, N.; Hashimoto, S.; Nomura, H.; Banno, K.; Nakahara, T.; Kameyama, K.; Aoki, D.			ANALYSIS OF THE RELATION BETWEEN DIAGNOSTIC ACCURACY OF FROZEN SECTION DIAGNOSIS AND TUMOR SIZE OF LYMPH NODE METASTASIS IN SENTINEL NODE BIOPSY FOR ENDOMETRIAL CANCER	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Kataoka, F.; Susumu, N.; Yamagami, W.; Ninomiya, T.; Takigawa, A.; Wada, M.; Nakadaira, N.; Iwasa, N.; Hashimoto, S.; Nomura, H.; Banno, K.; Nakahara, T.; Kameyama, K.; Aoki, D.] Keio Univ, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-1221	1552	1552				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502301		
J	Susumu, N; Yamagami, W; Ninomiya, T; Wada, M; Takigawa, A; Ichikawa, Y; Nomura, H; Kataoka, F; Hirasawa, A; Suzuki, A; Tominaga, E; Banno, K; Aoki, D				Susumu, N.; Yamagami, W.; Ninomiya, T.; Wada, M.; Takigawa, A.; Ichikawa, Y.; Nomura, H.; Kataoka, F.; Hirasawa, A.; Suzuki, A.; Tominaga, E.; Banno, K.; Aoki, D.			OUTCOMES OF REPEATED FERTILITY-PRESERVING HORMONAL THERAPY USING MEDROXYPROGESTERONE ACETATE AMONG 165 YOUNG PATIENTS WITH ENDOMETRIAL CANCER OR ATYPICAL ENDOMETRIAL HYPERPLASIA	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Meeting Abstract									[Susumu, N.; Yamagami, W.; Ninomiya, T.; Wada, M.; Takigawa, A.; Nomura, H.; Kataoka, F.; Hirasawa, A.; Suzuki, A.; Tominaga, E.; Banno, K.; Aoki, D.] Keio Univ, Sch Med, Tokyo, Japan; [Ichikawa, Y.] Shizuoka Red Cross Hosp, Shizuoka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		4		IGCSM-0839	1596	1596				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT5EP	WOS:000344966502332		
J	Moriguchi, T; Yamamoto, M				Moriguchi, Takashi; Yamamoto, Masayuki			A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						GATA1; GATA2; Transgenic mouse; Differentiation; Erythroid; BAC (bacterial artificial chromosome)	DNA-BINDING; IN-VIVO; HEMATOPOIETIC-CELLS; DEFINITIVE ERYTHROPOIESIS; MOUSE EMBRYOS; PROMOTER; EXPRESSION; MICE; ELEMENTS; ENHANCER	GATA transcription factor family members GATA1 and GATA2 play crucial roles in the regulation of lineage-restricted genes during erythroid differentiation. GATA1 is indispensable for survival and terminal differentiation of erythroid, megakaryocytic and eosinophilic progenitors, whereas GATA2 regulates proliferation and maintenance of hematopoietic stem and progenitor cells. Expression levels of GATA1 and GATA2 are primarily regulated at the transcriptional level through auto-and reciprocal regulatory networks formed by these GATA factors. The dynamic and strictly controlled change of expression from GATA2 to GATA1 during erythropoiesis has been referred to as GATA factor switching, which plays a crucial role in erythropoiesis. The regulatory network comprising GATA1 and GATA2 gives rise to the stage-specific changes in Gata1 and Gata2 gene expression during erythroid differentiation, which ensures specific expression of early and late erythroid genes at each stage. Recent studies have also shed light on the genome-wide binding profiles of GATA1 and GATA2, and the significance of epigenetic modification of Gata1 gene during erythroid differentiation. This review summarizes the current understanding of network regulation underlying stage-dependent Gata1 and Gata2 gene expressions and the functional contribution of these GATA factors in erythroid differentiation.	[Moriguchi, Takashi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan	Yamamoto, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	masiyamamoto@med.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010		JSPS KAKENHI [24249015, 22118001, 24590371]; Takeda Foundation; Naito foundation; Core Research for Evolutional Science and Technology from the JST	This work was supported through funding from JSPS KAKENHI Grant Number 24249015 (MY), 22118001(MY), 24590371 (TM), Takeda Foundation (to T. M. and M.Y.), Naito foundation (to M.Y.) and the Core Research for Evolutional Science and Technology from the JST (MY).	ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; KO LJ, 1993, MOL CELL BIOL, V13, P4011; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Onodera K, 1997, J BIOCHEM-TOKYO, V121, P251; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; ORKIN SH, 1992, BLOOD, V80, P575; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Suzuki N, 2002, BLOOD, V100, P2279, DOI 10.1182/blood-2002-01-0124; Yien YY, 2013, MOL CELL BIOL, V33, P4, DOI 10.1128/MCB.01058-12; Shimizu R, 2004, BLOOD, V103, P2560, DOI 10.1182/blood-2003-07-2514; Tsai FY, 1997, BLOOD, V89, P3636; Takai J, 2013, BLOOD, V122, P3450, DOI 10.1182/blood-2013-01-476911; Chae JH, 2003, MOL CELLS, V15, P40; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Bose F, 2006, MOL CELL BIOL, V26, P3942, DOI 10.1128/MCB.26.10.3942-3954.2006; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; Kobayashi E, 2010, J BIOL CHEM, V285, P773, DOI 10.1074/jbc.M109.030726; Lim KC, 2012, J CLIN INVEST, V122, P3705, DOI 10.1172/JCI61619; LIM LC, 1992, MOL CELL BIOL, V12, P828; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Minegishi N, 2003, BLOOD, V102, P896, DOI 10.1182/blood-2002-12-3809; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Moriguchi T, 2010, HEMATOPOIETIC STEM C, P172; Mukai HY, 2013, GENES CELLS, V18, P886, DOI 10.1111/gtc.12084; Nishimura S, 2000, MOL CELL BIOL, V20, P713, DOI 10.1128/MCB.20.2.713-723.2000; Ohneda K, 2002, GENES CELLS, V7, P1243, DOI 10.1046/j.1365-2443.2002.00595.x; Onodera K, P NATL ACAD SCI US, V94, P4487; Shimizu R, 2013, GENES CELLS, V18, P1032, DOI 10.1111/gtc.12096; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Suzuki M, 2011, INT J HEMATOL, V93, P150, DOI 10.1007/s12185-011-0770-6; Suzuki M, 2013, GENES CELLS, V18, P921, DOI 10.1111/gtc.12086; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Takahashi S, 2000, BLOOD, V96, P910; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Togarrati PP, 2012, INT J HEMATOL, V95, P617, DOI 10.1007/s12185-012-1094-x; Trainor CD, 2000, J BIOL CHEM, V275, P28157; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Whyatt D, 2000, NATURE, V406, P519; Yamamoto M, 1997, GENES CELLS, V2, P107, DOI 10.1046/j.1365-2443.1997.1080305.x	54	6	6	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					417	424		10.1007/s12185-014-1568-0		8	Hematology	Hematology	AT6XG	WOS:000345079600002		
J	Matsumoto, T; Fan, XP; Ishikawa, E; Ito, M; Amano, K; Toyoda, H; Komada, Y; Ohishi, K; Katayama, N; Yoshida, Y; Matsumoto, M; Fujimura, Y; Ikejiri, M; Wada, H; Miyata, T				Matsumoto, Takeshi; Fan, Xinping; Ishikawa, Eiji; Ito, Masaaki; Amano, Keishirou; Toyoda, Hidemi; Komada, Yoshihiro; Ohishi, Kohshi; Katayama, Naoyuki; Yoshida, Yoko; Matsumoto, Masanori; Fujimura, Yoshihiro; Ikejiri, Makoto; Wada, Hideo; Miyata, Toshiyuki			Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						aHUS; C3 mutation; Trigger factor; Renal failure; Thrombotic microangiopathy	COFACTOR PROTEIN CD46; ESCHERICHIA-COLI; ECULIZUMAB; IMPACT	Atypical hemolytic uremic syndrome (aHUS) is caused by abnormalities of the complement system and has a significantly poor prognosis. The clinical phenotypes of 12 patients in nine families with aHUS with familial or recurrent onset and ADAMTS13 activity of >= 20 % treated at the Mie University Hospital were examined. In seven of the patients, the first episode of aHUS occurred during childhood and ten patients experienced a relapse. All patients had renal dysfunction and three had been treated with hemodialysis. Seven patients experienced probable triggering events including common cold, influenza, bacterial infection and/or vaccination for influenza. All patients had entered remission, and renal function was improved in 11 patients. DNA sequencing of six candidate genes, identified a C3 p.I1157T missense mutation in all eight patients in six families examined and this mutation was causative for aHUS. A causative mutation THBD p.D486Y was also identified in an aHUS patient. Four missense mutations, CFH p.V837I, p.Y1058H, p.V1060L and THBD p.R403K may predispose to aHUS manifestation; the remaining seven missense mutations were likely neutral. In conclusion, the clinical phenotypes of aHUS are various, and there are often trigger factors. The C3 p.I1157T mutation was identified as the causative mutation for aHUS in all patients examined, and may be geographically concentrated in or around the Mie prefecture in central Japan.	[Matsumoto, Takeshi; Ohishi, Kohshi] Mie Univ Hosp, Blood Transfus Serv, Tsu, Mie, Japan; [Fan, Xinping; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka 5658565, Japan; [Ishikawa, Eiji; Ito, Masaaki] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie 5148507, Japan; [Amano, Keishirou; Toyoda, Hidemi; Komada, Yoshihiro] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie 5148507, Japan; [Katayama, Naoyuki] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 5148507, Japan; [Yoshida, Yoko; Matsumoto, Masanori; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan; [Ikejiri, Makoto; Wada, Hideo] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan; [Wada, Hideo] Mie Univ, Grad Sch Med, Dept Lab Med, Tsu, Mie 5148507, Japan	Wada, H (reprint author), Mie Univ, Grad Sch Med, Dept Lab Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	wadahide@clin.medic.mie-u.ac.jp; miyata@ri.ncvc.go.jp			Ministry of Health, Labour and Welfare of Japan for Blood Coagulation Abnormalities, the Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Takeda Science Foundation	This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan for Blood Coagulation Abnormalities, the Ministry of Education, Culture, Sports, Science and Technology of Japan, grant from the Uehara Memorial Foundation and grant from the Takeda Science Foundation.	Iioka F, 2012, INT J HEMATOL, V96, P506, DOI 10.1007/s12185-012-1162-2; Fremeaux-Bacchi V, 2006, J AM SOC NEPHROL, V17, P2017, DOI 10.1681/ASN.2005101051; Sanchez-Corral P, 2004, MOL IMMUNOL, V41, P81, DOI 10.1016/j.molimm.2004.01.003; Zimmerhackl LB, 2010, NEW ENGL J MED, V362, P1746, DOI 10.1056/NEJMc1001060; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Sethi S, 2012, NEW ENGL J MED, V366, P1119, DOI 10.1056/NEJMra1108178; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Sellier-Leclerc AL, 2007, J AM SOC NEPHROL, V18, P2392, DOI 10.1681/ASN.2006080811; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Fan XP, 2013, MOL IMMUNOL, V54, P238, DOI 10.1016/j.molimm.2012.12.006; Gruppo RA, 2009, NEW ENGL J MED, V360, P544, DOI 10.1056/NEJMc0809959; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Roumenina LT, 2011, J IMMUNOL METHODS, V365, P8, DOI 10.1016/j.jim.2010.12.020; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Ariceta G, 2009, PEDIATR NEPHROL, V24, P687, DOI 10.1007/s00467-008-0964-1; Heinen Stefan, 2006, Hum Mutat, V27, P292, DOI 10.1002/humu.9408; Ito N, 2009, INT J HEMATOL, V90, P328, DOI 10.1007/s12185-009-0421-3; Ito-Habe N, 2010, INT J HEMATOL, V92, P68, DOI 10.1007/s12185-010-0599-4; Kobayashi T, 2007, THROMB RES, V119, P447, DOI 10.1016/j.thromres.2006.04.007; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Tanabe S, 2012, INT J HEMATOL, V96, P789, DOI 10.1007/s12185-012-1221-8	25	5	5	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					444	449		10.1007/s12185-014-1655-2		6	Hematology	Hematology	AT6XG	WOS:000345079600006		
J	Aota, T; Naitoh, K; Wada, H; Yamashita, Y; Miyamoto, N; Hasegawa, M; Wakabayashi, H; Yoshida, K; Asanuma, K; Matsumoto, T; Ohishi, K; Shimokariya, Y; Yamada, N; Nishikawa, M; Katayama, N; Uchida, A; Sudo, A				Aota, Takumi; Naitoh, Katsuki; Wada, Hideo; Yamashita, Yoshiki; Miyamoto, Noriki; Hasegawa, Masahiro; Wakabayashi, Hiroki; Yoshida, Kakunoshin; Asanuma, Kunihiro; Matsumoto, Takeshi; Ohishi, Kohshi; Shimokariya, Yuji; Yamada, Norikazu; Nishikawa, Masakatsu; Katayama, Naoyuki; Uchida, Atsumasa; Sudo, Akihiro			Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Deep vein thrombosis; Orthopedic surgery; Major bleeding; sGPVI	DEEP-VEIN THROMBOSIS; MAJOR ORTHOPEDIC-SURGERY; RECEPTOR GAMMA-CHAIN; VENOUS THROMBOEMBOLISM; COLLAGEN RECEPTOR; PLASMA-LEVELS; TOTAL HIP; PREVENTION; DISEASE; GPVI	Prevention of deep vein thrombosis (DVT) is important in patients undergoing major orthopedic surgery. Although the detection of an elevated D-dimer level is useful for predicting DVT, it is not efficacious in postoperative patients being treated with anti-Xa agents. The soluble platelet glycoprotein VI (sGPVI) level is a marker of activated platelets, but not bleeding. Therefore, sGPVI levels are usually examined as a predictor of DVT in such patients. In the present study, 83 orthopedic patients were treated with 30 mg of edoxaban for prophylaxis of DVT. Fourteen patients developed DVT and 17 patients discontinued the prophylaxis due to decreased hemoglobin levels. Plasma levels of sGPVI in the patients were significantly higher after surgery than before surgery. On day 1, the sGPVI levels increased, while the platelet counts decreased. There were no significant differences in D-dimer, soluble fibrin, or FDP levels in orthopedic patients with and without DVT before surgery and on days 1, 4, and 8. Plasma sGPVI levels were significantly higher in the patients with DVT than in those without DVT on days 1 and 4. Plasma levels of D-dimer were significantly higher in patients with withdrawal than in those without. However, there were no significant differences in sGPVI levels between those with and without withdrawal. As D-dimer levels are known to increase in patients with withdrawal, this parameter is not useful for evaluating the risk of DVT in these patients. In contrast, the sGPVI level is not increased in those with withdrawal and may therefore be useful for evaluating the risk of DVT in postoperative patients treated with an anticoagulant.	[Aota, Takumi; Yamashita, Yoshiki; Katayama, Naoyuki] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 5148507, Japan; [Naitoh, Katsuki] Mochida Pharmaceut Co Ltd, Discovery Res, Biol Lab, Shizuoka, Japan; [Wada, Hideo] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan; [Miyamoto, Noriki; Hasegawa, Masahiro; Wakabayashi, Hiroki; Yoshida, Kakunoshin; Asanuma, Kunihiro; Uchida, Atsumasa; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan; [Matsumoto, Takeshi; Ohishi, Kohshi] Mie Univ, Grad Sch Med, Dept Blood Transfus, Tsu, Mie 5148507, Japan; [Shimokariya, Yuji] Mie Univ, Grad Sch Med, Cent Lab, Tsu, Mie 5148507, Japan; [Yamada, Norikazu] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie 5148507, Japan; [Nishikawa, Masakatsu] Mie Univ, Grad Sch Med, Clin Res Support Ctr, Tsu, Mie 5148507, Japan; [Uchida, Atsumasa] Mie Univ, Grad Sch Med, Tsu, Mie 5148507, Japan	Wada, H (reprint author), Mie Univ, Grad Sch Med, Dept Mol & Lab Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	wadahide@clin.medic.mie-u.ac.jp			Mochida Pharmaceutical Co., Ltd; Ministry of Health, Labour, and Welfare of Japan for Blood Coagulation Abnormalities; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported in part by a Grant-in-Aid from Mochida Pharmaceutical Co., Ltd, the Ministry of Health, Labour, and Welfare of Japan for Blood Coagulation Abnormalities and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Al-Tamimi M, 2011, BLOOD, V117, P3912, DOI 10.1182/blood-2010-08-301523; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Yamashita Y, 2014, THROMB RES, V133, P440, DOI 10.1016/j.thromres.2013.11.023; Hatzipantelis ES, 2013, INT J HEMATOL, V98, P158, DOI 10.1007/s12185-013-1392-y; Wada H, 2014, CLIN CHIM ACTA, V436, P130, DOI 10.1016/j.cca.2014.04.020; Yoshida K, 2012, INT J HEMATOL, V95, P160, DOI 10.1007/s12185-012-1004-2; Al-Tamimi M, 2012, BLOOD, V119, P4311, DOI 10.1182/blood-2011-10-386607; Takayama H, 2008, J CLIN INVEST, V118, P1785, DOI 10.1172/JCI32513; Colwell CW, 1999, J BONE JOINT SURG AM, V81A, P932; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Fuji T, 2010, J THROMB HAEMOST, V8, P2458, DOI 10.1111/j.1538-7836.2010.04021.x; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Piovella F, 2005, J THROMB HAEMOST, V3, P2664, DOI 10.1111/j.1538-7836.2005.01621.x; Al-Tamimi M, 2011, STROKE, V42, P498, DOI 10.1161/STROKEAHA.110.602532; Al-Tamimi M, 2009, PLATELETS, V20, P143, DOI 10.1080/09537100802710286; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; Schellong SM, 2003, THROMB HAEMOSTASIS, V89, P228; Al-Tamimi M, 2012, THROMB HAEMOSTASIS, V107, P648, DOI 10.1160/TH11-10-0745; Bigalke B, 2011, CLIN CHEM, V57, P898, DOI 10.1373/clinchem.2010.158527; Bigalke B, 2009, BASIC RES CARDIOL, V104, P352, DOI 10.1007/s00395-009-0779-7; Gardiner EE, 2004, BLOOD, V104, P3611, DOI 10.1182/blood-2004-04-1549; Gardiner EE, 2012, METHODS MOL BIOL, V788, P321, DOI 10.1007/978-1-61779-307-3_22; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Hasegawa M, 2013, CLIN CHIM ACTA, V425, P109, DOI 10.1016/j.cca.2013.07.009; Heit JA, 2000, ANN INTERN MED, V132, P853; Hosoka Y, 2007, European Patent Application publication, Patent No. [EP2000802 A1, 2000802]; Leclerc Jacques R., 1998, Chest, V114, p115S, DOI 10.1378/chest.114.2_Supplement.115S; Nurden P, 2009, J THROMB HAEMOST, V7, P1541, DOI 10.1111/j.1538-7836.2009.03537.x; Sudo A, 2009, INT J HEMATOL, V89, P572, DOI 10.1007/s12185-009-0323-4; Tsuji A, 2008, INT J HEMATOL, V88, P448, DOI 10.1007/s12185-008-0173-5; Wurster T, 2013, PLATELETS, V24, P560, DOI 10.3109/09537104.2012.746455	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					450	456		10.1007/s12185-014-1676-x		7	Hematology	Hematology	AT6XG	WOS:000345079600007		
J	Makiyama, J; Imaizumi, Y; Tsushima, H; Taniguchi, H; Moriwaki, Y; Sawayama, Y; Imanishi, D; Taguchi, J; Hata, T; Tsukasaki, K; Miyazaki, Y				Makiyama, Junya; Imaizumi, Yoshitaka; Tsushima, Hideki; Taniguchi, Hiroaki; Moriwaki, Yuji; Sawayama, Yasushi; Imanishi, Daisuke; Taguchi, Jun; Hata, Tomoko; Tsukasaki, Kunihiro; Miyazaki, Yasushi			Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Adult T cell leukemia-lymphoma (ATL); Elderly patients; Chemotherapy	LEUKEMIA/LYMPHOMA; TRANSPLANTATION; RETROVIRUS; SURVIVAL; SUBTYPES	VCAP (vincristine, cyclophosphamide, doxorubicin, and prednisone)-AMP (doxorubicin, ranimustine, and prednisone)-VECP (vindesine, etoposide, carboplatin, and prednisone) is a standard regimen for aggressive adult T cell leukemia-lymphoma (ATL). However, the efficacy of this regimen has not been fully elucidated for patients aged 70 years or older. Here, we retrospectively analyzed elderly patients with aggressive ATL at Nagasaki University Hospital between 1994 and 2010 to assess treatment outcomes. Of 148 evaluable patients, 54 were aged 70 years or older at diagnosis. The median survival time (MST) and overall survival (OS) at 2 years in elderly patients were 10.6 months and 22.1 %, respectively. Thirty-four patients received VCAP-AMP-VECP as the initial treatment, although the doses were reduced for most patients. In these patients, MST and OS at 2 years were 13.4 months and 26.6 %, respectively. Eleven of 34 patients (32 %) received maintenance oral chemotherapy after two or three cycles of VCAP-AMP-VECP, and MST and OS at 2 years were 16.7 months and 32.7 %, respectively. Our results suggest that the VCAP-AMP-VECP regimen may be effective and that maintenance oral chemotherapy may be considered as a therapeutic option for elderly patients with aggressive ATL.	[Makiyama, Junya] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Hematol, Nagasaki 8528523, Japan; [Makiyama, Junya; Imaizumi, Yoshitaka; Sawayama, Yasushi; Imanishi, Daisuke; Taguchi, Jun; Hata, Tomoko; Miyazaki, Yasushi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Hematol, Atom Bomb Dis & Hibakusha Med Unit, Nagasaki 8528523, Japan; [Makiyama, Junya; Moriwaki, Yuji] Nagasaki Natl Med Ctr, Dept Hematol, Omura, Nagasaki, Japan; [Tsushima, Hideki] City Hosp, Nagasaki Harbor Med Ctr, Dept Hematol, Nagasaki, Japan; [Taniguchi, Hiroaki] Sasebo City Hosp, Dept Hematol, Sasebo, Nagasaki, Japan; [Tsukasaki, Kunihiro] Natl Canc Ctr Hosp East, Dept Hematol Oncol, Kashiwa, Chiba, Japan	Imaizumi, Y (reprint author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Hematol, Atom Bomb Dis & Hibakusha Med Unit, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	y-imaizm@nagasaki-u.ac.jp			Ministry of Health, Labor and Welfare of Japan [H23-gan rinsho-ippan-022]	We thank the hematologists in the Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, for diagnosis and treatment of patients with ATL. This work was supported by a grant for cancer research (H23-gan rinsho-ippan-022) from the Ministry of Health, Labor and Welfare of Japan.	Yamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.x; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; UCHIYAMA T, 1977, BLOOD, V50, P481; Bazarbachi A, 2010, J CLIN ONCOL, V28, P4177, DOI 10.1200/JCO.2010.28.0669; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Hishizawa M, 2010, BLOOD, V116, P1369, DOI 10.1182/blood-2009-10-247510; Fukushima T, 2005, LEUKEMIA, V19, P829, DOI 10.1038/sj.leu.2403682; Fukushima T, 2013, INT J HEMATOL, V97, P485, DOI 10.1007/s12185-013-1307-y; Katusya H, 2012, J CLIN ONCOL, V30, P1635; Shimoyama M, 1994, ADULT T CELL LEUKEMI, P221; Tobinai K, 2004, CLIN ONCOLOGY, P3109; Yamada Yasuaki, 2011, Rinsho Ketsueki, V52, P1765	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					464	472		10.1007/s12185-014-1665-0		9	Hematology	Hematology	AT6XG	WOS:000345079600009		
J	Moriwaki, K; Manabe, A; Taketani, T; Kikuchi, A; Nakahata, T; Hayashi, Y				Moriwaki, Koichi; Manabe, Atsushi; Taketani, Takeshi; Kikuchi, Akira; Nakahata, Tatsutoshi; Hayashi, Yasuhide			Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Myelodysplastic syndrome; Childhood; Chromosomal abnormality	JUVENILE MYELOMONOCYTIC LEUKEMIA; PROGNOSTIC SCORING SYSTEM; APLASTIC-ANEMIA; CHILDHOOD; CLASSIFICATION; POPULATION; CHILDREN; MDS	We analyzed the cytogenetics and clinical features of pediatric myelodysplastic syndrome (MDS) in Japan. Data on patients (<16 years) diagnosed with MDS from 1990 to 2000 were retrospectively collected from pediatric hematologists in 234 institutions. Chromosome analysis was successfully performed in 255 of 277 MDS patients. The numbers of patients with refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess of blasts (RAEB), refractory anemia with excess of blasts in transformation (RAEBt), chronic myelomonocytic leukemia, and juvenile myelomonocytic leukemia were 67 (24 %), 51 (18 %), 51 (18 %), 20 (7 %), and 65 (23 %), respectively. The other 23 patients (8 %) could not be classified specifically. The distribution of childhood MDS in Japan according to the French-American-British subclassification was similar to that in other countries. However, we identified a higher incidence of therapy-related cases. As for relationship between cytogenetics and prognoses, abnormal karyotypes were related to poorer prognoses than normal karyotype (P < 0.01). However, patients with trisomy 8 had prognoses comparable to those with normal karyotypes. Complex karyotypes were associated with poorer prognoses among RAEB and RAEBt patients. In conclusion, prognosis of pediatric MDS is related to cytogenetics. A more precise diagnosis and classification system is needed for childhood MDS.	[Moriwaki, Koichi] Saitama Med Univ, Saitama Med Ctr, Dept Pediat, Saitama, Japan; [Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; [Taketani, Takeshi] Shimane Univ Hosp, Div Blood Transfus, Izumo, Shimane, Japan; [Kikuchi, Akira] Teikyo Univ, Dept Pediat, Tokyo 173, Japan; [Nakahata, Tatsutoshi] Kyoto Univ, Ctr IPS Cell Res & Applicat, Kyoto, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Dept Hematol Oncol, Gunma, Japan	Hayashi, Y (reprint author), Gunma Childrens Med Ctr, Dept Hematol Oncol, Gunma, Japan.	hayashiy-tky@umin.ac.jp					HASLE H, 1995, LEUKEMIA, V9, P1569; Pinkel D, 1998, BLOOD, V91, P365; Tsurusawa M, 2005, LEUKEMIA RES, V29, P625, DOI 10.1016/j.leukres.2004.11.018; Niemeyer CM, 2011, HEMATOL-AM SOC HEMAT, P84, DOI 10.1182/asheducation-2011.1.84; Hasle H, 2004, LEUKEMIA, V18, P2008, DOI 10.1038/sj.leu.2403489; Barnard DR, 2007, PEDIATR BLOOD CANCER, V49, P17, DOI 10.1002/pbc.20951; PASSMORE SJ, 1995, BLOOD, V85, P1742; Sasaki H, 2001, LEUKEMIA, V15, P1713; Gohring G, 2010, BLOOD, V116, P3766, DOI 10.1182/blood-2010-04-280313; Hasle H, 1999, BRIT J HAEMATOL, V106, P1027, DOI 10.1046/j.1365-2141.1999.01645.x; Greenberg P, 1997, BLOOD, V89, P2079; Yamazaki H, 2013, INT J HEMATOL, V97, P558, DOI 10.1007/s12185-013-1324-x; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Luna-Fineman S, 1999, BLOOD, V93, P459; Arico M, 1997, BLOOD, V90, P479; BaderMeunier B, 1996, BRIT J HAEMATOL, V92, P344; Hasegawa D, 2009, PEDIATR BLOOD CANCER, V53, P1011, DOI 10.1002/pbc.22121; Hasle H, 1992, BRIT J HAEMATOL, V1992, P495; HASLE H, 1995, CANCER GENET CYTOGEN, V79, P79, DOI 10.1016/0165-4608(94)00099-W; Lopes LF, 1999, PEDIATR HEMAT ONCOL, V16, P347, DOI 10.1080/088800199277182; Mandel K, 2002, J PEDIAT HEMATOL ONC, V24, P343, DOI 10.1097/00043426-200206000-00005; Mielot F, 1998, LEUKEMIA LYMPHOMA, V28, P531; Passmore SJ, 2003, BRIT J HAEMATOL, V121, P758, DOI 10.1046/j.1365-2141.2003.04361.x; TUNCER MA, 1992, BRIT J HAEMATOL, V82, P347, DOI 10.1111/j.1365-2141.1992.tb06428.x	24	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					478	484		10.1007/s12185-014-1674-z		7	Hematology	Hematology	AT6XG	WOS:000345079600011		
J	Suzuki, D; Kobayashi, R; Iguchi, A; Sano, H; Kishimoto, K; Yasuda, K; Kobayashi, K				Suzuki, Daisuke; Kobayashi, Ryoji; Iguchi, Akihiro; Sano, Hirozumi; Kishimoto, Kenji; Yasuda, Kazue; Kobayashi, Kunihiko			Tumor lysis syndrome as a risk factor for posterior reversible encephalopathy syndrome in children with hematological malignancies	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Posterior reversible encephalopathy syndrome; Tumor lysis syndrome; Hematological malignancy	ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; LEUKOENCEPHALOPATHY SYNDROME; CHEMOTHERAPY; NEUROTOXICITY; INFILTRATION	Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder characterized by seizures, altered mental status and visual disorders, along with characteristic radiological findings. It is strongly related to hypertension induced by steroids and other immunosuppressive agents. There are an increasing number of reports regarding PRES arising during the course of chemotherapy for hematological malignancies. To clarify the risk factors for this phenomenon, we retrospectively analyzed pediatric patients undergoing treatment for hematological malignancies. Of 161 patients, six patients (3.7 %) developed PRES with characteristic clinical and radiographic findings. Univariate analysis revealed that tumor lysis syndrome (TLS) was a significant risk factor for the onset of PRES. TLS is a significant risk factor for the development of PRES in pediatric patients receiving chemotherapy for hematological malignancies.	[Suzuki, Daisuke; Kobayashi, Ryoji; Sano, Hirozumi; Kishimoto, Kenji; Yasuda, Kazue; Kobayashi, Kunihiko] Sapporo Hokuyu Hosp, Dept Pediat, Shiroishi Ku, Sapporo, Hokkaido 0030006, Japan; [Iguchi, Akihiro] Hokkaido Univ Hosp, Dept Pediat, Sapporo, Hokkaido 0608648, Japan	Suzuki, D (reprint author), Sapporo Hokuyu Hosp, Dept Pediat, Shiroishi Ku, Higashi Sapporo 6-6, Sapporo, Hokkaido 0030006, Japan.	d-suzuki@chashu.org					de Laat P, 2011, ANN ONCOL, V22, P472, DOI 10.1093/annonc/mdq382; Hammerstrom AE, 2013, AM J HEMATOL, V88, P301, DOI 10.1002/ajh.23402; Suminoe A, 2003, J PEDIAT HEMATOL ONC, V25, P236, DOI 10.1097/00043426-200303000-00010; Pavlakis SG, 1997, PEDIATR NEUROL, V16, P145, DOI 10.1016/S0887-8994(96)00292-5; Garg RK, 2001, POSTGRAD MED J, V77, P24, DOI 10.1136/pmj.77.903.24; Wong R, 2003, BRIT J HAEMATOL, V122, P128, DOI 10.1046/j.1365-2141.2003.04447.x; Ito Y, 1998, AM J NEURORADIOL, V19, P415; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Antunes NL, 1999, PEDIATR NEUROL, V20, P241, DOI 10.1016/S0887-8994(98)00148-9; Coiffier B, 2008, J CLIN ONCOL, V26, P2767, DOI 10.1200/JCO.2007.15.0177; Cordelli DM, 2012, PEDIATR BLOOD CANCER, V58, P785, DOI 10.1002/pbc.23344; Tam CS, 2004, AM J HEMATOL, V77, P72, DOI 10.1002/ajh.20147; Lucchini G, 2008, PEDIATR BLOOD CANCER, V51, P629, DOI 10.1002/pbc.21688; Erten N, 2005, INT J CLIN PRACT, V59, P53, DOI 10.1111/j.1368-504X.2005.00049.x; Greenwood MJ, 2003, LEUKEMIA LYMPHOMA, V44, P719, DOI 10.1080/1042819031000060582; Hijiya N, 2005, PEDIATR BLOOD CANCER, V44, P63, DOI 10.1002/pbc.20192; HWANG TL, 1985, NEUROLOGY, V35, P1475; Kaito E, 2005, PEDIATR RADIOL, V35, P722, DOI 10.1007/s00247-005-1434-6; Lewis MB, 1999, BRIT MED J, V319, P54; Olgar S, 2006, J PEDIAT HEMATOL ONC, V28, P579, DOI 10.1097/01.mph.0000212990.64435.b9; Ozkan A, 2006, NEURORADIOLOGY, V48, P887, DOI 10.1007/s00234-006-0142-8; Sanchez-Carpintero R, 2001, PEDIATR NEUROL, V24, P145, DOI 10.1016/S0887-8994(00)00242-3; Shin RK, 2001, NEUROLOGY, V56, P388; Tsukamoto S, 2012, INT J HEMATOL, V95, P204, DOI 10.1007/s12185-011-0982-9; Turkmen Kultigin, 2010, Int J Nephrol Renovasc Dis, V3, P65	25	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					485	489		10.1007/s12185-014-1658-z		5	Hematology	Hematology	AT6XG	WOS:000345079600012		
J	Fujimi, A; Kamihara, Y; Kanisawa, Y; Hashimoto, A; Nakajima, C; Hayasaka, N; Uemura, N; Okuda, T; Minami, S; Iyama, S; Takada, K; Sato, T; Hara, A; Iwata, Y; Furuichi, K; Wada, T; Kato, J				Fujimi, Akihito; Kamihara, Yusuke; Kanisawa, Yuji; Hashimoto, Akari; Nakajima, Chisa; Hayasaka, Naotaka; Uemura, Naoki; Okuda, Toshinori; Minami, Shinya; Iyama, Satoshi; Takada, Koichi; Sato, Tsutomu; Hara, Akinori; Iwata, Yasunori; Furuichi, Kengo; Wada, Takashi; Kato, Junji			Anti-erythropoietin receptor antibody-associated pure red cell aplasia accompanied by Coombs-negative autoimmune hemolytic anemia in a patient with T cell/histiocyte-rich large B cell lymphoma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						T cell/histiocyte-rich large B cell lymphoma; Pure red cell aplasia; Autoimmune hemolytic anemia; Anti-erythropoietin receptor antibody; Rituximab	COLLABORATIVE STUDY-GROUP; NATIONWIDE COHORT; RITUXIMAB; LYMPHOCYTES; DISORDERS; DISEASES; JAPAN	A 79-year-old female diagnosed with T cell/histiocyte-rich large B cell lymphoma in complete remission after six cycles of rituximab-combined chemotherapy developed severe anemia, reticulocytopenia, and bone marrow erythroid hypoplasia. She was diagnosed with pure red cell aplasia (PRCA) accompanied by Coombs-negative autoimmune hemolytic anemia evidenced by a lack of glycophorin-A-positive cells in the bone marrow, haptoglobin under the detection level, and a high titer of RBC-bound IgG. Anti-erythropoietin receptor (EPOR) antibody was detected in the serum, and oligoclonal alpha/beta and gamma/delta T cells were also detected in her peripheral blood by Southern blotting analysis. Parvovirus B19 DNA was not detected by PCR. Although the treatment with rituximab had limited efficacy (specifically, only for hemolysis), subsequent cyclosporine therapy led to prompt recovery of erythropoiesis with the disappearance of anti-EPOR antibody and oligoclonal T cells. This is the first case report of anti-EPOR antibody-associated PRCA in a patient with malignant lymphoma treated successfully with cyclosporine.	[Fujimi, Akihito; Kamihara, Yusuke; Kanisawa, Yuji; Hashimoto, Akari] Oji Gen Hosp, Dept Hematol & Oncol, Tomakomai 0538506, Japan; [Nakajima, Chisa; Hayasaka, Naotaka; Uemura, Naoki; Okuda, Toshinori; Minami, Shinya] Oji Gen Hosp, Dept Gastroenterol, Tomakomai 0538506, Japan; [Iyama, Satoshi; Takada, Koichi; Sato, Tsutomu; Kato, Junji] Sapporo Med Univ, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan; [Hara, Akinori; Iwata, Yasunori; Furuichi, Kengo; Wada, Takashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan	Fujimi, A (reprint author), Oji Gen Hosp, Dept Hematol & Oncol, 3-4-8 Wakakusa Cho, Tomakomai 0538506, Japan.	akihito.fujimi@ojihosp.or.jp					ALTER R, 1990, LEUKEMIA RES, V14, P279, DOI 10.1016/0145-2126(90)90136-W; Kamesaki T, 2009, AM J HEMATOL, V84, P98, DOI 10.1002/ajh.21336; Hara A, 2013, BRIT J HAEMATOL, V160, P244, DOI 10.1111/bjh.12105; Dearden C, 2008, BLOOD, V111, P1820, DOI 10.1182/blood-2007-07-101303; Taylor RP, 2010, SEMIN HEMATOL, V47, P124, DOI 10.1053/j.seminhematol.2010.01.006; Sawada KI, 2007, HAEMATOL-HEMATOL J, V92, P1021, DOI 10.3324/haematol.11192; Hirokawa M, 2009, AM J HEMATOL, V84, P144, DOI 10.1002/ajh.21354; Hauswirth AW, 2007, LEUKEMIA LYMPHOMA, V48, P1139, DOI 10.1080/10428190701385173; Fisch P, 2000, BRIT J HAEMATOL, V111, P1010, DOI 10.1046/j.1365-2141.2000.02429.x; Bennett CM, 2006, PEDIATR BLOOD CANCER, V47, P706, DOI 10.1002/pbc.20974; Cervinek L, 2012, INT J HEMATOL, V96, P594, DOI 10.1007/s12185-012-1206-7; De Wolf-Peeters C., 2008, WHO CLASSIFICATION T, P238; DUHRSEN U, 1987, BRIT J HAEMATOL, V67, P235, DOI 10.1111/j.1365-2141.1987.tb02333.x; GRONBAEK K, 1995, LEUKEMIA LYMPHOMA, V18, P311, DOI 10.3109/10428199509059623; Handgretinger R, 1999, NEW ENGL J MED, V340, P278, DOI 10.1056/NEJM199901283400405; Jourdan E, 2003, LEUKEMIA LYMPHOMA, V44, P889, DOI 10.1080/1042819021000055110; Oyaizu N, 2005, ACTA HAEMATOL-BASEL, V113, P194, DOI 10.1159/000084450	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					490	493		10.1007/s12185-014-1652-5		4	Hematology	Hematology	AT6XG	WOS:000345079600013		
J	Ueda, S; Sakata, N; Muramatsu, H; Sakaguchi, H; Wang, XN; Xu, YY; Kojima, S; Yamaguchi, T; Higa, T; Takemura, T				Ueda, Satoshi; Sakata, Naoki; Muramatsu, Hideki; Sakaguchi, Hirotoshi; Wang, Xinan; Xu, Yinyan; Kojima, Seiji; Yamaguchi, Toshihiro; Higa, Takeshi; Takemura, Tsukasa			Clinical course of juvenile myelomonocytic leukemia in the blast crisis phase treated by acute myeloid leukemia-oriented chemotherapy and allogeneic hematopoietic stem cell transplantation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Juvenile myelomonocytic leukemia; Blast crisis; Hematopoietic stem cell transplantation; Acute erythroid leukemia	PROTEIN-TYROSINE PHOSPHATASES; MYELODYSPLASTIC SYNDROMES; ONCOGENIC KRAS; RAS MUTATIONS; CHILDREN; PTPN11; DISORDERS; PATHWAY; DISEASE; JMML	Juvenile myelomonocytic leukemia (JMML) is a mixed myeloproliferative and myelodysplastic disorder that occurs in early childhood. The clinical course of JMML is highly variable. A third of patients follow a relatively indolent course, although approximately 15 % cases are thought to develop acute myeloid leukemia, referred to as blast crisis. The etiology and clinical characteristics of blast crisis remain unclear. We document the case of a 27-month-old boy who presented with hepatosplenomegaly, skin rash, and lymphadenopathy. An initial diagnosis of acute erythroid leukemia was made according to the French-American-British classification. Following estimation of hypersensitivity to GM-CSF and genetic analysis of PTPN11, he was diagnosed with JMML in the blast crisis phase. Although he had several poor prognostic factors, including monosomy 7 and high HbF percentage, he achieved partial remission after treatment with acute myeloid leukemia-oriented chemotherapy followed by allogeneic hematopoietic stem cell transplantation.	[Ueda, Satoshi; Sakata, Naoki; Takemura, Tsukasa] Kinki Univ, Sch Med, Dept Pediat, Osaka 5898511, Japan; [Muramatsu, Hideki; Sakaguchi, Hirotoshi; Wang, Xinan; Xu, Yinyan; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Yamaguchi, Toshihiro] Kinki Univ, Sch Med, Dept Lab Med, Osaka 589, Japan; [Higa, Takeshi] Univ Ryukyus, Sch Med, Dept Pediat, Nishihara, Okinawa 90301, Japan	Sakata, N (reprint author), Kinki Univ, Sch Med, Dept Pediat, 377-2 Ohno Higashi, Osaka 5898511, Japan.	nsakata@med.kindai.ac.jp	Muramatsu, Hideki/I-3763-2012				Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Niemeyer CM, 2008, BRIT J HAEMATOL, V140, P610, DOI 10.1111/j.1365-2141.2007.06958.x; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Yoshida N, 2009, PEDIATR RES, V65, P334, DOI 10.1203/PDR.0b013e3181961d2a; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Xu D, 2011, J EXP MED, V208, P1977, DOI 10.1084/jem.20110450; Flotho C, 1999, LEUKEMIA, V13, P32, DOI 10.1038/sj.leu.2401240; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; PASSMORE SJ, 1995, BLOOD, V85, P1742; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Matsuda K, 2007, HAEMATOL-HEMATOL J, V92, P1576, DOI 10.3324/haematol.11503; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Sakaguchi H, 2013, NAT GENET, V45, P937, DOI 10.1038/ng.2698; Xu D, 2008, FRONT BIOSCI, V13, P4925, DOI 10.2741/3051; Tsukimoto I, 2009, J CLIN ONCOL, V27, P4007, DOI 10.1200/JCO.2008.18.7948; Kato M, 2013, J PEDIATR-US, V162, P1285, DOI 10.1016/j.jpeds.2013.01.003; EMANUEL PD, 1991, BLOOD, V77, P925; Matsuda K, 2007, BLOOD, V109, P5477, DOI 10.1182/blood-2006-09-046649; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Locatelli F, 2005, BLOOD, V105, P410, DOI 10.1182/blood-2004-05-1944; Luna-Fineman S, 1999, BLOOD, V93, P459; Arico M, 1997, BLOOD, V90, P479; Honda Y, 2014, BRIT J HAEMATOL, V165, P682, DOI 10.1111/bjh.12796; Lauchle JO, 2006, PEDIATR BLOOD CANCER, V46, P579, DOI 10.1002/pbc.20644; MacMillan ML, 1998, BRIT J HAEMATOL, V103, P552; Manabe A, 2002, LEUKEMIA, V16, P645, DOI 10.1038/sj/leu/2402407; Matthes Martin S, 2000, BONE MARROW TRANSPL, V26, P377; Niemeyer CM, 2006, CHILDHOOD LEUKEMIAS, 2ND EDITION, P571; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Yabe M, 2008, PEDIATR TRANSPLANT, V12, P862, DOI 10.1111/j.1399-3046.2008.00931.x	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					502	506		10.1007/s12185-014-1638-3		5	Hematology	Hematology	AT6XG	WOS:000345079600016		
J	Tsujimura, H; Miyaki, T; Yamada, S; Sugawara, T; Ise, M; Iwata, S; Yonemoto, T; Ikebe, D; Itami, M; Kumagai, K				Tsujimura, Hideki; Miyaki, Toshiko; Yamada, Shuhei; Sugawara, Takeaki; Ise, Mikiko; Iwata, Shintaro; Yonemoto, Tsukasa; Ikebe, Dai; Itami, Makiko; Kumagai, Kyoya			Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Histiocytic sarcoma; High-dose chemotherapy; Stem cell transplantation; Consolidation therapy	STEM-CELL TRANSPLANTATION; LYMPHOMA; REGIMEN	Histiocytic sarcoma (HS) is an extremely rare malignant neoplasm that often exhibits an aggressive clinical presentation. In this report, we describe the case of a 38-year-old female with advanced-stage HS who was found to have a subcutaneous tumor in the left calf and enlarged lymph nodes in the left inguinal and internal iliac regions. The subcutaneous tumor and inguinal nodes were resected operatively. Immunohistochemistry of the surgical specimens showed that the malignant cells stained positive for CD163, CD68, and related markers; a diagnosis of HS was established. Following the administration of induction chemotherapy consisting of dose-escalated CHOP plus etoposide, the remaining internal iliac tumors disappeared. At that point, high-dose chemotherapy with autologous stem cell transplantation was performed as consolidation treatment. The patient remains alive with no evidence of disease for 30 months post-treatment. This report provides valuable insight into the treatment of advanced HS.	[Tsujimura, Hideki; Miyaki, Toshiko; Yamada, Shuhei; Sugawara, Takeaki; Ise, Mikiko; Kumagai, Kyoya] Chiba Canc Ctr, Div Hematol Oncol, Chuo Ku, Chiba 2608717, Japan; [Iwata, Shintaro; Yonemoto, Tsukasa] Chiba Canc Ctr, Div Orthoped Surg, Chiba 2608717, Japan; [Ikebe, Dai; Itami, Makiko] Chiba Canc Ctr, Div Surg Pathol, Chiba 2608717, Japan	Tsujimura, H (reprint author), Chiba Canc Ctr, Div Hematol Oncol, Chuo Ku, 666-2 Nitona Cho, Chiba 2608717, Japan.	htsujimu@chiba-cc.jp					Abu-Sanad A, 2012, CURR ONCOL, V19, pE289, DOI 10.3747/co.19.964; Wilson WH, 2002, BLOOD, V99, P2685, DOI 10.1182/blood.V99.8.2685; Gergis U, 2011, J CLIN ONCOL, V29, pE251, DOI 10.1200/JCO.2010.32.6603; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; Pfreundschuh M, 2004, BLOOD, V104, P626, DOI 10.1182/blood-2003-06-2094; Hornick JL, 2004, AM J SURG PATHOL, V28, P1133, DOI 10.1097/01.pas.0000131541.95394.23; Morimoto A, 2013, INT J HEMATOL, V97, P103, DOI 10.1007/s12185-012-1245-0; Abidi MH, 2007, AM J HEMATOL, V82, P932, DOI 10.1002/ajh.20913; Shukla N, 2012, CANCER-AM CANCER SOC, V118, P3719, DOI 10.1002/cncr.26712; Vos JA, 2005, MODERN PATHOL, V18, P693, DOI 10.1038/modpathol.3800346; Grogan TM, 2008, WHO CLASSIFICATION T, P356; Kawabata KC, 2009, INTERNAL MED, V48, P111, DOI 10.2169/internalmedicine.48.1295; Kumagai K, 1999, ANN ONCOL, V10, P163; Mainardi C, 2011, LEUKEMIA LYMPHOMA, V52, P1367, DOI 10.3109/10428194.2011.565840; Takahashi Emiko, 2013, J Clin Exp Hematop, V53, P1; Takasaki H, 2013, CL LYMPH MYELOM LEUK, V13, P404, DOI 10.1016/j.clml.2013.03.003; Tateishi U, 2013, INT J HEMATOL, V98, P398, DOI 10.1007/s12185-013-1444-3; Zeidan A, 2013, LEUKEMIA LYMPHOMA, V54, P655, DOI 10.3109/10428194.2012.717082	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					507	510		10.1007/s12185-014-1630-y		4	Hematology	Hematology	AT6XG	WOS:000345079600017		
J	Oba, U; Koga, Y; Suminoe, A; Hara, T				Oba, Utako; Koga, Yuhki; Suminoe, Aiko; Hara, Toshiro			Donor lymphocyte infusion is an effective therapy for relapsed Hodgkin lymphoma after reduced-intensity allogeneic hematopoietic stem cell transplantation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Hodgkin lymphoma; Transplantation; Donor lymphocyte infusion	ADOLESCENTS; CHILDREN	A 3-year-old boy with Hodgkin lymphoma relapsed only 2 months after completion of first-line therapy. He received reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation (RIC allo-HSCT), but relapsed again. To treat the second relapse, donor lymphocyte infusions were performed four times. He showed no evidence of disease and his quality of life was maintained for 500 days after stem cell transplant. However, his condition worsened and he died 3 years and 3 months after onset. In high-risk patients fully intolerant to myeloablative regimens, RIC allo-HSCT followed by subsequent donor lymphocyte infusions must be considered an effective therapeutic approach.	[Oba, Utako; Koga, Yuhki; Suminoe, Aiko; Hara, Toshiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Higashi Ku, Fukuoka 8128582, Japan	Oba, U (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	utako89@pediatr.med.kyushu-u.ac.jp					Alvarez I, 2006, BIOL BLOOD MARROW TR, V12, P172, DOI 10.1016/j.bbmt.2005.09.009; Peggs KS, 2007, BRIT J HAEMATOL, V139, P70, DOI 10.1111/j.1365-2141.2007.06759.x; Sureda A, 2008, J CLIN ONCOL, V26, P455, DOI 10.1200/JCO.2007.13.2415; Claviez A, 2008, BONE MARROW TRANSPL, V42, pS16, DOI 10.1038/bmt.2008.278; Thomson KJ, 2008, BONE MARROW TRANSPL, V41, P765, DOI 10.1038/sj.bmt.1705977; Corradini P, 2011, BRIT J HAEMATOL, V152, P261, DOI 10.1111/j.1365-2141.2010.08492.x; Huff CA, 2006, BIOL BLOOD MARROW TR, V12, P414, DOI 10.1016/j.bbmt.2005.11.520; Daw S, 2011, BRIT J HAEMATOL, V152, P249, DOI 10.1111/j.1365-2141.2010.08455.x; Eichenauer DA, 2012, INT J HEMATOL, V96, P535, DOI 10.1007/s12185-012-1199-2; Paillard C, 2010, PEDIATR TRANSPLANT, V14, P109, DOI 10.1111/j.1399-3046.2009.01140.x; Porter DL, 2003, BONE MARROW TRANSPL, V31, P739, DOI 10.1038/sj.bmt.1703895	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					511	513		10.1007/s12185-014-1654-3		3	Hematology	Hematology	AT6XG	WOS:000345079600018		
J	Miyamoto, M; Onizuka, M; Machida, S; Toyosaki, M; Amaki, J; Aoyama, Y; Kawai, H; Sato, A; Hayama, N; Ogawa, Y; Kawada, H; Ando, K				Miyamoto, Mitsuki; Onizuka, Makoto; Machida, Shinichiro; Toyosaki, Masako; Amaki, Jun; Aoyama, Yasuyuki; Kawai, Hidetsugu; Sato, Ai; Hayama, Naoki; Ogawa, Yoshiaki; Kawada, Hiroshi; Ando, Kiyoshi			ACE deletion polymorphism is associated with a high risk of non-infectious pulmonary complications after stem cell transplantation (vol 99, pg 175, 2014)	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Correction									[Miyamoto, Mitsuki; Onizuka, Makoto; Machida, Shinichiro; Toyosaki, Masako; Amaki, Jun; Aoyama, Yasuyuki; Kawai, Hidetsugu; Sato, Ai; Ogawa, Yoshiaki; Kawada, Hiroshi; Ando, Kiyoshi] Tokai Univ, Dept Hematol & Oncol, Sch Med, Isehara, Kanagawa 2591143, Japan; [Hayama, Naoki] Tokai Univ, Sch Med, Dept Pulm Med, Tokyo 151, Japan	Onizuka, M (reprint author), Tokai Univ, Dept Hematol & Oncol, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591143, Japan.	moni5@mac.com					Miyamoto M, 2014, INT J HEMATOL, V99, P175, DOI 10.1007/s12185-013-1494-6	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2014	100	5					516	517				2	Hematology	Hematology	AT6XG	WOS:000345079600020		
J	Ohmura, Y; Tanaka, KF; Tsunematsu, T; Yamanaka, A; Yoshioka, M				Ohmura, Yu; Tanaka, Kenji F.; Tsunematsu, Tomomi; Yamanaka, Akihiro; Yoshioka, Mitsuhiro			Optogenetic activation of serotonergic neurons enhances anxiety-like behaviour in mice	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						Anxiety; median raphe nucleus; optogenetics; serotonin (5-HT)	DORSAL RAPHE NUCLEUS; ELEVATED PLUS-MAZE; ASCENDING PROJECTIONS; RAT; INHIBITORS; 8-OH-DPAT; STRESS	Whether increased serotonin (5-HT) release in the forebrain attenuates or enhances anxiety has been controversial for over 25 yr. Although there is considerable indirect evidence, there is no direct evidence that indicates a relationship between acute 5-HT release and anxiety. In particular, there is no known method that can reversibly, selectively, and temporally control serotonergic activity. To address this issue, we generated transgenic animals to manipulate the firing rates of central 5-HT neurons by optogenetic methods. Activation of serotonergic neurons in the median raphe nucleus was correlated to enhanced anxiety-like behaviour in mice, whereas activation of serotonergic neurons in the dorsal raphe nucleus had no effect on anxiety-like behaviour. These results indicate that an acute increase in 5-HT release from the median raphe nucleus enhances anxiety.	[Ohmura, Yu; Yoshioka, Mitsuhiro] Hokkaido Univ, Grad Sch Med, Dept Neuropharmacol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Tanaka, Kenji F.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Tsunematsu, Tomomi; Yamanaka, Akihiro] Nagoya Univ, Res Inst Environm Med RIEM, Dept Neurosci 2, Nagoya, Aichi 4648601, Japan	Ohmura, Y (reprint author), Hokkaido Univ, Grad Sch Med, Dept Neuropharmacol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	yohmura@med.hokudai.ac.jp; yamank@riem.nagoya-u.ac.jp			Research Foundation for Opto-Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23680042]; MEXT [24111551, 25116523, 24650219, 23115103, 23300142]; MEXT;  [12023490]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas to Y.O. [12023490], Research Foundation for Opto-Science and Technology to Y.O., Grant-in-Aid for Young Scientists (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to K.F.T. [23680042], Grant-in-Aid for Scientific Research on Innovative Areas 'Brain Environment' from MEXT to K.F.T. [24111551], Grant-in-Aid for Scientific Research on Innovative Areas 'Micro-endophenotypes' from MEXT to K.F.T. [25116523], Grant-in-Aid for Challenging Exploratory Research from MEXT to K.F.T. [24650219], 'Mesoscopic Neurocircuitry' and 'Comprehensive Brain Science Network' from MEXT to A.Y. [23115103], Grant-in-Aid for Scientific Research (B) from MEXT to A.Y. [23300142], and the Strategic Research Program for Brain Sciences 'Integrated Research on Neuropsychiatric Disorders' from MEXT to M.Y. The authors would like to thank Enago (www.enago.jp) for the English language review.	Ohmura Y, 2010, NEUROPSYCHOPHARMACOL, V35, P1271, DOI 10.1038/npp.2009.229; Liu RJ, 2002, J NEUROSCI, V22, P9453; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Andrade TGCS, 2001, PHARMACOL BIOCHEM BE, V70, P1, DOI 10.1016/S0091-3057(01)00512-3; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Birkett MA, 2011, PHARMACOL BIOCHEM BE, V98, P544, DOI 10.1016/j.pbb.2011.03.006; Potter AS, 2004, PSYCHOPHARMACOLOGY, V176, P182, DOI 10.1007/s00213-004-1874-y; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Challis C, 2013, J NEUROSCI, V33, P13978, DOI 10.1523/JNEUROSCI.2383-13.2013; MAIER SF, 1995, BEHAV NEUROSCI, V109, P404, DOI 10.1037/0735-7044.109.3.404; Ohmura Y, 2005, PSYCHOPHARMACOLOGY, V182, P508, DOI 10.1007/s00213-005-0110-8; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Silva RCB, 2000, PHARMACOL BIOCHEM BE, V65, P209, DOI 10.1016/S0091-3057(99)00193-8; De Almeida RMM, 1998, NEUROSCI BIOBEHAV R, V23, P259; DENBOER JA, 1987, INT CLIN PSYCHOPHARM, V2, P21, DOI 10.1097/00004850-198701000-00002; Fox JH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00169; Harada T, 2008, DEPRESS ANXIETY, V25, P1014, DOI 10.1002/da.20438; Konno K, 2007, BRAIN RES, V1172, P60, DOI 10.1016/j.brainres.2007.05.022; KREISS DS, 1995, J PHARMACOL EXP THER, V274, P866; Setem J, 1999, PHARMACOL BIOCHEM BE, V62, P515, DOI 10.1016/S0091-3057(98)00193-2; Shikanai H, 2012, J NEUROSCI, V32, P14415, DOI 10.1523/JNEUROSCI.5929-11.2012; Zohar J, 2000, Acta Psychiatr Scand Suppl, V403, P39	25	3	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1461-1457	1469-5111		INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	NOV	2014	17	11					1777	1783		10.1017/S1461145714000637		7	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AT5TQ	WOS:000345005400006		
J	Takimoto, T; Kanbayashi, Y; Toyoda, T; Adachi, Y; Furuta, C; Suzuki, K; Miwa, T; Bannai, M				Takimoto, T.; Kanbayashi, Y.; Toyoda, T.; Adachi, Y.; Furuta, C.; Suzuki, K.; Miwa, T.; Bannai, M.			4 beta-Hydroxywithanolide E isolated from Physalis pruinosa calyx decreases inflammatory responses by inhibiting the NF-kappa B signaling in diabetic mouse adipose tissue	INTERNATIONAL JOURNAL OF OBESITY			English	Article						anti-inflammation; adipose tissue; glucose metabolism; withanolide; inflammatory cytokines	DIET-INDUCED OBESITY; INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; WITHAFERIN-A; IKK-BETA; PERUVIANA EXTRACTS; HEPATIC STEATOSIS; AQUEOUS EXTRACT; CANCER CELLS; MICE MODEL	BACKGROUND: Chronic inflammation in adipose tissue together with obesity induces insulin resistance. Inhibitors of chronic inflammation in adipose tissue can be a potent candidate for the treatment of diabetes; however, only a few compounds have been discovered so far. The objective of this study was to find a novel inhibitor that can suppress the inflammatory response in adipose tissue and to elucidate the intracellular signaling mechanisms of the compound. METHODS: To find the active compounds, we established an assay system to evaluate the inhibition of induced MCP-1 production in adipocyte/macrophage coculture in a plant extract library. The active compound was isolated by performing high-performance liquid chromatography (HPLC) and was determined as 4 beta-hydroxywithanolide E (4 beta HWE) by nuclear magnetic resonance (NMR) and mass spectroscopy (MS) spectral analyses. The effect of 4 beta HWE on inflammation in adipose tissue was assessed with adipocyte culture and db/db mice. RESULTS: During the screening process, Physalis pruinosa calyx extract was found to inhibit production of MCP-1 in coculture strongly. 4 beta HWE belongs to the withanolide family of compounds, and it has the strongest MCP-1 production inhibitory effect and lowest toxicity than any other withanolides in coculture. Its anti-inflammatory effect was partially dependent on the attenuation of NF-kappa B signaling in adipocyte. Moreover, in vivo experiments showed that the oral administration of 4 beta HWE to db/db mice resulted in the inhibition of macrophage invasion and cytokine expression in adipose tissue after 2 weeks of treatment; improved the plasma adiponectin, non-esterified fatty acids and MCP-1 concentrations; and increased glucose tolerance after 3 to 4 weeks of treatment. CONCLUSIONS: These results suggest that 4 beta HWE has anti-inflammatory effect via inhibition of NF-kappa B activation in adipocyte. Moreover, the attenuation of inflammation in adipocyte has an effect on the inhibition of macrophage accumulation in obese adipose tissue. Consequently, 4 beta HWE improves impaired glucose tolerance. Thus, 4 beta HWE is a useful natural anti-inflammatory compound to attenuate progression of diabetes and obesity.	[Takimoto, T.; Kanbayashi, Y.; Toyoda, T.; Adachi, Y.; Furuta, C.; Suzuki, K.; Miwa, T.; Bannai, M.] Ajinomoto Co Inc, Inst Innovat, Frontier Res Labs, Kawasaki Ku, Kawasaki, Kanagawa 2108681, Japan	Bannai, M (reprint author), Ajinomoto Co Inc, Inst Innovat, Frontier Res Labs, Kawasaki Ku, 1-1 Suzuki Cho, Kawasaki, Kanagawa 2108681, Japan.	makoto_bannai@ajinomoto.com					Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Toyoda T, 2008, OBESITY, V16, P1199, DOI 10.1038/oby.2008.62; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Maurya R, 2008, BIOORG MED CHEM LETT, V18, P6534, DOI 10.1016/j.bmcl.2008.10.050; Hsieh PW, 2007, J NAT PROD, V70, P747, DOI 10.1021/np0605541; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Weisberg SP, 2008, ENDOCRINOLOGY, V149, P3549, DOI 10.1210/en.2008-0262; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1068/nm1185; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327; Xu AM, 2009, ENDOCRINOLOGY, V150, P625, DOI 10.1210/en.2008-0999; Cordero CP, 2009, FITOTERAPIA, V80, P364, DOI 10.1016/j.fitote.2009.05.011; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI2000319246; Wu SJ, 2004, LIFE SCI, V74, P2061, DOI 10.1016/j.lfs.2003.09.058; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Martinez W, 2010, IMMUNOPHARM IMMUNOT, V32, P63, DOI 10.1080/08923970903143957; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Kuboyama T, 2002, NEUROREPORT, V13, P1715, DOI 10.1097/00001756-200210070-00005; Kizelsztein P, 2009, AM J PHYSIOL-ENDOC M, V296, pE433, DOI 10.1152/ajpendo.90772.2008; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; UEDA A, 1994, J IMMUNOL, V153, P2052; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Arun M, 2007, J ETHNOPHARMACOL, V111, P110, DOI 10.1016/j.jep.2006.10.038; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498; Bastos GNT, 2008, J ETHNOPHARMACOL, V118, P246, DOI 10.1016/j.jep.2008.04.005; BUDHIRAJA RD, 1984, PLANTA MED, V50, P134, DOI 10.1055/s-2007-969651; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Giri S, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-31; GUNASEKERA SP, 1981, PLANTA MED, V43, P389, DOI 10.1055/s-2007-971530; Jacobo-Herrera NJ, 2006, J NAT PROD, V69, P328, DOI 10.1021/np050225t; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kamon J, 2004, BIOCHEM BIOPH RES CO, V323, P242, DOI 10.1016/j.bbrc.2004.08.083; Kang H, 2011, J ETHNOPHARMACOL, V135, P95, DOI 10.1016/j.jep.2011.02.028; Lee CC, 2005, J ETHNOPHARMACOL, V100, P237, DOI 10.1016/j.jep.2005.01.064; Lu M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1036, DOI 10.1152/ajpendo.00668.2009; Nakano D, 2011, J NAT MED-TOKYO, V65, P559, DOI 10.1007/s11418-011-0543-9; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Quispe-Mauricio Angel, 2009, Rev Gastroenterol Peru, V29, P239; SAKURAI K, 1976, CHEM PHARM BULL, V24, P1403; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; VESSAL M, 1995, COMP BIOCHEM PHYS B, V111, P675, DOI 10.1016/0305-0491(95)00004-R; VESSAL M, 1991, J ETHNOPHARMACOL, V34, P69, DOI 10.1016/0378-8741(91)90190-O; Vieira AT, 2005, BRIT J PHARMACOL, V146, P244, DOI 10.1038/sj.bjp.0706321; Yen CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-46	47	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0307-0565	1476-5497		INT J OBESITY	Int. J. Obes.	NOV	2014	38	11					1432	1439		10.1038/ijo.2014.33		8	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	AT8BE	WOS:000345158000008		
J	Yamada, T; Akaishi, R; Oda, Y; Nishida, R; Yamada, T; Ishikawa, S; Morikawa, M; Kojima, T; Minakami, H				Yamada, T.; Akaishi, R.; Oda, Y.; Nishida, R.; Yamada, T.; Ishikawa, S.; Morikawa, M.; Kojima, T.; Minakami, H.			Antenatal fibrinogen concentrations and postpartum haemorrhage	INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA			English	Article						Postpartum haemorrhage; Fibrinogen; Vaginal delivery; Caesarean delivery	BLOOD-LOSS; COAGULATION; MANAGEMENT; SEVERITY	Background: It is unclear whether antenatal fibrinogen concentrations are associated with postpartum haemorrhage. Methods: This retrospective study included 871 women with a singleton pregnancy but no known risk factors for postpartum haemorrhage, in whom fibrinogen concentration was measured within the 21 days before delivery. Correlation between antenatal fibrinogen concentrations and estimated blood loss was analysed. We tested the hypothesis that the risk of postpartum haemorrhage was higher in women with antenatal fibrinogen concentrations of <3.3 g/L. Postpartum haemorrhage was defined as an estimated blood loss >= 700 mL following vaginal delivery and >= 1000 mL following caesarean delivery. Results: In women delivering vaginally (n = 337), estimated blood loss tended to increase with decreasing antenatal fibrinogen concentration (R = -0.107, P = 0.05), median fibrinogen concentration was significantly lower in 69 women with postpartum haemorrhage than in 268 women without postpartum haemorrhage (3.93 vs. 4.18 g/L, P = 0.025), and postpartum haemorrhage occurred significantly more often in women with fibrinogen concentrations <3.3 g/L than in those with concentrations >= 3.3 g/L (38% [11/29] vs. 19% [58/308], P = 0.018). In women undergoing caesarean delivery (n = 534), median fibrinogen concentration did not differ between those who experienced postpartum haemorrhage (n = 128) and those who did not (n = 406) (4.18 g/L vs. 4.07 g/L, P = 0.43). Antenatal fibrinogen concentrations of <3.3 g/L were not associated with higher rates of postpartum haemorrhage (26% [11/43] vs. 24% [117/491], P = 0.80). Conclusions: Antenatal fibrinogen concentration <3.3 g/L may be a risk factor for postpartum haemorrhage among women following vaginal delivery. (C) 2014 Elsevier Ltd. All rights reserved.	[Yamada, T.; Akaishi, R.; Oda, Y.; Nishida, R.; Yamada, T.; Ishikawa, S.; Morikawa, M.; Kojima, T.; Minakami, H.] Hokkaido Univ, Grad Sch Med, Dept Obstet, Sapporo, Hokkaido 0608638, Japan	Yamada, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Obstet, Kita Ku, N14,W6, Sapporo, Hokkaido 0608638, Japan.	yamatakashi@me.com					American College of Obstetricians and Gynecologists, 2006, OBSTET GYNECOL, V108, P1039; Gayat E, 2011, INTENS CARE MED, V37, P1816, DOI 10.1007/s00134-011-2315-0; Charbit B, 2007, J THROMB HAEMOST, V5, P266, DOI 10.1111/j.1538-7836.2007.02297.x; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; de Lloyd L, 2011, INT J OBSTET ANESTH, V20, P135, DOI 10.1016/j.ijoa.2010.12.002; Bolliger D, 2009, BRIT J ANAESTH, V102, P793, DOI 10.1093/bja/aep098; Stainsby D, 2006, BRIT J HAEMATOL, V135, P634; Cortet M, 2012, BRIT J ANAESTH, V108, P984, DOI 10.1093/bja/aes096; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Butwick AJ, 2013, INT J OBSTET ANESTH, V22, P87, DOI 10.1016/j.ijoa.2013.01.002; Simon L, 1997, BRIT J ANAESTH, V78, P678; Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; BONNAR J, 1970, BRIT MED J, V2, P564; HAHN L, 1975, ACTA OBSTET GYN SCAN, V54, P49; Hui Chen, 2012, Arch Gynecol Obstet, V285, P1231, DOI 10.1007/s00404-011-2137-x; Japanese Ministry of Heath Labour and Welfare, CHANG MAT MORT RAT J; Mother's & Children's Health & Welfare Association, 2011, MAT CHILD HLTH STAT; Ohkuchi A, 2003, J PERINAT MED, V31, P209, DOI 10.1515/JPM.2003.028; Peyvandi F, 2012, J THROMB HAEMOST, V10, P1451, DOI 10.1111/j.1538-7836.2012.04755.x; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686	20	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-289X	1532-3374		INT J OBSTET ANESTH	Int. J. Obstet. Anesth.	NOV	2014	23	4					365	370		10.1016/j.ijoa.2014.06.004		6	Anesthesiology; Obstetrics & Gynecology	Anesthesiology; Obstetrics & Gynecology	AT8SW	WOS:000345203200011		
J	Yanamoto, S; Yamada, S; Takahashi, H; Naruse, T; Shigeta, T; Minamikawa, T; Shibuya, Y; Komori, T; Umeda, M				Yanamoto, S.; Yamada, S.; Takahashi, H.; Naruse, T.; Shigeta, T.; Minamikawa, T.; Shibuya, Y.; Komori, T.; Umeda, M.			Benefits of maxillectomy with internal dissection of the masticator space by transmandibular approach in the surgical management of malignant tumours of the upper gingiva and hard palate: a clinical review of 10 cases	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						oral malignant tumour; maxillectomy; masticator space; transmandibular approach	SQUAMOUS-CELL CARCINOMA; ORAL-CAVITY CANCER; MAXILLARY ALVEOLUS; PARAPHARYNGEAL SPACE; RECURRENCE	The aim of this study was to review patients with tumours extending to the posterior portion of the upper gingiva and hard palate, and to evaluate the postoperative outcomes. Ten consecutive patients with tumours in the upper gingiva and hard palate, who underwent maxillectomy with internal dissection of the masticator space by the transmandibular approach, were reviewed retrospectively. Among the 10 patients, the pathological diagnosis was squamous cell carcinoma in seven, adenoid cystic carcinoma in one, malignant melanoma in one, and osteosarcoma in one. Loco-regional control was achieved in eight of nine patients (88.9%). Three patients had residual moderate trismus. Cosmetic issues were not noted in any patient. En bloc resection of the maxilla with the internal portion of the masticator space and neck through the parapharyngeal space by the transmandibular approach is a useful and satisfactory technique for the excision of a tumour with involvement of the posterior portion of the upper gingiva and hard palate.	[Yanamoto, S.; Yamada, S.; Takahashi, H.; Naruse, T.; Umeda, M.] Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Clin Oral Oncol, Nagasaki 852, Japan; [Shigeta, T.; Minamikawa, T.; Shibuya, Y.; Komori, T.] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 657, Japan	Yanamoto, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Clin Oral Oncol, 1-7-1 Sakamoto, Nagasaki 852, Japan.	syana@nagasaki-u.ac.jp					Liao CT, 2006, CANCER, V107, P337, DOI 10.1002/cncr.21984; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Rogers SN, 2009, ORAL ONCOL, V45, P201, DOI 10.1016/j.oraloncology.2008.05.008; Morris LGT, 2011, HEAD NECK-J SCI SPEC, V33, P824, DOI 10.1002/hed.21547; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Mourouzis C, 2010, BRIT J ORAL MAX SURG, V48, P345, DOI 10.1016/j.bjoms.2009.07.012; Chatni SS, 2009, ORAL ONCOL, V45, P720, DOI 10.1016/j.oraloncology.2008.11.005; Beltramini GA, 2012, ORAL ONCOL, V48, P97, DOI 10.1016/j.oraloncology.2011.08.012; Brown JS, 2013, HEAD NECK-J SCI SPEC, V35, P265, DOI 10.1002/hed.22957; Binahmed A, 2008, ORAL SURG ORAL MED O, V105, P750, DOI 10.1016/j.tripleo.2007.09.001; CURTIN HD, 1987, RADIOLOGY, V163, P195; Fernandes T, 2013, Insights Imaging, V4, P605, DOI 10.1007/s13244-013-0266-4; Liao CT, 2013, ANN SURG ONCOL, V20, P257, DOI 10.1245/s10434-012-2580-3; Lin HW, 2009, LARYNGOSCOPE, V119, P312, DOI 10.1002/lary.20054; McMahon JD, 2013, BRIT J ORAL MAX SURG, V51, P389, DOI 10.1016/j.bjoms.2012.09.018; Mehanna P, 2010, BRIT J ORAL MAX SURG, V48, P314, DOI 10.1016/j.bjoms.2009.06.231; Nair S, 2011, J ORAL MAXIL SURG, V69, P2040, DOI 10.1016/j.joms.2010.10.030; Petruzzelli G J, 1994, Oncology (Williston Park), V8, P43; THOMAS F, 1988, INT J RADIAT ONCOL, V15, P1097; Tiwari R M, 2001, Indian J Otolaryngol Head Neck Surg, V53, P187, DOI 10.1007/BF03028550; Umeda M, 2002, J ORAL MAXIL SURG, V60, P408, DOI 10.1053/joms.2002.31253; Umeda M, 2009, INT J ORAL MAX SURG, V38, P1004, DOI 10.1016/j.ijom.2009.04.015; Umeda M, 2004, BR J ORAL MAXILLOFAC, V43, P17; Wang TC, 2010, ORAL SURG ORAL MED O, V110, P11, DOI 10.1016/j.tripleo.2009.11.035; Wei Y, 2007, AM J ROENTGENOL, V189, P488, DOI 10.2214/AJR.07.2212	25	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	NOV	2014	43	11					1319	1325		10.1016/j.ijom.2014.06.006		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AT8TD	WOS:000345203900003		
J	Mochizuki, Y; Omura, K; Harada, H; Marukawa, E; Shimamoto, H; Tomioka, H				Mochizuki, Y.; Omura, K.; Harada, H.; Marukawa, E.; Shimamoto, H.; Tomioka, H.			Functional outcomes and patient satisfaction after vascularized osteocutaneous scapula flap reconstruction of the mandible in patients with benign or cancerous tumours	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						mandibulectomy; scapula bone reconstruction; pre- and postoperative masticatory force; solid food masticatory ability; speech intelligibility; subjective satisfaction	QUALITY-OF-LIFE; MASTICATORY FUNCTION; CLASSIFICATION; RESECTION; SURGERY; DEFECTS	Pre- and postoperative longitudinal assessment of oral functions including masticatory force, masticatory ability with solids, speech intelligibility, and subjective satisfaction was conducted for patients who underwent vascularized osteocutaneous scapula flap reconstruction after mandibulectomy. Postoperative changes in oral function and patient satisfaction were examined in relation to tumour type (i.e., cancerous vs. benign). A change in masticatory force was associated with a reduction in the number of occlusal support zones after surgery and clearly differed by tumour type. Despite all patients showing reduced masticatory force postoperatively, all were satisfied with the improvements in eating and chewing, which were greater in patients with benign tumours than in those with cancerous tumours. Although both groups of patients expressed satisfaction with the aesthetic appearance after surgery, patients with cancerous tumours were more satisfied. However, both groups showed decreased speech intelligibility scores and lower satisfaction with speech after surgery. Preoperative support in the form of reassurance and helping to alleviate anxiety about postoperative appearance would be beneficial for all patients, with additional support provided based on the specific tumour type.	[Mochizuki, Y.; Omura, K.; Harada, H.; Marukawa, E.; Shimamoto, H.; Tomioka, H.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Oral Hlth Sci, Dept Oral Restitut, Tokyo 1138549, Japan	Mochizuki, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	mochizuki.osur@tmd.ac.jp					Goiato MC, 2009, J CRANIOFAC SURG, V20, P2163, DOI 10.1097/SCS.0b013e3181bf014a; JEWER DD, 1989, PLAST RECONSTR SURG, V84, P391, DOI 10.1097/00006534-198909000-00001; Chiapasco M, 2000, CLIN ORAL IMPLAN RES, V11, P66, DOI 10.1034/j.1600-0501.2000.011001066.x; BOYD JB, 1993, PLAST RECONSTR SURG, V92, P1266; KOMISAR A, 1990, LARYNGOSCOPE, V100, P364; Vickery LE, 2003, HEAD NECK-J SCI SPEC, V25, P289, DOI 10.1002/hed.10206; Fujiki M, 2013, J PLAST RECONSTR AES, V66, P372, DOI 10.1016/j.bjps.2012.10.003; Soh CL, 2013, INT J ORAL MAX SURG, V42, P974, DOI 10.1016/j.ijom.2013.03.023; Yoo J, 2013, HEAD NECK-J SCI SPEC, V35, P980, DOI 10.1002/hed.23065; Peled M, 2005, J ORAL MAXIL SURG, V63, P220, DOI 10.1016/j.joms.2004.06.052; Mochizuki Y, 2009, INT J ORAL MAX SURG, V38, P151, DOI 10.1016/j.ijom.2008.11.007; Curtis DA, 1997, HEAD NECK-J SCI SPEC, V19, P287, DOI 10.1002/(SICI)1097-0347(199707)19:4<287::AID-HED7>3.0.CO;2-X; Bianchini EMG, 2006, CRANIO, V24, P197; Furuya G, 1958, NIPPON JIBIINKOKA GA, V61, P1922; Hasan Z, 2013, PLAST RECONSTR SURG, V132, P645, DOI 10.1097/PRS.0b013e31829acf5c; Hirano K, 2002, NIHON HOTETSU SHIKA, V46, P103; Kadota C, 2008, J ORAL REHABIL, V35, P408, DOI 10.1111/j.1365-2842.2007.01814.x; Kamiyama Miho, 2010, J Prosthodont Res, V54, P24, DOI 10.1016/j.jpor.2009.08.001; MARUNICK M, 1992, J PROSTHET DENT, V67, P835, DOI 10.1016/0022-3913(92)90596-3; MARUNICK MT, 1992, J ORAL REHABIL, V19, P289, DOI 10.1111/j.1365-2842.1992.tb01104.x; Nthumba PM, 2013, ANN PLAS SURG, V70, P53, DOI 10.1097/SAP.0b013e318230992e; Pereda JC, 2000, AM J ORTHOD DENTOFAC, V118, P572, DOI 10.1067/mod.2000.110008; Roumanas ED, 2006, J PROSTHET DENT, V96, P289, DOI 10.1016/j.prosdent.2006.08.015; Shukla NK, 2001, J SURG ONCOL, V78, P145, DOI 10.1002/jso.1137; WATSON RM, 1984, J ORAL REHABIL, V11, P201, DOI 10.1111/j.1365-2842.1984.tb00569.x; Yamamoto T, 1972, HOTETSU RINSYOU, V5, P395	26	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	NOV	2014	43	11					1330	1338		10.1016/j.ijom.2014.06.012		9	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AT8TD	WOS:000345203900005		
J	Tomomatsu, N; Uzawa, N; Aragaki, T; Harada, K				Tomomatsu, N.; Uzawa, N.; Aragaki, T.; Harada, K.			Aperture width of the osteomeatal complex as a predictor of successful treatment of odontogenic maxillary sinusitis	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						odontogenic maxillary sinusitis; osteomeatal complex; aperture width of the osteomeatal complex; coronal CT image	CALDWELL-LUC OPERATION; ANATOMIC VARIATIONS; RHINOSINUSITIS; SURGERY; DISEASE; ORIGIN	Odontogenic maxillary sinusitis (OMS) is an inflammatory disease caused by the spread of dental inflammation into the sinus. The long-term administration of antibiotic medicine and/or treatment of the causative tooth are the usual initial treatments. These initial treatments are not always effective, and the reason is not well understood. The purpose of this study was to identify factors of significance that may contribute to the results of the initial treatment of OMS. Thirty-nine patients were studied, divided into two groups according to the results of initial treatment: effective or non-effective. The effective group comprised 20 patients who were cured by initial treatment. The non-effective group comprised 19 patients who required an additional operation. The duration of symptoms, spread into the other sinuses, aperture width of the osteomeatal complex (OMC) on the side of the maxillary sinus, and anatomical variations in the sinuses were compared between the groups. The only significant difference found was in the aperture width of the OMC, which was significantly narrower in the non-effective group than in the effective group. The aperture width of the OMC may be a significant predictor of the effectiveness of initial treatment of OMS.	[Tomomatsu, N.; Uzawa, N.; Aragaki, T.; Harada, K.] Tokyo Med & Dent Univ, Dept Maxillofacial Surg, Tokyo 1138549, Japan; [Aragaki, T.] Tokyo Med & Dent Univ, Dept Oral & Maxillofacial Radiol, Tokyo 1138549, Japan	Uzawa, N (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	n-uzawa.mfs@tmd.ac.jp					Anon JB, 1996, ANATOMY PARANASAL SI, P18; Nair UP, 2010, ORAL SURG ORAL MED O, V110, pE53, DOI 10.1016/j.tripleo.2010.06.020; Mehra P, 2009, CURR ALLERGY ASTHM R, V9, P238, DOI 10.1007/s11882-009-0035-0; Mehra P, 2004, OTOLARYNG CLIN N AM, V37, P347, DOI 10.1016/S0030-6665(03)00171-3; Cymerman JJ, 2011, J ENDODONT, V37, P1465, DOI 10.1016/j.joen.2011.06.015; ZWEIG MH, 1993, CLIN CHEM, V39, P561; Scadding GK, 2008, CLIN EXP ALLERGY, V38, P260, DOI 10.1111/j.1365-2222.2007.02889.x; Fadda GL, 2012, ACTA OTORHINOLARYNGO, V32, P244; Bell GW, 2011, BRIT DENT J, V210, P113, DOI 10.1038/sj.bdj.2011.47; Chiapasco M, 2013, CLIN ORAL IMPLAN RES, V24, P623, DOI 10.1111/j.1600-0501.2012.02440.x; Pruna X, 2003, EUR RADIOL, V13, P1461, DOI 10.1007/s00330-002-1644-3; Kretzschmar DP, 2003, ORAL SURG ORAL MED O, V96, P128, DOI 10.1016/S1079-2104(03)00306-8; Costa M, 2007, J ORAL MAXILLOFAC SU, V65, P223; Huang YC, 2011, J ORAL MAXILLOFAC SU, V70, P2080; Ikeda K, 1996, TOHOKU J EXP MED, V180, P27, DOI 10.1620/tjem.180.27; Iwabuchi H, 1999, J JPN STOMATOL SOC, V50, P371; Iwatsubo T, 2000, JIBIRINSHO, V93, P923; Kato M, 2007, DENT RADIOL, V47, P47; Kurabayashi T, 1995, ORAL RADIOL, V11, P71; MELONI F, 1992, SURG RADIOL ANAT, V14, P65, DOI 10.1007/BF01628046; Montani M, 1996, EUR RADIOL, V6, P920; NarkioMakela M, 1997, ACTA OTO-LARYNGOL, P177	22	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	NOV	2014	43	11					1386	1390		10.1016/j.ijom.2014.06.007		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AT8TD	WOS:000345203900013		
J	Kimoto, S; Kimoto, K; Murakami, H; Atsuko, G; Ogawa, A; Kawai, Y				Kimoto, Suguru; Kimoto, Katsuhiko; Murakami, Hiroshi; Atsuko, Gunji; Ogawa, Akina; Kawai, Yasuhiko			Effect of an Acrylic Resin-Based Resilient Liner Applied to Mandibular Complete Dentures on Satisfaction Ratings Among Edentulous Patients	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article							RANDOMIZED CONTROLLED-TRIAL; REMOVABLE PARTIAL DENTURES; FINITE-ELEMENT-ANALYSIS; QUALITY-OF-LIFE; MASTICATORY FUNCTION; CHEWING ABILITY; WEARERS	Purpose: The aim of this study was to investigate whether an acrylic resin based resilient liner (ARL) could improve the satisfaction ratings of complete denture wearers. The null hypothesis was that no difference exists between the satisfaction ratings of conventional acrylic resin denture (CARD) wearers and those of ARL denture (ARLD) wearers. Materials and Methods: From April 2004 to July 2006, a randomized controlled trial was conducted at two centers, including 74 edentulous patients. Of these, 37 patients were each randomly allocated to the ARLD and CARD groups. All of the patients rated their satisfaction with dentures, including general satisfaction and satisfaction with chewing ability, speaking, cleaning, stability, retention, comfort, and esthetics. These satisfaction ratings were measured by a 100-mm visual analog scale. Perceived chewing ability of different foods, divided into five grades, was measured using a questionnaire. The mastication index (Ml) was calculated for each grade. Results: General satisfaction, satisfaction with chewing, and satisfaction with speaking were significantly higher in the ARLD than in the CARD group (P = .049, .025, and .049, respectively). The chewing satisfaction with maxillary dentures in the ARLD group was significantly higher than that of the CARD group (P = .02). No significant difference existed between the Ml of the ARLD (69.2 +/- 17.0) and CARD groups (66.7 +/- 18.7). Conclusions: Within its limitations, this study showed that the ARL improves a complete denture wearer's satisfaction ratings.	[Kimoto, Suguru; Atsuko, Gunji; Ogawa, Akina; Kawai, Yasuhiko] Nihon Univ, Sch Dent Matsudo, Dept Removable Prosthodont, Matsudo, Chiba 2718587, Japan; [Kimoto, Katsuhiko] Kanagawa Dent Coll, Div Fixed Prosthodont, Dept Oral & Maxillofacial Rehabil, Yokosuka, Kanagawa 238, Japan; [Murakami, Hiroshi] Nihon Univ, Sch Dent Matsudo, Dept Oral & Maxillofacial Implantol, Matsudo, Chiba 2718587, Japan; Nihon Univ, Grad Sch Dent Matsudo, Matsudo, Chiba 2718587, Japan	Kimoto, S (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Removable Prosthodont, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	kimoto.suguru@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [C19592262]	This study has been conducted in accordance with the Declaration of Helsinki. Each subject received oral and written information regarding the study and provided informed consent. The study protocol was reviewed and approved by the Human Ethics Committees of Nihon University School of Dentistry at Matsudo (EC 02-036) and Kanagawa Dental College (no. 19). This study was supported by a Grant-in-Aid for Scientific Research (C19592262) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors reported no conflicts of interest related to this study.	Taguchi N, 2001, J ORAL REHABIL, V28, P1003, DOI 10.1046/j.1365-2842.2001.00770.x; Fueki K, 2011, J ORAL REHABIL, V38, P86, DOI 10.1111/j.1365-2842.2010.02134.x; Kimoto S, 2007, J ORAL REHABIL, V34, P862, DOI 10.1111/j.1365-2842.2007.01728.x; Kimoto S, 2006, INT J PROSTHODONT, V19, P593; Shim JS, 2000, INT J PROSTHODONT, V13, P19; Kimoto S, 2010, J ORAL REHABIL, V37, P553, DOI 10.1111/j.1365-2842.2010.02070.x; Murata H, 2002, J DENT RES, V81, P123; BUDTZJORGENSEN E, 1979, J PROSTHET DENT, V42, P619, DOI 10.1016/0022-3913(79)90190-2; Douglass CW, 2002, J PROSTHET DENT, V87, P9, DOI 10.1067/mpr.2002.121204; Attard NJ, 2004, INT J PROSTHODONT, V17, P425; Endo Y, 1991, J JPN PROSTHODONT SO, V35, P316; Feine J S, 2002, Int J Oral Maxillofac Implants, V17, P601; Gunji Atsuko, 2009, J Prosthodont Res, V53, P180, DOI 10.1016/j.jpor.2009.06.001; Heydecke G, 2005, J DENT, V33, P649, DOI 10.1016/j.jdent.2005.01.003; Hirai T, 1994, Int J Prosthodont, V7, P454; Kimoto S, 2010, INT J PROSTHODONT, V23, P110; Mante Francis K, 2008, J Prosthodont, V17, P384, DOI 10.1111/j.1532-849X.2008.00303.x; McGarry T J, 1999, J Prosthodont, V8, P27, DOI 10.1111/j.1532-849X.1999.tb00005.x; Satoh Y, 2000, J ORAL REHABIL, V27, P660, DOI 10.1046/j.1365-2842.2000.00566.x; Yamaga E, 2013, J DENT, V41, P710, DOI 10.1016/j.jdent.2013.05.015	20	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174	1942-4426		INT J PROSTHODONT	Int. J. Prosthodont.	NOV-DEC	2014	27	6					561	566				6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT6OW	WOS:000345059600010		
J	Hiraguchi, H; Kaketani, M; Hirose, H; Kikuchi, H; Yoneyama, T				Hiraguchi, Hisako; Kaketani, Masahiro; Hirose, Hideharu; Kikuchi, Hisaji; Yoneyama, Takayuki			Surface Porosity of Stone Casts Resulting from Immersion of Addition Silicone Rubber Impressions in Disinfectant Solutions	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article								This study investigated the effects of immersion of addition silicone rubber impressions in disinfectant solutions on the surface porosity of the resulting stone casts. Five brands of type 2 and 3 addition silicone rubber impression materials and one brand of type 4 dental stone were used. Impressions of a master die designed to simulate an abutment tooth were immersed in disinfectant for 30 minutes. The disinfectants used were 2% glutaraldehyde solution and 0.55% ortho-phthalaldehyde solution. The surface porosities of stone casts obtained from two brands of impression materials immersed in disinfectant for 30 minutes were determined. Results suggest that impression materials immersed in disinfectant solutions need sufficient time before pouring into dental stone.	[Hiraguchi, Hisako; Kaketani, Masahiro; Hirose, Hideharu; Kikuchi, Hisaji; Yoneyama, Takayuki] Nihon Univ, Sch Dent, Dept Dent Mat, Tokyo 1018310, Japan	Hiraguchi, H (reprint author), Nihon Univ, Sch Dent, Dept Dent Mat, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	hiraguchi.hisako@nihon-u.ac.jp			Dental Research Center, Nihon University School of Dentistry, Tokyo, Japan	This study was supported in part by grants from the Dental Research Center, Nihon University School of Dentistry, Tokyo, Japan. The authors reported no conflicts of interest related to this study.	Anusavice KJ, 2013, PHILLIPS SCI DENT MA, p[154, 166]; Bonsor SJ, 2013, CLIN GUIDE APPL DENT, P254; MCCROSSON J, 1987, J DENT, V15, P129, DOI 10.1016/0300-5712(87)90069-8; Okuda N, 1990, Shikwa Gakuho, V90, P225; Rutala WA, 2008, GUIDELINE DISINFECTI, p[20, 88, 104]	5	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174	1942-4426		INT J PROSTHODONT	Int. J. Prosthodont.	NOV-DEC	2014	27	6					567	569				3	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT6OW	WOS:000345059600011		
J	Chuapon, N; Naithanom, O; Sato, Y; Areerat, S; Ito, H				Chuapon, N.; Naithanom, O.; Sato, Y.; Areerat, S.; Ito, H.			Thermal Properties and Morphology Characteristics of a PP Mono-Filament and its Foam	INTERNATIONAL POLYMER PROCESSING			English	Article							FLOW-INDUCED CRYSTALLIZATION; ISOTACTIC POLYPROPYLENE; MELTING BEHAVIOR; SUPERCRITICAL CO2; NUCLEATING-AGENTS; SODIUM BENZOATE; COMPRESSED CO2; CARBON-DIOXIDE; BUBBLE-SIZE; SIMULATION	The polypropylene (PP) mono-filament is an alternative material that can be used for insulation, packaging, and polymer composite applications. In this study, PP mono-filaments were prepared by extrusion free-fall at temperatures of 190, 200, and 210 degrees C through a micro extrusion die with a diameter of 900 mu m. The free-fall speeds of the filament were controlled by a gear pump driving at speeds ranging from 12.5 to 20.0 min(-1), and the extrudates were cooled at room temperature. The PP mono-filaments were subsequently foamed by a batch foaming process with sc-CO2 as the blowing agent at foaming temperatures of 165, 170, 175 and 180 degrees C. The thermal properties and crystallinity of the prepared filaments and their foams were investigated using a DSC. The foam morphology and isotropic foam properties were characterized by SEM micrographs. The results show that the various morphologies of the PP mono-filament foams deviated from the isotropic foam behavior and had isotropic foam index values in the range of 1.1 to 2.3. In addition, the PP mono-filament that was foamed at 175 degrees C expanded in the longitudinal direction and exhibited the highest expansion ratio, but its degree of crystallinity decreased compared to the mono-filaments. PP mono-filament foam represented a narrow crystallization temperature range and crystallization time than mono-filament and tended to a faster crystalline growth.	[Chuapon, N.; Naithanom, O.; Areerat, S.] King Mongkuts Inst Technol Ladkrabang, Fac Engn, Sch Chem Engn, Bangkok 10520, Thailand; [Sato, Y.; Ito, H.] Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Yamagata 990, Japan	Areerat, S (reprint author), King Mongkuts Inst Technol Ladkrabang, Fac Engn, Sch Chem Engn, Bangkok 10520, Thailand.	kasurat@kmitl.ac.th			Japan Society for the Promotion of Science (JSPS)	The first author is grateful to the Japan Society for the Promotion of Science (JSPS) for financial support as a visiting fellow at Yamagata University.	Afshari M, 2005, IRAN POLYM J, V14, P1042; Takada M, 2001, POLYM ENG SCI, V41, P1938, DOI 10.1002/pen.10890; Zhai WT, 2009, INT J MOL SCI, V10, P5381, DOI 10.3390/ijms10125381; Taki K, 2008, CHEM ENG SCI, V63, P3643, DOI 10.1016/j.ces.2008.04.037; Zhai W, 2008, POLYMER, V49, P3146, DOI 10.1016/j.polymer.2008.05.018; Cho KW, 1999, POLYMER, V40, P1719, DOI 10.1016/S0032-3861(98)00404-2; Naguib HE, 2005, IND ENG CHEM RES, V44, P6685, DOI 10.1021/ie0489608; Xu ZM, 2007, J SUPERCRIT FLUID, V41, P299, DOI 10.1016/j.supflu.2006.09.007; Tsivintzelis I, 2007, POLYMER, V48, P5928, DOI 10.1016/j.polymer.2007.08.004; Shafi MA, 1997, CHEM ENG SCI, V52, P635, DOI 10.1016/S0009-2509(96)00433-2; Doufas AK, 2000, J NON-NEWTON FLUID, V92, P27, DOI 10.1016/S0377-0257(00)00088-4; Tomasko DL, 2003, IND ENG CHEM RES, V42, P6431, DOI 10.1021/ie030199z; Xin CL, 2011, J APPL POLYM SCI, V119, P1275, DOI 10.1002/app.30717; Jang GS, 2001, J POLYM SCI POL PHYS, V39, P1001, DOI 10.1002/polb.1077; Liao X, 2010, POLYM INT, V59, P1709, DOI 10.1002/pi.2910; Doufas AK, 2000, J NON-NEWTON FLUID, V92, P81, DOI 10.1016/S0377-0257(00)00089-6; Jiang XL, 2007, EXPRESS POLYM LETT, V1, P245, DOI 10.3144/expresspolymlett.2007.37; Varma-Nair M, 2003, THERMOCHIM ACTA, V396, P57, DOI 10.1016/S0040-6031(02)00516-6; Avalos F, 1996, POLYMER, V37, P5681, DOI 10.1016/S0032-3861(96)00429-6; Coccorullo I, 2003, POLYMER, V44, P307, DOI 10.1016/S0032-3861(02)00762-0; Shafi MA, 1996, POLYM ENG SCI, V36, P1950, DOI 10.1002/pen.10591; Jiang XL, 2009, J SUPERCRIT FLUID, V48, P167, DOI 10.1016/j.supflu.2008.10.006; Jang GS, 2002, J APPL POLYM SCI, V83, P201, DOI 10.1002/app.10068; Kong Y, 2002, POLYMER, V43, P3873, DOI 10.1016/S0032-3861(02)00235-5; Doroudiani S, 1996, POLYM ENG SCI, V36, P2645, DOI 10.1002/pen.10664; Bogoeva-Gaceva G, 2006, J SERB CHEM SOC, V71, P483, DOI 10.2298/JSC0605483B; Buahom P, 2011, J CELL PLAST, V47, P133, DOI 10.1177/0021955X10393182; Doroudiani S, 2003, J APPL POLYM SCI, V90, P1412, DOI 10.1002/app.12804; Gatos KG, 2007, MACROMOLECULES, V40, P786, DOI 10.1021/ma0623284; Jeon YP, 2009, J ENG FIBER FABR, V4, P34; Jeon YP, 2008, J APPL POLYM SCI, V110, P2153, DOI 10.1002/app.28827; Karger-Kocsis J., 1995, POLYPROPYLENE STRUCT, V2; Kemmere M. F., 2005, SUPERCRITICAL CARBON, DOI [10.1002/3527606726, DOI 10.1002/3527606726]; Liu T, 2010, PARTICUOLOGY, V8, P607, DOI 10.1016/j.partic.2010.09.008; Nemoto T, 2008, MACROMOL MATER ENG, V293, P574, DOI 10.1002/mame.200800015; Niu P.-F., 2011, J COMPOS MATER, V46, P203; Oh TH, 2006, J APPL POLYM SCI, V102, P1045, DOI 10.1002/app.24197; Seo Y, 2007, POLYMER, V48, P3844, DOI 10.1016/j.polymer.2007.04.024; Sharudin RWB, 2011, MACROMOL MATER ENG, V296, P1046, DOI 10.1002/mame.201100085; Supaphol P, 2004, MACROMOL MATER ENG, V289, P818, DOI 10.1002/mame.200400102	40	0	0	CARL HANSER VERLAG	MUNICH	KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY	0930-777X			INT POLYM PROC	Int. Polym. Process.	NOV	2014	29	5					579	587		10.3139/217.2920		9	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	AT7NQ	WOS:000345124900004		
J	Mawatari, K; Kitamori, T				Mawatari, Kazuma; Kitamori, Takehiko			Special Issue: Nanofluidic Systems	ISRAEL JOURNAL OF CHEMISTRY			English	Editorial Material									[Mawatari, Kazuma; Kitamori, Takehiko] Univ Tokyo, Tokyo 1138654, Japan	Mawatari, K (reprint author), Univ Tokyo, Tokyo 1138654, Japan.							0	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0021-2148	1869-5868		ISR J CHEM	Isr. J. Chem.	NOV	2014	54	11-12			SI		1508	1508		10.1002/ijch.201410014		1	Chemistry, Multidisciplinary	Chemistry	AT5XJ	WOS:000345012900001		
J	Hwang, J; Daiguji, H				Hwang, Junho; Daiguji, Hirofumi			Ion Transport in Sub-10 nm Nanofluidic Channels: Synthesis, Measurement, and Modeling	ISRAEL JOURNAL OF CHEMISTRY			English	Review						ion transport; nanostructures; nanotechnology; synthesis design; thin films	MESOPOROUS SILICA FILMS; SOLID-STATE NANOPORES; SBA-16 THIN-FILMS; ENERGY-CONVERSION; PROTON TRANSPORT; CUBIC STRUCTURES; NANOCHANNELS; MOLECULES; FIELD; RECTIFICATION	Recent advances in nanofabrication, measurement, and analysis techniques of nanofluidic systems have allowed ion transport to be systematically explored in narrow, confined channels with dimensions of less than about 10nm. In such small dimensions, anomalous ion transport can be observed. This review describes several unique ion-transport phenomena recently reported in sub-10nm fluidic channels and provides an introduction to recently developed nanofabrication techniques to create sub-10nm nanochannels by both top-down and bottom-up approaches.	[Hwang, Junho; Daiguji, Hirofumi] Univ Tokyo, Grad Sch Engn, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan	Hwang, J (reprint author), Univ Tokyo, Grad Sch Engn, Dept Mech Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	hwang@thml.t.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [23360092]	This work was supported by a Grant-in-Aid for Scientific Research (B) (no. 23360092) from the Japan Society for the Promotion of Science (JSPS).	Bocquet L, 2010, CHEM SOC REV, V39, P1073, DOI 10.1039/b909366b; Abgrall P, 2008, ANAL CHEM, V80, P2326, DOI 10.1021/ac702296u; Wu CW, 2007, ANGEW CHEM INT EDIT, V46, P5364, DOI 10.1002/anie.200700689; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; Yamauchi Y, 2005, J MATER CHEM, V15, P1137, DOI 10.1039/b418478e; Kovarik ML, 2009, J PHYS CHEM B, V113, P15960, DOI 10.1021/jp9076189; AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Sparreboom W, 2009, NAT NANOTECHNOL, V4, P713, DOI [10.1038/nnano.2009.332, 10.1038/NNANO.2009.332]; Karnik R, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2186967; HIEMSTRA T, 1989, J COLLOID INTERF SCI, V133, P105, DOI 10.1016/0021-9797(89)90285-3; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Siwy ZS, 2006, ADV FUNCT MATER, V16, P735, DOI 10.1002/adfm.200500471; Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988; Moyen E, 2012, ADV MATER, V24, P5094, DOI 10.1002/adma.201200648; Menard LD, 2011, NANO LETT, V11, P512, DOI 10.1021/nl103369g; Nam SW, 2009, NANO LETT, V9, P2044, DOI 10.1021/nl900309s; Karnik R, 2007, NANO LETT, V7, P547, DOI 10.1021/nl062806o; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Nam SW, 2010, NANO LETT, V10, P3324, DOI 10.1021/nl100999e; Karnik R, 2005, NANO LETT, V5, P943, DOI 10.1021/nl050493b; Schoch RB, 2008, REV MOD PHYS, V80, P839, DOI 10.1103/RevModPhys.80.839; Daiguji H, 2004, NANO LETT, V4, P137, DOI 10.1021/nl0348185; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; Fan R, 2008, NAT MATER, V7, P303, DOI 10.1038/nmat2127; Faustini M, 2010, J PHYS CHEM C, V114, P7637, DOI 10.1021/jp9114755; Duan CH, 2010, NAT NANOTECHNOL, V5, P848, DOI [10.1038/nnano.2010.233, 10.1038/NNANO.2010.233]; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; van der Heyden FHJ, 2006, NANO LETT, V6, P2232, DOI 10.1021/nl061524l; Daiguji H, 2012, LANGMUIR, V28, P3671, DOI 10.1021/la204477h; Peter C, 2005, BIOPHYS J, V89, P2222, DOI 10.1529/biophysj.105.065946; Daiguji H, 2010, CHEM SOC REV, V39, P901, DOI 10.1039/b820556f; Kim SJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.044501; Leng YS, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2172589; Chang H, 2004, NANO LETT, V4, P1551, DOI 10.1021/nl049267c; Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i; Kalman EB, 2009, ANAL BIOANAL CHEM, V394, P413, DOI 10.1007/s00216-008-2545-3; Vlassiouk I, 2007, NANO LETT, V7, P552, DOI 10.1021/nl062924b; Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9; YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P988, DOI 10.1246/bcsj.63.988; DU Q, 1994, PHYS REV LETT, V72, P238, DOI 10.1103/PhysRevLett.72.238; Cervera J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2179797; Daiguji H, 2004, NANO LETT, V4, P2315, DOI 10.1021/nl0489945; Cao H, 2002, APPL PHYS LETT, V81, P174, DOI 10.1063/1.1489102; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Hwang J, 2013, LANGMUIR, V29, P2406, DOI 10.1021/la304423p; Baldessari F, 2008, J COLLOID INTERF SCI, V325, P526, DOI 10.1016/j.jcis.2008.06.007; Mijatovic D, 2005, LAB CHIP, V5, P492, DOI 10.1039/b416951d; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Chang B., 2004, ADV MATER, V16, P1657; COOPER K, 1985, PROG BIOPHYS MOL BIO, V46, P51, DOI 10.1016/0079-6107(85)90012-4; Duan CH, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4794973; Goldberger J, 2006, ACCOUNTS CHEM RES, V39, P239, DOI 10.1021/ar040274h; Hille B, 2001, ION CHANNELS EXCITAB; Holt K., 2006, SCIENCE, V312, P1034; Iler R.K., 1979, CHEM SILICA; Israelachvili J. N., 1992, INTERMOLECULAR SURFA; Kovarik ML, 2009, ANAL CHEM, V81, P7133, DOI 10.1021/ac900614k; Mao P, 2005, LAB CHIP, V5, P837, DOI 10.1039/b502809d; MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466; Perry J., 2005, MICROFLUID NANOFLUID, V2, P185; Skoulidas AI, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.185901; Sparreboom W, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/1/015004; van der Heyden FHJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.224502; Xia QF, 2008, NANO LETT, V8, P3830, DOI 10.1021/nl802219b	64	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0021-2148	1869-5868		ISR J CHEM	Isr. J. Chem.	NOV	2014	54	11-12			SI		1509	1518		10.1002/ijch.201400088		10	Chemistry, Multidisciplinary	Chemistry	AT5XJ	WOS:000345012900002		
J	Yasui, T; Rahong, S; Kaji, N; Baba, Y				Yasui, Takao; Rahong, Sakon; Kaji, Noritada; Baba, Yoshinobu			Nanopillar, Nanowall, and Nanowire Devices for Fast Separation of Biomolecules	ISRAEL JOURNAL OF CHEMISTRY			English	Review						DNA; electrophoresis; nanostructures; nanotechnology; separation of biomolecules	LONG DNA-MOLECULES; ARRAY; ELECTROPHORESIS; CHIPS; FLOW; FRACTIONATION; GROWTH; FIELD	Nanostructures based on nanotechnologies have opened up a novel research field for the fast analysis of biomolecules with ultrahigh resolution, including the analysis of single biomolecules. Nanostructures for electrophoretic separation, especially, are an exciting topic among researchers in many areas, and their designs are widely expected to contribute to the goal of developing a single separation tool for a wide range of biomolecules. In this review, nanopillar, nanowall, and nanowire devices are introduced for fast separation of DNA molecules and protein samples, and the numerous advantages of these devices are described. This review also outlines the fabrication processes for nanostructures, including top-down and bottom-up nanofabrication approaches. Besides describing the fast separation of biomolecules, the electroosmotic flow (EOF) suppression effect, and its related online concentration technique in nanopillar devices, is reviewed. The nanowall devices have the unique feature that longer DNA molecules migrate faster than shorter ones, and that is completely different from the separation behavior of DNA molecules based on nanopillar devices. The feasibility is shown for self-assembly of the nanowire structure embedded in a microchannel on a fused silica substrate, as a means to separate DNA molecules. Applications of a newly-fabricated 3D network structure with spatial density control for the fast separation of a wide range of DNA molecules are also given.	[Yasui, Takao; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yasui, Takao; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, FIRST Res Ctr Innovat Nanobiodevices, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yasui, Takao; Rahong, Sakon; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan	Yasui, T (reprint author), Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	yasui@apchem.nagoya-u.ac.jp; babaymtt@apchem.nagoya-u.ac.jp			Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS); JSPS [24241050, 25790028]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	The authors' research on nanostructures was supported by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), the JSPS Grant-in-Aid for Scientific Research (A) 24241050, the JSPS Grant-in-Aid for Young Scientists (B) 25790028, and the Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Huang LR, 2002, NAT BIOTECHNOL, V20, P1048, DOI 10.1038/nbt733; Klamchuen A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3474605; Klamchuen A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3186080; Yasui T, 2013, MICROFLUID NANOFLUID, V14, P961, DOI 10.1007/s10404-012-1103-7; Wang D, 2004, NANO LETT, V4, P871, DOI 10.1021/nl049728u; Kaji N, 2004, ANAL CHEM, V76, P15, DOI 10.1021/ac030303m; Zeng Y, 2007, ANAL CHEM, V79, P2289, DOI 10.1021/ac061931h; Schoch RB, 2008, REV MOD PHYS, V80, P839, DOI 10.1103/RevModPhys.80.839; Dorfman KD, 2010, REV MOD PHYS, V82, P2903, DOI 10.1103/RevModPhys.82.2903; Wu YY, 2001, J AM CHEM SOC, V123, P3165, DOI 10.1021/ja0059084; Suzuki M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061606; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Han J, 2000, SCIENCE, V288, P1026, DOI 10.1126/science.288.5468.1026; Fu JP, 2007, NAT NANOTECHNOL, V2, P121, DOI 10.1038/nnano.2006.206; Yasui T, 2013, ACS NANO, V7, P3029, DOI 10.1021/nn4002424; Yasui T, 2011, ANAL CHEM, V83, P6635, DOI 10.1021/ac201184t; Araki N, 2010, ELECTROPHORESIS, V31, P3675, DOI 10.1002/elps.201000331; Chinzei Y, 1998, J VAC SCI TECHNOL A, V16, P1519, DOI 10.1116/1.581180; Kaji N, 2010, CHEM SOC REV, V39, P948, DOI 10.1039/b900410f; Kaji N, 2007, ISR J CHEM, V47, P161, DOI 10.1560/IJC.47.2.161; Klamchuen A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3549703; Klamchuen A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3660246; Landers J. P., 2008, HDB CAPILLARY ELECTR; Nazemifard N, 2010, ANGEW CHEM INT EDIT, V49, P3326, DOI 10.1002/anie.200906343; Ogawa R, 2007, JPN J APPL PHYS 1, V46, P2771, DOI 10.1143/JJAP.46.2771; Park SG, 2012, LAB CHIP, V12, P1463, DOI 10.1039/c2lc00016d; Rahong S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05252; Rickwood D, 1990, GEL ELECTROPHORESIS; Salieb-Beugelaar GB, 2009, LAB CHIP, V9, P2508, DOI 10.1039/b905448k; Tabuchi M, 2004, NAT BIOTECHNOL, V22, P337, DOI 10.1038/nbt939; Viovy JL, 2000, REV MOD PHYS, V72, P813, DOI 10.1103/RevModPhys.72.813; Volkmuth D., 1992, NATURE, V358, P600; Watson J. D., 2004, MOL BIOL GENE; Yasui T, 2011, ACS NANO, V5, P7775, DOI 10.1021/nn2030379; Zeng Y, 2008, ANGEW CHEM INT EDIT, V47, P6388, DOI 10.1002/anie.200800816	36	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0021-2148	1869-5868		ISR J CHEM	Isr. J. Chem.	NOV	2014	54	11-12			SI		1556	1563		10.1002/ijch.201400102		8	Chemistry, Multidisciplinary	Chemistry	AT5XJ	WOS:000345012900005		
J	Morikawa, K; Tsukahara, T				Morikawa, Kyojiro; Tsukahara, Takehiko			Investigation of Unique Protonic and Hydrodynamic Behavior of Aqueous Solutions Confined in Extended Nanospaces	ISRAEL JOURNAL OF CHEMISTRY			English	Review						molecular dynamics; nanofluidics; nanotechnology; NMR spectroscopy; proton transport	TOTAL ANALYSIS SYSTEMS; LASER-INDUCED FLUORESCENCE; NANOFLUIDIC CHANNELS; ION DISTRIBUTION; WATER; NANOCHANNELS; TRANSPORT; SEPARATION; CHIP; ENHANCEMENT	Studies on novel devices utilizing characteristics of confined geometries have attracted much attention. In particular, a 10-1,000nm space (extended nanospace) has been expected to establish superior chemical analysis systems in liquid phases, because it not only bridges the methodological gap between conventional nanotechnology and microfluidic technology, but also the scientific one between single molecules and the bulk condensed phase. Therefore, engineering, fluidics, and chemistry concerned with extended nanospaces have been investigated, and unique physicochemical phenomena in the spaces have been clarified. In this review, we summarize recent research outcomes about protonic and hydrodynamic properties of liquids confined in extended nanospaces. Furthermore, we assume a novel molecular description, composed of the electric double layer (EDL) model and the three-phase model, consisting of adsorbed, proton transfer, and bulk phases, to explain the unique properties induced by the extended nanospace confinement. Finally, the device applications using extended nanospaces are introduced and their potentials are discussed.	[Morikawa, Kyojiro; Tsukahara, Takehiko] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan	Morikawa, K (reprint author), Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, 2-12-1-N1-6,O Okayama, Tokyo 1528550, Japan.	ptsuka@nr.titech.ac.jp					Agmon N, 1996, J PHYS CHEM-US, V100, P1072, DOI 10.1021/jp9516295; Agmon N, 1997, J PHYS CHEM B, V101, P4352, DOI 10.1021/jp963826p; Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; van der Heyden FHJ, 2007, NANO LETT, V7, P1022, DOI 10.1021/nl070194h; Rassaei L, 2011, ANAL CHEM, V83, P3974, DOI 10.1021/ac200307n; Li LX, 2012, J PHYS CHEM LETT, V3, P2447, DOI 10.1021/jz3009198; Tsukahara T, 2007, ANGEW CHEM INT EDIT, V46, P1180, DOI 10.1002/anie.200604502; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; Bottenus D, 2009, LAB CHIP, V9, P219, DOI 10.1039/b803278e; Vilkner T, 2004, ANAL CHEM, V76, P3373, DOI 10.1021/ac040063q; Dittrich PS, 2006, ANAL CHEM, V78, P3887, DOI 10.1021/ac0605602; Broyles BS, 2003, ANAL CHEM, V75, P2761, DOI 10.1021/ac025503x; Tas NR, 2004, APPL PHYS LETT, V85, P3274, DOI 10.1063/1.1804602; BOUSSE L, 1991, J COLLOID INTERF SCI, V147, P22, DOI 10.1016/0021-9797(91)90130-Z; Pennathur S, 2005, ANAL CHEM, V77, P6782, DOI 10.1021/ac0508346; Koga K, 2001, NATURE, V412, P802, DOI 10.1038/35090532; Schoch RB, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1954899; Ishibashi R, 2012, SMALL, V8, P1237, DOI 10.1002/smll.201102420; Morikawa K, 2010, LAB CHIP, V10, P871, DOI 10.1039/b916776e; Cohen B, 2003, J PHYS CHEM A, V107, P3598, DOI 10.1021/jp026053f; Kaji N, 2006, ANAL BIOANAL CHEM, V386, P759, DOI 10.1007/s00216-006-0469-3; Tsukahara T, 2009, J PHYS CHEM B, V113, P10808, DOI 10.1021/jp903275t; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Schoch RB, 2006, NANO LETT, V6, P543, DOI 10.1021/nl052372h; Plecis A, 2005, NANO LETT, V5, P1147, DOI 10.1021/nl050265h; Chang CC, 2013, ANAL CHEM, V85, P4468, DOI 10.1021/ac400001v; Hibara A, 2002, ANAL CHEM, V74, P6170, DOI 10.1021/ac025808b; Rasaiah JC, 2008, ANNU REV PHYS CHEM, V59, P713, DOI 10.1146/annurev.physchem.59.032607.093815; Kornyshev AA, 2003, J PHYS CHEM B, V107, P3351, DOI 10.1021/jp020857d; Chinen H, 2012, ANGEW CHEM INT EDIT, V51, P3573, DOI 10.1002/anie.201104883; Reisner W, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058302; Liu SR, 2005, NANO LETT, V5, P1389, DOI 10.1021/nl050712t; Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0; Bergman R, 2000, NATURE, V403, P283, DOI 10.1038/35002027; Tsukahara T, 2008, ANAL BIOANAL CHEM, V391, P2745, DOI 10.1007/s00216-008-2198-2; Kim SM, 2006, ANAL CHEM, V78, P4779, DOI 10.1021/ac060031y; SCALES PJ, 1992, LANGMUIR, V8, P965, DOI 10.1021/la00039a037; Kazoe Y, 2011, ANAL CHEM, V83, P8152, DOI 10.1021/ac201654r; Contento NM, 2011, LAB CHIP, V11, P3634, DOI 10.1039/c1lc20570f; Anzo K, 2012, ANAL CHEM, V84, P10852, DOI 10.1021/ac302013b; Cheng LJ, 2010, MICROFLUID NANOFLUID, V9, P1033, DOI 10.1007/s10404-010-0621-4; Debye P., 1929, POLAR MOL; Detobel F, 2009, ANAL BIOANAL CHEM, V394, P399, DOI 10.1007/s00216-009-2614-2; Farrar T. C., 1971, PULSE FOURIER TRANSF; Guan WH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1514; Haneveld J, 2008, J APPL PHYS, V104, DOI 10.1063/1.2952053; Huber DE, 2009, LAB CHIP, V9, P2933, DOI 10.1039/b901739a; Kasai K., 2012, P MICROTAS, P1285; Lee C, 2012, NANO LETT, V12, P4037, DOI 10.1021/nl301412b; Morikawa K, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3644481; Morikawa K., 2012, P MICROTAS, P701; Mortensen NA, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857470; Pappaert K, 2005, LAB CHIP, V5, P1104, DOI 10.1039/b505122c; Pu Q., 2004, NANO LETT, V1, P2; Reccius CH, 2008, BIOPHYS J, V95, P273, DOI 10.1529/biophysj.107.121020; Renberg B, 2009, LAB CHIP, V9, P1517, DOI 10.1039/b823436a; Stein D., 2004, PHYS REV LETT, V93, P1; Sung K.B., 2012, MICROFLUID NANOFLUID, V14, P645; Tsukahara T, 2011, PROG NUCL ENERG, V53, P935, DOI 10.1016/j.pnucene.2011.04.028; Tsukahara T., 2008, P MICROTAS, P1537; Van Der Heyden F. H. J., 2005, PHYS REV LETT, V95, P9	61	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0021-2148	1869-5868		ISR J CHEM	Isr. J. Chem.	NOV	2014	54	11-12			SI		1564	1572		10.1002/ijch.201400095		9	Chemistry, Multidisciplinary	Chemistry	AT5XJ	WOS:000345012900006		
J	Pungetmongkol, P; Mogi, K; Hatsuki, R; Yamamoto, T				Pungetmongkol, Porpin; Mogi, Katsuo; Hatsuki, Ryuji; Yamamoto, Takatoki			Direct Evaluation of the Electrokinetic Properties of Electrolytes in a Nanochannel using Electrical Impedance Spectroscopy	ISRAEL JOURNAL OF CHEMISTRY			English	Article						electric double layer; electrical impedance spectroscopy; electrochemistry; nanofluidics; nanotechnology	SURFACE-CHARGE; ION-TRANSPORT; DOUBLE-LAYER; FUEL-CELL; FLOW; DIFFUSION; NANOSLITS; PROTEINS	An electric double layer is the local distribution of ions created at any liquid and solid interface. The thickness of the electric double layer is typically in nanometers, so that it is dominant in the nanoscale. Because the size of the nanospace is the same order of magnitude as the thickness of the electric double layer, the nanospace should be partially/totally filled with an electric double layer. Therefore, the investigation of the electrokinetics inside the electric double layer in nanospaces, such as nanopores and nanochannels, is very important for electrical/electrochemical analysis and for the manipulation of molecules and nanoparticles in nanofluidic systems. Here, electrical impedance spectroscopy was used to comprehensively investigate how the ionic concentration and the volume of the nanospace influenced the electrical properties of various ionic solutions in a nanochannel. The electrokinetic properties and the thickness of the electric double layer in the nanospace were determined to be dependent on the hydration diameter, mobility, and ionic strength of the various ion species. The electric double layer overlaps under particular conditions, such as with sufficiently narrow channels, and the qualitative properties of this were consistent with the Debye-Huckel-Onsager equation. These results should be a significant contribution to the improvement of the analysis and manipulation of molecules and particles in nanochannels, which could lead to further development in the application of nanofluidics.	[Pungetmongkol, Porpin; Mogi, Katsuo; Hatsuki, Ryuji; Yamamoto, Takatoki] Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, Tokyo 1528550, Japan	Yamamoto, T (reprint author), Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	yamamoto@mes.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [24651161, 25289096]; Casio Science Promotion Foundation	This work was conducted as part of the Four-University Nano-Micro Fabrication Kawasaki Consortium (Fab-4U). This work was supported by Kakenhi Grants-in-Aid (Nos. 24651161, 25289096) from the Japan Society for the Promotion of Science (JSPS), and partly by the Casio Science Promotion Foundation.	Andersen MB, 2011, J COLLOID INTERF SCI, V360, P262, DOI 10.1016/j.jcis.2011.04.011; Kalman EB, 2008, ADV MATER, V20, P293, DOI 10.1002/adma.200701867; GRAHAME DC, 1947, CHEM REV, V41, P441, DOI 10.1021/cr60130a002; Kjeang E, 2008, J AM CHEM SOC, V130, P4000, DOI 10.1021/ja078248c; Pennathur S, 2005, ANAL CHEM, V77, P6782, DOI 10.1021/ac0508346; Schoch RB, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1954899; Yanik AA, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3290633; Onsager L, 1932, J PHYS CHEM-US, V36, P2689, DOI 10.1021/j150341a001; Karnik R, 2007, NANO LETT, V7, P547, DOI 10.1021/nl062806o; Morikawa K, 2010, LAB CHIP, V10, P871, DOI 10.1039/b916776e; Debye P, 1923, PHYS Z, V24, P185; Schoch RB, 2006, NANO LETT, V6, P543, DOI 10.1021/nl052372h; Schoch RB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1896936; Wang YC, 2005, ANAL CHEM, V77, P4293, DOI 10.1021/ac050321z; Liu SR, 2005, NANO LETT, V5, P1389, DOI 10.1021/nl050712t; Hong J, 2009, DRUG DISCOV TODAY, V14, P134, DOI 10.1016/j.drudis.2008.10.001; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Tsukahara T, 2009, ELECTROPHORESIS, V30, P3212, DOI 10.1002/elps.200900155; Ren YQ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/19/195707; Gouy M., 1910, J PHYS, V9, P457, DOI DOI 10.1051/JPHYSTAP:019100090045700; Hatsuki R, 2013, MICROFLUID NANOFLUID, V14, P983, DOI 10.1007/s10404-012-1105-5; Levy SL, 2010, CHEM SOC REV, V39, P1133, DOI 10.1039/b820266b; Miller R. L., 1988, 2311 USGS; Robinson R. A., 1970, ELECTROLYTE SOLUTION, P284; Tegenfeldt JO, 2004, ANAL BIOANAL CHEM, V378, P1678, DOI 10.1007/s00216-004-2526-0; Wan QH, 1997, ANAL CHEM, V69, P361, DOI 10.1021/ac960478e; Xie YB, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3001590; Yamamoto T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/39/395502	28	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0021-2148	1869-5868		ISR J CHEM	Isr. J. Chem.	NOV	2014	54	11-12			SI		1607	1614		10.1002/ijch.201400098		8	Chemistry, Multidisciplinary	Chemistry	AT5XJ	WOS:000345012900010		
J	Nesterov, SV; Deshayes, E; Sciagra, R; Settimo, L; Declerck, JM; Pan, XB; Yoshinaga, K; Katoh, C; Slomka, PJ; Germano, G; Han, CL; Aalto, V; Alessio, AM; Ficaro, EP; Lee, BC; Nekolla, SG; Gwet, KL; deKemp, RA; Klein, R; Dickson, J; Case, JA; Bateman, T; Prior, JO; Knuuti, JM				Nesterov, Sergey V.; Deshayes, Emmanuel; Sciagra, Roberto; Settimo, Leonardo; Declerck, Jerome M.; Pan, Xiao-Bo; Yoshinaga, Keiichiro; Katoh, Chietsugu; Slomka, Piotr J.; Germano, Guido; Han, Chunlei; Aalto, Ville; Alessio, Adam M.; Ficaro, Edward P.; Lee, Benjamin C.; Nekolla, Stephan G.; Gwet, Kilem L.; deKemp, Robert A.; Klein, Ran; Dickson, John; Case, James A.; Bateman, Timothy; Prior, John O.; Knuuti, Juhani M.			Quantification of Myocardial Blood Flow in Absolute Terms Using Rb-82 PET Imaging The RUBY-10 Study	JACC-CARDIOVASCULAR IMAGING			English	Article						CAD; imaging software; PET; reproducibility; rubidium-82	POSITRON-EMISSION-TOMOGRAPHY; GENERATOR-PRODUCED RB-82; CORONARY-ARTERY-DISEASE; PROGNOSTIC VALUE; N-13-AMMONIA PET; PERFUSION; RESERVE; STRESS; MODEL; REPRODUCIBILITY	OBJECTIVES The purpose of this study was to compare myocardial blood flow (MBF) and myocardial flow reserve (MFR) estimates from rubidium-82 positron emission tomography (Rb-82 PET) data using 10 software packages (SPs) based on 8 tracer kinetic models. BACKGROUND It is unknown how MBF and MFR values from existing SPs agree for Rb-82 PET. METHODS Rest and stress Rb-82 PET scans of 48 patients with suspected or known coronary artery disease were analyzed in 10 centers. Each center used 1 of 10 SPs to analyze global and regional MBF using the different kinetic models implemented. Values were considered to agree if they simultaneously had an intraclass correlation coefficient >0.75 and a difference <20% of the median across all programs. RESULTS The most common model evaluated was the Ottawa Heart Institute 1-tissue compartment model (OHI-1-TCM). MBF values from 7 of 8 SPs implementing this model agreed best. Values from 2 other models (alternative 1-TCM and Axially distributed) also agreed well, with occasional differences. The MBF results from other models (e.g., 2-TCM and retention) were less in agreement with values from OHI-1-TCM. CONCLUSIONS SPs using the most common kinetic model-OHI-1-TCM-provided consistent results in measuring global and regional MBF values, suggesting that they may be used interchangeably to process data acquired with a common imaging protocol. (C) 2014 by the American College of Cardiology Foundation.	[Nesterov, Sergey V.; Han, Chunlei; Aalto, Ville; Knuuti, Juhani M.] Univ Turku, Turku PET Ctr, Turku 20520, Finland; [Nesterov, Sergey V.; Han, Chunlei; Aalto, Ville; Knuuti, Juhani M.] Turku Univ Hosp, FIN-20520 Turku, Finland; [Nesterov, Sergey V.] RAS, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg, Russia; [Deshayes, Emmanuel; Prior, John O.] Univ Lausanne Hosp, Lausanne, Switzerland; [Deshayes, Emmanuel] Reg Canc Inst Montpellier ICM Val Aurelle, Montpellier, France; [Sciagra, Roberto; Settimo, Leonardo] Univ Florence, Florence, Italy; [Declerck, Jerome M.; Pan, Xiao-Bo] Siemens Mol Imaging, Oxford, England; [Yoshinaga, Keiichiro; Katoh, Chietsugu] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Slomka, Piotr J.; Germano, Guido] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Alessio, Adam M.] Univ Washington, Seattle, WA 98195 USA; [Ficaro, Edward P.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Lee, Benjamin C.] INVIA Med Imaging Solut, Ann Arbor, MI USA; [Nekolla, Stephan G.] Tech Univ Munich, Dept Nucl Med, D-80290 Munich, Germany; [Gwet, Kilem L.] Adv Analyt LLC, Gaithersburg, MD USA; [deKemp, Robert A.; Klein, Ran] Univ Ottawa, Inst Heart, Natl Cardiac PET Ctr, Ottawa, ON, Canada; [Dickson, John] UCL, London, England; [Case, James A.; Bateman, Timothy] Cardiovasc Imaging Technol, Kansas City, MO USA	Nesterov, SV (reprint author), Univ Turku, Kiinamyllynkatu 4-8, Turku 20520, Finland.	sergey.nesterov@tyks.fi			Academy of Finland; University of Turku; Turku University Hospital; Abo Akademi University; Japanese Ministry of Education, Science and Culture [1959135]; Northern Advancement Center for Science Technology [H23-S2-17]; U.S. National Institutes of Health [K25-HL086713]; Siemens Healthcare; GE Healthcare; INVIA Medical Imaging Solutions	This study was conducted within the Finnish Centre of Excellence in Cardiovascular and Metabolic Diseases supported by the Academy of Finland, University of Turku, Turku University Hospital, and Abo Akademi University; and was supported in part by grants from the Japanese Ministry of Education, Science and Culture (No. 1959135), Northern Advancement Center for Science & Technology (H23-S2-17), and the U.S. National Institutes of Health grant K25-HL086713. Cedars-Sinai receives royalties from the licensing of QPET software, a minority of which is shared with developers, including Drs. Slomka and Germano. Dr. Slomka has received grant support from Siemens Healthcare. Dr. Alessio has received a research grant from GE Healthcare; and has served as a consultant for Lantheus Medical Imaging. Dr. Ficaro has received revenue shares from the sale of Corridor4DM and is the owner of INVIA Medical Imaging Solutions. Dr. Lee has received financial support from and is an employee of INVIA Medical Imaging Solutions. Drs. deKemp and Klein have received revenue shares from the sale of FlowQuant; and have served as consultants to and received revenue shares from Jubilant-Draxlmage. Dr. deKemp has received royalties from technologies licensed to Jubilant DraxImage and INVIA Medical Imaging Solutions. Drs. Case and Bateman are owners of Cardiovascular Imaging Technologies, which licenses and sells ImagenQ. Dr. Bateman has served on the advisory board of Lantheus Medical Imaging, GE, and FluoroPharma. Dr. Knuuti has served as a consultant to Lantheus Medical Imaging. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Drs. Nesterov and Deshayes contributed equally to this work as first authors. Drs. Prior and Knuuti contributed equally to this work as senior authors.	Alessio AM, 2013, J NUCL CARDIOL, V20, P64, DOI 10.1007/s12350-012-9632-8; Efseaff M, 2012, J NUCL CARDIOL, V19, P997, DOI 10.1007/s12350-012-9600-3; Saraste A, 2012, J NUCL CARDIOL, V19, P1044, DOI 10.1007/s12350-012-9588-8; Nesterov SV, 2009, EUR J NUCL MED MOL I, V36, P1594, DOI 10.1007/s00259-009-1143-8; Renaud JM, 2014, J NUCL MED, V55, P58, DOI 10.2967/jnumed.112.117515; Ficaro EP, 2007, J NUCL CARDIOL, V14, P455, DOI 10.1016/j.nuclcard.2007.06.006; El Fakhri G, 2009, J NUCL MED, V50, P1062, DOI 10.2967/jnumed.104.007831; Coxson PG, 1997, J NUCL MED, V38, P660; Ziadi MC, 2012, J NUCL CARDIOL, V19, P670, DOI 10.1007/s12350-011-9506-5; HERRERO P, 1992, CIRC RES, V70, P496; Slomka PJ, 2012, J NUCL MED, V53, P171, DOI 10.2967/jnumed.111.095398; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Yoshida K, 1996, J NUCL MED, V37, P1701; Yoshinaga K, 2006, J AM COLL CARDIOL, V48, P1029, DOI 10.1016/j.jacc.2006.06.025; Klein R, 2010, J NUCL CARDIOL, V17, P600, DOI 10.1007/s12350-010-9225-3; deKemp RA, 2013, J NUCL MED, V54, P571, DOI 10.2967/jnumed.112.112219; Sitek A, 2000, PHYS MED BIOL, V45, P2619, DOI 10.1088/0031-9155/45/9/314; Dorbala S, 2013, J AM COLL CARDIOL, V61, P176, DOI 10.1016/j.jacc.2012.09.043; Lautamaki R, 2009, EUR J NUCL MED MOL I, V36, P576, DOI 10.1007/s00259-008-0972-1; Tahari AK, 2014, EUR J NUCL MED MOL I, V41, P126, DOI 10.1007/s00259-013-2537-1; Nakazato R, 2012, J NUCL CARDIOL, V19, P265, DOI 10.1007/s12350-011-9496-3; BLAND JM, 1986, LANCET, V1, P307; Davis C. S., 2002, STAT METHODS ANAL RE; Farhad H, 2013, EUR HEART J-CARD IMG, V14, P1203, DOI 10.1093/ehjci/jet068; Gould KL, 2009, JACC-CARDIOVASC IMAG, V2, P664, DOI 10.1016/j.jcmg.2008.12.024; GOULD KL, 1989, CARDIOVASC INTER RAD, V12, P245, DOI 10.1007/BF02575408; Katoh C, 2012, J NUCL CARDIOL, V19, P763, DOI 10.1007/s12350-012-9558-1; Khorsand A, 2005, J NUCL CARDIOL, V12, P410, DOI 10.1016/j.nuclcard.2005.04.002; Knuuti J, 2012, J NUCL CARDIOL, V19, P643, DOI 10.1007/s12350-012-9530-0; Lee BC, 2013, J NUCL MED S2, V54, P1659; Lortie M, 2007, EUR J NUCL MED MOL I, V34, P1765, DOI 10.1007/s00259-007-0478-2; Rosner B., 2011, FUNDAMENTALS BIOSTAT; Saha K., 2007, THESIS U MISSOURI CO; Schindler TH, 2010, JACC-CARDIOVASC IMAG, V3, P623, DOI 10.1016/j.jcmg.2010.04.007; Yoshinaga K, 2011, CIRC J, V75, P2628, DOI 10.1253/circj.CJ-11-0502	35	8	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	NOV	2014	7	11					1119	1127		10.1016/j.jcmg.2014.08.003		9	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AT9NS	WOS:000345254500009		
J	Inami, T; Kataoka, M; Shimura, N; Ishiguro, H; Yanagisawa, R; Fukuda, K; Yoshino, H; Satoh, T				Inami, Takumi; Kataoka, Masaharu; Shimura, Nobuhiko; Ishiguro, Haruhisa; Yanagisawa, Ryoji; Fukuda, Keiichi; Yoshino, Hideaki; Satoh, Toru			Pressure-Wire-Guided Percutaneous Transluminal Pulmonary Angioplasty A Breakthrough in Catheter-Interventional Therapy for Chronic Thromboembolic Pulmonary Hypertension	JACC-CARDIOVASCULAR INTERVENTIONS			English	Article						chronic thromboembolic pulmonary hypertension; percutaneous transluminal pulmonary angioplasty; pressure wire; Pulmonary Edema Predictive Scoring Index; reperfusion pulmonary edema	HEMODYNAMICS; EFFICACY	OBJECTIVES This study sought to prove the safety and effectiveness of pressure-wire-guided percutaneous transluminal pulmonary angioplasty (PTPA). BACKGROUND PTPA has been demonstrated to be effective for treatment of chronic thromboembolic pulmonary hypertension. However, a major and occasionally fatal complication after PTPA is reperfusion pulmonary edema. To avoid this, we developed the PEPSI (Pulmonary Edema Predictive Scoring Index). The pressure wire has been used to detect insufficiency of flow in a vessel. METHODS We included 350 consecutive PTPA sessions in 103 patients with chronic thromboembolic pulmonary hypertension from January 1, 2009 to December 31, 2013. During these 5 years, 140 PTPA sessions were performed without guidance, 65 with guidance of PEPSI alone, and 145 with both PEPSI and pressure-wire guidance. Each PTPA session was finished after achieving PEPSI scores of <35.4 with PEPSI guidance and each target lesion achieving distal mean pulmonary arterial pressure <35 mm Hg with pressure-wire guidance. RESULTS The occurrence of clinically critical reperfusion pulmonary edema and vessel injuries were lowest in the group using the guidance of both pressure wire and PEPSI (0% and 6.9%, respectively). Furthermore, the group guided by pressure wire and PEPSI accomplished the same hemodynamic improvements with fewer numbers of target lesions treated and sessions performed. CONCLUSIONS The combined approach using pressure wire and PEPSI produced more efficient clinical results and greatly reduced reperfusion pulmonary edema and vessel complications. This is further evidence that PTPA is an alternative strategy for treating chronic thromboembolic pulmonary hypertension. (C) 2014 by the American College of Cardiology Foundation.	[Inami, Takumi; Kataoka, Masaharu; Shimura, Nobuhiko; Ishiguro, Haruhisa; Yanagisawa, Ryoji; Yoshino, Hideaki; Satoh, Toru] Kyorin Univ, Sch Med, Dept Internal Med 2, Div Cardiol, Tokyo, Japan; [Kataoka, Masaharu; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan	Kataoka, M (reprint author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	m.kataoka09@z5.keio.jp; tsatoh@ks.kyorin-u.ac.jp	Fukuda, Keiichi/L-3777-2013				Sugimura K, 2012, CIRC J, V76, P485, DOI 10.1253/circj.CJ-11-1217; Yanagisawa R, 2014, INT J CARDIOL, V175, P285, DOI 10.1016/j.ijcard.2014.05.011; Andreassen AK, 2013, HEART, V99, P1415, DOI 10.1136/heartjnl-2012-303549; Kataoka M, 2012, CIRC-CARDIOVASC INTE, V5, P756, DOI 10.1161/CIRCINTERVENTIONS.112.971390; Siebes M, 2004, CIRCULATION, V109, P756, DOI 10.1161/01.CIR.0000112571.06979.B2; Mizoguchi H, 2012, CIRC-CARDIOVASC INTE, V5, P748, DOI 10.1161/CIRCINTERVENTIONS.112.971077; Feinstein JA, 2001, CIRCULATION, V103, P10; Inami T, 2013, JACC-CARDIOVASC INTE, V6, P725, DOI 10.1016/j.jcin.2013.03.009; Inami T, 2014, AM J RESP CRIT CARE, V189, P1437, DOI 10.1164/rccm.201312-2254LE; Inami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094587; Ishiguro H, 2013, JACC-CARDIOVASC INTE, V6, P1212, DOI 10.1016/j.jcin.2013.03.025; Yanagisawa R, 2014, EUROINTERVENTION, V9, P1483, DOI 10.4244/EIJV9I12A248	12	8	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	NOV	2014	7	11					1297	1306		10.1016/j.jcin.2014.06.010		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU0BO	WOS:000345288400022		
J	Hoshi, T; Sato, A; Akiyama, D; Kawabe, M; Hiraya, D; Aonuma, K				Hoshi, Tomoya; Sato, Akira; Akiyama, Daiki; Kawabe, Masayuki; Hiraya, Daigo; Aonuma, Kazutaka			Kounis Syndrome Manifesting as Coronary Aneurysm and Very Late Coronary Stent Thrombosis	JACC-CARDIOVASCULAR INTERVENTIONS			English	Editorial Material						coronary angioscopy; eosinophil; optical coherence tomography; very late stent thrombosis			[Hoshi, Tomoya; Sato, Akira; Akiyama, Daiki; Kawabe, Masayuki; Hiraya, Daigo; Aonuma, Kazutaka] Univ Tsukuba, Fac Med, Div Cardiovasc, Tsukuba, Ibaraki 3058575, Japan	Hoshi, T (reprint author), Univ Tsukuba, Fac Med, Div Cardiovasc, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hoshi.tm@md.tsukuba.ac.jp					Chen JP, 2009, JACC-CARDIOVASC INTE, V2, P583, DOI 10.1016/j.jcin.2009.04.017; Biteker M, 2010, INT J CARDIOL, V145, P553, DOI 10.1016/j.ijcard.2010.05.020; Kounis NG, 2013, CLIN THER, V35, P563, DOI 10.1016/j.clinthera.2013.02.022	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	NOV	2014	7	11					E173	E176		10.1016/j.jcin.2014.05.031		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU0BO	WOS:000345288400004		
J	Mochizuki, N; Yamamoto, T; Enaida, H; Ishibashi, T; Yamashita, H				Mochizuki, Noriko; Yamamoto, Teiko; Enaida, Hiroshi; Ishibashi, Tatsuro; Yamashita, Hidetoshi			Long-term outcomes of 3 surgical adjuvants used for internal limiting membrane peeling in idiopathic macular hole surgery	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Brilliant blue G; Indocyanine green; Internal limiting membrane peeling; Macular hole; Triamcinolone acetonide	BRILLIANT BLUE-G; INDOCYANINE GREEN; TRIAMCINOLONE ACETONIDE; RECEPTORS; TOXICITY; EYES	Indocyanine green (ICG), an adjuvant used for peeling of the internal limiting membrane (ILM) during vitreous surgery for idiopathic macular hole (MH), has been reported to be toxic, possibly affecting postoperative visual acuity. We compared the long-term outcomes (within 2 years) of brilliant blue G (BBG), ICG, and triamcinolone acetonide (TA). This study involved 97 eyes of 94 patients who underwent vitreous surgery for MH at the Yamagata University Hospital between June 2002 and November 2010. The surgical adjuvants used were BBG for 15 eyes, ICG for 61 eyes, and TA for 21 eyes. We compared the postoperative visual acuities, initial closure rates, final closure rates, and complications of the 3 groups. In all 3 groups, the visual acuity significantly improved after surgery. The magnitude of the improvement at 2 years after surgery was significantly better in the BBG group than in the ICG group (Mann-Whitney test, P = 0.020). The postoperative visual acuity did not significantly differ between the BBG and TA groups (P = 0.627) or between the ICG and TA groups (P =0 .137). Thus, the surgery using BBG resulted in a significantly better outcome in visual acuity than did the surgery using ICG. The 3 groups did not differ in initial or final closure rates or in incidence of complications. Analysis of the long-term outcomes of vitreous surgeries provided evidence that BBG is a useful adjuvant for ILM peeling.	[Mochizuki, Noriko; Yamashita, Hidetoshi] Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata 9909585, Japan; [Yamamoto, Teiko] Kanamecho Yamamoto Eye Clin, Tokyo, Japan; [Enaida, Hiroshi] Saga Univ, Dept Ophthalmol, Fac Med, Saga 840, Japan; [Ishibashi, Tatsuro] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 812, Japan	Mochizuki, N (reprint author), Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	m.noriko@med.id.yamagata-u.ac.jp			Japan Medical Association; Japanese Ministry of Education, Culture, Sports, Science and Technology [24592673]	This work was supported in part by a grant from the Japan Medical Association and by a Grant-in-Aid for Scientific Research (#24592673) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Roth DB, 2003, ARCH OPHTHALMOL-CHIC, V121, P1279, DOI 10.1001/archopht.121.9.1279; Ip MS, 2002, ARCH OPHTHALMOL-CHIC, V120, P29; Jiang LH, 2000, MOL PHARMACOL, V58, P82; Kadonosono K, 2000, ARCH OPHTHALMOL-CHIC, V118, P1116; KELLY NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P654; Matsumiya W, 2013, JPN J OPHTHALMOL, V57, P308, DOI 10.1007/s10384-013-0232-1; Ullrich S, 2002, BRIT J OPHTHALMOL, V86, P390, DOI 10.1136/bjo.86.4.390; Baba T, 2012, OPHTHALMOLOGY, V119, P2609, DOI 10.1016/j.ophtha.2012.06.048; Brooks HL, 1995, VITREORETINAL SURG T, V7, P2; Ejstrup R, 2012, GRAEF ARCH CLIN EXP, V250, P669, DOI 10.1007/s00417-011-1886-3; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P623, DOI 10.1097/00006982-200607000-00006; Enaida H, 2002, GRAEF ARCH CLIN EXP, V240, P209, DOI 10.1007/s00417-002-0433-7; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007; Fukuda K, 2011, RETINA-J RET VIT DIS, V31, P1720, DOI 10.1097/IAE.0b013e31822a33d0; HIDA T, 1986, AM J OPHTHALMOL, V101, P190; Horio N, 2005, ARCH OPHTHALMOL-CHIC, V123, P96, DOI 10.1001/archopht.123.1.96; Isomae T, 2002, JPN J OPHTHALMOL, V46, P84, DOI 10.1016/S0021-5155(01)00468-3; Kimura H, 2004, AM J OPHTHALMOL, V137, P172, DOI 10.1016/S0002-9394(03)00782-7; Kuramoto N, 2006, JPN J CLIN OPHTHAL, V60, P853; Kusaka S, 1997, JPN J OPHTHALMOL, V41, P332, DOI 10.1016/S0021-5155(97)00055-5; Nishimura A, 2003, RETINA-J RET VIT DIS, V23, P777, DOI 10.1097/00006982-200312000-00005; Notomi S, 2011, AM J PATHOL, V179, P2798, DOI 10.1016/j.ajpath.2011.08.035; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; Ricarda GS, 2009, RETINA, V29, P669; Sippy BD, 2001, AM J OPHTHALMOL, V132, P433, DOI 10.1016/S0002-9394(01)01061-3; Tsuiki E, 2004, JPN J CLIN OPHTHAL, V58, P687	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	NOV	2014	58	6					455	461		10.1007/s10384-014-0345-1		7	Ophthalmology	Ophthalmology	AT7CK	WOS:000345093900001		
J	Tagami, M; Matsumiya, W; Imai, H; Kusuhara, S; Honda, S; Azumi, A				Tagami, Mizuki; Matsumiya, Wataru; Imai, Hisanori; Kusuhara, Sentaro; Honda, Shigeru; Azumi, Atsushi			Autologous antibodies to outer retina in acute zonal occult outer retinopathy	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Acute zonal occult outer retinopathy (AZOOR); Optical coherence tomography (OCT); Autoimmune disease; Antiretinal antibody; Immunohistochemistry	CANCER-ASSOCIATED RETINOPATHY; WHITE SPOT SYNDROMES; AUTOIMMUNE RETINOPATHY; AUTOANTIBODIES; DISEASES; SEGMENT; CELLS	Our aim was to use molecular biological methods to study evidence of autoimmune disease in five patients with acute zonal occult outer retinopathy (AZOOR). Ophthalmologic data and sera were collected from all patients, who underwent visual field (VF) examination, optical coherence tomography (OCT), and multifocal electroretinogram (mfERG) recording. Serum was prepared from each patient's blood and analyzed for antiretinal antibody activity using immunohistochemistry and Western blot analysis on mouse and human retinas. We also searched for antigen proteins using mass spectrometry. Symptoms were blurred vision in three patients and VF defects in two; all had enlargement of the Mariotte blind spot by VF testing. OCT findings in areas corresponding to the scotoma revealed disruptions of junction borders between inner and outer segment lines. mfERGs amplitudes were reduced in each corresponding scotoma area. Immunohistochemical serum staining revealed the target antigen was present in all photoreceptors of the mouse sensory retina. Western blot analysis using patient serum samples revealed some possible candidate antigens. Mass spectrometry could not determine the causative antigen; however, a list of candidates was discovered. We determined that AZOOR could be an autoimmune disease. All AZOOR patients tested using molecular biological methods had antiretinal antigens.	[Tagami, Mizuki; Imai, Hisanori; Azumi, Atsushi] Kobe Kaisei Hosp, Dept Ophthalmol, Nada Ku, Kobe, Hyogo, Japan; [Matsumiya, Wataru; Kusuhara, Sentaro; Honda, Shigeru; Azumi, Atsushi] Kobe Univ Grad Sch Med, Div Ophthalmol, Dept Surg Related, Kobe, Hyogo, Japan	Tagami, M (reprint author), Kobe Kaisei Hosp, Dept Ophthalmol, Nada Ku, 3-11-15 Shinoharakita Machi, Kobe, Hyogo, Japan.	mizuki1979feb@yahoo.co.jp					Adamus G, 1998, J AUTOIMMUN, V11, P671, DOI 10.1006/jaut.1998.0239; AMES A, 1983, STROKE, V14, P219; Spaide RF, 2008, AM J OPHTHALMOL, V146, P111, DOI 10.1016/j.ajo.2008.02.027; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Jampol LM, 2003, AM J OPHTHALMOL, V135, P376, DOI 10.1016/S0002-9394(02)02088-3; Kitakawa T, 2012, DOC OPHTHALMOL, V124, P249, DOI 10.1007/s10633-012-9318-1; Heckenlively JR, 2008, SEMIN IMMUNOPATHOL, V30, P127, DOI 10.1007/s00281-008-0114-7; Gass JD, 2002, AM J OPHTHALMOL, V134, P329, DOI 10.1016/S0002-9394(02)01640-9; GASS JDM, 1993, J CLIN NEURO-OPHTHAL, V13, P79; Dryja TP, 1997, P NATL ACAD SCI USA, V94, P12117, DOI 10.1073/pnas.94.22.12117; Fine HF, 2009, ARCH OPHTHALMOL-CHIC, V127, P66, DOI 10.1001/archophthalmol.2008.530; Francis PJ, 2005, BRIT J OPHTHALMOL, V89, P70, DOI 10.1136/bjo.2004.042416; Gass JD, 2003, AM J OPHTHALMOL, V135, P380, DOI 10.1016/S0002-9394(03)00030-8; JACOBSON SG, 1995, OPHTHALMOLOGY, V102, P1187; Ko AC, 2010, ARCH OPHTHALMOL-CHIC, V128, P1590, DOI 10.1001/archophthalmol.2010.295; Levin LA, 2011, A ALMSADLERS PHYSL E; Li D, 2007, ARCH OPHTHALMOL-CHIC, V125, P1194, DOI 10.1001/archopht.125.9.1194; MARMOR MF, 1994, RETINA-J RET VIT DIS, V14, P181, DOI 10.1097/00006982-199414020-00014; Neutzner RV, 2011, OPHTHALMOLOGE, V108, P1045, DOI 10.1007/s00347-011-2406-x; Ren GY, 2004, J AUTOIMMUN, V23, P161, DOI 10.1016/j.jaut.2004.06.003; Roehlecke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071570; Tang J, 2008, ARCH OPHTHALMOL-CHIC, V126, P130, DOI 10.1001/archophthalmol.2007.5; THIRKILL CE, 1989, NEW ENGL J MED, V321, P1589, DOI 10.1056/NEJM198912073212307; THIRKILL CE, 1992, INVEST OPHTH VIS SCI, V33, P2768	24	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	NOV	2014	58	6					462	472		10.1007/s10384-014-0347-z		11	Ophthalmology	Ophthalmology	AT7CK	WOS:000345093900002		
J	Takase, H; Kubono, R; Terada, Y; Imai, A; Fukuda, S; Tomita, M; Miyanaga, M; Kamoi, K; Sugita, S; Miyata, K; Mochizuki, M				Takase, Hiroshi; Kubono, Reo; Terada, Yukiko; Imai, Ayano; Fukuda, Shoko; Tomita, Makoto; Miyanaga, Masaru; Kamoi, Koju; Sugita, Sunao; Miyata, Kazunori; Mochizuki, Manabu			Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Anterior uveitis; Herpes simplex virus; Varicella-zoster virus; Cytomegalovirus	POLYMERASE-CHAIN-REACTION; EPIDEMIOLOGIC SURVEY; IRIDOCYCLITIS; DIAGNOSIS; JAPAN	To compare the clinical characteristics of anterior uveitis (AU) caused by herpes simplex virus (HSV), varicella-zoster virus (VZV), or cytomegalovirus (CMV). The medical records were reviewed of 46 patients whose diagnoses were based on their clinical characteristics [e.g., unilateral involvement, presence of keratic precipitates (KPs), and elevation of intraocular pressure (IOP)] and on PCR detection of herpes virus DNA in the aqueous humor. The demographics, chief complaints, and clinical characteristics of the three types of herpetic AU were compared. Of the 46 patients with AU, eight had HSV-AU, 20 had VZV-AU, and 18 had CMV-AU. HSV-AU and VZV-AU shared common features, i.e., a relatively acute disease process and the presence of large KPs. Among the three groups of patients, the characteristic features of those with VZV-AU were severe intraocular inflammation, as shown by severe aqueous flare, highest viral load in the aqueous humor, and presence of segmental iris atrophy. In comparison, patients with CMV-AU had the mildest intraocular inflammation, lowest corneal endothelial cell density, and highest IOP. Although the AU caused by each of the three types of herpes viruses has a number of common features, each disease also has distinct features that should facilitate an accurate diagnosis.	[Takase, Hiroshi; Kubono, Reo; Terada, Yukiko; Imai, Ayano; Fukuda, Shoko; Miyanaga, Masaru; Kamoi, Koju; Mochizuki, Manabu] TMDU, Grad Sch Med & Dent Sci, Dept Ophthalmol & Visual Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Terada, Yukiko; Miyata, Kazunori] Miyata Eye Hosp, Miyakonojo, Miyazaki 8850051, Japan; [Tomita, Makoto] Tokyo Med & Dent Univ Hosp, Med Clin Res Ctr, Bunkyo Ku, Tokyo 1138519, Japan; [Sugita, Sunao] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Chuo Ku, Kobe, Hyogo 6500047, Japan	Takase, H (reprint author), TMDU, Grad Sch Med & Dent Sci, Dept Ophthalmol & Visual Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	h.takase.oph@tmd.ac.jp					Sugita S, 2008, BRIT J OPHTHALMOL, V92, P928, DOI 10.1136/bjo.2007.133967; Goto H, 2007, JPN J OPHTHALMOL, V51, P41, DOI 10.1007/s10384-006-0383-4; Jap A, 2011, CURR OPIN OPHTHALMOL, V22, P483, DOI 10.1097/ICU.0b013e32834be021; Chee SP, 2008, AM J OPHTHALMOL, V145, P834, DOI 10.1016/j.ajo.2007.12.015; Hwang YS, 2010, GRAEF ARCH CLIN EXP, V248, P263, DOI 10.1007/s00417-009-1195-2; De Groot-Mijnes JDF, 2006, AM J OPHTHALMOL, V141, P313, DOI 10.1016/j.ajo.2005.09.017; Ohguro N, 2012, JPN J OPHTHALMOL, V56, P432, DOI 10.1007/s10384-012-0158-z; Zhang Y, 2003, JPN J OPHTHALMOL, V47, P260, DOI 10.1016/S0021-5155(03)00014-5; Miyanaga M, 2010, BRIT J OPHTHALMOL, V94, P336, DOI 10.1136/bjo.2008.156422; Chee SP, 2008, AM J OPHTHALMOL, V146; de Schryver I, 2006, BRIT J OPHTHALMOL, V90, P852, DOI 10.1136/bjo.2005.086546; Hogan M J, 1963, Trans Am Ophthalmol Soc, V61, P75; Kawaguchi Tatsushi, 2007, International Ophthalmology, V27, P383, DOI 10.1007/s10792-007-9090-5; Koizumi N, 2008, OPHTHALMOLOGY, V115; Kongyai N, 2012, JPN J OPHTHALMOL, V56, P390, DOI 10.1007/s10384-012-0144-5; MARSH RJ, 1974, AM J OPHTHALMOL, V78, P255	16	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	NOV	2014	58	6					473	482		10.1007/s10384-014-0340-6		10	Ophthalmology	Ophthalmology	AT7CK	WOS:000345093900003		
J	Maeda, N; Ueki, R; Fuchihata, M; Fujimoto, H; Koh, S; Nishida, K				Maeda, Naoyuki; Ueki, Ryotaro; Fuchihata, Mutsumi; Fujimoto, Hisataka; Koh, Shizuka; Nishida, Kohji			Corneal biomechanical properties in 3 corneal transplantation techniques with a dynamic Scheimpflug analyzer	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Corneal biomechanics; Corneal integrity; Keratoplasty; Scheimpflug image	ANTERIOR LAMELLAR KERATOPLASTY; MEMBRANE ENDOTHELIAL KERATOPLASTY; OCULAR RESPONSE ANALYZER; HIGHER-ORDER ABERRATIONS; PENETRATING KERATOPLASTY; NONCONTACT TONOMETRY; DESCEMETS-MEMBRANE; EYES	To compare the corneal biomechanical properties of eyes that have undergone penetrating keratoplasty (PK), deep anterior lamellar keratoplasty (DALK), and Descemet stripping automated endothelial keratoplasty (DSAEK). This case-control study comprised 20 post-PK eyes, 14 post-DALK eyes, 15 post-DSAEK eyes, and 50 normal control eyes. A dynamic Scheimpflug analyzer (the Corvis ST) was used to evaluate the corneal biomechanical properties including deformation amplitude (DA) and radius at the highest concavity (R (hc)). In post-PK eyes, the mean DA was 1.20 +/- A 0.13 mm, which was significantly higher than those of the control eyes (1.07 +/- A 0.09) and the post-DSAEK eyes (1.08 +/- A 0.12). The DA (1.18 +/- A 0.18) in the post-DALK eyes was significantly higher than in the control eyes. The R (hc) in the post-PK (6.34 +/- A 0.37 mm), -DALK (6.04 +/- A 1.22), and -DSAEK (6.44 +/- A 0.58) eyes was significantly smaller than in the control eyes (7.57 +/- A 0.78). The dynamic Scheimpflug analyzer provides a method to obtain new biomechanical information on the cornea such as the DA and R (hc), and these parameters differed among eyes that had undergone 3 different types of corneal surgery. Abnormalities in these parameters after the different corneal transplantation techniques may indicate larger deviations in the stress-strain reaction of the cornea and more uncertainty in the intraocular pressure measurements than in normal eyes.	[Maeda, Naoyuki; Fuchihata, Mutsumi; Fujimoto, Hisataka; Koh, Shizuka; Nishida, Kohji] Osaka Univ Grad Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan; [Ueki, Ryotaro] Nagasaki Univ, Dept Ophthalmol & Visual Sci, Grad Sch Biomed Sci, Nagasaki 852, Japan	Maeda, N (reprint author), Osaka Univ Grad Sch Med, Dept Ophthalmol, Room E7,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nmaeda@ophthal.med.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [24592669]	Publication of this article was supported in part by a Grant-in-Aid for Scientific Research (no. 24592669; to Naoyuki Maeda) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The authors would like to thank Duco Hamasaki, PhD, for the English language review.	Reznicek L, 2013, BRIT J OPHTHALMOL, V97, P1410, DOI 10.1136/bjophthalmol-2013-303400; Koh S, 2012, AM J OPHTHALMOL, V153, P284, DOI 10.1016/j.ajo.2011.06.027; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; Fontes BM, 2010, OPHTHALMOLOGY, V117, P673, DOI 10.1016/j.ophtha.2009.09.023; Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010; Hong JX, 2013, INVEST OPHTH VIS SCI, V54, P659, DOI 10.1167/iovs.12-10984; Vinciguerra P, 2010, J REFRACT SURG, V26, P669, DOI 10.3928/1081597X-20100331-01; Melles GRJ, 2006, CORNEA, V25, P987; Nemeth G, 2013, J REFRACT SURG, V29, P558, DOI 10.3928/1081597X-20130719-06; Hon Y, 2013, OPTOMETRY VISION SCI, V90, pE1, DOI 10.1097/OPX.0b013e318279eb87; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Faria-Correia F, 2013, J REFRACT SURG, V29, P356, DOI 10.3928/1081597X-20130129-03; Pepose JS, 2007, AM J OPHTHALMOL, V143, P39, DOI 10.1016/j.ajo.2006.09.036; Rudolph M, 2012, OPHTHALMOLOGY, V119, P528, DOI 10.1016/j.ophtha.2011.08.034; Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078; Acar BT, 2013, JPN J OPHTHALMOL, V57, P85, DOI 10.1007/s10384-012-0197-5; Anwar M, 2002, J CATARACT REFR SURG, V28, P398, DOI 10.1016/S0886-3350(01)01181-6; Lee WB, 2009, OPHTHALMOLOGY, V116, P1818, DOI 10.1016/j.ophtha.2009.06.021; Archila E A, 1984, Cornea, V3, P217; Hosny Mohamed, 2011, Clin Ophthalmol, V5, P767, DOI 10.2147/OPTH.S21297; Jafarinasab MR, 2011, CURR EYE RES, V36, P417, DOI 10.3109/02713683.2011.556303; Kawashima M, 2009, OPHTHALMOLOGY, V116, P2072, DOI 10.1016/j.ophtha.2009.04.047; Sari ES, 2013, AM J OPHTHALMOL, V156, P767, DOI 10.1016/j.ajo.2013.05.014; Sugita J, 1997, BRIT J OPHTHALMOL, V81, P184, DOI 10.1136/bjo.81.3.184; Terry MA, 2003, OPHTHALMOLOGY, V110, P755, DOI 10.1016/S0161-6420(02)01939-5; Yenerel NM, 2010, CORNEA, V29, P1247, DOI 10.1097/ICO.0b013e3181ca6383	26	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	NOV	2014	58	6					483	489		10.1007/s10384-014-0344-2		7	Ophthalmology	Ophthalmology	AT7CK	WOS:000345093900004		
J	Yamada, H; Sawada, A; Kuwayama, Y; Yamamoto, T				Yamada, Hiroki; Sawada, Akira; Kuwayama, Yasuaki; Yamamoto, Tetsuya			Blindness following bleb-related infection in open angle glaucoma	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Bleb-related infection; Blindness; Glaucoma; Surgery; Trabeculectomy	MITOMYCIN-C; FILTERING BLEBS; INTRAOCULAR-PRESSURE; CLINICAL-FEATURES; VISUAL-ACUITY; RISK-FACTORS; TRABECULECTOMY; ENDOPHTHALMITIS; COMPLICATIONS; OUTCOMES	To estimate the risk of blindness following bleb-related infection after trabeculectomy with mitomycin C in open angle glaucoma, utilizing data obtained from two prospective multicenter studies. The incidence of bleb-related infection in open angle glaucoma after the first or second glaucoma surgery was calculated using a Kaplan-Meier analysis and data from the Collaborative Bleb-related Infection Incidence and Treatment Study (CBIITS). The rate of blindness following bleb-related infection was calculated using data from the Japan Glaucoma Society Survey of Bleb-related Infection (JGSSBI). Finally, the rate of blindness following bleb-related infection after filtering surgery was estimated based on the above two data sets. Blindness was defined as an eye with a visual acuity of 0.04 or less. The incidences of development of bleb-related infection at 5 years were 2.6 +/- A 0.7 % (calculated cumulative incidence +/- A standard error) for all infections and 0.9 +/- A 0.4 % for endophthalmitis in all cases in the CBIITS data. The rates of blindness in the JGSSBI data were 14 % for the total cases with bleb-related infection and 30 % for the endophthalmitis subgroup. The rate of blindness developing within 5 years following trabeculectomy was estimated to be approximately 0.24-0.36 %. The rate of blindness following bleb-related infection within 5 years after trabeculectomy is considerable and thus careful consideration must be given to the indication for trabeculectomy and the selection of surgical techniques.	[Yamada, Hiroki; Sawada, Akira; Yamamoto, Tetsuya] Gifu Univ Grad Sch Med, Dept Ophthalmol, Gifu 5011194, Japan; [Kuwayama, Yasuaki] Fukushima Eye Clin, Osaka, Japan	Sawada, A (reprint author), Gifu Univ Grad Sch Med, Dept Ophthalmol, 1-1 Yanagido, Gifu 5011194, Japan.	sawadaa-gif@umin.ac.jp					Yamamoto T, 2011, OPHTHALMOLOGY, V118, P453, DOI 10.1016/j.ophtha.2010.07.002; MANDELBAUM S, 1985, OPHTHALMOLOGY, V92, P964; Higginbotham EJ, 1996, OPHTHALMOLOGY, V103, P650; KITAZAWA Y, 1991, ARCH OPHTHALMOL-CHIC, V109, P1693; Yamamoto T, 2014, OPHTHALMOLOGY, V121, P1001, DOI 10.1016/j.ophtha.2013.11.025; Song A, 2002, OPHTHALMOLOGY, V109, P985, DOI 10.1016/S0161-6420(02)00965-X; Jampel HD, 2012, OPHTHALMOLOGY, V119, P712, DOI 10.1016/j.ophtha.2011.09.049; Awai-Kasaoka N, 2013, JPN J OPHTHALMOL, V57, P514, DOI 10.1007/s10384-013-0257-5; Peters D, 2013, AM J OPHTHALMOL, V156, P724, DOI 10.1016/j.ajo.2013.05.027; Ciulla TA, 1997, OPHTHALMOLOGY, V104, P986; Solus JF, 2012, OPHTHALMOLOGY, V119, P703, DOI 10.1016/j.ophtha.2011.09.046; Yamamoto T, 2013, ACTA OPHTHALMOL, V91, P619, DOI 10.1111/j.1755-3768.2012.02480.x; Kangas TA, 1997, OPHTHALMOLOGY, V104, P746; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Azuara-Blanco A, 1998, SURV OPHTHALMOL, V43, P93, DOI 10.1016/S0039-6257(98)00025-3; Leng T, 2011, RETINA-J RET VIT DIS, V31, P344, DOI 10.1097/IAE.0b013e3181e09810; Aoyama A, 2010, JPN J OPHTHALMOL, V54, P117, DOI 10.1007/s10384-009-0779-z; Greenfield D S, 1998, J Glaucoma, V7, P132; Inoue T, 2012, JPN J OPHTHALMOL, V56, P464, DOI 10.1007/s10384-012-0171-2; Malihi M, 2013, OPHTHALMOLOGY, V121, P134; Our Atsushi, 2010, Nippon Ganka Gakkai Zasshi, V114, P598; Yamamoto T, 2013, ACTA OPHTHALMOL, V91, pe420, DOI 10.1111/aos.12079	22	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	NOV	2014	58	6					490	495		10.1007/s10384-014-0346-0		6	Ophthalmology	Ophthalmology	AT7CK	WOS:000345093900005		
J	Tanioka, H; Kuriki, Y; Sakamoto, A; Katsuta, O; Kawazu, K; Nakamura, M				Tanioka, Hidetoshi; Kuriki, Yumi; Sakamoto, Asuka; Katsuta, Osamu; Kawazu, Kouichi; Nakamura, Masatsugu			Expression of the P2Y(2) receptor on the rat ocular surface during a 1-year rearing period	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						P2Y(2) receptor; Diquafosol ophthalmic solution; Dry eye	DIQUAFOSOL OPHTHALMIC SOLUTION; PIGMENTED RABBIT CONJUNCTIVA; DRY EYE SYNDROME; FLUID SECRETION; P2 RECEPTORS; LOCALIZATION; STIMULATION; CELLS; GLAND; GLYCOPROTEIN	P2Y(2) receptors are expressed on ocular surface tissues. Diquafosol ophthalmic solution (DIQUAS(A (R)) ophthalmic solution 3 %; Santen Pharmaceutical Co., Ltd.) acts on these receptors and promotes the secretion of water and mucin. It has been shown to be an efficient dry eye treatment. If P2Y(2) receptor expression on the ocular surface decreases with age, the effect of diquafosol may be reduced in elderly persons. In this study, we investigated the changes in P2Y(2) receptor expression on the rat ocular surface over an extended period of time. P2Y(2) receptor expression in the conjunctiva, cornea, meibomian gland and lacrimal glands of male and female Sprague-Dawley rats was examined from 5 weeks until 53 weeks of age using immunostaining and quantitative-PCR. In the immunohistological examinations, P2Y(2) receptor expression was observed in the conjunctival epithelium containing goblet cells, corneal epithelium, meibomian gland ductal epithelium and lacrimal gland ductal epithelium. However, its expression was not significantly different between each age group or between sexes. Regarding P2Y(2) receptor mRNA expression, there was an age-related increase in the bulbar conjunctiva. In particular, a significant increase was observed in the 53-week-old age group as compared to the 5-week-old female age group. However, age-related changes in expression were not observed in the cornea or meibomian gland in males or females. We observed no significant age-related decrease was observed for P2Y(2) receptor protein and mRNA expression on rat ocular surface tissues.	[Tanioka, Hidetoshi; Kuriki, Yumi; Sakamoto, Asuka; Katsuta, Osamu; Kawazu, Kouichi; Nakamura, Masatsugu] Santen Pharmaceut Co Ltd, Ophthalm Res & Dev Ctr, Nara 6300101, Japan	Tanioka, H (reprint author), Santen Pharmaceut Co Ltd, Ophthalm Res & Dev Ctr, 8916-16 Takayama Cho, Nara 6300101, Japan.	hidetoshi.tanioka@santen.co.jp					Alves M, 2005, J ENDOCRINOL, V187, P159, DOI 10.1677/joe.1.06209; Ralevic V, 1998, PHARMACOL REV, V50, P413; Miao LY, 2001, EXP GERONTOL, V37, P67, DOI 10.1016/S0531-5565(01)00159-0; Arita R, 2013, BRIT J OPHTHALMOL, V97, P725, DOI 10.1136/bjophthalmol-2012-302668; Giaroni C, 2006, NEUROPHARMACOLOGY, V50, P690, DOI 10.1016/j.neuropharm.2005.11.015; Kawashima M, 2010, BIOCHEM BIOPH RES CO, V397, P724, DOI 10.1016/j.bbrc.2010.06.018; Hosoya KI, 1999, J PHARMACOL EXP THER, V291, P53; Kamiya K, 2012, EYE, V26, P1363, DOI 10.1038/eye.2012.166; Nichols KK, 2004, EXPERT OPIN INV DRUG, V13, P47, DOI 10.1517/eoid.13.1.47.25281; Murakami T, 2003, J OCUL PHARMACOL TH, V19, P345, DOI 10.1089/108076803322279390; Coutinho-Silva R, 2001, CELL TISSUE RES, V306, P373, DOI 10.1007/s004410100458; Koh S, 2013, JPN J OPHTHALMOL, V57, P440, DOI 10.1007/s10384-013-0251-y; Fujihara T, 2002, J OCUL PHARMACOL TH, V18, P363, DOI 10.1089/10807680260218524; Shimazaki-Den S, 2013, CORNEA, V32, P1120, DOI 10.1097/ICO.0b013e3182930b1d; Cowlen MS, 2003, EXP EYE RES, V77, P77, DOI 10.1016/S0014-4835(03)00068-X; Afework M, 2005, INT J DEV NEUROSCI, V23, P567, DOI 10.1016/j.ijdevneu.2005.07.004; Fujihara T, 2001, INVEST OPHTH VIS SCI, V42, P96; Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448; Nakamura M, 2012, ADV THER, V29, P579, DOI 10.1007/s12325-012-0033-9; Matsumoto Y, 2012, OPHTHALMOLOGY, V119, P1954, DOI 10.1016/j.ophtha.2012.04.010; Dartt DA, 2002, PROG RETIN EYE RES, V21, P555, DOI 10.1016/S1350-9462(02)00038-1; Fries JE, 2004, INVEST OPHTH VIS SCI, V45, P3410, DOI 10.1167/iovs.04-0141; Ishibashi K, 2008, AM J PHYSIOL-REG I, V294, pR1729, DOI 10.1152/ajpregu.00758.2007; Johansson PA, 2007, EUR J NEUROSCI, V25, P3319, DOI 10.1111/j.1460-9568.2007.05562.x; Murakami T, 2000, CURR EYE RES, V21, P782, DOI 10.1076/ceyr.21.4.782.5550; Nakamura M, 2011, JPN J OCULAR PHARM, V25, P42; Pendergast W, 2001, BIOORG MED CHEM LETT, V11, P157, DOI 10.1016/S0960-894X(00)00612-0; Shiue MHI, 2000, LIFE SCI, V66, pPL105, DOI 10.1016/S0024-3205(99)00638-4; Tauber J, 2007, CORNEA, V26, P514; Yamaguchi M, 2012, J EYE, V29, P527	30	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	NOV	2014	58	6					515	521		10.1007/s10384-014-0342-4		7	Ophthalmology	Ophthalmology	AT7CK	WOS:000345093900009		
J	Shibata, Y; Tanaka, Y; Tomita, T; Taogoshi, T; Kimura, Y; Chikama, T; Kihira, K				Shibata, Yuuka; Tanaka, Yuta; Tomita, Takashi; Taogoshi, Takanori; Kimura, Yasuhiro; Chikama, Taiichiro; Kihira, Kenji			Evaluation of corneal damage caused by iodine preparations using human corneal epithelial cells	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Corneal epithelial cell; Preoperative antisepsis; Polyvinyl alcohol-iodine; Povidone-iodine	CATARACT-SURGERY; POVIDONE-IODINE; ENDOTHELIUM; TOLERANCE; CULTURE; RABBIT; MODEL; EYE	To compare the cytotoxicity of povidone-iodine solution (PVP-I) with that of polyvinyl alcohol-iodine solution (PAI) for ophthalmic use. Cells of the human corneal epithelial cell line HCE-T were exposed to various dilutions of PVP-I or PAI, and the cytotoxicity of these two antiseptics was evaluated. The relative toxicities of PVP-I and PAI were also investigated following the inactivation of iodine by achromatization with sodium thiosulfate. PVP-I and PAI had equivalent antiseptic effects, but the cytotoxicity of PVP-I diluted 16-fold was higher than that of PAI diluted 6-fold. Following inactivation of iodine with sodium thiosulfate, the cytotoxicity of PVP-I remained concentration dependent, whereas PAI exhibited a low toxicity that was similar to the effect of saline on cell viability. Exposure to lauromacrogol, a surfactant used in PVP-I, in solution at concentrations of 1-1000 mg/mL clearly resulted in corneal cytotoxicity. The PVP-I and PAI solutions had a pH value of 4.0 and 5.2, respectively. HCE-T cells were significantly more viable at pH 7 than at pH 1-6. To avoid corneal damage, preoperative antisepsis of the surgical field should be accomplished with PAI diluted 6-fold, rather than with PVP-I diluted 16-fold. The toxicity of the iodine compound stems primarily from the available iodine concentration and partly from its pH, surfactant and osmolality. Further clinical investigations are required in order to determine the optimal concentrations for use.	[Shibata, Yuuka; Tomita, Takashi; Taogoshi, Takanori; Kimura, Yasuhiro; Kihira, Kenji] Hiroshima Univ Hosp, Dept Pharmaceut Serv, Minami Ku, Hiroshima 7348551, Japan; [Tanaka, Yuta] Hiroshima Univ, Fac Pharmaceut Sci, Hiroshima, Japan; [Chikama, Taiichiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	Shibata, Y (reprint author), Hiroshima Univ Hosp, Dept Pharmaceut Serv, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	utatti@nifty.com					Ciulla TA, 2002, OPHTHALMOLOGY, V109, P13, DOI 10.1016/S0161-6420(01)00899-5; Inoue Y, 2008, JPN J OPHTHALMOL, V52, P151, DOI 10.1007/s10384-008-0517-y; Inagaki K, 2013, JPN J OPHTHALMOL, V57, P74, DOI 10.1007/s10384-012-0201-0; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Nagai N, 2011, YAKUGAKU ZASSHI, V131, P985; Bratzler DW, 2013, AM J HEALTH-SYST PH, V70, P233; EDELHAUSER HF, 1981, ARCH OPHTHALMOL-CHIC, V99, P1281; GONNERING R, 1979, INVEST OPHTH VIS SCI, V18, P373; Ikuno Y, 2012, JPN J OPHTHALMOL, V56, P497, DOI 10.1007/s10384-012-0160-5; Isenberg SJ, 2002, DERMATOLOGY, V204, P92, DOI 10.1159/000057733; Iwasawa Atsuo, 2003, Kansenshogaku Zasshi, V77, P948; Iwasawa A, 2001, JPN J ENV INFECT, V16, P179; Taliana L, 2001, INVEST OPHTH VIS SCI, V42, P81; Toropainen E, 2001, INVEST OPHTH VIS SCI, V42, P2942; WILLE H, 1982, ACTA OPHTHALMOL, V60, P955	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	NOV	2014	58	6					522	527		10.1007/s10384-014-0348-y		6	Ophthalmology	Ophthalmology	AT7CK	WOS:000345093900010		
J	Suzuki, T; Fujimaki, T; Yanagawa, A; Arai, E; Fujiki, K; Wada, Y; Murakami, A				Suzuki, Takahide; Fujimaki, Takuro; Yanagawa, Ai; Arai, Eisuke; Fujiki, Keiko; Wada, Yuko; Murakami, Akira			A novel exon 17 deletion mutation of RPGRIP1 gene in two siblings with Leber congenital amaurosis	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						RPGRIP1; Leber congenital amaurosis; Deletion; Mutation	CONE-ROD DYSTROPHY; PHOTORECEPTOR DEGENERATION; MOLECULAR DIAGNOSIS; MURINE MODEL; THERAPY; PHENOTYPE; FAMILIES; PROTEIN	To investigate mutations of causal genes in two affected male siblings of a Japanese family with suspected Leber congenital amaurosis (LCA) and to characterize the related clinical features. After obtaining informed consent, genomic DNA was extracted from peripheral blood of the proband and his family members. Mutation screening was initially performed with microarrays. The PCR and direct sequencing were successively done for confirmation of mutation detected by microarray, and the two patients who are the subjects of this study were also clinically examined. Results of the microarray suggested deletion of exon 17 of RPGRIP1. Confirmation by PCR and direct sequencing following microarray analysis revealed that both siblings had homozygous deletion of exon 17 of the RPGRIP1 gene, while their unaffected parents were heterozygous carriers. Length of the deletion was 1339 bp including exon 17 at the position of c.2710+372_2895+76del1339. Clinical features of the two siblings showed nystagmus, poor visual acuity, hyperopia, and photophobia since early childhood; but there was no oculo-digital sign, vessel attenuation or RPE mottling from the mid-retina to the periphery. Full-field single flash ERG was recordable but 30 Hz flicker ERG was not detectable. Although the present patients did not show sufficient clinical findings as LCA, PCR findings and direct sequencing following microarray analysis confirmed that they were LCA. Genetic analyses are helpful for confirmation of clinical diagnosis.	[Suzuki, Takahide; Fujimaki, Takuro; Yanagawa, Ai; Arai, Eisuke; Fujiki, Keiko; Murakami, Akira] Juntendo Univ Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138431, Japan; [Wada, Yuko] Yuko Wada Eye Clin, Sendai, Miyagi, Japan	Fujimaki, T (reprint author), Juntendo Univ Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, 3-1-3 Hongo, Tokyo 1138431, Japan.	fujimaki@juntendo.ac.jp			Study Group on Chorioretinal Degeneration and Optic Atrophy, The Ministry of Health, Labor and Welfare, Japan [20261901]; Japan Society for the Promotion of Science [24592654]	The authors thank the patients and their family for assistance with this project. This study was supported in part by a Grant in Aid number 20261901 from the Study Group on Chorioretinal Degeneration and Optic Atrophy, The Ministry of Health, Labor and Welfare, Japan. This study was also supported by research grants from the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (C) 24592654). The authors thank Ms. Mari Takahashi (Department of Ophthalmology, Juntendo University) and Ms. Takako Ikegami (Laboratory of Molecular and Biological Research, Research Support Center, Juntendo University Graduate School of Medicine) for technical assistance.	Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P3965, DOI 10.1073/pnas.0637349100; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; Pawlyk BS, 2010, HUM GENE THER, V21, P993, DOI 10.1089/hum.2009.218; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Kuznetsova T, 2012, INVEST OPHTH VIS SCI, V53, P5486, DOI 10.1167/iovs.12-10178; Booij JC, 2011, OPHTHALMOLOGY, V118, P160, DOI 10.1016/j.ophtha.2010.04.022; Chen YB, 2013, INVEST OPHTH VIS SCI, V54, P4351, DOI 10.1167/iovs.13-11606; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Cremers FPM, 2002, HUM MOL GENET, V11, P1169, DOI 10.1093/hmg/11.10.1169; Damji KF, 2001, CAN J OPHTHALMOL, V36, P252; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Gerber S, 2001, EUR J HUM GENET, V9, P561, DOI 10.1038/sj.ejhg.5200689; Huang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065546; Jacobson SG, 2007, OPHTHALMOLOGY, V114, P895, DOI 10.1016/j.ophtha.2006.10.028; Khan AO, 2013, BRIT J OPHTHALMOL, V97, P760, DOI 10.1136/bjophthalmol-2012-303050; Koenekoop Robert K, 2005, Ophthalmic Genet, V26, P175, DOI 10.1080/13816810500374441; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019458; Li YM, 2009, INVEST OPHTH VIS SCI, V50, P1336, DOI 10.1167/iovs.08-2589; Miyadera K, 2009, MOL VIS, V15, P2287; Murakami Akira, 2014, Nippon Ganka Gakkai Zasshi, V118, P283; Narfstrom K, 2012, STEM CELLS INT, DOI 10.1155/2012/685901; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; von Leber TKG, 1869, ARCH OPHTHALMOLOGIE, V15, P1; Wang X, 2013, J MED GENET, V50, P674, DOI 10.1136/jmedgenet-2013-101558; Yousef YA, 2012, OPHTHAL SURG LAS IM, V43, P6, DOI 10.3928/15428877-20111129-09	32	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	NOV	2014	58	6					528	535		10.1007/s10384-014-0339-z		8	Ophthalmology	Ophthalmology	AT7CK	WOS:000345093900011		
J	Oguro, S; Nakatsuka, S; Jinzaki, M; Misu, M; Yashiro, H; Hashimoto, S; Kuribayashi, S				Oguro, Sota; Nakatsuka, Seishi; Jinzaki, Masahiro; Misu, Manabu; Yashiro, Hideki; Hashimoto, Subaru; Kuribayashi, Sachio			Visualization of the right adrenal vein using CT during right inferior phrenic arteriography in hepatocellular carcinoma patients	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Adrenal venous sampling; CT arteriography; Primary aldosteronism; Right adrenal vein; Transcatheter arterial chemoembolization (TACE)	PRIMARY ALDOSTERONISM; COMPUTED-TOMOGRAPHY; HYPERALDOSTERONISM; DIAGNOSIS; CENTERS; ANGIOGRAPHY; VENOGRAPHY; EXPERIENCE; ANATOMY	The objective of this retrospective study was to determine the frequency of right adrenal vein identification by computed tomography (CT) during right inferior phrenic arteriography (CTRIPA) and to describe the spectrum of anatomic variations of the right adrenal vein. CTRIPA performed on 104 patients treated with transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma in our hospital between August 2007 and July 2013 were reviewed. The right adrenal vein on CTRIPA images was evaluated for degree of visualization, anatomic variation, anatomic features, vessel direction, and length. CTRIPA images were compared with dynamic CT before TACE. Partial or entire enhancement of the adrenal gland was obtained in 101 patients. The right adrenal vein was detected using CTRIPA in 97 % (98/101) of patients, which was significantly higher than detection using dynamic multidetector CT (MDCT) [77 % (78/101)]. Vessel length and diameter averaged 8.5 +/- A 3.8 and 1.6 +/- A 0.5 mm, respectively. CTRIPA also showed venous drainage into the right capsular renal vein in nine patients. Almost all right adrenal veins were visualized using CTRIPA; the detection rate was significantly higher on CTRIPA than on MDCT before TACE.	[Oguro, Sota; Nakatsuka, Seishi; Jinzaki, Masahiro; Misu, Manabu; Yashiro, Hideki; Kuribayashi, Sachio] Keio Univ, Sch Med, Dept Radiol, Keio Univ Hosp,Shinjuku Ku, Tokyo 1608582, Japan; [Hashimoto, Subaru] Tachikawa Hosp, Dept Radiol, Tachikawa, Tokyo 1908531, Japan	Oguro, S (reprint author), Keio Univ, Sch Med, Dept Radiol, Keio Univ Hosp,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	soguro@rad.med.keio.ac.jp; nakatsuka@rad.med.keio.ac.jp					Betz MJ, 2011, EUR J ENDOCRINOL, V165, P301, DOI 10.1530/EJE-11-0287; Magill SB, 2001, J CLIN ENDOCR METAB, V86, P1066, DOI 10.1210/jc.86.3.1066; Trerotola SO, 2011, J VASC INTERV RADIOL, V22, P1306, DOI 10.1016/j.jvir.2010.12.040; Doppman JL, 1996, RADIOLOGY, V198, P309; GORDON RD, 1994, CLIN EXP PHARMACOL P, V21, P315, DOI 10.1111/j.1440-1681.1994.tb02519.x; Miyayama S, 2006, CARDIOVASC INTER RAD, V29, P39, DOI 10.1007/s00270-004-0287-y; Scholten A, 2013, JAMA SURG, V148, P378, DOI 10.1001/jamasurg.2013.610; Daunt N, 2005, RADIOGRAPHICS, V25, pS143, DOI 10.1148/rg.25si055514; Rossi GP, 2001, J CLIN ENDOCR METAB, V86, P1083, DOI 10.1210/jc.86.3.1083; Young WF, 2004, SURGERY, V136, P1227, DOI 10.1016/j.surg.2004.06.051; Zarnegar R, 2008, J VASC INTERV RADIOL, V19, P66, DOI 10.1016/j.jvir.2007.08.022; Elliott P, 2013, CLIN BIOCHEM, V46, P1399, DOI 10.1016/j.clinbiochem.2013.04.004; Young WF, 2009, CLIN ENDOCRINOL, V70, P14, DOI 10.1111/j.1365-2265.2008.03450.x; Georgiades CS, 2007, J VASC INTERV RADIOL, V18, P1102, DOI 10.1016/j.jvir.2007.06.018; CLARK K, 1959, J R Coll Surg Edinb, V4, P257; DAVIDSON JK, 1975, BRIT J RADIOL, V48, P435; Fowler AC, 2013, J GLACIOL, V59, P190, DOI 10.3189/2013JoG12J164; GLEASON PE, 1993, J UROLOGY, V150, P1365; Gordon RD, 2001, WORLD J SURG, V25, P941; Harper R, 1999, QJM-MON J ASSOC PHYS, V92, P643, DOI 10.1093/qjmed/92.11.643; Higashide T, 2013, INT J CARDIOL, V168, P3254, DOI 10.1016/j.ijcard.2013.04.140; Kahn S Lowell, 2010, Tech Vasc Interv Radiol, V13, P110, DOI 10.1053/j.tvir.2010.02.006; MASONI A, 1957, ACTA MED SCAND, V159, P225; Matsuura T, 2008, AM J ROENTGENOL, V191, P402, DOI 10.2214/AJR.07.3338; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Onozawa S, 2014, EUR J ENDOCRINOL, V170, P601, DOI 10.1530/EJE-13-0741; Sheaves R, 1996, EUR J ENDOCRINOL, V134, P308	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	NOV	2014	32	11					630	636		10.1007/s11604-014-0356-3		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT9YR	WOS:000345280500002		
J	Yamakado, K; Miyayama, S; Hirota, S; Mizunuma, K; Nakamura, K; Inaba, Y; Yamamoto, S; Matsuo, K; Nishida, N; Aramaki, T; Anai, H; Kora, S; Oikawa, S; Watanabe, K; Yasumoto, T; Furuichi, K; Yamaguchi, M				Yamakado, Koichiro; Miyayama, Shiro; Hirota, Shozo; Mizunuma, Kimiyoshi; Nakamura, Kenji; Inaba, Yoshitaka; Yamamoto, Satoshi; Matsuo, Kunihiro; Nishida, Norifumi; Aramaki, Takeshi; Anai, Hiroshi; Kora, Shinichi; Oikawa, Shigeo; Watanabe, Ken; Yasumoto, Taku; Furuichi, Kinya; Yamaguchi, Masato			Prognosis of patients with intermediate-stage hepatocellular carcinomas based on the Child-Pugh score: subclassifying the intermediate stage (Barcelona Clinic Liver Cancer stage B)	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Hepatocellular carcinoma; Chemoembolization; Child-Pugh score; Prognosis; Stage	TRANSARTERIAL CHEMOEMBOLIZATION; ARTERIAL EMBOLIZATION; SUBCLASSIFICATION; MANAGEMENT; SURVIVAL; TRIALS	Retrospective evaluation of intermediate-stage hepatocellular carcinoma (HCC) patient survival after undergoing chemoembolization based on the Child-Pugh score. Data of intermediate-stage HCC patients undergoing chemoembolization were gathered from 43 centers in Japan. Overall survival rates were compared with Child-Pugh scores. Of the 329 patients examined in this study, Child-Pugh scores were 5 (CP-5) in 136 patients (41.3 %), 6 (CP-6) in 101 patients (30.7 %), 7 (CP-7) in 58 (17.7 %), 8 (CP-8) in 22 (6.7 %), and 9 (CP-9) in 12 (3.6 %). Two-year survival rates were 77.5 % in CP-5 patients (p = 0.047 vs. CP-6), 65.1 % in CP-6 patients (p = 0.038 vs. CP-7), 51.3 % in CP-7 patients (p = 0.30 vs. CP-8, p = 0.034 vs. CP-9), 50.3 % in CP-8 patients (p = 0.0065 vs. CP-9), and 16.7 % in CP-9 patients. Two-year survival rates were 77.2 % in 139 patients meeting the 4 tumors of 7 cm criterion with Child-Pugh class A (B1) (p < 0.0001 vs. B2), 59.5 % in 178 patients other than B1 and B3 (B2) (p = 0.0014 vs. B3), and 16.7 % in 12 patients with Child-Pugh score 9 (B3). The Child-Pugh score is a useful prognostic factor to stratify intermediate-stage HCC patients.	[Yamakado, Koichiro] Mie Univ, Sch Med, Dept Intervent Radiol, Tsu, Mie 5148507, Japan; [Miyayama, Shiro] Fukui Ken Saiseikai Hosp, Dept Diagnost Radiol, Fukui, Japan; [Hirota, Shozo; Yamamoto, Satoshi] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo 6638501, Japan; [Mizunuma, Kimiyoshi] Nasu Red Cross Hosp, Dept Radiol, Nasu, Japan; [Nakamura, Kenji] Daito Cent Hosp, Dept Radiol, Daito, Japan; [Inaba, Yoshitaka] Aichi Canc Ctr Hosp & Res Inst, Dept Diagnost & Intervent Radiol, Nagoya, Aichi, Japan; [Matsuo, Kunihiro] Narumi Hosp, Dept Radiol, Aomori, Japan; [Nishida, Norifumi] Osaka City Univ, Dept Radiol, Osaka 558, Japan; [Aramaki, Takeshi] Shizuoka Canc Ctr, Dept Diagnost Radiol, Shizuoka, Japan; [Anai, Hiroshi] Nara Med Univ, Dept Radiol, Kashihara, Nara 634, Japan; [Kora, Shinichi] Fukuoka Univ, Dept Radiol, Fukuoka 81401, Japan; [Oikawa, Shigeo] Iwate Cent Prefectural Hosp, Dept Radiol, Morioka, Iwate, Japan; [Watanabe, Ken] Jikei Univ, Dept Radiol, Tokyo, Japan; [Yasumoto, Taku] Toyonaka City Hosp, Dept Radiol, Toyonaka, Osaka, Japan; [Furuichi, Kinya] Higashiosaka City Gen Hosp, Dept Radiol, Higashiosaka, Osaka, Japan; [Yamaguchi, Masato] Kobe Univ, Dept Radiol, Kobe, Hyogo 657, Japan	Yamakado, K (reprint author), Mie Univ, Sch Med, Dept Intervent Radiol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	yama@clin.medic.mie-u.ac.jp					Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Ha Y, 2014, J GASTROEN HEPATOL, V29, P787, DOI 10.1111/jgh.12452; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Yamakado K, 2012, JPN J RADIOL, V30, P560, DOI 10.1007/s11604-012-0088-1; Yamakado K, 2014, JPN J RADIOL, V32, P260, DOI 10.1007/s11604-014-0298-9; Bolondi L, 2012, SEMIN LIVER DIS, V32, P348, DOI 10.1055/s-0032-1329906; Cabibbo Giuseppe, 2012, World J Hepatol, V4, P256, DOI 10.4254/wjh.v4.i9.256; Mazzoferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Piscaglia F, 2013, DIGEST LIVER DIS, V45, P852, DOI 10.1016/j.dld.2013.03.002	13	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	NOV	2014	32	11					644	649		10.1007/s11604-014-0358-1		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT9YR	WOS:000345280500004		
J	Kojima, K; Kato, K; Fukazawa, T; Morita, I; Takigawa, N; Monobe, Y; Shibamoto, K; Soda, Y; Mimura, H				Kojima, Katsuhide; Kato, Katsuya; Fukazawa, Takuya; Morita, Ichiro; Takigawa, Nagio; Monobe, Yasumasa; Shibamoto, Kentaro; Soda, Yuko; Mimura, Hidefumi			A case of autoimmune pulmonary alveolar proteinosis appearing as a localized ground-glass opacity	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Pulmonary alveolar proteinosis; Localized ground-glass opacity; Anti-GM-CSF antibody; Computed tomography	CT	Pulmonary alveolar proteinosis (PAP) is a rare diffuse lung disease caused by abnormal intra-alveolar surfactant accumulation; it commonly appears as a "crazy-paving" pattern on high-resolution computed tomography. Here, we report a rare case of autoimmune PAP appearing as localized ground-glass opacity. An 82-year-old woman underwent chest computed tomography (CT) at another facility for cough, and a 2-cm localized ground-glass opacity was detected at the bottom of the right upper lung lobe. When she presented for follow-up at our hospital 6 months later, she was asymptomatic. The CT examinations performed at that point and 2 months thereafter did not reveal any changes. However, a CT examination performed after 5 months revealed slight increases in size and concentration. Adenocarcinoma in situ or minimally invasive adenocarcinoma was suspected. Incomplete lobulation between the upper and middle lobes of the right lung was detected, and video-assisted thoracoscopic lobectomy of the upper lobe and partial resection of the middle lobe of the right lung were performed. Histological examination revealed alveoli and terminal bronchioles filled with eosinophilic proteinaceous material positive for periodic acid-Schiff stain. The histopathological diagnosis was PAP and positive serum anti-GM-CSF antibody findings confirmed autoimmune PAP.	[Kojima, Katsuhide; Shibamoto, Kentaro; Soda, Yuko; Mimura, Hidefumi] Kawasaki Hosp, Dept Diagnost Radiol 2, Kawasaki Med Sch, Kita Ku, Okayama 7008505, Japan; [Kato, Katsuya] Okayama Univ, Dept Radiol, Sch Med, Kita Ku, Okayama 7008558, Japan; [Fukazawa, Takuya; Morita, Ichiro] Kawasaki Hosp, Kawasaki Med Sch, Dept Gen Surg, Kita Ku, Okayama 7008505, Japan; [Takigawa, Nagio] Kawasaki Hosp, Kawasaki Med Sch, Dept Gen Internal Med 4, Kita Ku, Okayama 7008505, Japan; [Monobe, Yasumasa] Kawasaki Hosp, Kawasaki Med Sch, Dept Pathol, Kita Ku, Okayama 7008505, Japan	Kojima, K (reprint author), Kawasaki Hosp, Dept Diagnost Radiol 2, Kawasaki Med Sch, Kita Ku, 2-1-80 Nakasange, Okayama 7008505, Japan.	kkojima@s.okayama-u.ac.jp					Inoue Y, 2008, AM J RESP CRIT CARE, V177, P752, DOI 10.1164/rccm.200708-1271OC; Frazier AA, 2008, RADIOGRAPHICS, V28, P883, DOI 10.1148/rg.283075219; Rossi SE, 2003, RADIOGRAPHICS, V23, P1509, DOI 10.1148/rg.236035101; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Guan YB, 2012, EUR J RADIOL, V81, P2430, DOI 10.1016/j.ejrad.2011.05.005; Ishii H, 2009, CHEST, V136, P1348, DOI 10.1378/chest.09-0097; Matsushima Sayomi, 2011, Nihon Kokyuki Gakkai Zasshi, V49, P553; Mehrian Payam, 2014, Pol J Radiol, V79, P65, DOI 10.12659/PJR.890218; Sugimoto Chikatoshi, 2006, Nihon Kokyuki Gakkai Zasshi, V44, P738; Sunadome Hironobu, 2010, Nihon Kokyuki Gakkai Zasshi, V48, P516	10	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	NOV	2014	32	11					657	660		10.1007/s11604-014-0348-3		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT9YR	WOS:000345280500006		
J	Itano, O; Itano, S; Nagamatsu, H; Tsutsui, R; Deguchi, A; Inoue, M; Nakatsuka, S				Itano, Osamu; Itano, Satoshi; Nagamatsu, Hiroaki; Tsutsui, Rina; Deguchi, Akihiro; Inoue, Masanori; Nakatsuka, Seishi			Intermittent transcatheter therapy through a new indwelling catheter system for patients with hepatocellular carcinoma	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Transcatheter arterial infusion; Indwelling catheter system; System-i	ARTERIAL INFUSION CHEMOTHERAPY; HEPATIC-ARTERY; CHEMOEMBOLIZATION; REDISTRIBUTION	This paper describes the technical details of the new indwelling catheter system, which we refer to as System-i, and provides an overview of our experience with this system at our institution. The system is implanted via the left brachial artery. The feeding artery of the tumor is catheterized at each treatment, and the system can be used for multiple treatments via more than one feeding artery. Between January 2004 and January 2013, System-i was used to administer 398 treatments in 30 patients with hepatocellular carcinoma (HCC). The technical aspects and outcomes of treatment procedures were evaluated. Implantation was successful in all cases. System-i was used for a median number of 11 treatments per patient over a median period of 5.7 months, and 71.6 % of all treatments were administered on an outpatient basis. System-i provides an effective and safe method for selective catheterization of feeding arteries for administration of transcatheter arterial chemoembolization or infusion in patients with HCC. Treatment regimens can be individualized without limiting the number of treatments or treatment locations, and patients can be treated on an outpatient basis.	[Itano, Osamu; Tsutsui, Rina] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Itano, Satoshi] Itano Clin, Kurume, Fukuoka 8300033, Japan; [Nagamatsu, Hiroaki; Deguchi, Akihiro] Yame Gen Hosp, Dept Med, Fukuoka 8340034, Japan; [Itano, Satoshi; Nakatsuka, Seishi] Keio Univ, Dept Radiol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Itano, S (reprint author), Itano Clin, 34-15 Tenjin Machi, Kurume, Fukuoka 8300033, Japan.	angiolion@gmail.com					Miyayama S, 2006, CARDIOVASC INTER RAD, V29, P39, DOI 10.1007/s00270-004-0287-y; Yamagami T, 2004, RADIOLOGY, V230, P792, DOI 10.1148/radiol.2303021564; Arai Y, 1997, INTERVENTIONAL RADIO, P192; Aramaki T, 2014, CARIOVASC INTERV RAD; Choi SY, 2010, KOREAN J RADIOL, V11, P648, DOI 10.3348/kjr.2010.11.6.648; CHUANG VP, 1980, RADIOLOGY, V135, P295; Habbe TG, 1998, J VASC INTERV RADIOL, V9, P233, DOI 10.1016/S1051-0443(98)70262-3; Itano SyHisatomi J, 2007, RADIOL FRONT, V10, P83; Matsumoto T, 2014, AM J ROENTGENOL, V202, P211, DOI 10.2214/AJR.12.10502; Maurizio G, 2000, CARIOVASC INTERV RAD, V23, P202; Mikami Koji, 2009, Gan To Kagaku Ryoho, V36, P959; Nagaoka S, 2007, AM J ROENTGENOL, V188, P652, DOI 10.2214/AJR.05.0693; Ohuchi Y, 2011, HEPATO-GASTROENTEROL, V58, P916; Okumura F, 2007, THER RES HEPATO BILI, V5, P46; Satoru M, 2005, HEPATO-GASTROENTEROL, V52, P852; Yagihashi K, 2010, CARDIOVASC INTER RAD, V33, P1153, DOI 10.1007/s00270-009-9779-0; Yamagami T, 2008, ACTA RADIOL, V49, P513, DOI 10.1080/02841850802007531	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	NOV	2014	32	11					670	675		10.1007/s11604-014-0361-6		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT9YR	WOS:000345280500009		
J	Aguilar, C; Lenoir, C; Lambert, N; Begue, B; Brousse, N; Canioni, D; Berrebi, D; Roy, M; Gerart, S; Chapel, H; Schwerd, T; Siproudhis, L; Schappi, M; Al-Ahmari, A; Mori, M; Yamaide, A; Galicier, L; Neven, B; Routes, J; Uhlig, HH; Koletzko, S; Patel, S; Kanegane, H; Picard, C; Fischer, A; Bensussan, NC; Ruemmele, F; Hugot, JP; Latour, S				Aguilar, Claire; Lenoir, Christelle; Lambert, Nathalie; Begue, Bernadette; Brousse, Nicole; Canioni, Danielle; Berrebi, Dominique; Roy, Maryline; Gerart, Stephane; Chapel, Helen; Schwerd, Tobias; Siproudhis, Laurent; Schaeppi, Michela; Al-Ahmari, Ali; Mori, Masaaki; Yamaide, Akiko; Galicier, Lionel; Neven, Benedicte; Routes, John; Uhlig, Holm H.; Koletzko, Sibylle; Patel, Smita; Kanegane, Hirokazu; Picard, Capucine; Fischer, Alain; Bensussan, Nadine Cerf; Ruemmele, Frank; Hugot, Jean-Pierre; Latour, Sylvain			Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Inflammatory bowel disease; Crohn disease; X-linked inhibitor of apoptosis immunodeficiency; NOD receptors; monocytes	INFLAMMATORY-BOWEL-DISEASE; XIAP DEFICIENCY; LYMPHOPROLIFERATIVE SYNDROME; NOD2; MUTATIONS; RECEPTOR; CELLS; IMMUNODEFICIENCY; SUSCEPTIBILITY; ASSOCIATION	Background: Crohn disease is an inflammatory bowel disease (IBD) with a complex mode of inheritance. Although nucleotide binding and oligomerization domain containing 2 (NOD2) is the strongest risk factor, the cause of Crohn disease remains unknown in the majority of the cases. X-linked inhibitor of apoptosis (XIAP) deficiency causes X-linked lymphoproliferative syndrome type 2. IBD has been reported in some XIAP-deficient patients. Objective: We characterize the IBD affecting a large cohort of patients with mutations in XIAP and examine the possible pathophysiologic mechanisms. Methods: We performed a phenotypical and histologic analysis of the IBD affecting 17 patients with hemizygous mutations in XIAP, including 3 patients identified by screening 83 patients with pediatric-onset IBD. The X chromosome inactivation was analyzed in female carriers of heterozygous XIAP mutations, including 2 adults with IBD. The functional consequences of XIAP deficiency were analyzed. Results: Clinical presentation and histology of IBD in patients with XIAP deficiency overlapped with those of patients with Crohn disease. The age at onset was variable (from 3 months to 41 years), and IBD was severe and difficult to treat. In 2 patients hematopoietic stem cell transplantation fully restored intestinal homeostasis. Monocytes of patients had impaired NOD2-mediated IL-8 and monocyte chemoattractant protein 1 (MCP-1) production, as well as IL-10, in response to NOD2 and Toll-like receptor 2/4 costimulation. Nucleotide binding and oligomerization domain containing 1 (NOD1)-mediated IL-6 and IL-8 production was defective in fibroblasts from XIAP-deficient patients. The 2 heterozygous female carriers of XIAP mutations with IBD displayed abnormal expression of the XIAP mutated allele, resulting in impaired activation of the NOD2 pathway. Conclusion: IBD in patients with XIAP deficiency is similar to Crohn disease and is associated with defective NOD2 function in monocytes. Importantly, we report that it is not restricted to male patients because we identified 2 symptomatic female heterozygous carriers of XIAP mutations.	[Aguilar, Claire; Lenoir, Christelle; Gerart, Stephane; Picard, Capucine; Fischer, Alain; Latour, Sylvain] Hop Necker Enfants Malad, Lab Lymphocyte Activat & EBV Susceptibil, F-75015 Paris, France; [Begue, Bernadette; Bensussan, Nadine Cerf; Ruemmele, Frank] Hop Necker Enfants Malad, Lab Interact Intestinal Epithelium & Immune Syst, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, Lab Human Genet Infect Dis, INSERM, UMR 1163, F-75015 Paris, France; [Aguilar, Claire; Lenoir, Christelle; Begue, Bernadette; Gerart, Stephane; Picard, Capucine; Fischer, Alain; Bensussan, Nadine Cerf; Ruemmele, Frank; Latour, Sylvain] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France; [Lambert, Nathalie; Picard, Capucine] Hosp Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiencies CEDI, Paris, France; [Brousse, Nicole; Canioni, Danielle] Hosp Necker Enfants Malades, AP HP, Dept Pathol, Paris, France; [Neven, Benedicte; Fischer, Alain] Hosp Necker Enfants Malades, AP HP, Dept Immunol & Haematol, Paris, France; [Ruemmele, Frank] Hosp Necker Enfants Malades, AP HP, Pediat Gastroenterol Unit, Paris, France; [Berrebi, Dominique] Hosp Robert Debre, Dept Pathol, Paris, France; [Berrebi, Dominique; Roy, Maryline; Hugot, Jean-Pierre] Hosp Bichat, INSERM, UMR 843, Paris, France; [Berrebi, Dominique; Roy, Maryline; Hugot, Jean-Pierre] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Chapel, Helen; Patel, Smita] Univ Oxford, Oxford NIHR Biomed Res Ctr, Primary Immunodeficiency Unit, Oxford OX1 2JD, England; [Schwerd, Tobias; Koletzko, Sibylle] Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Munich, Germany; [Siproudhis, Laurent] Univ Hosp Rennes, Dept Hepatogastroenterol, Rennes, France; [Schaeppi, Michela] Clin Grangettes, Pediat Ctr, Geneva, Switzerland; [Schaeppi, Michela] Ctr Med Univ Geneva, Geneva, Switzerland; [Al-Ahmari, Ali] Alfaisal Univ, King Faisal Specialist Hosp, Dept Pediat Hematol Oncol, Riyadh, Saudi Arabia; [Al-Ahmari, Ali] Alfaisal Univ, Res Ctr, Riyadh, Saudi Arabia; [Mori, Masaaki] Yokohama City Univ, Ctr Med, Dept Pediat, Yokohama, Kanagawa 232, Japan; [Yamaide, Akiko] Chiba Childrens Hosp, Div Allergy & Rheumatol, Chiba, Japan; [Galicier, Lionel] Hosp St Louis, AP HP, Dept Clin Immunol, Paris, France; [Routes, John] Med Coll Wisconsin, Childrens Canc Inst, Div Allergy & Clin Immunol, Milwaukee, WI 53226 USA; [Uhlig, Holm H.] Univ Oxford, Translat Gastroenterol Unit, Oxford OX1 2JD, England; [Uhlig, Holm H.] Univ Oxford, Childrens Hosp, Oxford OX1 2JD, England; [Kanegane, Hirokazu] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pediat, Toyama, Japan; [Hugot, Jean-Pierre] Hosp Robert Debre, AP HP, Pediat Gastroenterol Unit, Paris, France	Latour, S (reprint author), Hop Necker Enfants Malad, Lab Lymphocyte Activat & EBV Susceptibil, Imagine Inst Malad Genet, INSERM UMR 1163, 24 Blvd Montparnasse, F-75015 Paris, France.	sylvain.latour@inserm.fr		Picard, Capucine/0000-0001-8788-5056	INSERM; Agence Nationale de la Recherche (ANR) [ANR08 MIEN-012-01, ANR-2010-MIDI-005-02, ANR-10-IAHU-01]; Fondation ARC pour la Recherche sur le Cancer (France); European Research Council [ERC-2009-AdG_20090506]; Rare Diseases Fondation (France); Deutsche Forschungsgemeinschaft [SCHW1730/1-1]; Fondation ARC pour la Recherche sur le Cancer; Ministere de la Recherche et de l'Ecole Polytechnique (France); Fondation ARC	Supported by grants from INSERM, the Agence Nationale de la Recherche (ANR; ANR08 MIEN-012-01, ANR-2010-MIDI-005-02, and ANR-10-IAHU-01), the Fondation ARC pour la Recherche sur le Cancer (France), the European Research Council (ERC-2009-AdG_20090506 no. FP7-249816), and the Rare Diseases Fondation (France). This work was also supported by a grant from the Deutsche Forschungsgemeinschaft (SCHW1730/1-1; to T. S). S. L. is a senior scientist at the Centre National de la Recherche Scientifique-CNRS (France). C. A. is supported by the Fondation ARC pour la Recherche sur le Cancer. S. G. was a fellowship recipient of the Ministere de la Recherche et de l'Ecole Polytechnique (France) and the Fondation ARC.	Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Netea MG, 2005, J IMMUNOL, V174, P6518; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Yang X, 2012, J CLIN IMMUNOL, V32, P411, DOI 10.1007/s10875-011-9638-z; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Huang X, 2013, EMBO J, V32, P2204, DOI 10.1038/emboj.2013.133; Casanova JL, 2009, J EXP MED, V206, P1839, DOI 10.1084/jem.20091683; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Speckmann C, 2013, CLIN IMMUNOL, V149, P133, DOI 10.1016/j.clim.2013.07.004; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Marsh RA, 2010, J IMMUNOL METHODS, V362, P1, DOI 10.1016/j.jim.2010.08.010; Ammann S, 2014, CLIN EXP IMMUNOL, V176, P394, DOI 10.1111/cei.12306; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Gerart S, 2013, BLOOD, V121, P614, DOI 10.1182/blood-2012-09-456095; Strober W, 2011, MUCOSAL IMMUNOL, V4, P484, DOI 10.1038/mi.2011.29; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Muise AM, 2012, GUT, V61, P1028, DOI 10.1136/gutjnl-2011-300078; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Marks DJB, 2009, AM J GASTROENTEROL, V104, P117, DOI 10.1038/ajg.2008.72; Damgaard RB, 2012, MOL CELL, V46, P1; Galban S, 2009, CELL DEATH DIFFER, V17, P54; Rigaud S, 2011, BLOOD, V118, P252, DOI 10.1182/blood-2011-01-328849; Speckmann C, 2013, GUT; Travassos LH, 2006, NAT IMMUNOL, V11, P55; Zeissig Y, 2014, GUT	39	9	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2014	134	5					1131	+		10.1016/j.jaci.2014.04.031		20	Allergy; Immunology	Allergy; Immunology	AT4UN	WOS:000344938900019		
J	Kubo, K				Kubo, Keitaro			Active muscle stiffness in the human medial gastrocnemius muscle in vivo	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						plantar flexors; fascicle; tendon; ultrasonography	ELASTIC COMPONENT STIFFNESS; TENDON STIFFNESS; MUSCULOTENDINOUS STIFFNESS; MECHANICAL-PROPERTIES; PASSIVE PARTS; FASCICLES; BEHAVIOR; COMPLEX; STRETCH; KNEE	The aims of this study were to 1) directly assess active muscle stiffness according to actual length changes in muscle fibers (fascicles) during short range stretching; and 2) compare actual measured active muscle and tendon stiffness using ultrasonography with the stiffness of active (i.e., muscle) and passive (i.e., tendon) parts in series elastic component of plantar flexors using the alpha method. Twenty-four healthy men volunteered for this study. Active muscle stiffness in the medial gastrocnemius muscle was calculated according to changes in estimated muscle force and fascicle length during fast stretching after submaximal isometric contractions [10, 30, 50, 70, and 90% maximal voluntary contractions (MVC)]. Using the variables measured during this fast stretch experiment, the stiffness of active (i.e., muscle) and passive (i.e., tendon) parts in plantar flexors was assessed using alpha method. Tendon stiffness was determined during isometric plantar flexion by ultrasonography. Active muscle stiffness increased with the exerted torque levels. At 30, 50, 70, and 90% MVC, there were no significant correlations between muscle stiffness using ultrasonography and stiffness of active part (i. e., muscle) by alpha method, although this relationship at 10% MVC was significant (r = 0.552, P = 0.005). In addition, no correlation was noted in tendon stiffness between the two different methods (r = 0.226, P = 0.209). The present study demonstrated that ultrasonography could quantified active muscle stiffness in vivo. Furthermore, active muscle stiffness and tendon stiffness using ultrasonography were not related to active (i. e., muscle) or passive (i. e., tendon) stiffness in series elastic component of plantar flexors by alpha method.	[Kubo, Keitaro] Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Kubo, K (reprint author), Univ Tokyo, Dept Life Sci Sports Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.	kubo@idaten.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science [21680047]	This study was supported by a Grant-in-Aid for Young Scientists (A) (21680047 to K. Kubo) from the Japan Society for the Promotion of Science.	ALLUM JHJ, 1984, J NEUROPHYSIOL, V52, P797; Kubo K, 2007, EUR J APPL PHYSIOL, V99, P235, DOI 10.1007/s00421-006-0338-y; Svantesson U, 1998, SCAND J MED SCI SPOR, V8, P252, DOI 10.1111/j.1600-0838.1998.tb00479.x; Foure A, 2013, J APPL PHYSIOL, V114, P523, DOI 10.1152/japplphysiol.01313.2011; Kawakami Y, 2000, J APPL BIOMECH, V16, P88; Kubo K, 1999, J APPL PHYSIOL, V87, P2090; Kurokawa S, 2001, J APPL PHYSIOL, V90, P1349; Kubo K, 2000, ACTA PHYSIOL SCAND, V170, P127, DOI 10.1046/j.1365-201x.2000.00768.x; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Gajdosik RL, 2001, CLIN BIOMECH, V16, P87, DOI 10.1016/S0268-0033(00)00061-9; Muraoka T, 2002, CELLS TISSUES ORGANS, V171, P260, DOI 10.1159/000063128; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229; Nakamura M, 2012, EUR J APPL PHYSIOL, V112, P2749, DOI 10.1007/s00421-011-2250-3; Cook CS, 1996, EUR J APPL PHYSIOL O, V72, P380, DOI 10.1007/BF00599700; PURSLOW PP, 1989, J BIOMECH, V22, P21, DOI 10.1016/0021-9290(89)90181-4; Walshe AD, 1996, EUR J APPL PHYSIOL O, V73, P332, DOI 10.1007/BF02425495; Herbert RD, 2002, J PHYSIOL-LONDON, V539, P637, DOI 10.1013/jphysiol.2001.012756; SINKJAER T, 1988, J NEUROPHYSIOL, V60, P1110; Fukunaga T, 1996, J APPL PHYSIOL, V80, P158; BLANPIED P, 1992, J BIOMECH, V25, P29, DOI 10.1016/0021-9290(92)90243-T; Foure A, 2010, INT J SPORTS MED, V31, P51, DOI 10.1055/s-0029-1241210; Foure A, 2011, EUR J APPL PHYSIOL, V111, P539, DOI 10.1007/s00421-010-1667-4; Greive DW, 1978, BIOMECHANICS A, VVI, P405; Hoang PD, 2007, J EXP BIOL, V210, P4159, DOI 10.1242/jeb.002204; Hof AL, 1998, J BIOMECH, V31, P793, DOI 10.1016/S0021-9290(98)00062-1; Kubo K, 2009, J APPL PHYSIOL, V106, P412, DOI 10.1152/japplphysiol.91381.2008; Kubo K, 2002, J PHYSIOL-LONDON, V538, P219, DOI 10.1113/jphysiol.2001.012703; Lambertz D, 2003, J APPL PHYSIOL, V95, P64, DOI 10.1152/japplphysiol.00885.2002; Magnusson SP, 2001, J PHYSIOL-LONDON, V531, P277, DOI 10.1111/j.1469-7793.2001.0277j.x; MORGAN DL, 1977, AM J PHYSIOL, V232, pC45; Mrachacz-Kersting N, 2003, EXP BRAIN RES, V151, P72, DOI 10.1007/s00221-003-1483-8; Shorten MR, 1987, MED SPORT SCI, V25, P1; Wakahara T, 2007, J BIOMECH, V40, P2291, DOI 10.1016/j.jbiomech.2006.10.006	33	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	NOV 1	2014	117	9					1020	1026		10.1152/japplphysiol.00510.2014		7	Physiology; Sport Sciences	Physiology; Sport Sciences	AT5PT	WOS:000344995300010		
J	Ota, N; Soma, M				Ota, Nao; Soma, Masayo			Age-dependent song changes in a closed-ended vocal learner: elevation of song performance after song crystallization	JOURNAL OF AVIAN BIOLOGY			English	Article							BENGALESE FINCH SONG; MALE ZEBRA FINCHES; AUDITORY-FEEDBACK; MATE CHOICE; BIRD SONG; DEVELOPMENTAL STRESS; TAENIOPYGIA-GUTTATA; REPERTOIRE SIZE; HONEST SIGNAL; JAVA SPARROWS	Birdsong is a sexual signal that serves as an indicator of male quality. There is already abundant evidence that song elaboration reflects early life-history because early developmental stress affects neural development of song control systems, and leaves irreversible adverse effects on song phenotypes. Especially in closed-ended vocal learners, song features crystallized early in life are less subject to changes in adulthood. This is why less attention has been paid to lifelong song changes in closed-ended learners. However, in the eyes of female birds that gain benefits from choosing mates based on male songs, not only past but also current conditions encoded in songs would be meaningful, given that even crystallized songs in closed-ended learners would not be identical in the long term. In this study, we examine within-individual song changes in the Java sparrow Lonchura oryzivora, with the aim of shedding light on the relationship between song and long-term life history. Specifically, we compared song length, tempo, and song complexity measures between the point just after song crystallization and around 1 yr later, and also compared those traits between fathers and sons to clarify the effect of vocal learning. While it is not surprising that song complexity did not differ depending on age or between fathers and sons, we found that song length and tempo increased with age. Follow-up analyses have revealed that frequency bandwidth and peak frequency of song notes also elevated with age. Our results show that song performance related to motor skills can be improved even after song crystallization. We also suggest that song performance in closed-ended vocal learners gives a reliable clue for mate choice by reflecting male quality with aging.	[Ota, Nao] Hokkaido Univ, Grad Sch Life Sci, Behav Neurobiol Grp, Biosyst Sci Course,Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Soma, Masayo] Hokkaido Univ, Fac Sci, Dept Biol, Behav Neurobiol Grp, Sapporo, Hokkaido 0600810, Japan	Ota, N (reprint author), Hokkaido Univ, Grad Sch Life Sci, Behav Neurobiol Grp, Biosyst Sci Course,Kita Ku, Kita 10 Nishi 8, Sapporo, Hokkaido 0600810, Japan.	masayo.soma@sci.hokudai.ac.jp			JSPS [22800002, 23680027]	We thank Chihiro Mori, Raimu Imai and Shin Hayase for advice and technical assistance on the molecular sexing of chicks, and Kazutoshi Sasahara, Hiroko Kagawa and Eri Ohgushi for advice on song analysis. This study was supported by JSPS Grants-in-Aid for Young Scientists (22800002, 23680027) to MS.	Andersson M., 1994, SEXUAL SELECTION; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Vyas A, 2009, HORM BEHAV, V55, P50, DOI 10.1016/j.yhbeh.2008.08.005; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Buchanan KL, 2003, P ROY SOC B-BIOL SCI, V270, P1149, DOI 10.1098/rspb.2003.2330; Zollinger SA, 2012, ANIM BEHAV, V84, pE1, DOI 10.1016/j.anbehav.2012.04.026; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Ballentine B, 2009, ANIM BEHAV, V77, P973, DOI 10.1016/j.anbehav.2008.12.027; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1198/annals.1298.026; Soma M, 2013, BEHAVIOUR, V150, P1491, DOI 10.1163/1568539X-00003106; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Cooper BG, 2012, NEUROBIOL AGING, V33, P564, DOI 10.1016/j.neurobiolaging.2010.04.014; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; Podos J, 1996, ANIM BEHAV, V51, P1061, DOI 10.1006/anbe.1996.0107; MARTIN K, 1995, AM ZOOL, V35, P340; Hampton CM, 2009, J NEUROPHYSIOL, V101, P3235, DOI 10.1152/jn.91089.2008; Holveck MJ, 2008, BEHAV ECOL, V19, P1267, DOI 10.1093/beheco/arn078; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; de Kort SR, 2009, P ROY SOC B-BIOL SCI, V276, P2315, DOI 10.1098/rspb.2009.0127; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Suthers RA, 2002, CURR OPIN NEUROBIOL, V12, P684, DOI 10.1016/S0959-4388(02)00386-0; Schuster S, 2012, BIOL LETTERS, V8, P913, DOI 10.1098/rsbl.2012.0676; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; Brenowitz EA, 2005, TRENDS NEUROSCI, V28, P127, DOI 10.1016/j.tins.2005.01.004; Okanoya K, 1997, J NEUROBIOL, V33, P343; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; Holveck MJ, 2007, ANIM BEHAV, V74, P297, DOI 10.1016/j.anbehav.2006.08.016; Brainard MS, 2001, J NEUROSCI, V21, P2501; Gentner TQ, 2000, ANIM BEHAV, V59, P443, DOI 10.1006/anbe.1999.1313; Schmidt KL, 2013, ANIM BEHAV, V86, P25, DOI 10.1016/j.anbehav.2013.03.036; Hoese WJ, 2000, J EXP BIOL, V203, P1845; Pytte CL, 2007, DEV NEUROBIOL, V67, P1699, DOI 10.1002/dneu.20520; Nowicki S, 1998, AM ZOOL, V38, P179; Caro SP, 2010, BEHAV ECOL, V21, P562, DOI 10.1093/beheco/arq022; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Drgnoiu T. I., 2002, P BIOL SCI, V269, P2525; Hasegawa A, 2011, ORNITHOL SCI, V10, P73; Kagawa H, 2013, BEHAV PROCESS, V99, P138, DOI 10.1016/j.beproc.2013.07.012; Kagawa H, 2012, ZOOL SCI, V29, P645, DOI 10.2108/zsj.29.645; Kiefer S, 2009, J AVIAN BIOL, V40, P231, DOI 10.1111/j.1600-048X.2009.04500.x; Kipper S, 2010, ADV STUD BEHAV, V41, P77, DOI 10.1016/S0065-3454(10)41003-7; LEMON RE, 1993, ETHOLOGY, V93, P198; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; MacDougall-Shackleton S. A., 2012, J ORNITHOL, V53, P105; Mountjoy JD, 1995, ANIM BEHAV, V49, P357, DOI [10.1006/anbe.1995.0048, DOI 10.1006/ANBE.1995.0048]; Nakamura KZ, 2004, NEUROREPORT, V15, P1359, DOI 10.1097/01.wnr.0000125782.35268.d6; Neubauer RL, 1999, EVOL ECOL, V13, P365, DOI 10.1023/A:1006708826432; Nicholson JS, 2007, ANIM BEHAV, V74, P1585, DOI 10.1016/j.anbehav.2007.04.006; Nowicki S, 2005, AUK, V122, P1, DOI 10.1642/0004-8038(2005)122[0001:SAMCIB]2.0.CO;2; Soma Masayo, 2006, Ornithological Science, V5, P77, DOI 10.2326/osj.5.77; Soma M, 2006, ETHOLOGY, V112, P1071, DOI 10.1111/j.1439-0310.2006.01263.x; Soma MF, 2011, ORNITHOL SCI, V10, P89; Sprau P, 2013, J AVIAN BIOL, V44, P567, DOI 10.1111/j.1600-048X.2013.00113.x; Tchernichovski O, 1998, P NATL ACAD SCI USA, V95, P8951, DOI 10.1073/pnas.95.15.8951; Torres R, 2007, J ANIM ECOL, V76, P1161, DOI 10.1111/j.1365-2656.2007.01282.x; Vehrencamp SL, 2013, BEHAV ECOL SOCIOBIOL, V67, P409, DOI 10.1007/s00265-012-1461-x	61	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0908-8857	1600-048X		J AVIAN BIOL	J. Avian Biol.	NOV	2014	45	6					566	573		10.1111/jav.00383		8	Ornithology	Zoology	AT8UO	WOS:000345207500006		
J	Sakurai, Y; Uchida, Y				Sakurai, Yuji; Uchida, Yoshihiko			Rehypothecation dilemma: Impact of collateral rehypothecation on derivative prices under bilateral counterparty credit risk	JOURNAL OF BANKING & FINANCE			English	Article						Shadow banking; Collateral segregation; Credit rating migration; Margin call	SWAP RATES; CEV MODEL; DEFAULT; JUMP	Rehypothecation is the practice where a derivatives dealer reuses collateral posted from its end user in over-the-counter (OTC) derivatives markets. Although rehypothecation benefits the end user through cost reduction of derivative trades, it also creates additional counterparty credit risk since the end user may not receive the collateral back when the dealer suddenly defaults. To evaluate the benefits and risks of rehypothecation, we propose a derivative pricing framework with bilateral counterparty credit risk that determines the amount of rehypothecable collateral. We also model the realistic features of derivative trades: two different types of collateral, the time delay of collateral posting and the rating-dependent collateral agreement. We apply our pricing framework to cross currency swaps and investigate the impact of rehypothecation on the swap spreads. (C) 2013 Elsevier B.V. All rights reserved.	[Sakurai, Yuji] Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA 90095 USA; [Uchida, Yoshihiko] Bank Japan, Inst Monetary & Econ Studies, Chuo Ku, Tokyo 1038660, Japan	Sakurai, Y (reprint author), Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA 90095 USA.	yuji.sakurai.2015@anderson.ucla.edu; yoshihiko.uchida@boj.or.jp					Acharya V., 2011, TRANSPARENCY STANDAR; Albanese C, 2006, J BANK FINANC, V30, P607, DOI 10.1016/j.jbankfin.2005.04.011; Duffie D, 1996, J FINANC, V51, P921, DOI 10.2307/2329227; Burgard C, 2011, J CREDIT RISK, V7, P75; Linetsky V, 2006, MATH FINANC, V16, P255, DOI 10.1111/j.1467-9965.2006.00271.x; Collin-Dufresne P, 2001, J FINANC, V56, P1929, DOI 10.1111/0022-1082.00395; Carr P, 2006, FINANC STOCH, V10, P303, DOI 10.1007/s00780-006-0012-6; Banking Committee on Banking Supervision and Board of the International Organization of Securities Commissions, 2013, MARG REQ NONC CLEAR; Bliss R. R., 2006, J FINANCIAL STABILIT, V2, P55, DOI 10.1016/j.jfs.2005.05.001; Brigo D., 2011, WORKING PAPER; Campi L, 2009, J ECON DYN CONTROL, V33, P93, DOI 10.1016/j.jedc.2008.03.011; Acharya VV, 2011, WILEY FINANC SER, P1; Fender I., 2008, BIS Q REV        JUN, P1; Fortet R., 1943, J MATH PURE APPL, V22, P177; Fujii M., 2010, WORKING PAPER; Gregory J., 2010, COUNTERPARTY CREDIT; ISDA Managed Funds. Association SIFMA, 2010, IND AM; Johannes M, 2007, J FINANC, V62, P383, DOI 10.1111/j.1540-6261.2007.01210.x; Mendoza-Arriaga R, 2011, FINANC STOCH, V15, P513, DOI 10.1007/s00780-010-0139-3; Moore M., 2010, GOLDMAN SACHS DEMAND; Piterbarg V., 2010, RISK MAGAZINE, V23, P97; Pykhtin M., 2010, COUNTERPARTY CREDIT; SALMINEN P, 1988, ADV APPL PROBAB, V20, P411, DOI 10.2307/1427397; Sawyer N., 2010, RISK MAGAZINE, P23; Shreve S. E., 2004, STOCHASTIC CALCULUS, VII; Singh M., 2010, BANQUE FRANCE FINANC, P14; Singh M., 2010, IMF WORKING PAPER; White A., 2001, J DERIV, V8, P12, DOI DOI 10.3905/J0D.2001.319153	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4266	1872-6372		J BANK FINANC	J. Bank Financ.	NOV	2014	48						361	373		10.1016/j.jbankfin.2013.11.024		13	Business, Finance; Economics	Business & Economics	AT8SC	WOS:000345201300027		
J	Ochi, Y; Yamada, H; Mori, H; Kawada, N; Kayasuga, R; Nakanishi, Y; Tanaka, M; Imagawa, A; Ohmoto, K; Kawabata, K				Ochi, Yasuo; Yamada, Hiroyuki; Mori, Hiroshi; Kawada, Naoki; Kayasuga, Ryoji; Nakanishi, Yasutomo; Tanaka, Makoto; Imagawa, Akira; Ohmoto, Kazuyuki; Kawabata, Kazuhito			ONO-5334, a cathepsin K inhibitor, improves bone strength by preferentially increasing cortical bone mass in ovariectomized rats	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Cathepsin K; ONO-5334; Cortical bone; Bone strength; Ovariectomized rat	IN-VITRO; MECHANICAL-PROPERTIES; MATRIX DEGRADATION; RESORPTION; ACID; ALENDRONATE; OSTEOCLASTS; MICE; PYCNODYSOSTOSIS; APOPTOSIS	This study compared the effects of ONO-5334, a cathepsin K inhibitor, with those of alendronate on bone mass and strength in ovariectomized rats. Ovariectomy resulted in significant elevation in urinary deoxypyridinoline and plasma C-terminal cross-linking telopeptide of type I collagen (CTX) 8 weeks after surgery. Peripheral quantitative computed tomography analysis showed that total, trabecular, and cortical bone mineral content (BMC) decreased in the proximal tibia, which was paralleled with a significant decline in bone strength. Treatment with ONO-5334 (0.12, 0.6, 3 or 15 mg/kg) once daily for 8 weeks dose-dependently restored the decrease in total BMC and bone mineral density (BMD) in the proximal tibia and suppressed urinary deoxypyridinoline and plasma CTX levels. Alendronate (1 mg/kg, once daily) also fully restored these bone mass parameters. Separate analysis of trabecular and cortical bones, however, showed that ONO-5334 only partially restored trabecular BMD and BMC at 15 mg/kg, whereas alendronate fully restored these parameters. On the other hand, ONO-5334 increased both cortical BMD and BMC with an effect more potent than that of alendronate. Bone geometric analysis indicated that ONO-5334 at 15 mg/kg decreased endosteal circumference without affecting periosteal circumference, resulting in marked increase in cortical thickness. Interestingly, the effects of ONO-5334 on bone strength parameters were more prominent than those of alendronate, although the two test compounds had a similar effect on total BMC. Taken together, our results indicate that ONO-5334 has pharmacological characteristics different from those of alendronate and may offer a unique therapy for patients with osteoporosis.	[Ochi, Yasuo; Yamada, Hiroyuki; Mori, Hiroshi; Kawada, Naoki; Kayasuga, Ryoji; Nakanishi, Yasutomo; Tanaka, Makoto; Imagawa, Akira; Ohmoto, Kazuyuki; Kawabata, Kazuhito] Ono Pharmaceut Co Ltd, Minase Res Inst, Shimamoto, Osaka 6188585, Japan	Mori, H (reprint author), Ono Pharmaceut Co Ltd, Minase Res Inst, 3-1-1 Sakurai, Shimamoto, Osaka 6188585, Japan.	hir.mori@ono.co.jp	TANAKA, MAKOTO/I-1679-2012				Drake FH, 1996, J BIOL CHEM, V271, P12511; Gasser JA, 2008, J BONE MINER RES, V23, P544, DOI 10.1359/JBMR.071207; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Hogan HA, 2000, J BONE MINER RES, V15, P284, DOI 10.1359/jbmr.2000.15.2.284; Kim MK, 2006, J PHARMACOL EXP THER, V318, P555, DOI 10.1124/jpet.106.102798; Nishi Y, 1999, J BONE MINER RES, V14, P1902, DOI 10.1359/jbmr.1999.14.11.1902; Ochi Y, 2011, BONE, V49, P1351, DOI 10.1016/j.bone.2011.09.041; Stroup GB, 2001, J BONE MINER RES, V16, P1739, DOI 10.1359/jbmr.2001.16.10.1739; Pennypacker B, 2009, BONE, V44, P199, DOI 10.1016/j.bone.2008.08.130; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Cusick T, 2012, J BONE MINER RES, V27, P524, DOI 10.1002/jbmr.1477; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013; Li CY, 2006, J BONE MINER RES, V21, P865, DOI 10.1359/JBMR.060313; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Sato M, 1996, J PHARMACOL EXP THER, V279, P298; Mori H, 2008, BONE, V43, P840, DOI 10.1016/j.bone.2008.07.242; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; AZUMA Y, 1995, BONE, V16, P235, DOI 10.1016/8756-3282(94)00035-X; Azuma Y, 1998, J PHARMACOL EXP THER, V286, P128; Duong Le T, 2012, Bonekey Rep, V1, P67, DOI 10.1038/bonekey.2012.67; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Jerome C, 2011, OSTEOPOROSIS INT, V22, P3001, DOI 10.1007/s00198-011-1529-x; Johnson MR, 1996, GENOME RES, V6, P1050, DOI 10.1101/gr.6.11.1050; Kimoto A, 2013, BONE, V55, P189, DOI 10.1016/j.bone.2013.02.013; Lark MW, 2002, BONE, V30, P746, DOI 10.1016/S8756-3282(02)00675-0; Reszka AA, 1999, J BIOL CHEM, V274, P34967, DOI 10.1074/jbc.274.49.34967; Sato M, 1997, ENDOCRINOLOGY, V138, P4330, DOI 10.1210/en.138.10.4330	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	NOV	2014	32	6					645	652		10.1007/s00774-013-0542-x		8	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AU0AQ	WOS:000345285900005		
J	Yano, T; Yamada, M; Konda, T; Shiozaki, M; Inoue, D				Yano, Tetsuo; Yamada, Mei; Konda, Tomoyuki; Shiozaki, Makoto; Inoue, Daisuke			Risedronate improves bone architecture and strength faster than alendronate in ovariectomized rats on a low-calcium diet	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Risedronate; Bone quality; Bone architecture; Alendronate; Osteoporosis	POSTMENOPAUSAL WOMEN; BISPHOSPHONATES; FRACTURES; OSTEOPOROSIS; DENSITY	Clinical evidence suggests that, compared with alendronate, risedronate reduces fracture risk faster and more potently, with less bone mass gain. We tested the hypothesis that risedronate improves bone quality faster than alendronate using calcium-deficient, ovariectomized (OVX) rats. Female Sprague-Dawley rats at 24 weeks of age were divided into sham-operated and OVX groups and fed a low-calcium (0.05 %) diet under paired feeding. After 12 weeks, OVX rats were divided into five groups and treated with vehicle, risedronate (3.5 and 17.5 mu g/kg/week, s.c.) or alendronate (7 and 35 mu g/kg/week, s.c.). Rats were killed 6-8 weeks later and the bone architecture and strength of the left femur were evaluated by micro-computed tomography and a three-point bending test. Trabecular bone mineral density (BMD), number and thickness were significantly lower in OVX rats than in the sham-operated group. Cortical BMD, bone area (Ct.Ar), and thickness (Ct.Th) were similarly decreased. Risedronate significantly improved Ct.Ar (+8 %) and Ct.Th (+9 %) at 6 weeks, while alendronate only caused a significant improvement in Ct.Ar (+8 % at 6 weeks) and only at the higher dose. At 8 weeks, both risedronate and alendronate significantly increased trabecular BMD compared with the vehicle. Bone strength parameters showed a significant correlation between Ct.Ar and Ct.Th. Risedronate significantly improved maximum load at 6 weeks, while alendronate failed to produce any significant changes. Our results suggest that risedronate is superior to alendronate at improving cortical bone architecture and strength, and that enhanced bone quality partly accounts for risedronate's efficacy.	[Yano, Tetsuo; Yamada, Mei; Konda, Tomoyuki; Shiozaki, Makoto] Ajinomoto Pharmaceut Co Ltd, Res Ctr, Kawasaki Ku, Kawasaki, Kanagawa 2108681, Japan; [Inoue, Daisuke] Teikyo Univ, Sch Med, Dept Med 3, Chiba, Japan	Yano, T (reprint author), Ajinomoto Pharmaceut Co Ltd, Res Ctr, Kawasaki Ku, 1-1 Suzuki Cho, Kawasaki, Kanagawa 2108681, Japan.	tetsuo_yano@ajinomoto.com					Imai K, 2011, J BONE MINER METAB, V29, P645, DOI 10.1007/s00774-011-0281-9; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Silverman SL, 2007, OSTEOPOROSIS INT, V18, P25, DOI 10.1007/s00198-006-0274-z; Roelofs AJ, 2012, J BONE MINER RES, V27, P835, DOI 10.1002/jbmr.1543; Patsch JM, 2013, J BONE MINER RES, V28, P313, DOI 10.1002/jbmr.1763; HODGKINSON A, 1978, CLIN SCI MOL MED, V54, P439; Tsugeno H, 2002, OSTEOPOROSIS INT, V13, P650, DOI 10.1007/s001980200088; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; BULLAMOR.JR, 1970, LANCET, V2, P535; Kaastad TS, 1997, CALCIFIED TISSUE INT, V61, P158; NIH, 2000, NIH CONSENSUS STATE, V17, P1; Reid DM, 2008, INT J CLIN PRACT, V62, P575, DOI 10.1111/j.1742-1241.2008.01704.x; Rogers Maurice, 2011, Scottish Forestry, V65, P34; Zhang Y, 2007, AM J PHYSIOL-ENDOC M, V292, pE723, DOI 10.1152/ajpendo.00445.2006	17	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	NOV	2014	32	6					653	659		10.1007/s00774-013-0543-9		7	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AU0AQ	WOS:000345285900006		
J	Tsukanaka, M; Yamamoto, K; Fujibayashi, S; Pattanayak, DK; Matsushita, T; Kokubo, T; Matsuda, S; Akiyama, H				Tsukanaka, Masako; Yamamoto, Koji; Fujibayashi, Shunsuke; Pattanayak, Deepak K.; Matsushita, Tomiharu; Kokubo, Tadashi; Matsuda, Shuichi; Akiyama, Haruhiko			Evaluation of bioactivity of alkali- and heat-treated titanium using fluorescent mouse osteoblasts	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Fluorescence imaging; Bone-bonding ability; Biomaterial evaluation; Osteoblast calcification; Col1a1	MESENCHYMAL STEM-CELLS; IN-VITRO; BONE; EXPRESSION; PROTEIN; TISSUE; DIFFERENTIATION; BIOMATERIALS; SURFACES; ASSAY	Stimulation of osteoblast proliferation and differentiation is important for the in vivo bone-bonding ability of biomaterials. Previous in vitro studies have used biochemical assays to analyze osteoblast-specific gene expression in cultured osteoblasts. In this study, we generated transgenic mice harboring a monomeric red fluorescent protein 1 transgene under the control of a 2.3-kb fragment of the Col1a1 promoter, which is active specifically in osteoblasts and osteocytes. We established a fluorescent primary osteoblast culture system to allow noninvasive observation of osteoblast proliferation and differentiation on opaque materials in vitro. We used this system to evaluate alkali-and heat-treated titanium, which has a strong bone-bonding ability in vivo, and we observed a rapid increase in fluorescence intensity and characteristic multifocal nodule formation. A cell proliferation assay and RT-PCR to examine osteoblast-specific gene expression showed increased osteoblast proliferation and differentiation consistent with the fluorescence observations. This mouse model allowed us to use fluorescence intensity to visualize and quantify in vivo newly formed bone around implanted materials in femurs. The use of these fluorescent osteoblasts is a promising method for simple screening of the bone-bonding ability of new materials.	[Tsukanaka, Masako; Yamamoto, Koji; Fujibayashi, Shunsuke; Matsuda, Shuichi; Akiyama, Haruhiko] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan; [Pattanayak, Deepak K.; Matsushita, Tomiharu; Kokubo, Tadashi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	Akiyama, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Shogoinkawahara Cho 54, Kyoto 6068507, Japan.	hakiyama@kuhp.kyoto-u.ac.jp			Foundation for the Promotion of Ion Engineering	We thank Roger Y. Tsien for valuable help. This work was supported by the Foundation for the Promotion of Ion Engineering.	Kawanabe K, 2009, J BIOMED MATER RES B, V90B, P476, DOI 10.1002/jbm.b.31309; STANFORD CM, 1995, J BIOL CHEM, V270, P9420; Zhu HX, 2005, GENESIS, V42, P86, DOI 10.1002/gene.20129; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Kuhn LT, 2010, TISSUE ENG PART C-ME, V16, P1357, DOI 10.1089/ten.TEC.2009.0701; Long JZ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-20; Boskey AL, 2003, CALCIFIED TISSUE INT, V72, P533, DOI 10.1007/s00223-003-1002-8; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Goto T, 2003, BIOMATERIALS, V24, P3885, DOI 10.1016/S0142-9612(03)00258-8; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167; NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Isaac J, 2010, EUR CELLS MATER, V20, P178; Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B; Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y; Nishio K, 2000, J BIOMED MATER RES, V52, P652, DOI 10.1002/1097-4636(20001215)52:4<652::AID-JBM9>3.0.CO;2-W; Blum JS, 2004, BIOMATERIALS, V25, P5809, DOI 10.1016/j.biomaterials.2004.01.035; Declerq HA, 2005, BIOMATERIALS, V26, P4964, DOI 10.1016/j.biomaterials.2005.01.025; Flock A, 1998, J NEUROCYTOL, V27, P507, DOI 10.1023/A:1006999725663; Gade TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022608; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Iris Bar, 2003, J Bone Miner Res, V18, P570; Maeda M, 2007, J BIOCHEM, V141, P729, DOI 10.1093/jb/mvm077; Maniatopoulos C, 1986, Int J Oral Maxillofac Implants, V1, P31; Xia ZD, 2005, BIOMATERIALS, V26, P5790, DOI 10.1016/j.biomaterials.2005.02.018	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	NOV	2014	32	6					660	670		10.1007/s00774-013-0544-8		11	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AU0AQ	WOS:000345285900007		
J	Yamamoto, T; Taketsuna, M; Guo, XY; Sato, M; Sowa, H				Yamamoto, Takanori; Taketsuna, Masanori; Guo, Xiaoyan; Sato, Masayo; Sowa, Hideaki			The safety and effectiveness profile of daily teriparatide in a prospective observational study in Japanese patients with osteoporosis at high risk for fracture: interim report	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Bone markers; Bone mineral density; Japanese; Safety; Teriparatide	BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; CO-MORBIDITIES; DOUBLE-BLIND; IMPACT; PERSISTENCE; ALENDRONATE; EXPERIENCE; EFFICACY	This postmarketing surveillance study assessed the safety and effectiveness of daily teriparatide treatment in patients with osteoporosis in a Japanese clinical setting. In this prospective, multicenter, observational study, patients with osteoporosis at high risk for fracture received subcutaneous injections of teriparatide (20 mu g/day) for a maximum of 24 months. For this interim report, data from 1,671 patients were eligible for analysis at the cutoff date. The mean age was 75.3 years; 93 % of patients (1,552/1,671 patients) were women. There were 117 adverse drug reactions (ADRs) reported in 101 of 1,671 patients (6.04 %); the most common reported ADRs were nausea, dizziness, headache, and palpitations. No clinically significant safety issues were identified, although 5 serious ADRs were reported in 4/1,671 (0.24 %) patients. At 12 months, 71.9 % of patients remained on teriparatide treatment. From 1 month, there were rapid increases in the biomarkers of bone formation P1NP and, to a lesser extent, BAP. In contrast, increases in the biomarkers of bone resorption, serum NTX, urinary NTX, and TRACP5b, were smaller. After 12 months of treatment, there was an increase in bone mineral density at the lumbar spine, femoral neck, and total hip, and a decrease in the Visual Analog Scale score for back pain. The incidence of new vertebral and nonvertebral fractures was 1.21 % and 3.18 %, respectively. In conclusion, the favorable safety profile and effectiveness of teriparatide observed in this population of Japanese patients with osteoporosis were accompanied by relatively high persistence with treatment, which is a key factor in the success of osteoporosis treatment.	[Yamamoto, Takanori] Eli Lilly Japan KK, Med Sci, Lilly Res Labs, Dev Ctr Excellence Japan,Chuo Ku, Kobe, Hyogo 6510086, Japan; [Taketsuna, Masanori] Eli Lilly Japan KK, Asia Pacific Stat Sci, Lilly Res Labs, Dev Ctr Excellence Asia Pacific, Kobe, Hyogo 6510086, Japan; [Guo, Xiaoyan] Eli Lilly Japan KK, Global Patient Safety Japan, Lilly Res Labs, Dev Ctr Excellence Japan, Kobe, Hyogo 6510086, Japan; [Sato, Masayo; Sowa, Hideaki] Eli Lilly Japan KK, Med Sci, Lilly Res Labs, Dev Ctr Excellence Japan, Kobe, Hyogo 6510086, Japan	Yamamoto, T (reprint author), Eli Lilly Japan KK, Med Sci, Lilly Res Labs, Dev Ctr Excellence Japan,Chuo Ku, Sannomiya Plaza Bldg,7-1-5 Isogamidori, Kobe, Hyogo 6510086, Japan.	yamamoto_takanori@lilly.com			Eli Lilly and Company; Eli Lilly Japan K.K.	The authors acknowledge the efforts of the investigators who participated in the study and thank the contributors to manuscript preparation, editing, and review (Keisuke Shinkai, Noriko Takagaki, and Yasushige Masunaga of Eli Lilly Japan). Eli Lilly Japan was involved in the study design, data collection, data analysis, and preparation of the manuscript. This study was sponsored by Eli Lilly and Company, manufacturer of teriparatide. Medical writing assistance was provided by Justine Southby, PhD, and Janelle Keys, PhD, of ProScribe Medical Communications and was funded by Eli Lilly Japan K.K. ProScribe's services complied with international guidelines for Good Publication Practice (GPP2).	Blumsohn A, 2011, OSTEOPOROSIS INT, V22, P1935, DOI 10.1007/s00198-010-1379-y; Seeman E, 2007, OSTEOPOROSIS INT, V18, P711, DOI 10.1007/s00198-006-0294-8; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Miyauchi A, 2010, BONE, V47, P493, DOI 10.1016/j.bone.2010.05.022; Eastell R, 2009, J BONE MINER RES, V24, P726, DOI [10.1359/jbmr.081215, 10.1359/JBMR.081215]; [Anonymous], 2011, FORT PRESCR INF; Lindsay R, 2009, OSTEOPOROSIS INT, V20, P943, DOI 10.1007/s00198-008-0766-0; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Dowd R, 2000, OSTEOPOROSIS INT, V11, P533, DOI 10.1007/s001980070097; Tsujimoto M, 2012, J BONE MINER METAB, V30, P326, DOI 10.1007/s00774-011-0314-4; Dennison EM, 2012, BONE, V50, P1288, DOI 10.1016/j.bone.2012.02.639; Jakob F, 2012, EUR J ENDOCRINOL, V166, P87, DOI 10.1530/EJE-11-0740; Yu S, 2012, OSTEOPOROSIS INT, V23, P1103, DOI 10.1007/s00198-011-1843-3; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Siris ES, 2009, AM J MED, V122, P3, DOI 10.1016/j.amjmed.2008.12.002; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Boonen S, 2008, J CLIN ENDOCR METAB, V93, P852, DOI 10.1210/jc.2007-0711; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Arden NK, 2006, OSTEOPOROSIS INT, V17, P1626, DOI 10.1007/s00198-006-0171-5; Briot K, 2009, OSTEOPOROSIS INT, V20, P625, DOI 10.1007/s00198-008-0698-8; David C, 2010, JOINT BONE SPINE, V77, pS103, DOI 10.1016/S1297-319X(10)70003-8; Fahrleitner-Pammer A, 2011, OSTEOPOROSIS INT, V22, P2709, DOI 10.1007/s00198-010-1498-5; Gold DT, 1996, BONE, V18, pS185, DOI 10.1016/8756-3282(95)00500-5; Langdahl BL, 2009, CALCIFIED TISSUE INT, V85, P484, DOI 10.1007/s00223-009-9299-6; McClung MR, 2005, ARCH INTERN MED, V165, P1762, DOI 10.1001/archinte.165.15.1762; Miller Paul D, 2008, Curr Osteoporos Rep, V6, P12, DOI 10.1007/s11914-008-0003-y; Miyauchi A, 2008, J BONE MINER METAB, V26, P624, DOI 10.1007/s00774-008-0871-3; Nakamura T, 2012, J BONE MINER METAB, V30, P321, DOI 10.1007/s00774-011-0313-5; Obermayer-Pietsch BM, 2008, J BONE MINER RES, V23, P1591, DOI [10.1359/jbmr.080506, 10.1359/JBMR.080506]; Satterwhite J, 2010, CALCIFIED TISSUE INT, V87, P485, DOI 10.1007/s00223-010-9424-6; Tsujimoto M, 2011, BONE, V48, P798, DOI 10.1016/j.bone.2010.12.006	32	2	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	NOV	2014	32	6					699	708		10.1007/s00774-013-0546-6		10	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AU0AQ	WOS:000345285900011		
J	Omata, Y; Hagiwara, F; Nishino, J; Matsudaira, K; Kadono, Y; Juji, T; Mori, T; Nakayama, H; Nagase, Y; Hirose, J; Yasui, T; Matsumoto, T; Matsui, T; Tohma, S; Tanaka, S				Omata, Yasunori; Hagiwara, Futoshi; Nishino, Jinju; Matsudaira, Ko; Kadono, Yuho; Juji, Takuo; Mori, Toshihito; Nakayama, Hisanori; Nagase, Yuichi; Hirose, Jun; Yasui, Tetsuro; Matsumoto, Takumi; Matsui, Toshihiro; Tohma, Shigeto; Tanaka, Sakae			Vertebral fractures affect functional status in postmenopausal rheumatoid arthritis patients	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Osteoporosis; Prednisolone; Quality of life; Rheumatoid arthritis; Vertebral fracture	BONE-MINERAL DENSITY; QUALITY-OF-LIFE; RISK-FACTORS; NONVERTEBRAL FRACTURES; RANDOMIZED-TRIAL; DISEASE-ACTIVITY; HIGH PREVALENCE; JAPANESE WOMEN; BACK-PAIN; OSTEOPOROSIS	Functional disability is a major concern in patients with rheumatoid arthritis (RA). This retrospective study investigated the risk factors for vertebral fractures (VFs) in postmenopausal RA patients and determined the impact of VFs on functional status. Data from a cohort of 200 postmenopausal RA patients in a single hospital registry were analyzed. Demographic and clinical data, imaging data from spine radiographs, and bone mineral density (BMD) data were collected from the patients at baseline and at the final visit (a mean of 2.9 years after the first visit). Risk factors for incident VFs and their impact on the modified health assessment questionnaire (mHAQ) were analyzed. Twenty-eight patients (14 %) developed new VFs (NVFs). Logistic regression analysis adjusted for age, BMI, and disease duration revealed that daily dose of prednisolone, femoral neck BMD, use of active vitamin D-3, and use of a bisphosphonate at baseline were factors associated with NVF, with odds ratios (95 % confidence interval) of 1.27 (1.05-1.54), 0.94 (0.91-0.97), 0.34 (0.13-0.89), and 0.31 (0.12-0.82), respectively. Patients with NVF exhibited worse mHAQ scores and a greater increase in mHAQ scores from baseline compared with those without NVF. In conclusion, incident VFs were associated with reduced functional status in postmenopausal patients with RA. It is important to prevent VFs to maintain the functional status of RA patients.	[Omata, Yasunori; Kadono, Yuho; Nagase, Yuichi; Hirose, Jun; Yasui, Tetsuro; Matsumoto, Takumi; Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Hagiwara, Futoshi; Nakayama, Hisanori; Matsui, Toshihiro; Tohma, Shigeto] Sagamihara Natl Hosp, Natl Hosp Org, Dept Rheumatol, Kanagawa, Japan; [Nishino, Jinju] Nishino Clin Orthoped & Rheumatol, Tokyo, Japan; [Matsudaira, Ko] Kanto Rosai Hosp, Clin Res Ctr Occupat Musculoskeletal Disorders, Kanagawa, Japan; [Juji, Takuo; Mori, Toshihito] Sagamihara Natl Hosp, Natl Hosp Org, Dept Orthopaed Surg, Kanagawa, Japan	Tanaka, S (reprint author), Univ Tokyo, Dept Orthopaed Surg, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tanakas-ort@h.u-tokyo.ac.jp					Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Furneri G, 2012, CLIN EXP RHEUMATOL, V30, pS72; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Tanaka S, 2007, AM J NEPHROL, V27, P466, DOI 10.1159/000106484; Welsing PMJ, 2001, ARTHRITIS RHEUM, V44, P2009, DOI 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L; Sokka T, 2000, ARTHRITIS RHEUM, V43, P386, DOI 10.1002/1529-0131(200002)43:2<386::AID-ANR19>3.0.CO;2-Z; Sinigaglia L, 2000, J RHEUMATOL, V27, P2582; Angeli A, 2006, BONE, V39, P253, DOI 10.1016/j.bone.2006.02.005; El Maghraoui A, 2010, RHEUMATOLOGY, V49, P1303, DOI 10.1093/rheumatology/keq084; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Breedveld FC, 2005, ANN RHEUM DIS, V64, P52, DOI 10.1136/ard.2003.017160; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Cockerill W, 2000, ANN RHEUM DIS, V59, P368, DOI 10.1136/ard.59.5.368; Vis M, 2011, OSTEOPOROSIS INT, V22, P2413, DOI 10.1007/s00198-010-1517-6; Adachi JD, 2010, MAYO CLIN PROC, V85, P806, DOI 10.4065/mcp.2010.0082; Wolfe F, 1999, RHEUMATOLOGY, V38, P355, DOI 10.1093/rheumatology/38.4.355; Ghazi M, 2012, OSTEOPOROSIS INT, V23, P581, DOI 10.1007/s00198-011-1584-3; Arai K, 2006, J BONE MINER METAB, V24, P118, DOI 10.1007/s00774-005-0657-9; Baskan BM, 2007, RHEUMATOL INT, V27, P579, DOI 10.1007/s00296-007-0323-8; Dirven L, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-125; Fautrel B, 2002, CURR OPIN RHEUMATOL, V14, P121, DOI 10.1097/00002281-200203000-00008; Fujita T, 2007, J BONE MINER METAB, V25, P130, DOI 10.1007/s00774-006-0738-4; Furuya T, 2007, J RHEUMATOL, V34, P303; HARRIS ST, 1993, AM J MED, V95, P557, DOI 10.1016/0002-9343(93)90350-X; Orstavik RE, 2003, ARTHRIT RHEUM-ARTHR, V49, P355, DOI 10.1002/art.11118; Orstavik RE, 2004, ARCH INTERN MED, V164, P420, DOI 10.1001/archinte.164.4.420; SPECTOR TD, 1993, BRIT MED J, V306, P558; Suzuki N, 2009, EUR SPINE J, V18, P77, DOI 10.1007/s00586-008-0847-y; Tanaka E, 2010, MOD RHEUMATOL, V20, P46, DOI 10.1007/s10165-009-0236-3; Ursum J, 2009, ANN RHEUM DIS, V68, P1512, DOI 10.1136/ard.2008.105957; Yamanaka H, 2013, MOD RHEUMATOL, DOI [10.1007/s10165-013-0863-6, DOI 10.1007/S10165-013-0863-6]	33	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	NOV	2014	32	6					725	731		10.1007/s00774-013-0552-8		7	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AU0AQ	WOS:000345285900014		
J	Kunita-Takanezawa, M; Abe, K; Hirooka, Y; Kuwabara, Y; Hirano, K; Oka, M; Sunagawa, K				Kunita-Takanezawa, Mutsumi; Abe, Kohtaro; Hirooka, Yoshitaka; Kuwabara, Yukimitsu; Hirano, Katsuya; Oka, Masahiko; Sunagawa, Kenji			Novel Dual Endothelin Receptor Antagonist Macitentan Reverses Severe Pulmonary Arterial Hypertension in Rats	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						macitentan; pulmonary arterial hypertension; endothelin; endothelin receptor antagonist; luminal occlusive lesions	BOSENTAN; PHARMACOLOGY; SAFETY	The efficacy of endothelin (ET) receptor antagonist bosentan in patients with severe pulmonary arterial hypertension (PAH) remains limited, partly because its higher doses for potential blockade of ET receptors have never been tested due to liver dysfunction. We hypothesized that rigorous blockade of ET receptors using the novel dual ET receptor antagonist macitentan would be effective in treating severe PAH without major side effects in a preclinical model appropriately representing the human disorder. In normal rats, 30 mg.kg(-1).d(-1) of macitentan completely abolished big ET-1-induced increases in right ventricle (RV) systolic pressure. Adult male rats were injected with SU5416, a vascular endothelial growth factor blocker, and exposed to hypoxia for 3 weeks and then to normoxia for an additional 5 weeks (total 8 weeks). In intrapulmonary arterial rings isolated from rats with severe PAH, macitentan concentration dependently inhibited ET-1-induced contraction. Long-term treatment with macitentan (30 mg.kg(-1).d(-1), from week 3 to 8) reversed the high RV systolic pressure with preserved cardiac output. Development of RV hypertrophy, luminal occlusive lesions and medial wall thickening were also significantly improved without increasing serum levels of liver enzymes by macitentan. In conclusion, efficacious blockade of ET receptors with macitentan would reverse severe PAH without major adverse effects.	[Kunita-Takanezawa, Mutsumi; Kuwabara, Yukimitsu; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med, Dept Cardiovasc Med, Fukuoka 8128582, Japan; [Abe, Kohtaro; Hirooka, Yoshitaka] Kyushu Univ, Grad Sch Med, Dept Adv Cardiovasc Regulat & Therapeut, Fukuoka 8128582, Japan; [Hirano, Katsuya] Kyushu Univ, Grad Sch Med, Angiocardiol Res Inst, Div Mol Cardiol, Fukuoka 8128582, Japan; [Oka, Masahiko] Univ S Alabama, Dept Internal Med, Mobile, AL 36688 USA	Abe, K (reprint author), Kyushu Univ, Grad Sch Med, Dept Adv Cardiovasc Regulat & Therapeut, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	koabe@cardiol.med.kyushu-u.ac.jp	Hirano, Katsuya/B-2785-2008	Hirano, Katsuya/0000-0003-0164-1283	Japan Society for the Promotion Science [20588107, 24390198, 23220013]; Actelion Pharmaceuticals Japan Inc.	Supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion Science (20588107, 24390198, 23220013) and, in part, a grant from Actelion Pharmaceuticals Japan Inc. Macitentan was provided by Actelion Pharmaceuticals Ltd, Switzerland.	Saha DC, 2007, J AM ASSOC LAB ANIM, V46, P74; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Choudhary G, 2011, J HEART LUNG TRANSPL, V30, P827, DOI 10.1016/j.healun.2011.03.010; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Jasmin JF, 2001, CIRCULATION, V103, P314; Sidharta PN, 2011, EUR J CLIN PHARMACOL, V67, P977, DOI 10.1007/s00228-011-1043-2; STEWART DJ, 1991, ANN INTERN MED, V114, P464; Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; CLOZEL M, 1994, J PHARMACOL EXP THER, V270, P228; Rafikova O, 2013, FREE RADICAL BIO MED, V56, P28, DOI 10.1016/j.freeradbiomed.2012.09.013; Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; REEVES JT, 1986, AM REV RESPIR DIS, V134, P342; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Kummer O, 2009, EUR J PHARM SCI, V38, P384, DOI 10.1016/j.ejps.2009.09.005; Dingemanse J, 2014, EXPERT OPIN DRUG SAF, V13, P391, DOI 10.1517/14740338.2014.859674; Eddahibi S, 1995, AM J PHYSIOL, V268, P828; Gatfield J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047662; Hill NS, 1997, J APPL PHYSIOL, V83, P1209; HISLOP A, 1976, BRIT J EXP PATHOL, V57, P542; Iglarz M, 2014, LIFE SCI, V26, P260; MCMAHON EG, 1991, P NATL ACAD SCI USA, V88, P703, DOI 10.1073/pnas.88.3.703; Mouchaers KT, 2009, AM J PHYSIOL-HEART C, V297, P200; Nahrendorf M, 2003, AM J PHYSIOL-HEART C, V284, P241; Oka M, 2001, AM J PHYSIOL-LUNG C, V280, P432; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Rabinovitch M., 1979, AM J PHYSIOL, V236, P818; Sato K, 1995, AM J PHYSIOL, V269, P668; Sauvageau S, 2007, J VASC RES, V44, P375, DOI 10.1159/000102534; Sidharta PN, 2013, J CLIN PHARMACOL, V53, P1131, DOI 10.1002/jcph.152; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, P1013; Toba M, 2014, AM J PHYSIOL-HEART C, V306, pH243, DOI 10.1152/ajpheart.00728.2013; Weigand L, 2006, AM J PHYSIOL-LUNG C, V290, P284; Williamson DJ, 2000, CIRCULATION, V102, P411; Yap EYS, 2000, BRIT J PHARMACOL, V129, P170, DOI 10.1038/sj.bjp.0703006	36	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0160-2446	1533-4023		J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	NOV	2014	64	5					473	480				8	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	AT7FL	WOS:000345102200011		
J	Funakoshi, Y; Chou, MM; Kanaho, Y; Donaldson, JG				Funakoshi, Yuji; Chou, Margaret M.; Kanaho, Yasunori; Donaldson, Julie G.			TRE17/USP6 regulates ubiquitylation and trafficking of cargo proteins that enter cells by clathrin-independent endocytosis	JOURNAL OF CELL SCIENCE			English	Article						TRE17; USP6; Ubiquitin; Cargo sorting; Ubiquitin-specific protease; Lysosome	ANEURYSMAL BONE-CYST; 6 USP6 ONCOGENE; NF-KAPPA-B; ENDOSOMAL TRAFFICKING; UBIQUITINATION; CANCER; ACTIVATION; RECEPTOR; FUSION; DEGRADATION	Plasma membrane proteins that enter cells by clathrin-independent endocytosis (CIE) are sorted either to lysosomes for degradation or recycled back to the plasma membrane. Expression of some MARCH E3 ubiquitin ligases promotes trafficking of CIE cargo proteins to lysosomes by ubiquitylating the proteins. Here, we show that co-expression of the ubiquitin-specific protease TRE17/USP6 counteracts the MARCH-dependent targeting of CIE cargo proteins, but not that of transferrin receptor, to lysosomes, leading to recovery of the stability and cell surface level of the proteins. The ubiquitylation of CIE cargo proteins by MARCH8 was reversed by TRE17, suggesting that TRE17 leads to deubiquitylation of CIE cargo proteins. The effects of TRE17 were dependent on its deubiquitylating activity and expression of TRE17 alone led to a stabilization of surface major histocompatibility complex class I (MHCI) molecules, a CIE cargo, suggesting that deubiquitylation of endogenous CIE cargo proteins promotes their stability. This study demonstrates that cycles of ubiquitylation and deubiquitylation can determine whether CIE cargo proteins are degraded or recycled.	[Funakoshi, Yuji; Donaldson, Julie G.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20891 USA; [Funakoshi, Yuji; Kanaho, Yasunori] Univ Tsukuba, Dept Physiol Chem, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Funakoshi, Yuji; Kanaho, Yasunori] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Chou, Margaret M.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Donaldson, JG (reprint author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20891 USA.	donaldsonj@helix.nih.gov			Intramural Research Program in the National Heart, Lung and Blood Institute at the National Institutes of Health [HL006060]; National Cancer Institute [CA126452]; Ministry of Education, Science, Sports and Culture of Japan [26440044]	This work was supported by the Intramural Research Program in the National Heart, Lung and Blood Institute at the National Institutes of Health [grant number HL006060] to J.G.D.; and by a grant from the National Cancer Institute [grant number CA126452] to M.M.C. This work was also supported by the Institutional Program for Young Researcher Overseas Visits and the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Ministry of Education, Science, Sports and Culture of Japan to Y.F. and a research grant [grant number 26440044] from the Ministry of Education, Science, Sports and Culture of Japan to Y.K. Deposited in PMC for release after 12 months.	Lau AW, 2010, J BIOL CHEM, V285, P37111, DOI 10.1074/jbc.M110.175133; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Panagopoulos I, 2008, CANCER GENET CYTOGEN, V180, P70, DOI 10.1016/j.cancergencyto.2007.09.017; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; HANCOCK JF, 1991, EMBO J, V10, P4033; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; Erickson-Johnson MR, 2011, LAB INVEST, V91, P1427, DOI 10.1038/labinvest.2011.118; Zhou RF, 2013, J BIOL CHEM, V288, P5389, DOI 10.1074/jbc.M112.425272; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Ye Y, 2010, ONCOGENE, V29, P3619, DOI 10.1038/onc.2010.116; Kumta SM, 2003, LIFE SCI, V73, P1427, DOI 10.1016/S0024-3205(03)00434-X; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Oliveira AM, 2004, CANCER RES, V64, P1920, DOI 10.1158/0008-5472.CAN-03-2827; Oliveira AM, 2004, AM J PATHOL, V165, P1773, DOI 10.1016/S0002-9440(10)63432-3; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; Oliveira AM, 2005, ONCOGENE, V24, P3419, DOI 10.1038/sj.onc.1208506; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Martinu L, 2004, MOL CELL BIOL, V24, P9752, DOI 10.1128/MCB.24.22.9752-9762.2004; Masuda-Robens JM, 2003, MOL CELL BIOL, V23, P2151, DOI 10.1128/MCB.23.6.2151-2161.2003; McKay J, 2011, BBA-MOL CELL RES, V1813, P298, DOI 10.1016/j.bbamcr.2010.11.019; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; NAKAMURA T, 1992, ONCOGENE, V7, P733; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pringle LM, 2012, ONCOGENE, V31, P3525, DOI 10.1038/onc.2011.520; Rueckert C, 2012, BIOL CELL, V104, P22, DOI 10.1111/boc.201100108; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200	40	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	NOV 1	2014	127	21					4750	4761		10.1242/jcs.156786		12	Cell Biology	Cell Biology	AT3QK	WOS:000344848700019		
J	Nishimoto, Y; Fedorov, DG; Irle, S				Nishimoto, Yoshio; Fedorov, Dmitri G.; Irle, Stephan			Density-Functional Tight-Binding Combined with the Fragment Molecular Orbital Method	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							AB-INITIO; INTERMOLECULAR INTERACTIONS; CONSISTENT CALCULATIONS; BIOLOGICAL MOLECULES; COMPLEX MATERIALS; ELECTRON-DENSITY; WATER CLUSTERS; 1ST PRINCIPLES; LARGE SYSTEMS; TOTAL-ENERGY	We developed the energy and its gradient for the self-consistent-charge density-functional tight-binding (DFTB) method, combined with the fragment molecular orbital (FMO) approach, FMO-DFTB, including an optional a posteriori treatment for dispersion interaction, and evaluated its accuracy as well as computational efficiency for a set of representative systems: polypeptides, a DNA segment, and a small protein. The error in the total energy of FMO-DFTB versus full SCC-DFTB was below 1 kcal/mol for the polyalanine system consisting of about 2000 atoms partitioned into fragments containing 2 residues, and the optimized structures had root-mean-square deviations below 0.1 angstrom. The scaling of FMO-DFTB with the system size N is only marginally larger than linear [O(N-1.2) in the worst case]. A parallelization efficiency of 94% was achieved using 128 CPU cores, and we demonstrate the applicability of FMO-DFTB for systems containing more than one million atoms by performing a geometry optimization of a fullerite cluster.	[Nishimoto, Yoshio; Irle, Stephan] Nagoya Univ, Dept Chem, Nagoya, Aichi 4648602, Japan; [Irle, Stephan] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648602, Japan; [Fedorov, Dmitri G.] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst NRI, Tsukuba, Ibaraki 3058565, Japan	Fedorov, DG (reprint author), Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst NRI, Tsukuba, Ibaraki 3058565, Japan.	d.g.fedorov@aist.go.jp; sirle@chem.nagoya-u.ac.jp	Irle, Stephan/E-8984-2011	Irle, Stephan/0000-0003-4995-4991	Japan Society for Promotion of Science for Young Scientists [DC1]; L-Daigakuin program; Next Generation Super Computing Project, Nanoscience Program (MEXT, Japan); Computational Materials Science Initiative (CMSI, Japan)	The authors thank the Research Center for Computational Science, Okazaki, Japan, for providing computational resources. Y.N. is supported by a Research Fellowship of the Japan Society for Promotion of Science for Young Scientists (DC1), and the L-Daigakuin program. D.G.F. acknowledges support of the Next Generation Super Computing Project, Nanoscience Program (MEXT, Japan), and D.G.F. and S.I. are grateful for support from the Computational Materials Science Initiative (CMSI, Japan). D.G.F. thanks Prof. Kazuo Kitaura for many helpful discussions on the nature of the FMO method.	Gaus M, 2014, WIRES COMPUT MOL SCI, V4, P49, DOI 10.1002/wcms.1156; Xie W, 2009, J CHEM THEORY COMPUT, V5, P459, DOI 10.1021/ct800239q; Oliveira AF, 2009, J BRAZIL CHEM SOC, V20, P1193, DOI 10.1590/S0103-50532009000700002; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Nikitina E, 2004, INT J QUANTUM CHEM, V97, P747, DOI 10.1002/qua.10778; Fedorov DG, 2014, CHEM PHYS LETT, V597, P99, DOI 10.1016/j.cplett.2014.02.029; Frauenheim T, 2002, J PHYS-CONDENS MAT, V14, P3015, DOI 10.1088/0953-8984/14/11/313; FRAUENHEIM T, 1995, PHYS REV B, V52, P11492, DOI 10.1103/PhysRevB.52.11492; Nagata T, 2010, CHEM PHYS LETT, V492, P302, DOI 10.1016/j.cplett.2010.04.043; Ufimtsev IS, 2011, J PHYS CHEM LETT, V2, P1789, DOI 10.1021/jz200697c; Nakano T, 2002, CHEM PHYS LETT, V351, P475, DOI 10.1016/S0009-2614(01)01416-6; Hirano T, 2014, PHYS CHEM CHEM PHYS, V16, P14496, DOI 10.1039/c3cp55514c; Sawada T, 2010, J PHYS CHEM B, V114, P15700, DOI 10.1021/jp1068895; Collins MA, 2012, PHYS CHEM CHEM PHYS, V14, P7744, DOI 10.1039/c2cp23832b; Fedorov DG, 2011, J PHYS CHEM LETT, V2, P282, DOI 10.1021/jz1016894; Fukuzawa K, 2006, J COMPUT CHEM, V27, P948, DOI 10.1002/jcc.20399; Avramov PV, 2012, J PHYS CHEM LETT, V3, P2003, DOI 10.1021/jz300625t; Wang KD, 2014, J CHEM THEORY COMPUT, V10, P1546, DOI 10.1021/ct401060m; Gordon MS, 2013, ANNU REV PHYS CHEM, V64, P553, DOI 10.1146/annurev-physchem-040412-110031; Frank A, 2012, J CHEM THEORY COMPUT, V8, P1480, DOI 10.1021/ct200913r; Cawkwell MJ, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4755991; Ikegami T, 2010, J COMPUT CHEM, V31, P447, DOI 10.1002/jcc.21272; Huang LL, 2012, FUTURE MED CHEM, V4, P1479, DOI [10.4155/fmc.12.92, 10.4155/FMC.12.92]; PIPEK J, 1989, J CHEM PHYS, V90, P4916, DOI 10.1063/1.456588; Shimodo Y, 2006, J MOL STRUC-THEOCHEM, V770, P163, DOI 10.1016/j.theochem.2006.05.056; Li H, 2010, J COMPUT CHEM, V31, P778, DOI 10.1002/jcc.21363; Fedorov DG, 2009, CHEM PHYS LETT, V477, P169, DOI 10.1016/j.cplett.2009.06.072; Nakata H, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4800990; Elstner M, 2001, J CHEM PHYS, V114, P5149, DOI 10.1063/1.1329889; POREZAG D, 1995, PHYS REV B, V51, P12947, DOI 10.1103/PhysRevB.51.12947; Nakano T, 2012, CHEM PHYS LETT, V523, P128, DOI 10.1016/j.cplett.2011.12.004; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Koskinen P, 2009, COMP MATER SCI, V47, P237, DOI 10.1016/j.commatsci.2009.07.013; Kiewisch K, 2013, J CHEM THEORY COMPUT, V9, P2425, DOI 10.1021/ct3008759; Hu H, 2007, J PHYS CHEM A, V111, P5685, DOI 10.1021/jp070308d; Tanaka S, 2014, PHYS CHEM CHEM PHYS, V16, P10310, DOI 10.1039/c4cp00316k; Soderhjelm P, 2010, J CHEM THEORY COMPUT, V6, P1726, DOI 10.1021/ct9006986; Sahu N, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793706; Finnis MW, 1998, PHYS REV LETT, V81, P5149, DOI 10.1103/PhysRevLett.81.5149; Fedorov DG, 2004, J COMPUT CHEM, V25, P872, DOI 10.1002/jcc.20018; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Stewart JJP, 2009, J MOL MODEL, V15, P765, DOI 10.1007/s00894-008-0420-y; Fedorov DG, 2004, J CHEM PHYS, V120, P6832, DOI 10.1063/1.1687334; Irle S, 2006, J PHYS CHEM B, V110, P14531, DOI 10.1021/jp061173z; Kaminski S, 2012, J PHYS CHEM A, V116, P11927, DOI 10.1021/jp307264f; Seifert G, 1996, INT J QUANTUM CHEM, V58, P185, DOI 10.1002/(SICI)1097-461X(1996)58:2<185::AID-QUA7>3.0.CO;2-U; Huang L, 2009, P NATL ACAD SCI USA, V106, P1731, DOI 10.1073/pnas.0811959106; He X, 2010, J CHEM THEORY COMPUT, V6, P405, DOI 10.1021/ct9006635; Seifert G, 2012, WIRES COMPUT MOL SCI, V2, P456, DOI 10.1002/wcms.1094; Sena AMP, 2011, J CHEM THEORY COMPUT, V7, P884, DOI 10.1021/ct100601n; Nakano T, 2000, CHEM PHYS LETT, V318, P614, DOI 10.1016/S0009-2614(00)00070-1; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; Zheng GS, 2005, CHEM PHYS LETT, V412, P210, DOI 10.1016/j.cplett.2005.06.105; Goedecker S, 2003, COMPUT SCI ENG, V5, P14, DOI 10.1109/MCISE.2003.1208637; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Fedorov DG, 2004, CHEM PHYS LETT, V389, P129, DOI 10.1016/j.cplett.2004.03.072; PARR RG, 1983, J AM CHEM SOC, V105, P7512, DOI 10.1021/ja00364a005; Sato M, 2008, J AM CHEM SOC, V130, P2396, DOI 10.1021/ja710038c; OTTO P, 1975, CHEM PHYS, V8, P192, DOI 10.1016/0301-0104(75)80107-8; Haugk M, 1997, J PHYS-CONDENS MAT, V9, P7305, DOI 10.1088/0953-8984/9/35/006; Zhechkov L, 2005, J CHEM THEORY COMPUT, V1, P841, DOI 10.1021/ct050065y; Giese TJ, 2013, J CHEM THEORY COMPUT, V9, P1417, DOI 10.1021/ct3010134; JOHNSON DD, 1988, PHYS REV B, V38, P12807, DOI 10.1103/PhysRevB.38.12807; Gaus M, 2011, J CHEM THEORY COMPUT, V7, P931, DOI 10.1021/ct100684s; Yang Y, 2007, J PHYS CHEM A, V111, P10861, DOI 10.1021/jp074167r; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162; Alexeev Y, 2012, CURR TOP MED CHEM, V12, P2013; Carlson PJ, 2012, J PHYS CHEM B, V116, P503, DOI 10.1021/jp207840q; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Brazhkin VV, 1997, PHYS REV B, V56, P11465, DOI 10.1103/PhysRevB.56.11465; Canfield P, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2148956; Chiba M, 2007, CHEM PHYS LETT, V444, P346, DOI 10.1016/j.cplett.2007.07.034; Dennington R., 2009, GAUSSVIEW VERSION 5; Fedorov DG, 2009, FRAGMENT MOLECULAR ORBITAL METHOD: PRACTICAL APPLICATIONS TO LARGE MOLECULAR SYSTEMS, P1, DOI 10.1201/9781420078497; Fedorov DG, 2010, J PHYS CHEM A, V114, P8742, DOI 10.1021/jp101724p; Fedorov DG, 2007, J PHYS CHEM A, V111, P2722, DOI 10.1021/jp0671042; Frenzel J., 2004, SEMI RELATIVISTIC SE; Fukuzawa K, 2014, COMPUT THEOR CHEM, V1034, P7, DOI 10.1016/j.comptc.2014.02.002; Gao JL, 1997, J PHYS CHEM B, V101, P657, DOI 10.1021/jp962833a; Gao JL, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3688232; Hohenberg P., 1964, PHYS REV B, V136, P864; Howard JC, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4829463; Kobayashi M, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4776228; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; MATTHEW W, 1989, PHYS REV B, V39, P12520; Mazanetz MP, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-2; Mochizuki Y, 2010, CHEM PHYS LETT, V493, P346, DOI 10.1016/j.cplett.2010.05.034; Nakata H, 2014, THEOR CHEM ACC, V133, DOI 10.1007/s00214-014-1477-6; Nishimoto Y, 2012, PHYS STATUS SOLIDI B, V249, P324, DOI 10.1002/pssb.201100767; Okiyama Y, 2013, CHEM PHYS LETT, V566, P25, DOI 10.1016/j.cplett.2013.02.020; Ponder J.W., 2009, TINKER SOFTWARE TOOL; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Roskop L, 2013, MOL PHYS, V111, P1622, DOI 10.1080/00268976.2013.780102; Sankey OF, 1998, INT J QUANTUM CHEM, V69, P327, DOI 10.1002/(SICI)1097-461X(1998)69:3<327::AID-QUA11>3.3.CO;2-5; Sawada T, 2010, J AM CHEM SOC, V132, P16862, DOI 10.1021/ja105051e; Schmidt N. W., 1993, J COMPUT CHEM, V14, P1347; Sugiki SI, 2003, CHEM PHYS LETT, V382, P611, DOI 10.1016/j.cplett.2003.10.087; Tong Y, 2009, J THEOR COMPUT CHEM, V8, P1265, DOI 10.1142/S0219633609005313; Watanabe T, 2007, J PHYS CHEM B, V111, P9621, DOI 10.1021/jp071710v; YANG WT, 1991, PHYS REV LETT, V66, P1438, DOI 10.1103/PhysRevLett.66.1438; Friedrich J, 2014, J PHYS CHEM LETT, V5, P666, DOI 10.1021/jz500079e; Zalesny R, 2011, CHALL ADV COMPUT CHE, V13, P1, DOI 10.1007/978-90-481-2853-2	103	8	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	NOV	2014	10	11					4801	4812		10.1021/ct500489d		12	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AT4JI	WOS:000344905300006		
J	Nakata, A; Bowler, DR; Miyazaki, T				Nakata, Ayako; Bowler, David R.; Miyazaki, Tsuyoshi			Efficient Calculations with Multisite Local Orbitals in a Large-Scale DFT Code CONQUEST	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							DENSITY-FUNCTIONAL-THEORY; BAND-STRUCTURE; APPROXIMATION; EXCHANGE; SILICON; SYSTEMS	Multisite local orbitals, which are formed from linear combinations of pseudoatomic orbitals from a target atom and its neighbor atoms, have been introduced in the large-scale density functional theory calculation code CONQUEST. Multisite local orbitals correspond to local molecular orbitals so that the number of required local orbitals can be minimal. The multisite support functions are determined by using the localized filter diagonalization (LFD) method [ Phys. Rev. B 2009, 80, 205104]. Two new methods, the double cutoff method and the smoothing method, are introduced to the LFD method to improve efficiency and stability. The Hamiltonian and overlap matrices with multisite local orbitals are constructed by efficient sparse-matrix multiplications in CONQUEST. The investigation of the calculated energetic and geometrical properties and band structures of bulk Si, Al, and DNA systems demonstrate the accuracy and the computational efficiency of the present method. The representability of both occupied and unoccupied band structures with the present method has been also confirmed	[Nakata, Ayako] Natl Inst Mat Sci NIMS, Int Ctr Young Sci ICYS, Tsukuba, Ibaraki 3050044, Japan; [Nakata, Ayako; Miyazaki, Tsuyoshi] Natl Inst Mat Sci NIMS, Computat Mat Sci Unit CMSU, Tsukuba, Ibaraki 3050044, Japan; [Bowler, David R.; Miyazaki, Tsuyoshi] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Bowler, David R.] Natl Inst Mat Sci NIMS, WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Bowler, David R.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England	Nakata, A (reprint author), Natl Inst Mat Sci NIMS, Int Ctr Young Sci ICYS, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	NAKATA.Ayako@nims.go.jp; MIYAZAKI.Tsuyoshi@nims.go.jp	Bowler, David/C-1515-2008	Bowler, David/0000-0001-7853-1520	ICYS-NAMIKI, NIMS; MEXT, Japan [22104005]; JSPS, Japan [25810015, 26610120]; Strategic Programs for Innovative Research (SPIRE); Computational Materials Science Initiative (CMSI), Japan	A.N. is funded by ICYS-NAMIKI, NIMS. This work is supported by KAKENHI projects by MEXT (No. 22104005) and by JSPS (No. 25810015 and 26610120), Japan. This work is also supported by the Strategic Programs for Innovative Research (SPIRE) and the Computational Materials Science Initiative (CMSI), Japan. Calculations where performed in the Numerical Materials Simulator at NIMS, Tsukuba, Japan and the supercomputer HA8000 system at Kyushu-university, Fukuoka, Japan.	SANKEY OF, 1989, PHYS REV B, V40, P3979, DOI 10.1103/PhysRevB.40.3979; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Rayson MJ, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205104; Ozaki T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.195113; Bowler DR, 2001, COMPUT PHYS COMMUN, V137, P255, DOI 10.1016/S0010-4655(01)00164-3; Bowler DR, 2006, PHYS STATUS SOLIDI B, V243, P989, DOI 10.1002/pssb.200541386; Miyazaki T, 2004, J CHEM PHYS, V121, P6186, DOI 10.1063/1.1787832; Hernandez E, 1997, PHYS REV B, V55, P13485, DOI 10.1103/PhysRevB.55.13485; Torralba AS, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/29/294206; Bowler DR, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/7/074207; Otsuka T, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/29/294201; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Rayson MJ, 2010, COMPUT PHYS COMMUN, V181, P1051, DOI 10.1016/j.cpc.2010.02.012; Ozaki T, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155108; Hernandez E, 1996, PHYS REV B, V53, P7147, DOI 10.1103/PhysRevB.53.7147; Lin L, 2012, J COMPUT PHYS, V231, P2140, DOI 10.1016/j.jcp.2011.11.032; Apalkov V, 2007, NANOSCI TECHNOL, P77, DOI 10.1007/978-3-540-72494-0_5; KERKER GP, 1981, PHYS REV B, V24, P3468, DOI 10.1103/PhysRevB.24.3468; Lin L, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235144; Miyazaki T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.115327; O'Rourke C., 2014, J CHEM THEORY COMPUT; Szabo A., 1996, MODERN QUANTUM CHEM, P180; SZMULOWICZ F, 1981, PHYS REV B, V23, P1652, DOI 10.1103/PhysRevB.23.1652; Torralba AS, 2009, J CHEM THEORY COMPUT, V5, P1499, DOI 10.1021/ct8005425	25	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	NOV	2014	10	11					4813	4822		10.1021/ct5004934		10	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AT4JI	WOS:000344905300007		
J	Ohnishi, YY; Ishimura, K; Ten-no, S				Ohnishi, Yu-ya; Ishimura, Kazuya; Ten-no, Seiichiro			Interaction Energy of Large Molecules from Restrained Denominator MP2-F12	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							PLESSET PERTURBATION-THEORY; ELECTRONIC-STRUCTURE METHOD; CORRELATED WAVE-FUNCTIONS; HARTREE-FOCK MODEL; INTERMOLECULAR INTERACTIONS; ORBITAL METHODS; BASIS SETS; DENSITY; SPIN; DISPERSION	A new one-parameter correction scheme to second-order Moller-Plesset many-body perturbation theory (MP2) has been proposed to correctly evaluate intermolecular interaction energies of large pi-pi dispersion interaction systems as well as hydrogen-bonded and ss dispersion interaction ones. The scheme restrains the denominator of the MP2 correlation energy expression based on the observation that larger corrections to MP2 are required as the orbital energy gaps become small as in large pi-pi stacking systems. The root-mean-square-deviation of the restrained denominator MP2 with F12 correction (RD-MP2-F12) on the S66 set of 0.346 kcal/mol is less than half of that of MP2-F12. The interaction energies of RD-MP2 are similar to those of dispersion corrected density functional theory for a series of polyaromatic hydrocarbon dimers. For the C-60-fullerene dimer, however, the RD-MP2-F12 result somewhat deviates from the experimental estimate, indicating that an explicit inclusion of higher order correlation is required for the system.	[Ohnishi, Yu-ya; Ten-no, Seiichiro] Kobe Univ, Grad Sch Syst Informat, Nada Ku, Kobe, Hyogo 6578501, Japan; [Ishimura, Kazuya] Inst Mol Sci, Okazaki, Aichi 4448585, Japan	Ten-no, S (reprint author), Kobe Univ, Grad Sch Syst Informat, Nada Ku, Kobe, Hyogo 6578501, Japan.	tenno@garnet.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [00270471, 26810007]; Strategic Programs for Innovative Research (SPIRE), MEXT; Computational Materials Science Initiative (CMSI), Japan; RIKEN Advanced Institute for Computational Science through HPCI System Research project [hp120290, hp130032, hp140225]	This work is supported in part by the Grant-in-Aids for Scientific Research (B) (Grant No. 00270471) and for Young Scientists (B) (Grant No. 26810007) from the Japan Society for the Promotion of Science (JSPS), as well as the Strategic Programs for Innovative Research (SPIRE), MEXT, and the Computational Materials Science Initiative (CMSI), Japan. This research used computational resources' of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID: hp120290, hp130032, hp140225).	Klopper W, 2006, INT REV PHYS CHEM, V25, P427, DOI 10.1080/01442350600799921; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Rezac J, 2011, J CHEM THEORY COMPUT, V7, P2427, DOI 10.1021/ct2002946; Grimme S, 2003, J CHEM PHYS, V118, P9095, DOI 10.1063/1.1569242; Jung Y, 2006, PHYS CHEM CHEM PHYS, V8, P2831, DOI 10.1039/b602438f; Janowski T, 2012, J AM CHEM SOC, V134, P17520, DOI 10.1021/ja303676q; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; VOSKO SH, 1980, CAN J PHYS, V58, P1200; Hattig C, 2012, CHEM REV, V112, P4, DOI 10.1021/cr200168z; Ohtsuka Y, 2008, CHEM PHYS LETT, V463, P431, DOI 10.1016/j.cplett.2008.08.090; Grimme S, 2012, WIRES COMPUT MOL SCI, V2, P886, DOI 10.1002/wcms.1110; Bachorz RA, 2008, PHYS CHEM CHEM PHYS, V10, P2758, DOI 10.1039/b718494h; Ten-no S, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4802766; Jung YS, 2004, J CHEM PHYS, V121, P9793, DOI 10.1063/1.1809602; Distasio RA, 2007, MOL PHYS, V105, P1073, DOI 10.1080/00268970701283781; Shepherd JJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.226401; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Johnson ER, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2190220; ABREFAH J, 1992, APPL PHYS LETT, V60, P1313, DOI 10.1063/1.107327; Kong LG, 2012, CHEM REV, V112, P75, DOI 10.1021/cr200204r; Shepherd JJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.133002; [Anonymous], 2014, GELLAN HIER QUANT CH; Riley KE, 2010, CHEM REV, V110, P5023, DOI 10.1021/cr1000173; GILL PMW, 1993, CHEM PHYS LETT, V209, P506, DOI 10.1016/0009-2614(93)80125-9; Sinnokrot MO, 2004, J PHYS CHEM A, V108, P10200, DOI 10.1021/jp0469517; Sedlak R, 2013, J CHEM THEORY COMPUT, V9, P3364, DOI 10.1021/ct400036b; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; HEINEY PA, 1991, PHYS REV LETT, V66, P2911, DOI 10.1103/PhysRevLett.66.2911; Ten-No S, 2004, CHEM PHYS LETT, V398, P56, DOI 10.1016/j.cplett.2004.09.041; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Booth GH, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3193710; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Austin B. M., 2011, CHEM REV, V112, P263; Johnson ER, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1949201; Becke AD, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2065267; Fink RF, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3503041; Frisch M. J., 2009, GAUSSIAN 09 REVISION; GELLMANN M, 1957, PHYS REV, V106, P364, DOI 10.1103/PhysRev.106.364; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; HASER M, 1991, CHEM PHYS LETT, V181, P497, DOI 10.1016/0009-2614(91)80301-D; Helgaker T., 2000, MOL ELECT STRUCTURE, P817; Hill JG, 2007, J CHEM THEORY COMPUT, V3, P80, DOI 10.1021/ct6002737; Ishimura K, 2011, THEOR CHEM ACC, V130, P317, DOI 10.1007/s00214-011-0980-2; Ishimura K., 2014, INT J QUANTUM UNPUB; Jimenez-Hoyos C. A., ARXIV14084386V1 PHYS; King RA, 2009, MOL PHYS, V107, P789, DOI 10.1080/00268970802641242; Szabados A, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2404660; Ten-No S, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2403853; Ten-no S, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-011-1070-1; Ten-no S, 2012, WIRES COMPUT MOL SCI, V2, P114, DOI 10.1002/wcms.68; Tournus F, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1855884	56	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	NOV	2014	10	11					4857	4861		10.1021/ct500738g		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AT4JI	WOS:000344905300011		
J	Kaihara, T; Eguchi, K; Kario, K				Kaihara, Toshiki; Eguchi, Kazuo; Kario, Kazuomi			Home BP Monitoring Using a Telemonitoring System is Effective for Controlling BP in a Remote Island in Japan	JOURNAL OF CLINICAL HYPERTENSION			English	Article							BLOOD-PRESSURE-MEASUREMENT; RANDOMIZED CLINICAL-TRIAL; SELF-MEASUREMENT; HYPERTENSIVE PATIENTS; SOCIETY; ASSOCIATION; POPULATION; GUIDELINES; MANAGEMENT; ADHERENCE	The purpose of this study was to assess whether a home blood pressure (HBP) telemonitoring system could improve BP control and overcome the problems of HBP monitoring in a remote location. The authors enrolled 60 subjects and randomized them to either a Telemonitoring group or a Control group. The outcomes were changes in HBP level, adherence to HBP monitoring, and visual analog scale (VAS; score 0-100) as a measure of the motivation to perform HBP measurements. The reductions in morning systolic BP (-5.5 +/- 0.9mm Hg vs 0.7 +/- 0.7mm Hg, P<.001) and evening systolic BP (-4.6 +/- 1.0mm Hg vs 1.0 +/- 1.1mm Hg, P<.001) and the change in VAS (12.8 +/- 3.3 vs -1.6 +/- 2.2, P=.001) were significantly greater in the Telemonitoring group than in the Control group. The measure of the adherence to HBP monitoring tended to be better (P=.064) in the Telemonitoring group than in the Control group. These results indicate that an HBP telemonitoring system would be a beneficial healthcare measure in remote geographical locations.	[Kaihara, Toshiki] Niijima Mura Natl Hlth Insurance Clin, Tokyo, Japan; [Eguchi, Kazuo; Kario, Kazuomi] Jichi Med Univ Sch Med, Div Cardiovasc Med, Dept Med, Shimotsuke, Tochigi 33111, Japan	Eguchi, K (reprint author), Jichi Med Univ Sch Med, Div Cardiovasc Med, Dept Med, 3311-1 Shimotsuke, Shimotsuke, Tochigi 33111, Japan.	ke112@jichi.ac.jp					Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; Kim MT, 2011, J CLIN HYPERTENS, V13, P605, DOI 10.1111/j.1751-7176.2011.00479.x; Hoshide S, 2014, AM J HYPERTENS, V27, P939, DOI 10.1093/ajh/hpt290; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011; Bobrie G, 2004, JAMA-J AM MED ASSOC, V291, P1342, DOI 10.1001/jama.291.11.1342; Kerby TJ, 2012, J CLIN HYPERTENS, V14, P668, DOI 10.1111/j.1751-7176.2012.00685.x; Margolis KL, 2013, JAMA-J AM MED ASSOC, V310, P46, DOI 10.1001/jama.2013.6549; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; Niiranen TJ, 2010, HYPERTENSION, V55, P1346, DOI 10.1161/HYPERTENSIONAHA.109.149336; Asayama K, 2004, STROKE, V35, P2356, DOI 10.1161/01.STR.0000141679.42349.9f; Kario K, 2001, J AM COLL CARDIOL, V38, P238, DOI 10.1016/S0735-1097(01)01325-0; Logan AG, 2012, HYPERTENSION, V60, P51, DOI 10.1161/HYPERTENSIONAHA.111.188409; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; El Assaad MA, 2003, BLOOD PRESS MONIT, V8, P127, DOI 10.1097/01.mbp.0000087393.96145.b1; Imai Y, 2003, HYPERTENS RES, V26, P771, DOI 10.1291/hypres.26.771; Dabl Educational Web site, DEV BLOOD PRESS MEAS; Mengden T, 1998, AM J HYPERTENS, V11, P1413, DOI 10.1016/S0895-7061(98)00241-6; Parati G, 2013, TRIALS, V23, P14; STODDART A, 2013, BMJ OPEN, V28, P3; Yarows SA, 2001, BLOOD PRESS MONIT, V6, P145, DOI 10.1097/00126097-200106000-00005	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1524-6175	1751-7176		J CLIN HYPERTENS	J. Clin. Hypertens.	NOV	2014	16	11					814	819		10.1111/jch.12421		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT3QT	WOS:000344849600008		
J	Lee, M; Choi, Y; Matsugi, K; Sasaki, G; Kelimu, T				Lee, Moonhee; Choi, Yongbum; Matsugi, Kazuhiro; Sasaki, Gen; Kelimu, Tulugan			Effect of SiO2 amount on microstructures and tensile properties of alumina short fiber-reinforced composites by low-pressure infiltration method	JOURNAL OF COMPOSITE MATERIALS			English	Article						Al2O3 short fiber; low-pressure infiltration; composites; short fiber; tensile strength fracture behavior	METAL-MATRIX COMPOSITES; BEHAVIOR; FABRICATION; STRENGTH; PREFORM; SAFFIL; SYSTEM	The tensile properties of two types of alumina (Al2O3 and Al2O3-SiO2) and short fiber-reinforced A366 alloy composite created by low-pressure infiltration have been studied. The applied pressure and temperature of molten alloy are 0.4 MPa and 1073 K, respectively. The composite containing 10 vol.% of fiber preform was sectioned and the microstructure was observed by scanning electron microscopy and energy dispersive X-ray spectroscopy. Tensile properties of Al2O3 fiber-reinforced A366 alloy composites were investigated, in conjunction with investigation of effects of amounts of SiO2 sol added as binder to fabricated preform and effects of changed chemical composition of Al2O3 fiber. The composite with SiO2 sol of 8 mass% has higher relative density in comparison with composite with SiO2 sol of 2 mass%. SiO2 sol raised the relative density of composite by the reaction with aluminum. In addition, the ultimate tensile strength of composite which has Al2O3 fiber-reinforced A366 alloy composite containing SiO2 sol of 8 mass% was approximately 20% higher than that of Al2O3-SiO2 fiber-reinforced A366 alloy composite containing SiO2 sol of 8 mass%.	[Lee, Moonhee; Choi, Yongbum; Matsugi, Kazuhiro; Sasaki, Gen] Hiroshima Univ, Grad Sch Engn, Dept Mat & Prod Engn, Higashihiroshima 7398527, Japan; [Kelimu, Tulugan] Gyeongsang Natl Univ, Dept Mech & Precis Engn, Jinju, Gyeongsangnam D, South Korea	Choi, Y (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Mat & Prod Engn, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	ybchoi@hiroshima-u.ac.jp	Choi, yongbum/D-7189-2011				Yu ZQ, 2003, MATER LETT, V57, P3111, DOI 10.1016/S0167-577X(03)00006-5; Ksiazek M, 2002, MAT SCI ENG A-STRUCT, V324, P162, DOI 10.1016/S0921-5093(01)01305-3; LAURENT V, 1988, ACTA METALL MATER, V36, P1797, DOI 10.1016/0001-6160(88)90248-9; Bahraini M, 2009, COMPOS PART A-APPL S, V40, P1566, DOI 10.1016/j.compositesa.2009.06.016; Badini C, 2000, MATER CHEM PHYS, V64, P247, DOI 10.1016/S0254-0584(00)00215-7; Baxter WJ, 1998, SCRIPTA MATER, V38, P1589, DOI 10.1016/S1359-6462(98)00084-0; Choi YB, 2006, KEY ENG MATER, V326-328, P1741; Kang CG, 1996, J MATER PROCESS TECH, V61, P241, DOI 10.1016/0924-0136(95)02180-9; KEHOE FP, 1991, MAT SCI ENG A-STRUCT, V135, P209, DOI 10.1016/0921-5093(91)90563-3; Lee M, 2011, SCI ENG COMPOS MATER, V18, P167, DOI 10.1515/SECM.2011.027; Lee M, 2011, MATER TRANS, V52, P939, DOI 10.2320/matertrans.L-MZ201110; Seo YH, 1995, J MATER PROCESS TECH, V55, P370, DOI 10.1016/0924-0136(95)02033-0; Tjong SC, 1997, COMPOS SCI TECHNOL, V57, P1551	13	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	NOV	2014	48	27					3435	3441		10.1177/0021998313509867		7	Materials Science, Composites	Materials Science	AU0TF	WOS:000345336700009		
J	Takeda, A; Akimoto, M; Park, K; Kounoike, N; Shimakura, Y; Nemoto, M; Uchinuma, E				Takeda, Akira; Akimoto, Minekatsu; Park, Keiichi; Kounoike, Natsuko; Shimakura, Yasuhito; Nemoto, Mitsuru; Uchinuma, Eiju			Single-Stage Reconstruction of a Full-Thickness Alar Defect Using a Folded Nasolabial Flap Combined With a Redundant Skin Turnover Flap	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Nasal skin defect; nasolabial flap; turnover flap; reconstruction	NASAL RECONSTRUCTION	Background: The reconstructive strategy for full-thickness nasal skin defects should include recreation of a cutaneous cover, support, and internal nasal lining. The most challenging aspect of this procedure is provision of the nasal lining. These reconstructions typically require a 2-step process. Satisfactory nasal skin reconstruction in a single operation is ideal. Objective: We used a folded nasolabial flap combined with a turnover flap for reconstruction of full-thickness alar defects. Methods: The donor material of the lining flap was a combination of the distal portion of the nasolabial flap and redundant skin resected during its transposition. The redundant skin flap was turned upside down, with the skin surface inside the nasal cavity. The remaining portion of the defect was covered with a folded nasolabial flap. Results: This procedure was successful in all 5 patients. All flaps survived completely without evidence of necrosis or narrowing of airways. Aesthetic concerns, including effacement of the nasofacial sulcus, were minor. Conclusion: This method has the advantage of providing well-vascularized tissue of appropriate color, texture, and thickness for external coverage, as well as a satisfactory internal lining in a single-stage procedure.	[Takeda, Akira; Akimoto, Minekatsu; Park, Keiichi; Kounoike, Natsuko; Shimakura, Yasuhito; Nemoto, Mitsuru; Uchinuma, Eiju] Kitasato Univ, Sch Med, Dept Plast & Aesthet Surg, Sagamihara, Kanagawa 228, Japan	Takeda, A (reprint author), Kitasato Univ, Sch Med, Dept Plast & Aesthet Surg, Kitasato 1-15-1,Minami Ward, Sagamihara, Kanagawa 228, Japan.	takeda@kitasato-u.ac.jp					Mureau MAM, 2007, PLAST RECONSTR SURG, V120, P1217, DOI 10.1097/01.prs.0000279145.95073.ed; HERBERT DC, 1975, BRIT J PLAST SURG, V28, P85, DOI 10.1016/S0007-1226(75)90163-0; Fader DJ, 2000, J AM ACAD DERMATOL, V43, P837, DOI 10.1067/mjd.2000.108374; Han DH, ARCH FACIAL PLAST SU; Hosaka Y, 1999, BRIT J PLAST SURG, V52, P29, DOI 10.1054/bjps.1998.3012; Jin HR, 2009, AURIS NASUS LARYNX, V36, P560, DOI 10.1016/j.anl.2009.01.007; Koshima I, 2002, J RECONSTR MICROSURG, V18, P585, DOI 10.1055/s-2002-35096; Ohtsuka H, 1981, Ann Plast Surg, V6, P207, DOI 10.1097/00000637-198103000-00006; Parrett BM, 2009, CLIN PLAST SURG, V36, P407, DOI 10.1016/j.cps.2009.02.004; Uchinuma E, 1997, AESTHET PLAST SURG, V21, P86, DOI 10.1007/s002669900089; Valentini V, 2012, J CRANIOFAC SURG, V23, P474	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	NOV	2014	25	6					2144	2146		10.1097/SCS.0000000000001141		3	Surgery	Surgery	AT5XB	WOS:000345012000079		
J	Ohba, S; Yoshimura, H; Matsuda, S; Sano, K				Ohba, Seigo; Yoshimura, Hitoshi; Matsuda, Shinpei; Sano, Kazuo			Aspiration Pneumonia Associated With a Double Fracture of the Mandible	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Aspiration pneumonia; mandibular fracture; hyoid bone; swallowing function	RISK-FACTORS; HYOID BONE; COMPLICATIONS; SURGERY	Aspiration pneumonia is one of the most life-threatening diseases in the elderly. A 73-year-old woman was diagnosed with aspiration pneumonia after a mandibular fracture. Because her persistent aspiration pneumonia was accompanied by a diminished swallowing function that was believed to be due to a double fracture of the mandible, the patient underwent an open reduction while having pneumonia. Her symptoms of aspiration pneumonia improved immediately after the surgery. The hyoid bone was repositioned to its original position, and the movements of the hyoid bone and mandible were recovered after the surgery. In cases in which the medial bone segment of the mandible moves inside because of a double fracture and the movement of the hyoid bone declines, we strongly suggest that an open reduction should be performed as soon as possible to prevent aspiration pneumonia caused by a swallowing dysfunction.	[Ohba, Seigo; Yoshimura, Hitoshi; Matsuda, Shinpei; Sano, Kazuo] Univ Fukui, Dept Sensory & Locomotor Med, Div Dent & Oral Surg, Fac Med Sci, Eiheiji, Fukui 9101193, Japan	Ohba, S (reprint author), Univ Fukui, Dept Sensory & Locomotor Med, Div Dent & Oral Surg, Fac Med Sci, 23-3 Shimoaizuki, Eiheiji, Fukui 9101193, Japan.	sohba@u-fukui.ac.jp					PEDERSEN T, 1990, ACTA ANAESTH SCAND, V34, P144; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; van der Maarel-Wierink CD, 2011, J AM MED DIR ASSOC, V12, P344, DOI 10.1016/j.jamda.2010.12.099; Theunissen EAR, 2012, ARCH OTOLARYNGOL, V138, P548, DOI 10.1001/archoto.2012.862; Kang BS, 2010, GERONTOLOGY, V56, P474, DOI 10.1159/000274517; Kikawada M, 2005, DRUG AGING, V22, P115, DOI 10.2165/00002512-200522020-00003; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Ebihara S, 2011, PULM PHARMACOL THER, V24, P318, DOI 10.1016/j.pupt.2010.10.003; FEINBERG M J, 1990, Dysphagia, V5, P61, DOI 10.1007/BF02412646; KROENKE K, 1993, CHEST, V104, P1445, DOI 10.1378/chest.104.5.1445; La Croix AZ, 1989, PUBLIC HLTH REP, V104, P3360; Lo IL, 2010, OSTEOPOROSIS INT, V21, pS579, DOI 10.1007/s00198-010-1427-7; Macht M, 2013, CRIT CARE MED, V41, P2641, DOI 10.1097/CCM.0b013e3182a84be1; O'Meara ES, 2005, J AM GERIATR SOC, V53, P1108, DOI 10.1111/j.1532-5415.2005.53352.x; Smetana GW, 1999, NEW ENGL J MED, V340, P937, DOI 10.1056/NEJM199903253401207; van der Kruis JGJ, 2011, DYSPHAGIA, V26, P171, DOI 10.1007/s00455-010-9318-9; Yamaya M, 2001, J AM GERIATR SOC, V49, P685; Yokoo S, 2001, BRIT J ORAL MAX SURG, V39, P252, DOI 10.1054/bjom.2001.0636	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	NOV	2014	25	6					E569	E571		10.1097/SCS.0000000000001167		4	Surgery	Surgery	AT5XB	WOS:000345012000022		
J	Watanabe, M; Hibi, T; Mostafa, NM; Chao, JD; Arora, V; Camez, A; Petersson, J; Thakkar, R				Watanabe, Mamoru; Hibi, Toshifumi; Mostafa, Nael M.; Chao, Jingdong; Arora, Vipin; Camez, Anne; Petersson, Joel; Thakkar, Roopal			Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease	JOURNAL OF CROHNS & COLITIS			English	Article; Proceedings Paper	98th General Meeting of the Japanese Society of Gastroenterology	APR 19-21, 2012	Tokyo, JAPAN			Crohn's disease; Adalimumab; Japan; Long-term; Maintenance	INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; CLINICAL REMISSION; RANDOMIZED-TRIAL; MAINTENANCE; INFLIXIMAB; THERAPY; INDUCTION; CHARM	Background and aims: Adalimumab has been shown to be effective and well tolerated in patients with Crohn's disease. This analysis reports the results of a cohort of Japanese patients with moderate to severe Crohn's disease who were evaluated for up to 3 years to assess the long-term use of adalimumab. Methods: The study consisted of a double-blind part and an open-label part. Patients were included either in the 52-week double-blind, placebo-controlled part of the study followed by a 96-week open-label extension or in the open-label part from the beginning or in the event of a flare. Patients were treated with adalimumab and evaluated for up to 148 weeks as 3 data cohorts: the all-adalimumab cohort (patients receiving 1 injection of adalimumab), the 148-week follow-up subcohort (patients who completed 148 weeks of follow-up after the first adalimumab dose), and the dose-escalation subcohort (patients receiving adalimumab doses that increased to 80 mg every other week). Results: In the all-adalimumab cohort (n = 79), clinical remission rates were approximately 30% after 36 weeks of exposure to adalimumab and for the remainder of the study (35%, 33%, and 28% for weeks 48, 108, and 144, respectively). An improvement in quality of life was also maintained over the same period. In the dose-escalation subcohort (n = 40), the clinical remission rate was 75% (6/8) 48 weeks after dose escalation. Adalimumab was tolerated, and no deaths were reported. Conclusions: Adalimumab is effective for maintaining long-term clinical remission in Japanese patients with moderate to severe Crohn's disease (NCT00445432). (C) 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.	[Watanabe, Mamoru] Tokyo Med & Dent Univ, Tokyo, Japan; [Hibi, Toshifumi] Kitasato Univ, Kitasato Inst Hosp, Tokyo, Japan; [Mostafa, Nael M.; Chao, Jingdong; Arora, Vipin; Thakkar, Roopal] AbbVie Inc, N Chicago, IL USA; [Camez, Anne] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany; [Petersson, Joel] AbbVie Inc, Rungis, France	Watanabe, M (reprint author), Tokyo Med & Dent Univ, Dept Gastroenterol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	mamoru.gast@tmd.ac.jp					MURCH SH, 1991, GUT, V32, P913, DOI 10.1136/gut.32.8.913; Cheifetz A, 2003, AM J GASTROENTEROL, V98, P1315, DOI 10.1016/S0002-9270(03)00231-4; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2007.11.041; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Sandborn WJ, 2007, ANN INTERN MED, V146, P829; Panaccione R, 2010, ALIMENT PHARM THER, V31, P1296, DOI 10.1111/j.1365-2036.2010.04304.x; Panaccione R, 2013, ALIMENT PHARM THER, V38, P1236, DOI 10.1111/apt.12499; Watanabe M, 2012, J CROHNS COLITIS, V6, P160, DOI 10.1016/j.crohns.2011.07.013; MURCH SH, 1993, GUT, V34, P1705, DOI 10.1136/gut.34.12.1705; Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; Sandborn WJ, 2007, GUT, V56, P1232, DOI 10.1136/gut.2006.106781; Cohen RD, 2002, ALIMENT PHARM THERAP, V16, P1603, DOI 10.1046/j.1365-2036.2002.01323.x; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Economou M, 2008, INFLAMM BOWEL DIS, V14, P709, DOI 10.1002/ibd.20352; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Sandborn WJ, 2011, INFLAMM BOWEL DIS, V17, P141, DOI 10.1002/ibd.21328; Wu EQ, 2008, VALUE HEALTH, V11, P820, DOI 10.1111/j.1524-4733.2008.00335.x	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	NOV 1	2014	8	11					1407	1416		10.1016/j.crohns.2014.04.012		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8KL	WOS:000345182200007		
J	Kobayashi, K; Hirai, F; Naganuma, M; Watanabe, K; Ando, T; Nakase, H; Matsuoka, K; Watanabe, M				Kobayashi, Kiyonori; Hirai, Fumihito; Naganuma, Makoto; Watanabe, Kenji; Ando, Takafumi; Nakase, Hiroshi; Matsuoka, Katsuyoshi; Watanabe, Mamoru			A randomized clinical trial of mesalazine suppository: The usefulness and problems of central review of evaluations of colonic mucosal findings	JOURNAL OF CROHNS & COLITIS			English	Article						Ulcerative colitis; Colonoscopy; Mucosal findings; Central review; Inter-rater reliability	INFLAMMATORY-BOWEL-DISEASE; ACTIVE ULCERATIVE-COLITIS; 5-AMINOSALICYLIC ACID; DOUBLE-BLIND; MESALAMINE; PROCTITIS; RELIABILITY; ENDOSCOPY; VARIABILITY; AGREEMENT	Background: The methods of evaluating endoscopic mucosal findings and the definition of mucosal healing in inflammatory bowel disease have not been standardized. Aim: To examine a third-party central review of colonic mucosal evaluations. Methods: A double-blind, placebo-controlled, parallel-group trial was performed for 4 weeks, which involved continuous administration of a 1-g mesalazine suppository to 129 patients with mild to moderate ulcerative colitis and active rectal inflammatory findings. Mucosal findings were evaluated by using a 4-grade score (0, 1, 2, 3). Reviews by attending physicians were considered the primary evaluations. Concurrently, a central review committee of 7 gastroenterologists served as the third party. Results: The endoscopic remission induction rate from the attending physicians' evaluations was 82.8% in the mesalazine suppository group and 31.1% in the placebo suppository group, whereas the respective rates from the central review committee were 90.6% and 59.0%. However, there was a difference of 27.9 percentage points between the remission induction rates of the placebo group found by the two groups of raters. Differences in the evaluations of mucosal finding scores were also found among the third-party reviewers. Conclusions: The evaluations of the attending physicians were consistent with those of the central review committee in showing the effectiveness of mesalazine suppository through the index of mucosal healing. However, differences were observed among the raters in their evaluations of mucosal finding scores. Therefore, standardizing evaluation criteria and improving review methods for mucosal findings would enable the more effective use of third-party central reviews in clinical drug trials. (C) 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.	[Kobayashi, Kiyonori] Kitasato Univ, Sch Med, Ctr New Med Frontiers, Dept Res & Dev, Sagamihara, Kanagawa 2520380, Japan; [Hirai, Fumihito] Fukuoka Univ, Chikushi Hosp, Dept Gastroenterol, Fukuoka 81401, Japan; [Naganuma, Makoto] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Watanabe, Kenji] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan; [Ando, Takafumi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol, Nagoya, Aichi 4648601, Japan; [Nakase, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Matsuoka, Katsuyoshi] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Watanabe, Mamoru] Tokyo Med & Dent Univ, Grad Sch, Dept Gastroenterol & Hepatol, Tokyo, Japan	Kobayashi, K (reprint author), Kitasato Univ, Sch Med, Ctr New Med Frontiers, Dept Res & Dev,Minami Ku, 2-1-1 Asamizodai, Sagamihara, Kanagawa 2520380, Japan.	koba-eus@kitasato-u.ac.jp			Kyorin Pharmaceutical Co., Ltd.	This trial was funded entirely by Kyorin Pharmaceutical Co., Ltd. Employees of Kyorin Pharmaceutical Co., Ltd., were involved in the analysis and interpretation of the data, and in the writing of the manuscript.; Kiyonori Kobayashi, Fumihiro Hirai, Makoto Naganunna, Kenji Watanabe, Takafumi Ando, Hiroshi Nakase, and Katsuyoshi Matsuoka have served on advisory boards and received consultancy funding from Kyorin Pharmaceutical Co. Ltd. Mamoru Watanabe have counseled the central review committee as the medical expert of this study and received a consultancy funding from Kyorin Pharmaceutical Co. Ltd.	SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420; Lee YC, 2007, GASTROINTEST ENDOSC, V66, P230, DOI 10.1016/j.gie.2006.10.056; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra020831; Travis SPL, 2013, GASTROENTEROLOGY, V145, P987, DOI 10.1053/j.gastro.2013.07.024; Lichtenstein GR, 2010, INFLAMM BOWEL DIS, V16, P338, DOI 10.1002/ibd.20997; Feagan BG, 2013, GASTROENTEROLOGY, V145, P149, DOI 10.1053/j.gastro.2013.03.025; Edebo A, 2007, ENDOSCOPY, V39, P195, DOI 10.1055/s-2006-945112; MATTS SG, 1961, Q J MED, V30, P393; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Watanabe M, 2013, ALIMENT PHARM THER, V38, P264, DOI 10.1111/apt.12362; Rutgeerts P, 2007, GUT, V56, P453, DOI 10.1136/gut.2005.088732; BARON JH, 1964, BRIT MED J, V1, P89; HANAUER S, 1993, AM J GASTROENTEROL, V88, P1188; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894; Cooney RM, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-17; de Lange T, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-9; Delvaux M, 2008, ENDOSCOPY, V40, P16, DOI 10.1055/s-2007-966935; Farup PG, 2001, INFLAMM BOWEL DIS, V7, P237, DOI 10.1097/00054725-200108000-00009; Feinstein A R, 1987, CLINIMETRICS; Ito H, 2010, INFLAMM BOWEL DIS, V16, P1567, DOI 10.1002/ibd.21193; Kishi H, 1998, Diagn Ther Endosc, V5, P37, DOI 10.1155/DTE.5.37; Lakatos PL, 2008, EXPERT OPIN PHARMACO, V9, P741, DOI 10.1517/14656566.9.5.741; Lucidarme D, 1997, ALIMENT PHARM THERAP, V11, P335, DOI 10.1046/j.1365-2036.1997.126297000.x; Mourn B, 1997, SCAND J GASTROENTERO, V32, P1005; NGO Y, 1992, GASTROEN CLIN BIOL, V16, P782; Orlandi F, 1998, ITAL J GASTROENTEROL, V30, P539; RACHMILEWITZ D, 1989, BRIT MED J, V298, P82; Travis S, 2006, AM J GASTROENTEROL, V101, pS429	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	NOV 1	2014	8	11					1444	1453		10.1016/j.crohns.2014.05.005		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8KL	WOS:000345182200011		
J	Capkova, H				Capkova, Helena			Transnational Networkers-Iwao and Michiko Yamawaki and the Formation of Japanese Modernist Design	JOURNAL OF DESIGN HISTORY			English	Article						1930s; architecture; Bauhaus; Japonisme; modernism; Yamawaki, Iwao & Michiko		The network of Japanese designers who trained abroad in the inter-war period significantly shaped the phenomenon of Japanese Modernism-a phenomenon still to be thoroughly explored in the context of Modernism studies. This article offers a new perspective focusing on the mutual nature of transnational exchanges rather than the mono local context or the one way 'influence' of the Bauhaus and Constructivism on Japan which has been studied in the past. My analysis of the Bauhaus network as a component of the larger network of 1930s Japanese modernity in architecture and design confirms that one cannot capture this transnational landscape properly unless one considers the hybrid and productive outcomes shared by a network of artists involved. The analysis presents a number of networks that interact and overlap, with particular attention to the network of women artists.	Waseda Univ, Sch Int Liberal Studies, Tokyo, Japan	Capkova, H (reprint author), Waseda Univ, Sch Int Liberal Studies, Tokyo, Japan.	Helena.capkova@gmail.com					[Anonymous], 1936, FUNDAMENTALS JAPANES; [Anonymous], 1937, FUJIN GAHO, P166; [Anonymous], 1937, HOUSES PEOPLE JAPAN; Benjamin W., 1968, ILLUMINATIONS, P75; BHABHA Homi K., 1994, LOCATION CULTURE, P212; Fujiya Y., 2010, STUDY IWAO YAMAWAKI, P289; Izutsu A., 1992, BAUHAUS JAPANESE PER; Kawahata N., 1995, BAUHAUS PHOTOGRAPHY; Kawahata N., 1995, BAUHAUS 1919 1933, P133; Kikuchi Y., 2011, 38 INT RES S QUEST O, p[211, 214, 225]; Koyama M., 1941, GENDAI JUTAKU 1933 4, V2; Koyama M., 1941, GENDAI JUTAKU 1933 4, V3; Koyama M., 1941, GENDAI JUTAKU 1933 4, V1; Sand J., 2004, HOUSE HOME MODERN JA, P370; Suga Y., 2006, J DESIGN HIST, V19, p[137, 137], DOI 10.1093/jdh/epl008; Tomiyama H., 1995, SHISEIDO GALLERY 75; Tsunemi M., 2007, DESIGN ACTIVITIES WO; Ueda M., 2007, TOSHI JUTAKU KURONIK, P384; Valdivieso M., 2005, BAUHAUS FESTA 1919 1; Wohr U., 2008, HIROSHIMA J INT STUD, V14, P75; Yamawaki I., 1943, KEYAKI ZELKOVA TREE; Yamawaki I., 1933, KOGA, V2; Yamawaki I., 1932, KEHYUKAI GEPPO, V31; Yamawaki I., 1932, KOKUSAI KENCHIKU, V8; Yamawaki I., 1954, BAUHAUSU HITOBITO PE; Yamawaki I., 1973, ZELKOVA TREE SERIES; Yamawaki M., 1995, BAUHAUSU TO CHANOYU	27	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0952-4649	1741-7279		J DES HIST	J. Des. Hist.	NOV	2014	27	4			SI		370	385		10.1093/jdh/epu009		16	Art	Art	AU1HW	WOS:000345372700004		
J	Iida, M; Yamamoto, M; Ishiguro, YS; Yamazaki, M; Ueda, N; Honjo, H; Kamiya, K				Iida, Masato; Yamamoto, Mitsuru; Ishiguro, Yuko S.; Yamazaki, Masatoshi; Ueda, Norihiro; Honjo, Haruci; Kamiya, Kaichirou			Urinary type IV collagen is related to left ventricular diastolic function and brain natriuretic peptide in hypertensive patients with prediabetes	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						Urinary type IV collagen; Echocardiography; BNP; Left ventricular diastolic function; Prediabetes; Hypertension	SOCIETY-OF-CARDIOLOGY; PLASMA-GLUCOSE LEVELS; DIABETIC-NEPHROPATHY; RENAL FIBROSIS; ANGIOTENSIN-II; KIDNEY-DISEASE; FOLLOW-UP; ECHOCARDIOGRAPHY; RECOMMENDATIONS; ASSOCIATION	Aim: Urinary type IV collagen is an early biomarker of diabetic nephropathy. Concomitant prediabetes (the early stage of diabetes) was associated with left ventricular (LV) diastolic dysfunction and increased brain natriuretic peptide (BNP) in hypertensive patients. We hypothesized that urinary type IV collagen may be related to these cardiac dysfunctions. Methods: We studied hypertensive patients with early prediabetes (HbA1c <5.7% and fasting glucose >110, n = 18), those with prediabetes (HbA1c 5.7-6.4, n = 98), and those with diabetes (HbA1c > 6.5 or on diabetes medications, n = 92). The participants underwent echocardiography to assess left atrial volume/body surface area (BSA) and the ratio of early mitral flow velocity to mitral annular velocity (E/e'). Left ventricular diastolic dysfunction (LVDD) was defined if patients had E/e' >= 15, or E/e' = 9-14 accompanied by left atrial volume/BSA >= 32 ml/mm(2). Urinary samples were collected for type IV collagen and albumin, and blood samples were taken for BNP and HbA1c. Results: Urinary type IV collagen and albumin increased in parallel with the deterioration of glycemic status. In hypertensive patients with prediabetes, subjects with LVDD had higher levels of BNP and urinary type IV collagen than those without LVDD. In contrast, in hypertensive patients with diabetes, subjects with LVDD had higher urinary albumin and BNP than those without LVDD. Urinary type IV collagen correlated positively with BNP in hypertensive patients with prediabetes, whereas it correlated with HbA1c in those with diabetes. Conclusions: In hypertensive patients with prediabetes, urinary type IV collagen was associated with LV diastolic dysfunction and BNP. (C) 2014 Elsevier Inc. All rights reserved.	[Iida, Masato; Yamamoto, Mitsuru; Ishiguro, Yuko S.; Yamazaki, Masatoshi] Mitsubishi Nagoya Hosp, Dept Cardiol, Nagoya, Aichi 4560013, Japan; [Ueda, Norihiro; Honjo, Haruci; Kamiya, Kaichirou] Nagoya Univ, Environm Med Res Inst, Dept Cardiovasc Res, Nagoya, Aichi 4648601, Japan	Iida, M (reprint author), Mitsubishi Nagoya Hosp, Dept Cardiol, Atsuta Ku, 7-8 Sotodoi Cho, Nagoya, Aichi 4560013, Japan.	masato2_iida@mhi.co.jp					American Diabetes Association, 2010, DIABETES CARE S1, V33, pS62, DOI DOI 10.2337/DC10-S062; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; JOHNSON RJ, 1992, HYPERTENSION, V19, P464; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Matheson A, 2010, DIABETES-METAB RES, V26, P150, DOI 10.1002/dmrr.1068; Catena C, 2013, AM J HYPERTENS, V26, P1353, DOI 10.1093/ajh/hpt114; Sciacqua A, 2011, DIABETES CARE, V34, P2291, DOI 10.2337/dc11-0879; Liu JE, 2001, J AM COLL CARDIOL, V37, P1943, DOI 10.1016/S0735-1097(01)01230-X; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Devereux RB, 2012, AM J CARDIOL, V110, P1189, DOI 10.1016/j.amjcard.2012.05.063; EGHBALI M, 1989, J MOL CELL CARDIOL, V21, P103, DOI 10.1016/0022-2828(89)91498-3; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liu JE, 2003, J AM COLL CARDIOL, V41, P2022, DOI 10.1016/S0735-1097(03)00403-0; MAI M, 1993, HYPERTENSION, V22, P754; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; Kroon MH, 2012, DIABETES CARE, V35, P2510, DOI 10.2337/dc11-1959; Yu HCM, 1998, CIRCULATION, V98, P2621; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Tsioufis C, 2006, J HYPERTENS, V24, P965, DOI 10.1097/01.hjh.0000222768.15100.00; BANU N, 1995, DIABETES RES CLIN PR, V29, P57, DOI 10.1016/0168-8227(95)01119-X; Conen D, 2006, AM J CARDIOL, V97, P249, DOI 10.1016/j.amjcard.2005.08.028; Furumatsu Y, 2011, NEPHRON CLIN PRACT, V117, pC160, DOI 10.1159/000319794; Huntley BK, 2010, J CELL PHYSIOL, V225, P251, DOI 10.1002/jcp.22253; Iijima T, 1998, J CLIN LAB ANAL, V12, P378, DOI 10.1002/(SICI)1098-2825(1998)12:6<378::AID-JCLA8>3.0.CO;2-J; Ishimitsu T, 2000, HYPERTENS RES, V23, P459, DOI 10.1291/hypres.23.459; Kim S, 1996, BRIT J PHARMACOL, V118, P549; Seki N, 2013, J DIABETES COMPLICAT, V27, P92, DOI 10.1016/j.jdiacomp.2012.06.013; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Yanagi M, 2013, HYPERTENS RES, V36, P262, DOI 10.1038/hr.2012.184	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	NOV-DEC	2014	28	6					824	830		10.1016/j.jdiacomp.2014.08.005		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AT5KD	WOS:000344981200014		
J	Sakamoto, M; Sugimoto, N; Kawabata, H; Yamakawa, E; Kodera, N; Pillai, R; Tatsumi, Y				Sakamoto, Misao; Sugimoto, Noriaki; Kawabata, Hideki; Yamakawa, Eiko; Kodera, Nobuyuki; Pillai, Radhakrishnan; Tatsumi, Yoshiyuki			Transungual Delivery of Efinaconazole: Its Deposition in the Nail of Onychomycosis Patients and In Vitro Fungicidal Activity in Human Nails	JOURNAL OF DRUGS IN DERMATOLOGY			English	Article							10-PERCENT SOLUTION; ANTIFUNGAL AGENTS; PENETRATION; EFFICACY; LACQUER; SAFETY	Background: Effective transungual delivery of topical antifungal agents in onychomycosis has been hampered by poor nail permeation. To be effective they must have antifungal efficacy, and effectively permeate through the dense keratinized nail plate to the site of infection in the nail bed and nail matrix. The therapeutic efficacy of efinaconazole topical solution, 10% has been established in two phase 3 clinical trials in distal lateral subungual onychomycosis. Objective: To investigate the transungual delivery of efinaconazole in onychomycosis patients and its fungicidal activity in the toenail. Methods: Concentrations of efinaconazole were determined as part of a multi-center, open label study in forty onychomycosis patients following repeated application of efinaconazole topical solution, 5% and 10% to the toenails over 28 days, with a 2-week follow-up. Fungicidal activity against T rubrum in the ventral layer of human nails was determined using an in vitro human nail infection model (ChubTur (R)). Results: Efinaconazole concentrations in the nail were four orders of magnitude higher than MIC values of efinaconazole against dermatophytes. Further, nail drug concentrations were not influenced by the presence of disease or nail thickness, and maintained at high antifungal levels post-treatment. Efinaconazole was effective in reducing fungal viability, suggesting that sufficient amounts of efinaconazole were being delivered into the ventral layer of the nail plate. Conclusions: Effective transungual delivery of efinaconazole was demonstrated. The high efinaconazole concentrations in patient toenails and fungicidal activity in vitro potentially contribute to the clinical efficacy reported in phase 3 studies.	[Sakamoto, Misao; Kawabata, Hideki; Yamakawa, Eiko; Kodera, Nobuyuki] Kaken Pharmaceut Co Ltd, Tokyo, Japan; [Sugimoto, Noriaki] Kaken Pharmaceut Co Ltd, Shizuoka, Japan; [Pillai, Radhakrishnan] Dow Pharmaceut Sci, Petaluma, CA USA; [Tatsumi, Yoshiyuki] Kaken Pharmaceut Co Ltd, Kyoto, Japan	Tatsumi, Y (reprint author), Kaken Pharmaceut Co Ltd, Kyoto, Japan.	tatsumi_yoshiyuki@kaken.co.jp			Kaken Pharmaceutical Co Ltd, Tokyo, Japan; Valeant Pharmaceuticals North America LLC., Bridgewater, NJ	Funding of this study was provided by Kaken Pharmaceutical Co Ltd, Tokyo, Japan and Valeant Pharmaceuticals North America LLC., Bridgewater, NJ. Dr Tatsumi and Ms. Sakamoto, Yamakawa, Mr. Sugimoto, Kawabata, and Kodera are employees of Kaken Pharmaceuticals. Dr Pillai is an employee of Dow Pharmaceutical Sciences, a division of Valeant Pharmaceuticals.	Traynor MJ, 2010, J PHARM PHARMACOL, V62, P730, DOI [10.1211/jpp.62.06.0009, 10.1211/jpp/62.06.0009]; Sugiura K, 2014, ANTIMICROB AGENTS CH, V58, P3837, DOI 10.1128/AAC.00111-14; Elewski BE, 2013, J AM ACAD DERMATOL, V68, P600, DOI 10.1016/j.jaad.2012.10.013; Gupta AK, 2000, J AM PODIAT MED ASSN, V90, P495; Iorizzo M, 2010, J DTSCH DERMATOL GES, V8, P875, DOI 10.1111/j.1610-0387.2010.07499.x; Siu WJJ, 2013, ANTIMICROB AGENTS CH, V57, P1610, DOI 10.1128/AAC.02056-12; Watanabe S, 2010, J DERMATOL, V37, P397, DOI 10.1111/j.1346-8138.2009.00741.x; Tatsumi Y, 2002, ANTIMICROB AGENTS CH, V46, P3797, DOI 10.1128/AAC.46.12.3797-3801.2002; Gupta AK, 2014, J DRUGS DERMATOL, V13, P815; Gupta AK, 2000, J AM ACAD DERMATOL, V43, P244, DOI 10.1067/mjd.2000.104794; Bohn M, 2000, J AM PODIAT MED ASSN, V90, P491; Jarratt M, 2013, J DRUGS DERMATOL, V12, P1010; Monti D, 2013, J EUR ACAD DERMATOL, V27, pE153, DOI 10.1111/j.1468-3083.2012.04529.x; SCHER RK, 1998, HOSP MED, V34, P11	14	2	2	JOURNAL OF DRUGS IN DERMATOLOGY	NEW YORK	377 PARK AVE SOUTH, 6TH FLOOR, NEW YORK, NY 10016 USA	1545-9616			J DRUGS DERMATOL	J. Drugs Dermatol.	NOV	2014	13	11					1388	1392				5	Dermatology	Dermatology	AT5IJ	WOS:000344976800016		
J	Tsujimoto, M; Irifune, Y; Tsujimoto, Y; Yamada, S; Watanabe, I; Hayashi, Y				Tsujimoto, Masaki; Irifune, Yuu; Tsujimoto, Yasuhisa; Yamada, Shizuka; Watanabe, Ikuya; Hayashi, Yoshihiko			Comparison of Conventional and New-generation Nickel-Titanium Files in Regard to Their Physical Properties	JOURNAL OF ENDODONTICS			English	Article						Cyclic fatigue resistance test; differential scanning calorimetry; heat treatment; nickel-titanium files; scanning electron microscopy	CYCLIC FATIGUE RESISTANCE; SCANNING-ELECTRON-MICROSCOPY; ROTARY INSTRUMENTS; ENDODONTIC INSTRUMENTS; TORSIONAL RESISTANCE; CLINICAL-USE; NITINOL; STRESS; ALLOYS	Introduction: This study investigated the surface, fractured structure, and physicochemical properties related to cyclic fatigue in various nickel-titanium (NiTi) files. Methods: Among a total of 10 groups of NiTi files, conventional NiTi - files (ProFile [Dentsply Maillefer, Ballaigues, Switzerland] and K3 [SybronEndo, Orange, CAD and new-generation NiTi files (ProFile Vortex [PV; Tulsa Dental Specialties, Tulsa, OK], Vortex Blue [VB; Tulsa Dental Specialties], and K3 XF [XF; SybronEndo, Orange, CA]) with the same tip diameter (ISO size 25) and 2 types of taper (0.04 and 0.06) were used in this study. Scanning electron microscopy of the file surface structure, differential scanning calorimetry, and cyclic fatigue resistance tests were conducted. Results: Many mechanical grooves were recognized on the file surface. The surface in the ProFile group was extremely smooth compared with that observed for the other files. Many shallow hollows besides mechanical grooves were noted on the surface in the XF group. A smooth curve was observed in the ProFile, K3, and PV groups. Defined peaks in differential scanning calorimetry were observed in the VB and XF groups. The 0.04 taper files exhibited a statistically higher number of cycles to fracture than the 0.06 taper files in all groups (P <.05). Cracks along the mechanical grooves were observed in the NiTi files, with the exception of the XF group. The start of cracking was detected at U-shape sites in the ProFile group, the cutting edge in the PV and VB groups, and radial islands in the K3 and XF groups. Conclusions: The present findings suggest that new-generation NiTi files are not necessarily improved compared with conventional files.	[Tsujimoto, Masaki; Irifune, Yuu; Yamada, Shizuka; Hayashi, Yoshihiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Nagasaki 8528588, Japan; [Tsujimoto, Yasuhisa] Nihon Univ, Sch Dent, Dept Endodont, Matsudo, Chiba 271, Japan; [Watanabe, Ikuya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dent & Biomed Mat Sci, Nagasaki 8528588, Japan	Hayashi, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Sakamoto 1-7-1, Nagasaki 8528588, Japan.	hayashi@nagasaki-u.ac.jp					Gao Y, 2012, J ENDODONT, V38, P398, DOI 10.1016/j.joen.2011.11.004; Johnson E, 2008, J ENDODONT, V34, P1406, DOI 10.1016/j.joen.2008.07.029; Eggert C, 1999, J ENDODONT, V25, P494, DOI 10.1016/S0099-2399(99)80289-1; Anderson ME, 2007, J ENDODONT, V33, P1212, DOI 10.1016/j.joen.2007.07.007; Gambarini G, 2008, J ENDODONT, V34, P1003, DOI 10.1016/j.joen.2008.05.007; Shen Y, 2013, J ENDODONT, V39, P163, DOI 10.1016/j.joen.2012.11.005; Shen Y, 2011, J ENDODONT, V37, P1566, DOI 10.1016/j.joen.2011.08.005; Kramkowski TR, 2009, J ENDODONT, V35, P404, DOI 10.1016/j.joen.2008.12.003; Xu XJ, 2006, J ENDODONT, V32, P372, DOI 10.1016/j.joen.2005.08.012; Perez-Higueras JJ, 2013, J ENDODONT, V39, P1585, DOI 10.1016/j.joen.2013.07.020; Peters OA, 2010, QUINTESSENCE INT, V41, P479; Thompson SA, 2000, INT ENDOD J, V33, P297, DOI 10.1046/j.1365-2591.2000.00339.x; Sattapan B, 2000, J ENDODONT, V26, P161, DOI 10.1097/00004770-200003000-00008; WALIA H, 1988, J ENDODONT, V14, P346; Al-Hadlaq SMS, 2010, J ENDODONT, V36, P305, DOI 10.1016/j.joen.2009.10.032; Bird DC, 2009, J ENDODONT, V35, P1193, DOI 10.1016/j.joen.2009.05.027; Brantley WA, 2002, J ENDODONT, V28, P567, DOI 10.1097/00004770-200208000-00001; Bui TB, 2008, J ENDODONT, V34, P190, DOI 10.1016/j.joen.2007.10.007; Cheung GSP, 2007, J ENDODONT, V33, P1217, DOI 10.1016/j.joen.2007.07.022; Cheung GSP, 2007, INT ENDOD J, V40, P619, DOI 10.1111/j.1365-2591.2007.01256.x; Gambarini G, 2010, Minerva Stomatol, V59, P401; Herold KS, 2007, J ENDODONT, V33, P712, DOI 10.1016/j.joen.2007.03.014; Kim HC, 2008, J ENDODONT, V34, P743, DOI 10.1016/j.joen.2008.03.015; Kim JY, 2012, J ENDODONT, V38, P527, DOI 10.1016/j.joen.2011.12.018; Larsen CM, 2009, J ENDODONT, V35, P401, DOI 10.1016/j.joen.2008.12.010; Marending M, 1998, INT ENDOD J, V31, P57, DOI 10.1046/j.1365-2591.1998.t01-1-00104.x; Otsuka K, 1998, SHAPE MEMORY MAT; Plotino G, 2014, ODONTOLOGY, V102, P31, DOI 10.1007/s10266-012-0088-8; Ray JJ, 2007, J ENDODONT, V33, P1212; Schijve J, 2001, FATIGUE STRUCTURES M, P175; Setzer FC, 2013, J ENDODONT, V39, P133, DOI 10.1016/j.joen.2012.10.001; Tripi TR, 2006, ORAL SURG ORAL MED O, V102, pE106, DOI 10.1016/j.tripleo.2005.12.012; West JD, 1994, PATHWAYS PULP, P206	33	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399	1878-3554		J ENDODONT	J. Endod.	NOV	2014	40	11					1824	1829		10.1016/j.joen.2014.06.009		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT5JP	WOS:000344979900016		
J	Iino, Y; Ebihara, A; Yoshioka, T; Kawamura, J; Watanabe, S; Hanada, T; Nakano, K; Sumi, Y; Suda, H				Iino, Yoshiko; Ebihara, Arata; Yoshioka, Toshihiko; Kawamura, Jun; Watanabe, Satoshi; Hanada, Takahiro; Nakano, Kiwako; Sumi, Yasunori; Suda, Hideaki			Detection of a Second Mesiobuccal Canal in Maxillary Molars by Swept-source Optical Coherence Tomography	JOURNAL OF ENDODONTICS			English	Article						Canal detection; mesiobuccal canal; molar; optical coherence tomography	COMPOSITE RESTORATIONS; OPERATING MICROSCOPE; 1ST MOLARS; EX-VIVO; ROOT; MORPHOLOGY; FRACTURES; FREQUENCY; CRACKS; TEETH	Introduction: The purpose of this study was to investigate the ability of swept-source optical coherence tomographic (SS-OCT) imaging to detect a second mesiobuccal canal (MB2) in maxillary molars compared with visual inspection (VI) and dental operating microscopy (DOM). Methods: Forty extracted human maxillary molars were examined. After the removal of half the crown and access cavity preparation, the existence of MB2 canals was confirmed based on cross-sectional images of each tooth obtained by micro-computed tomographic scanning as the reference standard. Then, the pulp chamber floor was scanned by SS-OCT imaging. Three dentists independently evaluated the SS-OCT images and the pulp chamber floor under VI and DOM for the presence of MB2 canals. The detection rate of MB2 canals for SS-OCT imaging, VI, and DOM was calculated, and statistical analysis was performed. Results: MB2 canals existed in 19 of 40 teeth (47.5%) using micro-CT imaging. Sensitivity of DOM (0.947) was significantly higher than that of SS-OCT imaging (0.632). Specificity of SS-OCT imaging (0.714) was significantly higher than that of DOM (0.333). No statistically significant differences were found for accuracy among the 3 methods. Kappa values of SS-OCT, VI, and DOM were 0.526, 0.417, and 0.326, respectively. Conclusions: SS-OCT imaging is noninvasive, involves no ionizing radiation, and is accurate for the detection of MB2 canals.	[Iino, Yoshiko; Ebihara, Arata; Yoshioka, Toshihiko; Kawamura, Jun; Watanabe, Satoshi; Hanada, Takahiro; Nakano, Kiwako; Suda, Hideaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Oral Hlth Sci, Dept Pulp Biol & Endodont, Tokyo 1138549, Japan; [Sumi, Yasunori] Ctr Adv Med Dent & Oral Dis, Natl Ctr Geriatr & Gerontol, Dept Adv Dent Res, Obu, Aichi, Japan	Ebihara, A (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Oral Hlth Sci, Dept Pulp Biol & Endodont,Bunkyo Ku, 1-5-4 Yushima, Tokyo 1138549, Japan.	a.ebihara.endo@tmd.ac.jp			Research Grant for Longevity Sciences from the Ministry of Health, Labour and Welfare [23-20]; Japan Society for the Promotion of Science [23390432, 25293385, 25861790, 25870196]	Supported by a Research Grant for Longevity Sciences (grant no. 23-20) from the Ministry of Health, Labour and Welfare and a Grant-in-Aid for Scientific Research (B) (grant nos. 23390432, 25293385, 25861790, and 25870196) from the Japan Society for the Promotion of Science.	Shemesh H, 2007, J ENDODONT, V33, P1369, DOI 10.1016/j.joen.2007.06.022; Makishi P, 2011, J DENT, V39, P316, DOI 10.1016/j.jdent.2011.01.011; Smadi L, 2007, ORAL SURG ORAL MED O, V103, pE77, DOI 10.1016/j.tripleo.2006.10.007; Nakajima Y, 2012, INT ENDOD J, V45, P933, DOI 10.1111/j.1365-2591.2012.02052.x; Shimada Y, 2010, J DENT, V38, P655, DOI 10.1016/j.jdent.2010.05.004; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Imura N, 1998, INT ENDOD J, V31, P410; Buhrley LJ, 2002, J ENDODONT, V28, P324, DOI 10.1097/00004770-200204000-00016; Somma F, 2009, INT ENDOD J, V42, P165, DOI 10.1111/j.1365-2591.2008.01472.x; Gorduysus MO, 2001, J ENDODONT, V27, P683; Ishibashi K, 2011, J DENT, V39, P543, DOI 10.1016/j.jdent.2011.05.005; Zuccaro G, 2001, AM J GASTROENTEROL, V96, P2633; Choma MA, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1961474; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Shemesh H, 2008, J ENDODONT, V34, P739, DOI 10.1016/j.joen.2008.03.013; Wolcott J, 2005, J ENDODONT, V31, P262, DOI 10.1097/01.don.0000140581.38492.8b; HARTWELL G, 1982, J ENDODONT, V8, P555, DOI 10.1016/S0099-2399(82)80016-2; Imai K, 2012, J ENDODONT, V38, P1269, DOI 10.1016/j.joen.2012.05.008; Domark JD, 2013, J ENDODONT, V39, P901, DOI 10.1016/j.joen.2013.01.010; KULILD JC, 1990, J ENDODONT, V16, P311; Verma P, 2011, INT ENDOD J, V44, P210, DOI 10.1111/j.1365-2591.2010.01800.x; Pécora J D, 1992, Braz Dent J, V3, P53; Pomerantz Rebecca, 2011, Case Rep Dermatol, V3, P212, DOI 10.1159/000333000; POMERANZ HH, 1974, J AM DENT ASSOC, V88, P119; SEIDBERG BH, 1973, J AM DENT ASSOC, V87, P852; Sempira HN, 2000, J ENDODONT, V26, P673, DOI 10.1097/00004770-200011000-00010; Stropko JJ, 1999, J ENDODONT, V25, P446, DOI 10.1016/S0099-2399(99)80276-3; Yoshioka T, 2013, PHOTOMED LASER SURG, V31, P23, DOI 10.1089/pho.2012.3383; Yoshioka T, 2005, INT ENDOD J, V38, P124, DOI 10.1111/j.1365-2591.2004.00918.x	29	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399	1878-3554		J ENDODONT	J. Endod.	NOV	2014	40	11					1865	1868		10.1016/j.joen.2014.07.012		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT5JP	WOS:000344979900023		
J	Pandey, A; Satoh, S				Pandey, Abhed; Satoh, Shuichi			Effects of organic acids on growth and phosphorus utilization in rainbow trout, Oncorhynchus mykiss	JOURNAL OF ENVIRONMENTAL BIOLOGY			English	Article						Fish feed; Oncorhynchus mykiss; Organic acid; Phosphorus	FEED INGREDIENTS; SOYBEAN-MEAL; DIGESTIBILITY; WALBAUM; DIET; AVAILABILITY; RETENTION; MINERALS	The present study aimed to investigate the effect of phosphorus and various organic acids supplementation on growth, nutrient retention and loading in rainbow trout fed on low fishmeal based diets. Five experimental diets were formulated, Diet D1 (0.5P) was positive control with 0.5% inorganic phosphorus addition and D2 (OP, negative control) without addition of inorganic phosphorus. D3, D4 and D5 were supplemented with 1% fumaric (FuA), formic (FoA) and acetic (AA) acids, respectively. All the diets were fed until satiation to duplicate groups of 25 fish for 12 weeks. Feed conversion ratio (FCR) was recorded best with FoA diet and absorption of phosphorus was significantly higher (P < 0.05) in all the diets supplemented with organic acids and was similar to positive control. The phosphorus and nitrogen retention with FoA diet was significantly high (P < 0.05) as compared to OP diet, in turn reducing their excretion. Hence, the present study demonstrated that, without additional phosphorus in the low fish meal-based diets, FoA supplement improved growth performance, absorption and retention of phosphorus and nitrogen and reducing excretion; thus it can be better incorporated to develop environment-friendly feed for rainbow trout.	[Pandey, Abhed] Guru Angad Dev Vet & Anim Sci Univ, Coll Fisheries, Ludhiana 141004, Punjab, India; [Satoh, Shuichi] Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Lab Fish Nutr, Tokyo 1088477, Japan	Pandey, A (reprint author), Guru Angad Dev Vet & Anim Sci Univ, Coll Fisheries, Ludhiana 141004, Punjab, India.	abhed@gadvasu.in	SATOH, Shuichi/O-1934-2014		Japanese Ministry of Education, Culture, Sports, Science and Technology (MONBUKGAKASHO)	We want to express our appreciation to the Okutama Branch of Tokyo Metropolitan Fisheries Experimental Station for providing the fish employed in this research and to the Japanese Ministry of Education, Culture, Sports, Science and Technology (MONBUKGAKASHO) for financially supporting this work.	Vielma J, 1998, FISH PHYSIOL BIOCHEM, V19, P83, DOI 10.1023/A:1007757321695; Vielma J, 1997, AQUACULT NUTR, V3, P265, DOI 10.1111/j.1365-2095.1997.00041.x; Vielma J, 1999, AQUACULT NUTR, V5, P65; Cheng ZJ, 2003, AQUAC RES, V34, P1303, DOI 10.1046/j.1365-2109.2003.00940.x; Satoh S, 2001, AQUAC RES, V32, P18, DOI 10.1046/j.1355-557x.2001.00002.x; Sugiura SH, 1998, AQUACULTURE, V159, P177, DOI 10.1016/S0044-8486(97)00177-4; Pandey A, 2008, FISHERIES SCI, V74, P867, DOI 10.1111/j.1444-2906.2008.01601.x; Sugiura SH, 2006, J EXP BIOL, V209, P3719, DOI 10.1242/jeb.02436; Chao-Xia Ye, 2006, Aquaculture, V255, P263, DOI 10.1016/j.aquaculture.2005.12.028; Hernandez A, 2005, FISHERIES SCI, V71, P817, DOI 10.1111/j.1444-2906.2005.01032.x; LALL SP, 1991, NUTRITIONAL STRATEGIES & AQUACULTURE WASTE, P21; Partanen KH, 1999, NUTR RES REV, V12, P1; Satoh S, 2002, FISHERIES SCI, V68, P325, DOI 10.1046/j.1444-2906.2002.00429.x; Satoh S, 1996, FISHERIES SCI, V62, P483; SATOH S, 1987, NIPPON SUISAN GAKK, V53, P595; Satoh S., 2005, AQUACULTURE, V248, P3; Satoh S, 2003, AQUACULTURE, V224, P271, DOI 10.1016/S0044-8486(03)00217-5; SATOH S, 1992, NIPPON SUISAN GAKK, V58, P1123; Sugiura SH, 2000, J NUTR, V130, P865; Sugiura S.H., 2000, ENCY AQUACULTURE, P299; Tucker C.S., 1996, REV FISH SCI, V4, P1; Watanabe T., 1988, GEN AQUACULTURE COUR, P233	22	0	0	TRIVENI ENTERPRISES	LUCKNOW	C/O KIRAN DALELA, 1/206 VIKAS NAGAR, KURSI RD, LUCKNOW 226 022, INDIA	0254-8704			J ENVIRON BIOL	J.Environ.Biol.	NOV	2014	35	6					1081	1085				5	Environmental Sciences	Environmental Sciences & Ecology	AT8RQ	WOS:000345200200011		
J	Ogihara, N; Oku, T; Andrada, E; Blickhan, R; Nyakatura, JA; Fischer, MS				Ogihara, Naomichi; Oku, Takaaki; Andrada, Emanuel; Blickhan, Reinhard; Nyakatura, John A.; Fischer, Martin S.			Planar covariation of limb elevation angles during bipedal locomotion in common quails (Coturnix coturnix)	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Kinematics; Inter-segmental coordination; Human; Macaque; Grounded running	NEWLY WALKING TODDLERS; TERRESTRIAL LOCOMOTION; INTERSEGMENTAL COORDINATION; REDUCED GRAVITY; MOTOR PATTERNS; BODY MECHANICS; HUMAN GAIT; KINEMATICS; SPEED; DETERMINANTS	In human bipedal walking, temporal changes in the elevation angle of the thigh, shank and foot segments covary to form a regular loop within a single plane in three-dimensional space. In this study, we quantified the planar covariation of limb elevation angles during bipedal locomotion in common quails to test whether the degree of planarity and the orientation of the covariance plane differ between birds, humans and Japanese macaques as reported in published accounts. Five quails locomoted on a treadmill and were recorded by a lateral X-ray fluoroscopy. The elevation angle of the thigh, shank and foot segments relative to the vertical axis was calculated and compared with published data on human and macaque bipedal locomotion. The results showed that the planar covariation applied to quail bipedal locomotion and planarity was stronger in quails than in humans. The orientation of the covariation plane in quails differed from that in humans, and was more similar to the orientation of the covariation plane in macaques. Although human walking is characterized by vaulting mechanics of the body center of mass, quails and macaques utilize spring-like running mechanics even though the duty factor is >0.5. Therefore, differences in the stance leg mechanics between quails and humans may underlie the difference in the orientation of the covariation plane. The planar covariation of inter-segmental coordination has evolved independently in both avian and human locomotion, despite the different mechanical constraints.	[Ogihara, Naomichi; Oku, Takaaki] Keio Univ, Fac Sci & Technol, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan; [Andrada, Emanuel; Blickhan, Reinhard] Univ Jena, Inst Sportwissensch, D-07749 Jena, Germany; [Nyakatura, John A.; Fischer, Martin S.] Univ Jena, Inst Spezielle Zool, D-07743 Jena, Germany; [Nyakatura, John A.; Fischer, Martin S.] Univ Jena, Evolut Biol Phyletischem Museum, D-07743 Jena, Germany	Ogihara, N (reprint author), Keio Univ, Fac Sci & Technol, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan.	ogihara@mech.keio.ac.jp			Japan Society for the Promotion of Science [23247041]; Inamori Foundation Grant; DAAD (German Academic Exchange Service) scholarship; DGF (German Research Council) [B1 236/22-1, Fi 410/15-1]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science [no. 23247041 to N.O.], an Inamori Foundation Grant for Scientific Research to N.O., a DAAD (German Academic Exchange Service) scholarship to T.O., and DGF (German Research Council) grants [B1 236/22-1 to R.B., Fi 410/15-1 to M.S.F.].	Ahn AN, 2004, J EXP BIOL, V207, P399, DOI 10.1242/jeb.00761; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243; Nyakatura JA, 2012, J EXP ZOOL PART A, V317A, P580, DOI 10.1002/jez.1750; Barliya A, 2009, EXP BRAIN RES, V193, P371, DOI 10.1007/s00221-008-1633-0; Muir GD, 1996, J PHYSIOL-LONDON, V493, P589; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.00815.2001; Bianchi L, 1998, J NEUROPHYSIOL, V79, P2155; Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; Stoessel A, 2012, J EXP BIOL, V215, P4055, DOI 10.1242/jeb.070458; Ogihara N, 2010, J HUM EVOL, V58, P252, DOI 10.1016/j.jhevol.2009.11.009; Ivanenko YP, 2008, J NEUROPHYSIOL, V99, P1890, DOI 10.1152/jn.01308.2007; Bauman JM, 2010, J NEUROSCI METH, V186, P18, DOI 10.1016/j.jneumeth.2009.10.017; Hicheur H, 2006, J NEUROPHYSIOL, V96, P1406, DOI 10.1152/jn.00289.2006; Andrada E, 2013, J EXP BIOL, V216, P3906, DOI 10.1242/jeb.085399; Massaad F, 2007, J PHYSIOL-LONDON, V582, P789, DOI 10.1113/jphysiol.2007.127969; Ogihara N, 2012, J R SOC INTERFACE, V9, P2181, DOI 10.1098/rsif.2012.0026; GATESY SM, 1991, J ZOOL, V224, P127; Hancock JA, 2007, IBIS, V149, P605, DOI 10.1111/j.1474-919X.2007.00688.x; Abourachid A, 2011, ZOOLOGY, V114, P360, DOI 10.1016/j.zool.2011.07.002; Reilly SM, 2000, J MORPHOL, V243, P173, DOI 10.1002/(SICI)1097-4687(200002)243:2<173::AID-JMOR6>3.0.CO;2-E; Ortega JD, 2005, J APPL PHYSIOL, V99, P2099, DOI 10.1152/japplphysiol.00103.2005; Ivanenko YP, 2005, J NEUROPHYSIOL, V94, P754, DOI 10.1152/jn.00088.2004; Rubenson J, 2007, J EXP BIOL, V210, P2548, DOI 10.1242/jeb.02792; Grasso R, 1998, J NEUROPHYSIOL, V80, P1868; Borghese NA, 1996, J PHYSIOL-LONDON, V494, P863; Cappellini G, 2010, J NEUROPHYSIOL, V104, P3064, DOI 10.1152/jn.00318.2010; Courtine G, 2005, J NEUROPHYSIOL, V93, P3127, DOI 10.1152/jn.01073.2004; Dominici N, 2010, J NEUROPHYSIOL, V103, P1673, DOI 10.1152/jn.00945.2009; Fujita M, 2004, COMP BIOCHEM PHYS A, V139, P117, DOI 10.1016/j.cbpb.2004.07.005; Grasso R, 2000, J NEUROPHYSIOL, V83, P288; Hutchinson J. R., 2001, ENCY LIFE SCI; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Leurs F, 2012, GAIT POSTURE, V35, P647, DOI 10.1016/j.gaitpost.2011.12.017; Noble JW, 2008, EXP BRAIN RES, V189, P249, DOI 10.1007/s00221-008-1464-z; Ogihara N, 2007, J HUM EVOL, V53, P302, DOI 10.1016/j.jhevol.2007.04.004; Sylos-Labini F, 2013, J MOTOR BEHAV, V45, P495, DOI 10.1080/00222895.2013.833080	37	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	NOV	2014	217	22					3968	3973		10.1242/jeb.109355		6	Biology	Life Sciences & Biomedicine - Other Topics	AT3XG	WOS:000344867000009		
J	Pilloud, MA; Hefner, JT; Hanihara, T; Hayashi, A				Pilloud, Marin A.; Hefner, Joseph T.; Hanihara, Tsunehiko; Hayashi, Atsuko			The Use of Tooth Crown Measurements in the Assessment of Ancestry	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; forensic anthropology; dental metrics; ancestry; discriminant function; observer error	MAJOR HUMAN-POPULATIONS; DENTAL TRAITS; SIZE; MOLARS; MORPHOLOGY; AMERICAN; RACE	As the hardest tissue in the body, teeth have the potential to offer a wealth of biological information to the forensic anthropologist, which can include the assessment of ancestry. Using a large data set of dental measurements, the efficacy of mesiodistal and buccolingual tooth dimensions to discriminate between broad, geographically based groups is explored. A general pattern is identified: African populations have the largest teeth, Asians possess teeth of intermediate size, and Europeans have the smallest teeth. In a discriminant function analysis using crown measurements of all teeth (mandibular and maxillary and excluding the third molar), individuals were correctly classified in 71.3% of cases. When the sex of the individual is known, classification is improved up to 88.1% in females and 71.9% of males (cross-validated). Based on these results, we argue that dental metrics can be regularly employed as part of the development of the biological profile.	[Pilloud, Marin A.] Univ Nevada, Dept Anthropol, Reno, NV USA; [Hefner, Joseph T.] Michigan State Univ, Dept Anthropol, E Lansing, MI 48824 USA; [Hanihara, Tsunehiko] Kitasato Univ, Dept Anat, Sch Med, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Hayashi, Atsuko] Joint POW MIA Accounting Command, Cent Identificat Lab, Jbphh, HI USA	Pilloud, MA (reprint author), Univ Nevada, Dept Anthropol, Reno, NV 89557 USA.	mpilloud@unr.edu		Hefner, Joseph/0000-0001-5535-4410			Agenter MK, 2009, AM J ORTHOD DENTOFAC, V136, P795, DOI 10.1016/j.ajodo.2007.12.030; Harris EF, 2001, AM J PHYS ANTHROPOL, V115, P223, DOI 10.1002/ajpa.1077; MINCER HH, 1993, J FORENSIC SCI, V38, P379; Hefner JT, 2009, J FORENSIC SCI, V54, P985, DOI 10.1111/j.1556-4029.2009.01118.x; Hanihara T, 2005, AM J PHYS ANTHROPOL, V128, P287, DOI 10.1002/ajpa.20080; FALK D, 1982, AM J PHYS ANTHROPOL, V57, P123, DOI 10.1002/ajpa.1330570113; ALVESALO L, 1974, HEREDITAS, V77, P311; Dempsey PJ, 2001, HEREDITY, V86, P685, DOI 10.1046/j.1365-2540.2001.00878.x; Edgar HJH, 2005, J FORENSIC SCI, V50, P269; Edgar HJH, 2013, J FORENSIC SCI, V58, pS3, DOI 10.1111/j.1556-4029.2012.02295.x; GARN SM, 1966, J DENT RES, V45, P970, DOI 10.1177/00220345660450037801; Haddow S, 2003, DENT ANTHR, V16, P73; HANIHARA K, 1967, J DENT RES, V46, P923, DOI 10.1177/00220345670460055101; Hanihara T, 1998, HUMAN DENTAL DEV MOR, P173; Hanihara T, 2008, AM J PHYS ANTHROPOL, V136, P169, DOI 10.1002/ajpa.20792; HARRIS EF, 1990, J FORENSIC SCI, V35, P859; Harris EF, 2007, AM J PHYS ANTHROPOL, V132, P238, DOI 10.1002/ajpa.20503; HARRIS EF, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P121; Harris EF, 2003, DENT ANTHR, V16, P84; Hefner JT, 2012, COMPANION FORENSIC A, V1st, P287; Hillson S., 1996, DENT ANTHR; Hughes T, 2000, ARCH ORAL BIOL, V45, P997, DOI 10.1016/S0003-9969(00)00066-2; Irish JD, 1997, AM J PHYS ANTHROPOL, V102, P455; Jantz R.L., 2005, FORDISC 3 COMPUTERIZ; KIESER JA, 1986, AM J PHYS ANTHROPOL, V71, P437, DOI 10.1002/ajpa.1330710407; Kieser JA, 1988, AM J PHYS ANTHROPOL, V79, P331; Kieser JA, 1990, HUMAN ADULT ODONTOME; KOLAKOWSKI D, 1981, AM J PHYS ANTHROPOL, V54, P377, DOI 10.1002/ajpa.1330540311; Lasker GW, 1957, J FORENSIC SCI, V2, P401; LAVELLE CLB, 1973, HUM BIOL, V45, P123; Lease LR, 2005, AM J PHYS ANTHROPOL, V126, P56, DOI 10.1002/ajpa.20062; LUKACS JR, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P77; Moorrees CFA, 1957, ALEUT DENT; Pilloud MA, 2009, THESIS OHIO STATE U; Schmidt CW, 2008, TECHNIQUE APPL DENT, P266, DOI 10.1017/CBO9780511542442.012; Schnutenhaus S, 1998, DENT ANTHR FUNDAMENT, P522; Scott GR, 2000, ANTHR MODERN HUMAN T; SHIELDS ED, 1990, J CRAN GENET DEV BIO, V10, P7; Townsend GC, 1992, CULTURE ECOLOGY DENT, P61; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; Ubelaker D.H., 1994, ARKANSAS ARCHEOLOGIC, V44	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	NOV	2014	59	6					1493	1501		10.1111/1556-4029.12540		9	Medicine, Legal	Legal Medicine	AT4NI	WOS:000344915600005		
J	Nakahara, T; Hyogo, H; Yoneda, M; Sumida, Y; Eguchi, Y; Fujii, H; Ono, M; Kawaguchi, T; Imajo, K; Aikata, H; Tanaka, S; Kanemasa, K; Fujimoto, K; Anzai, K; Saibara, T; Sata, M; Nakajima, A; Itoh, Y; Chayama, K; Okanoue, T				Nakahara, Takashi; Hyogo, Hideyuki; Yoneda, Masato; Sumida, Yoshio; Eguchi, Yuichiro; Fujii, Hideki; Ono, Masafumi; Kawaguchi, Takumi; Imajo, Kento; Aikata, Hiroshi; Tanaka, Saiyu; Kanemasa, Kazuyuki; Fujimoto, Kazuma; Anzai, Keizo; Saibara, Toshiji; Sata, Michio; Nakajima, Atushi; Itoh, Yoshito; Chayama, Kazuaki; Okanoue, Takeshi			Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients	JOURNAL OF GASTROENTEROLOGY			English	Article						NAFLD; Histology; Diabetes mellitus; Retrospective study	CLINICAL SCORING SYSTEM; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; FOLLOW-UP; STEATOHEPATITIS; CIRRHOSIS; GLUCOSE; PREVALENCE	The prevalence of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome have been increasing worldwide. The associations between metabolic factors and the histologic severity of NAFLD have not yet been clarified. Therefore, we studied the relationships between relevant metabolic factors and the histological severity of NAFLD. In a cross-sectional multicenter study conducted in Japan, we examined 1,365 biopsy-proven NAFLD patients. The frequencies of underlying lifestyle-related diseases and their relationships to the NAFLD histology were investigated. The hepatic fibrosis stages (Stage 0/1/2/3/4) were 22.6/34.1/26.7/14.5/2.1 (%) in the male patients, and 16.2/31.7/23.9/21.6/6.6 (%) in the female patients. Dyslipidemia was present in 65.7 % (hypertriglyceridemia, 45.3 %; increased low-density lipoprotein cholesterol, 37.5 %; decreased high density lipoprotein cholesterol, 19.5 %) of patients. Hypertension was present in 30.2 %, and diabetes mellitus (DM) in 47.3 %. The fibrosis stage increased with age, especially in postmenopausal females. The body mass index was positively correlated with the fibrosis stage. Deterioration of glucose control was positively correlated with the fibrosis stage, this correlation being more prominent in females. Multivariate analysis identified age and DM as significant risk factors for advanced fibrosis. No significant correlation of the fibrosis stage was observed with hypertension. There was a negative correlation between the serum triglyceride levels and the fibrosis stage. DM appeared to be a significant risk factor for advanced fibrosis in patients with NAFLD, and would therefore need to be properly managed to prevent the progression of NAFLD.	[Nakahara, Takashi; Hyogo, Hideyuki; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Hiroshima, Japan; [Yoneda, Masato; Imajo, Kento; Nakajima, Atushi] Yokohama City Univ, Grad Sch Med, Div Gastroenterol, Yokohama, Kanagawa 232, Japan; [Yoneda, Masato] Univ Miami, Miller Sch Med, Ctr Liver Dis, Miami, FL 33136 USA; [Sumida, Yoshio; Itoh, Yoshito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan; [Eguchi, Yuichiro] Saga Med Sch, Ctr Liver, Saga, Japan; [Fujii, Hideki] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan; [Ono, Masafumi; Saibara, Toshiji] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Kawaguchi, Takumi; Sata, Michio] Kurume Univ, Sch Med, Dept Med & Digest Dis Informat & Res, Div Gastroenterol, Kurume, Fukuoka 830, Japan; [Tanaka, Saiyu; Kanemasa, Kazuyuki] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan; [Fujimoto, Kazuma; Anzai, Keizo] Saga Med Sch, Saga, Japan; [Okanoue, Takeshi] Saiseikai Suita Hosp, Hepatol Ctr, Suita, Osaka, Japan	Yoneda, M (reprint author), Yokohama City Univ, Grad Sch Med, Div Gastroenterol, Yokohama, Kanagawa 232, Japan.	dryoneda@yahoo.co.jp					Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Iwamoto K, 2008, J GASTROENTEROL, V43, P298, DOI 10.1007/s00535-007-2152-7; Ono M, 2006, J GASTROENTEROL, V41, P725, DOI 10.1007/s00535-006-1876-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Arase Y, 2013, HEPATOLOGY, V57, P964, DOI 10.1002/hep.26087; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; MEGYESI C, 1967, LANCET, V2, P1051; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; Sumida Y, 2011, J GASTROENTEROL, V46, P257, DOI 10.1007/s00535-010-0305-6; Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055; James O, 1999, LANCET, V353, P1634; Angulo P, 2007, NUTR REV, V65, pS57, DOI 10.1301/nr.2007.jun.S57-S63; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1016/0270-9139(95)90196-5; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Hyogo H, 2008, METABOLISM, V57, P1711, DOI 10.1016/j.metabol.2008.07.030; Larter CZ, 2010, J GASTROEN HEPATOL, V25, P672, DOI 10.1111/j.1440-1746.2010.06253.x; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718; PETRIDES AS, 1989, J HEPATOL, V8, P107, DOI 10.1016/0168-8278(89)90169-4; Donati G, 2004, GUT, V53, P1020, DOI 10.1136/gut.2003.027086; Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001; Yoneda M, 2011, J GASTROENTEROL, V46, P1300, DOI 10.1007/s00535-011-0436-4; VALLANCE P, 1991, LANCET, V337, P776, DOI 10.1016/0140-6736(91)91384-7; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; Hui JM, 2003, J GASTROEN HEPATOL, V18, P1115, DOI 10.1046/j.1440-1746.2003.03170.x; Kamada Y, 2011, AM J PHYSIOL-GASTR L, V301, P1031; Matsuzawa U, 2000, J JPN SOC STUDY OBES, V6, P18; Neuschwander-Tetri Brent A, 2010, Hepatology, V52, P913, DOI 10.1002/hep.23784; Ricci C, 1997, J HEPATOL, V27, P108, DOI 10.1016/S0168-8278(97)80288-7; The World Medical Association Inc, 2008, DECL HELS ETH PRINC; Tokushige K, 2011, J GASTROENTEROL, V46, P1230, DOI 10.1007/s00535-011-0431-9; World Health Organization, 2006, DEF DIAGN DIAB MELL	44	5	5	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2014	49	11					1477	1484		10.1007/s00535-013-0911-1		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT4NP	WOS:000344916500004		
J	Shimada, N; Toyoda, H; Tsubota, A; Ide, T; Takaguchi, K; Kato, K; Kondoh, M; Matsuyama, K; Kumada, T; Sata, M				Shimada, Noritomo; Toyoda, Hidenori; Tsubota, Akihito; Ide, Tatsuya; Takaguchi, Koichi; Kato, Keizo; Kondoh, Masaki; Matsuyama, Kazuhiro; Kumada, Takashi; Sata, Michio			Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study	JOURNAL OF GASTROENTEROLOGY			English	Article						Chronic hepatitis C; Reduction in HCV RNA at week 1; Telaprevir; IL28B	AMINO-ACID SUBSTITUTION; CHRONIC HCV INFECTION; PEGYLATED INTERFERON; VIRUS-INFECTION; RESISTANT VARIANTS; GENETIC-VARIATION; CORE REGION; RIBAVIRIN; PEGINTERFERON; IL28B	Genetic polymorphisms near Interleukin 28B (IL28B) (rs8099917) and a rapid virological response (RVR) have been reported as predictors for a sustained virological response (SVR) to telaprevir (TVR)-based triple combination therapy. However, the association between SVR and viral kinetics earlier than week 4 after initiation of therapy remains unclear. Thus, we evaluated the SVR prediction ability of baseline factors and reduced hepatitis C virus (HCV) RNA levels at week 1 after the initiation of TVR-based therapy in Japanese genotype-1b chronic hepatitis C (CHC) patients. A total of 156 Japanese CHC patients received a 24-week regimen of TVR-based therapy. Baseline factors and reduction in HCV RNA levels at weeks 1 and 4 after the initiation of therapy were analyzed for SVR prediction. Multiple logistic regression analysis for SVR in TVR-based therapy identified the IL28B TT genotype, a reduction of a parts per thousand yen4.7 log(10)IU/mL in HCV RNA levels at week 1, RVR, and treatment-na < ve/relapse. Whereas the SVR rate was higher than 90 % regardless of the reduction in HCV RNA levels at week 1 in patients with the TT genotype, a reduction of a parts per thousand yen4.7 log(10)IU/mL in HCV RNA levels at week 1 was the strongest predictor of SVR in patients with the non-TT genotype, as determined by multiple logistic regression analysis (P = 0.0043). The IL28B TT genotype is the most important baseline factor for predicting SVR, and a a parts per thousand yen4.7 log(10)IU/mL reduction in HCV RNA at week 1 is a useful very early on-treatment predictor of SVR, especially in the non-TT genotype.	[Shimada, Noritomo; Kato, Keizo] Shinmatsudo Cent Gen Hosp, Div Gastroenterol & Hepatol, Matsudo, Chiba 2700034, Japan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu 5038502, Japan; [Tsubota, Akihito] Jikei Univ, Sch Med, Inst Clin Med & Res, Kashiwa, Chiba 2778567, Japan; [Ide, Tatsuya; Sata, Michio] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka 8300011, Japan; [Takaguchi, Koichi] Kagawa Prefectural Cent Hosp, Dept Hepatol, Takamatsu, Kagawa 7608557, Japan; [Kondoh, Masaki; Matsuyama, Kazuhiro] Roche Diagnost KK, Dept Life Cycle Management, Minato Ku, Tokyo 1050014, Japan	Shimada, N (reprint author), Shinmatsudo Cent Gen Hosp, Div Gastroenterol & Hepatol, 1-380 Shinmatsudo, Matsudo, Chiba 2700034, Japan.	noritomos@jcom.home.ne.jp					Akuta N, 2012, J MED VIROL, V84, P1097, DOI 10.1002/jmv.23262; Akuta N, 2013, J CLIN MICROBIOL, V51, P2862, DOI 10.1128/JCM.01129-13; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Furusyo N, 2013, J HEPATOL, V59, P205, DOI 10.1016/j.jhep.2013.03.020; Yoshizawa K, 2013, J MED VIROL, V85, P1180, DOI 10.1002/jmv.23597; Chayama K, 2013, J GASTROENTEROL, V48, P1, DOI 10.1007/s00535-012-0714-9; [Anonymous], 2013, HEPATOL RES, V2013, P1; Chayama K, 2011, J INFECT DIS, V204, P84, DOI 10.1093/infdis/jir210; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; Simmonds P, 1996, J GEN VIROL, V77, P3013, DOI 10.1099/0022-1317-77-12-3013; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Akuta N, 2007, J HEPATOL, V46, P403, DOI 10.1016/j.jhep.2006.09.019; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Pol S, 2013, J HEPATOL, V58, P883, DOI 10.1016/j.jhep.2012.12.023; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Hayashi N, 2013, J GASTROENTEROL; Muir AJ, 2011, HEPATOLOGY, V54, P1538, DOI 10.1002/hep.24549; Muir AJ, 2013, J CLIN GASTROENTEROL, V47, P222, DOI 10.1097/MCG.0b013e3182680221; Shimada N, 2013, J MED VIROL; The French METAVIR Cooperative Study Group, 1994, HEPATOLOGY, V20, P15; Toyoda H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-324; Toyoda H, 2013, J MED VIROL, V85, P65, DOI 10.1002/jmv.23428; Tsubota A, 2012, LIVER INT, V32, P826, DOI 10.1111/j.1478-3231.2011.02727.x; Tsubota A, 2013, J GASTROENTEROL HEPA	36	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2014	49	11					1485	1494		10.1007/s00535-013-0918-7		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT4NP	WOS:000344916500005		
J	Tamaki, N; Kurosaki, M; Matsuda, S; Muraoka, M; Yasui, Y; Suzuki, S; Hosokawa, T; Ueda, K; Tsuchiya, K; Nakanishi, H; Itakura, J; Takahashi, Y; Asahina, Y; Izumi, N				Tamaki, Nobuharu; Kurosaki, Masayuki; Matsuda, Shuya; Muraoka, Masaru; Yasui, Yutaka; Suzuki, Shoko; Hosokawa, Takanori; Ueda, Ken; Tsuchiya, Kaoru; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Asahina, Yasuhiro; Izumi, Namiki			Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients	JOURNAL OF GASTROENTEROLOGY			English	Article						FIB-4 index; Hepatocellular carcinoma; Chronic hepatitis C; Liver fibrosis; Non-invasive	ALANINE AMINOTRANSFERASE LEVELS; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; VIRUS-INFECTION; FIB-4 INDEX; BIOPSY; STIFFNESS; RISK; PROGRESSION; FIBROTEST	The FIB-4 index is a simple formula to predict liver fibrosis. This study aimed to evaluate the utility of the FIB-4 index and associated time-course changes as a predictor of hepatocellular carcinoma (HCC) development. A total of 171 chronic hepatitis C patients who underwent paired liver biopsies and 875 patients who underwent a single liver biopsy (validation group) were investigated during mean follow-up periods of 6.4 and 5.9 years, respectively. All patients had received interferon therapy and had not achieved a sustained virological response. Factors associated with HCC development were analyzed in these patients. HCC developed in 30 patients in the paired biopsy group and 89 patients in the validation group. Univariate analysis demonstrated that the FIB-4 index > 3.25 and change in the FIB-4 index per year (Delta FIB-4/year) a parts per thousand yen0.3 were predictive factors for HCC development in both groups. Multivariate analysis in the combined population revealed that these two factors were independent. The hazard ratio (HR) for the FIB-4 index > 3.25 was 2.7 (p < 0.001) and Delta FIB-4/year a parts per thousand yen0.3 was 1.8 (p = 0.003). Patients with a FIB-4 index > 3.25 and a Delta FIB-4/year a parts per thousand yen0.3 were defined as high risk, and those with a FIB-4 index a parts per thousand currency sign3.25 and a Delta FIB-4/year < 0.3 were defined as low risk. The HR of HCC development in patients at high risk was 7.3 (95 % confidence interval 4.3-12.5, p < 0.001). It was possible to define a group at high risk of developing HCC by intermittently measuring the FIB-4 index and considering time-course changes in this index.	[Tamaki, Nobuharu; Kurosaki, Masayuki; Matsuda, Shuya; Muraoka, Masaru; Yasui, Yutaka; Suzuki, Shoko; Hosokawa, Takanori; Ueda, Ken; Tsuchiya, Kaoru; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Musashino, Tokyo 1808610, Japan; [Asahina, Yasuhiro] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan	Izumi, N (reprint author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, 1-26-1 Kyonan Cho, Musashino, Tokyo 1808610, Japan.	nizumi@musashino.jrc.or.jp			Ministry of Health, Labor and Welfare, Japan	This study was supported by a Grant-in-Aid from Ministry of Health, Labor and Welfare, Japan.	Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Nagamine T, 1996, J HEPATOL, V24, P135, DOI 10.1016/S0168-8278(96)80021-3; Regev A, 2002, AM J GASTROENTEROL, V97, P2614; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Tamaki N, 2013, J VIRAL HEPATITIS, V20, P72, DOI 10.1111/j.1365-2893.2012.01635.x; Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1002/hep.510230607; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Namiki I, 2010, HEPATOL RES, V40, P347, DOI 10.1111/j.1872-034X.2010.00642.x; Yu ML, 2006, HEPATOLOGY, V44, P1086, DOI 10.1002/hep.21363; Castera L, 1999, HEPATOLOGY, V30, P1529, DOI 10.1002/hep.510300624; Park LS, 2011, CANCER EPIDEM BIOMAR, V20, P2512, DOI 10.1158/1055-9965.EPI-11-0582; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Nunes D, 2010, AM J GASTROENTEROL, V105, P1346, DOI 10.1038/ajg.2009.746; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506; Holmberg SD, 2013, CLIN INFECT DIS, V57, P240, DOI 10.1093/cid/cit245; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Friedrich-Rust M, 2012, J VIRAL HEPATITIS, V19, pE212, DOI 10.1111/j.1365-2893.2011.01537.x; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; Kurosaki M, 2008, J HEPATOL, V48, P736, DOI 10.1016/j.jhep.2007.12.025; Zarski JP, 2012, J HEPATOL, V56, P55, DOI 10.1016/j.jhep.2011.05.024; Dienstag JL, 2002, HEPATOLOGY, V36, pS152, DOI 10.1053/jhep.2002.36381; [Anonymous], 1994, HEPATOLOGY 1, V20, P15; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Izumi N, 2012, J GASTROENTEROL, V9, P9; Kumada T, 2009, J HEPATOL, V50, P729, DOI 10.1016/j.jhep.2008.11.019; Poynard Thierry, 2011, Gastroenterol Hepatol (N Y), V7, P445; Tamaki N, 2013, HEPATOL RES, V6, P12179	35	5	5	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2014	49	11					1495	1503		10.1007/s00535-013-0914-y		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT4NP	WOS:000344916500006		
J	Yamashita, N; Ohho, A; Yamasaki, A; Kurokawa, M; Kotoh, K; Kajiwara, E				Yamashita, Naoki; Ohho, Aritsune; Yamasaki, Akihiro; Kurokawa, Miho; Kotoh, Kazuhiro; Kajiwara, Eiji			Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes	JOURNAL OF GASTROENTEROLOGY			English	Article						Chronic hepatitis C; Interferon therapy; Sustained virological response; Hepatocellular carcinoma; Follow-up protocol	HEPATOCELLULAR-CARCINOMA DEVELOPMENT; TERM-FOLLOW-UP; VIRUS-INFECTION; PEGYLATED INTERFERON; ELDERLY-PATIENTS; HCV RNA; THERAPY; RIBAVIRIN; RISK; IMPACT	Due to advances in interferon (IFN) therapy for chronic hepatitis C, most elderly patients, and even many of those with advanced hepatic fibrosis, now achieve a sustained virological response (SVR). However, carcinogenesis remains problematic in these patients. Hence, we aimed to elucidate risk factors for hepatocarcinogenesis in SVR patients and to present an appropriate follow-up protocol for improving outcomes. We retrospectively studied 562 consecutive SVR patients for a median observation period of 4.8 years. Hepatocellular carcinoma was diagnosed in 31 patients (5.5 %). Respective cumulative incidences were 3.1, 10.1, and 15.9 % at 5, 10, and 15 years after completion of IFN therapy. The proportional hazards model identified moderate or advanced fibrosis stage, advanced age, habitual alcohol consumption, and alpha-fetoprotein elevation as determinants of carcinogenesis, with hazard ratios of 10.7 (p < 0.001), 4.1 (p < 0.01), 3.9 (p < 0.01), and 2.6 (p < 0.05), respectively. Carcinoma was diagnosed in 26 % of patients more than 10 years after completion of IFN therapy. Unexpectedly, F2 fibrosis was detected in 42 % of these patients. The 5-year survival rate was 93 % in the patients who had received periodic cancer screening but only 60 % in those who had not. We recommend that SVR patients be observed at 6-month intervals, at a minimum, to facilitate diagnosis at an early stage, for as long as possible after completion of therapy even if not at an advanced stage of fibrosis.	[Yamashita, Naoki; Ohho, Aritsune; Yamasaki, Akihiro; Kurokawa, Miho; Kajiwara, Eiji] Steel Mem Yawata Hosp, Dept Hepatol, Yahatahigashi Ku, Kitakyushu, Fukuoka 8058508, Japan; [Kotoh, Kazuhiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan	Yamashita, N (reprint author), Steel Mem Yawata Hosp, Dept Hepatol, Yahatahigashi Ku, 1-1-1 Harunomachi, Kitakyushu, Fukuoka 8058508, Japan.	naoyamgggg@gmail.com					Hirakawa M, 2008, INTERNAL MED, V47, P1637, DOI 10.2169/internalmedicine.47.1087; Miki D, 2008, J GASTROENTEROL, V43, P550, DOI 10.1007/s00535-008-2194-5; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; Marcellin P, 1997, ANN INTERN MED, V127, P875; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI 10.1016/j.jhep.2004.02.007; Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224; Ohishi W, 2003, SCAND J GASTROENTERO, V38, P894, DOI 10.1080/00365520310004434; Tokita H, 2005, J GASTROEN HEPATOL, V20, P752, DOI 10.1111/j.1400-1746.2005.03800.x; Khattab MA, 2012, ANN HEPATOL, V11, P487; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Khan KN, 2000, ALCOHOL ALCOHOLISM, V35, P286, DOI 10.1093/alcalc/35.3.286; Conteduca V, 2014, J INFECTION, V68, P1, DOI 10.1016/j.jinf.2013.08.019; Kobayashi S, 2007, LIVER INT, V27, P186, DOI 10.1111/j.1478-3231.2006.01406.x; Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.25585; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Chang KC, 2012, J ANTIMICROB CHEMOTH, V67, P2766, DOI 10.1093/jac/dks269; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Colombo M, 1999, J HEPATOL, V31, P25, DOI 10.1016/S0168-8278(99)80370-5; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Tateyama M, 2011, J GASTROENTEROL, V46, P92, DOI 10.1007/s00535-010-0293-6; Honda T, 2011, ONCOL LETT, V2, P851, DOI 10.3892/ol.2011.359; Yoshida H, 1999, ANN INTERN MED, V131, P174; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1016/0270-9139(94)90250-X; Enokimura N, 2003, ANTICANCER RES, V23, P593; Hamada H, 2002, CANCER, V95, P331, DOI 10.1002/cncr.10662; Ito Y, 2005, WORLD J GASTROENTERO, V11, P7218; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Mashitani Tsuyoshi, 2009, Cases J, V2, P18, DOI 10.1186/1757-1626-2-18; Nishiguchi S, 2001, LANCET, V357, P196, DOI 10.1016/S0140-6736(00)03595-9; Okanoue T, 1999, J HEPATOL, V30, P653, DOI 10.1016/S0168-8278(99)80196-2; Sangiovanni A, 2001, AM J GASTROENTEROL, V96, P1575; Taura N, 2012, EXP THER MED, V4, P972, DOI 10.3892/etm.2012.709; Toyoda H, 2000, J VIRAL HEPATITIS, V7, P414, DOI 10.1046/j.1365-2893.2000.00241.x; Uemura T, 2009, J GASTROENTEL, V44, P102; Urquijo JJ, 2013, ANN HEPATOL, V12, P30	39	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2014	49	11					1504	1513		10.1007/s00535-013-0921-z		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT4NP	WOS:000344916500007		
J	Yohei, T; Inokuma, T; Yukitaka, Y				Yohei, Taniguchi; Inokuma, Tetsuro; Yukitaka, Yamashita			Efficacy and safety of endoscopic papillary large balloon dilation following with an endoscopic sphincterotomy (EPLBD plus EST) for large or multiple common bile duct stones (CBDS)	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract									[Yohei, Taniguchi; Inokuma, Tetsuro; Yukitaka, Yamashita] Kobe City Med Ctr Gen Hosp, Japanese Red Cross Soc, Wakayama Med Ctr, Kobe, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-003	2	2				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300004		
J	Adachi, T; Tanaka, R; Yamada, M; Takayama, M; Mine, H; Nagai, T; Kawasaki, M; Asakuma, Y; Okazaki, Y; Komeda, Y; Sakurai, T; Matsui, S; Kashida, H; Kudo, M				Adachi, Teppei; Tanaka, Rie; Yamada, Mitsunari; Takayama, Masaki; Mine, Hiromasa; Nagai, Tomoyuki; Kawasaki, Masanori; Asakuma, Yutaka; Okazaki, Yoshihisa; Komeda, Yoriaki; Sakurai, Toshiharu; Matsui, Shigenaga; Kashida, Hiroshi; Kudo, Masatoshi			The usefulness of single-balloon endoscopy for the small bowel lesions	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						small bowel endoscopy; single balloon endoscopy			[Adachi, Teppei; Tanaka, Rie; Yamada, Mitsunari; Takayama, Masaki; Mine, Hiromasa; Nagai, Tomoyuki; Kawasaki, Masanori; Asakuma, Yutaka; Okazaki, Yoshihisa; Komeda, Yoriaki; Sakurai, Toshiharu; Matsui, Shigenaga; Kashida, Hiroshi; Kudo, Masatoshi] Kindai Univ, Fac Med, Higashiosaka, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-008	3	4				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300009		
J	Sano, W; Sano, Y; Iwatate, M; Hasuike, N; Hattori, S; Kosaka, H; Ikumoto, T; Kotaka, M; Fujimori, T				Sano, Wataru; Sano, Yasushi; Iwatate, Mineo; Hasuike, Noriaki; Hattori, Santa; Kosaka, Hidekazu; Ikumoto, Taro; Kotaka, Masahito; Fujimori, Takahiro			Prospective evaluation of the incidence of sessile serrated adenoma/polyps in hyperplastic polyps diagnosed by pan-chromo with high definition magnifying colonoscopy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						hyperplastic polyp; sessile serrated adenoma/polyp			Sano Hosp, Tokyo, Japan; Shinko Hosp, Kobe, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-006	3	3				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300007		
J	Imagawa, A; Matsumi, A; Ueta, E; Suto, K; Terasawa, H; Takeuchi, K; Morito, Y; Endo, H; Jinno, H; Akita, M; Hata, H; Moriya, A; Nakatsu, M; Ando, M				Imagawa, Atsushi; Matsumi, Akihiro; Ueta, Eijiro; Suto, Kozue; Terasawa, Hiroyuki; Takeuchi, Keiko; Morito, Yuki; Endo, Hitomi; Jinno, Hideki; Akita, Mitsuhiro; Hata, Hidenori; Moriya, Akio; Nakatsu, Morihito; Ando, Masaharu			Efficacy and safety of flunitrazepam and diazepam for conscious sedation during esophagogastroduodenoscopy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						conscious sedation esophagogastroduodenoscopy			[Imagawa, Atsushi; Matsumi, Akihiro; Ueta, Eijiro; Suto, Kozue; Terasawa, Hiroyuki; Takeuchi, Keiko; Morito, Yuki; Endo, Hitomi; Jinno, Hideki; Akita, Mitsuhiro; Hata, Hidenori; Moriya, Akio; Nakatsu, Morihito; Ando, Masaharu] Mitoyo Gen Hosp, Kanonji, Kagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-012	5	5				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300013		
J	Isomoto, H; Senoo, T; Ohnita, K; Minami, H; Yamaguchi, N; Ishii, H; Hidaka, S; Kunizaki, M; Nanashima, A; Nagayasu, T; Nakao, K				Isomoto, Hajime; Senoo, Takemasa; Ohnita, Ken; Minami, Hitomi; Yamaguchi, Naoyuki; Ishii, Hiroyuki; Hidaka, Shigekazu; Kunizaki, Masaki; Nanashima, Atsushi; Nagayasu, Takeshi; Nakao, Kazuhiko			Novel photodynamic diagnosis with blue laser-based endoscopy using 5-aminolevulinic acid for upper GI cancer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						photodynamic diagnosis; upper GI cancer			[Isomoto, Hajime; Senoo, Takemasa; Ohnita, Ken; Minami, Hitomi; Yamaguchi, Naoyuki; Ishii, Hiroyuki; Hidaka, Shigekazu; Kunizaki, Masaki; Nanashima, Atsushi; Nagayasu, Takeshi; Nakao, Kazuhiko] Nagasaki Univ Hosp, Nagasaki, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-013	5	6				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300014		
J	Niimi, K; Goto, O; Kawakubo, K; Nakai, Y; Minatsuki, C; Hirayama, I; Mochizuki, S; Ono, S; Kodashima, S; Yamamichi, N; Isayama, H; Fujishiro, M; Koike, K				Niimi, Keiko; Goto, Osamu; Kawakubo, Kazumichi; Nakai, Yosuke; Minatsuki, Chihiro; Hirayama, Itsuko; Mochizuki, Satoshi; Ono, Satoshi; Kodashima, Shinya; Yamamichi, Nobutake; Isayama, Hiroyuki; Fujishiro, Mitsuhiro; Koike, Kazuhiko			Learning curve for endoscopic ultrasound guided fine needle aspiration of gastrointestinal submucosal tumors	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						learning curve; gastrointestinal submucosal tumors; endoscopic ultrasound guided fine needle aspiration			[Niimi, Keiko; Goto, Osamu; Kawakubo, Kazumichi; Nakai, Yosuke; Minatsuki, Chihiro; Hirayama, Itsuko; Mochizuki, Satoshi; Ono, Satoshi; Kodashima, Shinya; Yamamichi, Nobutake; Isayama, Hiroyuki; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Tokyo 1138654, Japan			Kawakubo, Kazumichi/F-2937-2011					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-020	10	10				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300021		
J	Yamamura, T; Nakamura, M; Watanabe, O; Hurukawa, K; Hunasaka, K; Ohno, E; Miyahara, R; Kawashima, H; Hirooka, Y; Ando, T; Goto, H				Yamamura, Takeshi; Nakamura, Masanao; Watanabe, Osamu; Hurukawa, Kazuhiro; Hunasaka, Kohei; Ohno, Eizaburo; Miyahara, Ryoji; Kawashima, Hiroki; Hirooka, Yoshiki; Ando, Takafumi; Goto, Hidemi			Utility of double-balloon endoscopy for extracting a foreign body from the small bowel	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						double-balloon endoscopy; foreign body; small bowel			[Yamamura, Takeshi; Nakamura, Masanao; Watanabe, Osamu; Hurukawa, Kazuhiro; Hunasaka, Kohei; Ohno, Eizaburo; Miyahara, Ryoji; Kawashima, Hiroki; Hirooka, Yoshiki; Ando, Takafumi; Goto, Hidemi] Nagoya Univ, Nagoya, Aichi 4648601, Japan			KAWASHIMA, Hiroki/I-7285-2014					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-022	10	10				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300022		
J	Yane, K; Katanuma, A; Maguchi, H; Takahashi, K; Osanai, M; Kin, T; Ikarashi, S; Minami, R; Sen-Yo, M; Sano, I; Yamazaki, H				Yane, Kei; Katanuma, Akio; Maguchi, Hiroyuki; Takahashi, Kuniyuki; Osanai, Manabu; Kin, Toshifumi; Ikarashi, Satoshi; Minami, Ryuki; Sen-Yo, Manabu; Sano, Itsuki; Yamazaki, Hajime			Utility of endoscopic ultrasound-guided fine needle aspiration for the diagnosis of pancreatobiliary cancer recurrence after surgical resection	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						endoscopic ultrasound-guided fine needle aspiration; pancreatobiliary cancer recurrence			[Yane, Kei; Katanuma, Akio; Maguchi, Hiroyuki; Takahashi, Kuniyuki; Osanai, Manabu; Kin, Toshifumi; Ikarashi, Satoshi; Minami, Ryuki; Sen-Yo, Manabu; Sano, Itsuki; Yamazaki, Hajime] Teine Keijinkai Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-023	10	11				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300023		
J	Sato, M; Kato, M; Suzuki, M; Abe, K; Takada, H; Hirata, T; Takatori, Y; Naruse, T; Takabayashi, K; Fujiyama, Y; Takahashi, M; Uraoka, T				Sato, Michiko; Kato, Motohiko; Suzuki, Masayuki; Abe, Keiichiro; Takada, Hiroaki; Hirata, Tetsu; Takatori, Yusaku; Naruse, Tomoyasu; Takabayashi, Kaoru; Fujiyama, Yoichi; Takahashi, Masahiko; Uraoka, Toshio			The history of diverticular hemorrhage is an independent predictor for recurrent hemorrhage	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						colonic diverticular hemorrhage; reccurence; predictors			[Sato, Michiko; Kato, Motohiko; Suzuki, Masayuki; Abe, Keiichiro; Takada, Hiroaki; Hirata, Tetsu; Takatori, Yusaku; Naruse, Tomoyasu; Takabayashi, Kaoru; Fujiyama, Yoichi; Takahashi, Masahiko; Uraoka, Toshio] Natl Tokyo Med Ctr, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-026	12	12				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300026		
J	Takatori, Y; Kato, M; Suzuki, M; Abe, K; Takada, Y; Hirata, T; Sato, M; Naruse, T; Takabayashi, K; Hujiyama, Y; Takahashi, M; Uraoka, T				Takatori, Yusaku; Kato, Motohiko; Suzuki, Masayuki; Abe, Keiichiro; Takada, Yasuaki; Hirata, Tetsu; Sato, Michiko; Naruse, Tomoyasu; Takabayashi, Kaoru; Hujiyama, Yoichi; Takahashi, Masahiko; Uraoka, Toshio			History of gastro-duodenal ulcer as an independent predictor for requirement of endoscopic intervention for non-variceal upper gastrointestinal bleeding.	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						upper gastrointestinal bleeding; predictors; endoscopic intervention			[Takatori, Yusaku; Kato, Motohiko; Suzuki, Masayuki; Abe, Keiichiro; Takada, Yasuaki; Hirata, Tetsu; Sato, Michiko; Naruse, Tomoyasu; Takabayashi, Kaoru; Hujiyama, Yoichi; Takahashi, Masahiko; Uraoka, Toshio] Natl Tokyo Med Ctr, Tokyo, Japan; Suzuki Clin, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-027	12	12				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300027		
J	Kinugasa, H; Nouso, K; Tanaka, T; Miyahara, K; Morimoto, Y; Dohi, C; Okada, H; Yamamoto, K				Kinugasa, Hideaki; Nouso, Kazuhiro; Tanaka, Takehiro; Miyahara, Koji; Morimoto, Yuki; Dohi, Chihiro; Okada, Hiroyuki; Yamamoto, Kazuhide			Droplet digital PCR measurement of HER2 in patients with gastric cancer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						digital PCR; HER2; circulating DNA; gastric cancer			[Kinugasa, Hideaki; Nouso, Kazuhiro; Tanaka, Takehiro; Miyahara, Koji; Morimoto, Yuki; Dohi, Chihiro; Okada, Hiroyuki; Yamamoto, Kazuhide] Okayama Univ Hosp, Okayama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-032	14	14				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300032		
J	Hayashi, K; Ishigami, M; Ishizu, Y; Kuzuya, T; Honda, T; Katano, Y; Hirooka, Y; Goto, H				Hayashi, Kazuhiko; Ishigami, Masatoshi; Ishizu, Yoji; Kuzuya, Teiji; Honda, Takashi; Katano, Yoshiaki; Hirooka, Yoshiki; Goto, Hidemi			Reactivation of hepatitis B virus in patients without hepatitis B surface antigen treated with immunosuppressive or chemotherapy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						HBV			[Hayashi, Kazuhiko; Ishigami, Masatoshi; Ishizu, Yoji; Kuzuya, Teiji; Honda, Takashi; Katano, Yoshiaki; Hirooka, Yoshiki; Goto, Hidemi] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-038	16	16				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300038		
J	Kaido, T; Ogawa, K; Uemura, T; Mori, A; Okajima, H; Tamai, Y; Inagaki, N; Uemoto, S				Kaido, Toshimi; Ogawa, Kohei; Uemura, Tadahiro; Mori, Akira; Okajima, Hideaki; Tamai, Yumiko; Inagaki, Nobuya; Uemoto, Shinji			Impact of sarcopenia and perioperative nutritional therapy on survival in patients undergoing living donor liver transplantation	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						sarcopenia; liver transplantation; nutritional therapy			[Kaido, Toshimi; Ogawa, Kohei; Uemura, Tadahiro; Mori, Akira; Okajima, Hideaki; Tamai, Yumiko; Inagaki, Nobuya; Uemoto, Shinji] Kyoto Univ, Kyoto 6068501, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-039	17	17				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300039		
J	Adachi, T; Tanaka, R; Yamada, M; Takayama, M; Mine, H; Nagai, T; Kawasaki, M; Asakuma, Y; Okazaki, Y; Komeda, Y; Sakurai, T; Matsui, S; Kashida, H; Kudo, M				Adachi, Teppei; Tanaka, Rie; Yamada, Mitsunari; Takayama, Masaki; Mine, Hiromasa; Nagai, Tomoyuki; Kawasaki, Masanori; Asakuma, Yutaka; Okazaki, Yoshihisa; Komeda, Yoriaki; Sakurai, Toshiharu; Matsui, Shigenaga; Kashida, Hiroshi; Kudo, Masatoshi			Comparison of Japanese primary and secondary regimen of Helicobacter pylori eradication	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						H. pylori; eradication			[Adachi, Teppei; Tanaka, Rie; Yamada, Mitsunari; Takayama, Masaki; Mine, Hiromasa; Nagai, Tomoyuki; Kawasaki, Masanori; Asakuma, Yutaka; Okazaki, Yoshihisa; Komeda, Yoriaki; Sakurai, Toshiharu; Matsui, Shigenaga; Kashida, Hiroshi; Kudo, Masatoshi] Kindai Univ, Fac Med, Higashiosaka, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-055	22	22				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300053		
J	Furuta, T; Sugimoto, M; Yamade, M; Uotani, T; Sahara, S; Ichikawa, H; Kagami, T; Hamaya, Y; Iwaizumi, M; Osawa, S; Sugimoto, K				Furuta, Takahisa; Sugimoto, Mitsushige; Yamade, Mihoko; Uotani, Takahiro; Sahara, Shu; Ichikawa, Hitomi; Kagami, Takuma; Hamaya, Yasushi; Iwaizumi, Moriya; Osawa, Satoshi; Sugimoto, Ken			Eradication of H. pylori infection in patients allergic to penicillin	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						H. pylori; sitafloxacin; penicillin allergy			[Furuta, Takahisa; Sugimoto, Mitsushige; Yamade, Mihoko; Uotani, Takahiro; Sahara, Shu; Ichikawa, Hitomi; Kagami, Takuma; Hamaya, Yasushi; Iwaizumi, Moriya; Osawa, Satoshi; Sugimoto, Ken] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-057	23	23				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300055		
J	Harima, H; Kaino, S; Shinoda, S; Kawano, M; Suenaga, S; Yamamoto, N; Yamasaki, T; Sakaida, I				Harima, Hirofumi; Kaino, Seiji; Shinoda, Shuhei; Kawano, Michitaka; Suenaga, Shigeyuki; Yamamoto, Naoki; Yamasaki, Takahiro; Sakaida, Isao			The oral iron chelator, deferasirox, may be a novel potential therapeutic agent for pancreatic cancer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						deferasirox; iron chelator; pancreatic cancer			[Harima, Hirofumi; Kaino, Seiji; Shinoda, Shuhei; Kawano, Michitaka; Suenaga, Shigeyuki; Yamamoto, Naoki; Yamasaki, Takahiro; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-084	34	34				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300079		
J	Hirosawa, T; Hayashi, H; Sakata, N; Ishida, M; Fukase, K; Yabuuchi, S; Ohtsuka, H; Mizuma, M; Okada, T; Nakagawa, K; Morikawa, T; Yoshida, H; Motoi, F; Naitoh, T; Katayose, Y; Unno, M				Hirosawa, Takashi; Hayashi, Hiroki; Sakata, Naoaki; Ishida, Masaharu; Fukase, Koji; Yabuuchi, Shinichi; Ohtsuka, Hideo; Mizuma, Masamichi; Okada, Takaho; Nakagawa, Kei; Morikawa, Takanori; Yoshida, Hiroshi; Motoi, Fuyuhiko; Naitoh, Takeshi; Katayose, Yu; Unno, Michiaki			A report of 4 cases of Trousseau's syndrome during postoperative chemotherapy for pancreatic adenocarcinoma	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Trousseau's syndrome; pancreatic adenocarcinoma; postoperative chemotherapy; unfractionated heparin; CA19-9; DUPAN-2			[Hirosawa, Takashi; Hayashi, Hiroki; Sakata, Naoaki; Ishida, Masaharu; Fukase, Koji; Yabuuchi, Shinichi; Ohtsuka, Hideo; Mizuma, Masamichi; Okada, Takaho; Nakagawa, Kei; Morikawa, Takanori; Yoshida, Hiroshi; Motoi, Fuyuhiko; Naitoh, Takeshi; Katayose, Yu; Unno, Michiaki] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-089	36	36				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300084		
J	Horibe, M; Shinomiya, W; Okawa, O; Nakatani, Y; Sasaki, M; Sato, M; Sanui, M				Horibe, Masayasu; Shinomiya, Wataru; Okawa, Osamu; Nakatani, Yukihiro; Sasaki, Mitsuhito; Sato, Mizuki; Sanui, Masamitsu			Continuous regional arterial infusion of protease inhibitors potentially reduces mortality in patients with severe acute pancreatitis: a retrospective multicenter study	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						severe acute pancreatitis; continuous regional arterial infusion; CRAI; protease inhibitors			Tokyo Metropolitan Tama Med Ctr, Fuchu, Tokyo, Japan; Natl Canc Ctr, Tokyo, Japan; Kurashiki Cent Hosp, Kurashiki, Okayama, Japan; Jichi Med Univ, Saitama Med Ctr, Shimotsuke, Tochigi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-090	36	36				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300085		
J	Ito, K; Okano, N; Mimura, T; Hara, S; Takuma, K; Kishimoto, Y; Igarashi, Y				Ito, Ken; Okano, Naoki; Mimura, Takahiko; Hara, Seiichi; Takuma, Kensuke; Kishimoto, Yui; Igarashi, Yoshinori			Efficacy and long-term clinical results of endoscopic pancreatic stenting with chronic pancreatitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						endoscopic pancreatic stenting long term results chronic pancreatitis			[Ito, Ken; Okano, Naoki; Mimura, Takahiko; Hara, Seiichi; Takuma, Kensuke; Kishimoto, Yui; Igarashi, Yoshinori] Toho Omori Med Ctr, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-091	36	37				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300086		
J	Nakashima, Y; Yoshida, K; Aoki, H; Syunzo, T; Kawase, T; Hino, K; Hirose, K; Kyosaka, T; Tada, Y; Iwao, T				Nakashima, Yoshihiro; Yoshida, Koji; Aoki, Hirozumi; Syunzo, Tokioka; Kawase, Tomoya; Hino, Keisuke; Hirose, Katsuya; Kyosaka, Tomoki; Tada, Yamato; Iwao, Toshiyasu			Separate collection of pancreatic juice using endoscopic naso-pancreatic drainage catheter	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						carcinoma in situ; ENPD			Kawasaki Med Univ, Kurashiki, Okayama, Japan; Kawakita Gen Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-093	37	37				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300088		
J	Sano, I; Katanuma, A; Maguchi, H; Takahashi, K; Osanai, M; Yane, K; Toshifumi, K; Ikarashi, S; Sen-Yo, M; Minami, R; Yamazaki, H				Sano, Itsuki; Katanuma, Akio; Maguchi, Hiroyuki; Takahashi, Kuniyuki; Osanai, Manabu; Yane, Kei; Toshifumi, Kin; Ikarashi, Satoshi; Sen-Yo, Manabu; Minami, Ryuki; Yamazaki, Hajime			Diagnostic accuracy of EUS-FNA for WHO-grading of pancreatic neuroendocrine tumors	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						EUS-FNA pancreatic neuroendocrine tumors			[Sano, Itsuki; Katanuma, Akio; Maguchi, Hiroyuki; Takahashi, Kuniyuki; Osanai, Manabu; Yane, Kei; Toshifumi, Kin; Ikarashi, Satoshi; Sen-Yo, Manabu; Minami, Ryuki; Yamazaki, Hajime] Teine Keijinkai Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-094	38	38				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300089		
J	Sen-Yo, M; Maguchi, H; Takahashi, K; Katanuma, A; Osanai, M; Yane, K; Kin, T; Ikarashi, S; Minami, R; Sano, I; Yamazaki, H				Sen-Yo, Manabu; Maguchi, Hiroyuki; Takahashi, Kuniyuki; Katanuma, Akio; Osanai, Manabu; Yane, Kei; Kin, Toshifumi; Ikarashi, Satoshi; Minami, Ryuki; Sano, Itsuki; Yamazaki, Hajime			Clinical features and long-term follow-up outcomes of serous cystic neoplasms of the pancreas	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						SCN			[Sen-Yo, Manabu; Maguchi, Hiroyuki; Takahashi, Kuniyuki; Katanuma, Akio; Osanai, Manabu; Yane, Kei; Kin, Toshifumi; Ikarashi, Satoshi; Minami, Ryuki; Sano, Itsuki; Yamazaki, Hajime] Teine Keijinkai Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-095	38	38				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300090		
J	Furuichi, Y; Taira, J; Sano, T; Sugimoto, K; Imai, Y; Nakamura, I; Moriyasu, F				Furuichi, Yoshihiro; Taira, Junichi; Sano, Takatomo; Sugimoto, Katsutoshi; Imai, Yasuharu; Nakamura, Ikuo; Moriyasu, Fuminori			Treatment of bleeding from gastric fundal varices: comparison between EIS using cyanoacrylate and B-RTO	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						EIS; B-RTO; esophageal varices; cyanoacrylate			[Furuichi, Yoshihiro; Taira, Junichi; Sano, Takatomo; Sugimoto, Katsutoshi; Imai, Yasuharu; Nakamura, Ikuo; Moriyasu, Fuminori] Tokyo Med Univ Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-101	41	41				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300096		
J	Goto, O; Fujimoto, A; Shimoda, M; Matsuda, T; Ochiai, Y; Kawakubo, H; Uraoka, T; Takeuchi, H; Kameyama, K; Kitagawa, Y; Yahagi, N				Goto, Osamu; Fujimoto, Ai; Shimoda, Masayuki; Matsuda, Tatsuo; Ochiai, Yasutoshi; Kawakubo, Hirofumi; Uraoka, Toshio; Takeuchi, Hiroya; Kameyama, Kaori; Kitagawa, Yuko; Yahagi, Naohisa			Histological analysis of subepithelial extent of submucosal early gastric cancer in 60 surgical cases	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						early gastric cancer; endoscopic full-thickness resection; non-exposed endoscopic wall-inversion surgery; tumor extent			[Goto, Osamu; Fujimoto, Ai; Shimoda, Masayuki; Matsuda, Tatsuo; Ochiai, Yasutoshi; Kawakubo, Hirofumi; Uraoka, Toshio; Takeuchi, Hiroya; Kameyama, Kaori; Kitagawa, Yuko; Yahagi, Naohisa] Keio Univ, Sch Med, Tokyo 108, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-102	41	41				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300097		
J	Kashida, H; Adachi, T; Komeda, Y; Sakurai, T; Asakuma, Y; Takayama, M; Mine, H; Kudo, M				Kashida, Hiroshi; Adachi, Teppei; Komeda, Yoriaki; Sakurai, Toshiharu; Asakuma, Yutaka; Takayama, Masaki; Mine, Hiromasa; Kudo, Masatoshi			Colorectal endoscopic submucosal dissection is useful and safe	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						colorectal neoplasm; endoscopic submucosal dissection			[Kashida, Hiroshi; Adachi, Teppei; Komeda, Yoriaki; Sakurai, Toshiharu; Asakuma, Yutaka; Takayama, Masaki; Mine, Hiromasa; Kudo, Masatoshi] Kinki Univ, Higashiosaka, Osaka 577, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-103	41	42				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300098		
J	Kusano, C; Gotoda, T; Kikuchi, K; Asakura, K; Masaharu, H; Fuminori, M				Kusano, Chika; Gotoda, Takuji; Kikuchi, Kenji; Asakura, Kenichi; Masaharu, Hashimoto; Fuminori, Moriyasu			Long-term outcome and satisfaction survey after percutaneous endoscopic gastrostomy in a general hospital in Japan	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						percutaneous endoscopic gastrostomy			Tokyo Med Univ, Tokyo 1608402, Japan; Yuri Kumiai Gen Hosp, Akita, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-104	42	42				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300099		
J	Sakai, A; Shiomi, H; Fujigaki, S; Yamanaka, K; Ezaki, T; Hirata, Y; Iemoto, T; Nakagawa, T; Yagi, Y; Kobayashi, T; Takao, T; Takenaka, M; Arisaka, Y; Kutsumi, H; Okabe, Y; Azuma, T				Sakai, Arata; Shiomi, Hideyuki; Fujigaki, Seiji; Yamanaka, Koudai; Ezaki, Takeshi; Hirata, Yuichi; Iemoto, Takao; Nakagawa, Takashi; Yagi, Yousuke; Kobayashi, Takashi; Takao, Toshitatsu; Takenaka, Mamoru; Arisaka, Yoshifumi; Kutsumi, Hiromu; Okabe, Yoshihiro; Azuma, Takeshi			Effectiveness of self-expandable metal stent for afferent loop obstruction caused by cancer recurrence after pancreaticoduodenectomy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						afferent loop obstruction; SEMS; endoscopy			[Sakai, Arata; Shiomi, Hideyuki; Fujigaki, Seiji; Yamanaka, Koudai; Ezaki, Takeshi; Hirata, Yuichi; Iemoto, Takao; Nakagawa, Takashi; Yagi, Yousuke; Kobayashi, Takashi; Takao, Toshitatsu; Takenaka, Mamoru; Arisaka, Yoshifumi; Kutsumi, Hiromu; Okabe, Yoshihiro; Azuma, Takeshi] Kobe Univ Hosp, Kobe, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-106	43	43				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300101		
J	Yoshizaki, T; Toyonaga, T; Ohara, Y; Kawara, F; Watanabe, D; Tanaka, S; Ishida, T; Hoshi, N; Morita, Y; Umegaki, E; Azuma, T				Yoshizaki, Tetsuya; Toyonaga, Takashi; Ohara, Yoshiko; Kawara, Fumiaki; Watanabe, Daisuke; Tanaka, Shinwa; Ishida, Tsukasa; Hoshi, Namiko; Morita, Yoshinori; Umegaki, Eiji; Azuma, Takeshi			Feasibility of endoscopic submucosal dissection for the treatment of colorectal neoplasms on ileocecal valve	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						endoscopic submucosal dissection; ileocecal valve			[Yoshizaki, Tetsuya; Toyonaga, Takashi; Ohara, Yoshiko; Kawara, Fumiaki; Watanabe, Daisuke; Tanaka, Shinwa; Ishida, Tsukasa; Hoshi, Namiko; Morita, Yoshinori; Umegaki, Eiji; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Kobe, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	O-108	44	44				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300103		
J	Hirano, N; Igarashi, Y; Sumino, Y; Koyama, Y; Dan, N; Asai, Y; Takeda, Y; Ueki, N; Ito, K; Oba, N; Nishinakagawa, S; Kojima, T				Hirano, Naoki; Igarashi, Yoshinori; Sumino, Yasukiyo; Koyama, Yohei; Dan, Nobuhiro; Asai, Yasutsugu; Takeda, Yuki; Ueki, Nobuo; Ito, Ken; Oba, Nobuyuki; Nishinakagawa, Shuta; Kojima, Tatsuya			Clinical analysis for sigmoid colon volvulus performed treated endoscopic intervention	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						colon volvulus			Toho Univ, Omori Med Ctr, Tokyo Rosai Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-013	55	55				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300125		
J	Hirose, M; Naoki, H; Shinji, S; Kaoru, D; Tomoko, U; Yoshinori, I				Hirose, Motohiko; Naoki, Hirano; Shinji, Sato; Kaoru, Domon; Tomoko, Umakoshi; Yoshinori, Igarashi			Endoscopic treatments for patients with sigmoid colon volvulus	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						sigmoid colon volvulus			[Hirose, Motohiko; Naoki, Hirano; Shinji, Sato; Kaoru, Domon; Tomoko, Umakoshi; Yoshinori, Igarashi] Toho Univ, Omori Med Ctr, Ota, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-014	55	55				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300126		
J	Hotta, K; Mastuda, T; Kakugawa, Y; Ikematsu, H; Kobayashi, N; Kushima, R; Murakami, Y; Ishikawa, H; Nakajima, T; Otake, Y; Sakamoto, T; Matsumoto, M; Abe, S; Mori, M; Fujii, T; Saito, Y				Hotta, Kinichi; Mastuda, Takahisa; Kakugawa, Yasuo; Ikematsu, Hiroaki; Kobayashi, Nozomu; Kushima, Ryoji; Murakami, Yoshitaka; Ishikawa, Hideki; Nakajima, Takeshi; Otake, Yosuke; Sakamoto, Taku; Matsumoto, Minori; Abe, Seiichiro; Mori, Mika; Fujii, Takahiro; Saito, Yutaka			Regional colorectal cancer screening program using colonoscopy on an island: a prospective Niijima study	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						colon cancer screening; colonoscopy; adenoma detection rate			Natl Canc Ctr, Tokyo, Japan; Shiga Univ Med Sci, Tochigi Canc Ctr, Shiga, Tochigi, Japan; Toho Univ, Kyoto Prefectural Univ Med, Tokyo, Japan; Natl Canc Ctr, Takahiro Fujii Clin, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-016	56	56				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300128		
J	Inuyama, M; Fujimoto, A; Igarashi, Y				Inuyama, Mitsuko; Fujimoto, Ai; Igarashi, Yoshinori			Effectiveness of the therapeutic barium enema for recurrent colonic diverticular bleeding in short periods	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						barium enema			[Inuyama, Mitsuko; Fujimoto, Ai; Igarashi, Yoshinori] Toho Univ, Omori Med Ctr, Ota, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-017	56	56				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300129		
J	Kawai, D; Takemoto, K; Yasutomi, E; Okanoue, S; Murakami, M; Sakaguchi, C; Sunami, T; Oka, S; Okazaki, N; Baba, Y; Ishikawa, H; Takenaka, R; Tsugeno, H; Fujiki, S				Kawai, Daisuke; Takemoto, Koji; Yasutomi, Eriko; Okanoue, Shotaro; Murakami, Mayu; Sakaguchi, Chihiro; Sunami, Tomoko; Oka, Shohei; Okazaki, Noriko; Baba, Yuki; Ishikawa, Hisashi; Takenaka, Ryuta; Tsugeno, Hirohumi; Fujiki, Shigeatsu			Stenting of the proximal malignant obstruction improved quality of life, provided surgical advantage as primary anastomosis, and enabled early introduction of chemotherapy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						self-expandable metallic stent (SEMS); bridge-to-surgery (BTS); palliative care; chemotherapy			[Kawai, Daisuke; Takemoto, Koji; Yasutomi, Eriko; Okanoue, Shotaro; Murakami, Mayu; Sakaguchi, Chihiro; Sunami, Tomoko; Oka, Shohei; Okazaki, Noriko; Baba, Yuki; Ishikawa, Hisashi; Takenaka, Ryuta; Tsugeno, Hirohumi; Fujiki, Shigeatsu] Tsuyama Cent Hosp, Tsuyama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-019	57	57				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300130		
J	Masaya, I; Satoru, N; Manabu, H; Kunihiro, K; Ryoichi, Y				Masaya, Iwata; Satoru, Nyuzuki; Manabu, Harada; Kunihiro, Kawauchi; Ryoichi, Yamakawa			Clinical features of colonic diverticulitis and diverticular bleeding	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						diverticulitis; diverticular bleeding; diverticulum			[Masaya, Iwata; Satoru, Nyuzuki; Manabu, Harada; Kunihiro, Kawauchi; Ryoichi, Yamakawa] Kaetsu Hosp, Niigata, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-026	59	59				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300135		
J	Mizuno, KI; Yokoyama, J; Kobayashi, M; Takahashi, Y; Takahashi, K; Nishigaki, Y; Yamamoto, T; Honda, Y; Hashimoto, S; Takeuchi, M; Sato, Y; Ajioka, Y				Mizuno, Ken Ichi; Yokoyama, Junji; Kobayashi, Masaaki; Takahashi, Yoshifumi; Takahashi, Kazuya; Nishigaki, Yuki; Yamamoto, Takashi; Honda, Yutaka; Hashimoto, Satoru; Takeuchi, Manabu; Sato, Yuichi; Ajioka, Yoichi			Endoscopic submucosal dissection for correct diagnosis of dysplasia in ulcerative colitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						ulcerative colitis; dysplasia; endoscopic submucosal dissection			Nanjing Univ, Grad Sch Med & Dent Sci, Med & Dent Hosp, Nanjing, Jiangsu, Peoples R China; Niigata Univ, Med & Dent Hosp, Niigata, Japan; Niigata Univ Med & Dent Hosp, Grad Sch Med & Dent Sci, Niigata, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-027	59	59				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300136		
J	Nakano, R; Shimoda, H; Kuroda, T; Tanoue, Y; Sasahira, N; Maekawa, H				Nakano, Rika; Shimoda, Hiroki; Kuroda, Takaaki; Tanoue, Yasushi; Sasahira, Naoki; Maekawa, Hisato			Colooscopy for women	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						women colonoscopist			[Nakano, Rika; Shimoda, Hiroki; Kuroda, Takaaki; Tanoue, Yasushi; Sasahira, Naoki; Maekawa, Hisato] Tokyo Takanawa Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-028	59	60				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300137		
J	Ryogo, H; Hiro-O, Y; Hiro-O, M; Kenjiro, Y; Eiji, H; Ryo, T; Yoshihito, T; Michiko, N; Yuko, K; Kentaro, S; Makoto, E; Tamotsu, S; Hironori, A; Eiichiro, Y; Hiromu, S; Yasushi, I				Ryogo, Himori; Hiro-O, Yamano; Hiro-O, Matsushita; Kenjiro, Yoshikawa; Eiji, Harada; Ryo, Takagi; Yoshihito, Tanaka; Michiko, Nakaoka; Yuko, Katano; Kentaro, Sato; Makoto, Eizuka; Tamotsu, Sugai; Hironori, Aoki; Eiichiro, Yamamoto; Hiromu, Suzuki; Yasushi, Imai			A study of advanced colorectal cancer with BRAF mutation	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						serrated pathway BRAF mutation			Akita Red Cross Hosp, Akita, Japan; Iwate Med Univ, Sch Med, Morioka, Iwate, Japan; Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan; Sapporo Med Univ, Sch Med, Akita Red Cross Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-034	61	61				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300141		
J	Shirahige, A; Namba, N; Watanabe, Y; Oyama, R; Yabe, M; Ota, K; Tanioka, H; Shimizu, S; Kishimoto, T				Shirahige, Akinori; Namba, Naoko; Watanabe, Yukito; Oyama, Reiko; Yabe, Maiko; Ota, Kyouko; Tanioka, Hiroaki; Shimizu, Shinichi; Kishimoto, Takumi			Clinical course and management of sigmoid volvulus after colonoscopic treatment	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						sigmoid volvulus; colonoscope; management; operation			[Shirahige, Akinori; Namba, Naoko; Watanabe, Yukito; Oyama, Reiko; Yabe, Maiko; Ota, Kyouko; Tanioka, Hiroaki; Shimizu, Shinichi; Kishimoto, Takumi] Okayama Rosai Hosp, Okayama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-036	62	62				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300143		
J	Sunami, T; Kawai, D; Takemoto, K; Okanoue, S; Yasutomi, E; Sakaguchi, C; Murakami, M; Oka, S; Okazaki, N; Baba, Y; Ishikawa, H; Takenaka, R; Tsugeno, H; Fujiki, S				Sunami, Tomoko; Kawai, Daisuke; Takemoto, Koji; Okanoue, Syotaro; Yasutomi, Eriko; Sakaguchi, Chihiro; Murakami, Mayu; Oka, Shohei; Okazaki, Noriko; Baba, Yuki; Ishikawa, Hisashi; Takenaka, Ryuta; Tsugeno, Hirofumi; Fujiki, Sigeatsu			Clinical significance of CYFRA 21-1 in patients with colorectal cancer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						CYFRA 21-1; colorectal cancer			[Sunami, Tomoko; Kawai, Daisuke; Takemoto, Koji; Okanoue, Syotaro; Yasutomi, Eriko; Sakaguchi, Chihiro; Murakami, Mayu; Oka, Shohei; Okazaki, Noriko; Baba, Yuki; Ishikawa, Hisashi; Takenaka, Ryuta; Tsugeno, Hirofumi; Fujiki, Sigeatsu] Tsuyama Cent Hosp, Tsuyama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-037	62	62				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300144		
J	Takahashi, K; Tadashi, S; Yoichi, Y; Shimaya, K; Itoh, S; Hanabata, N; Kanazawa, K; Tanaka, M; Numao, H; Munakata, M; Fukuda, S				Takahashi, Kazunori; Tadashi, Shimoyama; Yoichi, Yamamoto; Shimaya, Koji; Itoh, Satoko; Hanabata, Norihiro; Kanazawa, Kosuke; Tanaka, Masanori; Numao, Hiroshi; Munakata, Masaki; Fukuda, Shinsaku			Two cases of mesenteric phlebosclerosis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						herbal medicine; mesenteric phlebosclerosis; colonic cancer			Hirosaki Univ, Aomori Prefectural Hosp, Hirosaki, Aomori, Japan; Hirosaki City Hosp, Aomori Prefectural Hosp, Hirosaki, Aomori, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-038	63	63				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300145		
J	Authors, YTA; Mizuno, KI; Kobayashi, M; Takahashi, K; Nishigaki, YK; Hashimoto, S; Takeuchi, M; Yamamoto, T; Yutaka, H; Yokoyama, J; Sato, YI				Takahashi, Yoshifumi; Mizuno, Ken Ichi; Kobayashi, Masaaki; Takahashi, Kazuya; Nishigaki, Yu Ki; Hashimoto, Satoru; Takeuchi, Manabu; Yamamoto, Takashi; Yutaka, Honda; Yokoyama, Junji; Sato, Yu Ichi			Long-term outcomes of endoscopic submucosal dissection for colorectal neoplasms	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						endoscopic submucosal dissection (ESD); long-term outcome; overall survival			Grad Sch Med & Dent Sci, Dept Endoscopy, Niigata, Japan; Grad Sch Med & Dent Sci, Niigata, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-039	63	63				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300146		
J	Takisawa, H; Terazawa, T; Sakamoto, T; Kakugawa, Y; Saito, Y				Takisawa, Hajime; Terazawa, Tetsuji; Sakamoto, Taku; Kakugawa, Yasuo; Saito, Yutaka			Do women prefer to undergo colonoscopies for the first time by female doctors?	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						sex preference; women subjects; colonoscopy			[Takisawa, Hajime; Terazawa, Tetsuji; Sakamoto, Taku; Kakugawa, Yasuo; Saito, Yutaka] Natl Canc Ctr, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-040	63	64				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300147		
J	Yasutomi, E; Baba, Y; Okanoue, S; Murakami, M; Sakaguchi, C; Sunami, T; Oka, S; Okazaki, N; Kawai, D; Takemoto, K; Takenaka, R; Tsugeno, H; Fujiki, S				Yasutomi, Eriko; Baba, Yuki; Okanoue, Shotaro; Murakami, Mayu; Sakaguchi, Chihiro; Sunami, Tomoko; Oka, Shohei; Okazaki, Noriko; Kawai, Daisuke; Takemoto, Koji; Takenaka, Ryuta; Tsugeno, Hirofumi; Fujiki, Shigeatsu			Adult onset schonlein-henoch purpura: study of 8 cases	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Schonlein-Henoch purpura			[Yasutomi, Eriko; Baba, Yuki; Okanoue, Shotaro; Murakami, Mayu; Sakaguchi, Chihiro; Sunami, Tomoko; Oka, Shohei; Okazaki, Noriko; Kawai, Daisuke; Takemoto, Koji; Takenaka, Ryuta; Tsugeno, Hirofumi; Fujiki, Shigeatsu] Tsuyama Cent Hosp, Tsuyama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-043	65	66				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300150		
J	Omata, YY; Tsuchiya, A; Watanabe, A; Sasamoto, T; Nishikawa, K; Yamanaka, M				Omata, Yu Yu; Tsuchiya, Akihiko; Watanabe, Azuma; Sasamoto, Takahiro; Nishikawa, Ko; Yamanaka, Masami			Is colonoscopy truly needed in elderly patients aged 85 years or over with positive FOBT?	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						very elderly patient; FOBT-positive; colonoscopy			[Omata, Yu Yu; Tsuchiya, Akihiko; Watanabe, Azuma; Sasamoto, Takahiro; Nishikawa, Ko; Yamanaka, Masami] Ageo Cent Gen Hosp, Ageo City, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-044	66	66				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300151		
J	Makmun, D; Abdullah, M; Syam, AF; Fauzi, A; Renaldi, K; Rani, AA; Simadibrata, M				Makmun, Dadang; Abdullah, Murdani; Syam, Ari Fahrial; Fauzi, Achmad; Renaldi, Kaka; Rani, Abdul Aziz; Simadibrata, Marcellus			The efficacy and cost efficiency of hospital-made polyethylene glycol (PEG) compared to branded PEG for colonoscopy preparation	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						colon clearance; hospital-made PEG; branded PEG; efficacy; efficiency			[Makmun, Dadang; Abdullah, Murdani; Syam, Ari Fahrial; Fauzi, Achmad; Renaldi, Kaka; Rani, Abdul Aziz; Simadibrata, Marcellus] Dr Cipto Mangunkusuko Gen Hosp, Fmui, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-055	69	69				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300157		
J	Akahoshi, K; Masafumi, O; Koga, T; Motomura, Y; Kubokawa, M; Gibo, J; Kinoshita, N; Osada, S; Tokumaru, K; Tomoeda, N				Akahoshi, Kazuya; Masafumi, Oya; Koga, Tadashi; Motomura, Yasuaki; Kubokawa, Masaru; Gibo, Jyunya; Kinoshita, Nobukatsu; Osada, Shigeki; Tokumaru, Kayo; Tomoeda, Naru			Prospective comparison of endoscopic ultrasound-guided fine-needle aspiration and surgical histology in gastric submucosal tumors	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						EUS-FNA; GIST; SMT; stomach; immunohistochemical analysis; histology			[Akahoshi, Kazuya; Masafumi, Oya; Koga, Tadashi; Motomura, Yasuaki; Kubokawa, Masaru; Gibo, Jyunya; Kinoshita, Nobukatsu; Osada, Shigeki; Tokumaru, Kayo; Tomoeda, Naru] Aso Iizuka Hosp, Iizuka, Fukuoka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-059	70	70				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300161		
J	Akimoto, T; Miyake, K; Maruki, Y; Yamawaki, H; Kodaka, Y; Nagoya, H; Ueki, N; Kawagoe, T; Futagami, S; Sakamoto, C				Akimoto, Teppei; Miyake, Kazumasa; Maruki, Yuta; Yamawaki, Hiroshi; Kodaka, Yasuhiro; Nagoya, Hiroyuki; Ueki, Nobue; Kawagoe, Tetsuro; Futagami, Seiji; Sakamoto, Choitsu			Endoscopic biopsy in the user of antithrombotic agents	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						antithrombotic; biopsy			Nippon Med Sch, Tokyo, Japan; Nippon Med Schoo, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-060	70	70				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300162		
J	Ako, S; Takemoto, K; Sakaguchi, C; Murakami, M; Sunami, T; Oka, S; Okazaki, N; Baba, Y; Kawai, D; Takenaka, R; Tsugeno, H; Fujiki, S				Ako, Soichiro; Takemoto, Kouji; Sakaguchi, Chihiro; Murakami, Mayu; Sunami, Tomoko; Oka, Shohei; Okazaki, Noriko; Baba, Yuuki; Kawai, Daisuke; Takenaka, Ryuuta; Tsugeno, Hirofumi; Fujiki, Shigeatsu			Randomized prospective trial comparing tolerability to 2 L polyethylene glycol and sodium phosphate tablets	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						colonoscopy; polyethylene glycol; preparation; randomised prospective trial; sodium phosphate tablet			[Ako, Soichiro; Takemoto, Kouji; Sakaguchi, Chihiro; Murakami, Mayu; Sunami, Tomoko; Oka, Shohei; Okazaki, Noriko; Baba, Yuuki; Kawai, Daisuke; Takenaka, Ryuuta; Tsugeno, Hirofumi; Fujiki, Shigeatsu] Tsuyama Chuo Hosp, Tsuyama, Okayama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-061	71	71				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300163		
J	Asai, S; Fujimoto, N; Tanoue, K; Akamine, E; Nambara, M; Hirooka, N; Hirooka, N; Yanagi, H; Ogawa, M; Ogawa, A				Asai, Satoshi; Fujimoto, Naoki; Tanoue, Koujirou; Akamine, Eisuke; Nambara, Mikio; Hirooka, Norifumi; Hirooka, Norifumi; Yanagi, Hideo; Ogawa, Minoru; Ogawa, Atsuhiro			Water immersion colonoscopy facilitates straight passage of the colonoscope through the sigmoid colon without loop formation: randomized controlled trial	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Water immersion; water navigation colonoscopy; water assisted colonoscopy; cap fitted colonosocpy			[Asai, Satoshi; Fujimoto, Naoki; Tanoue, Koujirou; Akamine, Eisuke; Nambara, Mikio; Hirooka, Norifumi; Hirooka, Norifumi; Yanagi, Hideo; Ogawa, Minoru; Ogawa, Atsuhiro] Tane Gen Hosp, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-063	71	71				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300164		
J	Dohi, O; Majima, A; Onozawa, Y; Kitaichi, T; Horii, Y; Suzuki, K; Tomie, A; Kamada, K; Yagi, N; Naito, Y; Itoh, Y				Dohi, Osamu; Majima, Atsushi; Onozawa, Yuriko; Kitaichi, Tomoko; Horii, Yusuke; Suzuki, Kentaro; Tomie, Akira; Kamada, Kazuhiro; Yagi, Nobuaki; Naito, Yuji; Itoh, Yoshito			Diagnostic usefulness of magnifying endoscopy with blue laser imaging for early gastric cancer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						BLI; VS classification; gastric cancer			Kyoto Prefectural Univ Med, Kyoto 602, Japan; Asahi Univ, Murakami Mem Hosp, Mizuho, Gifu, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-074	75	75				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300174		
J	Hattori, M; Katayama, M; Yamasaki, M; Nonogaki, H; Yanase, T; Suematsu, S				Hattori, Masashi; Katayama, Makoto; Yamasaki, Michihiro; Nonogaki, Hidehiko; Yanase, Tadahiko; Suematsu, Seiji			Investigation of a novel bowel preparation method using laxative tablets for CT colonography	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						CT colonography; colon preparation; laxative tablet			[Hattori, Masashi; Katayama, Makoto; Yamasaki, Michihiro; Nonogaki, Hidehiko; Yanase, Tadahiko; Suematsu, Seiji] Med Corp Yamashita Hosp, Yamashita, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-079	76	76				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300178		
J	Igarashi, H; Nakamura, H; Tsuchiya, K; Yamashita, H; Hirayama, M; Ogata, I				Igarashi, Hiroaki; Nakamura, Hiroshi; Tsuchiya, Kiyoshi; Yamashita, Hiroko; Hirayama, Miki; Ogata, Itsuro			Should people of advanced age undergo colonoscopy as a detailed examination for colorectal cancer screening?	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Colorectal cancer; screening; colonoscopy; aged people			[Igarashi, Hiroaki; Nakamura, Hiroshi; Tsuchiya, Kiyoshi; Yamashita, Hiroko; Hirayama, Miki; Ogata, Itsuro] Kawakita Gen Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-084	79	79				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300183		
J	Ino, Y; Yano, T; Hayashi, Y; Sakamoto, H; Osawa, H; Sunada, K; Sato, H; Miura, Y; Shinhata, H; Takezawa, T; Yamamoto, H				Ino, Yuji; Yano, Tomonori; Hayashi, Yoshikazu; Sakamoto, Hirotsugu; Osawa, Hiroyuki; Sunada, Keijiro; Sato, Hiroyuki; Miura, Yoshimasa; Shinhata, Hakuei; Takezawa, Takahito; Yamamoto, Hironori			A novel method for endoscopic placement of the capsule endoscope using the transparent hood and real time viewer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Capsule endoscopy; endoscopic placement; real time viewer			[Ino, Yuji; Yano, Tomonori; Hayashi, Yoshikazu; Sakamoto, Hirotsugu; Osawa, Hiroyuki; Sunada, Keijiro; Sato, Hiroyuki; Miura, Yoshimasa; Shinhata, Hakuei; Takezawa, Takahito; Yamamoto, Hironori] Jichi Med Univ, Shimotsuke, Japan			Sakamoto, Hirotsugu/G-6426-2013	Sakamoto, Hirotsugu/0000-0002-2458-1693				0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-085	79	79				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300184		
J	Inoue, N; Iwao, Y; Mtsuzaki, J; Yoshida, T; Shimizu, R; Takayama, M; Sugino, Y				Inoue, Nagamu; Iwao, Yasushi; Mtsuzaki, Juntaro; Yoshida, Toshifumi; Shimizu, Ryoko; Takayama, Michiyo; Sugino, Yoshinori			A new, rapid, effective, tolerable, and safe preparation suitable for colonoscopy: a morning-only preparation using reduced-volume polyethylene glycol and electrolyte solution (peg-els) plus ascorbic acid	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Colonosopy; preparation; polyethylene glycol; ascorbic acid			[Inoue, Nagamu; Iwao, Yasushi; Mtsuzaki, Juntaro; Yoshida, Toshifumi; Shimizu, Ryoko; Takayama, Michiyo; Sugino, Yoshinori] Keio Univ Hosp, Keio, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-086	79	80				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300185		
J	Ishikawa, S; Inaba, T; Mizukawa, S; Izumikawa, K; Sakakihara, I; Yamamoto, K; Takahashi, S; Tanaka, S; Wato, M; Kawai, K				Ishikawa, Shigenao; Inaba, Tomoki; Mizukawa, Syo; Izumikawa, Kouichi; Sakakihara, Ichiro; Yamamoto, Kumiko; Takahashi, Sakuma; Tanaka, Shigetomi; Wato, Masaki; Kawai, Kozo			Efficacy of sedation by propofol during endoscopic submucosal dissection(esd)	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Endoscopic submucosal dissection; sedation; propofol			[Ishikawa, Shigenao; Inaba, Tomoki; Mizukawa, Syo; Izumikawa, Kouichi; Sakakihara, Ichiro; Yamamoto, Kumiko; Takahashi, Sakuma; Tanaka, Shigetomi; Wato, Masaki; Kawai, Kozo] Kagawa Prefectural Cent Hosp, Takamatsu, Kagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-087	80	80				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300186		
J	Kawara, F; Yoshizaki, T; Ohara, Y; Tanaka, S; Ishida, T; Morita, Y; Toyonaga, T; Umegaki, E; Yokozaki, H; Azuma, T				Kawara, Fumiaki; Yoshizaki, Tetsuya; Ohara, Yoshiko; Tanaka, Shinwa; Ishida, Tsukasa; Morita, Yoshinori; Toyonaga, Takashi; Umegaki, Eiji; Yokozaki, Hiroshi; Azuma, Takeshi			Lobulated villous polyps with gastric mucin phenotype in the duodenal bulb: two case reports	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Duodenal polyp; gastric mucin phenotype; NBI			[Kawara, Fumiaki; Yoshizaki, Tetsuya; Ohara, Yoshiko; Tanaka, Shinwa; Ishida, Tsukasa; Morita, Yoshinori; Toyonaga, Takashi; Umegaki, Eiji; Yokozaki, Hiroshi; Azuma, Takeshi] Kobe Univ Hosp, Kobe, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-093	82	83				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300192		
J	Kishihara, T; Tamegai, Y; Chino, A; Igarashi, M				Kishihara, Teruhito; Tamegai, Yoshirou; Chino, Akiko; Igarashi, Masahiro			Endoscopic submucosal dissection (esd) for rectal tumor became safe and curative procedure as compared with trans anal resection(tar)	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						ESD; TAR			[Kishihara, Teruhito; Tamegai, Yoshirou; Chino, Akiko; Igarashi, Masahiro] Canc Inst Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-101	85	85				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300199		
J	Minato, Y; Ken, O; Kouichi, N; Maiko, T; Yasushi, M; Yoshitsugu, M; Nobuyuki, M				Minato, Yohei; Ken, Ohata; Kouichi, Nonaka; Maiko, Takita; Yasushi, Matsuyama; Yoshitsugu, Misumi; Nobuyuki, Matsuhashi			Feasibility of confocal laser endomicroscopy for duodenum lesions	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Probe-based confocal laser endomicroscopy (PCLE)			[Minato, Yohei; Ken, Ohata; Kouichi, Nonaka; Maiko, Takita; Yasushi, Matsuyama; Yoshitsugu, Misumi; Nobuyuki, Matsuhashi] Ntt Med Ctr Tokyo, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-109	87	87				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300205		
J	Minowa, S; Hayashida, M; Saito, D; Sakuraba, A; Yamada, Y; Yamaguchi, Y; Koyama, G; Yamazaki, H; Takahashi, S				Minowa, Shintaro; Hayashida, Mari; Saito, Daisuke; Sakuraba, Akihito; Yamada, Yuji; Yamaguchi, Yasuharu; Koyama, Genichi; Yamazaki, Hiroshi; Takahashi, Shin'ichi			Capsule endoscopy is a very useful tool as a decision of treatment strategy for neurocysticercosis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Capsule endoscopy neurocysticercosis			Kyorin Univ, Sch Med, Tokyo, Japan; Natl Inst Infect Dis, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-110	88	88				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300206		
J	Mitani, T; Shu, H; Kaise, M				Mitani, Toshifumi; Shu, Hoteya; Kaise, Mitsuru			Clinical outcomes of endoscopic submucosal dissection for 958 colorectal epithelial neoplasms	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Colorectal ESD; outcomes			[Mitani, Toshifumi; Shu, Hoteya; Kaise, Mitsuru] Toranomon Gen Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-111	88	88				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300207		
J	Moon, HS; Hwang, SW; Jeong, HY				Moon, Hee Seok; Hwang, Se Woong; Jeong, Hyun Yong			Clinical factors for consideration in patients with gastric hyperplastic polyps treated by endoscopic polypectomy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Stomach; hyperplastic; polyps; neoplastic; transformation			[Moon, Hee Seok; Hwang, Se Woong; Jeong, Hyun Yong] Dept Internal Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-112	88	88				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300208		
J	Muramatsu, Y; Kishihara, T; Tamegai, Y; Igarashi, M; Chino, A				Muramatsu, Yusuke; Kishihara, Teruhito; Tamegai, Yoshiro; Igarashi, Masahiro; Chino, Akiko			Usefulness of magnified endoscopy with nbi for the detection and diagnosis of anal canal cancer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						NBI; analcanal cancer			[Muramatsu, Yusuke; Kishihara, Teruhito; Tamegai, Yoshiro; Igarashi, Masahiro; Chino, Akiko] Canc Inst Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-113	89	89				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300209		
J	Nakano, M; Oka, S; Tanaka, S; Igawa, A; Aoyama, T; Sagami, S; Kominami, Y; Nagai, K; Chayama, K				Nakano, Makoto; Oka, Shiro; Tanaka, Shinji; Igawa, Atushi; Aoyama, Taiki; Sagami, Shintaro; Kominami, Yoko; Nagai, Kenta; Chayama, Kazuaki			Usefulness of transabdominal ultrasonography for improved safety of capsule endoscopy in patients with crohn's disease	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Transabdominal ultrasonography capsule endoscopy; Crohn's disease			[Nakano, Makoto; Oka, Shiro; Tanaka, Shinji; Igawa, Atushi; Aoyama, Taiki; Sagami, Shintaro; Kominami, Yoko; Nagai, Kenta; Chayama, Kazuaki] Hiroshima Univ Hosp, Hiroshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-114	89	89				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300210		
J	Nakashima, O; Murayama, M; Yamazaki, K; Koizumi, K				Nakashima, Osamu; Murayama, Minoru; Yamazaki, Katsuo; Koizumi, Kazuo			Clinical outcomes of metallic stent for malignant colorectal obstruction	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Metallic stent obstruction of colorectal cancer			[Nakashima, Osamu; Murayama, Minoru; Yamazaki, Katsuo; Koizumi, Kazuo] Izumi Mem Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-115	89	89				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300211		
J	Nonaka, K; Ohata, K; Takita, M; Matsuyama, Y; Tashima, T; Minato, Y; Matsuhashi, N				Nonaka, Kouichi; Ohata, Ken; Takita, Maiko; Matsuyama, Yasushi; Tashima, Tomoaki; Minato, Yohei; Matsuhashi, Nobuyuki			Confocal laser endomicroscopy using dye dispersion	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Confocal laser endomicroscopy; fluorescein			[Nonaka, Kouichi; Ohata, Ken; Takita, Maiko; Matsuyama, Yasushi; Tashima, Tomoaki; Minato, Yohei; Matsuhashi, Nobuyuki] Ntt Med Ctr Tokyo, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-117	90	90				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300213		
J	Nonaka, K; Ohata, K; Matsuhashi, N; Shimizu, M; Arai, S; Hiejima, Y; Kita, H				Nonaka, Kouichi; Ohata, Ken; Matsuhashi, Nobuyuki; Shimizu, Michio; Arai, Shin; Hiejima, Yoshimitsu; Kita, Hiroto			Is narrow-band imaging useful for histological evaluation of gastric mucosa-associated lymphoid tissue lymphoma after treatment?	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						NBI; malt			Ntt Med Ctr Tokyo, Tokyo, Japan; Saitama Med Univ Int Med C, Moroyama, Saitama, Japan; Tokyo Healthcare Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-116	90	90				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300212		
J	Okada, M; Osawa, H; Miura, Y; Ino, Y; Takezawa, T; Satoh, H; Yamamoto, H				Okada, Masahiro; Osawa, Hiroyuki; Miura, Yoshimasa; Ino, Yuji; Takezawa, Takehito; Satoh, Hiroyuki; Yamamoto, Hironori			Blue laser imaging is useful for detection and detailed examination of early flat gastric cancers	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Blue laser imaging; gastric cancer; microvascular patterns			[Okada, Masahiro; Osawa, Hiroyuki; Miura, Yoshimasa; Ino, Yuji; Takezawa, Takehito; Satoh, Hiroyuki; Yamamoto, Hironori] Jichi Med Univ, Shimotsuke, Tochigi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-118	90	91				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300214		
J	Okuda, M; Hagihara, H; Matsubara, M; Matsumura, S; Suzuki, S				Okuda, Masato; Hagihara, Hiroaki; Matsubara, Minoru; Matsumura, Shyuji; Suzuki, Seiyuu			Ingestion of a kwik lok bag closure - a small bread bag clip poses a large health risk	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Kwik Lok; bag closure; bread bag clip; bread clip			[Okuda, Masato; Hagihara, Hiroaki; Matsubara, Minoru; Matsumura, Shyuji; Suzuki, Seiyuu] Sumitomobesshi Hosp, Niihama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-119	91	91				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300215		
J	Ozawa, SI; Tadateru, M; Ishigooka, S; Sato, Y; Ikeda, Y; Hosoya, K; Matsuo, Y; Yamashita, M; Yamamoto, H; Yasuda, H; Fujino, T; Itoh, F				Ozawa, Shun Ichiro; Tadateru, Maehata; Ishigooka, Shinya; Sato, Yoshinori; Ikeda, Yoshiko; Hosoya, Kosuke; Matsuo, Yasumasa; Yamashita, Masaki; Yamamoto, Hiroyuki; Yasuda, Hiroshi; Fujino, Takashi; Itoh, Fumio			Endoscopic submucosal dissection for depressed-type squamous cell carcinoma at anal canal: a case report	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Anal canal cancer. scc. ESD			[Ozawa, Shun Ichiro; Tadateru, Maehata; Ishigooka, Shinya; Sato, Yoshinori; Ikeda, Yoshiko; Hosoya, Kosuke; Matsuo, Yasumasa; Yamashita, Masaki; Yamamoto, Hiroyuki; Yasuda, Hiroshi; Fujino, Takashi; Itoh, Fumio] St Marianna Univ, Sch Med, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-120	91	92				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300216		
J	Sasao, W; Wada, Y; Sato, K; Abe, S; Hisada, Y; Oku, T				Sasao, Wataru; Wada, Yoshiki; Sato, Kengo; Abe, Sawako; Hisada, Yuichiro; Oku, Tadashi			Usefulness of drinking oolong tea before premedication for improving visualization during esophagogastroduodenoscopy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Oolong tea; premedication			[Sasao, Wataru; Wada, Yoshiki; Sato, Kengo; Abe, Sawako; Hisada, Yuichiro; Oku, Tadashi] Hokkaido Prefecture Haboro Hosp, Haboro, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-124	92	93				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300219		
J	Shirakawa, A; Kawamura, T; Kawabata, H; Miyata, M; Uno, K; Yasuda, K				Shirakawa, Atsushi; Kawamura, Takuji; Kawabata, Hideaki; Miyata, Masatoshi; Uno, Koji; Yasuda, Kenjiro			The optimal endoscopic screening interval for detecting early gastric cancers	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Screening endoscope; gastric cancer			[Shirakawa, Atsushi; Kawamura, Takuji; Kawabata, Hideaki; Miyata, Masatoshi; Uno, Koji; Yasuda, Kenjiro] Kyoto Second Red Cross Hosp, Kyoto, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-128	94	94				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300223		
J	Suzuki, S; Miike, T; Noda, T; Noda, Y; Natsumi, U; Takeda, S; Sakaguchi, M; Natsuda, S; Hashimoto, K; Maemura, K; Yamaji, T; Abe, H; Yamamoto, S; Yorita, K; Kataoka, H; Shimoda, K				Suzuki, Sho; Miike, Tadashi; Noda, Takaho; Noda, Yuko; Natsumi, Uehara; Takeda, Sachiko; Sakaguchi, Mai; Natsuda, Shuichiro; Hashimoto, Kanna; Maemura, Kousuke; Yamaji, Takumi; Abe, Hiroo; Yamamoto, Shojiro; Yorita, Kenji; Kataoka, Hiroaki; Shimoda, Kazuya			A discrepancy in pathological diagnosis of gastric neoplasia between biopsy and endoscopic submucosal dissection	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Biopsy; ESD			[Suzuki, Sho; Miike, Tadashi; Noda, Takaho; Noda, Yuko; Natsumi, Uehara; Takeda, Sachiko; Sakaguchi, Mai; Natsuda, Shuichiro; Hashimoto, Kanna; Maemura, Kousuke; Yamaji, Takumi; Abe, Hiroo; Yamamoto, Shojiro; Yorita, Kenji; Kataoka, Hiroaki; Shimoda, Kazuya] Miyazaki Univ, Miyazaki, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-133	96	96				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300227		
J	Takemoto, K; Kawai, D; Okanoue, S; Takenaka, R; Tsugeno, H; Fujiki, S				Takemoto, Koji; Kawai, Daisuke; Okanoue, Shotaro; Takenaka, Ryuta; Tsugeno, Hirofumi; Fujiki, Shigeatsu			Significant increase of colorectal polyps in asymptomatic fecal immunochemical stool test positive patients on maintenance hemodialysis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Hemodialysis; colorectal polyps			[Takemoto, Koji; Kawai, Daisuke; Okanoue, Shotaro; Takenaka, Ryuta; Tsugeno, Hirofumi; Fujiki, Shigeatsu] Tsuyama Cent Hosp, Tsuyama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-134	96	96				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300228		
J	Tanaka, Y; Imai, K; Hotta, K; Yamaguchi, Y; Kawata, N; Tanaka, M; Takizawa, K; Kakushima, N; Matsubayashi, H; Ono, H				Tanaka, Yasuyuki; Imai, Kenichiro; Hotta, Kinichi; Yamaguchi, Yuichiro; Kawata, Noboru; Tanaka, Masaki; Takizawa, Kohei; Kakushima, Naomi; Matsubayashi, Hiroyuki; Ono, Hiroyuki			Treatment outcomes of cecal tumors spreading to the appendiceal orifice	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Endoscopic resection			[Tanaka, Yasuyuki; Imai, Kenichiro; Hotta, Kinichi; Yamaguchi, Yuichiro; Kawata, Noboru; Tanaka, Masaki; Takizawa, Kohei; Kakushima, Naomi; Matsubayashi, Hiroyuki; Ono, Hiroyuki] Shizuoka Canc Ctr, Shizuoka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-137	97	98				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300231		
J	Tomie, A; Dohi, O; Majima, A; Onozawa, Y; Kitaichi, T; Horii, Y; Suzuki, K; Kamada, K; Naito, Y; Itoh, Y				Tomie, Akira; Dohi, Osamu; Majima, Atsushi; Onozawa, Yuriko; Kitaichi, Tomoko; Horii, Yusuke; Suzuki, Kentaro; Kamada, Kazuhiro; Naito, Yuji; Itoh, Yoshito			Usefulness of endoscopic recognition using blue laser imaging for superficial esophageal squamous cell carcinoma	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Blue laser imaging; esophageal squamous cell carcinoma			[Tomie, Akira; Dohi, Osamu; Majima, Atsushi; Onozawa, Yuriko; Kitaichi, Tomoko; Horii, Yusuke; Suzuki, Kentaro; Kamada, Kazuhiro; Naito, Yuji; Itoh, Yoshito] Kyoto Prefectural Univ Med, Kyoto 602, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-139	98	98				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300233		
J	Tomohiro, M; Oka, S; Tanaka, S; Yoshifuku, Y; Kagemoto, K; Numata, N; Sanomura, Y; Urabe, Y; Cyayama, K				Tomohiro, Miwata; Oka, Shiro; Tanaka, Shinji; Yoshifuku, Yoshikazu; Kagemoto, Kenichi; Numata, Norifumi; Sanomura, Yoji; Urabe, Yuji; Cyayama, Kazuaki			Clinical outcome of endoscopic submucosal dissection for entire circumferential superficial esophageal squamous cell carcinoma	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Entire circumferential superficial esophageal squamous cell carcinoma; ESD			[Tomohiro, Miwata; Oka, Shiro; Tanaka, Shinji; Yoshifuku, Yoshikazu; Kagemoto, Kenichi; Numata, Norifumi; Sanomura, Yoji; Urabe, Yuji; Cyayama, Kazuaki] Hiroshima Univ Hosp, Hiroshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-140	99	99				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300234		
J	Yamakita, K; Kitano, Y; Takasoe, A; Suzuki, Y; Iwamoto, H; Imazawa, M; Takahashi, K; Wada, K; Ota, Y; Sudou, R; Tamaki, Y; Okada, M; Aso, K; Haneda, M				Yamakita, Keisuke; Kitano, Yohei; Takasoe, Ai; Suzuki, Yuko; Iwamoto, Hidetaka; Imazawa, Masako; Takahashi, Kenji; Wada, Kaori; Ota, Yu; Sudou, Ryuji; Tamaki, Yosui; Okada, Mitsuyoshi; Aso, Kazunobu; Haneda, Masakatsu			Comparative study of anti-peristaltic agents for upper gastrointestinal endoscopy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Antispasmodic agents			[Yamakita, Keisuke; Kitano, Yohei; Takasoe, Ai; Suzuki, Yuko; Iwamoto, Hidetaka; Imazawa, Masako; Takahashi, Kenji; Wada, Kaori; Ota, Yu; Sudou, Ryuji; Tamaki, Yosui; Okada, Mitsuyoshi; Aso, Kazunobu; Haneda, Masakatsu] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-147	100	101				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300240		
J	Kawada, A; Motoyasu, K; Shiko, K; Hiroko, H; Yasuyuki, S; Osamu, K; Masanobu, Y				Kawada, Akiyo; Motoyasu, Kusano; Shiko, Kuribayashi; Hiroko, Hosaka; Yasuyuki, Shimoyama; Osamu, Kawamura; Masanobu, Yamada			Esophagography in the left anterior oblique position for esophageal achalasia. A prospective pilot study	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Achalasia; esophagogpraphy; LAO (left anterior position)			Gunma Univ Hosp, Maebashi, Gumma, Japan; Gunma Univ, Grad Sch Med, Maebashi, Gumma, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-152	102	102				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300245		
J	Fujimoto, A; Goto, O; Ochiai, Y; Horii, J; Takahashi, K; Takabayashi, K; Sasaki, M; Nakamura, R; Nishizawa, T; Maehata, T; Sagara, S; Kinoshita, S; Akimoto, T; Uraoka, T; Yahagi, N				Fujimoto, Ai; Goto, Osamu; Ochiai, Yasutoshi; Horii, Jyoichiro; Takahashi, Koji; Takabayashi, Kaoru; Sasaki, Motoki; Nakamura, Rieko; Nishizawa, Toshihiro; Maehata, Tadateru; Sagara, Seiji; Kinoshita, Satoshi; Akimoto, Teppei; Uraoka, Toshio; Yahagi, Naohisa			The significance of gastric endoscopic submucosal dissection (esd) as total pathological diagnosis in excluded indication criteria	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						ESD included indication criteria			Keio Univ, Tokyo 108, Japan; Keio Univ Hosp, Tokyo, Japan; Fukuyama Med Ctr, Fukuyama, Hiroshima, Japan; Tokushima Prefectural Cent Hosp, Tokushima, Japan; Tokyo Med Ctr, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-157	105	105				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300250		
J	Hajime, S; Satoshi, M; Akimichi, I				Hajime, Suzuki; Satoshi, Maeda; Akimichi, Imamura			Clinical outcomes of endoscopic submucosal dissection for submucosal invasive early gastric cancer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						ESD; submucosal invasion; early gastric cancer			[Hajime, Suzuki; Satoshi, Maeda; Akimichi, Imamura] Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-159	106	106				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300252		
J	Inokuma, T; Suginoshita, Y; Thei, H; Inoue, S; Shimeno, N; Wada, M; Fukushima, M; Taniguchi, Y; Kitamoto, H; Minamide, T; Hosotani, K; Matsumoto, K; Itoh, T				Inokuma, Tetsuro; Suginoshita, Yoshiki; Thei, Hiroshi; Inoue, Satoko; Shimeno, Naoto; Wada, Masaya; Fukushima, Masashi; Taniguchi, Yohei; Kitamoto, Hiroki; Minamide, Tatsunori; Hosotani, Kazuya; Matsumoto, Kazuhiro; Itoh, Takahiko			Clinical consideration of metastatic gastric tumor	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Metastatic gastric tumor			[Inokuma, Tetsuro; Suginoshita, Yoshiki; Thei, Hiroshi; Inoue, Satoko; Shimeno, Naoto; Wada, Masaya; Fukushima, Masashi; Taniguchi, Yohei; Kitamoto, Hiroki; Minamide, Tatsunori; Hosotani, Kazuya; Matsumoto, Kazuhiro; Itoh, Takahiko] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-160	106	106				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300253		
J	Ito, S; Sato, K; Kitagawa, T; Suzuki, T; Tominaga, K; Nemoto, Y; Kato, M; Hirayama, K; Yoshida, Y; Makino, T; Mito, K; Takaki, A; Hihara, D; Maetani, I				Ito, Sayo; Sato, Koiciro; Kitagawa, Tomoyuki; Suzuki, Takeshi; Tominaga, Kenji; Nemoto, Yukako; Kato, Mitsuru; Hirayama, Kaho; Yoshida, Yuki; Makino, Toshiyuki; Mito, Kumiko; Takaki, Atsuko; Hihara, Daisuke; Maetani, Iruru			Clinical outcome of gastric endoscopic submucosal dissection in oldest-old patients	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Endoscopic submucosal dissection; early gastric cancer			[Ito, Sayo; Sato, Koiciro; Kitagawa, Tomoyuki; Suzuki, Takeshi; Tominaga, Kenji; Nemoto, Yukako; Kato, Mitsuru; Hirayama, Kaho; Yoshida, Yuki; Makino, Toshiyuki; Mito, Kumiko; Takaki, Atsuko; Hihara, Daisuke; Maetani, Iruru] Toho Univ, Ohashi Med Ctr, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-161	107	107				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300254		
J	Katano, T; Mizoshita, T; Joh, T				Katano, Takahito; Mizoshita, Tsutomu; Joh, Takashi			Long-term three-dimensional primary gastric culture within gastric mesenchymal myofibroblasts as a stem cell niche	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Stem cell; stomach			[Katano, Takahito; Mizoshita, Tsutomu; Joh, Takashi] Nagoya City Univ, Grad Sch, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-165	108	108				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300258		
J	Mabuchi, M; Yasuda, I; Doi, S; Ozawa, N; Iwashita, T				Mabuchi, Masatoshi; Yasuda, Ichiro; Doi, Shinpei; Ozawa, Noritaka; Iwashita, Takuji			Histopathological assessment of gastrointestinal submucosal tumors by EUS-FNA using a 19-gauge needle	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						EUS-FNA; GIST			Teikyo Univ, Mizonokuchi Hosp, Tokyo, Tokyo, Japan; Gifu Univ Hosp, Gifu, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-183	113	113				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300272		
J	Matsui, S; Kashida, H; Okamoto, K; Asakuma, Y; Sakurai, T; Kudo, M				Matsui, Shigenaga; Kashida, Hiroshi; Okamoto, Kazuki; Asakuma, Yutaka; Sakurai, Toshiharu; Kudo, Masatoshi			Two cases of gastric amyloidosis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Gastric amyloidosis diagnosis			[Matsui, Shigenaga; Kashida, Hiroshi; Okamoto, Kazuki; Asakuma, Yutaka; Sakurai, Toshiharu; Kudo, Masatoshi] Kinki Univ, Fac Med, Higashiosaka, Osaka 577, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-187	114	114				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300275		
J	Matsui, S; Kashida, H; Kawasaki, M; Asakuma, Y; Sakurai, T; Kudo, M				Matsui, Shigenaga; Kashida, Hiroshi; Kawasaki, Masanori; Asakuma, Yutaka; Sakurai, Toshiharu; Kudo, Masatoshi			The clinical characteristics and treatment of eosinophilic esophagitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Eosinophilic esophagitis treatment			[Matsui, Shigenaga; Kashida, Hiroshi; Kawasaki, Masanori; Asakuma, Yutaka; Sakurai, Toshiharu; Kudo, Masatoshi] Kinki Univ, Fac Med, Higashiosaka, Osaka 577, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-188	114	115				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300276		
J	Morikawa, D; Hiraoka, E				Morikawa, Daiki; Hiraoka, Eiji			Sushi worm: a case of anisakiasis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Anisakiasis			[Morikawa, Daiki; Hiraoka, Eiji] Tokyo Bay Urayasu Ichikawa Med Ctr, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-190	115	115				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300278		
J	Ogawa, O; Suzuki, Y; Matsui, A; Mitani, T; Hoteya, S; Kaise, M				Ogawa, Osamu; Suzuki, Yugo; Matsui, Akira; Mitani, Toshifumi; Hoteya, Shu; Kaise, Mitsuru			Endoscopic features of gastric adenocarcinoma of fundic grand type	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Gastric adenocarcinoma of fundic grand type			[Ogawa, Osamu; Suzuki, Yugo; Matsui, Akira; Mitani, Toshifumi; Hoteya, Shu; Kaise, Mitsuru] Toranomon Gen Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-191	115	116				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300279		
J	Quach, D; Hiyama, T; Shimamoto, F; Uemura, N				Duc Quach; Hiyama, Toru; Shimamoto, Fumio; Uemura, Naomi			Erosive reflux esophagitis in naive vietnamese patients with upper gastrointestinal symptoms and its association with h. Pylori infection	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						GERD; erosive reflux disease; Helicobacter pylori; Vietnamese			Hiroshima Univ, Hiroshima 730, Japan; [Duc Quach] Prefectural Univ Hiroshima, Hiroshima, Japan; Natl Ctr Global Hlth & Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-198	118	119				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300286		
J	Sakata, H; Tanaka, Y; Takashima, T; Nakayama, M; Shimoda, R; Tsuruoka, N; Sakata, Y; Iwakiri, R; Kusano, M; Fujimoto, K				Sakata, Hiroyuki; Tanaka, Yuichiro; Takashima, Toru; Nakayama, Masayuki; Shimoda, Ryo; Tsuruoka, Nanae; Sakata, Yasuhisa; Iwakiri, Ryuichi; Kusano, Motoyasu; Fujimoto, Kazuma			Reflux esophagitis in young healthy Japanese medical school students evaluated by endoscopy and FSSG	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Reflux esophagitis			Saga Univ, Saga, Japan; Gunma Univ, Maebashi, Gumma, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-199	119	119				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300287		
J	Yoshikazu, Y; Shiro, O; Shinji, T; Tomohiro, M; Norifumi, N; Yoji, S; Kazuaki, C				Yoshikazu, Yoshifuku; Shiro, Oka; Shinji, Tanaka; Tomohiro, Miwata; Norifumi, Numata; Yoji, Sanomura; Kazuaki, Chayama			Prognosis of early gastric cancer patients with advanced stage cancer of other organs after endoscopic submucosal dissection	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Endoscopic submucosal dissection			[Yoshikazu, Yoshifuku; Shiro, Oka; Shinji, Tanaka; Tomohiro, Miwata; Norifumi, Numata; Yoji, Sanomura; Kazuaki, Chayama] Hiroshima Univ Hosp, Hiroshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-217	125	125				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300302		
J	Chiba, M; Takayama, Y; Sugawara, K; Takahashi, K; Yoshida, T; Ohno, H; Ishii, H; Tsuda, S; Tsuji, T; Nakane, K; Komatsu, M				Chiba, Mitsuro; Takayama, Yuko; Sugawara, Kae; Takahashi, Kenichi; Yoshida, Tatsuya; Ohno, Hideo; Ishii, Hajime; Tsuda, Satoko; Tsuji, Tsuyotoshi; Nakane, Kunio; Komatsu, Masafumi			Development of a plant-based diet score: its application for crohn's disease	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Crohn's disease; plant-based diet; vegetarian diet; inflammatory bowel disease			Seirei WomenS Jr Coll, Akita, Japan; Akita City Hosp, Akita, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-220	126	126				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300305		
J	Hisamatsu, T; Miyoshi, J; Matsuoka, K; Naganuma, M; Mori, K; Kiyohara, H; Nanki, K; Yajima, T; Iwao, Y; Ogata, H; Hibi, T; Kanai, T				Hisamatsu, Tadakazu; Miyoshi, Jun; Matsuoka, Katsuyoshi; Naganuma, Makoto; Mori, Kiyoto; Kiyohara, Hiroki; Nanki, Kosaku; Yajima, Tomoharu; Iwao, Yasushi; Ogata, Haruhiko; Hibi, Toshifumi; Kanai, Takanori			Early intervention with adalimumab may contribute to favorable clinical efficacy in patients with crohn's disease	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Crohn; adalimumab			Ichikawa Gen Hosp, Tokyo Dent Coll, Ichikawa, Chiba, Japan; Keio Univ, Sch Med, Tokyo 108, Japan; Kitasato Univ, Kitasato Inst Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-225	127	127				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300308		
J	Miyakawa, M; Sakemi, R; Nasuno, M; Tanaka, H; Motoya, S; Imamura, A				Miyakawa, Maki; Sakemi, Ryosuke; Nasuno, Masanao; Tanaka, Hiroki; Motoya, Satoshi; Imamura, Akimichi			Investigation of the relationship between endoscopic mucosal healing and maintenance of long-term remission in ulcerative colitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Ulcerative colitis; mucosal healing			[Miyakawa, Maki; Sakemi, Ryosuke; Nasuno, Masanao; Tanaka, Hiroki; Motoya, Satoshi; Imamura, Akimichi] Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-236	130	130				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300317		
J	Nasuno, M; Miyakawa, M; Sakemi, R; Tanaka, H; Motoya, S; Akimichi, I				Nasuno, Masanao; Miyakawa, Maki; Sakemi, Ryosuke; Tanaka, Hiroki; Motoya, Satoshi; Akimichi, Imamura			Influence of endoscopic mucosal healing on long-term efficacy of infliximab in patients with refractory ulcerative colitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Ulcerative colitis; infliximub; mucosal healing			[Nasuno, Masanao; Miyakawa, Maki; Sakemi, Ryosuke; Tanaka, Hiroki; Motoya, Satoshi; Akimichi, Imamura] Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-239	131	131				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300320		
J	Nomura, E; Sato, T; Kannno, N; Sakuta, K; Mizumoto, N; Shibuya, R; Yagi, M; Iwano, D; Sasaki, Y; Abe, Y; Nishise, S; Ueno, Y				Nomura, Eiki; Sato, Takeshi; Kannno, Nana; Sakuta, Kazuhiro; Mizumoto, Naoko; Shibuya, Rika; Yagi, Makoto; Iwano, Daisuke; Sasaki, Yu; Abe, Yasuhiko; Nishise, Syoichi; Ueno, Yoshiyuki			Baseline tumor necrosis factor alpha levels predict the clinical response of infliximab therapy in patients with crohn's disease	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Crohn's disease; infliximab; TNFalpha			[Nomura, Eiki; Sato, Takeshi; Kannno, Nana; Sakuta, Kazuhiro; Mizumoto, Naoko; Shibuya, Rika; Yagi, Makoto; Iwano, Daisuke; Sasaki, Yu; Abe, Yasuhiko; Nishise, Syoichi; Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Yamagata 990, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-240	131	131				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300321		
J	Oomori, S; Kannno, A; Kazuyoshi, Y				Oomori, Shinya; Kannno, Atsushi; Kazuyoshi, Yamashita			Analyses of infliximab therapy for patients with inflammatory bowel disease: mainly with respect to safety	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						IBD; infliximab; safety			Japanease Red Cross Sendai Hosp, Sendai, Miyagi, Japan; Japanease Red Cross Sendai Hosp, Sendai, Miyagi, Japan; [Oomori, Shinya; Kannno, Atsushi; Kazuyoshi, Yamashita] Japanease Red Cross Sendai Hosp, Sendai, Miyagi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-242	132	132				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300323		
J	Ozeki, K; Tanida, S; Mizoshita, T; Tsukamoto, H; Katano, T; Hayashi, N; Tanaka, M; Nishiwaki, H; Ebi, M; Sawada, T; Mori, Y; Kubota, E; Kataoka, H; Joh, T				Ozeki, Keiji; Tanida, Satoshi; Mizoshita, Tsutomu; Tsukamoto, Hironobu; Katano, Takahito; Hayashi, Noriyuki; Tanaka, Mamoru; Nishiwaki, Hirotaka; Ebi, Masahide; Sawada, Takeshi; Mori, Yoshinori; Kubota, Eiji; Kataoka, Hiromi; Joh, Takashi			Effectiveness of combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis in patients with crohn's disease	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						adalimumab; Crohn's disease; granulocyte and monocyte adsorptive apheresis			[Ozeki, Keiji; Tanida, Satoshi; Mizoshita, Tsutomu; Tsukamoto, Hironobu; Katano, Takahito; Hayashi, Noriyuki; Tanaka, Mamoru; Nishiwaki, Hirotaka; Ebi, Masahide; Sawada, Takeshi; Mori, Yoshinori; Kubota, Eiji; Kataoka, Hiromi; Joh, Takashi] Nagoya City Univ, Grad Sch Med, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-243	133	133				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300324		
J	Sato, S; Hirose, M; Morita, H; Hirano, N; Itoh, K; Kurakata, H; Nagai, H; Sumino, Y; Yoshinori, I				Sato, Shinji; Hirose, Motohiko; Morita, Hiroshi; Hirano, Naoki; Itoh, Ken; Kurakata, Hidenori; Nagai, Hidenari; Sumino, Yasukiyo; Yoshinori, Igarashi			Usefulness of tacrolimus in ulcerative colitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						ulcerative colitis; tacrolimus			[Sato, Shinji; Hirose, Motohiko; Morita, Hiroshi; Hirano, Naoki; Itoh, Ken; Kurakata, Hidenori; Nagai, Hidenari; Sumino, Yasukiyo; Yoshinori, Igarashi] Toho Univ, Omori Med Ctr, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-244	133	133				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300325		
J	Shiraki, M; Yamamoto, T; Matsumoto, K				Shiraki, Manabu; Yamamoto, Takayuki; Matsumoto, Koichi			Efficacy of low dose CT for evaluation of disease activity in ulcerative colitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						low dose CT; sigmoidsocpy; ulcerative colitis			[Shiraki, Manabu; Yamamoto, Takayuki; Matsumoto, Koichi] Yokkaichi Hazu Med Cener, Yokaichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-245	133	134				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300326		
J	Shirose, D; Matsuda, K; Suenaga, D; Kinoshita, Y; Kumon, D; Hayashi, M; Adachi, K; Ishii, T; Sato, A				Shirose, Daimon; Matsuda, Koji; Suenaga, Daisuke; Kinoshita, Yuichi; Kumon, Daisuke; Hayashi, Mikihito; Adachi, Kayo; Ishii, Toshiya; Sato, Akira			A case report of sporadic colorectal cancer in the patient with ulcerative colitis, difficult to distinguish from colitic cancer endoscopically	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						colitic cancer; sporadic cancer; ulcerative colitis			[Shirose, Daimon; Matsuda, Koji; Suenaga, Daisuke; Kinoshita, Yuichi; Kumon, Daisuke; Hayashi, Mikihito; Adachi, Kayo; Ishii, Toshiya; Sato, Akira] St Marianna Univ, Yokohama City Seibu Hopsital, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-246	134	134				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300327		
J	Tanaka, H; Miyakawa, M; Sakemi, R; Nasuno, M; Motoya, S; Imamura, A				Tanaka, Hiroki; Miyakawa, Maki; Sakemi, Ryosuke; Nasuno, Masanao; Motoya, Satoshi; Imamura, Akimichi			The effectiveness of adalimumab maintenance treatment for crohn's disease and related prognostic factors: a japanese single-center study	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Crohn's disease; adalimumab			[Tanaka, Hiroki; Miyakawa, Maki; Sakemi, Ryosuke; Nasuno, Masanao; Motoya, Satoshi; Imamura, Akimichi] Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-247	134	134				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300328		
J	Tsukamoto, H; Katano, T; Ozeki, K; Mizoshita, T; Tanida, S; Joh, T				Tsukamoto, Hironobu; Katano, Takahito; Ozeki, Keiji; Mizoshita, Tsutomu; Tanida, Satoshi; Joh, Takashi			Efficacy of infliximab therapy for patients with ulcerative colitis who failed to respond to tacrolimus	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						ulcerative colitis; infliximab; tacrolimus			[Tsukamoto, Hironobu; Katano, Takahito; Ozeki, Keiji; Mizoshita, Tsutomu; Tanida, Satoshi; Joh, Takashi] Nagoya City Univ, Grad Sch, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-251	135	136				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300332		
J	Ban, T; Toyohara, T; Araki, H; Suzuki, Y; Shibata, S; Kojima, I; Nojiri, Y; Yoshimine, T; Yasuaki, H; Nomura, S; Kusakabe, A; Kanie, H; Sawaki, A; Yamada, T; Hayashi, K; Orito, E				Ban, Tesshin; Toyohara, Tadashi; Araki, Hiromichi; Suzuki, Yuka; Shibata, Shunsuke; Kojima, Issei; Nojiri, Yu; Yoshimine, Takashi; Yasuaki, Hujita; Nomura, Satoshi; Kusakabe, Atsunori; Kanie, Hiroshi; Sawaki, Akira; Yamada, Tomonori; Hayashi, Katsumi; Orito, Etsuro			Evaluation of the algorithm for selective bile duct cannulation for patient with naive choledocholithiasis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						bile duct cannulation; choledocholithiasis; post-ERCP pancreatitis			[Ban, Tesshin; Toyohara, Tadashi; Araki, Hiromichi; Suzuki, Yuka; Shibata, Shunsuke; Kojima, Issei; Nojiri, Yu; Yoshimine, Takashi; Yasuaki, Hujita; Nomura, Satoshi; Kusakabe, Atsunori; Kanie, Hiroshi; Sawaki, Akira; Yamada, Tomonori; Hayashi, Katsumi; Orito, Etsuro] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-255	137	137				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300335		
J	Ishihara, S; Hata, H; Imagawa, A; Matsumi, A; Sudou, K; Takeuchi, K; Moritou, Y; Akita, M; Jinno, H; Nakatsu, M				Ishihara, Shinichi; Hata, Hidenori; Imagawa, Atsushi; Matsumi, Akihiro; Sudou, Kozue; Takeuchi, Keiko; Moritou, Yuki; Akita, Mitsuhiro; Jinno, Hideki; Nakatsu, Morito			Treatment of common bile duct stone for the oldest-old patients	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						treatment of common bile duct stone			[Ishihara, Shinichi; Hata, Hidenori; Imagawa, Atsushi; Matsumi, Akihiro; Sudou, Kozue; Takeuchi, Keiko; Moritou, Yuki; Akita, Mitsuhiro; Jinno, Hideki; Nakatsu, Morito] Mitoyo Gen Hosp, Kanonji, Kagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-263	140	140				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300343		
J	Iwaya, H; Hashimoto, S; Yamasuji, A; Nakamura, Y; Nakazawa, J; Taguchi, H; Sasaki, F; Nasu, Y; Kanmura, S; Numata, M; Ido, A				Iwaya, Hiromichi; Hashimoto, Shinichi; Yamasuji, Akihiro; Nakamura, Yoshitaka; Nakazawa, Junichi; Taguchi, Hiroki; Sasaki, Fumisato; Nasu, Yuuichiro; Kanmura, Shyuji; Numata, Masatsugu; Ido, Akio			Risk factors for cholangitis after endoscopic extraction of bile duct stones and palliative endoscopic biliary stenting after incomplete stone extraction	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						biliary stenting bile duct stone cholangitis			Kagoshima Univ, Kagoshima 890, Japan; Satsunan Prefectural Hosp, Kagoshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-265	140	141				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300345		
J	Kambayashi, H; Nisimura, M; Nakajima, K; Ushio, Y; Sasaki, M; Uegaki, S				Kambayashi, Harutaka; Nisimura, Makoto; Nakajima, Kenichiro; Ushio, Yasuko; Sasaki, Mina; Uegaki, Satoko			Comparison of endoscopic retrograde cholangiopancreatography between elderly patients and very elderly patients.	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						ERCP; very elderly patients			[Kambayashi, Harutaka; Nisimura, Makoto; Nakajima, Kenichiro; Ushio, Yasuko; Sasaki, Mina; Uegaki, Satoko] Tokyo Metropolitan Geriatr Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-270	142	142				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300349		
J	Kanezaki, M; Kato, T; Koyama, S; Misawa, N; Ishikawa, Y; Niikura, T; Suzuki, R; Fujii, T; Jono, F; Akimoto, K; Hojo, Y; Fujisawa, N; Kubota, K; Nakajima, A				Kanezaki, Mineo; Kato, Takayuki; Koyama, Shigeru; Misawa, Noboru; Ishikawa, Yutaro; Niikura, Toshihiro; Suzuki, Ryoji; Fujii, Tetsuro; Jono, Fumitake; Akimoto, Keiko; Hojo, Yumiko; Fujisawa, Nobutaka; Kubota, Kensuke; Nakajima, Atsushi			Acute cholangitis from islands in tokyo by emergency aircraft	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Cholangitis; ERCP			Tokyo Metropolitan Hiroo Gen Hosp, Tokyo, Japan; Yokohama City Univ, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-271	143	143				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300350		
J	Matsumi, A; Ishihara, S; Imagawa, A; Ueta, E; Sutou, K; Terasawa, H; Takeuchi, K; Moritou, Y; Akita, M; Jino, H; Hata, H; Moriya, A; Nakatsu, M; Ando, M				Matsumi, Akihiro; Ishihara, Shinichi; Imagawa, Atsushi; Ueta, Eijiro; Sutou, Kozue; Terasawa, Hiroyuki; Takeuchi, Keiko; Moritou, Yuki; Akita, Mitsuhiro; Jino, Hideki; Hata, Hidenori; Moriya, Akio; Nakatsu, Morihito; Ando, Masaharu			The effectiveness and safety of endoscopic papillary large balloon dilation for aged people	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						EPLBD			Ishihara Gastroennterol Clin, Kumamoto, Japan; Mitoyo Gen Hosp, Kanonji, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-291	150	150				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300367		
J	Niikura, T; Kato, T; Koyama, S; Misawa, N; Ishikawa, Y; Kanezaki, M; Suzuki, R; Fujii, T; Jono, F; Akimoto, K; Hojo, Y; Fujisawa, N; Kubota, K; Nakajima, A				Niikura, Toshihiro; Kato, Takayuki; Koyama, Shigeru; Misawa, Noboru; Ishikawa, Yutaro; Kanezaki, Mineo; Suzuki, Ryoji; Fujii, Tetsuro; Jono, Fumitake; Akimoto, Keiko; Hojo, Yumiko; Fujisawa, Nobutaka; Kubota, Kensuke; Nakajima, Atsushi			Therapeutic ercp for common bile duct stones is safe and effective even in the elderly	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						ERCP; elderly			Tokyo Metropolitan Hiroo Gen Hosp, Tokyo, Japan; Yokohama City Univ, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-292	151	151				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300368		
J	Tamaki, H; Noda, T; Morioka, Y; Arasawa, S; Izuta, M; Kubo, A; Ogawa, C; Matsunaka, T; Shibatoge, M				Tamaki, Hiroyuki; Noda, Teruyo; Morioka, Yumiko; Arasawa, Souichi; Izuta, Masako; Kubo, Atsushi; Ogawa, Chikara; Matsunaka, Toshihiro; Shibatoge, Mitsushige			Novel, modified approach to single-balloon enteroscopy for endoscopic retrograde cholangiography in patients with altered gastrointestinal anatomy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						single-balloon enteroscopy; endoscopic retrograde cholangiography (ERC); roux-en-y reconstruction; billroth-II gastrectomy			[Tamaki, Hiroyuki; Noda, Teruyo; Morioka, Yumiko; Arasawa, Souichi; Izuta, Masako; Kubo, Atsushi; Ogawa, Chikara; Matsunaka, Toshihiro; Shibatoge, Mitsushige] Takamatsu Red Cross Hosp, Takamatsu, Kagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-302	155	155				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300378		
J	Teramoto, A; Kobashikawa, K; Tomisato, K; Kondo, A; Iraha, A; Nakamura, S; Matsukawa, S; Yabutani, A; Nakamura, M; Nakayoshi, T; Uchima, N; Kinjyo, F; Kameyama, S; Ishimine, T; Isa, T; Yanagisawa, A				Teramoto, Akira; Kobashikawa, Kasen; Tomisato, Kota; Kondo, Akiyuki; Iraha, Atsushi; Nakamura, Shoko; Matsukawa, Shinobu; Yabutani, Akira; Nakamura, Masamoto; Nakayoshi, Tomokuni; Uchima, Nobufumi; Kinjyo, Fukunori; Kameyama, Shinichiro; Ishimine, Tomonari; Isa, Tsutomu; Yanagisawa, Akio			Benign biliary stenosis caused by chronic cholangitis with small duct hyperplasia: a case report and literature review	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						biliary; stenosis; inflammatory; pseudotumor; IPT; benign			Urasoe Gen Hosp, Urasoe, Okinawa, Japan; Kyoto Prefectural Hosp Med, Kyoto, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-303	155	156				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300379		
J	Akira, F; Ando, S; Uchida, Y; Fujii, Y; Handa, T; Uchiya, H; Hirahara, K; Chikayama, T; Nakazawa, M; Sugawara, K; Nakao, M; Inao, M; Nakayama, N; Imai, Y; Oka, M; Mochida, S				Akira, Fuchigami; Ando, Satsuki; Uchida, Yoshihito; Fujii, Youhei; Handa, Takahiro; Uchiya, Hiroshi; Hirahara, Kazuki; Chikayama, Taku; Nakazawa, Manabu; Sugawara, Kayoko; Nakao, Masamitsu; Inao, Mie; Nakayama, Nobuaki; Imai, Yukinori; Oka, Masashi; Mochida, Satoshi			Two cases with advanced gastric cancer showing massive bleeding successfully treated by transcatehter arterial embolization	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						gastrointestinal hemorrhage; gastric cancer; transcatheter arterial embolization (TAE)			[Akira, Fuchigami; Ando, Satsuki; Uchida, Yoshihito; Fujii, Youhei; Handa, Takahiro; Uchiya, Hiroshi; Hirahara, Kazuki; Chikayama, Taku; Nakazawa, Manabu; Sugawara, Kayoko; Nakao, Masamitsu; Inao, Mie; Nakayama, Nobuaki; Imai, Yukinori; Oka, Masashi; Mochida, Satoshi] Saitama Med Univ Hosp, Saitama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-312	159	160				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300388		
J	Inaba, T; Ishikawa, S; Hasui, T; Wato, M; Matsuura, M; Tanaka, S; Takahashi, S; Izumikawa, K; Yamamoto, K; Sakakihara, I; Nakamura, S; Mano, S				Inaba, Tomoki; Ishikawa, Shigenao; Hasui, Toshimi; Wato, Masaki; Matsuura, Mihoko; Tanaka, Shigetomi; Takahashi, Sakuma; Izumikawa, Kouichi; Yamamoto, Kumiko; Sakakihara, Ichirou; Nakamura, Satoko; Mano, Shohei			Clinical study on performing upper gastrointestinal biopsy with small cup biopsy forceps in patients receiving antiplatelet agents	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						endoscopic biopsy; antiplatelet agent; bleeding; biopsy forceps; antithrombotic agent			[Inaba, Tomoki; Ishikawa, Shigenao; Hasui, Toshimi; Wato, Masaki; Matsuura, Mihoko; Tanaka, Shigetomi; Takahashi, Sakuma; Izumikawa, Kouichi; Yamamoto, Kumiko; Sakakihara, Ichirou; Nakamura, Satoko; Mano, Shohei] Kagawa Prefectural Cent Hosp, Okayama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-320	163	163				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300396		
J	Iwatsuka, K; Gotoda, T; Kono, S; Suzuki, S; Yagi, N; Kusano, C; Fukuzawa, M; Kawai, T; Moriyasu, F				Iwatsuka, Kunio; Gotoda, Takuji; Kono, Shin; Suzuki, Sho; Yagi, Naoko; Kusano, Chika; Fukuzawa, Masakatsu; Kawai, Takashi; Moriyasu, Fuminori			Current clinical features in elderly patients with gastrointestinal bleeding	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						elderly; gastrointestinal bleeding			[Iwatsuka, Kunio; Gotoda, Takuji; Kono, Shin; Suzuki, Sho; Yagi, Naoko; Kusano, Chika; Fukuzawa, Masakatsu; Kawai, Takashi; Moriyasu, Fuminori] Tokyo Med Univ, Tokyo 1608402, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-321	163	164				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300397		
J	Kanie, H; Nomura, S; Kojima, I; Nojiri, Y; Yoshimine, T; Fujita, Y; Kusakabe, A; Ban, T; Yamada, T; Hayashi, K; Orito, E				Kanie, Hiroshi; Nomura, Satoshi; Kojima, Issei; Nojiri, Yu; Yoshimine, Takashi; Fujita, Yasuaki; Kusakabe, Atsunori; Ban, Tesshin; Yamada, Tomonori; Hayashi, Katsumi; Orito, Etsuro			Postoperative hemorrhage after endoscopic treatment of colorectal tumors undergoing antithrombotic treatment	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						postoperative hemorrhage; antithrombotic treatment; colorectal			[Kanie, Hiroshi; Nomura, Satoshi; Kojima, Issei; Nojiri, Yu; Yoshimine, Takashi; Fujita, Yasuaki; Kusakabe, Atsunori; Ban, Tesshin; Yamada, Tomonori; Hayashi, Katsumi; Orito, Etsuro] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-324	165	165				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300400		
J	Kato, T; Kanezaki, M; Misawa, N; Ishikawa, Y; Niikura, T; Suzuki, R; Fujii, T; Jono, F; Akimoto, K; Hojo, Y; Fujisawa, N; Koyama, S; Kubota, K; Atsushi, N				Kato, Takayuki; Kanezaki, Mineo; Misawa, Noboru; Ishikawa, Yutaro; Niikura, Toshihiro; Suzuki, Ryoji; Fujii, Tetsuro; Jono, Fumitake; Akimoto, Keiko; Hojo, Yumiko; Fujisawa, Nobutaka; Koyama, Shigeru; Kubota, Kensuke; Atsushi, Nakajima			Factors related to re-bleeding after endoscopic hemostasis of peptic ulcer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						re-bleeding; peptic ulcer			Tokyo Metropolitan Hiroo Gen Hosp, Tokyo, Japan; Yokohama City Univ, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-325	165	165				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300401		
J	Kono, T; Tomita, T; Sakamoto, H; Ikahara, H; Oshima, T; Fukui, H; Watari, J; Miwa, H				Kono, Tomoaki; Tomita, Toshihiko; Sakamoto, Haruka; Ikahara, Hisatomo; Oshima, Tadayuki; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroro			Clinical characteristics of rebleeding cases with overt obscure gastrointestinal bleeding	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						obscure gastrointestinal bleeding; rebleeding			[Kono, Tomoaki; Tomita, Toshihiko; Sakamoto, Haruka; Ikahara, Hisatomo; Oshima, Tadayuki; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroro] Hyogo Coll Med, Nishinomiya, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-330	166	167				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300405		
J	Miyazaki, T; Akahoshi, K; Koga, H; Miyagaki, A; Kubokawa, M; Motomura, Y; Gibo, J; Kinoshita, N; Osada, S; Shimokawa, Y; Tokumaru, K; Otuka, Y; Hosokawa, T; Tomoeda, N; Utunomiya, R; Miyamoto, K				Miyazaki, Takehiro; Akahoshi, Kazuya; Koga, Hidenobu; Miyagaki, Aki; Kubokawa, Masaru; Motomura, Yasuaki; Gibo, Jyunya; Kinoshita, Nobukatu; Osada, Shigeji; Shimokawa, Yuzou; Tokumaru, Kayo; Otuka, Yoshihiro; Hosokawa, Taizou; Tomoeda, Naru; Utunomiya, Ran; Miyamoto, Kazuaki			Comparison of clinical outcome between first year GI fellows and attending doctors on the treatment of UGIB in the emergency department at night	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						first year GI fellows upper gastrointestinal bleeding emergency department case control study			[Miyazaki, Takehiro; Akahoshi, Kazuya; Koga, Hidenobu; Miyagaki, Aki; Kubokawa, Masaru; Motomura, Yasuaki; Gibo, Jyunya; Kinoshita, Nobukatu; Osada, Shigeji; Shimokawa, Yuzou; Tokumaru, Kayo; Otuka, Yoshihiro; Hosokawa, Taizou; Tomoeda, Naru; Utunomiya, Ran; Miyamoto, Kazuaki] Iizuka Hosp, Iizuka, Fukuoka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-333	168	168				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300408		
J	Nagai, T; Tanaka, R; Yamada, M; Adachi, T; Takayama, M; Mine, H; Okazaki, Y; Komeda, Y; Asakuma, Y; Sakurai, T; Mastui, S; Kashida, H; Kudo, M				Nagai, Tomoyuki; Tanaka, Rie; Yamada, Mitsunari; Adachi, Teppei; Takayama, Masaki; Mine, Hiromasa; Okazaki, Yoshihisa; Komeda, Yoriaki; Asakuma, Yutaka; Sakurai, Toshiharu; Mastui, Shigenaga; Kashida, Hiroshi; Kudo, Masatoshi			Small-intestinal mucosal injury induced by non-steroidal anti-inflammatory drugs or antiplatelet agents in our hospital	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Na			[Nagai, Tomoyuki; Tanaka, Rie; Yamada, Mitsunari; Adachi, Teppei; Takayama, Masaki; Mine, Hiromasa; Okazaki, Yoshihisa; Komeda, Yoriaki; Asakuma, Yutaka; Sakurai, Toshiharu; Mastui, Shigenaga; Kashida, Hiroshi; Kudo, Masatoshi] Kinki Univ, Higashiosaka, Osaka 577, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-334	168	168				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300409		
J	Nagamatsu, S; Nakatani, T; Kaya, D; Takagi, H; Fujinaga, Y; Saikawa, S; Kobe, D; Shimozato, N; Matsuo, H; Kikuchi, E				Nagamatsu, Shinsaku; Nakatani, Toshiya; Kaya, Daisuke; Takagi, Hirotetsu; Fujinaga, Yukihisa; Saikawa, Soichiro; Kobe, Daisuke; Shimozato, Naotaka; Matsuo, Hideki; Kikuchi, Eiryo			Clinical features of cases with insufficient endoscopic hemostasis against hemorrhagic gastroduodenal ulcers	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						endoscopic hemostasis; hemorrhagic gastroduodenal ulcers			[Nagamatsu, Shinsaku; Nakatani, Toshiya; Kaya, Daisuke; Takagi, Hirotetsu; Fujinaga, Yukihisa; Saikawa, Soichiro; Kobe, Daisuke; Shimozato, Naotaka; Matsuo, Hideki; Kikuchi, Eiryo] Nara Prefecture Gen Med Ctr, Nara, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-335	169	169				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300410		
J	Nakanowatari, M; Sato, T; Iida, M; Honma, J; Fukuhara, T				Nakanowatari, Masayuki; Sato, Takahiro; Iida, Michio; Honma, Jiro; Fukuhara, Takashi			Successful endoscopic treatment of bleeding anorectal varices in a terminally ill cancer patient	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						anorectal varices; hematochezia; endoscopic treatment			[Nakanowatari, Masayuki; Sato, Takahiro; Iida, Michio; Honma, Jiro; Fukuhara, Takashi] Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-336	169	169				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300411		
J	Omote, S; Toyokawa, T; Horii, J; Isao, F; Takako, M; Tomoda, J				Omote, Shizuma; Toyokawa, Tatsuya; Horii, Joichiro; Isao, Fujita; Takako, Murakami; Tomoda, Jun			Efficiency and safety of immediate capsule endoscopy after acute obscure gastrointestinal bleeding	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						OGIB; CE			[Omote, Shizuma; Toyokawa, Tatsuya; Horii, Joichiro; Isao, Fujita; Takako, Murakami; Tomoda, Jun] Fukuyama Med Ctr, Fukuyama, Hiroshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-339	170	170				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300414		
J	Terakado, Y; Otoguro, Y; Suzuki, H; Nishioka, H; Maeda, S; Kurokawa, S; Imamura, A				Terakado, Yohei; Otoguro, Yuuhei; Suzuki, Hajime; Nishioka, Hitoshi; Maeda, Satoshi; Kurokawa, Sei; Imamura, Akimishi			Endoscopic therapy for lower gastrointestinal bleeding in the elderly	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						lower gastrointestinal bleeding endoscopic therapy			[Terakado, Yohei; Otoguro, Yuuhei; Suzuki, Hajime; Nishioka, Hitoshi; Maeda, Satoshi; Kurokawa, Sei; Imamura, Akimishi] Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-346	173	173				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300421		
J	Yamakawa, R; Iwata, M; Nyzuki, S; Harada, M; Kawauchi, K				Yamakawa, Ryoichi; Iwata, Masaya; Nyzuki, Satoru; Harada, Manabu; Kawauchi, Kunihiro			Therapeutic barium enema for colonic diverticular bleeding	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						barium enema; colonic diverticular bleeding			[Yamakawa, Ryoichi; Iwata, Masaya; Nyzuki, Satoru; Harada, Manabu; Kawauchi, Kunihiro] Kaetsu Hosp, Gosen, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-354	176	176				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300429		
J	Yasumasa, M; Yasuda, H; Sato, Y; Ikeda, Y; Ishigooka, S; Ozawa, SI; Hosoya, K; Yamashita, M; Maehata, T; Yamamoto, H; Itoh, F				Yasumasa, Matsuo; Yasuda, Hiroshi; Sato, Yoshinori; Ikeda, Yoshiko; Ishigooka, Shinya; Ozawa, Shun Ichiro; Hosoya, Kosuke; Yamashita, Masaki; Maehata, Tadateru; Yamamoto, Hiroyuki; Itoh, Fumio			Endoscopic hemostasis for the gastrointestinal bleeding from the diverticulum of third portion of duodenum, a case report	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						duodenal diverticulum bleeding			[Yasumasa, Matsuo; Yasuda, Hiroshi; Sato, Yoshinori; Ikeda, Yoshiko; Ishigooka, Shinya; Ozawa, Shun Ichiro; Hosoya, Kosuke; Yamashita, Masaki; Maehata, Tadateru; Yamamoto, Hiroyuki; Itoh, Fumio] St Marianna Univ, Sch Med, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-355	176	176				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300430		
J	Ando, S; Imai, Y; Fuchigami, A; Nakazawa, M; Mochida, S				Ando, Satsuki; Imai, Yukinori; Fuchigami, Akira; Nakazawa, Manabu; Mochida, Satoshi			Usefulness of balloon-occluded retrograde transvenous obliteration for the treatment of portal vein thrombosis in patients with liver cirrhosis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						B-RTO; portal vein thrombosis			[Ando, Satsuki; Imai, Yukinori; Fuchigami, Akira; Nakazawa, Manabu; Mochida, Satoshi] Saitama Med Univ, Saitama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-368	180	180				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300440		
J	Kogame, M; Shinohara, M; Ishii, K; Shinohara, M; Ikehara, T; Nagai, H; Watanabe, M; Igarashi, Y; Sumino, Y				Kogame, Michio; Shinohara, Mie; Ishii, Koji; Shinohara, Masao; Ikehara, Takashi; Nagai, Hidenari; Watanabe, Manabu; Igarashi, Yoshinori; Sumino, Yasukiyo			Efficacy of low-dose and long-term administration of IFN-alpha 2a in patients with chronic hepatitis C who failed to obtain sustained viral response by after PEG-IFN plus ribavirin therapy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						chronic hepatitis C			Toho Univ, Sch Med, Nagoya, Aichi, Japan; Jcho Tokyo Kamata Med Ctr, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-406	192	192				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300470		
J	Nakazawa, M; Yukinori, I; Uchida, Y; Hujii, Y; Handa, T; Uchiya, H; Hirahara, K; Chikayama, T; Ando, S; Sugawara, K; Nakao, M; Motoya, D; Inao, M; Nakayama, N; Oka, M; Mochida, S				Nakazawa, Manabu; Yukinori, Imai; Uchida, Yoshihito; Hujii, Youhei; Handa, Takahiro; Uchiya, Hiroshi; Hirahara, Kazuki; Chikayama, Taku; Ando, Satsuki; Sugawara, Kayoko; Nakao, Masamitsu; Motoya, Daisuke; Inao, Mie; Nakayama, Nobuaki; Oka, Masashi; Mochida, Satoshi			Balloon-occluded retrograde transvenous obliteration (B-RTO) for the treatment of hepatic encephalopathy and liver failure in patients with cirrhosis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						B-RTO; hepatic encephalopathy; porto-systemic shunts			[Nakazawa, Manabu; Yukinori, Imai; Uchida, Yoshihito; Hujii, Youhei; Handa, Takahiro; Uchiya, Hiroshi; Hirahara, Kazuki; Chikayama, Taku; Ando, Satsuki; Sugawara, Kayoko; Nakao, Masamitsu; Motoya, Daisuke; Inao, Mie; Nakayama, Nobuaki; Oka, Masashi; Mochida, Satoshi] Saitama Med Univ Hosp, Saitama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-434	198	198				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300485		
J	Sasaki, M; Tanaka, C; Obata, M; Takeguchi, M; Matsushita, H; Yoshida, K				Sasaki, Masato; Tanaka, C.; Obata, Masahiro; Takeguchi, Masataka; Matsushita, Hiroshi; Yoshida, Kenichi			Efficacy and factors associated with SVR in telaprevir-based triple therapy in hepatitis C patients	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						hepatitis			[Sasaki, Masato; Tanaka, C.; Obata, Masahiro; Takeguchi, Masataka; Matsushita, Hiroshi; Yoshida, Kenichi] Kumamoto Rosai Hosp, Kumamoto, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-448	202	203				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300497		
J	Shimizu, Y; Hayashi, K; Mori, H; Toriyama, K; Yoshizaki, M; Furune, S; Takenaka, H; Hayashi, T; Matuura, T; Kuroiwa, M; Morita, K; Ishigami, M; Goto, H				Shimizu, Yuko; Hayashi, Kazuhiko; Mori, Hiroshi; Toriyama, Kazuhiro; Yoshizaki, Michiyo; Furune, Satoshi; Takenaka, Hiroyuki; Hayashi, Takao; Matuura, Tetuo; Kuroiwa, Masanori; Morita, Keiichi; Ishigami, Masatoshi; Goto, Hidemi			Hepatitis C virus NS5A polymorphisms in patients with HCV genotype 1B	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						HCV IFN NS5A			Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; Tosei Gen Hosp, Seto, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-452	203	203				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300498		
J	Shinohara, M; Koji, I; Michio, K; Wakui, N; Ikehara, T; Masao, S; Nagai, H; Watanabe, M; Igarashi, Y; Sumino, Y				Shinohara, Mie; Koji, Ishii; Michio, Kogame; Wakui, Noritaka; Ikehara, Takashi; Masao, Shinohara; Nagai, Hidenari; Watanabe, Manabu; Igarashi, Yoshihiro; Sumino, Yasukiyo			Serum levels of tyrosine decrease with sustained virological response in patients with chronic hepatitis C treated by interferon-based therapy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						chronic hepatitis C; BTR			Tokyo Kamata Med Ctr, Tokyo, Japan; Toho Univ, Med Ctr, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-453	203	204				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300499		
J	Suetsugu, A; Homma, K; Saji, S; Moriwaki, H; Osawa, Y; Ochiya, T; Hoffman, RM				Suetsugu, Atsushi; Homma, Kimi; Saji, Shigetoyo; Moriwaki, Hisataka; Osawa, Yosuke; Ochiya, Takahiro; Hoffman, Robert M.			Imaging exosome transfer from colon cancer cells to stroma at liver metastatic sites	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						pre-metastatic niche; exosomes; liver metastasis			Natl Canc Ctr, Tokyo, Japan; Gifu Univ, Grad Sch Med, Gifu, Japan; Univ Calif San Diego, San Diego, CA 92103 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-457	204	205				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300502		
J	Sugano, M; Matsuno, T				Sugano, Masahiko; Matsuno, Takako			Clinical chronic hepatitis C: device of individual medical treatment for over the age of 60, and the PEG-IFN alpha 2a low-dose therapy for carcinogenic prevention	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						chronic hepatitis c; peg-IFN alpha 2a; carcinogenic prevention			[Sugano, Masahiko; Matsuno, Takako] Sugano Internal Med Clin, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-458	205	205				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300503		
J	Taira, J; Andou, M; Sano, T; Imai, Y; Moriyasu, F				Taira, Junichi; Andou, Mayumi; Sano, Takatomo; Imai, Yasuharu; Moriyasu, Fuminori			Usefulness of shearwave elastography for the evaluation of acute hepatitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						SWE ShearWave Elastography; acute hepatitis			[Taira, Junichi; Andou, Mayumi; Sano, Takatomo; Imai, Yasuharu; Moriyasu, Fuminori] Tokyo Med Univ, Tokyo 1608402, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-463	206	207				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300508		
J	Yoshizaki, M; Hayashi, K; Mori, H; Toriyama, K; Furune, S; Takenaka, H; Matuura, T; Shimizu, Y; Hayashi, T; Kuroiwa, M; Morita, K; Ishigami, M; Goto, H				Yoshizaki, Michiyo; Hayashi, Kazuhiko; Mori, Hiroshi; Toriyama, Kazuhiro; Furune, Satoshi; Takenaka, Hiroyuki; Matuura, Tetuo; Shimizu, Yuko; Hayashi, Takao; Kuroiwa, Masanori; Morita, Keiichi; Ishigami, Masatoshi; Goto, Hidemi			Polymorphism in the NS3 region in patients with hepatitis C virus genotype 1B and response to telaprevir or simeprevir plus pegylated-interferon-alpha 2b and ribavirin combination therapy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						HCV IFN NS3			Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; Tosei Gen Hosp, Seto, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-476	210	210				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300519		
J	Harima, H; Kaino, S; Shinoda, S; Kawano, M; Suenaga, S; Sakaida, I				Harima, Hirofumi; Kaino, Seiji; Shinoda, Shuhei; Kawano, Michitaka; Suenaga, Shigeyuki; Sakaida, Isao			Role of contrast-enhanced endoscopic ultrasonography in the differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						contrast-enhanced endoscopic ultrasonography; branch duct intraductal papillary mucinous neoplasm			[Harima, Hirofumi; Kaino, Seiji; Shinoda, Shuhei; Kawano, Michitaka; Suenaga, Shigeyuki; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-481	212	212				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300523		
J	Hijioka, S; Mizuno, N; Hara, K; Imaoka, H; Yamao, K				Hijioka, Susumu; Mizuno, Nobumasa; Hara, Kazuo; Imaoka, Hiroshi; Yamao, Kenji			Is the WHO 2010 classification system of pancreatic neuroendocrine neoplasms sufficient to clearly characterize pancreatic neuroendocrine carcinomas?	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						NEC; WHO; NET; NEN			[Hijioka, Susumu; Mizuno, Nobumasa; Hara, Kazuo; Imaoka, Hiroshi; Yamao, Kenji] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-483	213	213				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300525		
J	Hirose, K; Iwao, T; Tada, Y; Kyosaka, T				Hirose, Katsuya; Iwao, Toshiyasu; Tada, Yamato; Kyosaka, Tomoki			A case of carcinoma in situ of the pancreas discovered by abdominal ultrasonography	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						carcinoma in situ; pancreas; cytological examination			[Hirose, Katsuya; Iwao, Toshiyasu; Tada, Yamato; Kyosaka, Tomoki] Aidu Chuo Hosp, Fukushima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-484	213	213				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300526		
J	Hori, Y; Miyabe, K; Yoshida, M; Nakazawa, T; Hayashi, K; Naitoh, I; Shimizu, S; Kondo, H; Nishi, Y; Umemura, S; Ohara, H; Joh, T				Hori, Yasuki; Miyabe, Katsuyuki; Yoshida, Michihiro; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Umemura, Shuichiro; Ohara, Hirotaka; Joh, Takashi			Tp53 codon 72 and MDM2 SNP309 polymorphisms in pancreatic cancer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						single-nucleotide polymorphisms; TP53; mouse double minute 2; pancreatic cancer			[Hori, Yasuki; Miyabe, Katsuyuki; Yoshida, Michihiro; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Umemura, Shuichiro; Ohara, Hirotaka; Joh, Takashi] Nagoya City Univ Hosp, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-485	213	214				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300527		
J	Ito, K; Okano, N; Mimura, T; Hara, S; Takuma, K; Kishimoto, Y; Ohba, N; Shuta, N; Kojima, T; Igarashi, Y				Ito, Ken; Okano, Naoki; Mimura, Takahiko; Hara, Seiichi; Takuma, Kensuke; Kishimoto, Yui; Ohba, Nobuyuki; Shuta, Nishinakagawa; Kojima, Tatsuya; Igarashi, Yoshinori			Efficacy and long-term clinical results of endoscopic pancreatic stenting with chronic pancreatitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						Endoscopic Pancreatic Stenting long term results chronic pancreatitis			Toho Omori Med Ctr, Tokyo, Japan; Tokyo Rosai Occupat Dis & Injuries Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-487	214	215				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300529		
J	Iwasaki, E; Yamagishi, Y; Kawasaki, S; Seino, T; Matsuchita, M; Higuchi, H; Matsuzaki, J; Hosoe, N; Kashiwagi, K; Naganuma, M; Suzuki, H; Kanai, T; Ogata, H				Iwasaki, Eisuke; Yamagishi, Yoshiyuki; Kawasaki, Shintaro; Seino, Takashi; Matsuchita, Misako; Higuchi, Hajime; Matsuzaki, Juntaro; Hosoe, Naoki; Kashiwagi, Kazuhiro; Naganuma, Makoto; Suzuki, Hidekazu; Kanai, Takanori; Ogata, Haruhiko			Endoscopic transluminal drainage and necrosectomy for walled off pancreatic necrosis after severe necrotizing pancreatitis: report of 3 cases	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						necrosectomy; WOPN			Keio Univ, Sch Med, Tokyo 108, Japan; Kitasato Univ, Kitasato Inst Hosp, Tokyo, Japan			Suzuki, Hidekazu/J-4396-2013					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-488	215	215				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300530		
J	Kanai, R; Kameyama, S; Hara, T; Motonari, H; Taniguchi, H; Hori, Y; Arakaki, J; Ishimine, T; Kohagura, F; Nagamine, Y; Isa, T; Kobashikawa, K				Kanai, Risa; Kameyama, Shinichiro; Hara, Tetsuhiro; Motonari, Haruka; Taniguchi, Haruki; Hori, Yoshiki; Arakaki, Junya; Ishimine, Tomonari; Kohagura, Fumiko; Nagamine, Yoshitetsu; Isa, Tsutomu; Kobashikawa, Kasen			A benign pancreatic tumor adjacent to splenic artery aneurysm masquerading a pancreatic carcinoma	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						pancreatic tumor; splenic artery aneurysm			[Kanai, Risa; Kameyama, Shinichiro; Hara, Tetsuhiro; Motonari, Haruka; Taniguchi, Haruki; Hori, Yoshiki; Arakaki, Junya; Ishimine, Tomonari; Kohagura, Fumiko; Nagamine, Yoshitetsu; Isa, Tsutomu; Kobashikawa, Kasen] Urasoe Gen Hosp, Urasoe, Okinawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-489	215	216				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300531		
J	Kato, A; Naiki-Ito, A; Nakazawa, T; Hayashi, K; Naitoh, I; Miyabe, K; Shimizu, S; Kondo, H; Nishi, Y; Umemura, S; Hori, Y; Ohara, H; Takahashi, S; Joh, T				Kato, Akihisa; Naiki-Ito, Aya; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Miyabe, Katsuyuki; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Umemura, Shuichiro; Hori, Yasuki; Ohara, Hirotaka; Takahashi, Satoru; Joh, Takashi			Effects of resveratrol and apocynin on pancreatic carcinogenesis in hamsters	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						pancreatic cancer; animal model			[Kato, Akihisa; Naiki-Ito, Aya; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Miyabe, Katsuyuki; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Umemura, Shuichiro; Hori, Yasuki; Ohara, Hirotaka; Takahashi, Satoru; Joh, Takashi] Nagoya City Univ, Grad Sch, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-490	216	216				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300532		
J	Kubo, A; Ishida, E; Yamamoto, H; Noda, T; Arasawa, S; Izuta, M; Ogawa, C; Matsunaka, T; Tamaki, H; Shibatoge, M				Kubo, Atsushi; Ishida, Etsuji; Yamamoto, Hiroshi; Noda, Teruyo; Arasawa, Soichi; Izuta, Masako; Ogawa, Chikara; Matsunaka, Toshihiro; Tamaki, Hiroyuki; Shibatoge, Mitsushige			Follow up of main duct intraductal papillary mucinous neoplasms of the pancreas	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						IPMN			Kurashiki Cent Hosp, Kurashiki, Okayama, Japan; Takamatsu Red Cross Hosp, Takamatsu, Kagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-494	217	218				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300535		
J	Kyosaka, T; Iwao, T; Tada, Y; Hirose, K				Kyosaka, Tomoki; Iwao, Toshiyasu; Tada, Yamato; Hirose, Katsuya			A case with which we followed up for 15 years from the occurrence to the growth of invasive ductal carcinoma of the pancreas	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						growth; pancreas; carcinoma in situ			[Kyosaka, Tomoki; Iwao, Toshiyasu; Tada, Yamato; Hirose, Katsuya] Aidu Chuo Hosp, Fukushima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-495	218	218				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300536		
J	Maruyama, M; Watanabe, T; Kanai, K; Oguchi, T; Asano, J; Ito, T; Ozaki, Y; Muraki, T; Hamano, H; Arakura, N; Kawa, S				Maruyama, Masahiro; Watanabe, Takayuki; Kanai, Keita; Oguchi, Takaya; Asano, Jumpei; Ito, Tetsuya; Ozaki, Yayoi; Muraki, Takashi; Hamano, Hideaki; Arakura, Norikazu; Kawa, Shigeyuki			ESWL treatment of pancreatic stones complicated with advanced stage autoimmune pancreatitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						autoimmune pancreatitis; chronic pancreatitis; pancreatic stone; pancreatic calcification; ESWL			[Maruyama, Masahiro; Watanabe, Takayuki; Kanai, Keita; Oguchi, Takaya; Asano, Jumpei; Ito, Tetsuya; Ozaki, Yayoi; Muraki, Takashi; Hamano, Hideaki; Arakura, Norikazu; Kawa, Shigeyuki] Shinshu Univ, Sch Med, Matsumoto, Nagano, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-497	219	219				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300538		
J	Ohno, E; Hirooka, Y; Kawashima, H; Sugimoto, H; Sumi, H; Hayashi, D; Kuwahara, T; Morishima, H; Kawai, M; Suhara, H; Furukawa, K; Funasaka, K; Masanao, N; Miyahara, R; Goto, H				Ohno, Eizaburo; Hirooka, Yoshiki; Kawashima, Hiroki; Sugimoto, Hiroyuki; Sumi, Hajime; Hayashi, Daijyuro; Kuwahara, Takamichi; Morishima, Hiromasa; Kawai, Manabu; Suhara, Hiroki; Furukawa, Kazuhiro; Funasaka, Kohei; Masanao, Nakamura; Miyahara, Ryoji; Goto, Hidemi			Natural history of IPMNs of the pancreas, based on international consensus guidelines 2012 for IPMN/MCN	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Meeting Abstract						IPMN; EUS; guideline			Nagoya Univ Hosp, Nagoya, Aichi, Japan; Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan			KAWASHIMA, Hiroki/I-7285-2014					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	NOV	2014	29			3	SI	P-499	219	219				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT8TR	WOS:000345205300539		
